program_id,submitter_donor_id,submitter_treatment_id,immunotherapy_type,drug_name,drug_reference_identifier,drug_reference_database,immunotherapy_drug_dose_units,prescribed_cumulative_drug_dose,actual_cumulative_drug_dose
SYNTHETIC-5,DONOR_2001,TREATMENT_8001,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,mg/kg,137.0,103.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8002,,,278936,PubChem,cells/kg,,180.0
SYNTHETIC-5,DONOR_2003,TREATMENT_8003,Immune checkpoint inhibitors,Yervoy,987654,NCI Thesaurus,mg/m2,,183.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8004,Cell-based,,278936,NCI Thesaurus,IU/kg,53.0,
SYNTHETIC-5,DONOR_2005,TREATMENT_8005,Immune checkpoint inhibitors,Gilotrif,987654,RxNorm,,184.0,129.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8006,Other immunomodulatory substances,Pexidartinib,987654,,IU/m2,177.0,88.0
SYNTHETIC-5,DONOR_2007,TREATMENT_8007,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,,PubChem,mg/m2,112.0,
SYNTHETIC-5,DONOR_2008,TREATMENT_8008,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,987654,,g/m2,124.0,103.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8009,Cell-based,Ribociclib,,PubChem,IU/m2,,146.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8010,Immune checkpoint inhibitors,Brentuximab vedotin,8756456,RxNorm,IU/m2,171.0,88.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8011,Cell-based,,8756456,PubChem,cells/kg,165.0,67.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8012,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,,,IU/kg,67.0,177.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8013,,Belantamab,,NCI Thesaurus,,164.0,81.0
SYNTHETIC-5,DONOR_2014,TREATMENT_8014,Other immunomodulatory substances,Venclexta,239766,NCI Thesaurus,mg/kg,,130.0
SYNTHETIC-5,DONOR_2015,TREATMENT_8015,Immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,mg/kg,135.0,81.0
SYNTHETIC-5,DONOR_2016,TREATMENT_8016,Immune checkpoint inhibitors,Kisqali,,NCI Thesaurus,ug/m2,122.0,121.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8017,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,RxNorm,cells/kg,,165.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8018,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,RxNorm,mg/kg,108.0,121.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8019,Other immunomodulatory substances,Braftovi,8836851,NCI Thesaurus,ug/m2,,142.0
SYNTHETIC-5,DONOR_2020,TREATMENT_8020,Other immunomodulatory substances,Niraparib,,RxNorm,,172.0,130.0
SYNTHETIC-5,DONOR_2021,TREATMENT_8021,Immune checkpoint inhibitors,Cobimetinib,4459876,RxNorm,IU/m2,133.0,96.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8022,Other immunomodulatory substances,,4459876,NCI Thesaurus,cells/kg,164.0,77.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8023,Cell-based,Braftovi,8756456,NCI Thesaurus,IU/kg,136.0,
SYNTHETIC-5,DONOR_2024,TREATMENT_8024,Immune checkpoint inhibitors,Enhertu,,PubChem,mg/m2,126.0,
SYNTHETIC-5,DONOR_2025,TREATMENT_8025,Cell-based,Zykadia,,NCI Thesaurus,,,183.0
SYNTHETIC-5,DONOR_2026,TREATMENT_8026,Immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,,190.0,
SYNTHETIC-5,DONOR_2027,TREATMENT_8027,Other immunomodulatory substances,Nivolumab,278936,,mg/kg,121.0,
SYNTHETIC-5,DONOR_2028,TREATMENT_8028,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,RxNorm,g/m2,132.0,112.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8029,,Herceptin,239766,PubChem,ug/m2,114.0,82.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8030,Other immunomodulatory substances,,8756456,,cells/kg,199.0,125.0
SYNTHETIC-5,DONOR_2031,TREATMENT_8031,Other immunomodulatory substances,,8756456,NCI Thesaurus,IU/m2,68.0,93.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8032,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,NCI Thesaurus,IU/m2,,192.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8033,Cell-based,Pembrolizumab,8836851,,cells/kg,144.0,193.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8034,Other immunomodulatory substances,Nexavar,,RxNorm,mg/m2,167.0,183.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8035,Cell-based,Tecentriq,987654,NCI Thesaurus,,170.0,65.0
SYNTHETIC-5,DONOR_2036,TREATMENT_8036,Immune checkpoint inhibitors,Brentuximab vedotin,,RxNorm,IU/kg,93.0,88.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8037,,Rituximab,8836851,PubChem,mg/kg,134.0,
SYNTHETIC-5,DONOR_2038,TREATMENT_8038,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,NCI Thesaurus,IU/kg,,190.0
SYNTHETIC-5,DONOR_2039,TREATMENT_8039,Other immunomodulatory substances,Darzalex,987654,NCI Thesaurus,ug/m2,57.0,
SYNTHETIC-5,DONOR_2040,TREATMENT_8040,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,8836851,RxNorm,mg/m2,,117.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8041,Other immunomodulatory substances,Gefitinib,8836851,PubChem,mg/kg,88.0,136.0
SYNTHETIC-5,DONOR_2042,TREATMENT_8042,,Nivolumab,4459876,RxNorm,mg/kg,155.0,87.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8043,,Verzenio,8756456,,IU/m2,83.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_8044,Immune checkpoint inhibitors,Cometriq,,RxNorm,g/m2,68.0,183.0
SYNTHETIC-5,DONOR_2045,TREATMENT_8045,Immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,ug/m2,71.0,127.0
SYNTHETIC-5,DONOR_2046,TREATMENT_8046,Immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/m2,,
SYNTHETIC-5,DONOR_2047,TREATMENT_8047,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,RxNorm,IU/kg,68.0,60.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8048,Cell-based,Ceritinib,,PubChem,g/m2,103.0,61.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8049,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,NCI Thesaurus,IU/kg,145.0,
SYNTHETIC-5,DONOR_2050,TREATMENT_8050,Immune checkpoint inhibitors,,278936,NCI Thesaurus,IU/m2,124.0,161.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8051,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,,PubChem,ug/m2,64.0,133.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8052,Other immunomodulatory substances,Abemaciclib,8836851,NCI Thesaurus,g/m2,162.0,
SYNTHETIC-5,DONOR_2053,TREATMENT_8053,Immune checkpoint inhibitors,Atezolizumab,987654,PubChem,ug/m2,,182.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8054,Immune checkpoint inhibitors,Inotuzumab ozogamicin,239766,PubChem,IU/kg,146.0,155.0
SYNTHETIC-5,DONOR_2055,TREATMENT_8055,Cell-based,Alectinib,278936,RxNorm,g/m2,155.0,126.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8056,Cell-based,,278936,RxNorm,ug/m2,,127.0
SYNTHETIC-5,DONOR_2057,TREATMENT_8057,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,PubChem,,161.0,115.0
SYNTHETIC-5,DONOR_2058,TREATMENT_8058,Immune checkpoint inhibitors,Perjeta,987654,RxNorm,ug/m2,124.0,139.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8059,Immune checkpoint inhibitors,Cometriq,8836851,PubChem,cells/kg,193.0,
SYNTHETIC-5,DONOR_2060,TREATMENT_8060,Cell-based,Kymriah,,NCI Thesaurus,,128.0,
SYNTHETIC-5,DONOR_2061,TREATMENT_8061,Other immunomodulatory substances,Opdivo,987654,,cells/kg,106.0,164.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8062,Immune checkpoint inhibitors,Kymriah,987654,NCI Thesaurus,ug/m2,108.0,
SYNTHETIC-5,DONOR_2063,TREATMENT_8063,Other immunomodulatory substances,Yervoy,278936,NCI Thesaurus,ug/m2,141.0,114.0
SYNTHETIC-5,DONOR_2064,TREATMENT_8064,,,8756456,NCI Thesaurus,mg/kg,90.0,
SYNTHETIC-5,DONOR_2065,TREATMENT_8065,Other immunomodulatory substances,Tecentriq,278936,PubChem,,173.0,
SYNTHETIC-5,DONOR_2066,TREATMENT_8066,Other immunomodulatory substances,Tecentriq,239766,PubChem,mg/m2,135.0,75.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8067,Other immunomodulatory substances,,278936,PubChem,mg/m2,197.0,99.0
SYNTHETIC-5,DONOR_2068,TREATMENT_8068,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,RxNorm,IU/kg,190.0,
SYNTHETIC-5,DONOR_2069,TREATMENT_8069,Other immunomodulatory substances,,,RxNorm,,59.0,200.0
SYNTHETIC-5,DONOR_2070,TREATMENT_8070,,,4459876,RxNorm,ug/m2,186.0,197.0
SYNTHETIC-5,DONOR_2071,TREATMENT_8071,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,4459876,PubChem,mg/m2,135.0,77.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8072,Other immunomodulatory substances,Pembrolizumab,987654,NCI Thesaurus,cells/kg,140.0,144.0
SYNTHETIC-5,DONOR_2073,TREATMENT_8073,Cell-based,,4459876,PubChem,cells/kg,,
SYNTHETIC-5,DONOR_2074,TREATMENT_8074,Cell-based,Atezolizumab,8756456,NCI Thesaurus,mg/kg,99.0,70.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8075,Cell-based,Yervoy,8756456,NCI Thesaurus,,52.0,134.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8076,Other immunomodulatory substances,Brentuximab vedotin,239766,NCI Thesaurus,,,111.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8077,Other immunomodulatory substances,Opdivo,8836851,PubChem,mg/kg,96.0,88.0
SYNTHETIC-5,DONOR_2078,TREATMENT_8078,Other immunomodulatory substances,Vemurafenib,278936,NCI Thesaurus,mg/kg,118.0,150.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8079,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,4459876,NCI Thesaurus,,121.0,124.0
SYNTHETIC-5,DONOR_2080,TREATMENT_8080,,Venetoclax,278936,PubChem,cells/kg,151.0,
SYNTHETIC-5,DONOR_2081,TREATMENT_8081,Other immunomodulatory substances,,8756456,PubChem,IU/m2,95.0,67.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8082,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,mg/kg,92.0,
SYNTHETIC-5,DONOR_2083,TREATMENT_8083,Other immunomodulatory substances,Besponsa,239766,RxNorm,IU/kg,73.0,
SYNTHETIC-5,DONOR_2084,TREATMENT_8084,Cell-based,Alectinib,4459876,PubChem,,138.0,
SYNTHETIC-5,DONOR_2085,TREATMENT_8085,Cell-based,Keytruda,4459876,PubChem,mg/m2,91.0,106.0
SYNTHETIC-5,DONOR_2086,TREATMENT_8086,Immune checkpoint inhibitors,Obinutuzumab,239766,RxNorm,mg/m2,,193.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8087,Other immunomodulatory substances,Tarceva,239766,NCI Thesaurus,mg/m2,123.0,148.0
SYNTHETIC-5,DONOR_2088,TREATMENT_8088,,Gefitinib,,RxNorm,ug/m2,55.0,108.0
SYNTHETIC-5,DONOR_2089,TREATMENT_8089,Cell-based,,8756456,PubChem,mg/kg,,149.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8090,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,,,80.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8091,,Iressa,278936,RxNorm,cells/kg,,71.0
SYNTHETIC-5,DONOR_2092,TREATMENT_8092,,Rucaparib,987654,NCI Thesaurus,ug/m2,76.0,197.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8093,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,,PubChem,g/m2,52.0,
SYNTHETIC-5,DONOR_2094,TREATMENT_8094,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,,159.0,
SYNTHETIC-5,DONOR_2095,TREATMENT_8095,Immune checkpoint inhibitors,Rucaparib,278936,RxNorm,ug/m2,179.0,123.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8096,Immune checkpoint inhibitors,Gazyva,8836851,NCI Thesaurus,mg/kg,110.0,129.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8097,Cell-based,Tecentriq,987654,PubChem,ug/m2,,108.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8098,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,NCI Thesaurus,cells/kg,,132.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8099,,Yervoy,,NCI Thesaurus,,182.0,162.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8100,,Nivolumab,8756456,RxNorm,mg/m2,177.0,
SYNTHETIC-5,DONOR_2101,TREATMENT_8101,Other immunomodulatory substances,Gilotrif,4459876,NCI Thesaurus,IU/kg,176.0,116.0
SYNTHETIC-5,DONOR_2102,TREATMENT_8102,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,PubChem,ug/m2,52.0,91.0
SYNTHETIC-5,DONOR_2103,TREATMENT_8103,Cell-based,Gazyva,,PubChem,,50.0,127.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8104,Other immunomodulatory substances,Darzalex,987654,,g/m2,139.0,140.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8105,Cell-based,Atezolizumab,4459876,RxNorm,mg/kg,132.0,90.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8106,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,278936,RxNorm,ug/m2,69.0,182.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8107,Cell-based,Mekinist,8756456,,ug/m2,163.0,144.0
SYNTHETIC-5,DONOR_2108,TREATMENT_8108,,,,,IU/m2,195.0,76.0
SYNTHETIC-5,DONOR_2109,TREATMENT_8109,,Ado-trastuzumab emtansine,239766,NCI Thesaurus,IU/m2,74.0,70.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8110,,,239766,,g/m2,54.0,127.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8111,Cell-based,Durvalumab,8836851,NCI Thesaurus,ug/m2,145.0,198.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8112,,Iressa,239766,NCI Thesaurus,cells/kg,,152.0
SYNTHETIC-5,DONOR_2113,TREATMENT_8113,Other immunomodulatory substances,Lenvatinib,,PubChem,mg/m2,53.0,77.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8114,,Pembrolizumab,239766,PubChem,IU/m2,160.0,119.0
SYNTHETIC-5,DONOR_2115,TREATMENT_8115,Cell-based,Venclexta,278936,PubChem,,130.0,145.0
SYNTHETIC-5,DONOR_2116,TREATMENT_8116,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8756456,RxNorm,mg/kg,171.0,
SYNTHETIC-5,DONOR_2117,TREATMENT_8117,Immune checkpoint inhibitors,,278936,RxNorm,,180.0,138.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8118,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,239766,NCI Thesaurus,IU/m2,170.0,57.0
SYNTHETIC-5,DONOR_2119,TREATMENT_8119,Immune checkpoint inhibitors,Trastuzumab,,RxNorm,ug/m2,187.0,140.0
SYNTHETIC-5,DONOR_2120,TREATMENT_8120,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,278936,,mg/m2,128.0,87.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8121,Cell-based,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,IU/m2,85.0,151.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8122,,Ibrance,8756456,NCI Thesaurus,ug/m2,172.0,130.0
SYNTHETIC-5,DONOR_2123,TREATMENT_8123,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8836851,NCI Thesaurus,mg/m2,,200.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8124,Other immunomodulatory substances,Encorafenib,239766,PubChem,ug/m2,,167.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8125,Cell-based,Keytruda,987654,,,,115.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8126,Other immunomodulatory substances,,239766,NCI Thesaurus,cells/kg,111.0,153.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8127,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/kg,63.0,106.0
SYNTHETIC-5,DONOR_2128,TREATMENT_8128,Immune checkpoint inhibitors,Nivolumab,239766,PubChem,g/m2,70.0,
SYNTHETIC-5,DONOR_2129,TREATMENT_8129,Other immunomodulatory substances,Ibrance,278936,RxNorm,IU/kg,131.0,
SYNTHETIC-5,DONOR_2130,TREATMENT_8130,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,,114.0,195.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8131,Other immunomodulatory substances,Zykadia,,NCI Thesaurus,ug/m2,90.0,85.0
SYNTHETIC-5,DONOR_2132,TREATMENT_8132,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,cells/kg,168.0,131.0
SYNTHETIC-5,DONOR_2133,TREATMENT_8133,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,RxNorm,ug/m2,92.0,100.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8134,Other immunomodulatory substances,Pembrolizumab,8836851,RxNorm,,153.0,53.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8135,,Venclexta,239766,RxNorm,cells/kg,115.0,124.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8136,Cell-based,Ipilimumab,278936,NCI Thesaurus,,169.0,
SYNTHETIC-5,DONOR_2137,TREATMENT_8137,Cell-based,Cotellic,4459876,PubChem,mg/kg,78.0,
SYNTHETIC-5,DONOR_2138,TREATMENT_8138,Immune checkpoint inhibitors,Perjeta,239766,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2139,TREATMENT_8139,Immune checkpoint inhibitors,Darzalex,278936,PubChem,,186.0,76.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8140,Immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,cells/kg,70.0,190.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8141,Other immunomodulatory substances,Niraparib,,NCI Thesaurus,g/m2,168.0,96.0
SYNTHETIC-5,DONOR_2142,TREATMENT_8142,Immune checkpoint inhibitors,Pembrolizumab,8836851,RxNorm,IU/m2,185.0,
SYNTHETIC-5,DONOR_2143,TREATMENT_8143,Other immunomodulatory substances,Ribociclib,8836851,,,53.0,59.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8144,Cell-based,Trastuzumab,,PubChem,IU/m2,178.0,107.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8145,Other immunomodulatory substances,Necitumumab,987654,NCI Thesaurus,g/m2,,144.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8146,Cell-based,Venetoclax,239766,NCI Thesaurus,g/m2,167.0,183.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8147,Other immunomodulatory substances,Palbociclib,4459876,,mg/kg,177.0,92.0
SYNTHETIC-5,DONOR_2148,TREATMENT_8148,Immune checkpoint inhibitors,,239766,,,146.0,106.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8149,,Sorafenib,239766,PubChem,mg/m2,,69.0
SYNTHETIC-5,DONOR_2150,TREATMENT_8150,,Yervoy,987654,NCI Thesaurus,g/m2,163.0,166.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8151,Other immunomodulatory substances,Pexidartinib,239766,NCI Thesaurus,IU/kg,78.0,186.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8152,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,,,g/m2,83.0,146.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8153,Cell-based,Lenvatinib,8836851,NCI Thesaurus,cells/kg,69.0,65.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8154,Other immunomodulatory substances,Adcetris,,RxNorm,,131.0,184.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8155,Other immunomodulatory substances,,4459876,PubChem,,144.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_8156,Immune checkpoint inhibitors,Gazyva,987654,RxNorm,g/m2,,150.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8157,Cell-based,Pembrolizumab,8756456,NCI Thesaurus,cells/kg,130.0,91.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8158,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,IU/kg,172.0,
SYNTHETIC-5,DONOR_2159,TREATMENT_8159,Immune checkpoint inhibitors,Osimertinib,8756456,RxNorm,cells/kg,155.0,69.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8160,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,239766,PubChem,,84.0,105.0
SYNTHETIC-5,DONOR_2161,TREATMENT_8161,,Nivolumab,4459876,,mg/m2,145.0,142.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8162,,Afatinib,8836851,,g/m2,181.0,58.0
SYNTHETIC-5,DONOR_2163,TREATMENT_8163,Other immunomodulatory substances,Rituximab,239766,RxNorm,IU/kg,,176.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8164,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,,,mg/kg,63.0,104.0
SYNTHETIC-5,DONOR_2165,TREATMENT_8165,Immune checkpoint inhibitors,Necitumumab,987654,NCI Thesaurus,mg/kg,151.0,133.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8166,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,987654,PubChem,,78.0,174.0
SYNTHETIC-5,DONOR_2167,TREATMENT_8167,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,,
SYNTHETIC-5,DONOR_2168,TREATMENT_8168,Cell-based,Tecentriq,4459876,RxNorm,mg/kg,,92.0
SYNTHETIC-5,DONOR_2169,TREATMENT_8169,,Tecentriq,4459876,PubChem,,112.0,
SYNTHETIC-5,DONOR_2170,TREATMENT_8170,Other immunomodulatory substances,Venetoclax,239766,NCI Thesaurus,g/m2,,78.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8171,,Keytruda,,RxNorm,g/m2,85.0,80.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8172,Cell-based,Rituxan,8836851,RxNorm,mg/m2,128.0,164.0
SYNTHETIC-5,DONOR_2173,TREATMENT_8173,,Pembrolizumab,239766,PubChem,IU/m2,128.0,174.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8174,Other immunomodulatory substances,Cobimetinib,,RxNorm,ug/m2,111.0,124.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8175,,Opdivo,278936,NCI Thesaurus,mg/m2,115.0,99.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8176,Immune checkpoint inhibitors,Olaparib,,RxNorm,IU/kg,115.0,105.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8177,Immune checkpoint inhibitors,Durvalumab,8836851,NCI Thesaurus,g/m2,93.0,110.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8178,Other immunomodulatory substances,Yervoy,239766,NCI Thesaurus,cells/kg,114.0,175.0
SYNTHETIC-5,DONOR_2179,TREATMENT_8179,Other immunomodulatory substances,Yescarta,,RxNorm,IU/m2,158.0,85.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8180,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,,g/m2,109.0,75.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8181,Immune checkpoint inhibitors,Olaparib,8836851,PubChem,,,177.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8182,Cell-based,Xalkori,239766,NCI Thesaurus,cells/kg,,165.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8183,,Rituxan,278936,,cells/kg,68.0,170.0
SYNTHETIC-5,DONOR_2184,TREATMENT_8184,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,4459876,RxNorm,IU/kg,166.0,68.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8185,Other immunomodulatory substances,Venclexta,278936,RxNorm,IU/m2,88.0,87.0
SYNTHETIC-5,DONOR_2186,TREATMENT_8186,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,mg/m2,79.0,172.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8187,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,4459876,NCI Thesaurus,ug/m2,140.0,195.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8188,Cell-based,Nivolumab,,NCI Thesaurus,mg/m2,,80.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8189,Immune checkpoint inhibitors,Atezolizumab,,PubChem,,200.0,82.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8190,Cell-based,Ipilimumab,4459876,PubChem,cells/kg,163.0,187.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8191,Immune checkpoint inhibitors,Daratumumab,8756456,NCI Thesaurus,IU/kg,109.0,52.0
SYNTHETIC-5,DONOR_2192,TREATMENT_8192,Immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,,173.0,157.0
SYNTHETIC-5,DONOR_2193,TREATMENT_8193,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,239766,PubChem,cells/kg,162.0,
SYNTHETIC-5,DONOR_2194,TREATMENT_8194,,Daratumumab,,RxNorm,IU/m2,,141.0
SYNTHETIC-5,DONOR_2195,TREATMENT_8195,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,NCI Thesaurus,mg/kg,112.0,
SYNTHETIC-5,DONOR_2196,TREATMENT_8196,Immune checkpoint inhibitors,Inotuzumab ozogamicin,,RxNorm,mg/kg,125.0,136.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8197,,Verzenio,278936,NCI Thesaurus,g/m2,147.0,153.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8198,Other immunomodulatory substances,Cabozantinib,,NCI Thesaurus,,160.0,97.0
SYNTHETIC-5,DONOR_2199,TREATMENT_8199,Cell-based,Gazyva,239766,NCI Thesaurus,mg/kg,149.0,152.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8200,Cell-based,Gefitinib,987654,NCI Thesaurus,cells/kg,72.0,81.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8201,Other immunomodulatory substances,Ado-trastuzumab emtansine,8756456,PubChem,mg/kg,,154.0
SYNTHETIC-5,DONOR_2202,TREATMENT_8202,Immune checkpoint inhibitors,Atezolizumab,987654,RxNorm,,,96.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8203,Cell-based,Sorafenib,8756456,RxNorm,IU/m2,86.0,
SYNTHETIC-5,DONOR_2204,TREATMENT_8204,,Vandetanib,4459876,RxNorm,mg/m2,196.0,
SYNTHETIC-5,DONOR_2205,TREATMENT_8205,Immune checkpoint inhibitors,,278936,PubChem,,,110.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8206,,,8756456,RxNorm,mg/kg,144.0,134.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8207,,Zelboraf,8756456,PubChem,,112.0,118.0
SYNTHETIC-5,DONOR_2208,TREATMENT_8208,Other immunomodulatory substances,Gazyva,8836851,RxNorm,mg/kg,85.0,78.0
SYNTHETIC-5,DONOR_2209,TREATMENT_8209,Other immunomodulatory substances,Tecentriq,,RxNorm,g/m2,190.0,126.0
SYNTHETIC-5,DONOR_2210,TREATMENT_8210,Immune checkpoint inhibitors,Belantamab,8836851,NCI Thesaurus,IU/kg,190.0,99.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8211,Immune checkpoint inhibitors,Gilotrif,8756456,PubChem,ug/m2,96.0,
SYNTHETIC-5,DONOR_2212,TREATMENT_8212,Cell-based,Sorafenib,278936,RxNorm,cells/kg,,76.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8213,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8756456,,cells/kg,100.0,
SYNTHETIC-5,DONOR_2214,TREATMENT_8214,Cell-based,Imfinzi,,PubChem,IU/kg,143.0,
SYNTHETIC-5,DONOR_2215,TREATMENT_8215,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,4459876,PubChem,,124.0,94.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8216,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,,NCI Thesaurus,IU/kg,125.0,88.0
SYNTHETIC-5,DONOR_2217,TREATMENT_8217,Immune checkpoint inhibitors,Yervoy,987654,,ug/m2,77.0,120.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8218,Immune checkpoint inhibitors,Opdivo,8756456,PubChem,IU/kg,135.0,138.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8219,Immune checkpoint inhibitors,Tecentriq,4459876,RxNorm,mg/m2,138.0,128.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8220,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,PubChem,IU/kg,,83.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8221,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,4459876,NCI Thesaurus,cells/kg,78.0,69.0
SYNTHETIC-5,DONOR_2222,TREATMENT_8222,Other immunomodulatory substances,Mektovi,8756456,RxNorm,mg/m2,63.0,198.0
SYNTHETIC-5,DONOR_2223,TREATMENT_8223,Immune checkpoint inhibitors,Tisagenlecleucel,278936,RxNorm,,150.0,172.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8224,,Durvalumab,239766,NCI Thesaurus,,156.0,54.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8225,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,NCI Thesaurus,mg/kg,161.0,182.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8226,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,987654,PubChem,IU/m2,80.0,
SYNTHETIC-5,DONOR_2227,TREATMENT_8227,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,4459876,RxNorm,mg/m2,109.0,151.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8228,Immune checkpoint inhibitors,Atezolizumab,8836851,,mg/kg,134.0,164.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8229,Immune checkpoint inhibitors,Rubraca,8756456,NCI Thesaurus,cells/kg,,127.0
SYNTHETIC-5,DONOR_2230,TREATMENT_8230,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,IU/kg,130.0,134.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8231,Cell-based,Kymriah,,NCI Thesaurus,IU/kg,169.0,64.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8232,Immune checkpoint inhibitors,Tagrisso,8836851,PubChem,ug/m2,171.0,
SYNTHETIC-5,DONOR_2233,TREATMENT_8233,Immune checkpoint inhibitors,Erlotinib,8836851,RxNorm,mg/kg,,
SYNTHETIC-5,DONOR_2234,TREATMENT_8234,Immune checkpoint inhibitors,Alunbrig,8836851,NCI Thesaurus,mg/m2,,
SYNTHETIC-5,DONOR_2235,TREATMENT_8235,Immune checkpoint inhibitors,Keytruda,239766,,,179.0,
SYNTHETIC-5,DONOR_2236,TREATMENT_8236,Immune checkpoint inhibitors,Zelboraf,8836851,NCI Thesaurus,mg/m2,111.0,54.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8237,Immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,g/m2,126.0,102.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8238,Cell-based,Pexidartinib,8836851,RxNorm,IU/m2,177.0,185.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8239,,Gazyva,,PubChem,cells/kg,104.0,183.0
SYNTHETIC-5,DONOR_2240,TREATMENT_8240,Other immunomodulatory substances,Obinutuzumab,987654,RxNorm,IU/m2,162.0,146.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8241,,Palbociclib,278936,RxNorm,cells/kg,159.0,77.0
SYNTHETIC-5,DONOR_2242,TREATMENT_8242,Other immunomodulatory substances,Pembrolizumab,239766,PubChem,cells/kg,155.0,108.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8243,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,,ug/m2,142.0,147.0
SYNTHETIC-5,DONOR_2244,TREATMENT_8244,Cell-based,Blinatumomab,239766,NCI Thesaurus,IU/m2,133.0,196.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8245,,Yervoy,278936,,g/m2,186.0,105.0
SYNTHETIC-5,DONOR_2246,TREATMENT_8246,Immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,IU/kg,140.0,166.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8247,Other immunomodulatory substances,Rucaparib,4459876,NCI Thesaurus,mg/kg,125.0,
SYNTHETIC-5,DONOR_2248,TREATMENT_8248,Immune checkpoint inhibitors,,278936,RxNorm,IU/kg,162.0,177.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8249,Cell-based,Darzalex,278936,RxNorm,,88.0,160.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8250,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,NCI Thesaurus,cells/kg,70.0,167.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8251,,Venetoclax,,,mg/kg,129.0,171.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8252,Immune checkpoint inhibitors,Lenvatinib,987654,NCI Thesaurus,mg/kg,,63.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8253,Other immunomodulatory substances,Olaparib,987654,RxNorm,,50.0,
SYNTHETIC-5,DONOR_2254,TREATMENT_8254,Cell-based,Rituxan,4459876,,IU/m2,178.0,64.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8255,Cell-based,Brigatinib,8756456,PubChem,g/m2,194.0,85.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8256,Other immunomodulatory substances,Kadcyla,239766,,cells/kg,75.0,
SYNTHETIC-5,DONOR_2257,TREATMENT_8257,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,,NCI Thesaurus,,199.0,140.0
SYNTHETIC-5,DONOR_2258,TREATMENT_8258,Immune checkpoint inhibitors,Opdivo,8836851,PubChem,g/m2,125.0,199.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8259,Cell-based,Zykadia,239766,PubChem,cells/kg,85.0,91.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8260,,Zejula,,,cells/kg,196.0,74.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8261,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,239766,,IU/kg,169.0,175.0
SYNTHETIC-5,DONOR_2262,TREATMENT_8262,Other immunomodulatory substances,Imfinzi,987654,RxNorm,IU/kg,,161.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8263,Cell-based,,8836851,RxNorm,ug/m2,55.0,
SYNTHETIC-5,DONOR_2264,TREATMENT_8264,,Ribociclib,239766,RxNorm,IU/m2,149.0,
SYNTHETIC-5,DONOR_2265,TREATMENT_8265,Immune checkpoint inhibitors,Imfinzi,987654,PubChem,,82.0,119.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8266,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,,,,80.0,161.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8267,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,,NCI Thesaurus,g/m2,175.0,61.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8268,Cell-based,Ipilimumab,8836851,PubChem,cells/kg,88.0,
SYNTHETIC-5,DONOR_2269,TREATMENT_8269,,,8756456,NCI Thesaurus,,151.0,85.0
SYNTHETIC-5,DONOR_2270,TREATMENT_8270,Immune checkpoint inhibitors,Gilteritinib,,PubChem,cells/kg,155.0,194.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8271,Immune checkpoint inhibitors,,,RxNorm,IU/m2,51.0,169.0
SYNTHETIC-5,DONOR_2272,TREATMENT_8272,Other immunomodulatory substances,Pexidartinib,278936,NCI Thesaurus,,51.0,165.0
SYNTHETIC-5,DONOR_2273,TREATMENT_8273,Immune checkpoint inhibitors,Lynparza,278936,PubChem,IU/kg,127.0,
SYNTHETIC-5,DONOR_2274,TREATMENT_8274,Immune checkpoint inhibitors,Ceritinib,8756456,RxNorm,ug/m2,131.0,
SYNTHETIC-5,DONOR_2275,TREATMENT_8275,Immune checkpoint inhibitors,,987654,,,,111.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8276,Other immunomodulatory substances,Keytruda,4459876,PubChem,,197.0,183.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8277,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,PubChem,IU/m2,88.0,105.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8278,Immune checkpoint inhibitors,Atezolizumab,8836851,PubChem,ug/m2,193.0,123.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8279,Other immunomodulatory substances,Yervoy,8756456,,,141.0,128.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8280,,Brentuximab vedotin,8756456,RxNorm,IU/m2,151.0,196.0
SYNTHETIC-5,DONOR_2281,TREATMENT_8281,Immune checkpoint inhibitors,,987654,RxNorm,g/m2,174.0,118.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8282,Cell-based,Rituximab,8836851,PubChem,g/m2,58.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_8283,Immune checkpoint inhibitors,Erlotinib,8756456,NCI Thesaurus,IU/m2,116.0,120.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8284,,Tecentriq,4459876,RxNorm,ug/m2,104.0,105.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8285,Cell-based,Zelboraf,987654,PubChem,IU/m2,154.0,
SYNTHETIC-5,DONOR_2286,TREATMENT_8286,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,IU/m2,146.0,154.0
SYNTHETIC-5,DONOR_2287,TREATMENT_8287,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,,NCI Thesaurus,cells/kg,138.0,54.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8288,Cell-based,Tecentriq,987654,NCI Thesaurus,,122.0,131.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8289,Cell-based,Tafinlar,,NCI Thesaurus,IU/m2,140.0,148.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8290,Immune checkpoint inhibitors,,4459876,RxNorm,IU/m2,151.0,153.0
SYNTHETIC-5,DONOR_2291,TREATMENT_8291,Immune checkpoint inhibitors,Besponsa,278936,PubChem,ug/m2,144.0,
SYNTHETIC-5,DONOR_2292,TREATMENT_8292,Cell-based,Tecentriq,987654,PubChem,IU/kg,132.0,57.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8293,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8836851,NCI Thesaurus,IU/kg,182.0,177.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8294,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,PubChem,g/m2,,
SYNTHETIC-5,DONOR_2295,TREATMENT_8295,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,,mg/kg,144.0,55.0
SYNTHETIC-5,DONOR_2296,TREATMENT_8296,Cell-based,Trametinib,987654,NCI Thesaurus,,141.0,187.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8297,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8836851,NCI Thesaurus,mg/m2,131.0,65.0
SYNTHETIC-5,DONOR_2298,TREATMENT_8298,Immune checkpoint inhibitors,,,PubChem,g/m2,72.0,122.0
SYNTHETIC-5,DONOR_2299,TREATMENT_8299,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,PubChem,,164.0,98.0
SYNTHETIC-5,DONOR_2300,TREATMENT_8300,Other immunomodulatory substances,Yervoy,278936,NCI Thesaurus,cells/kg,130.0,168.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8301,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,8756456,,cells/kg,87.0,116.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8302,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,239766,NCI Thesaurus,mg/kg,105.0,169.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8303,Immune checkpoint inhibitors,,8836851,RxNorm,IU/kg,116.0,90.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8304,Immune checkpoint inhibitors,Zejula,987654,PubChem,IU/m2,157.0,77.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8305,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8756456,PubChem,ug/m2,196.0,182.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8306,Other immunomodulatory substances,Tecentriq,8836851,PubChem,g/m2,,161.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8307,Cell-based,Cobimetinib,8836851,PubChem,,,70.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8308,Cell-based,,987654,PubChem,mg/kg,,187.0
SYNTHETIC-5,DONOR_2309,TREATMENT_8309,Cell-based,Brentuximab vedotin,8836851,RxNorm,g/m2,,71.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8310,Cell-based,Niraparib,239766,NCI Thesaurus,,158.0,150.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8311,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,4459876,PubChem,mg/m2,131.0,117.0
SYNTHETIC-5,DONOR_2312,TREATMENT_8312,Immune checkpoint inhibitors,Brentuximab vedotin,8836851,RxNorm,mg/kg,173.0,127.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8313,Other immunomodulatory substances,Kymriah,4459876,NCI Thesaurus,g/m2,91.0,192.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8314,Cell-based,Yervoy,,NCI Thesaurus,mg/m2,70.0,
SYNTHETIC-5,DONOR_2315,TREATMENT_8315,Immune checkpoint inhibitors,Vandetanib,239766,RxNorm,ug/m2,75.0,60.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8316,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,278936,NCI Thesaurus,,,69.0
SYNTHETIC-5,DONOR_2317,TREATMENT_8317,Immune checkpoint inhibitors,Caprelsa,987654,,IU/kg,96.0,169.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8318,Immune checkpoint inhibitors,Nivolumab,,,mg/kg,112.0,145.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8319,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,278936,RxNorm,IU/kg,131.0,56.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8320,Other immunomodulatory substances,Tisagenlecleucel,239766,NCI Thesaurus,ug/m2,61.0,77.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8321,Other immunomodulatory substances,Durvalumab,,,cells/kg,104.0,119.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8322,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,PubChem,IU/kg,133.0,196.0
SYNTHETIC-5,DONOR_2323,TREATMENT_8323,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,4459876,NCI Thesaurus,mg/kg,149.0,198.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8324,Cell-based,Trastuzumab,,PubChem,mg/m2,164.0,167.0
SYNTHETIC-5,DONOR_2325,TREATMENT_8325,Cell-based,Tagrisso,987654,PubChem,IU/m2,71.0,
SYNTHETIC-5,DONOR_2326,TREATMENT_8326,Immune checkpoint inhibitors,Vandetanib,987654,PubChem,IU/kg,157.0,160.0
SYNTHETIC-5,DONOR_2327,TREATMENT_8327,Cell-based,Cabozantinib,239766,NCI Thesaurus,g/m2,183.0,127.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8328,Immune checkpoint inhibitors,Blinatumomab,239766,PubChem,ug/m2,60.0,125.0
SYNTHETIC-5,DONOR_2329,TREATMENT_8329,Cell-based,Keytruda,8756456,,,196.0,70.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8330,Cell-based,Ado-trastuzumab emtansine,8756456,PubChem,,,166.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8331,Cell-based,Keytruda,8756456,NCI Thesaurus,IU/m2,126.0,120.0
SYNTHETIC-5,DONOR_2332,TREATMENT_8332,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,278936,PubChem,IU/m2,186.0,83.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8333,Cell-based,Gilteritinib,4459876,NCI Thesaurus,IU/m2,,80.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8334,Immune checkpoint inhibitors,Ribociclib,,PubChem,cells/kg,51.0,183.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8335,,,,PubChem,mg/kg,198.0,184.0
SYNTHETIC-5,DONOR_2336,TREATMENT_8336,Other immunomodulatory substances,Gilteritinib,987654,RxNorm,ug/m2,97.0,
SYNTHETIC-5,DONOR_2337,TREATMENT_8337,Immune checkpoint inhibitors,Pexidartinib,278936,NCI Thesaurus,g/m2,107.0,112.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8338,Other immunomodulatory substances,Necitumumab,4459876,RxNorm,IU/kg,,103.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8339,,Brentuximab vedotin,8756456,PubChem,,90.0,87.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8340,Cell-based,Rituximab,4459876,NCI Thesaurus,mg/kg,,200.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8341,Cell-based,Alunbrig,8756456,RxNorm,cells/kg,184.0,183.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8342,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,PubChem,cells/kg,162.0,66.0
SYNTHETIC-5,DONOR_2343,TREATMENT_8343,Cell-based,Tafinlar,8756456,PubChem,IU/kg,150.0,
SYNTHETIC-5,DONOR_2344,TREATMENT_8344,Immune checkpoint inhibitors,Tecentriq,8756456,,,135.0,118.0
SYNTHETIC-5,DONOR_2345,TREATMENT_8345,Cell-based,Yervoy,987654,NCI Thesaurus,mg/kg,73.0,80.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8346,Cell-based,Imfinzi,8756456,,cells/kg,196.0,195.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8347,Immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,ug/m2,,148.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8348,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8756456,NCI Thesaurus,IU/kg,191.0,192.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8349,Other immunomodulatory substances,Verzenio,278936,PubChem,IU/m2,65.0,
SYNTHETIC-5,DONOR_2350,TREATMENT_8350,Other immunomodulatory substances,Adcetris,987654,NCI Thesaurus,IU/m2,,59.0
SYNTHETIC-5,DONOR_2351,TREATMENT_8351,Cell-based,Zejula,4459876,PubChem,mg/m2,113.0,115.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8352,Immune checkpoint inhibitors,Tecentriq,239766,,mg/kg,116.0,54.0
SYNTHETIC-5,DONOR_2353,TREATMENT_8353,Other immunomodulatory substances,,4459876,,mg/kg,74.0,
SYNTHETIC-5,DONOR_2354,TREATMENT_8354,Other immunomodulatory substances,Enhertu,278936,PubChem,cells/kg,195.0,147.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8355,Cell-based,Rituxan,278936,NCI Thesaurus,IU/kg,168.0,52.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8356,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,PubChem,ug/m2,106.0,118.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8357,Immune checkpoint inhibitors,Gazyva,8836851,RxNorm,,116.0,93.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8358,Other immunomodulatory substances,Ibrance,8756456,PubChem,IU/kg,163.0,135.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8359,Immune checkpoint inhibitors,Lynparza,4459876,PubChem,g/m2,120.0,114.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8360,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,239766,PubChem,IU/m2,52.0,162.0
SYNTHETIC-5,DONOR_2361,TREATMENT_8361,,,278936,PubChem,mg/m2,53.0,148.0
SYNTHETIC-5,DONOR_2362,TREATMENT_8362,Immune checkpoint inhibitors,Verzenio,987654,RxNorm,g/m2,142.0,109.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8363,Immune checkpoint inhibitors,Durvalumab,239766,,cells/kg,120.0,160.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8364,Cell-based,Nivolumab,8836851,NCI Thesaurus,ug/m2,188.0,161.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8365,Other immunomodulatory substances,Herceptin,278936,PubChem,,178.0,94.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8366,Immune checkpoint inhibitors,Trastuzumab,,PubChem,mg/m2,180.0,74.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8367,Cell-based,Pexidartinib,4459876,PubChem,IU/kg,197.0,50.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8368,Immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,cells/kg,196.0,
SYNTHETIC-5,DONOR_2369,TREATMENT_8369,Immune checkpoint inhibitors,Tecentriq,8756456,PubChem,mg/kg,183.0,163.0
SYNTHETIC-5,DONOR_2370,TREATMENT_8370,,Pertuzumab,239766,RxNorm,,162.0,
SYNTHETIC-5,DONOR_2371,TREATMENT_8371,Other immunomodulatory substances,Cobimetinib,8836851,RxNorm,IU/kg,129.0,120.0
SYNTHETIC-5,DONOR_2372,TREATMENT_8372,Immune checkpoint inhibitors,Yervoy,239766,PubChem,g/m2,111.0,111.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8373,Other immunomodulatory substances,Encorafenib,8836851,NCI Thesaurus,mg/kg,140.0,186.0
SYNTHETIC-5,DONOR_2374,TREATMENT_8374,Immune checkpoint inhibitors,Osimertinib,8756456,RxNorm,IU/kg,139.0,
SYNTHETIC-5,DONOR_2375,TREATMENT_8375,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8756456,NCI Thesaurus,IU/m2,106.0,191.0
SYNTHETIC-5,DONOR_2376,TREATMENT_8376,Cell-based,Sorafenib,4459876,PubChem,mg/kg,140.0,89.0
SYNTHETIC-5,DONOR_2377,TREATMENT_8377,Cell-based,,,NCI Thesaurus,,149.0,
SYNTHETIC-5,DONOR_2378,TREATMENT_8378,Cell-based,Adcetris,278936,,mg/m2,193.0,92.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8379,Other immunomodulatory substances,Alunbrig,239766,PubChem,,158.0,
SYNTHETIC-5,DONOR_2380,TREATMENT_8380,Other immunomodulatory substances,,8836851,RxNorm,mg/kg,73.0,
SYNTHETIC-5,DONOR_2381,TREATMENT_8381,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,4459876,PubChem,mg/m2,,119.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8382,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,987654,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2383,TREATMENT_8383,Immune checkpoint inhibitors,,239766,NCI Thesaurus,,100.0,142.0
SYNTHETIC-5,DONOR_2384,TREATMENT_8384,Immune checkpoint inhibitors,Tecentriq,,NCI Thesaurus,mg/kg,174.0,140.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8385,,Rucaparib,,RxNorm,g/m2,68.0,184.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8386,Other immunomodulatory substances,Crizotinib,987654,PubChem,,132.0,90.0
SYNTHETIC-5,DONOR_2387,TREATMENT_8387,Immune checkpoint inhibitors,Darzalex,8756456,PubChem,cells/kg,94.0,80.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8388,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,8756456,PubChem,cells/kg,200.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_8389,Other immunomodulatory substances,Opdivo,4459876,RxNorm,mg/kg,76.0,78.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8390,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,,RxNorm,mg/m2,113.0,54.0
SYNTHETIC-5,DONOR_2391,TREATMENT_8391,Immune checkpoint inhibitors,,278936,PubChem,ug/m2,80.0,195.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8392,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8836851,RxNorm,g/m2,105.0,140.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8393,,Pembrolizumab,8836851,NCI Thesaurus,g/m2,107.0,189.0
SYNTHETIC-5,DONOR_2394,TREATMENT_8394,Cell-based,,4459876,RxNorm,mg/kg,158.0,165.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8395,Immune checkpoint inhibitors,Braftovi,8756456,RxNorm,ug/m2,121.0,
SYNTHETIC-5,DONOR_2396,TREATMENT_8396,Immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,g/m2,59.0,190.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8397,Other immunomodulatory substances,Ibrance,4459876,,mg/m2,107.0,95.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8398,Immune checkpoint inhibitors,,8756456,,mg/m2,59.0,54.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8399,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8756456,,mg/m2,186.0,180.0
SYNTHETIC-5,DONOR_2400,TREATMENT_8400,Cell-based,Yervoy,8756456,PubChem,mg/m2,76.0,95.0
SYNTHETIC-5,DONOR_2401,TREATMENT_8401,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,8836851,,g/m2,132.0,53.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8402,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,,PubChem,g/m2,115.0,52.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8403,Immune checkpoint inhibitors,Trastuzumab,278936,NCI Thesaurus,cells/kg,144.0,168.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8404,Cell-based,Xalkori,987654,PubChem,IU/kg,116.0,196.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8405,,,8756456,PubChem,IU/m2,126.0,99.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8406,Other immunomodulatory substances,Pertuzumab,8836851,RxNorm,IU/m2,169.0,70.0
SYNTHETIC-5,DONOR_2407,TREATMENT_8407,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,987654,PubChem,g/m2,,95.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8408,Cell-based,Vandetanib,,PubChem,g/m2,68.0,146.0
SYNTHETIC-5,DONOR_2409,TREATMENT_8409,,,987654,,mg/kg,165.0,81.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8410,Immune checkpoint inhibitors,,,,,79.0,149.0
SYNTHETIC-5,DONOR_2411,TREATMENT_8411,Cell-based,Selumitinib,4459876,RxNorm,mg/m2,,196.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8412,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,8836851,PubChem,cells/kg,162.0,105.0
SYNTHETIC-5,DONOR_2413,TREATMENT_8413,Other immunomodulatory substances,Darzalex,8756456,,,99.0,110.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8414,Cell-based,Alecensa,8836851,RxNorm,mg/kg,119.0,
SYNTHETIC-5,DONOR_2415,TREATMENT_8415,Other immunomodulatory substances,Tecentriq,8756456,NCI Thesaurus,,126.0,
SYNTHETIC-5,DONOR_2416,TREATMENT_8416,Immune checkpoint inhibitors,Tecentriq,239766,,,114.0,200.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8417,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,ug/m2,162.0,84.0
SYNTHETIC-5,DONOR_2418,TREATMENT_8418,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,RxNorm,mg/kg,121.0,
SYNTHETIC-5,DONOR_2419,TREATMENT_8419,Cell-based,Tecentriq,239766,RxNorm,IU/m2,,143.0
SYNTHETIC-5,DONOR_2420,TREATMENT_8420,Cell-based,Yervoy,239766,RxNorm,cells/kg,182.0,161.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8421,,Trametinib,8756456,NCI Thesaurus,IU/kg,72.0,
SYNTHETIC-5,DONOR_2422,TREATMENT_8422,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,ug/m2,186.0,86.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8423,Cell-based,Keytruda,239766,,cells/kg,,
SYNTHETIC-5,DONOR_2424,TREATMENT_8424,,Nivolumab,987654,,mg/kg,95.0,64.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8425,Other immunomodulatory substances,Blinatumomab,987654,NCI Thesaurus,IU/kg,149.0,119.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8426,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,987654,,IU/m2,184.0,98.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8427,Immune checkpoint inhibitors,Lynparza,987654,RxNorm,IU/kg,61.0,120.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8428,Immune checkpoint inhibitors,,239766,PubChem,,79.0,115.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8429,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,g/m2,109.0,93.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8430,Immune checkpoint inhibitors,Copanlisib,239766,RxNorm,IU/m2,,94.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8431,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2432,TREATMENT_8432,Cell-based,Yervoy,278936,NCI Thesaurus,mg/m2,143.0,120.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8433,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8756456,PubChem,mg/m2,133.0,70.0
SYNTHETIC-5,DONOR_2434,TREATMENT_8434,Other immunomodulatory substances,Nexavar,239766,RxNorm,,72.0,74.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8435,,Adcetris,239766,RxNorm,,106.0,162.0
SYNTHETIC-5,DONOR_2436,TREATMENT_8436,,Cabozantinib,278936,RxNorm,IU/m2,111.0,170.0
SYNTHETIC-5,DONOR_2437,TREATMENT_8437,Cell-based,Imfinzi,,NCI Thesaurus,g/m2,162.0,128.0
SYNTHETIC-5,DONOR_2438,TREATMENT_8438,Other immunomodulatory substances,Venetoclax,,RxNorm,IU/m2,73.0,
SYNTHETIC-5,DONOR_2439,TREATMENT_8439,Immune checkpoint inhibitors,,8756456,PubChem,,192.0,96.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8440,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,RxNorm,mg/kg,120.0,85.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8441,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,987654,NCI Thesaurus,ug/m2,127.0,
SYNTHETIC-5,DONOR_2442,TREATMENT_8442,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,g/m2,,131.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8443,,Rucaparib,,RxNorm,mg/m2,110.0,73.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8444,Immune checkpoint inhibitors,Imfinzi,4459876,NCI Thesaurus,mg/kg,105.0,72.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8445,Other immunomodulatory substances,Pembrolizumab,8836851,RxNorm,mg/kg,,
SYNTHETIC-5,DONOR_2446,TREATMENT_8446,Cell-based,Lynparza,8836851,NCI Thesaurus,IU/kg,,108.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8447,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,PubChem,cells/kg,93.0,131.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8448,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,PubChem,g/m2,141.0,191.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8449,Other immunomodulatory substances,Tisagenlecleucel,278936,PubChem,IU/kg,173.0,128.0
SYNTHETIC-5,DONOR_2450,TREATMENT_8450,Other immunomodulatory substances,Trastuzumab,4459876,NCI Thesaurus,mg/m2,137.0,198.0
SYNTHETIC-5,DONOR_2451,TREATMENT_8451,Other immunomodulatory substances,Ibrance,8836851,NCI Thesaurus,,176.0,
SYNTHETIC-5,DONOR_2452,TREATMENT_8452,Other immunomodulatory substances,Tagrisso,239766,RxNorm,,143.0,113.0
SYNTHETIC-5,DONOR_2453,TREATMENT_8453,Other immunomodulatory substances,Keytruda,4459876,RxNorm,,146.0,
SYNTHETIC-5,DONOR_2454,TREATMENT_8454,,Copanlisib,4459876,PubChem,mg/m2,96.0,92.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8455,Immune checkpoint inhibitors,Alectinib,,RxNorm,IU/m2,103.0,55.0
SYNTHETIC-5,DONOR_2456,TREATMENT_8456,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,RxNorm,cells/kg,128.0,197.0
SYNTHETIC-5,DONOR_2457,TREATMENT_8457,Other immunomodulatory substances,Nivolumab,8836851,NCI Thesaurus,IU/m2,105.0,
SYNTHETIC-5,DONOR_2458,TREATMENT_8458,Other immunomodulatory substances,Rituxan,278936,NCI Thesaurus,mg/m2,155.0,179.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8459,Other immunomodulatory substances,Ribociclib,278936,RxNorm,ug/m2,157.0,69.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8460,Immune checkpoint inhibitors,Ceritinib,278936,NCI Thesaurus,g/m2,,99.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8461,Immune checkpoint inhibitors,Tecentriq,8836851,NCI Thesaurus,g/m2,52.0,129.0
SYNTHETIC-5,DONOR_2462,TREATMENT_8462,Other immunomodulatory substances,Kymriah,239766,PubChem,ug/m2,132.0,90.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8463,Other immunomodulatory substances,Durvalumab,8756456,,,107.0,116.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8464,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,4459876,RxNorm,IU/kg,84.0,104.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8465,Cell-based,Afatinib,987654,RxNorm,mg/m2,153.0,136.0
SYNTHETIC-5,DONOR_2466,TREATMENT_8466,,Nivolumab,8836851,PubChem,ug/m2,179.0,
SYNTHETIC-5,DONOR_2467,TREATMENT_8467,Immune checkpoint inhibitors,,8756456,RxNorm,IU/kg,50.0,185.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8468,Cell-based,Zykadia,8756456,NCI Thesaurus,ug/m2,70.0,154.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8469,Immune checkpoint inhibitors,Afatinib,,RxNorm,mg/m2,130.0,69.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8470,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,239766,PubChem,mg/m2,,154.0
SYNTHETIC-5,DONOR_2471,TREATMENT_8471,Immune checkpoint inhibitors,Verzenio,4459876,,IU/m2,168.0,95.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8472,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,,ug/m2,181.0,50.0
SYNTHETIC-5,DONOR_2473,TREATMENT_8473,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,239766,PubChem,g/m2,124.0,60.0
SYNTHETIC-5,DONOR_2474,TREATMENT_8474,,Darzalex,4459876,PubChem,,,
SYNTHETIC-5,DONOR_2475,TREATMENT_8475,Other immunomodulatory substances,Ipilimumab,239766,NCI Thesaurus,IU/kg,63.0,164.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8476,,Encorafenib,4459876,PubChem,g/m2,159.0,172.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8477,Other immunomodulatory substances,Rucaparib,278936,NCI Thesaurus,mg/kg,56.0,135.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8478,Other immunomodulatory substances,Gazyva,8756456,PubChem,mg/kg,192.0,
SYNTHETIC-5,DONOR_2479,TREATMENT_8479,Other immunomodulatory substances,Pexidartinib,987654,,IU/kg,190.0,161.0
SYNTHETIC-5,DONOR_2480,TREATMENT_8480,Cell-based,Encorafenib,239766,NCI Thesaurus,cells/kg,88.0,156.0
SYNTHETIC-5,DONOR_2481,TREATMENT_8481,,Encorafenib,239766,NCI Thesaurus,ug/m2,188.0,184.0
SYNTHETIC-5,DONOR_2482,TREATMENT_8482,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,PubChem,mg/m2,159.0,
SYNTHETIC-5,DONOR_2483,TREATMENT_8483,Cell-based,Perjeta,8756456,PubChem,,96.0,105.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8484,Immune checkpoint inhibitors,Ipilimumab,8756456,,mg/m2,143.0,137.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8485,Immune checkpoint inhibitors,,8756456,RxNorm,g/m2,110.0,149.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8486,,,8836851,,,147.0,93.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8487,,Belantamab,8756456,NCI Thesaurus,cells/kg,59.0,100.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8488,,Nivolumab,8836851,NCI Thesaurus,,64.0,
SYNTHETIC-5,DONOR_2489,TREATMENT_8489,Immune checkpoint inhibitors,,8756456,PubChem,cells/kg,83.0,
SYNTHETIC-5,DONOR_2490,TREATMENT_8490,Other immunomodulatory substances,Imfinzi,8756456,RxNorm,ug/m2,196.0,94.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8491,Immune checkpoint inhibitors,Lenvatinib,239766,,IU/kg,,115.0
SYNTHETIC-5,DONOR_2492,TREATMENT_8492,,Gilotrif,8836851,RxNorm,IU/m2,98.0,56.0
SYNTHETIC-5,DONOR_2493,TREATMENT_8493,Other immunomodulatory substances,Inotuzumab ozogamicin,987654,RxNorm,g/m2,82.0,118.0
SYNTHETIC-5,DONOR_2494,TREATMENT_8494,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2495,TREATMENT_8495,Immune checkpoint inhibitors,Afatinib,987654,RxNorm,mg/m2,157.0,74.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8496,Cell-based,Opdivo,8836851,RxNorm,IU/m2,163.0,70.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8497,Immune checkpoint inhibitors,Tagrisso,239766,NCI Thesaurus,mg/m2,199.0,
SYNTHETIC-5,DONOR_2498,TREATMENT_8498,Cell-based,Braftovi,239766,RxNorm,mg/kg,63.0,77.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8499,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,,92.0,
SYNTHETIC-5,DONOR_2500,TREATMENT_8500,Immune checkpoint inhibitors,Copanlisib,4459876,RxNorm,,119.0,117.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8501,Other immunomodulatory substances,Trametinib,987654,RxNorm,mg/m2,60.0,55.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8502,,Pexidartinib,8836851,,cells/kg,138.0,135.0
SYNTHETIC-5,DONOR_2003,TREATMENT_8503,Other immunomodulatory substances,Tisagenlecleucel,8756456,NCI Thesaurus,mg/kg,63.0,78.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8504,Cell-based,Trastuzumab,8836851,,mg/kg,95.0,106.0
SYNTHETIC-5,DONOR_2005,TREATMENT_8505,Cell-based,Nivolumab,8756456,NCI Thesaurus,,56.0,79.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8506,,Ipilimumab,239766,RxNorm,g/m2,194.0,
SYNTHETIC-5,DONOR_2007,TREATMENT_8507,Cell-based,Tecentriq,4459876,NCI Thesaurus,mg/kg,137.0,158.0
SYNTHETIC-5,DONOR_2008,TREATMENT_8508,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,IU/m2,120.0,91.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8509,Immune checkpoint inhibitors,Vandetanib,,,ug/m2,153.0,
SYNTHETIC-5,DONOR_2010,TREATMENT_8510,Cell-based,Tagrisso,4459876,NCI Thesaurus,mg/kg,57.0,111.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8511,Other immunomodulatory substances,Alunbrig,8756456,PubChem,mg/m2,192.0,62.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8512,Other immunomodulatory substances,,278936,RxNorm,cells/kg,129.0,99.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8513,Other immunomodulatory substances,Encorafenib,4459876,PubChem,,75.0,159.0
SYNTHETIC-5,DONOR_2014,TREATMENT_8514,Cell-based,Gazyva,239766,RxNorm,g/m2,188.0,183.0
SYNTHETIC-5,DONOR_2015,TREATMENT_8515,,Inotuzumab ozogamicin,8836851,PubChem,ug/m2,94.0,165.0
SYNTHETIC-5,DONOR_2016,TREATMENT_8516,Immune checkpoint inhibitors,Yervoy,,,,,107.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8517,Cell-based,Rubraca,4459876,,IU/kg,70.0,123.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8518,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,155.0,52.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8519,Cell-based,,8836851,NCI Thesaurus,IU/kg,184.0,171.0
SYNTHETIC-5,DONOR_2020,TREATMENT_8520,Other immunomodulatory substances,Tecentriq,987654,PubChem,mg/m2,,198.0
SYNTHETIC-5,DONOR_2021,TREATMENT_8521,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,157.0,105.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8522,Immune checkpoint inhibitors,Iressa,4459876,RxNorm,cells/kg,135.0,196.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8523,,,239766,,g/m2,142.0,79.0
SYNTHETIC-5,DONOR_2024,TREATMENT_8524,Cell-based,Copanlisib,8756456,,mg/m2,120.0,77.0
SYNTHETIC-5,DONOR_2025,TREATMENT_8525,Immune checkpoint inhibitors,Brentuximab vedotin,987654,NCI Thesaurus,mg/m2,98.0,161.0
SYNTHETIC-5,DONOR_2026,TREATMENT_8526,,Lenvima,278936,PubChem,mg/m2,125.0,193.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8527,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,239766,NCI Thesaurus,mg/m2,64.0,77.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8528,Other immunomodulatory substances,Opdivo,,RxNorm,cells/kg,170.0,93.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8529,Immune checkpoint inhibitors,Perjeta,8756456,NCI Thesaurus,IU/kg,54.0,59.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8530,Cell-based,Trametinib,8836851,RxNorm,mg/m2,84.0,97.0
SYNTHETIC-5,DONOR_2031,TREATMENT_8531,Other immunomodulatory substances,Opdivo,8836851,PubChem,mg/kg,102.0,146.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8532,Immune checkpoint inhibitors,Blincyto,8756456,PubChem,IU/kg,146.0,86.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8533,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,g/m2,182.0,200.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8534,Other immunomodulatory substances,Alunbrig,278936,NCI Thesaurus,IU/kg,119.0,91.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8535,,Inotuzumab ozogamicin,8836851,,cells/kg,70.0,
SYNTHETIC-5,DONOR_2036,TREATMENT_8536,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,4459876,NCI Thesaurus,mg/m2,,59.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8537,Immune checkpoint inhibitors,Rituxan,,,mg/kg,197.0,
SYNTHETIC-5,DONOR_2038,TREATMENT_8538,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,278936,RxNorm,mg/m2,97.0,186.0
SYNTHETIC-5,DONOR_2039,TREATMENT_8539,Other immunomodulatory substances,Cabozantinib,4459876,NCI Thesaurus,ug/m2,78.0,196.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8540,Other immunomodulatory substances,Cotellic,4459876,NCI Thesaurus,cells/kg,169.0,173.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8541,Immune checkpoint inhibitors,Pexidartinib,8836851,RxNorm,g/m2,,134.0
SYNTHETIC-5,DONOR_2042,TREATMENT_8542,Cell-based,Nivolumab,987654,NCI Thesaurus,mg/kg,111.0,
SYNTHETIC-5,DONOR_2043,TREATMENT_8543,Cell-based,Atezolizumab,239766,PubChem,IU/m2,105.0,160.0
SYNTHETIC-5,DONOR_2044,TREATMENT_8544,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,4459876,PubChem,mg/kg,156.0,98.0
SYNTHETIC-5,DONOR_2045,TREATMENT_8545,Immune checkpoint inhibitors,,987654,PubChem,mg/m2,,169.0
SYNTHETIC-5,DONOR_2046,TREATMENT_8546,Cell-based,,8836851,PubChem,g/m2,148.0,
SYNTHETIC-5,DONOR_2047,TREATMENT_8547,Other immunomodulatory substances,Tarceva,278936,,,123.0,187.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8548,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,mg/m2,114.0,155.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8549,Other immunomodulatory substances,Tecentriq,239766,PubChem,IU/kg,99.0,50.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8550,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,,mg/m2,148.0,178.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8551,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,g/m2,143.0,116.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8552,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8756456,PubChem,mg/m2,127.0,110.0
SYNTHETIC-5,DONOR_2053,TREATMENT_8553,,Atezolizumab,,NCI Thesaurus,,146.0,184.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8554,Cell-based,Gilteritinib,,PubChem,IU/m2,,
SYNTHETIC-5,DONOR_2055,TREATMENT_8555,Immune checkpoint inhibitors,Rituxan,239766,NCI Thesaurus,cells/kg,116.0,131.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8556,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,171.0,175.0
SYNTHETIC-5,DONOR_2057,TREATMENT_8557,Cell-based,Vandetanib,8836851,PubChem,mg/m2,107.0,177.0
SYNTHETIC-5,DONOR_2058,TREATMENT_8558,Cell-based,Yervoy,,,mg/m2,,196.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8559,Immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,mg/m2,150.0,150.0
SYNTHETIC-5,DONOR_2060,TREATMENT_8560,Cell-based,Afatinib,987654,RxNorm,mg/kg,178.0,168.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8561,Other immunomodulatory substances,Tafinlar,987654,,mg/m2,149.0,183.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8562,,Pembrolizumab,239766,,g/m2,65.0,
SYNTHETIC-5,DONOR_2063,TREATMENT_8563,Other immunomodulatory substances,Tecentriq,987654,RxNorm,g/m2,92.0,
SYNTHETIC-5,DONOR_2064,TREATMENT_8564,Cell-based,Iressa,,,mg/kg,132.0,146.0
SYNTHETIC-5,DONOR_2065,TREATMENT_8565,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,4459876,NCI Thesaurus,IU/kg,124.0,125.0
SYNTHETIC-5,DONOR_2066,TREATMENT_8566,Cell-based,Rubraca,8756456,RxNorm,,184.0,113.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8567,Immune checkpoint inhibitors,Brentuximab vedotin,8836851,RxNorm,cells/kg,85.0,133.0
SYNTHETIC-5,DONOR_2068,TREATMENT_8568,Other immunomodulatory substances,Enhertu,239766,RxNorm,mg/m2,88.0,123.0
SYNTHETIC-5,DONOR_2069,TREATMENT_8569,Cell-based,Cotellic,4459876,NCI Thesaurus,ug/m2,,86.0
SYNTHETIC-5,DONOR_2070,TREATMENT_8570,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,,,IU/m2,150.0,124.0
SYNTHETIC-5,DONOR_2071,TREATMENT_8571,Other immunomodulatory substances,Keytruda,278936,NCI Thesaurus,IU/m2,190.0,134.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8572,Cell-based,Perjeta,8756456,NCI Thesaurus,mg/kg,98.0,68.0
SYNTHETIC-5,DONOR_2073,TREATMENT_8573,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8756456,RxNorm,ug/m2,152.0,93.0
SYNTHETIC-5,DONOR_2074,TREATMENT_8574,Cell-based,Sorafenib,987654,,mg/kg,90.0,102.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8575,,Nexavar,987654,NCI Thesaurus,ug/m2,199.0,
SYNTHETIC-5,DONOR_2076,TREATMENT_8576,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/kg,127.0,141.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8577,Other immunomodulatory substances,Zykadia,278936,PubChem,,52.0,83.0
SYNTHETIC-5,DONOR_2078,TREATMENT_8578,Cell-based,Yervoy,239766,RxNorm,mg/kg,134.0,120.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8579,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,8836851,RxNorm,cells/kg,101.0,
SYNTHETIC-5,DONOR_2080,TREATMENT_8580,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,PubChem,IU/kg,150.0,147.0
SYNTHETIC-5,DONOR_2081,TREATMENT_8581,Other immunomodulatory substances,Tafinlar,8756456,NCI Thesaurus,ug/m2,139.0,162.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8582,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,,,mg/kg,72.0,162.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8583,Other immunomodulatory substances,Tecentriq,,PubChem,IU/m2,,119.0
SYNTHETIC-5,DONOR_2084,TREATMENT_8584,Other immunomodulatory substances,,8756456,,cells/kg,125.0,186.0
SYNTHETIC-5,DONOR_2085,TREATMENT_8585,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,RxNorm,,183.0,
SYNTHETIC-5,DONOR_2086,TREATMENT_8586,Immune checkpoint inhibitors,Pertuzumab,8756456,NCI Thesaurus,mg/m2,96.0,116.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8587,Other immunomodulatory substances,Copanlisib,987654,PubChem,,156.0,75.0
SYNTHETIC-5,DONOR_2088,TREATMENT_8588,Other immunomodulatory substances,Yervoy,8836851,RxNorm,,98.0,89.0
SYNTHETIC-5,DONOR_2089,TREATMENT_8589,,Braftovi,239766,RxNorm,,77.0,155.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8590,Other immunomodulatory substances,Nivolumab,239766,RxNorm,mg/kg,59.0,134.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8591,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,4459876,RxNorm,IU/m2,165.0,
SYNTHETIC-5,DONOR_2092,TREATMENT_8592,Other immunomodulatory substances,Yervoy,278936,NCI Thesaurus,IU/m2,67.0,122.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8593,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,278936,PubChem,g/m2,167.0,68.0
SYNTHETIC-5,DONOR_2094,TREATMENT_8594,Cell-based,,278936,NCI Thesaurus,mg/kg,102.0,64.0
SYNTHETIC-5,DONOR_2095,TREATMENT_8595,,Ipilimumab,8756456,PubChem,IU/m2,159.0,147.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8596,Cell-based,Tecentriq,239766,RxNorm,mg/kg,145.0,142.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8597,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,ug/m2,66.0,197.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8598,Other immunomodulatory substances,Kymriah,,PubChem,ug/m2,59.0,65.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8599,Cell-based,Herceptin,8756456,,g/m2,160.0,113.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8600,,Dabrafenib,278936,PubChem,,81.0,137.0
SYNTHETIC-5,DONOR_2101,TREATMENT_8601,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,8756456,RxNorm,g/m2,179.0,68.0
SYNTHETIC-5,DONOR_2102,TREATMENT_8602,Cell-based,Yervoy,278936,PubChem,IU/m2,,
SYNTHETIC-5,DONOR_2103,TREATMENT_8603,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,PubChem,mg/kg,182.0,65.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8604,Immune checkpoint inhibitors,Gilotrif,8756456,NCI Thesaurus,IU/kg,77.0,147.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8605,Other immunomodulatory substances,Binimetinib,239766,RxNorm,cells/kg,149.0,119.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8606,Immune checkpoint inhibitors,Opdivo,8756456,RxNorm,ug/m2,166.0,
SYNTHETIC-5,DONOR_2107,TREATMENT_8607,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,278936,NCI Thesaurus,mg/kg,73.0,144.0
SYNTHETIC-5,DONOR_2108,TREATMENT_8608,Immune checkpoint inhibitors,Tecentriq,239766,RxNorm,IU/kg,110.0,103.0
SYNTHETIC-5,DONOR_2109,TREATMENT_8609,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,mg/m2,74.0,174.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8610,,Tafinlar,278936,NCI Thesaurus,mg/m2,,165.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8611,Cell-based,,4459876,RxNorm,cells/kg,145.0,170.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8612,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,NCI Thesaurus,cells/kg,57.0,103.0
SYNTHETIC-5,DONOR_2113,TREATMENT_8613,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,NCI Thesaurus,IU/m2,65.0,71.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8614,Other immunomodulatory substances,Kymriah,8756456,PubChem,IU/m2,181.0,66.0
SYNTHETIC-5,DONOR_2115,TREATMENT_8615,,Rituxan,8756456,,IU/kg,147.0,156.0
SYNTHETIC-5,DONOR_2116,TREATMENT_8616,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,ug/m2,76.0,
SYNTHETIC-5,DONOR_2117,TREATMENT_8617,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,161.0,190.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8618,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,,86.0,134.0
SYNTHETIC-5,DONOR_2119,TREATMENT_8619,Other immunomodulatory substances,,8836851,,ug/m2,69.0,
SYNTHETIC-5,DONOR_2120,TREATMENT_8620,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8836851,,cells/kg,61.0,195.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8621,Cell-based,,239766,NCI Thesaurus,cells/kg,80.0,176.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8622,,Keytruda,278936,,mg/m2,123.0,104.0
SYNTHETIC-5,DONOR_2123,TREATMENT_8623,Cell-based,Opdivo,239766,RxNorm,ug/m2,131.0,172.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8624,Other immunomodulatory substances,Tecentriq,,NCI Thesaurus,ug/m2,139.0,71.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8625,Immune checkpoint inhibitors,Opdivo,987654,NCI Thesaurus,,144.0,53.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8626,Immune checkpoint inhibitors,Blinatumomab,8836851,,g/m2,79.0,123.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8627,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,,RxNorm,IU/kg,120.0,108.0
SYNTHETIC-5,DONOR_2128,TREATMENT_8628,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,4459876,PubChem,ug/m2,95.0,84.0
SYNTHETIC-5,DONOR_2129,TREATMENT_8629,Cell-based,Atezolizumab,,NCI Thesaurus,g/m2,189.0,119.0
SYNTHETIC-5,DONOR_2130,TREATMENT_8630,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,239766,PubChem,mg/m2,143.0,129.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8631,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,NCI Thesaurus,cells/kg,103.0,
SYNTHETIC-5,DONOR_2132,TREATMENT_8632,Other immunomodulatory substances,Ado-trastuzumab emtansine,987654,NCI Thesaurus,mg/kg,,64.0
SYNTHETIC-5,DONOR_2133,TREATMENT_8633,,Ceritinib,239766,PubChem,ug/m2,161.0,68.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8634,,Perjeta,239766,NCI Thesaurus,cells/kg,159.0,168.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8635,Other immunomodulatory substances,Ipilimumab,239766,,IU/m2,100.0,195.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8636,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,cells/kg,194.0,
SYNTHETIC-5,DONOR_2137,TREATMENT_8637,Cell-based,Alectinib,8836851,RxNorm,IU/m2,145.0,185.0
SYNTHETIC-5,DONOR_2138,TREATMENT_8638,Immune checkpoint inhibitors,,,RxNorm,g/m2,93.0,75.0
SYNTHETIC-5,DONOR_2139,TREATMENT_8639,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,278936,NCI Thesaurus,mg/m2,137.0,71.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8640,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,NCI Thesaurus,g/m2,100.0,63.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8641,Cell-based,Opdivo,8756456,PubChem,mg/kg,138.0,103.0
SYNTHETIC-5,DONOR_2142,TREATMENT_8642,Immune checkpoint inhibitors,Selumitinib,4459876,NCI Thesaurus,mg/kg,111.0,
SYNTHETIC-5,DONOR_2143,TREATMENT_8643,Other immunomodulatory substances,,8756456,PubChem,IU/kg,153.0,116.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8644,Immune checkpoint inhibitors,Pertuzumab,,NCI Thesaurus,mg/m2,108.0,
SYNTHETIC-5,DONOR_2145,TREATMENT_8645,Other immunomodulatory substances,Inotuzumab ozogamicin,8756456,RxNorm,mg/kg,146.0,104.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8646,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8836851,PubChem,g/m2,184.0,
SYNTHETIC-5,DONOR_2147,TREATMENT_8647,Other immunomodulatory substances,Ado-trastuzumab emtansine,278936,NCI Thesaurus,IU/kg,101.0,
SYNTHETIC-5,DONOR_2148,TREATMENT_8648,,Inotuzumab ozogamicin,987654,NCI Thesaurus,mg/kg,83.0,119.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8649,Cell-based,Pexidartinib,8836851,,IU/kg,137.0,64.0
SYNTHETIC-5,DONOR_2150,TREATMENT_8650,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,4459876,RxNorm,IU/kg,66.0,125.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8651,Other immunomodulatory substances,Niraparib,8756456,NCI Thesaurus,g/m2,,58.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8652,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,IU/m2,52.0,
SYNTHETIC-5,DONOR_2153,TREATMENT_8653,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,mg/m2,176.0,159.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8654,Cell-based,Zelboraf,,NCI Thesaurus,mg/kg,196.0,179.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8655,Immune checkpoint inhibitors,Cabozantinib,239766,RxNorm,IU/m2,119.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_8656,Immune checkpoint inhibitors,,239766,PubChem,IU/m2,,77.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8657,Immune checkpoint inhibitors,Yervoy,8836851,NCI Thesaurus,cells/kg,176.0,93.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8658,Other immunomodulatory substances,Venetoclax,,RxNorm,mg/kg,60.0,104.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8659,Cell-based,Copanlisib,,PubChem,mg/kg,154.0,183.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8660,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,PubChem,mg/m2,163.0,
SYNTHETIC-5,DONOR_2161,TREATMENT_8661,Cell-based,,8836851,,ug/m2,197.0,102.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8662,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,8756456,RxNorm,cells/kg,181.0,141.0
SYNTHETIC-5,DONOR_2163,TREATMENT_8663,Other immunomodulatory substances,,239766,RxNorm,IU/m2,108.0,182.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8664,,Zelboraf,278936,NCI Thesaurus,,185.0,179.0
SYNTHETIC-5,DONOR_2165,TREATMENT_8665,Other immunomodulatory substances,Venetoclax,,RxNorm,ug/m2,58.0,72.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8666,Cell-based,Ribociclib,239766,RxNorm,g/m2,169.0,
SYNTHETIC-5,DONOR_2167,TREATMENT_8667,,Atezolizumab,8756456,RxNorm,ug/m2,156.0,188.0
SYNTHETIC-5,DONOR_2168,TREATMENT_8668,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,PubChem,IU/kg,117.0,160.0
SYNTHETIC-5,DONOR_2169,TREATMENT_8669,Immune checkpoint inhibitors,,8756456,PubChem,mg/m2,192.0,58.0
SYNTHETIC-5,DONOR_2170,TREATMENT_8670,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,,NCI Thesaurus,,74.0,92.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8671,Other immunomodulatory substances,Nivolumab,4459876,,cells/kg,154.0,127.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8672,Cell-based,Keytruda,,,g/m2,,96.0
SYNTHETIC-5,DONOR_2173,TREATMENT_8673,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,239766,,IU/kg,,94.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8674,Immune checkpoint inhibitors,Ibrance,4459876,RxNorm,ug/m2,,99.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8675,,Durvalumab,,PubChem,IU/m2,182.0,78.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8676,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,ug/m2,80.0,75.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8677,Immune checkpoint inhibitors,Dabrafenib,278936,RxNorm,IU/kg,88.0,80.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8678,Immune checkpoint inhibitors,Perjeta,8836851,,,65.0,165.0
SYNTHETIC-5,DONOR_2179,TREATMENT_8679,Cell-based,Tecentriq,8756456,RxNorm,ug/m2,,100.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8680,,Pembrolizumab,239766,PubChem,ug/m2,154.0,65.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8681,Cell-based,,8756456,PubChem,g/m2,68.0,92.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8682,Other immunomodulatory substances,Brigatinib,8836851,NCI Thesaurus,cells/kg,164.0,
SYNTHETIC-5,DONOR_2183,TREATMENT_8683,Other immunomodulatory substances,Gazyva,8836851,,mg/m2,185.0,135.0
SYNTHETIC-5,DONOR_2184,TREATMENT_8684,Other immunomodulatory substances,Gazyva,278936,RxNorm,mg/kg,,88.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8685,,Kisqali,278936,RxNorm,mg/m2,122.0,85.0
SYNTHETIC-5,DONOR_2186,TREATMENT_8686,Cell-based,,987654,RxNorm,mg/m2,136.0,145.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8687,Other immunomodulatory substances,Tecentriq,4459876,,mg/kg,143.0,164.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8688,Cell-based,,,RxNorm,ug/m2,153.0,124.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8689,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,8756456,PubChem,mg/kg,,103.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8690,Cell-based,Opdivo,4459876,NCI Thesaurus,mg/kg,172.0,126.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8691,Other immunomodulatory substances,Yescarta,987654,PubChem,g/m2,92.0,53.0
SYNTHETIC-5,DONOR_2192,TREATMENT_8692,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,239766,PubChem,IU/kg,90.0,60.0
SYNTHETIC-5,DONOR_2193,TREATMENT_8693,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,,,,104.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8694,Cell-based,,239766,NCI Thesaurus,IU/m2,,147.0
SYNTHETIC-5,DONOR_2195,TREATMENT_8695,Other immunomodulatory substances,Tarceva,4459876,PubChem,IU/m2,57.0,186.0
SYNTHETIC-5,DONOR_2196,TREATMENT_8696,Other immunomodulatory substances,Encorafenib,,NCI Thesaurus,IU/kg,146.0,93.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8697,Immune checkpoint inhibitors,Kadcyla,278936,RxNorm,mg/kg,126.0,195.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8698,Other immunomodulatory substances,Gilotrif,278936,NCI Thesaurus,IU/m2,170.0,
SYNTHETIC-5,DONOR_2199,TREATMENT_8699,Other immunomodulatory substances,,278936,NCI Thesaurus,ug/m2,90.0,
SYNTHETIC-5,DONOR_2200,TREATMENT_8700,Immune checkpoint inhibitors,Axicabtagene ciloleucel,,,,76.0,126.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8701,Other immunomodulatory substances,Gilotrif,,PubChem,,,189.0
SYNTHETIC-5,DONOR_2202,TREATMENT_8702,Other immunomodulatory substances,Gazyva,987654,PubChem,IU/kg,179.0,175.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8703,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2204,TREATMENT_8704,Other immunomodulatory substances,Tecentriq,4459876,PubChem,,180.0,198.0
SYNTHETIC-5,DONOR_2205,TREATMENT_8705,Immune checkpoint inhibitors,Pembrolizumab,4459876,NCI Thesaurus,,132.0,147.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8706,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8756456,RxNorm,IU/m2,88.0,181.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8707,Cell-based,Kymriah,,RxNorm,mg/kg,186.0,132.0
SYNTHETIC-5,DONOR_2208,TREATMENT_8708,Immune checkpoint inhibitors,Niraparib,4459876,NCI Thesaurus,g/m2,178.0,165.0
SYNTHETIC-5,DONOR_2209,TREATMENT_8709,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,8756456,NCI Thesaurus,,118.0,
SYNTHETIC-5,DONOR_2210,TREATMENT_8710,Immune checkpoint inhibitors,Alectinib,278936,RxNorm,,62.0,119.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8711,Cell-based,,278936,RxNorm,g/m2,,138.0
SYNTHETIC-5,DONOR_2212,TREATMENT_8712,Other immunomodulatory substances,Trastuzumab,987654,RxNorm,IU/m2,177.0,56.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8713,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,PubChem,mg/kg,,148.0
SYNTHETIC-5,DONOR_2214,TREATMENT_8714,Immune checkpoint inhibitors,,8756456,PubChem,g/m2,96.0,154.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8715,Cell-based,Lenvatinib,987654,NCI Thesaurus,g/m2,194.0,133.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8716,Immune checkpoint inhibitors,Selumitinib,4459876,,ug/m2,,
SYNTHETIC-5,DONOR_2217,TREATMENT_8717,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,IU/m2,142.0,119.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8718,Other immunomodulatory substances,,8756456,,cells/kg,,185.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8719,Cell-based,Yervoy,,PubChem,mg/kg,115.0,126.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8720,,Inotuzumab ozogamicin,4459876,RxNorm,,,111.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8721,,Lenvima,239766,,mg/kg,141.0,
SYNTHETIC-5,DONOR_2222,TREATMENT_8722,Cell-based,,239766,NCI Thesaurus,cells/kg,92.0,
SYNTHETIC-5,DONOR_2223,TREATMENT_8723,Other immunomodulatory substances,Darzalex,8756456,NCI Thesaurus,g/m2,183.0,129.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8724,Other immunomodulatory substances,Keytruda,4459876,,cells/kg,54.0,131.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8725,Other immunomodulatory substances,Atezolizumab,987654,RxNorm,ug/m2,,170.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8726,Other immunomodulatory substances,Gilotrif,8836851,,cells/kg,190.0,73.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8727,Cell-based,Tarceva,4459876,PubChem,,,92.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8728,Other immunomodulatory substances,Niraparib,8756456,RxNorm,IU/kg,,126.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8729,Other immunomodulatory substances,Keytruda,,,IU/m2,77.0,163.0
SYNTHETIC-5,DONOR_2230,TREATMENT_8730,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,4459876,,,158.0,58.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8731,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,,,IU/kg,171.0,82.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8732,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,NCI Thesaurus,mg/kg,,128.0
SYNTHETIC-5,DONOR_2233,TREATMENT_8733,Immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,IU/m2,133.0,105.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8734,Other immunomodulatory substances,Olaparib,8756456,PubChem,mg/m2,133.0,52.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8735,Other immunomodulatory substances,,4459876,RxNorm,ug/m2,69.0,132.0
SYNTHETIC-5,DONOR_2236,TREATMENT_8736,Immune checkpoint inhibitors,,239766,RxNorm,mg/kg,59.0,112.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8737,Cell-based,Atezolizumab,278936,PubChem,g/m2,190.0,67.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8738,Cell-based,Caprelsa,8836851,,g/m2,181.0,125.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8739,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,278936,PubChem,cells/kg,,144.0
SYNTHETIC-5,DONOR_2240,TREATMENT_8740,,Caprelsa,8756456,PubChem,g/m2,197.0,151.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8741,Other immunomodulatory substances,Ipilimumab,987654,PubChem,IU/kg,,131.0
SYNTHETIC-5,DONOR_2242,TREATMENT_8742,,Opdivo,,PubChem,IU/kg,59.0,184.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8743,Immune checkpoint inhibitors,Zelboraf,239766,PubChem,,143.0,111.0
SYNTHETIC-5,DONOR_2244,TREATMENT_8744,Immune checkpoint inhibitors,Tecentriq,8756456,PubChem,g/m2,,
SYNTHETIC-5,DONOR_2245,TREATMENT_8745,,Mektovi,987654,PubChem,cells/kg,111.0,105.0
SYNTHETIC-5,DONOR_2246,TREATMENT_8746,,Alunbrig,278936,,,51.0,86.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8747,Cell-based,Rituxan,8756456,RxNorm,mg/kg,76.0,188.0
SYNTHETIC-5,DONOR_2248,TREATMENT_8748,Cell-based,,278936,,,64.0,
SYNTHETIC-5,DONOR_2249,TREATMENT_8749,Immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,IU/m2,,142.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8750,Immune checkpoint inhibitors,Osimertinib,4459876,RxNorm,IU/m2,153.0,106.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8751,Cell-based,Caprelsa,239766,PubChem,mg/m2,,117.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8752,Other immunomodulatory substances,,239766,RxNorm,,68.0,190.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8753,Immune checkpoint inhibitors,Xalkori,8836851,RxNorm,,194.0,163.0
SYNTHETIC-5,DONOR_2254,TREATMENT_8754,Other immunomodulatory substances,Besponsa,8836851,PubChem,,147.0,
SYNTHETIC-5,DONOR_2255,TREATMENT_8755,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,4459876,NCI Thesaurus,ug/m2,86.0,162.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8756,Other immunomodulatory substances,Rucaparib,239766,PubChem,cells/kg,,98.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8757,Cell-based,Enhertu,8836851,RxNorm,g/m2,,77.0
SYNTHETIC-5,DONOR_2258,TREATMENT_8758,Immune checkpoint inhibitors,Nexavar,8756456,,IU/kg,158.0,
SYNTHETIC-5,DONOR_2259,TREATMENT_8759,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,,PubChem,mg/kg,127.0,
SYNTHETIC-5,DONOR_2260,TREATMENT_8760,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,RxNorm,mg/m2,167.0,197.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8761,,Yervoy,8836851,NCI Thesaurus,mg/kg,120.0,83.0
SYNTHETIC-5,DONOR_2262,TREATMENT_8762,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,987654,,ug/m2,,79.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8763,Other immunomodulatory substances,,278936,RxNorm,mg/kg,166.0,192.0
SYNTHETIC-5,DONOR_2264,TREATMENT_8764,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,8836851,NCI Thesaurus,IU/kg,,91.0
SYNTHETIC-5,DONOR_2265,TREATMENT_8765,,Atezolizumab,4459876,RxNorm,IU/m2,179.0,
SYNTHETIC-5,DONOR_2266,TREATMENT_8766,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,IU/kg,187.0,96.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8767,Cell-based,Enhertu,,NCI Thesaurus,IU/m2,187.0,142.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8768,Cell-based,Zykadia,239766,NCI Thesaurus,IU/m2,104.0,60.0
SYNTHETIC-5,DONOR_2269,TREATMENT_8769,,Olaparib,,PubChem,cells/kg,,134.0
SYNTHETIC-5,DONOR_2270,TREATMENT_8770,Other immunomodulatory substances,Yescarta,278936,RxNorm,mg/kg,189.0,192.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8771,Immune checkpoint inhibitors,Opdivo,4459876,PubChem,mg/kg,65.0,83.0
SYNTHETIC-5,DONOR_2272,TREATMENT_8772,Other immunomodulatory substances,Xalkori,987654,NCI Thesaurus,mg/m2,124.0,
SYNTHETIC-5,DONOR_2273,TREATMENT_8773,Cell-based,,987654,PubChem,g/m2,196.0,
SYNTHETIC-5,DONOR_2274,TREATMENT_8774,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8836851,,ug/m2,196.0,132.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8775,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,ug/m2,153.0,112.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8776,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,4459876,,,,177.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8777,Cell-based,Gilotrif,8756456,,mg/kg,,73.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8778,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,PubChem,mg/kg,77.0,175.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8779,Cell-based,Crizotinib,8836851,,,132.0,103.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8780,Other immunomodulatory substances,Inotuzumab ozogamicin,4459876,RxNorm,mg/kg,145.0,83.0
SYNTHETIC-5,DONOR_2281,TREATMENT_8781,Cell-based,Trastuzumab,239766,RxNorm,,149.0,105.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8782,Cell-based,Afatinib,8836851,RxNorm,ug/m2,114.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_8783,Other immunomodulatory substances,Opdivo,987654,NCI Thesaurus,mg/kg,167.0,
SYNTHETIC-5,DONOR_2284,TREATMENT_8784,Other immunomodulatory substances,Keytruda,239766,RxNorm,g/m2,172.0,169.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8785,Cell-based,Atezolizumab,278936,NCI Thesaurus,cells/kg,64.0,83.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8786,Cell-based,Rituxan,239766,RxNorm,IU/kg,85.0,
SYNTHETIC-5,DONOR_2287,TREATMENT_8787,Other immunomodulatory substances,Tecentriq,8836851,,IU/m2,59.0,182.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8788,Cell-based,Durvalumab,278936,NCI Thesaurus,mg/m2,124.0,68.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8789,Immune checkpoint inhibitors,Tecentriq,987654,PubChem,IU/kg,,132.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8790,,Nexavar,278936,PubChem,ug/m2,,96.0
SYNTHETIC-5,DONOR_2291,TREATMENT_8791,Cell-based,Atezolizumab,239766,NCI Thesaurus,,171.0,50.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8792,Cell-based,,278936,NCI Thesaurus,cells/kg,,193.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8793,Cell-based,Yervoy,278936,NCI Thesaurus,,,190.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8794,Immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,IU/m2,108.0,190.0
SYNTHETIC-5,DONOR_2295,TREATMENT_8795,Other immunomodulatory substances,Tecentriq,987654,NCI Thesaurus,,200.0,50.0
SYNTHETIC-5,DONOR_2296,TREATMENT_8796,Immune checkpoint inhibitors,Trametinib,239766,NCI Thesaurus,ug/m2,190.0,131.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8797,Immune checkpoint inhibitors,Keytruda,987654,,g/m2,164.0,119.0
SYNTHETIC-5,DONOR_2298,TREATMENT_8798,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,239766,NCI Thesaurus,mg/m2,,176.0
SYNTHETIC-5,DONOR_2299,TREATMENT_8799,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,8836851,PubChem,ug/m2,159.0,68.0
SYNTHETIC-5,DONOR_2300,TREATMENT_8800,Immune checkpoint inhibitors,Atezolizumab,4459876,NCI Thesaurus,IU/kg,145.0,137.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8801,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,987654,RxNorm,g/m2,166.0,168.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8802,Other immunomodulatory substances,Erlotinib,239766,NCI Thesaurus,g/m2,,166.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8803,Other immunomodulatory substances,,,NCI Thesaurus,,198.0,188.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8804,Other immunomodulatory substances,Alunbrig,8756456,PubChem,,158.0,186.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8805,Cell-based,Mekinist,239766,NCI Thesaurus,IU/kg,178.0,184.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8806,Immune checkpoint inhibitors,Pexidartinib,239766,PubChem,mg/m2,168.0,198.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8807,Cell-based,Inotuzumab ozogamicin,987654,RxNorm,ug/m2,172.0,92.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8808,Immune checkpoint inhibitors,Yervoy,4459876,PubChem,cells/kg,80.0,56.0
SYNTHETIC-5,DONOR_2309,TREATMENT_8809,Immune checkpoint inhibitors,Ipilimumab,,PubChem,ug/m2,127.0,104.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8810,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,PubChem,g/m2,175.0,108.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8811,Other immunomodulatory substances,Alecensa,987654,RxNorm,mg/m2,75.0,159.0
SYNTHETIC-5,DONOR_2312,TREATMENT_8812,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,PubChem,mg/kg,189.0,110.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8813,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,8836851,,g/m2,175.0,
SYNTHETIC-5,DONOR_2314,TREATMENT_8814,,,239766,RxNorm,IU/kg,51.0,155.0
SYNTHETIC-5,DONOR_2315,TREATMENT_8815,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,8836851,NCI Thesaurus,g/m2,190.0,95.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8816,Cell-based,Zelboraf,,RxNorm,ug/m2,166.0,
SYNTHETIC-5,DONOR_2317,TREATMENT_8817,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,8756456,,cells/kg,,164.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8818,Cell-based,Perjeta,278936,,ug/m2,100.0,175.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8819,,Durvalumab,278936,,ug/m2,59.0,164.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8820,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,278936,RxNorm,mg/kg,197.0,129.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8821,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,PubChem,g/m2,168.0,181.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8822,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,239766,PubChem,,67.0,
SYNTHETIC-5,DONOR_2323,TREATMENT_8823,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,8836851,RxNorm,IU/m2,166.0,170.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8824,Immune checkpoint inhibitors,Rituximab,4459876,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2325,TREATMENT_8825,Cell-based,Dabrafenib,,,cells/kg,51.0,92.0
SYNTHETIC-5,DONOR_2326,TREATMENT_8826,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,987654,RxNorm,mg/kg,120.0,114.0
SYNTHETIC-5,DONOR_2327,TREATMENT_8827,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,278936,PubChem,cells/kg,176.0,188.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8828,Cell-based,Obinutuzumab,4459876,RxNorm,IU/kg,103.0,183.0
SYNTHETIC-5,DONOR_2329,TREATMENT_8829,Immune checkpoint inhibitors,Caprelsa,239766,RxNorm,IU/kg,71.0,58.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8830,Immune checkpoint inhibitors,Blincyto,239766,,IU/m2,89.0,191.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8831,Immune checkpoint inhibitors,Obinutuzumab,4459876,RxNorm,mg/m2,169.0,
SYNTHETIC-5,DONOR_2332,TREATMENT_8832,Cell-based,,8756456,NCI Thesaurus,cells/kg,152.0,
SYNTHETIC-5,DONOR_2333,TREATMENT_8833,Other immunomodulatory substances,Nivolumab,239766,RxNorm,mg/m2,154.0,62.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8834,Immune checkpoint inhibitors,Enhertu,987654,PubChem,mg/kg,175.0,189.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8835,Cell-based,Iressa,987654,NCI Thesaurus,cells/kg,71.0,157.0
SYNTHETIC-5,DONOR_2336,TREATMENT_8836,Immune checkpoint inhibitors,Lenvatinib,278936,PubChem,IU/kg,87.0,79.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8837,Immune checkpoint inhibitors,Binimetinib,4459876,RxNorm,mg/m2,,155.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8838,Cell-based,,8756456,RxNorm,ug/m2,88.0,51.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8839,Cell-based,Osimertinib,8756456,RxNorm,IU/m2,75.0,64.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8840,Cell-based,Opdivo,8836851,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2341,TREATMENT_8841,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,g/m2,76.0,
SYNTHETIC-5,DONOR_2342,TREATMENT_8842,Immune checkpoint inhibitors,Cometriq,278936,PubChem,IU/m2,196.0,146.0
SYNTHETIC-5,DONOR_2343,TREATMENT_8843,,Yervoy,8756456,NCI Thesaurus,mg/m2,157.0,56.0
SYNTHETIC-5,DONOR_2344,TREATMENT_8844,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2345,TREATMENT_8845,Immune checkpoint inhibitors,Zelboraf,4459876,PubChem,IU/kg,70.0,100.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8846,Other immunomodulatory substances,Venetoclax,278936,,ug/m2,65.0,185.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8847,Cell-based,Zejula,987654,NCI Thesaurus,,119.0,199.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8848,Cell-based,,987654,PubChem,,150.0,54.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8849,Other immunomodulatory substances,Sorafenib,987654,PubChem,,155.0,99.0
SYNTHETIC-5,DONOR_2350,TREATMENT_8850,Cell-based,Trastuzumab,987654,NCI Thesaurus,mg/kg,188.0,71.0
SYNTHETIC-5,DONOR_2351,TREATMENT_8851,Immune checkpoint inhibitors,Mekinist,987654,RxNorm,,99.0,129.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8852,Other immunomodulatory substances,Gazyva,987654,PubChem,,73.0,82.0
SYNTHETIC-5,DONOR_2353,TREATMENT_8853,Other immunomodulatory substances,Necitumumab,239766,RxNorm,IU/kg,179.0,98.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8854,Cell-based,Ribociclib,4459876,RxNorm,IU/m2,189.0,113.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8855,Cell-based,,8836851,NCI Thesaurus,ug/m2,64.0,109.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8856,Immune checkpoint inhibitors,Yervoy,,RxNorm,mg/m2,71.0,117.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8857,,Pembrolizumab,278936,PubChem,mg/kg,181.0,180.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8858,Immune checkpoint inhibitors,Xalkori,239766,PubChem,ug/m2,160.0,124.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8859,Cell-based,Atezolizumab,987654,NCI Thesaurus,mg/kg,119.0,145.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8860,Cell-based,Palbociclib,239766,NCI Thesaurus,IU/kg,134.0,
SYNTHETIC-5,DONOR_2361,TREATMENT_8861,,Ipilimumab,8756456,RxNorm,mg/m2,,
SYNTHETIC-5,DONOR_2362,TREATMENT_8862,Other immunomodulatory substances,Alecensa,239766,RxNorm,ug/m2,81.0,97.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8863,Immune checkpoint inhibitors,Obinutuzumab,4459876,RxNorm,ug/m2,178.0,187.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8864,Cell-based,Opdivo,,NCI Thesaurus,mg/m2,193.0,162.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8865,Immune checkpoint inhibitors,Osimertinib,8836851,PubChem,mg/m2,85.0,
SYNTHETIC-5,DONOR_2366,TREATMENT_8866,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,,PubChem,IU/kg,156.0,92.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8867,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,987654,NCI Thesaurus,,154.0,169.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8868,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,239766,NCI Thesaurus,ug/m2,94.0,168.0
SYNTHETIC-5,DONOR_2369,TREATMENT_8869,Other immunomodulatory substances,Osimertinib,8836851,NCI Thesaurus,mg/kg,91.0,176.0
SYNTHETIC-5,DONOR_2370,TREATMENT_8870,Other immunomodulatory substances,,278936,RxNorm,IU/m2,137.0,
SYNTHETIC-5,DONOR_2371,TREATMENT_8871,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,PubChem,g/m2,196.0,82.0
SYNTHETIC-5,DONOR_2372,TREATMENT_8872,,Belantamab,278936,RxNorm,g/m2,143.0,166.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8873,Cell-based,Verzenio,4459876,PubChem,IU/kg,133.0,92.0
SYNTHETIC-5,DONOR_2374,TREATMENT_8874,Other immunomodulatory substances,Zelboraf,239766,PubChem,,161.0,81.0
SYNTHETIC-5,DONOR_2375,TREATMENT_8875,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,PubChem,g/m2,142.0,135.0
SYNTHETIC-5,DONOR_2376,TREATMENT_8876,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,987654,RxNorm,,169.0,77.0
SYNTHETIC-5,DONOR_2377,TREATMENT_8877,Other immunomodulatory substances,Pexidartinib,239766,PubChem,cells/kg,97.0,169.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8878,Cell-based,Obinutuzumab,987654,RxNorm,IU/kg,,161.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8879,Cell-based,Brentuximab vedotin,8756456,NCI Thesaurus,g/m2,106.0,
SYNTHETIC-5,DONOR_2380,TREATMENT_8880,Cell-based,Lynparza,987654,RxNorm,cells/kg,173.0,132.0
SYNTHETIC-5,DONOR_2381,TREATMENT_8881,Cell-based,Keytruda,,RxNorm,ug/m2,120.0,94.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8882,,Copanlisib,987654,,,175.0,157.0
SYNTHETIC-5,DONOR_2383,TREATMENT_8883,Immune checkpoint inhibitors,Pembrolizumab,239766,NCI Thesaurus,,,74.0
SYNTHETIC-5,DONOR_2384,TREATMENT_8884,Immune checkpoint inhibitors,Gefitinib,8836851,NCI Thesaurus,mg/m2,152.0,103.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8885,Other immunomodulatory substances,Tecentriq,987654,,,103.0,69.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8886,Cell-based,Nivolumab,239766,NCI Thesaurus,cells/kg,61.0,
SYNTHETIC-5,DONOR_2387,TREATMENT_8887,Other immunomodulatory substances,Darzalex,8756456,PubChem,IU/kg,61.0,
SYNTHETIC-5,DONOR_2388,TREATMENT_8888,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,4459876,NCI Thesaurus,cells/kg,139.0,91.0
SYNTHETIC-5,DONOR_2389,TREATMENT_8889,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,mg/m2,,51.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8890,Other immunomodulatory substances,Sorafenib,8836851,RxNorm,IU/kg,96.0,73.0
SYNTHETIC-5,DONOR_2391,TREATMENT_8891,Cell-based,Belantamab,8756456,RxNorm,cells/kg,125.0,86.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8892,Other immunomodulatory substances,Gefitinib,278936,NCI Thesaurus,IU/kg,50.0,166.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8893,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,8836851,NCI Thesaurus,mg/m2,175.0,176.0
SYNTHETIC-5,DONOR_2394,TREATMENT_8894,Immune checkpoint inhibitors,,278936,PubChem,mg/kg,137.0,105.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8895,Immune checkpoint inhibitors,Zykadia,8756456,NCI Thesaurus,,,97.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8896,Other immunomodulatory substances,Cobimetinib,8756456,PubChem,IU/m2,58.0,175.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8897,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,RxNorm,mg/m2,85.0,108.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8898,Other immunomodulatory substances,Atezolizumab,8756456,NCI Thesaurus,cells/kg,149.0,117.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8899,Immune checkpoint inhibitors,Gilteritinib,239766,,mg/m2,131.0,
SYNTHETIC-5,DONOR_2400,TREATMENT_8900,Immune checkpoint inhibitors,Binimetinib,4459876,NCI Thesaurus,IU/m2,76.0,143.0
SYNTHETIC-5,DONOR_2401,TREATMENT_8901,Other immunomodulatory substances,Besponsa,8756456,RxNorm,g/m2,176.0,80.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8902,Other immunomodulatory substances,Dabrafenib,239766,PubChem,IU/m2,82.0,132.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8903,Other immunomodulatory substances,Ibrance,8756456,,,145.0,87.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8904,Other immunomodulatory substances,Ipilimumab,,RxNorm,g/m2,123.0,
SYNTHETIC-5,DONOR_2405,TREATMENT_8905,Cell-based,Braftovi,8836851,PubChem,mg/m2,119.0,50.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8906,Other immunomodulatory substances,Sorafenib,987654,PubChem,IU/kg,132.0,
SYNTHETIC-5,DONOR_2407,TREATMENT_8907,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8836851,NCI Thesaurus,mg/kg,183.0,65.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8908,Immune checkpoint inhibitors,Ibrance,8836851,RxNorm,mg/m2,178.0,
SYNTHETIC-5,DONOR_2409,TREATMENT_8909,Other immunomodulatory substances,Ibrance,987654,NCI Thesaurus,mg/m2,119.0,120.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8910,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,cells/kg,77.0,
SYNTHETIC-5,DONOR_2411,TREATMENT_8911,,Crizotinib,987654,RxNorm,IU/m2,77.0,173.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8912,,Opdivo,239766,,IU/kg,120.0,112.0
SYNTHETIC-5,DONOR_2413,TREATMENT_8913,Cell-based,Cobimetinib,,PubChem,mg/m2,159.0,164.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8914,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,,g/m2,183.0,86.0
SYNTHETIC-5,DONOR_2415,TREATMENT_8915,Immune checkpoint inhibitors,Gazyva,,PubChem,cells/kg,,183.0
SYNTHETIC-5,DONOR_2416,TREATMENT_8916,Other immunomodulatory substances,Kisqali,8836851,NCI Thesaurus,IU/kg,,95.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8917,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,PubChem,mg/kg,176.0,167.0
SYNTHETIC-5,DONOR_2418,TREATMENT_8918,Other immunomodulatory substances,Crizotinib,4459876,RxNorm,IU/kg,170.0,99.0
SYNTHETIC-5,DONOR_2419,TREATMENT_8919,Other immunomodulatory substances,Darzalex,239766,NCI Thesaurus,mg/m2,,154.0
SYNTHETIC-5,DONOR_2420,TREATMENT_8920,Cell-based,Imfinzi,239766,PubChem,g/m2,146.0,109.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8921,Cell-based,Gilteritinib,4459876,,mg/m2,158.0,71.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8922,Cell-based,,8756456,RxNorm,ug/m2,86.0,69.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8923,Cell-based,,4459876,RxNorm,,125.0,
SYNTHETIC-5,DONOR_2424,TREATMENT_8924,Cell-based,,278936,PubChem,mg/m2,94.0,176.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8925,Cell-based,Yervoy,8756456,PubChem,IU/m2,,140.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8926,Cell-based,Trametinib,278936,RxNorm,,141.0,195.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8927,Cell-based,Kadcyla,,,IU/m2,133.0,122.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8928,Other immunomodulatory substances,Necitumumab,8836851,PubChem,IU/m2,192.0,55.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8929,Cell-based,Enhertu,278936,,mg/m2,93.0,88.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8930,Immune checkpoint inhibitors,,278936,RxNorm,ug/m2,187.0,195.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8931,Other immunomodulatory substances,Braftovi,,PubChem,mg/kg,114.0,159.0
SYNTHETIC-5,DONOR_2432,TREATMENT_8932,Other immunomodulatory substances,Inotuzumab ozogamicin,987654,RxNorm,g/m2,56.0,102.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8933,Other immunomodulatory substances,Sorafenib,8756456,NCI Thesaurus,g/m2,64.0,
SYNTHETIC-5,DONOR_2434,TREATMENT_8934,Other immunomodulatory substances,Kadcyla,278936,RxNorm,,129.0,125.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8935,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,,cells/kg,164.0,
SYNTHETIC-5,DONOR_2436,TREATMENT_8936,Immune checkpoint inhibitors,Keytruda,,PubChem,ug/m2,119.0,151.0
SYNTHETIC-5,DONOR_2437,TREATMENT_8937,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,8756456,RxNorm,ug/m2,90.0,129.0
SYNTHETIC-5,DONOR_2438,TREATMENT_8938,Cell-based,,239766,PubChem,g/m2,,145.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8939,Cell-based,,8836851,NCI Thesaurus,g/m2,199.0,101.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8940,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,4459876,RxNorm,g/m2,80.0,179.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8941,Other immunomodulatory substances,Selumitinib,8836851,RxNorm,,,147.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8942,Cell-based,Brentuximab vedotin,4459876,RxNorm,IU/m2,,72.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8943,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,987654,RxNorm,mg/m2,110.0,66.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8944,Other immunomodulatory substances,Cotellic,4459876,RxNorm,mg/kg,184.0,181.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8945,Immune checkpoint inhibitors,Rituximab,8756456,NCI Thesaurus,IU/m2,149.0,115.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8946,Immune checkpoint inhibitors,Lenvatinib,239766,RxNorm,IU/m2,52.0,
SYNTHETIC-5,DONOR_2447,TREATMENT_8947,Other immunomodulatory substances,Nivolumab,278936,PubChem,ug/m2,109.0,97.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8948,Other immunomodulatory substances,Atezolizumab,8756456,NCI Thesaurus,,142.0,169.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8949,Cell-based,Fam-trastuzumab deruxtecan-nxki,,,ug/m2,79.0,154.0
SYNTHETIC-5,DONOR_2450,TREATMENT_8950,Immune checkpoint inhibitors,Mekinist,8836851,PubChem,mg/kg,,191.0
SYNTHETIC-5,DONOR_2451,TREATMENT_8951,Other immunomodulatory substances,Atezolizumab,239766,NCI Thesaurus,,170.0,193.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8952,Immune checkpoint inhibitors,Vemurafenib,4459876,RxNorm,g/m2,160.0,154.0
SYNTHETIC-5,DONOR_2453,TREATMENT_8953,Cell-based,Osimertinib,8836851,PubChem,ug/m2,83.0,50.0
SYNTHETIC-5,DONOR_2454,TREATMENT_8954,Other immunomodulatory substances,Crizotinib,239766,NCI Thesaurus,mg/m2,65.0,87.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8955,Other immunomodulatory substances,Tagrisso,8756456,NCI Thesaurus,ug/m2,197.0,
SYNTHETIC-5,DONOR_2456,TREATMENT_8956,Immune checkpoint inhibitors,Caprelsa,8756456,PubChem,mg/m2,96.0,197.0
SYNTHETIC-5,DONOR_2457,TREATMENT_8957,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8756456,NCI Thesaurus,g/m2,111.0,128.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8958,Other immunomodulatory substances,Afatinib,8836851,PubChem,mg/kg,132.0,126.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8959,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,mg/kg,135.0,82.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8960,,Zykadia,278936,PubChem,,108.0,88.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8961,Other immunomodulatory substances,Dabrafenib,239766,PubChem,mg/kg,62.0,136.0
SYNTHETIC-5,DONOR_2462,TREATMENT_8962,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,NCI Thesaurus,IU/m2,170.0,121.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8963,Other immunomodulatory substances,Nivolumab,278936,PubChem,,,77.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8964,Other immunomodulatory substances,Vandetanib,8756456,PubChem,mg/m2,68.0,123.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8965,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8836851,RxNorm,,83.0,117.0
SYNTHETIC-5,DONOR_2466,TREATMENT_8966,Immune checkpoint inhibitors,Rubraca,278936,NCI Thesaurus,g/m2,54.0,171.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8967,,Blincyto,8756456,PubChem,g/m2,,126.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8968,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,8756456,RxNorm,mg/m2,149.0,150.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8969,Other immunomodulatory substances,Atezolizumab,4459876,RxNorm,,188.0,52.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8970,,Axicabtagene ciloleucel,,PubChem,mg/kg,60.0,99.0
SYNTHETIC-5,DONOR_2471,TREATMENT_8971,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,PubChem,,104.0,129.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8972,,Nivolumab,8836851,RxNorm,IU/m2,139.0,
SYNTHETIC-5,DONOR_2473,TREATMENT_8973,Other immunomodulatory substances,Lenvima,8756456,NCI Thesaurus,,107.0,169.0
SYNTHETIC-5,DONOR_2474,TREATMENT_8974,Immune checkpoint inhibitors,Xalkori,278936,,cells/kg,185.0,176.0
SYNTHETIC-5,DONOR_2475,TREATMENT_8975,Cell-based,,278936,,mg/kg,120.0,56.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8976,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,NCI Thesaurus,IU/m2,,57.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8977,Immune checkpoint inhibitors,Keytruda,4459876,RxNorm,g/m2,78.0,116.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8978,,Afatinib,,RxNorm,ug/m2,,55.0
SYNTHETIC-5,DONOR_2479,TREATMENT_8979,Cell-based,,987654,RxNorm,mg/kg,117.0,146.0
SYNTHETIC-5,DONOR_2480,TREATMENT_8980,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,58.0,186.0
SYNTHETIC-5,DONOR_2481,TREATMENT_8981,Cell-based,Yervoy,239766,NCI Thesaurus,cells/kg,67.0,102.0
SYNTHETIC-5,DONOR_2482,TREATMENT_8982,Cell-based,Abemaciclib,,NCI Thesaurus,mg/m2,,136.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8983,Other immunomodulatory substances,,8756456,PubChem,mg/m2,87.0,86.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8984,Cell-based,,8836851,PubChem,IU/m2,162.0,159.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8985,Immune checkpoint inhibitors,Cometriq,8756456,NCI Thesaurus,mg/kg,,85.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8986,,Afatinib,8836851,PubChem,IU/m2,176.0,74.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8987,Immune checkpoint inhibitors,Cobimetinib,4459876,PubChem,cells/kg,122.0,96.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8988,Immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,ug/m2,105.0,58.0
SYNTHETIC-5,DONOR_2489,TREATMENT_8989,,Alecensa,8836851,NCI Thesaurus,mg/kg,192.0,184.0
SYNTHETIC-5,DONOR_2490,TREATMENT_8990,,Lynparza,4459876,PubChem,ug/m2,112.0,
SYNTHETIC-5,DONOR_2491,TREATMENT_8991,Cell-based,Adcetris,239766,RxNorm,g/m2,159.0,187.0
SYNTHETIC-5,DONOR_2492,TREATMENT_8992,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,RxNorm,mg/m2,81.0,
SYNTHETIC-5,DONOR_2493,TREATMENT_8993,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,278936,PubChem,ug/m2,113.0,99.0
SYNTHETIC-5,DONOR_2494,TREATMENT_8994,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,239766,PubChem,cells/kg,137.0,120.0
SYNTHETIC-5,DONOR_2495,TREATMENT_8995,Cell-based,Yervoy,987654,PubChem,IU/m2,98.0,
SYNTHETIC-5,DONOR_2496,TREATMENT_8996,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,8836851,NCI Thesaurus,IU/m2,95.0,157.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8997,Cell-based,Rucaparib,278936,NCI Thesaurus,g/m2,71.0,
SYNTHETIC-5,DONOR_2498,TREATMENT_8998,Immune checkpoint inhibitors,Nivolumab,,NCI Thesaurus,cells/kg,,128.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8999,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,4459876,PubChem,IU/kg,162.0,184.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9000,,Binimetinib,987654,NCI Thesaurus,mg/kg,52.0,
SYNTHETIC-5,DONOR_2001,TREATMENT_9001,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,mg/kg,144.0,170.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9002,,Atezolizumab,4459876,PubChem,cells/kg,190.0,
SYNTHETIC-5,DONOR_2003,TREATMENT_9003,Other immunomodulatory substances,Axicabtagene ciloleucel,987654,NCI Thesaurus,ug/m2,,193.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9004,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,cells/kg,145.0,118.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9005,Immune checkpoint inhibitors,Olaparib,278936,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2006,TREATMENT_9006,Other immunomodulatory substances,Alecensa,8756456,NCI Thesaurus,IU/kg,75.0,195.0
SYNTHETIC-5,DONOR_2007,TREATMENT_9007,Cell-based,Gefitinib,239766,NCI Thesaurus,IU/m2,113.0,168.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9008,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,239766,RxNorm,IU/kg,156.0,85.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9009,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,278936,PubChem,mg/kg,120.0,135.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9010,Other immunomodulatory substances,Nivolumab,,NCI Thesaurus,g/m2,141.0,176.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9011,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,,PubChem,ug/m2,187.0,175.0
SYNTHETIC-5,DONOR_2012,TREATMENT_9012,Other immunomodulatory substances,Yervoy,8836851,NCI Thesaurus,,,90.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9013,Other immunomodulatory substances,Osimertinib,4459876,NCI Thesaurus,ug/m2,74.0,99.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9014,Cell-based,Alectinib,4459876,NCI Thesaurus,,53.0,110.0
SYNTHETIC-5,DONOR_2015,TREATMENT_9015,Immune checkpoint inhibitors,Opdivo,239766,PubChem,,172.0,113.0
SYNTHETIC-5,DONOR_2016,TREATMENT_9016,Cell-based,Kadcyla,,PubChem,IU/m2,109.0,
SYNTHETIC-5,DONOR_2017,TREATMENT_9017,Cell-based,Vandetanib,239766,RxNorm,g/m2,186.0,
SYNTHETIC-5,DONOR_2018,TREATMENT_9018,Cell-based,Nexavar,8836851,,g/m2,116.0,189.0
SYNTHETIC-5,DONOR_2019,TREATMENT_9019,Immune checkpoint inhibitors,Nivolumab,,NCI Thesaurus,IU/m2,183.0,55.0
SYNTHETIC-5,DONOR_2020,TREATMENT_9020,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,PubChem,ug/m2,117.0,
SYNTHETIC-5,DONOR_2021,TREATMENT_9021,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,278936,NCI Thesaurus,mg/kg,161.0,142.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9022,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,cells/kg,70.0,154.0
SYNTHETIC-5,DONOR_2023,TREATMENT_9023,Other immunomodulatory substances,Abemaciclib,4459876,PubChem,IU/m2,142.0,180.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9024,Cell-based,Brentuximab vedotin,239766,PubChem,cells/kg,163.0,87.0
SYNTHETIC-5,DONOR_2025,TREATMENT_9025,Cell-based,Pembrolizumab,,,IU/kg,67.0,82.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9026,Immune checkpoint inhibitors,Lenvatinib,4459876,,IU/m2,165.0,185.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9027,Other immunomodulatory substances,,239766,PubChem,ug/m2,93.0,89.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9028,Immune checkpoint inhibitors,Alecensa,278936,PubChem,IU/m2,136.0,82.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9029,Other immunomodulatory substances,Atezolizumab,4459876,PubChem,IU/kg,138.0,191.0
SYNTHETIC-5,DONOR_2030,TREATMENT_9030,Cell-based,Brigatinib,8756456,,,135.0,69.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9031,Other immunomodulatory substances,Verzenio,8836851,PubChem,IU/kg,79.0,90.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9032,Cell-based,Ceritinib,987654,PubChem,IU/m2,,153.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9033,,,4459876,,,93.0,74.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9034,,Zykadia,8756456,NCI Thesaurus,cells/kg,56.0,117.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9035,Other immunomodulatory substances,Atezolizumab,,,IU/m2,60.0,166.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9036,Cell-based,Atezolizumab,8836851,NCI Thesaurus,ug/m2,117.0,191.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9037,,Trametinib,4459876,NCI Thesaurus,g/m2,186.0,163.0
SYNTHETIC-5,DONOR_2038,TREATMENT_9038,Immune checkpoint inhibitors,Ipilimumab,4459876,NCI Thesaurus,mg/m2,146.0,141.0
SYNTHETIC-5,DONOR_2039,TREATMENT_9039,Immune checkpoint inhibitors,Ibrance,,NCI Thesaurus,g/m2,178.0,
SYNTHETIC-5,DONOR_2040,TREATMENT_9040,Other immunomodulatory substances,Pembrolizumab,4459876,,mg/kg,70.0,144.0
SYNTHETIC-5,DONOR_2041,TREATMENT_9041,Cell-based,Inotuzumab ozogamicin,8836851,NCI Thesaurus,ug/m2,,104.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9042,,Venetoclax,278936,NCI Thesaurus,IU/kg,127.0,115.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9043,Immune checkpoint inhibitors,Keytruda,987654,,,100.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_9044,Immune checkpoint inhibitors,Ipilimumab,239766,RxNorm,g/m2,136.0,107.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9045,,Sorafenib,4459876,PubChem,g/m2,140.0,82.0
SYNTHETIC-5,DONOR_2046,TREATMENT_9046,Cell-based,Opdivo,8756456,NCI Thesaurus,mg/m2,103.0,
SYNTHETIC-5,DONOR_2047,TREATMENT_9047,,Belantamab,4459876,NCI Thesaurus,mg/m2,105.0,143.0
SYNTHETIC-5,DONOR_2048,TREATMENT_9048,Other immunomodulatory substances,Trametinib,4459876,,cells/kg,107.0,
SYNTHETIC-5,DONOR_2049,TREATMENT_9049,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,PubChem,cells/kg,,139.0
SYNTHETIC-5,DONOR_2050,TREATMENT_9050,,Yescarta,987654,,cells/kg,131.0,93.0
SYNTHETIC-5,DONOR_2051,TREATMENT_9051,Cell-based,Pembrolizumab,4459876,PubChem,,65.0,138.0
SYNTHETIC-5,DONOR_2052,TREATMENT_9052,Immune checkpoint inhibitors,,278936,RxNorm,IU/m2,169.0,155.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9053,Cell-based,Copanlisib,4459876,PubChem,mg/m2,133.0,
SYNTHETIC-5,DONOR_2054,TREATMENT_9054,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,ug/m2,,59.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9055,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,cells/kg,187.0,180.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9056,Other immunomodulatory substances,Tecentriq,8756456,NCI Thesaurus,g/m2,98.0,58.0
SYNTHETIC-5,DONOR_2057,TREATMENT_9057,,Mektovi,278936,NCI Thesaurus,IU/kg,171.0,
SYNTHETIC-5,DONOR_2058,TREATMENT_9058,Immune checkpoint inhibitors,Tisagenlecleucel,987654,PubChem,IU/m2,194.0,162.0
SYNTHETIC-5,DONOR_2059,TREATMENT_9059,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,,g/m2,149.0,77.0
SYNTHETIC-5,DONOR_2060,TREATMENT_9060,Cell-based,Durvalumab,278936,NCI Thesaurus,cells/kg,169.0,195.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9061,Other immunomodulatory substances,Pexidartinib,8836851,NCI Thesaurus,g/m2,,177.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9062,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,PubChem,IU/m2,58.0,75.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9063,,Keytruda,8756456,NCI Thesaurus,,,161.0
SYNTHETIC-5,DONOR_2064,TREATMENT_9064,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,PubChem,IU/m2,124.0,
SYNTHETIC-5,DONOR_2065,TREATMENT_9065,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,ug/m2,159.0,182.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9066,Cell-based,Pembrolizumab,4459876,NCI Thesaurus,,160.0,
SYNTHETIC-5,DONOR_2067,TREATMENT_9067,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,mg/m2,161.0,92.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9068,Cell-based,,278936,,mg/kg,147.0,104.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9069,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,ug/m2,195.0,54.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9070,Other immunomodulatory substances,Venclexta,278936,RxNorm,g/m2,68.0,139.0
SYNTHETIC-5,DONOR_2071,TREATMENT_9071,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,278936,,g/m2,187.0,104.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9072,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,ug/m2,176.0,154.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9073,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,NCI Thesaurus,ug/m2,130.0,
SYNTHETIC-5,DONOR_2074,TREATMENT_9074,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,cells/kg,130.0,
SYNTHETIC-5,DONOR_2075,TREATMENT_9075,Other immunomodulatory substances,Atezolizumab,987654,PubChem,mg/kg,162.0,74.0
SYNTHETIC-5,DONOR_2076,TREATMENT_9076,Other immunomodulatory substances,Ceritinib,8836851,PubChem,mg/kg,133.0,108.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9077,,Kisqali,239766,RxNorm,IU/m2,166.0,142.0
SYNTHETIC-5,DONOR_2078,TREATMENT_9078,Cell-based,Osimertinib,8756456,PubChem,g/m2,112.0,89.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9079,Immune checkpoint inhibitors,Yervoy,278936,PubChem,cells/kg,96.0,101.0
SYNTHETIC-5,DONOR_2080,TREATMENT_9080,Cell-based,Trastuzumab,987654,NCI Thesaurus,g/m2,193.0,186.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9081,Cell-based,Ipilimumab,4459876,RxNorm,IU/kg,58.0,200.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9082,Cell-based,Mekinist,4459876,RxNorm,g/m2,,190.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9083,Immune checkpoint inhibitors,Zejula,239766,PubChem,g/m2,80.0,82.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9084,Cell-based,Mektovi,4459876,PubChem,ug/m2,88.0,
SYNTHETIC-5,DONOR_2085,TREATMENT_9085,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,IU/kg,176.0,78.0
SYNTHETIC-5,DONOR_2086,TREATMENT_9086,Other immunomodulatory substances,Ipilimumab,8836851,RxNorm,mg/m2,166.0,179.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9087,,Encorafenib,,RxNorm,mg/m2,66.0,58.0
SYNTHETIC-5,DONOR_2088,TREATMENT_9088,Other immunomodulatory substances,Yervoy,8756456,RxNorm,IU/m2,158.0,
SYNTHETIC-5,DONOR_2089,TREATMENT_9089,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,278936,RxNorm,mg/m2,,134.0
SYNTHETIC-5,DONOR_2090,TREATMENT_9090,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,278936,PubChem,IU/kg,197.0,144.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9091,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,NCI Thesaurus,IU/m2,189.0,
SYNTHETIC-5,DONOR_2092,TREATMENT_9092,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,4459876,NCI Thesaurus,IU/kg,117.0,63.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9093,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,987654,RxNorm,g/m2,120.0,53.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9094,Cell-based,Imfinzi,8756456,RxNorm,cells/kg,181.0,200.0
SYNTHETIC-5,DONOR_2095,TREATMENT_9095,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,278936,NCI Thesaurus,mg/kg,165.0,105.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9096,Immune checkpoint inhibitors,Tecentriq,4459876,PubChem,g/m2,199.0,68.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9097,Cell-based,Durvalumab,278936,NCI Thesaurus,ug/m2,162.0,
SYNTHETIC-5,DONOR_2098,TREATMENT_9098,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,PubChem,mg/m2,50.0,
SYNTHETIC-5,DONOR_2099,TREATMENT_9099,Other immunomodulatory substances,Rubraca,8836851,RxNorm,,117.0,
SYNTHETIC-5,DONOR_2100,TREATMENT_9100,Immune checkpoint inhibitors,Belantamab,8836851,NCI Thesaurus,g/m2,101.0,127.0
SYNTHETIC-5,DONOR_2101,TREATMENT_9101,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,987654,,mg/m2,141.0,
SYNTHETIC-5,DONOR_2102,TREATMENT_9102,,,239766,PubChem,mg/m2,109.0,117.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9103,Other immunomodulatory substances,Adcetris,987654,,IU/m2,147.0,85.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9104,Other immunomodulatory substances,Tarceva,278936,NCI Thesaurus,IU/m2,197.0,189.0
SYNTHETIC-5,DONOR_2105,TREATMENT_9105,Immune checkpoint inhibitors,Opdivo,4459876,RxNorm,mg/kg,110.0,
SYNTHETIC-5,DONOR_2106,TREATMENT_9106,Cell-based,Daratumumab,987654,RxNorm,,132.0,
SYNTHETIC-5,DONOR_2107,TREATMENT_9107,,Ceritinib,8836851,,,144.0,136.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9108,Cell-based,Venclexta,239766,RxNorm,IU/m2,55.0,90.0
SYNTHETIC-5,DONOR_2109,TREATMENT_9109,Cell-based,,8756456,NCI Thesaurus,,145.0,192.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9110,,Ribociclib,278936,RxNorm,IU/m2,113.0,55.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9111,Other immunomodulatory substances,Gilotrif,4459876,PubChem,ug/m2,108.0,125.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9112,,Vandetanib,4459876,RxNorm,mg/kg,102.0,
SYNTHETIC-5,DONOR_2113,TREATMENT_9113,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,NCI Thesaurus,IU/m2,,194.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9114,Cell-based,Erlotinib,278936,PubChem,IU/m2,60.0,99.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9115,Immune checkpoint inhibitors,Yervoy,8756456,RxNorm,,127.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_9116,,Tafinlar,987654,RxNorm,IU/m2,,136.0
SYNTHETIC-5,DONOR_2117,TREATMENT_9117,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,987654,RxNorm,cells/kg,104.0,176.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9118,Immune checkpoint inhibitors,Tarceva,4459876,RxNorm,IU/m2,147.0,144.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9119,Cell-based,Brigatinib,239766,PubChem,ug/m2,,170.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9120,Immune checkpoint inhibitors,Imfinzi,,,g/m2,79.0,156.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9121,Cell-based,Alecensa,278936,RxNorm,,98.0,141.0
SYNTHETIC-5,DONOR_2122,TREATMENT_9122,Immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,ug/m2,108.0,167.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9123,Other immunomodulatory substances,Trametinib,8756456,,mg/kg,119.0,156.0
SYNTHETIC-5,DONOR_2124,TREATMENT_9124,Immune checkpoint inhibitors,,987654,PubChem,ug/m2,85.0,91.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9125,,Nivolumab,,NCI Thesaurus,ug/m2,71.0,
SYNTHETIC-5,DONOR_2126,TREATMENT_9126,Cell-based,Blincyto,278936,NCI Thesaurus,mg/m2,77.0,171.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9127,Cell-based,Gefitinib,,PubChem,,173.0,
SYNTHETIC-5,DONOR_2128,TREATMENT_9128,Cell-based,Enhertu,239766,PubChem,mg/m2,,108.0
SYNTHETIC-5,DONOR_2129,TREATMENT_9129,Other immunomodulatory substances,Nivolumab,,PubChem,,180.0,59.0
SYNTHETIC-5,DONOR_2130,TREATMENT_9130,Other immunomodulatory substances,Mekinist,987654,NCI Thesaurus,cells/kg,75.0,198.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9131,Other immunomodulatory substances,Alectinib,278936,RxNorm,cells/kg,129.0,69.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9132,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,8756456,PubChem,IU/kg,189.0,
SYNTHETIC-5,DONOR_2133,TREATMENT_9133,,Ipilimumab,,RxNorm,g/m2,,194.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9134,Immune checkpoint inhibitors,Crizotinib,278936,NCI Thesaurus,cells/kg,,186.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9135,Immune checkpoint inhibitors,Lenvima,,,,104.0,65.0
SYNTHETIC-5,DONOR_2136,TREATMENT_9136,Other immunomodulatory substances,Pexidartinib,278936,RxNorm,g/m2,168.0,
SYNTHETIC-5,DONOR_2137,TREATMENT_9137,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,239766,NCI Thesaurus,,,76.0
SYNTHETIC-5,DONOR_2138,TREATMENT_9138,Cell-based,Iressa,239766,RxNorm,IU/m2,177.0,113.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9139,Cell-based,Daratumumab,987654,PubChem,IU/kg,,52.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9140,Other immunomodulatory substances,Ceritinib,8756456,RxNorm,IU/kg,185.0,
SYNTHETIC-5,DONOR_2141,TREATMENT_9141,Immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,IU/m2,167.0,72.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9142,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,987654,,ug/m2,62.0,114.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9143,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,8836851,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2144,TREATMENT_9144,Immune checkpoint inhibitors,Tagrisso,4459876,NCI Thesaurus,ug/m2,200.0,102.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9145,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,mg/kg,89.0,90.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9146,Cell-based,Kadcyla,8836851,PubChem,g/m2,176.0,
SYNTHETIC-5,DONOR_2147,TREATMENT_9147,Cell-based,Tecentriq,,,mg/kg,192.0,54.0
SYNTHETIC-5,DONOR_2148,TREATMENT_9148,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,239766,NCI Thesaurus,ug/m2,185.0,116.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9149,Immune checkpoint inhibitors,Alunbrig,8836851,RxNorm,mg/m2,73.0,74.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9150,,Inotuzumab ozogamicin,278936,RxNorm,cells/kg,158.0,
SYNTHETIC-5,DONOR_2151,TREATMENT_9151,,Durvalumab,4459876,NCI Thesaurus,mg/m2,134.0,53.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9152,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,,193.0,104.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9153,Cell-based,,239766,PubChem,,,
SYNTHETIC-5,DONOR_2154,TREATMENT_9154,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2155,TREATMENT_9155,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,,,59.0
SYNTHETIC-5,DONOR_2156,TREATMENT_9156,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,,RxNorm,,140.0,151.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9157,Cell-based,Atezolizumab,278936,RxNorm,IU/kg,151.0,69.0
SYNTHETIC-5,DONOR_2158,TREATMENT_9158,Cell-based,Besponsa,278936,,mg/kg,134.0,186.0
SYNTHETIC-5,DONOR_2159,TREATMENT_9159,,,8756456,NCI Thesaurus,mg/kg,53.0,51.0
SYNTHETIC-5,DONOR_2160,TREATMENT_9160,Immune checkpoint inhibitors,Dabrafenib,278936,RxNorm,mg/kg,94.0,78.0
SYNTHETIC-5,DONOR_2161,TREATMENT_9161,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,,,188.0,97.0
SYNTHETIC-5,DONOR_2162,TREATMENT_9162,Cell-based,Keytruda,239766,PubChem,mg/m2,,
SYNTHETIC-5,DONOR_2163,TREATMENT_9163,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,g/m2,191.0,142.0
SYNTHETIC-5,DONOR_2164,TREATMENT_9164,Other immunomodulatory substances,Rucaparib,8756456,RxNorm,ug/m2,131.0,102.0
SYNTHETIC-5,DONOR_2165,TREATMENT_9165,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,ug/m2,58.0,
SYNTHETIC-5,DONOR_2166,TREATMENT_9166,Immune checkpoint inhibitors,Gefitinib,987654,RxNorm,mg/kg,89.0,131.0
SYNTHETIC-5,DONOR_2167,TREATMENT_9167,Immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,IU/kg,148.0,181.0
SYNTHETIC-5,DONOR_2168,TREATMENT_9168,Immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,mg/kg,151.0,102.0
SYNTHETIC-5,DONOR_2169,TREATMENT_9169,,,987654,RxNorm,cells/kg,145.0,83.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9170,,Tisagenlecleucel,4459876,PubChem,mg/kg,130.0,
SYNTHETIC-5,DONOR_2171,TREATMENT_9171,Other immunomodulatory substances,Opdivo,239766,RxNorm,IU/kg,74.0,
SYNTHETIC-5,DONOR_2172,TREATMENT_9172,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,g/m2,103.0,
SYNTHETIC-5,DONOR_2173,TREATMENT_9173,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,278936,PubChem,IU/kg,170.0,61.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9174,Cell-based,Blincyto,278936,,mg/m2,82.0,155.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9175,Immune checkpoint inhibitors,Darzalex,8836851,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2176,TREATMENT_9176,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,cells/kg,77.0,182.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9177,Cell-based,Ado-trastuzumab emtansine,987654,PubChem,ug/m2,178.0,134.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9178,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,,PubChem,IU/m2,154.0,
SYNTHETIC-5,DONOR_2179,TREATMENT_9179,Monoclonal antibodies other than immune checkpoint inhibitors,,,,g/m2,100.0,160.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9180,Immune checkpoint inhibitors,,239766,NCI Thesaurus,,,111.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9181,,Lenvima,278936,RxNorm,IU/m2,145.0,
SYNTHETIC-5,DONOR_2182,TREATMENT_9182,Cell-based,Yervoy,8756456,PubChem,mg/m2,,102.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9183,Immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,mg/m2,98.0,156.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9184,Immune checkpoint inhibitors,Yervoy,239766,PubChem,cells/kg,125.0,118.0
SYNTHETIC-5,DONOR_2185,TREATMENT_9185,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,,IU/kg,88.0,82.0
SYNTHETIC-5,DONOR_2186,TREATMENT_9186,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,mg/m2,53.0,87.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9187,Other immunomodulatory substances,Lenvatinib,,NCI Thesaurus,,157.0,161.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9188,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,278936,RxNorm,cells/kg,199.0,156.0
SYNTHETIC-5,DONOR_2189,TREATMENT_9189,Cell-based,Abemaciclib,,PubChem,IU/kg,134.0,138.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9190,Other immunomodulatory substances,Afatinib,278936,NCI Thesaurus,g/m2,,183.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9191,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,mg/m2,150.0,154.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9192,Cell-based,Enhertu,987654,,IU/kg,89.0,106.0
SYNTHETIC-5,DONOR_2193,TREATMENT_9193,,Nivolumab,,RxNorm,ug/m2,57.0,
SYNTHETIC-5,DONOR_2194,TREATMENT_9194,Immune checkpoint inhibitors,Brentuximab vedotin,8756456,RxNorm,mg/kg,52.0,156.0
SYNTHETIC-5,DONOR_2195,TREATMENT_9195,Cell-based,Ipilimumab,4459876,PubChem,,146.0,139.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9196,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,PubChem,IU/kg,143.0,97.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9197,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,4459876,PubChem,g/m2,76.0,
SYNTHETIC-5,DONOR_2198,TREATMENT_9198,Immune checkpoint inhibitors,Caprelsa,239766,NCI Thesaurus,IU/m2,72.0,187.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9199,Cell-based,Tisagenlecleucel,987654,RxNorm,,59.0,119.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9200,Immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,ug/m2,176.0,56.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9201,Cell-based,Opdivo,239766,NCI Thesaurus,mg/kg,97.0,122.0
SYNTHETIC-5,DONOR_2202,TREATMENT_9202,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,mg/kg,,
SYNTHETIC-5,DONOR_2203,TREATMENT_9203,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,RxNorm,mg/kg,104.0,159.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9204,Immune checkpoint inhibitors,,8756456,RxNorm,g/m2,61.0,135.0
SYNTHETIC-5,DONOR_2205,TREATMENT_9205,Other immunomodulatory substances,Erlotinib,4459876,RxNorm,mg/kg,89.0,70.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9206,,Nivolumab,239766,NCI Thesaurus,IU/m2,71.0,107.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9207,Other immunomodulatory substances,Axicabtagene ciloleucel,8836851,NCI Thesaurus,mg/m2,106.0,80.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9208,Immune checkpoint inhibitors,Imfinzi,239766,RxNorm,mg/m2,66.0,159.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9209,Immune checkpoint inhibitors,Vandetanib,239766,PubChem,g/m2,130.0,140.0
SYNTHETIC-5,DONOR_2210,TREATMENT_9210,Other immunomodulatory substances,Zykadia,8836851,,cells/kg,95.0,200.0
SYNTHETIC-5,DONOR_2211,TREATMENT_9211,Immune checkpoint inhibitors,Tafinlar,8756456,NCI Thesaurus,g/m2,146.0,199.0
SYNTHETIC-5,DONOR_2212,TREATMENT_9212,Cell-based,Kymriah,278936,PubChem,IU/m2,109.0,
SYNTHETIC-5,DONOR_2213,TREATMENT_9213,Other immunomodulatory substances,Brentuximab vedotin,4459876,NCI Thesaurus,mg/kg,55.0,98.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9214,Other immunomodulatory substances,Binimetinib,278936,RxNorm,ug/m2,200.0,120.0
SYNTHETIC-5,DONOR_2215,TREATMENT_9215,Cell-based,Kisqali,239766,RxNorm,mg/m2,127.0,
SYNTHETIC-5,DONOR_2216,TREATMENT_9216,Other immunomodulatory substances,,239766,PubChem,mg/m2,,57.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9217,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,IU/m2,,189.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9218,Immune checkpoint inhibitors,,239766,RxNorm,mg/kg,,
SYNTHETIC-5,DONOR_2219,TREATMENT_9219,Other immunomodulatory substances,,4459876,,IU/m2,122.0,
SYNTHETIC-5,DONOR_2220,TREATMENT_9220,,Mektovi,8836851,NCI Thesaurus,IU/m2,109.0,102.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9221,Cell-based,Iressa,278936,PubChem,g/m2,166.0,91.0
SYNTHETIC-5,DONOR_2222,TREATMENT_9222,Other immunomodulatory substances,Mektovi,,PubChem,mg/kg,170.0,81.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9223,Cell-based,Pertuzumab,278936,NCI Thesaurus,cells/kg,94.0,90.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9224,Cell-based,,987654,RxNorm,IU/kg,,98.0
SYNTHETIC-5,DONOR_2225,TREATMENT_9225,Other immunomodulatory substances,Lenvatinib,,,ug/m2,148.0,157.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9226,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8836851,PubChem,mg/m2,62.0,86.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9227,Immune checkpoint inhibitors,Rucaparib,8836851,PubChem,mg/kg,195.0,195.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9228,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,PubChem,cells/kg,67.0,196.0
SYNTHETIC-5,DONOR_2229,TREATMENT_9229,,Caprelsa,239766,PubChem,g/m2,112.0,75.0
SYNTHETIC-5,DONOR_2230,TREATMENT_9230,Cell-based,Opdivo,4459876,PubChem,,62.0,125.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9231,Immune checkpoint inhibitors,Yescarta,278936,,IU/m2,,140.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9232,,,,NCI Thesaurus,mg/kg,54.0,85.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9233,Cell-based,Yescarta,,,g/m2,139.0,128.0
SYNTHETIC-5,DONOR_2234,TREATMENT_9234,,Palbociclib,278936,,mg/kg,159.0,154.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9235,Other immunomodulatory substances,Erlotinib,4459876,NCI Thesaurus,mg/m2,182.0,
SYNTHETIC-5,DONOR_2236,TREATMENT_9236,Immune checkpoint inhibitors,,8756456,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2237,TREATMENT_9237,Other immunomodulatory substances,Abemaciclib,987654,NCI Thesaurus,ug/m2,143.0,187.0
SYNTHETIC-5,DONOR_2238,TREATMENT_9238,,Blincyto,8756456,,,184.0,
SYNTHETIC-5,DONOR_2239,TREATMENT_9239,Cell-based,Pembrolizumab,,NCI Thesaurus,cells/kg,99.0,176.0
SYNTHETIC-5,DONOR_2240,TREATMENT_9240,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,987654,,,161.0,82.0
SYNTHETIC-5,DONOR_2241,TREATMENT_9241,Other immunomodulatory substances,Ado-trastuzumab emtansine,278936,RxNorm,g/m2,142.0,161.0
SYNTHETIC-5,DONOR_2242,TREATMENT_9242,Other immunomodulatory substances,Selumitinib,278936,NCI Thesaurus,cells/kg,79.0,56.0
SYNTHETIC-5,DONOR_2243,TREATMENT_9243,Cell-based,Osimertinib,278936,NCI Thesaurus,cells/kg,159.0,93.0
SYNTHETIC-5,DONOR_2244,TREATMENT_9244,Cell-based,,239766,RxNorm,ug/m2,101.0,162.0
SYNTHETIC-5,DONOR_2245,TREATMENT_9245,Other immunomodulatory substances,Alecensa,8836851,RxNorm,,179.0,194.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9246,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,,101.0,145.0
SYNTHETIC-5,DONOR_2247,TREATMENT_9247,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,PubChem,mg/kg,195.0,115.0
SYNTHETIC-5,DONOR_2248,TREATMENT_9248,,Ipilimumab,,RxNorm,cells/kg,167.0,74.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9249,Cell-based,Rubraca,278936,RxNorm,,,
SYNTHETIC-5,DONOR_2250,TREATMENT_9250,Other immunomodulatory substances,Adcetris,,,cells/kg,73.0,67.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9251,Cell-based,Tecentriq,239766,NCI Thesaurus,,181.0,68.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9252,Immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,,114.0,66.0
SYNTHETIC-5,DONOR_2253,TREATMENT_9253,Immune checkpoint inhibitors,Alunbrig,239766,RxNorm,mg/m2,146.0,89.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9254,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,PubChem,,74.0,68.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9255,Other immunomodulatory substances,Pertuzumab,278936,,mg/kg,158.0,190.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9256,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,8756456,PubChem,cells/kg,120.0,131.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9257,Cell-based,Erlotinib,4459876,PubChem,,184.0,
SYNTHETIC-5,DONOR_2258,TREATMENT_9258,Immune checkpoint inhibitors,Kisqali,8836851,,IU/m2,119.0,
SYNTHETIC-5,DONOR_2259,TREATMENT_9259,Other immunomodulatory substances,Gilteritinib,278936,PubChem,,,81.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9260,Cell-based,Brentuximab vedotin,8756456,PubChem,g/m2,177.0,101.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9261,Immune checkpoint inhibitors,Yervoy,8756456,NCI Thesaurus,,121.0,80.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9262,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,RxNorm,mg/m2,70.0,92.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9263,Other immunomodulatory substances,Venetoclax,239766,PubChem,mg/kg,,147.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9264,Cell-based,Keytruda,987654,NCI Thesaurus,ug/m2,64.0,
SYNTHETIC-5,DONOR_2265,TREATMENT_9265,Other immunomodulatory substances,Pembrolizumab,8756456,PubChem,g/m2,121.0,143.0
SYNTHETIC-5,DONOR_2266,TREATMENT_9266,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,,177.0,144.0
SYNTHETIC-5,DONOR_2267,TREATMENT_9267,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,278936,RxNorm,,149.0,
SYNTHETIC-5,DONOR_2268,TREATMENT_9268,Cell-based,Imfinzi,239766,PubChem,,140.0,183.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9269,,Venetoclax,8756456,PubChem,ug/m2,,150.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9270,Other immunomodulatory substances,Caprelsa,239766,PubChem,IU/m2,128.0,51.0
SYNTHETIC-5,DONOR_2271,TREATMENT_9271,Immune checkpoint inhibitors,Niraparib,8836851,PubChem,cells/kg,162.0,
SYNTHETIC-5,DONOR_2272,TREATMENT_9272,Other immunomodulatory substances,Tafinlar,4459876,NCI Thesaurus,IU/m2,99.0,73.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9273,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,IU/m2,152.0,
SYNTHETIC-5,DONOR_2274,TREATMENT_9274,,Pexidartinib,987654,PubChem,,146.0,154.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9275,Cell-based,,987654,PubChem,g/m2,,77.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9276,Immune checkpoint inhibitors,Binimetinib,987654,NCI Thesaurus,,,97.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9277,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,RxNorm,cells/kg,159.0,138.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9278,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,NCI Thesaurus,g/m2,59.0,
SYNTHETIC-5,DONOR_2279,TREATMENT_9279,Immune checkpoint inhibitors,Kymriah,8836851,RxNorm,mg/m2,136.0,196.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9280,Cell-based,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,IU/m2,89.0,117.0
SYNTHETIC-5,DONOR_2281,TREATMENT_9281,Immune checkpoint inhibitors,Palbociclib,8756456,PubChem,,105.0,
SYNTHETIC-5,DONOR_2282,TREATMENT_9282,Other immunomodulatory substances,Copanlisib,8836851,NCI Thesaurus,IU/kg,166.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_9283,Cell-based,Encorafenib,8756456,PubChem,mg/kg,84.0,129.0
SYNTHETIC-5,DONOR_2284,TREATMENT_9284,,Adcetris,8836851,NCI Thesaurus,cells/kg,154.0,116.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9285,Cell-based,Pembrolizumab,8836851,PubChem,ug/m2,,168.0
SYNTHETIC-5,DONOR_2286,TREATMENT_9286,Other immunomodulatory substances,Darzalex,8756456,NCI Thesaurus,mg/kg,98.0,155.0
SYNTHETIC-5,DONOR_2287,TREATMENT_9287,Cell-based,,4459876,RxNorm,mg/kg,141.0,120.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9288,Immune checkpoint inhibitors,,278936,PubChem,mg/m2,163.0,195.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9289,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,4459876,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2290,TREATMENT_9290,,Nivolumab,8756456,PubChem,mg/m2,91.0,102.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9291,Cell-based,Trametinib,8756456,NCI Thesaurus,mg/m2,135.0,
SYNTHETIC-5,DONOR_2292,TREATMENT_9292,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,987654,RxNorm,ug/m2,94.0,109.0
SYNTHETIC-5,DONOR_2293,TREATMENT_9293,Other immunomodulatory substances,Perjeta,8836851,,mg/m2,83.0,
SYNTHETIC-5,DONOR_2294,TREATMENT_9294,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,,cells/kg,82.0,
SYNTHETIC-5,DONOR_2295,TREATMENT_9295,Cell-based,Keytruda,987654,,,122.0,
SYNTHETIC-5,DONOR_2296,TREATMENT_9296,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,,NCI Thesaurus,cells/kg,139.0,164.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9297,,Braftovi,987654,PubChem,mg/m2,187.0,104.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9298,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,,PubChem,mg/m2,118.0,109.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9299,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,4459876,PubChem,mg/kg,169.0,143.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9300,Immune checkpoint inhibitors,Sorafenib,239766,,mg/kg,87.0,115.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9301,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,RxNorm,IU/kg,95.0,56.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9302,Cell-based,,4459876,RxNorm,mg/m2,158.0,
SYNTHETIC-5,DONOR_2303,TREATMENT_9303,Immune checkpoint inhibitors,Vemurafenib,8836851,NCI Thesaurus,g/m2,137.0,79.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9304,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,IU/kg,140.0,69.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9305,,Cotellic,8756456,RxNorm,,102.0,83.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9306,Immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,ug/m2,142.0,
SYNTHETIC-5,DONOR_2307,TREATMENT_9307,Other immunomodulatory substances,Dabrafenib,4459876,NCI Thesaurus,cells/kg,191.0,
SYNTHETIC-5,DONOR_2308,TREATMENT_9308,Cell-based,Axicabtagene ciloleucel,,,mg/kg,196.0,99.0
SYNTHETIC-5,DONOR_2309,TREATMENT_9309,Cell-based,Cometriq,987654,PubChem,mg/kg,120.0,153.0
SYNTHETIC-5,DONOR_2310,TREATMENT_9310,Immune checkpoint inhibitors,Nivolumab,987654,RxNorm,ug/m2,87.0,151.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9311,Cell-based,Durvalumab,239766,RxNorm,mg/kg,115.0,69.0
SYNTHETIC-5,DONOR_2312,TREATMENT_9312,,Ribociclib,239766,PubChem,cells/kg,162.0,
SYNTHETIC-5,DONOR_2313,TREATMENT_9313,,Necitumumab,4459876,RxNorm,IU/kg,87.0,194.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9314,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,NCI Thesaurus,g/m2,182.0,87.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9315,Immune checkpoint inhibitors,,987654,RxNorm,,62.0,200.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9316,,,278936,RxNorm,ug/m2,165.0,194.0
SYNTHETIC-5,DONOR_2317,TREATMENT_9317,Other immunomodulatory substances,Inotuzumab ozogamicin,4459876,PubChem,cells/kg,90.0,54.0
SYNTHETIC-5,DONOR_2318,TREATMENT_9318,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,ug/m2,85.0,89.0
SYNTHETIC-5,DONOR_2319,TREATMENT_9319,Cell-based,Pexidartinib,8836851,RxNorm,,,136.0
SYNTHETIC-5,DONOR_2320,TREATMENT_9320,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,987654,NCI Thesaurus,mg/m2,200.0,198.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9321,Cell-based,Keytruda,4459876,,mg/m2,54.0,64.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9322,Other immunomodulatory substances,,278936,NCI Thesaurus,,96.0,
SYNTHETIC-5,DONOR_2323,TREATMENT_9323,Other immunomodulatory substances,,,NCI Thesaurus,IU/kg,182.0,136.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9324,Other immunomodulatory substances,,8756456,PubChem,ug/m2,,94.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9325,Cell-based,Lynparza,4459876,PubChem,g/m2,158.0,59.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9326,Other immunomodulatory substances,Imfinzi,8756456,RxNorm,,175.0,93.0
SYNTHETIC-5,DONOR_2327,TREATMENT_9327,Cell-based,Ipilimumab,987654,,g/m2,,68.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9328,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,ug/m2,190.0,
SYNTHETIC-5,DONOR_2329,TREATMENT_9329,Cell-based,,278936,NCI Thesaurus,mg/m2,91.0,161.0
SYNTHETIC-5,DONOR_2330,TREATMENT_9330,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,g/m2,154.0,131.0
SYNTHETIC-5,DONOR_2331,TREATMENT_9331,Cell-based,Nivolumab,4459876,,ug/m2,200.0,169.0
SYNTHETIC-5,DONOR_2332,TREATMENT_9332,Cell-based,Tisagenlecleucel,,PubChem,,134.0,96.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9333,Cell-based,,987654,RxNorm,ug/m2,81.0,56.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9334,,Caprelsa,987654,,cells/kg,179.0,
SYNTHETIC-5,DONOR_2335,TREATMENT_9335,Immune checkpoint inhibitors,Tagrisso,,RxNorm,,109.0,174.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9336,,Tecentriq,4459876,PubChem,ug/m2,99.0,148.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9337,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,,RxNorm,mg/m2,,106.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9338,Cell-based,Pertuzumab,239766,RxNorm,g/m2,128.0,166.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9339,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,278936,NCI Thesaurus,mg/m2,,158.0
SYNTHETIC-5,DONOR_2340,TREATMENT_9340,,Yescarta,,NCI Thesaurus,,86.0,
SYNTHETIC-5,DONOR_2341,TREATMENT_9341,,Yervoy,8756456,RxNorm,mg/kg,,51.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9342,Cell-based,Pertuzumab,8836851,PubChem,,,109.0
SYNTHETIC-5,DONOR_2343,TREATMENT_9343,Other immunomodulatory substances,,,NCI Thesaurus,,63.0,113.0
SYNTHETIC-5,DONOR_2344,TREATMENT_9344,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,987654,,cells/kg,75.0,66.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9345,Immune checkpoint inhibitors,Nexavar,278936,PubChem,IU/m2,68.0,58.0
SYNTHETIC-5,DONOR_2346,TREATMENT_9346,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,987654,NCI Thesaurus,mg/kg,138.0,135.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9347,Cell-based,Brentuximab vedotin,239766,NCI Thesaurus,ug/m2,88.0,143.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9348,Immune checkpoint inhibitors,Blincyto,8836851,RxNorm,IU/kg,143.0,51.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9349,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,,PubChem,IU/kg,172.0,
SYNTHETIC-5,DONOR_2350,TREATMENT_9350,,Pembrolizumab,4459876,PubChem,,68.0,
SYNTHETIC-5,DONOR_2351,TREATMENT_9351,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,IU/m2,134.0,125.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9352,,Mekinist,278936,RxNorm,IU/m2,154.0,67.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9353,,Imfinzi,4459876,RxNorm,IU/m2,118.0,144.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9354,,Nivolumab,8756456,,mg/m2,96.0,78.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9355,,,239766,PubChem,,,96.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9356,Other immunomodulatory substances,Tecentriq,,,,108.0,80.0
SYNTHETIC-5,DONOR_2357,TREATMENT_9357,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,278936,NCI Thesaurus,mg/kg,154.0,116.0
SYNTHETIC-5,DONOR_2358,TREATMENT_9358,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,,133.0,
SYNTHETIC-5,DONOR_2359,TREATMENT_9359,Other immunomodulatory substances,,278936,,mg/m2,105.0,100.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9360,Other immunomodulatory substances,Nivolumab,278936,PubChem,g/m2,117.0,78.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9361,Cell-based,Ipilimumab,4459876,RxNorm,IU/m2,79.0,60.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9362,Other immunomodulatory substances,Cometriq,987654,PubChem,IU/kg,96.0,73.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9363,,,4459876,NCI Thesaurus,mg/kg,80.0,74.0
SYNTHETIC-5,DONOR_2364,TREATMENT_9364,Other immunomodulatory substances,Mektovi,987654,RxNorm,mg/kg,101.0,82.0
SYNTHETIC-5,DONOR_2365,TREATMENT_9365,Immune checkpoint inhibitors,Xalkori,4459876,,cells/kg,129.0,
SYNTHETIC-5,DONOR_2366,TREATMENT_9366,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,PubChem,cells/kg,132.0,124.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9367,Other immunomodulatory substances,Ipilimumab,239766,NCI Thesaurus,,,158.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9368,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,278936,PubChem,IU/kg,78.0,160.0
SYNTHETIC-5,DONOR_2369,TREATMENT_9369,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,RxNorm,ug/m2,,109.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9370,Immune checkpoint inhibitors,Crizotinib,8756456,RxNorm,IU/m2,125.0,58.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9371,Other immunomodulatory substances,Yervoy,8836851,,ug/m2,124.0,155.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9372,Immune checkpoint inhibitors,Rituxan,,RxNorm,mg/kg,94.0,
SYNTHETIC-5,DONOR_2373,TREATMENT_9373,Other immunomodulatory substances,,4459876,,IU/m2,158.0,195.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9374,Cell-based,,239766,NCI Thesaurus,mg/m2,,118.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9375,,Yervoy,8836851,NCI Thesaurus,IU/kg,,101.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9376,Immune checkpoint inhibitors,Brentuximab vedotin,239766,RxNorm,,60.0,165.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9377,Immune checkpoint inhibitors,Kisqali,,RxNorm,,200.0,195.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9378,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,,IU/kg,89.0,57.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9379,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8836851,NCI Thesaurus,cells/kg,164.0,
SYNTHETIC-5,DONOR_2380,TREATMENT_9380,Other immunomodulatory substances,Cobimetinib,278936,,cells/kg,66.0,108.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9381,Cell-based,Trametinib,278936,RxNorm,mg/kg,130.0,78.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9382,Other immunomodulatory substances,Tisagenlecleucel,8836851,NCI Thesaurus,,,
SYNTHETIC-5,DONOR_2383,TREATMENT_9383,Immune checkpoint inhibitors,Durvalumab,,PubChem,IU/m2,181.0,108.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9384,Other immunomodulatory substances,Kymriah,987654,NCI Thesaurus,mg/m2,131.0,59.0
SYNTHETIC-5,DONOR_2385,TREATMENT_9385,,Vandetanib,8836851,NCI Thesaurus,IU/kg,97.0,178.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9386,Other immunomodulatory substances,Ipilimumab,8756456,NCI Thesaurus,cells/kg,189.0,112.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9387,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,,g/m2,162.0,190.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9388,Other immunomodulatory substances,,,PubChem,IU/m2,164.0,85.0
SYNTHETIC-5,DONOR_2389,TREATMENT_9389,,,239766,NCI Thesaurus,ug/m2,,60.0
SYNTHETIC-5,DONOR_2390,TREATMENT_9390,Immune checkpoint inhibitors,Enhertu,4459876,,,78.0,156.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9391,Cell-based,,987654,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2392,TREATMENT_9392,Immune checkpoint inhibitors,Ibrance,987654,PubChem,cells/kg,88.0,
SYNTHETIC-5,DONOR_2393,TREATMENT_9393,Other immunomodulatory substances,Opdivo,239766,RxNorm,g/m2,,149.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9394,,,278936,,cells/kg,182.0,
SYNTHETIC-5,DONOR_2395,TREATMENT_9395,Immune checkpoint inhibitors,Pexidartinib,278936,NCI Thesaurus,g/m2,63.0,145.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9396,Immune checkpoint inhibitors,Ipilimumab,987654,NCI Thesaurus,mg/m2,105.0,
SYNTHETIC-5,DONOR_2397,TREATMENT_9397,Cell-based,Opdivo,8836851,NCI Thesaurus,cells/kg,148.0,67.0
SYNTHETIC-5,DONOR_2398,TREATMENT_9398,Cell-based,Vemurafenib,8836851,RxNorm,g/m2,188.0,142.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9399,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,mg/kg,197.0,
SYNTHETIC-5,DONOR_2400,TREATMENT_9400,Cell-based,Opdivo,4459876,NCI Thesaurus,cells/kg,113.0,143.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9401,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,987654,RxNorm,mg/m2,90.0,111.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9402,Immune checkpoint inhibitors,,278936,,,,166.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9403,Cell-based,Atezolizumab,8836851,RxNorm,mg/m2,56.0,164.0
SYNTHETIC-5,DONOR_2404,TREATMENT_9404,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,NCI Thesaurus,mg/m2,108.0,109.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9405,Other immunomodulatory substances,Iressa,,NCI Thesaurus,mg/kg,175.0,157.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9406,Cell-based,,8756456,RxNorm,IU/m2,171.0,158.0
SYNTHETIC-5,DONOR_2407,TREATMENT_9407,Cell-based,,,,IU/m2,199.0,
SYNTHETIC-5,DONOR_2408,TREATMENT_9408,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,239766,PubChem,IU/m2,81.0,
SYNTHETIC-5,DONOR_2409,TREATMENT_9409,,Keytruda,987654,RxNorm,IU/m2,196.0,191.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9410,Cell-based,Tisagenlecleucel,987654,,IU/kg,167.0,148.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9411,Other immunomodulatory substances,Zejula,4459876,,mg/m2,155.0,165.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9412,Immune checkpoint inhibitors,,239766,NCI Thesaurus,mg/kg,197.0,167.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9413,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,,,,63.0,88.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9414,,Tagrisso,8836851,PubChem,g/m2,116.0,128.0
SYNTHETIC-5,DONOR_2415,TREATMENT_9415,Cell-based,Opdivo,239766,,mg/kg,188.0,187.0
SYNTHETIC-5,DONOR_2416,TREATMENT_9416,Cell-based,Braftovi,8756456,,,128.0,141.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9417,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,4459876,PubChem,cells/kg,139.0,186.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9418,Immune checkpoint inhibitors,Pertuzumab,4459876,PubChem,mg/kg,184.0,133.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9419,Cell-based,Lenvatinib,8836851,NCI Thesaurus,cells/kg,,77.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9420,Immune checkpoint inhibitors,Verzenio,987654,,mg/kg,81.0,76.0
SYNTHETIC-5,DONOR_2421,TREATMENT_9421,Immune checkpoint inhibitors,Yervoy,239766,NCI Thesaurus,g/m2,170.0,91.0
SYNTHETIC-5,DONOR_2422,TREATMENT_9422,Immune checkpoint inhibitors,Tecentriq,8836851,NCI Thesaurus,g/m2,106.0,171.0
SYNTHETIC-5,DONOR_2423,TREATMENT_9423,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,8756456,NCI Thesaurus,mg/m2,187.0,111.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9424,Other immunomodulatory substances,Durvalumab,4459876,NCI Thesaurus,ug/m2,66.0,74.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9425,Immune checkpoint inhibitors,Ribociclib,239766,PubChem,cells/kg,,
SYNTHETIC-5,DONOR_2426,TREATMENT_9426,Immune checkpoint inhibitors,Atezolizumab,278936,NCI Thesaurus,cells/kg,64.0,52.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9427,Immune checkpoint inhibitors,Niraparib,239766,PubChem,ug/m2,55.0,72.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9428,Other immunomodulatory substances,,278936,PubChem,IU/m2,156.0,141.0
SYNTHETIC-5,DONOR_2429,TREATMENT_9429,Cell-based,Obinutuzumab,4459876,RxNorm,ug/m2,200.0,102.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9430,Cell-based,Perjeta,239766,PubChem,IU/kg,153.0,187.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9431,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,278936,PubChem,IU/kg,197.0,200.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9432,,Rituximab,8836851,PubChem,cells/kg,105.0,157.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9433,Other immunomodulatory substances,Pertuzumab,8836851,PubChem,IU/m2,,
SYNTHETIC-5,DONOR_2434,TREATMENT_9434,Cell-based,Lenvatinib,239766,RxNorm,cells/kg,128.0,174.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9435,Immune checkpoint inhibitors,Tecentriq,8836851,RxNorm,cells/kg,174.0,88.0
SYNTHETIC-5,DONOR_2436,TREATMENT_9436,Cell-based,Imfinzi,8756456,RxNorm,mg/m2,,164.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9437,,Necitumumab,8756456,,IU/m2,149.0,61.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9438,Immune checkpoint inhibitors,Rucaparib,278936,RxNorm,ug/m2,101.0,164.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9439,Other immunomodulatory substances,Abemaciclib,8756456,NCI Thesaurus,ug/m2,,195.0
SYNTHETIC-5,DONOR_2440,TREATMENT_9440,Immune checkpoint inhibitors,Gilotrif,,RxNorm,cells/kg,118.0,101.0
SYNTHETIC-5,DONOR_2441,TREATMENT_9441,Cell-based,Durvalumab,987654,PubChem,cells/kg,176.0,79.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9442,Cell-based,,278936,NCI Thesaurus,IU/kg,58.0,72.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9443,Cell-based,,,PubChem,IU/kg,,166.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9444,Other immunomodulatory substances,Pembrolizumab,,PubChem,,63.0,67.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9445,Immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,cells/kg,,157.0
SYNTHETIC-5,DONOR_2446,TREATMENT_9446,Other immunomodulatory substances,Ceritinib,8836851,NCI Thesaurus,IU/kg,171.0,176.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9447,Cell-based,Perjeta,8756456,NCI Thesaurus,ug/m2,182.0,
SYNTHETIC-5,DONOR_2448,TREATMENT_9448,,Opdivo,8836851,NCI Thesaurus,mg/m2,106.0,
SYNTHETIC-5,DONOR_2449,TREATMENT_9449,Cell-based,Cometriq,278936,PubChem,ug/m2,,102.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9450,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,239766,RxNorm,mg/kg,180.0,
SYNTHETIC-5,DONOR_2451,TREATMENT_9451,Other immunomodulatory substances,Kadcyla,987654,PubChem,ug/m2,72.0,193.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9452,Cell-based,Iressa,239766,RxNorm,cells/kg,168.0,173.0
SYNTHETIC-5,DONOR_2453,TREATMENT_9453,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,ug/m2,176.0,87.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9454,Immune checkpoint inhibitors,Tarceva,4459876,NCI Thesaurus,g/m2,188.0,
SYNTHETIC-5,DONOR_2455,TREATMENT_9455,Immune checkpoint inhibitors,,,NCI Thesaurus,ug/m2,93.0,127.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9456,,Selumitinib,239766,NCI Thesaurus,mg/kg,,195.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9457,,Alectinib,239766,RxNorm,IU/m2,184.0,147.0
SYNTHETIC-5,DONOR_2458,TREATMENT_9458,Other immunomodulatory substances,Daratumumab,4459876,RxNorm,ug/m2,185.0,120.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9459,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,RxNorm,mg/m2,55.0,159.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9460,Cell-based,Tecentriq,987654,PubChem,IU/m2,109.0,98.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9461,Immune checkpoint inhibitors,Pembrolizumab,8836851,NCI Thesaurus,IU/m2,73.0,
SYNTHETIC-5,DONOR_2462,TREATMENT_9462,Immune checkpoint inhibitors,Rituximab,278936,NCI Thesaurus,g/m2,59.0,156.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9463,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,PubChem,IU/kg,98.0,
SYNTHETIC-5,DONOR_2464,TREATMENT_9464,Immune checkpoint inhibitors,Tafinlar,239766,PubChem,mg/kg,95.0,
SYNTHETIC-5,DONOR_2465,TREATMENT_9465,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2466,TREATMENT_9466,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,278936,RxNorm,,,78.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9467,Cell-based,Belantamab,239766,PubChem,mg/m2,137.0,
SYNTHETIC-5,DONOR_2468,TREATMENT_9468,Cell-based,Pembrolizumab,,,IU/kg,87.0,77.0
SYNTHETIC-5,DONOR_2469,TREATMENT_9469,Other immunomodulatory substances,Venclexta,239766,,,194.0,191.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9470,Other immunomodulatory substances,Dabrafenib,278936,RxNorm,IU/kg,112.0,98.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9471,Other immunomodulatory substances,Nivolumab,239766,PubChem,IU/m2,147.0,125.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9472,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,987654,,mg/kg,92.0,128.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9473,Immune checkpoint inhibitors,Alectinib,278936,PubChem,IU/m2,,57.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9474,Cell-based,Enhertu,987654,RxNorm,mg/m2,170.0,76.0
SYNTHETIC-5,DONOR_2475,TREATMENT_9475,Other immunomodulatory substances,Cometriq,987654,RxNorm,mg/kg,135.0,157.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9476,Other immunomodulatory substances,Ado-trastuzumab emtansine,,NCI Thesaurus,mg/m2,60.0,96.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9477,Other immunomodulatory substances,Vandetanib,278936,NCI Thesaurus,IU/m2,92.0,106.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9478,Immune checkpoint inhibitors,Lynparza,278936,RxNorm,mg/kg,116.0,124.0
SYNTHETIC-5,DONOR_2479,TREATMENT_9479,Other immunomodulatory substances,Ado-trastuzumab emtansine,987654,PubChem,cells/kg,105.0,95.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9480,,Brigatinib,278936,PubChem,cells/kg,169.0,157.0
SYNTHETIC-5,DONOR_2481,TREATMENT_9481,Immune checkpoint inhibitors,Alectinib,278936,,IU/m2,,89.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9482,Other immunomodulatory substances,Cotellic,8756456,,,187.0,174.0
SYNTHETIC-5,DONOR_2483,TREATMENT_9483,Immune checkpoint inhibitors,,239766,,cells/kg,83.0,56.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9484,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,ug/m2,70.0,84.0
SYNTHETIC-5,DONOR_2485,TREATMENT_9485,Cell-based,Keytruda,987654,PubChem,mg/m2,116.0,53.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9486,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8836851,PubChem,,67.0,
SYNTHETIC-5,DONOR_2487,TREATMENT_9487,Cell-based,Vemurafenib,987654,PubChem,IU/kg,146.0,74.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9488,Immune checkpoint inhibitors,Nivolumab,987654,RxNorm,ug/m2,62.0,52.0
SYNTHETIC-5,DONOR_2489,TREATMENT_9489,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8836851,RxNorm,ug/m2,199.0,54.0
SYNTHETIC-5,DONOR_2490,TREATMENT_9490,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,,RxNorm,mg/kg,154.0,
SYNTHETIC-5,DONOR_2491,TREATMENT_9491,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,RxNorm,,103.0,
SYNTHETIC-5,DONOR_2492,TREATMENT_9492,Cell-based,Atezolizumab,8756456,RxNorm,cells/kg,183.0,133.0
SYNTHETIC-5,DONOR_2493,TREATMENT_9493,Other immunomodulatory substances,Ipilimumab,,NCI Thesaurus,ug/m2,165.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_9494,Immune checkpoint inhibitors,Olaparib,987654,,g/m2,135.0,60.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9495,Immune checkpoint inhibitors,Keytruda,4459876,RxNorm,mg/m2,90.0,
SYNTHETIC-5,DONOR_2496,TREATMENT_9496,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,PubChem,cells/kg,75.0,95.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9497,Immune checkpoint inhibitors,Rucaparib,8836851,NCI Thesaurus,ug/m2,65.0,166.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9498,Immune checkpoint inhibitors,Tecentriq,,NCI Thesaurus,,179.0,51.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9499,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,4459876,,ug/m2,95.0,126.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9500,,Kymriah,239766,PubChem,ug/m2,,177.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9501,Cell-based,Nivolumab,987654,RxNorm,cells/kg,130.0,194.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9502,Immune checkpoint inhibitors,Gazyva,239766,NCI Thesaurus,IU/kg,171.0,101.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9503,Other immunomodulatory substances,Gefitinib,8756456,RxNorm,IU/kg,85.0,94.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9504,Cell-based,Opdivo,987654,PubChem,mg/m2,182.0,189.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9505,,,987654,,mg/kg,,179.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9506,Other immunomodulatory substances,,8836851,NCI Thesaurus,,153.0,
SYNTHETIC-5,DONOR_2007,TREATMENT_9507,Cell-based,Yervoy,278936,,,137.0,131.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9508,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,,NCI Thesaurus,,,61.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9509,Other immunomodulatory substances,Gilotrif,8756456,PubChem,IU/kg,61.0,164.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9510,Other immunomodulatory substances,Venclexta,4459876,NCI Thesaurus,cells/kg,,193.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9511,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,987654,,mg/kg,161.0,117.0
SYNTHETIC-5,DONOR_2012,TREATMENT_9512,Immune checkpoint inhibitors,Iressa,278936,NCI Thesaurus,ug/m2,112.0,131.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9513,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8836851,NCI Thesaurus,IU/m2,152.0,
SYNTHETIC-5,DONOR_2014,TREATMENT_9514,Other immunomodulatory substances,Lynparza,8756456,NCI Thesaurus,IU/m2,118.0,68.0
SYNTHETIC-5,DONOR_2015,TREATMENT_9515,Immune checkpoint inhibitors,Kisqali,4459876,PubChem,,193.0,
SYNTHETIC-5,DONOR_2016,TREATMENT_9516,Cell-based,,987654,,IU/m2,52.0,98.0
SYNTHETIC-5,DONOR_2017,TREATMENT_9517,Immune checkpoint inhibitors,Atezolizumab,,PubChem,IU/kg,185.0,104.0
SYNTHETIC-5,DONOR_2018,TREATMENT_9518,Other immunomodulatory substances,Ipilimumab,278936,,mg/m2,195.0,
SYNTHETIC-5,DONOR_2019,TREATMENT_9519,Cell-based,Alecensa,239766,RxNorm,,62.0,
SYNTHETIC-5,DONOR_2020,TREATMENT_9520,Immune checkpoint inhibitors,Vandetanib,987654,RxNorm,g/m2,190.0,136.0
SYNTHETIC-5,DONOR_2021,TREATMENT_9521,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,RxNorm,mg/kg,111.0,127.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9522,Immune checkpoint inhibitors,Daratumumab,8756456,NCI Thesaurus,mg/m2,107.0,148.0
SYNTHETIC-5,DONOR_2023,TREATMENT_9523,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,8756456,NCI Thesaurus,,101.0,177.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9524,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,PubChem,ug/m2,198.0,101.0
SYNTHETIC-5,DONOR_2025,TREATMENT_9525,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,4459876,RxNorm,IU/m2,152.0,133.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9526,Immune checkpoint inhibitors,Cabozantinib,8756456,PubChem,mg/m2,102.0,167.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9527,Immune checkpoint inhibitors,Mektovi,8756456,PubChem,cells/kg,139.0,122.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9528,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2029,TREATMENT_9529,Cell-based,Axicabtagene ciloleucel,8756456,PubChem,,137.0,114.0
SYNTHETIC-5,DONOR_2030,TREATMENT_9530,Immune checkpoint inhibitors,Yescarta,8756456,PubChem,mg/m2,,86.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9531,Immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,ug/m2,165.0,
SYNTHETIC-5,DONOR_2032,TREATMENT_9532,Other immunomodulatory substances,Erlotinib,4459876,PubChem,,77.0,153.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9533,Cell-based,Osimertinib,4459876,NCI Thesaurus,ug/m2,88.0,97.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9534,Cell-based,Cabozantinib,278936,,IU/m2,167.0,132.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9535,,Zejula,8836851,,IU/kg,128.0,167.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9536,Immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,,183.0,101.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9537,Cell-based,Keytruda,,NCI Thesaurus,ug/m2,158.0,67.0
SYNTHETIC-5,DONOR_2038,TREATMENT_9538,Cell-based,Alecensa,4459876,PubChem,IU/kg,109.0,
SYNTHETIC-5,DONOR_2039,TREATMENT_9539,Other immunomodulatory substances,Ibrance,,RxNorm,,100.0,91.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9540,Cell-based,Lenvima,278936,NCI Thesaurus,IU/kg,141.0,64.0
SYNTHETIC-5,DONOR_2041,TREATMENT_9541,Immune checkpoint inhibitors,,278936,RxNorm,g/m2,121.0,191.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9542,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,239766,RxNorm,IU/kg,79.0,179.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9543,,Yervoy,8836851,PubChem,IU/kg,,133.0
SYNTHETIC-5,DONOR_2044,TREATMENT_9544,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,g/m2,120.0,150.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9545,Immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,cells/kg,,193.0
SYNTHETIC-5,DONOR_2046,TREATMENT_9546,Cell-based,Daratumumab,278936,NCI Thesaurus,ug/m2,174.0,
SYNTHETIC-5,DONOR_2047,TREATMENT_9547,Cell-based,Selumitinib,987654,PubChem,,57.0,194.0
SYNTHETIC-5,DONOR_2048,TREATMENT_9548,Cell-based,Enhertu,8756456,RxNorm,,54.0,178.0
SYNTHETIC-5,DONOR_2049,TREATMENT_9549,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,278936,NCI Thesaurus,mg/kg,144.0,79.0
SYNTHETIC-5,DONOR_2050,TREATMENT_9550,Cell-based,,,NCI Thesaurus,,141.0,178.0
SYNTHETIC-5,DONOR_2051,TREATMENT_9551,Cell-based,Belantamab,8756456,RxNorm,mg/m2,113.0,
SYNTHETIC-5,DONOR_2052,TREATMENT_9552,Other immunomodulatory substances,,4459876,RxNorm,mg/m2,118.0,118.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9553,Immune checkpoint inhibitors,Pertuzumab,8756456,,ug/m2,147.0,128.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9554,,Iressa,239766,RxNorm,mg/m2,115.0,96.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9555,Other immunomodulatory substances,Xalkori,,NCI Thesaurus,mg/kg,136.0,143.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9556,Other immunomodulatory substances,Blinatumomab,8836851,NCI Thesaurus,g/m2,52.0,67.0
SYNTHETIC-5,DONOR_2057,TREATMENT_9557,Immune checkpoint inhibitors,Ribociclib,239766,RxNorm,ug/m2,122.0,132.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9558,Immune checkpoint inhibitors,Yescarta,4459876,RxNorm,g/m2,78.0,166.0
SYNTHETIC-5,DONOR_2059,TREATMENT_9559,Other immunomodulatory substances,Verzenio,278936,RxNorm,mg/kg,60.0,151.0
SYNTHETIC-5,DONOR_2060,TREATMENT_9560,Cell-based,Tecentriq,8756456,PubChem,IU/kg,159.0,126.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9561,,,4459876,PubChem,mg/kg,99.0,110.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9562,Cell-based,Tecentriq,8836851,NCI Thesaurus,ug/m2,170.0,152.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9563,Other immunomodulatory substances,Tarceva,987654,RxNorm,IU/kg,130.0,
SYNTHETIC-5,DONOR_2064,TREATMENT_9564,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,4459876,,g/m2,67.0,191.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9565,Immune checkpoint inhibitors,Durvalumab,8756456,RxNorm,mg/kg,178.0,185.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9566,Cell-based,Yervoy,4459876,NCI Thesaurus,,172.0,73.0
SYNTHETIC-5,DONOR_2067,TREATMENT_9567,Other immunomodulatory substances,Lynparza,987654,NCI Thesaurus,g/m2,191.0,127.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9568,Other immunomodulatory substances,Nexavar,278936,PubChem,mg/m2,62.0,132.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9569,Immune checkpoint inhibitors,,8756456,PubChem,mg/kg,63.0,55.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9570,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,987654,PubChem,IU/m2,80.0,174.0
SYNTHETIC-5,DONOR_2071,TREATMENT_9571,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,,PubChem,cells/kg,104.0,
SYNTHETIC-5,DONOR_2072,TREATMENT_9572,Cell-based,Axicabtagene ciloleucel,,PubChem,g/m2,76.0,123.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9573,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,RxNorm,ug/m2,150.0,92.0
SYNTHETIC-5,DONOR_2074,TREATMENT_9574,Other immunomodulatory substances,Alectinib,4459876,NCI Thesaurus,mg/m2,135.0,79.0
SYNTHETIC-5,DONOR_2075,TREATMENT_9575,Immune checkpoint inhibitors,Nivolumab,987654,PubChem,IU/m2,147.0,55.0
SYNTHETIC-5,DONOR_2076,TREATMENT_9576,,Alectinib,239766,PubChem,g/m2,,185.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9577,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,278936,RxNorm,ug/m2,108.0,
SYNTHETIC-5,DONOR_2078,TREATMENT_9578,Cell-based,Nivolumab,8836851,PubChem,mg/m2,189.0,171.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9579,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,cells/kg,116.0,85.0
SYNTHETIC-5,DONOR_2080,TREATMENT_9580,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,4459876,,cells/kg,129.0,130.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9581,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,,cells/kg,104.0,144.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9582,Other immunomodulatory substances,Ipilimumab,,PubChem,cells/kg,156.0,104.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9583,Other immunomodulatory substances,Opdivo,8756456,PubChem,mg/m2,72.0,58.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9584,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,cells/kg,197.0,
SYNTHETIC-5,DONOR_2085,TREATMENT_9585,Cell-based,Encorafenib,278936,,cells/kg,,84.0
SYNTHETIC-5,DONOR_2086,TREATMENT_9586,Other immunomodulatory substances,,8836851,PubChem,mg/kg,142.0,125.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9587,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,,g/m2,186.0,
SYNTHETIC-5,DONOR_2088,TREATMENT_9588,Other immunomodulatory substances,Daratumumab,8836851,PubChem,IU/m2,67.0,159.0
SYNTHETIC-5,DONOR_2089,TREATMENT_9589,Cell-based,Tagrisso,987654,PubChem,,63.0,92.0
SYNTHETIC-5,DONOR_2090,TREATMENT_9590,Immune checkpoint inhibitors,Osimertinib,278936,PubChem,g/m2,110.0,92.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9591,,,8756456,,IU/m2,59.0,167.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9592,Immune checkpoint inhibitors,Yervoy,987654,PubChem,ug/m2,157.0,
SYNTHETIC-5,DONOR_2093,TREATMENT_9593,Other immunomodulatory substances,Durvalumab,278936,RxNorm,,65.0,158.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9594,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,PubChem,mg/kg,97.0,
SYNTHETIC-5,DONOR_2095,TREATMENT_9595,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,239766,NCI Thesaurus,IU/m2,,141.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9596,Other immunomodulatory substances,Opdivo,4459876,NCI Thesaurus,ug/m2,189.0,
SYNTHETIC-5,DONOR_2097,TREATMENT_9597,Immune checkpoint inhibitors,,278936,NCI Thesaurus,,162.0,75.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9598,Other immunomodulatory substances,Venclexta,8836851,NCI Thesaurus,mg/m2,140.0,
SYNTHETIC-5,DONOR_2099,TREATMENT_9599,Cell-based,Atezolizumab,278936,PubChem,mg/m2,89.0,
SYNTHETIC-5,DONOR_2100,TREATMENT_9600,Cell-based,Atezolizumab,8756456,NCI Thesaurus,IU/m2,187.0,115.0
SYNTHETIC-5,DONOR_2101,TREATMENT_9601,Other immunomodulatory substances,Zejula,278936,,ug/m2,,85.0
SYNTHETIC-5,DONOR_2102,TREATMENT_9602,Other immunomodulatory substances,Ipilimumab,8756456,,mg/m2,100.0,
SYNTHETIC-5,DONOR_2103,TREATMENT_9603,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8836851,NCI Thesaurus,mg/kg,187.0,53.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9604,,Durvalumab,8756456,NCI Thesaurus,IU/m2,134.0,106.0
SYNTHETIC-5,DONOR_2105,TREATMENT_9605,Immune checkpoint inhibitors,,8756456,RxNorm,,163.0,77.0
SYNTHETIC-5,DONOR_2106,TREATMENT_9606,Other immunomodulatory substances,Keytruda,987654,NCI Thesaurus,mg/kg,79.0,172.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9607,Other immunomodulatory substances,Alectinib,8756456,PubChem,ug/m2,88.0,127.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9608,Immune checkpoint inhibitors,Zejula,987654,PubChem,mg/kg,155.0,
SYNTHETIC-5,DONOR_2109,TREATMENT_9609,,Atezolizumab,239766,NCI Thesaurus,g/m2,169.0,119.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9610,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,PubChem,,62.0,177.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9611,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,8836851,NCI Thesaurus,mg/m2,,150.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9612,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,278936,RxNorm,g/m2,113.0,104.0
SYNTHETIC-5,DONOR_2113,TREATMENT_9613,Other immunomodulatory substances,Inotuzumab ozogamicin,4459876,RxNorm,IU/kg,101.0,60.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9614,Other immunomodulatory substances,Osimertinib,4459876,NCI Thesaurus,ug/m2,82.0,125.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9615,Cell-based,Axicabtagene ciloleucel,278936,RxNorm,IU/kg,127.0,198.0
SYNTHETIC-5,DONOR_2116,TREATMENT_9616,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,,mg/m2,182.0,
SYNTHETIC-5,DONOR_2117,TREATMENT_9617,Cell-based,Gazyva,8756456,PubChem,ug/m2,150.0,115.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9618,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,NCI Thesaurus,g/m2,151.0,57.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9619,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,,NCI Thesaurus,,151.0,75.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9620,Immune checkpoint inhibitors,Opdivo,987654,PubChem,,103.0,122.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9621,Cell-based,Kadcyla,8756456,,cells/kg,,180.0
SYNTHETIC-5,DONOR_2122,TREATMENT_9622,Other immunomodulatory substances,,8836851,NCI Thesaurus,mg/m2,145.0,152.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9623,Other immunomodulatory substances,Atezolizumab,4459876,RxNorm,cells/kg,61.0,
SYNTHETIC-5,DONOR_2124,TREATMENT_9624,Other immunomodulatory substances,,,RxNorm,IU/m2,182.0,159.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9625,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,ug/m2,185.0,174.0
SYNTHETIC-5,DONOR_2126,TREATMENT_9626,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,239766,,,118.0,176.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9627,Immune checkpoint inhibitors,Yervoy,278936,,mg/m2,,148.0
SYNTHETIC-5,DONOR_2128,TREATMENT_9628,Immune checkpoint inhibitors,Caprelsa,8836851,PubChem,IU/m2,92.0,135.0
SYNTHETIC-5,DONOR_2129,TREATMENT_9629,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,4459876,NCI Thesaurus,mg/m2,63.0,174.0
SYNTHETIC-5,DONOR_2130,TREATMENT_9630,Immune checkpoint inhibitors,,4459876,RxNorm,mg/kg,77.0,115.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9631,Other immunomodulatory substances,,,RxNorm,mg/m2,72.0,
SYNTHETIC-5,DONOR_2132,TREATMENT_9632,Immune checkpoint inhibitors,Braftovi,987654,NCI Thesaurus,IU/kg,91.0,143.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9633,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,NCI Thesaurus,g/m2,156.0,137.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9634,Immune checkpoint inhibitors,Tecentriq,8836851,NCI Thesaurus,g/m2,200.0,125.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9635,Cell-based,Tecentriq,987654,RxNorm,g/m2,136.0,
SYNTHETIC-5,DONOR_2136,TREATMENT_9636,Immune checkpoint inhibitors,Gefitinib,8836851,RxNorm,,131.0,75.0
SYNTHETIC-5,DONOR_2137,TREATMENT_9637,Other immunomodulatory substances,Verzenio,,NCI Thesaurus,ug/m2,56.0,74.0
SYNTHETIC-5,DONOR_2138,TREATMENT_9638,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,987654,RxNorm,IU/kg,175.0,128.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9639,Immune checkpoint inhibitors,Zykadia,987654,,,135.0,73.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9640,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,987654,RxNorm,IU/kg,133.0,157.0
SYNTHETIC-5,DONOR_2141,TREATMENT_9641,Immune checkpoint inhibitors,Xalkori,8756456,NCI Thesaurus,mg/kg,126.0,144.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9642,Other immunomodulatory substances,Vandetanib,4459876,RxNorm,IU/m2,163.0,112.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9643,Cell-based,Pembrolizumab,987654,RxNorm,ug/m2,68.0,106.0
SYNTHETIC-5,DONOR_2144,TREATMENT_9644,,Alectinib,,RxNorm,mg/kg,126.0,76.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9645,Other immunomodulatory substances,Trametinib,8756456,NCI Thesaurus,mg/kg,,173.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9646,Other immunomodulatory substances,Iressa,8756456,,IU/kg,69.0,
SYNTHETIC-5,DONOR_2147,TREATMENT_9647,Immune checkpoint inhibitors,Darzalex,239766,,mg/m2,164.0,163.0
SYNTHETIC-5,DONOR_2148,TREATMENT_9648,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,PubChem,IU/kg,53.0,
SYNTHETIC-5,DONOR_2149,TREATMENT_9649,Other immunomodulatory substances,Kisqali,987654,NCI Thesaurus,cells/kg,,67.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9650,Other immunomodulatory substances,Encorafenib,8756456,RxNorm,cells/kg,59.0,189.0
SYNTHETIC-5,DONOR_2151,TREATMENT_9651,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8756456,PubChem,mg/m2,66.0,76.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9652,Other immunomodulatory substances,Cometriq,,RxNorm,cells/kg,166.0,114.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9653,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,PubChem,IU/kg,189.0,112.0
SYNTHETIC-5,DONOR_2154,TREATMENT_9654,Cell-based,Opdivo,987654,RxNorm,IU/m2,,144.0
SYNTHETIC-5,DONOR_2155,TREATMENT_9655,Immune checkpoint inhibitors,Herceptin,239766,PubChem,IU/m2,84.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_9656,Other immunomodulatory substances,Keytruda,,NCI Thesaurus,ug/m2,,163.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9657,Immune checkpoint inhibitors,Ipilimumab,,RxNorm,,143.0,196.0
SYNTHETIC-5,DONOR_2158,TREATMENT_9658,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,cells/kg,117.0,
SYNTHETIC-5,DONOR_2159,TREATMENT_9659,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,4459876,RxNorm,mg/kg,173.0,
SYNTHETIC-5,DONOR_2160,TREATMENT_9660,Cell-based,Atezolizumab,8756456,PubChem,mg/kg,135.0,191.0
SYNTHETIC-5,DONOR_2161,TREATMENT_9661,Other immunomodulatory substances,Ipilimumab,4459876,PubChem,mg/kg,152.0,
SYNTHETIC-5,DONOR_2162,TREATMENT_9662,Immune checkpoint inhibitors,Yervoy,8836851,RxNorm,,69.0,171.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9663,Cell-based,Vandetanib,8756456,RxNorm,,149.0,100.0
SYNTHETIC-5,DONOR_2164,TREATMENT_9664,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,,RxNorm,IU/kg,,120.0
SYNTHETIC-5,DONOR_2165,TREATMENT_9665,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,278936,RxNorm,g/m2,94.0,71.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9666,Immune checkpoint inhibitors,Yervoy,4459876,PubChem,IU/m2,107.0,189.0
SYNTHETIC-5,DONOR_2167,TREATMENT_9667,Other immunomodulatory substances,Olaparib,4459876,NCI Thesaurus,cells/kg,,118.0
SYNTHETIC-5,DONOR_2168,TREATMENT_9668,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8836851,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2169,TREATMENT_9669,Other immunomodulatory substances,Tafinlar,278936,RxNorm,IU/kg,51.0,170.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9670,Immune checkpoint inhibitors,Mekinist,4459876,,cells/kg,55.0,74.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9671,Other immunomodulatory substances,Erlotinib,8756456,NCI Thesaurus,IU/kg,57.0,134.0
SYNTHETIC-5,DONOR_2172,TREATMENT_9672,,Kisqali,987654,PubChem,ug/m2,191.0,88.0
SYNTHETIC-5,DONOR_2173,TREATMENT_9673,Immune checkpoint inhibitors,Yervoy,8756456,NCI Thesaurus,cells/kg,,58.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9674,Other immunomodulatory substances,Daratumumab,8756456,,IU/m2,155.0,128.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9675,Immune checkpoint inhibitors,Verzenio,4459876,RxNorm,,65.0,68.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9676,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,PubChem,IU/kg,,91.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9677,Immune checkpoint inhibitors,Crizotinib,4459876,NCI Thesaurus,g/m2,,191.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9678,Other immunomodulatory substances,,,,IU/kg,178.0,
SYNTHETIC-5,DONOR_2179,TREATMENT_9679,Other immunomodulatory substances,Niraparib,239766,PubChem,mg/m2,,138.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9680,Other immunomodulatory substances,Cobimetinib,987654,RxNorm,IU/m2,,119.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9681,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,ug/m2,102.0,59.0
SYNTHETIC-5,DONOR_2182,TREATMENT_9682,Other immunomodulatory substances,Mektovi,,NCI Thesaurus,ug/m2,132.0,78.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9683,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,PubChem,mg/m2,69.0,191.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9684,Immune checkpoint inhibitors,,8836851,PubChem,IU/m2,194.0,143.0
SYNTHETIC-5,DONOR_2185,TREATMENT_9685,Cell-based,Gilteritinib,4459876,,IU/m2,86.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_9686,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,239766,RxNorm,g/m2,95.0,136.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9687,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,8756456,PubChem,,77.0,158.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9688,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,4459876,RxNorm,mg/m2,,187.0
SYNTHETIC-5,DONOR_2189,TREATMENT_9689,Other immunomodulatory substances,Obinutuzumab,239766,PubChem,IU/kg,191.0,53.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9690,Immune checkpoint inhibitors,Kadcyla,278936,NCI Thesaurus,IU/m2,131.0,115.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9691,Cell-based,Crizotinib,4459876,,ug/m2,180.0,153.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9692,,Braftovi,8756456,PubChem,,,
SYNTHETIC-5,DONOR_2193,TREATMENT_9693,Cell-based,Durvalumab,,PubChem,,165.0,135.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9694,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,8836851,PubChem,,,182.0
SYNTHETIC-5,DONOR_2195,TREATMENT_9695,,,,RxNorm,g/m2,105.0,
SYNTHETIC-5,DONOR_2196,TREATMENT_9696,Other immunomodulatory substances,,8756456,NCI Thesaurus,cells/kg,89.0,97.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9697,,Kadcyla,8756456,PubChem,mg/m2,186.0,90.0
SYNTHETIC-5,DONOR_2198,TREATMENT_9698,Immune checkpoint inhibitors,Tisagenlecleucel,,RxNorm,mg/m2,68.0,191.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9699,Other immunomodulatory substances,Kadcyla,,NCI Thesaurus,mg/kg,93.0,179.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9700,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,ug/m2,192.0,151.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9701,Cell-based,Rituxan,4459876,NCI Thesaurus,mg/kg,77.0,
SYNTHETIC-5,DONOR_2202,TREATMENT_9702,Other immunomodulatory substances,Zelboraf,8756456,NCI Thesaurus,mg/m2,,160.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9703,Other immunomodulatory substances,Pexidartinib,239766,RxNorm,,196.0,170.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9704,Other immunomodulatory substances,Keytruda,987654,NCI Thesaurus,cells/kg,153.0,180.0
SYNTHETIC-5,DONOR_2205,TREATMENT_9705,,,278936,PubChem,mg/m2,182.0,177.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9706,Immune checkpoint inhibitors,Niraparib,8836851,PubChem,mg/m2,,98.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9707,Cell-based,Erlotinib,987654,NCI Thesaurus,g/m2,176.0,72.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9708,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,4459876,NCI Thesaurus,IU/m2,,169.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9709,Other immunomodulatory substances,Enhertu,278936,RxNorm,mg/m2,192.0,
SYNTHETIC-5,DONOR_2210,TREATMENT_9710,Cell-based,Pembrolizumab,8756456,RxNorm,mg/m2,112.0,
SYNTHETIC-5,DONOR_2211,TREATMENT_9711,Immune checkpoint inhibitors,Cobimetinib,,RxNorm,g/m2,121.0,
SYNTHETIC-5,DONOR_2212,TREATMENT_9712,Other immunomodulatory substances,,239766,PubChem,g/m2,164.0,127.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9713,Cell-based,Nivolumab,4459876,NCI Thesaurus,g/m2,,72.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9714,Other immunomodulatory substances,Ibrance,8836851,RxNorm,mg/kg,69.0,194.0
SYNTHETIC-5,DONOR_2215,TREATMENT_9715,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,239766,PubChem,ug/m2,199.0,190.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9716,Immune checkpoint inhibitors,Tecentriq,8756456,,IU/kg,86.0,138.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9717,Immune checkpoint inhibitors,,8756456,RxNorm,mg/m2,,159.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9718,Immune checkpoint inhibitors,Ipilimumab,987654,NCI Thesaurus,IU/kg,175.0,195.0
SYNTHETIC-5,DONOR_2219,TREATMENT_9719,Immune checkpoint inhibitors,Gilotrif,4459876,NCI Thesaurus,IU/kg,80.0,180.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9720,Other immunomodulatory substances,Zelboraf,8756456,PubChem,cells/kg,105.0,139.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9721,Immune checkpoint inhibitors,Encorafenib,8836851,NCI Thesaurus,,91.0,65.0
SYNTHETIC-5,DONOR_2222,TREATMENT_9722,,Herceptin,,PubChem,mg/kg,192.0,110.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9723,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,8756456,PubChem,IU/m2,,125.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9724,Cell-based,Durvalumab,4459876,PubChem,mg/kg,199.0,
SYNTHETIC-5,DONOR_2225,TREATMENT_9725,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,8756456,NCI Thesaurus,ug/m2,,157.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9726,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,PubChem,cells/kg,,151.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9727,Immune checkpoint inhibitors,Durvalumab,987654,RxNorm,g/m2,166.0,56.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9728,Other immunomodulatory substances,Tisagenlecleucel,8756456,NCI Thesaurus,IU/m2,,94.0
SYNTHETIC-5,DONOR_2229,TREATMENT_9729,Other immunomodulatory substances,Pembrolizumab,4459876,PubChem,mg/kg,124.0,102.0
SYNTHETIC-5,DONOR_2230,TREATMENT_9730,,Darzalex,278936,NCI Thesaurus,g/m2,,51.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9731,Immune checkpoint inhibitors,,239766,RxNorm,mg/m2,183.0,82.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9732,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,4459876,NCI Thesaurus,IU/kg,181.0,61.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9733,Cell-based,Keytruda,,PubChem,mg/m2,69.0,151.0
SYNTHETIC-5,DONOR_2234,TREATMENT_9734,Cell-based,Nivolumab,4459876,NCI Thesaurus,IU/m2,140.0,154.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9735,Immune checkpoint inhibitors,,278936,NCI Thesaurus,mg/kg,,169.0
SYNTHETIC-5,DONOR_2236,TREATMENT_9736,Immune checkpoint inhibitors,Cotellic,987654,RxNorm,cells/kg,139.0,
SYNTHETIC-5,DONOR_2237,TREATMENT_9737,Other immunomodulatory substances,Pertuzumab,987654,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2238,TREATMENT_9738,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,987654,RxNorm,mg/kg,84.0,184.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9739,Cell-based,Ipilimumab,4459876,NCI Thesaurus,mg/m2,159.0,
SYNTHETIC-5,DONOR_2240,TREATMENT_9740,Cell-based,Opdivo,987654,PubChem,IU/kg,125.0,140.0
SYNTHETIC-5,DONOR_2241,TREATMENT_9741,Other immunomodulatory substances,Iressa,239766,NCI Thesaurus,mg/m2,143.0,
SYNTHETIC-5,DONOR_2242,TREATMENT_9742,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,mg/kg,150.0,73.0
SYNTHETIC-5,DONOR_2243,TREATMENT_9743,Other immunomodulatory substances,Rituxan,8756456,RxNorm,mg/kg,74.0,118.0
SYNTHETIC-5,DONOR_2244,TREATMENT_9744,,Kadcyla,,RxNorm,cells/kg,156.0,187.0
SYNTHETIC-5,DONOR_2245,TREATMENT_9745,Cell-based,Rucaparib,239766,NCI Thesaurus,cells/kg,151.0,
SYNTHETIC-5,DONOR_2246,TREATMENT_9746,Cell-based,Yervoy,8836851,RxNorm,cells/kg,107.0,96.0
SYNTHETIC-5,DONOR_2247,TREATMENT_9747,,,4459876,RxNorm,,198.0,107.0
SYNTHETIC-5,DONOR_2248,TREATMENT_9748,Cell-based,Nivolumab,8836851,RxNorm,cells/kg,185.0,163.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9749,Other immunomodulatory substances,Opdivo,987654,RxNorm,mg/kg,138.0,62.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9750,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,278936,PubChem,,144.0,116.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9751,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,987654,PubChem,IU/m2,141.0,59.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9752,Other immunomodulatory substances,Gazyva,8756456,PubChem,ug/m2,,181.0
SYNTHETIC-5,DONOR_2253,TREATMENT_9753,Cell-based,Durvalumab,239766,PubChem,,175.0,179.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9754,Other immunomodulatory substances,Daratumumab,8756456,,g/m2,77.0,60.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9755,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,239766,NCI Thesaurus,mg/kg,104.0,143.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9756,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,8756456,NCI Thesaurus,g/m2,108.0,65.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9757,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,278936,RxNorm,,,60.0
SYNTHETIC-5,DONOR_2258,TREATMENT_9758,,Keytruda,,,IU/kg,,138.0
SYNTHETIC-5,DONOR_2259,TREATMENT_9759,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,4459876,RxNorm,mg/m2,152.0,65.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9760,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,4459876,RxNorm,IU/kg,70.0,102.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9761,Other immunomodulatory substances,Atezolizumab,239766,RxNorm,ug/m2,127.0,183.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9762,Immune checkpoint inhibitors,Zykadia,8836851,,g/m2,72.0,143.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9763,,Pembrolizumab,278936,,,82.0,130.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9764,Immune checkpoint inhibitors,Yescarta,987654,RxNorm,g/m2,70.0,74.0
SYNTHETIC-5,DONOR_2265,TREATMENT_9765,Immune checkpoint inhibitors,Nivolumab,987654,PubChem,IU/m2,156.0,142.0
SYNTHETIC-5,DONOR_2266,TREATMENT_9766,Cell-based,Besponsa,987654,,ug/m2,164.0,87.0
SYNTHETIC-5,DONOR_2267,TREATMENT_9767,Cell-based,Blincyto,,PubChem,mg/m2,118.0,
SYNTHETIC-5,DONOR_2268,TREATMENT_9768,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,987654,,mg/m2,189.0,107.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9769,Cell-based,Pembrolizumab,4459876,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2270,TREATMENT_9770,Immune checkpoint inhibitors,Rituxan,987654,RxNorm,cells/kg,,80.0
SYNTHETIC-5,DONOR_2271,TREATMENT_9771,Cell-based,Fam-trastuzumab deruxtecan-nxki,,PubChem,IU/m2,100.0,85.0
SYNTHETIC-5,DONOR_2272,TREATMENT_9772,,Zejula,239766,PubChem,mg/kg,,98.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9773,Cell-based,Niraparib,,NCI Thesaurus,,136.0,
SYNTHETIC-5,DONOR_2274,TREATMENT_9774,Cell-based,Trastuzumab,8836851,NCI Thesaurus,mg/kg,136.0,172.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9775,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,278936,NCI Thesaurus,IU/m2,54.0,193.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9776,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,,IU/m2,,194.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9777,Immune checkpoint inhibitors,Vemurafenib,987654,PubChem,,146.0,103.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9778,Immune checkpoint inhibitors,Braftovi,,RxNorm,,,
SYNTHETIC-5,DONOR_2279,TREATMENT_9779,Other immunomodulatory substances,Herceptin,987654,,IU/m2,,
SYNTHETIC-5,DONOR_2280,TREATMENT_9780,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,8756456,PubChem,IU/kg,111.0,179.0
SYNTHETIC-5,DONOR_2281,TREATMENT_9781,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,,,76.0,108.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9782,Other immunomodulatory substances,Trametinib,239766,NCI Thesaurus,,62.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_9783,Other immunomodulatory substances,Nivolumab,239766,RxNorm,mg/kg,167.0,92.0
SYNTHETIC-5,DONOR_2284,TREATMENT_9784,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,8756456,RxNorm,IU/kg,,113.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9785,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,IU/m2,98.0,68.0
SYNTHETIC-5,DONOR_2286,TREATMENT_9786,Immune checkpoint inhibitors,,278936,,mg/m2,169.0,171.0
SYNTHETIC-5,DONOR_2287,TREATMENT_9787,Immune checkpoint inhibitors,Palbociclib,987654,PubChem,IU/kg,181.0,78.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9788,Other immunomodulatory substances,Lenvima,8836851,,mg/m2,76.0,186.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9789,Immune checkpoint inhibitors,Blincyto,239766,RxNorm,mg/kg,83.0,80.0
SYNTHETIC-5,DONOR_2290,TREATMENT_9790,,Rubraca,987654,NCI Thesaurus,mg/kg,195.0,145.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9791,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,239766,NCI Thesaurus,,99.0,77.0
SYNTHETIC-5,DONOR_2292,TREATMENT_9792,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,239766,RxNorm,ug/m2,71.0,65.0
SYNTHETIC-5,DONOR_2293,TREATMENT_9793,Cell-based,Imfinzi,8756456,NCI Thesaurus,IU/kg,79.0,172.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9794,Cell-based,Atezolizumab,239766,PubChem,mg/m2,196.0,60.0
SYNTHETIC-5,DONOR_2295,TREATMENT_9795,Cell-based,,8836851,PubChem,,150.0,89.0
SYNTHETIC-5,DONOR_2296,TREATMENT_9796,,Cotellic,4459876,,ug/m2,,55.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9797,Immune checkpoint inhibitors,Yescarta,,,g/m2,104.0,95.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9798,Other immunomodulatory substances,,,NCI Thesaurus,mg/kg,53.0,77.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9799,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,,cells/kg,151.0,106.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9800,Other immunomodulatory substances,Yescarta,278936,NCI Thesaurus,IU/kg,,100.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9801,Immune checkpoint inhibitors,Enhertu,4459876,PubChem,g/m2,68.0,141.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9802,Other immunomodulatory substances,Ibrance,8836851,,mg/m2,162.0,55.0
SYNTHETIC-5,DONOR_2303,TREATMENT_9803,Cell-based,Kadcyla,987654,NCI Thesaurus,IU/kg,120.0,153.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9804,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,987654,RxNorm,g/m2,143.0,192.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9805,Immune checkpoint inhibitors,Copanlisib,,PubChem,cells/kg,195.0,
SYNTHETIC-5,DONOR_2306,TREATMENT_9806,Immune checkpoint inhibitors,,4459876,PubChem,IU/m2,,155.0
SYNTHETIC-5,DONOR_2307,TREATMENT_9807,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,,160.0,
SYNTHETIC-5,DONOR_2308,TREATMENT_9808,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,cells/kg,,54.0
SYNTHETIC-5,DONOR_2309,TREATMENT_9809,Other immunomodulatory substances,Yervoy,4459876,NCI Thesaurus,IU/kg,172.0,
SYNTHETIC-5,DONOR_2310,TREATMENT_9810,Cell-based,Pembrolizumab,278936,PubChem,IU/kg,86.0,160.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9811,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8836851,PubChem,IU/m2,102.0,
SYNTHETIC-5,DONOR_2312,TREATMENT_9812,Immune checkpoint inhibitors,Braftovi,8836851,PubChem,cells/kg,55.0,159.0
SYNTHETIC-5,DONOR_2313,TREATMENT_9813,Immune checkpoint inhibitors,Cometriq,987654,NCI Thesaurus,IU/m2,,187.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9814,Cell-based,Nivolumab,,NCI Thesaurus,IU/kg,136.0,
SYNTHETIC-5,DONOR_2315,TREATMENT_9815,Immune checkpoint inhibitors,,4459876,RxNorm,IU/kg,185.0,121.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9816,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,NCI Thesaurus,mg/m2,173.0,150.0
SYNTHETIC-5,DONOR_2317,TREATMENT_9817,Other immunomodulatory substances,Tecentriq,239766,NCI Thesaurus,IU/kg,144.0,78.0
SYNTHETIC-5,DONOR_2318,TREATMENT_9818,Other immunomodulatory substances,Pexidartinib,278936,RxNorm,cells/kg,148.0,
SYNTHETIC-5,DONOR_2319,TREATMENT_9819,Immune checkpoint inhibitors,Besponsa,8836851,PubChem,mg/kg,,130.0
SYNTHETIC-5,DONOR_2320,TREATMENT_9820,Immune checkpoint inhibitors,Alunbrig,239766,PubChem,IU/kg,84.0,70.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9821,Other immunomodulatory substances,Sorafenib,987654,RxNorm,mg/m2,,167.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9822,Cell-based,Zykadia,,RxNorm,,167.0,138.0
SYNTHETIC-5,DONOR_2323,TREATMENT_9823,Cell-based,Lenvatinib,4459876,RxNorm,IU/m2,77.0,120.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9824,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,239766,PubChem,cells/kg,,193.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9825,Cell-based,Tafinlar,8836851,,mg/kg,50.0,53.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9826,Cell-based,Nivolumab,278936,NCI Thesaurus,IU/kg,156.0,
SYNTHETIC-5,DONOR_2327,TREATMENT_9827,,Enhertu,278936,RxNorm,,85.0,
SYNTHETIC-5,DONOR_2328,TREATMENT_9828,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,RxNorm,cells/kg,66.0,125.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9829,Immune checkpoint inhibitors,Lenvima,987654,,mg/kg,84.0,
SYNTHETIC-5,DONOR_2330,TREATMENT_9830,Cell-based,Nexavar,987654,PubChem,IU/kg,194.0,198.0
SYNTHETIC-5,DONOR_2331,TREATMENT_9831,Immune checkpoint inhibitors,Atezolizumab,239766,PubChem,IU/m2,113.0,76.0
SYNTHETIC-5,DONOR_2332,TREATMENT_9832,,Yervoy,8756456,,,145.0,101.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9833,Cell-based,Kymriah,4459876,NCI Thesaurus,,,147.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9834,Other immunomodulatory substances,,8756456,RxNorm,IU/m2,149.0,141.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9835,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,RxNorm,,103.0,175.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9836,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,,IU/kg,,186.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9837,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,IU/kg,50.0,200.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9838,Immune checkpoint inhibitors,Obinutuzumab,4459876,RxNorm,mg/m2,180.0,151.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9839,Immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,mg/m2,123.0,101.0
SYNTHETIC-5,DONOR_2340,TREATMENT_9840,Other immunomodulatory substances,Crizotinib,278936,RxNorm,ug/m2,171.0,194.0
SYNTHETIC-5,DONOR_2341,TREATMENT_9841,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,mg/m2,85.0,193.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9842,Cell-based,Keytruda,239766,,cells/kg,52.0,189.0
SYNTHETIC-5,DONOR_2343,TREATMENT_9843,Cell-based,Fam-trastuzumab deruxtecan-nxki,239766,NCI Thesaurus,cells/kg,103.0,
SYNTHETIC-5,DONOR_2344,TREATMENT_9844,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,IU/m2,167.0,129.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9845,Other immunomodulatory substances,Tecentriq,987654,RxNorm,IU/kg,77.0,100.0
SYNTHETIC-5,DONOR_2346,TREATMENT_9846,Other immunomodulatory substances,Ipilimumab,987654,NCI Thesaurus,mg/m2,,146.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9847,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,,NCI Thesaurus,mg/m2,144.0,176.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9848,,,8756456,RxNorm,cells/kg,163.0,176.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9849,Immune checkpoint inhibitors,,8836851,,IU/kg,148.0,180.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9850,Other immunomodulatory substances,Kymriah,,RxNorm,cells/kg,118.0,113.0
SYNTHETIC-5,DONOR_2351,TREATMENT_9851,Immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,mg/m2,69.0,
SYNTHETIC-5,DONOR_2352,TREATMENT_9852,,Atezolizumab,278936,RxNorm,g/m2,,78.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9853,Immune checkpoint inhibitors,Brentuximab vedotin,239766,NCI Thesaurus,,98.0,66.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9854,Other immunomodulatory substances,Alectinib,4459876,NCI Thesaurus,cells/kg,74.0,200.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9855,Other immunomodulatory substances,Pembrolizumab,278936,,,173.0,198.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9856,Other immunomodulatory substances,Cometriq,987654,RxNorm,IU/kg,188.0,
SYNTHETIC-5,DONOR_2357,TREATMENT_9857,Immune checkpoint inhibitors,Imfinzi,8756456,RxNorm,mg/m2,197.0,55.0
SYNTHETIC-5,DONOR_2358,TREATMENT_9858,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,PubChem,IU/m2,100.0,134.0
SYNTHETIC-5,DONOR_2359,TREATMENT_9859,Other immunomodulatory substances,Verzenio,239766,PubChem,mg/m2,119.0,
SYNTHETIC-5,DONOR_2360,TREATMENT_9860,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,mg/kg,173.0,139.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9861,Cell-based,Copanlisib,987654,NCI Thesaurus,IU/m2,189.0,160.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9862,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,,133.0,93.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9863,Immune checkpoint inhibitors,Perjeta,987654,,ug/m2,,
SYNTHETIC-5,DONOR_2364,TREATMENT_9864,Immune checkpoint inhibitors,Lenvima,239766,RxNorm,ug/m2,123.0,85.0
SYNTHETIC-5,DONOR_2365,TREATMENT_9865,Immune checkpoint inhibitors,,8836851,PubChem,IU/kg,120.0,146.0
SYNTHETIC-5,DONOR_2366,TREATMENT_9866,,,,NCI Thesaurus,,79.0,94.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9867,,Vemurafenib,8756456,PubChem,,144.0,67.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9868,Other immunomodulatory substances,Opdivo,278936,RxNorm,IU/m2,,190.0
SYNTHETIC-5,DONOR_2369,TREATMENT_9869,Immune checkpoint inhibitors,Tecentriq,278936,PubChem,IU/m2,129.0,100.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9870,Immune checkpoint inhibitors,Ipilimumab,,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2371,TREATMENT_9871,Other immunomodulatory substances,Crizotinib,,NCI Thesaurus,,188.0,171.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9872,,Erlotinib,8756456,PubChem,mg/m2,112.0,191.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9873,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,PubChem,,121.0,122.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9874,,Ado-trastuzumab emtansine,4459876,NCI Thesaurus,cells/kg,125.0,115.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9875,Immune checkpoint inhibitors,Kymriah,278936,,mg/kg,131.0,132.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9876,Immune checkpoint inhibitors,Selumitinib,8756456,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2377,TREATMENT_9877,Cell-based,Lenvima,8756456,,mg/m2,159.0,174.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9878,Cell-based,Iressa,,RxNorm,IU/kg,110.0,172.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9879,Cell-based,Brentuximab vedotin,,PubChem,mg/m2,,73.0
SYNTHETIC-5,DONOR_2380,TREATMENT_9880,Other immunomodulatory substances,Osimertinib,278936,RxNorm,mg/m2,,103.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9881,Immune checkpoint inhibitors,Gefitinib,4459876,,g/m2,135.0,100.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9882,,Necitumumab,4459876,,IU/kg,163.0,103.0
SYNTHETIC-5,DONOR_2383,TREATMENT_9883,Other immunomodulatory substances,Venetoclax,278936,NCI Thesaurus,mg/kg,79.0,176.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9884,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,278936,NCI Thesaurus,ug/m2,137.0,62.0
SYNTHETIC-5,DONOR_2385,TREATMENT_9885,Immune checkpoint inhibitors,,278936,,IU/m2,68.0,68.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9886,Other immunomodulatory substances,Imfinzi,4459876,PubChem,ug/m2,164.0,70.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9887,Cell-based,Rubraca,8836851,,g/m2,90.0,170.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9888,Immune checkpoint inhibitors,Tagrisso,,PubChem,IU/m2,145.0,83.0
SYNTHETIC-5,DONOR_2389,TREATMENT_9889,Other immunomodulatory substances,Atezolizumab,8836851,PubChem,IU/m2,149.0,106.0
SYNTHETIC-5,DONOR_2390,TREATMENT_9890,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,mg/m2,149.0,
SYNTHETIC-5,DONOR_2391,TREATMENT_9891,Cell-based,Venetoclax,4459876,,g/m2,167.0,152.0
SYNTHETIC-5,DONOR_2392,TREATMENT_9892,Cell-based,Tecentriq,239766,NCI Thesaurus,cells/kg,79.0,122.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9893,Other immunomodulatory substances,,239766,RxNorm,IU/m2,90.0,54.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9894,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,PubChem,g/m2,121.0,
SYNTHETIC-5,DONOR_2395,TREATMENT_9895,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,NCI Thesaurus,IU/m2,117.0,90.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9896,Immune checkpoint inhibitors,Blincyto,8836851,RxNorm,IU/m2,184.0,106.0
SYNTHETIC-5,DONOR_2397,TREATMENT_9897,Other immunomodulatory substances,Gefitinib,239766,NCI Thesaurus,mg/kg,,119.0
SYNTHETIC-5,DONOR_2398,TREATMENT_9898,Immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,IU/kg,158.0,56.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9899,,Ceritinib,4459876,NCI Thesaurus,,92.0,115.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9900,Immune checkpoint inhibitors,Alectinib,,NCI Thesaurus,ug/m2,,127.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9901,Other immunomodulatory substances,Ado-trastuzumab emtansine,278936,RxNorm,cells/kg,98.0,111.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9902,Cell-based,Tagrisso,8836851,RxNorm,IU/m2,,82.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9903,Cell-based,Alectinib,4459876,PubChem,ug/m2,132.0,182.0
SYNTHETIC-5,DONOR_2404,TREATMENT_9904,Cell-based,Trametinib,8836851,NCI Thesaurus,g/m2,126.0,144.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9905,Other immunomodulatory substances,Axicabtagene ciloleucel,8836851,RxNorm,cells/kg,120.0,
SYNTHETIC-5,DONOR_2406,TREATMENT_9906,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,mg/kg,160.0,153.0
SYNTHETIC-5,DONOR_2407,TREATMENT_9907,Other immunomodulatory substances,Darzalex,278936,RxNorm,ug/m2,173.0,84.0
SYNTHETIC-5,DONOR_2408,TREATMENT_9908,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,4459876,RxNorm,cells/kg,148.0,103.0
SYNTHETIC-5,DONOR_2409,TREATMENT_9909,Other immunomodulatory substances,Pembrolizumab,987654,RxNorm,IU/m2,,120.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9910,Immune checkpoint inhibitors,Cometriq,8756456,,IU/m2,178.0,188.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9911,Immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,g/m2,92.0,149.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9912,Immune checkpoint inhibitors,Erlotinib,987654,NCI Thesaurus,IU/m2,184.0,140.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9913,,,8836851,NCI Thesaurus,mg/m2,80.0,153.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9914,Cell-based,Ipilimumab,987654,PubChem,mg/kg,94.0,
SYNTHETIC-5,DONOR_2415,TREATMENT_9915,Cell-based,Durvalumab,,NCI Thesaurus,cells/kg,143.0,
SYNTHETIC-5,DONOR_2416,TREATMENT_9916,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,4459876,,g/m2,90.0,104.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9917,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,RxNorm,g/m2,119.0,100.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9918,,Nivolumab,987654,NCI Thesaurus,cells/kg,186.0,
SYNTHETIC-5,DONOR_2419,TREATMENT_9919,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,,196.0,106.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9920,Cell-based,Brigatinib,239766,PubChem,IU/kg,169.0,
SYNTHETIC-5,DONOR_2421,TREATMENT_9921,Immune checkpoint inhibitors,Lenvatinib,8836851,PubChem,IU/kg,85.0,66.0
SYNTHETIC-5,DONOR_2422,TREATMENT_9922,Immune checkpoint inhibitors,Imfinzi,278936,NCI Thesaurus,IU/kg,,103.0
SYNTHETIC-5,DONOR_2423,TREATMENT_9923,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,,PubChem,mg/kg,65.0,189.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9924,Other immunomodulatory substances,Herceptin,987654,NCI Thesaurus,mg/m2,129.0,92.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9925,Immune checkpoint inhibitors,Zelboraf,8836851,NCI Thesaurus,cells/kg,111.0,70.0
SYNTHETIC-5,DONOR_2426,TREATMENT_9926,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,4459876,RxNorm,mg/m2,57.0,191.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9927,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,NCI Thesaurus,IU/m2,120.0,80.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9928,Cell-based,Pembrolizumab,239766,NCI Thesaurus,,200.0,130.0
SYNTHETIC-5,DONOR_2429,TREATMENT_9929,Immune checkpoint inhibitors,Trametinib,,RxNorm,g/m2,120.0,177.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9930,Cell-based,Durvalumab,8836851,RxNorm,mg/m2,191.0,77.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9931,Cell-based,Keytruda,8756456,PubChem,cells/kg,75.0,85.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9932,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,239766,NCI Thesaurus,mg/kg,148.0,178.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9933,Other immunomodulatory substances,Atezolizumab,987654,NCI Thesaurus,IU/m2,83.0,
SYNTHETIC-5,DONOR_2434,TREATMENT_9934,Other immunomodulatory substances,Alecensa,8756456,PubChem,ug/m2,104.0,200.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9935,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,278936,NCI Thesaurus,mg/m2,146.0,117.0
SYNTHETIC-5,DONOR_2436,TREATMENT_9936,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,,PubChem,,183.0,146.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9937,Cell-based,Daratumumab,8756456,NCI Thesaurus,mg/kg,74.0,119.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9938,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,4459876,RxNorm,,126.0,200.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9939,Cell-based,Necitumumab,987654,RxNorm,mg/kg,88.0,92.0
SYNTHETIC-5,DONOR_2440,TREATMENT_9940,,Nivolumab,987654,PubChem,IU/kg,99.0,
SYNTHETIC-5,DONOR_2441,TREATMENT_9941,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,987654,,mg/kg,,89.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9942,Immune checkpoint inhibitors,Zelboraf,278936,PubChem,g/m2,77.0,176.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9943,,Ibrance,239766,RxNorm,IU/m2,94.0,170.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9944,Other immunomodulatory substances,,239766,RxNorm,mg/kg,163.0,102.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9945,Immune checkpoint inhibitors,Blincyto,239766,RxNorm,g/m2,73.0,62.0
SYNTHETIC-5,DONOR_2446,TREATMENT_9946,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,,g/m2,114.0,175.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9947,Cell-based,Durvalumab,987654,PubChem,IU/kg,122.0,76.0
SYNTHETIC-5,DONOR_2448,TREATMENT_9948,Cell-based,Tecentriq,8836851,NCI Thesaurus,IU/m2,128.0,169.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9949,Cell-based,Nivolumab,,RxNorm,g/m2,92.0,114.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9950,Immune checkpoint inhibitors,Pembrolizumab,8756456,PubChem,mg/m2,156.0,163.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9951,Immune checkpoint inhibitors,Keytruda,239766,RxNorm,g/m2,95.0,181.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9952,Cell-based,Yervoy,8756456,RxNorm,IU/m2,170.0,55.0
SYNTHETIC-5,DONOR_2453,TREATMENT_9953,Cell-based,Ipilimumab,4459876,PubChem,mg/kg,60.0,174.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9954,Other immunomodulatory substances,Durvalumab,239766,NCI Thesaurus,cells/kg,65.0,
SYNTHETIC-5,DONOR_2455,TREATMENT_9955,Cell-based,Atezolizumab,,RxNorm,IU/m2,195.0,74.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9956,,Keytruda,239766,,ug/m2,161.0,154.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9957,Cell-based,,4459876,NCI Thesaurus,IU/m2,162.0,
SYNTHETIC-5,DONOR_2458,TREATMENT_9958,Cell-based,Mekinist,4459876,RxNorm,mg/kg,197.0,197.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9959,Other immunomodulatory substances,Cometriq,4459876,,,113.0,188.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9960,Other immunomodulatory substances,Encorafenib,278936,PubChem,,187.0,173.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9961,Immune checkpoint inhibitors,Caprelsa,8756456,NCI Thesaurus,cells/kg,125.0,136.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9962,Cell-based,Encorafenib,8756456,RxNorm,cells/kg,158.0,82.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9963,Other immunomodulatory substances,Kisqali,8756456,RxNorm,,121.0,72.0
SYNTHETIC-5,DONOR_2464,TREATMENT_9964,Other immunomodulatory substances,Atezolizumab,8836851,,IU/m2,95.0,175.0
SYNTHETIC-5,DONOR_2465,TREATMENT_9965,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8836851,,,159.0,196.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9966,,Caprelsa,987654,NCI Thesaurus,mg/m2,166.0,147.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9967,Immune checkpoint inhibitors,Daratumumab,,,,90.0,181.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9968,Immune checkpoint inhibitors,Kadcyla,278936,RxNorm,mg/m2,182.0,
SYNTHETIC-5,DONOR_2469,TREATMENT_9969,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8756456,NCI Thesaurus,IU/m2,107.0,104.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9970,,Cotellic,8836851,RxNorm,IU/m2,198.0,183.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9971,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,4459876,PubChem,cells/kg,84.0,160.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9972,Cell-based,Cabozantinib,8836851,RxNorm,IU/m2,181.0,119.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9973,Other immunomodulatory substances,Pembrolizumab,278936,,IU/kg,108.0,188.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9974,Cell-based,,4459876,RxNorm,g/m2,78.0,
SYNTHETIC-5,DONOR_2475,TREATMENT_9975,Cell-based,Inotuzumab ozogamicin,278936,PubChem,g/m2,196.0,143.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9976,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,278936,RxNorm,cells/kg,102.0,86.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9977,Cell-based,Ipilimumab,987654,PubChem,IU/kg,77.0,189.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9978,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,987654,RxNorm,IU/kg,131.0,70.0
SYNTHETIC-5,DONOR_2479,TREATMENT_9979,Immune checkpoint inhibitors,Kymriah,,NCI Thesaurus,mg/kg,118.0,92.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9980,,Sorafenib,,PubChem,ug/m2,126.0,
SYNTHETIC-5,DONOR_2481,TREATMENT_9981,Cell-based,Xalkori,8756456,PubChem,g/m2,129.0,
SYNTHETIC-5,DONOR_2482,TREATMENT_9982,Cell-based,Gilteritinib,,NCI Thesaurus,cells/kg,119.0,
SYNTHETIC-5,DONOR_2483,TREATMENT_9983,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,4459876,NCI Thesaurus,mg/m2,124.0,127.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9984,Other immunomodulatory substances,Lenvima,987654,PubChem,IU/kg,136.0,186.0
SYNTHETIC-5,DONOR_2485,TREATMENT_9985,Cell-based,Keytruda,239766,RxNorm,cells/kg,114.0,107.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9986,Immune checkpoint inhibitors,Nivolumab,278936,NCI Thesaurus,mg/kg,137.0,149.0
SYNTHETIC-5,DONOR_2487,TREATMENT_9987,Cell-based,,987654,NCI Thesaurus,ug/m2,,118.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9988,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,987654,PubChem,IU/kg,,186.0
SYNTHETIC-5,DONOR_2489,TREATMENT_9989,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,4459876,PubChem,ug/m2,193.0,
SYNTHETIC-5,DONOR_2490,TREATMENT_9990,Immune checkpoint inhibitors,Daratumumab,987654,NCI Thesaurus,IU/kg,79.0,129.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9991,,Opdivo,,PubChem,ug/m2,94.0,105.0
SYNTHETIC-5,DONOR_2492,TREATMENT_9992,Other immunomodulatory substances,Cometriq,4459876,,mg/kg,176.0,
SYNTHETIC-5,DONOR_2493,TREATMENT_9993,,,239766,RxNorm,cells/kg,144.0,153.0
SYNTHETIC-5,DONOR_2494,TREATMENT_9994,Cell-based,Yervoy,239766,NCI Thesaurus,,,80.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9995,Immune checkpoint inhibitors,Venetoclax,987654,NCI Thesaurus,mg/m2,72.0,138.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9996,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,,135.0,108.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9997,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,278936,RxNorm,mg/kg,56.0,73.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9998,Other immunomodulatory substances,Brentuximab vedotin,239766,NCI Thesaurus,IU/m2,95.0,186.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9999,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,,138.0,196.0
SYNTHETIC-5,DONOR_2500,TREATMENT_10000,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,mg/m2,89.0,118.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8001,Other immunomodulatory substances,Pembrolizumab,987654,PubChem,cells/kg,60.0,76.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8002,Immune checkpoint inhibitors,Daratumumab,8836851,,mg/m2,,
SYNTHETIC-5,DONOR_2003,TREATMENT_8003,Cell-based,Zejula,8756456,RxNorm,IU/kg,60.0,53.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8004,Other immunomodulatory substances,Cometriq,987654,NCI Thesaurus,,,115.0
SYNTHETIC-5,DONOR_2005,TREATMENT_8005,,Adcetris,,RxNorm,,78.0,141.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8006,Other immunomodulatory substances,Nexavar,278936,,ug/m2,93.0,193.0
SYNTHETIC-5,DONOR_2007,TREATMENT_8007,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,8756456,PubChem,,155.0,155.0
SYNTHETIC-5,DONOR_2008,TREATMENT_8008,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,mg/m2,,163.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8009,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,NCI Thesaurus,g/m2,,181.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8010,Cell-based,Daratumumab,8756456,RxNorm,ug/m2,108.0,80.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8011,,Mektovi,239766,,IU/kg,,151.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8012,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,239766,NCI Thesaurus,,,147.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8013,Other immunomodulatory substances,Kadcyla,8756456,RxNorm,mg/kg,139.0,
SYNTHETIC-5,DONOR_2014,TREATMENT_8014,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,239766,RxNorm,g/m2,79.0,144.0
SYNTHETIC-5,DONOR_2015,TREATMENT_8015,Other immunomodulatory substances,Pembrolizumab,239766,NCI Thesaurus,g/m2,,190.0
SYNTHETIC-5,DONOR_2016,TREATMENT_8016,Other immunomodulatory substances,Perjeta,239766,NCI Thesaurus,cells/kg,144.0,63.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8017,Cell-based,Atezolizumab,4459876,RxNorm,IU/kg,179.0,176.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8018,Cell-based,,239766,PubChem,cells/kg,94.0,139.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8019,Immune checkpoint inhibitors,Adcetris,278936,RxNorm,,111.0,72.0
SYNTHETIC-5,DONOR_2020,TREATMENT_8020,Other immunomodulatory substances,,4459876,PubChem,IU/kg,94.0,
SYNTHETIC-5,DONOR_2021,TREATMENT_8021,Cell-based,Tecentriq,278936,RxNorm,g/m2,194.0,165.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8022,,Atezolizumab,,NCI Thesaurus,mg/m2,154.0,132.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8023,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,278936,NCI Thesaurus,IU/kg,183.0,
SYNTHETIC-5,DONOR_2024,TREATMENT_8024,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,8836851,NCI Thesaurus,cells/kg,182.0,
SYNTHETIC-5,DONOR_2025,TREATMENT_8025,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,8756456,NCI Thesaurus,IU/m2,170.0,97.0
SYNTHETIC-5,DONOR_2026,TREATMENT_8026,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,278936,,ug/m2,180.0,111.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8027,Immune checkpoint inhibitors,Lenvima,8836851,RxNorm,,85.0,140.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8028,,Tecentriq,4459876,,,,198.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8029,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,8836851,NCI Thesaurus,cells/kg,,194.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8030,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,PubChem,IU/m2,144.0,154.0
SYNTHETIC-5,DONOR_2031,TREATMENT_8031,,Cometriq,8756456,PubChem,,50.0,125.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8032,Other immunomodulatory substances,Pertuzumab,8756456,RxNorm,mg/m2,153.0,73.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8033,Cell-based,Nivolumab,239766,NCI Thesaurus,g/m2,147.0,167.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8034,Immune checkpoint inhibitors,Osimertinib,8836851,,cells/kg,,63.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8035,Other immunomodulatory substances,Selumitinib,8836851,PubChem,,92.0,50.0
SYNTHETIC-5,DONOR_2036,TREATMENT_8036,Cell-based,Nivolumab,987654,NCI Thesaurus,g/m2,99.0,162.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8037,Immune checkpoint inhibitors,Belantamab,8836851,NCI Thesaurus,mg/m2,93.0,
SYNTHETIC-5,DONOR_2038,TREATMENT_8038,Immune checkpoint inhibitors,Yervoy,239766,PubChem,,119.0,119.0
SYNTHETIC-5,DONOR_2039,TREATMENT_8039,Immune checkpoint inhibitors,Darzalex,239766,,g/m2,167.0,166.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8040,Cell-based,Tecentriq,239766,RxNorm,IU/m2,169.0,129.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8041,Other immunomodulatory substances,Copanlisib,239766,PubChem,mg/kg,80.0,
SYNTHETIC-5,DONOR_2042,TREATMENT_8042,Cell-based,Dabrafenib,8836851,,ug/m2,89.0,148.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8043,Cell-based,,278936,,cells/kg,106.0,102.0
SYNTHETIC-5,DONOR_2044,TREATMENT_8044,Other immunomodulatory substances,Copanlisib,4459876,,g/m2,135.0,191.0
SYNTHETIC-5,DONOR_2045,TREATMENT_8045,,Cabozantinib,4459876,PubChem,IU/kg,169.0,
SYNTHETIC-5,DONOR_2046,TREATMENT_8046,,,4459876,NCI Thesaurus,cells/kg,,88.0
SYNTHETIC-5,DONOR_2047,TREATMENT_8047,Cell-based,,,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2048,TREATMENT_8048,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,RxNorm,mg/m2,127.0,155.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8049,Cell-based,Ipilimumab,8756456,PubChem,mg/kg,87.0,66.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8050,Cell-based,Mektovi,278936,,g/m2,178.0,
SYNTHETIC-5,DONOR_2051,TREATMENT_8051,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,RxNorm,g/m2,195.0,132.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8052,Cell-based,,8756456,PubChem,mg/kg,139.0,121.0
SYNTHETIC-5,DONOR_2053,TREATMENT_8053,,Cotellic,8836851,RxNorm,cells/kg,70.0,54.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8054,,Trametinib,4459876,PubChem,cells/kg,116.0,61.0
SYNTHETIC-5,DONOR_2055,TREATMENT_8055,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,,RxNorm,cells/kg,112.0,62.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8056,Other immunomodulatory substances,Ceritinib,8836851,NCI Thesaurus,,73.0,155.0
SYNTHETIC-5,DONOR_2057,TREATMENT_8057,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,ug/m2,197.0,
SYNTHETIC-5,DONOR_2058,TREATMENT_8058,Immune checkpoint inhibitors,Niraparib,239766,PubChem,cells/kg,106.0,102.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8059,Cell-based,Ado-trastuzumab emtansine,4459876,NCI Thesaurus,cells/kg,171.0,
SYNTHETIC-5,DONOR_2060,TREATMENT_8060,Immune checkpoint inhibitors,Tecentriq,278936,NCI Thesaurus,,,56.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8061,Cell-based,Afatinib,8836851,NCI Thesaurus,mg/m2,112.0,149.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8062,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,,120.0,
SYNTHETIC-5,DONOR_2063,TREATMENT_8063,Other immunomodulatory substances,,4459876,PubChem,mg/m2,97.0,177.0
SYNTHETIC-5,DONOR_2064,TREATMENT_8064,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,239766,,,111.0,
SYNTHETIC-5,DONOR_2065,TREATMENT_8065,Immune checkpoint inhibitors,Dabrafenib,8756456,RxNorm,cells/kg,188.0,163.0
SYNTHETIC-5,DONOR_2066,TREATMENT_8066,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,4459876,PubChem,g/m2,184.0,188.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8067,Other immunomodulatory substances,Brigatinib,239766,PubChem,IU/kg,168.0,
SYNTHETIC-5,DONOR_2068,TREATMENT_8068,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8756456,RxNorm,ug/m2,55.0,93.0
SYNTHETIC-5,DONOR_2069,TREATMENT_8069,Cell-based,Yervoy,278936,PubChem,,76.0,65.0
SYNTHETIC-5,DONOR_2070,TREATMENT_8070,,Vemurafenib,278936,RxNorm,,125.0,149.0
SYNTHETIC-5,DONOR_2071,TREATMENT_8071,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,8836851,,,118.0,130.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8072,Other immunomodulatory substances,Nivolumab,987654,PubChem,g/m2,165.0,
SYNTHETIC-5,DONOR_2073,TREATMENT_8073,Immune checkpoint inhibitors,Durvalumab,987654,RxNorm,,179.0,98.0
SYNTHETIC-5,DONOR_2074,TREATMENT_8074,Immune checkpoint inhibitors,Gazyva,987654,,ug/m2,122.0,83.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8075,Cell-based,Zejula,278936,PubChem,ug/m2,174.0,187.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8076,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,4459876,RxNorm,,186.0,
SYNTHETIC-5,DONOR_2077,TREATMENT_8077,Other immunomodulatory substances,Xalkori,239766,PubChem,g/m2,108.0,76.0
SYNTHETIC-5,DONOR_2078,TREATMENT_8078,,Caprelsa,4459876,,IU/m2,120.0,123.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8079,Cell-based,Palbociclib,8756456,PubChem,g/m2,99.0,132.0
SYNTHETIC-5,DONOR_2080,TREATMENT_8080,Immune checkpoint inhibitors,Necitumumab,8756456,RxNorm,mg/m2,75.0,
SYNTHETIC-5,DONOR_2081,TREATMENT_8081,Cell-based,Xalkori,4459876,,IU/m2,102.0,150.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8082,Immune checkpoint inhibitors,,8756456,,mg/kg,68.0,166.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8083,Immune checkpoint inhibitors,Durvalumab,239766,PubChem,cells/kg,187.0,
SYNTHETIC-5,DONOR_2084,TREATMENT_8084,Cell-based,Nexavar,8756456,NCI Thesaurus,g/m2,63.0,
SYNTHETIC-5,DONOR_2085,TREATMENT_8085,Immune checkpoint inhibitors,Braftovi,8836851,RxNorm,IU/kg,54.0,114.0
SYNTHETIC-5,DONOR_2086,TREATMENT_8086,,Lenvatinib,,RxNorm,g/m2,64.0,115.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8087,Cell-based,,8836851,RxNorm,,147.0,
SYNTHETIC-5,DONOR_2088,TREATMENT_8088,Cell-based,Trastuzumab,8756456,RxNorm,IU/kg,167.0,
SYNTHETIC-5,DONOR_2089,TREATMENT_8089,Cell-based,,8836851,PubChem,,191.0,123.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8090,Immune checkpoint inhibitors,Cobimetinib,8836851,RxNorm,ug/m2,198.0,
SYNTHETIC-5,DONOR_2091,TREATMENT_8091,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,IU/kg,149.0,183.0
SYNTHETIC-5,DONOR_2092,TREATMENT_8092,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,278936,NCI Thesaurus,cells/kg,184.0,190.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8093,Immune checkpoint inhibitors,Nexavar,4459876,NCI Thesaurus,ug/m2,162.0,155.0
SYNTHETIC-5,DONOR_2094,TREATMENT_8094,Cell-based,Alectinib,4459876,PubChem,ug/m2,135.0,
SYNTHETIC-5,DONOR_2095,TREATMENT_8095,,,239766,PubChem,mg/m2,133.0,135.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8096,,Trametinib,4459876,NCI Thesaurus,IU/m2,161.0,174.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8097,Cell-based,Durvalumab,8756456,PubChem,ug/m2,144.0,73.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8098,Cell-based,Trametinib,4459876,PubChem,IU/kg,154.0,186.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8099,Immune checkpoint inhibitors,Necitumumab,987654,RxNorm,mg/m2,54.0,97.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8100,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,,RxNorm,mg/kg,,192.0
SYNTHETIC-5,DONOR_2101,TREATMENT_8101,Immune checkpoint inhibitors,Zejula,4459876,NCI Thesaurus,,70.0,98.0
SYNTHETIC-5,DONOR_2102,TREATMENT_8102,,Durvalumab,239766,NCI Thesaurus,IU/kg,91.0,
SYNTHETIC-5,DONOR_2103,TREATMENT_8103,Other immunomodulatory substances,Nivolumab,239766,RxNorm,ug/m2,69.0,152.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8104,Other immunomodulatory substances,Rituxan,8836851,RxNorm,g/m2,140.0,109.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8105,Immune checkpoint inhibitors,Adcetris,278936,RxNorm,mg/m2,88.0,147.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8106,Other immunomodulatory substances,Belantamab,8756456,RxNorm,,85.0,158.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8107,Other immunomodulatory substances,,8836851,RxNorm,ug/m2,104.0,105.0
SYNTHETIC-5,DONOR_2108,TREATMENT_8108,Cell-based,Crizotinib,278936,RxNorm,,64.0,161.0
SYNTHETIC-5,DONOR_2109,TREATMENT_8109,,Besponsa,987654,RxNorm,mg/m2,80.0,103.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8110,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8836851,RxNorm,,138.0,193.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8111,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,NCI Thesaurus,IU/m2,176.0,130.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8112,Immune checkpoint inhibitors,,,RxNorm,IU/m2,191.0,
SYNTHETIC-5,DONOR_2113,TREATMENT_8113,Immune checkpoint inhibitors,Opdivo,8756456,PubChem,IU/kg,160.0,114.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8114,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,,PubChem,,178.0,193.0
SYNTHETIC-5,DONOR_2115,TREATMENT_8115,Other immunomodulatory substances,Verzenio,8836851,NCI Thesaurus,mg/kg,114.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_8116,,Brigatinib,987654,NCI Thesaurus,ug/m2,,55.0
SYNTHETIC-5,DONOR_2117,TREATMENT_8117,Other immunomodulatory substances,Osimertinib,,PubChem,mg/m2,,118.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8118,Immune checkpoint inhibitors,Pembrolizumab,8836851,NCI Thesaurus,cells/kg,87.0,89.0
SYNTHETIC-5,DONOR_2119,TREATMENT_8119,Cell-based,Gilotrif,4459876,RxNorm,,76.0,101.0
SYNTHETIC-5,DONOR_2120,TREATMENT_8120,Immune checkpoint inhibitors,Herceptin,4459876,RxNorm,cells/kg,73.0,184.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8121,Cell-based,,278936,RxNorm,cells/kg,148.0,140.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8122,Immune checkpoint inhibitors,,278936,RxNorm,mg/m2,121.0,
SYNTHETIC-5,DONOR_2123,TREATMENT_8123,Immune checkpoint inhibitors,Rubraca,,RxNorm,IU/m2,155.0,147.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8124,Immune checkpoint inhibitors,Darzalex,8756456,PubChem,g/m2,94.0,
SYNTHETIC-5,DONOR_2125,TREATMENT_8125,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/kg,95.0,102.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8126,,Zelboraf,987654,RxNorm,IU/kg,174.0,100.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8127,Immune checkpoint inhibitors,Inotuzumab ozogamicin,8836851,NCI Thesaurus,mg/m2,85.0,142.0
SYNTHETIC-5,DONOR_2128,TREATMENT_8128,,Ipilimumab,278936,NCI Thesaurus,,136.0,115.0
SYNTHETIC-5,DONOR_2129,TREATMENT_8129,,Tecentriq,4459876,,g/m2,,
SYNTHETIC-5,DONOR_2130,TREATMENT_8130,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8756456,,cells/kg,124.0,143.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8131,Other immunomodulatory substances,Belantamab,,PubChem,g/m2,,164.0
SYNTHETIC-5,DONOR_2132,TREATMENT_8132,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,PubChem,,130.0,
SYNTHETIC-5,DONOR_2133,TREATMENT_8133,,Yescarta,987654,RxNorm,IU/kg,178.0,71.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8134,Immune checkpoint inhibitors,,8836851,PubChem,cells/kg,97.0,62.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8135,Cell-based,,4459876,PubChem,mg/m2,75.0,190.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8136,Other immunomodulatory substances,Zejula,8836851,NCI Thesaurus,mg/kg,116.0,162.0
SYNTHETIC-5,DONOR_2137,TREATMENT_8137,Other immunomodulatory substances,,8756456,RxNorm,,193.0,103.0
SYNTHETIC-5,DONOR_2138,TREATMENT_8138,Immune checkpoint inhibitors,Brentuximab vedotin,987654,NCI Thesaurus,g/m2,191.0,
SYNTHETIC-5,DONOR_2139,TREATMENT_8139,Other immunomodulatory substances,,278936,NCI Thesaurus,g/m2,118.0,186.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8140,Immune checkpoint inhibitors,Blincyto,8756456,PubChem,g/m2,179.0,109.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8141,Immune checkpoint inhibitors,Selumitinib,987654,RxNorm,,87.0,131.0
SYNTHETIC-5,DONOR_2142,TREATMENT_8142,Cell-based,Zejula,278936,RxNorm,IU/m2,,146.0
SYNTHETIC-5,DONOR_2143,TREATMENT_8143,Immune checkpoint inhibitors,Xalkori,278936,RxNorm,ug/m2,125.0,145.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8144,Other immunomodulatory substances,Adcetris,239766,PubChem,IU/kg,,102.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8145,Other immunomodulatory substances,Yervoy,239766,,g/m2,,169.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8146,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,987654,,IU/m2,111.0,65.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8147,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,NCI Thesaurus,mg/m2,172.0,59.0
SYNTHETIC-5,DONOR_2148,TREATMENT_8148,Immune checkpoint inhibitors,,8756456,PubChem,ug/m2,96.0,145.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8149,Cell-based,Nivolumab,8756456,NCI Thesaurus,cells/kg,157.0,68.0
SYNTHETIC-5,DONOR_2150,TREATMENT_8150,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,278936,RxNorm,cells/kg,,188.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8151,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,,NCI Thesaurus,,106.0,158.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8152,Cell-based,Durvalumab,239766,RxNorm,g/m2,86.0,62.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8153,Other immunomodulatory substances,Lenvima,278936,RxNorm,IU/m2,80.0,98.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8154,Other immunomodulatory substances,Rituxan,8756456,NCI Thesaurus,mg/kg,,75.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8155,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,8836851,RxNorm,,73.0,103.0
SYNTHETIC-5,DONOR_2156,TREATMENT_8156,Cell-based,,239766,RxNorm,ug/m2,99.0,155.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8157,Cell-based,Pembrolizumab,987654,PubChem,g/m2,68.0,127.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8158,Other immunomodulatory substances,Keytruda,4459876,,,88.0,191.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8159,Other immunomodulatory substances,Encorafenib,8836851,RxNorm,IU/kg,185.0,
SYNTHETIC-5,DONOR_2160,TREATMENT_8160,,Abemaciclib,,PubChem,IU/kg,153.0,194.0
SYNTHETIC-5,DONOR_2161,TREATMENT_8161,Other immunomodulatory substances,Mekinist,239766,RxNorm,IU/m2,84.0,97.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8162,Other immunomodulatory substances,Gazyva,239766,NCI Thesaurus,g/m2,157.0,
SYNTHETIC-5,DONOR_2163,TREATMENT_8163,Immune checkpoint inhibitors,Tisagenlecleucel,239766,,ug/m2,,121.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8164,,Tafinlar,8836851,NCI Thesaurus,g/m2,,151.0
SYNTHETIC-5,DONOR_2165,TREATMENT_8165,Other immunomodulatory substances,Erlotinib,,NCI Thesaurus,mg/m2,166.0,180.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8166,Cell-based,Herceptin,,PubChem,IU/m2,141.0,158.0
SYNTHETIC-5,DONOR_2167,TREATMENT_8167,Cell-based,Ipilimumab,987654,PubChem,cells/kg,61.0,
SYNTHETIC-5,DONOR_2168,TREATMENT_8168,Cell-based,Durvalumab,4459876,RxNorm,,165.0,
SYNTHETIC-5,DONOR_2169,TREATMENT_8169,Cell-based,Nivolumab,278936,PubChem,IU/m2,71.0,170.0
SYNTHETIC-5,DONOR_2170,TREATMENT_8170,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,,PubChem,mg/m2,130.0,109.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8171,Cell-based,Cotellic,239766,RxNorm,IU/kg,74.0,94.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8172,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,8756456,NCI Thesaurus,g/m2,73.0,
SYNTHETIC-5,DONOR_2173,TREATMENT_8173,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,278936,NCI Thesaurus,IU/m2,90.0,62.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8174,Cell-based,Tagrisso,8756456,NCI Thesaurus,,152.0,57.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8175,Cell-based,Tecentriq,239766,,ug/m2,,198.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8176,Cell-based,Abemaciclib,8756456,NCI Thesaurus,g/m2,122.0,103.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8177,,Gilotrif,8836851,RxNorm,mg/kg,159.0,162.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8178,Cell-based,Osimertinib,4459876,PubChem,ug/m2,167.0,
SYNTHETIC-5,DONOR_2179,TREATMENT_8179,Other immunomodulatory substances,Brentuximab vedotin,8756456,,cells/kg,69.0,88.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8180,Other immunomodulatory substances,Tagrisso,8836851,NCI Thesaurus,cells/kg,92.0,138.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8181,,,278936,RxNorm,mg/kg,62.0,96.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8182,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,PubChem,IU/m2,185.0,187.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8183,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,PubChem,mg/m2,65.0,151.0
SYNTHETIC-5,DONOR_2184,TREATMENT_8184,Immune checkpoint inhibitors,Palbociclib,278936,RxNorm,g/m2,123.0,101.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8185,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,,PubChem,IU/m2,143.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_8186,Other immunomodulatory substances,Tarceva,8756456,NCI Thesaurus,IU/m2,177.0,188.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8187,,,987654,,IU/m2,153.0,61.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8188,Cell-based,Ipilimumab,8836851,NCI Thesaurus,g/m2,199.0,187.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8189,Cell-based,Durvalumab,8836851,PubChem,mg/m2,179.0,102.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8190,Immune checkpoint inhibitors,Alecensa,987654,NCI Thesaurus,cells/kg,151.0,152.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8191,Immune checkpoint inhibitors,Tisagenlecleucel,8756456,NCI Thesaurus,IU/m2,,118.0
SYNTHETIC-5,DONOR_2192,TREATMENT_8192,Cell-based,,8756456,PubChem,cells/kg,124.0,154.0
SYNTHETIC-5,DONOR_2193,TREATMENT_8193,Cell-based,Rucaparib,4459876,,IU/kg,88.0,182.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8194,Other immunomodulatory substances,,8756456,RxNorm,IU/kg,142.0,117.0
SYNTHETIC-5,DONOR_2195,TREATMENT_8195,Cell-based,Keytruda,8756456,NCI Thesaurus,g/m2,137.0,55.0
SYNTHETIC-5,DONOR_2196,TREATMENT_8196,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,278936,PubChem,cells/kg,120.0,166.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8197,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,NCI Thesaurus,mg/kg,,71.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8198,Cell-based,,8836851,,mg/m2,104.0,100.0
SYNTHETIC-5,DONOR_2199,TREATMENT_8199,Cell-based,Durvalumab,,NCI Thesaurus,mg/kg,168.0,68.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8200,Cell-based,Keytruda,,PubChem,IU/m2,138.0,91.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8201,Cell-based,Ribociclib,8756456,PubChem,,121.0,124.0
SYNTHETIC-5,DONOR_2202,TREATMENT_8202,Immune checkpoint inhibitors,Tecentriq,8756456,RxNorm,ug/m2,172.0,147.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8203,Other immunomodulatory substances,Caprelsa,4459876,NCI Thesaurus,,144.0,
SYNTHETIC-5,DONOR_2204,TREATMENT_8204,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,278936,PubChem,,50.0,
SYNTHETIC-5,DONOR_2205,TREATMENT_8205,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,NCI Thesaurus,ug/m2,143.0,59.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8206,Cell-based,Nivolumab,278936,RxNorm,g/m2,105.0,88.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8207,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,,NCI Thesaurus,ug/m2,57.0,154.0
SYNTHETIC-5,DONOR_2208,TREATMENT_8208,Other immunomodulatory substances,Pertuzumab,8836851,RxNorm,,175.0,197.0
SYNTHETIC-5,DONOR_2209,TREATMENT_8209,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,239766,PubChem,,71.0,100.0
SYNTHETIC-5,DONOR_2210,TREATMENT_8210,Cell-based,Obinutuzumab,8756456,NCI Thesaurus,cells/kg,190.0,170.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8211,Other immunomodulatory substances,Necitumumab,,,cells/kg,195.0,50.0
SYNTHETIC-5,DONOR_2212,TREATMENT_8212,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,mg/m2,80.0,60.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8213,Cell-based,Venetoclax,8836851,NCI Thesaurus,mg/m2,188.0,
SYNTHETIC-5,DONOR_2214,TREATMENT_8214,Cell-based,Tarceva,8836851,RxNorm,,164.0,94.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8215,Cell-based,Selumitinib,8756456,NCI Thesaurus,IU/kg,178.0,193.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8216,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,IU/m2,59.0,
SYNTHETIC-5,DONOR_2217,TREATMENT_8217,Cell-based,,278936,PubChem,ug/m2,165.0,141.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8218,Other immunomodulatory substances,Daratumumab,987654,NCI Thesaurus,ug/m2,56.0,142.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8219,Immune checkpoint inhibitors,Keytruda,239766,,IU/kg,138.0,
SYNTHETIC-5,DONOR_2220,TREATMENT_8220,Immune checkpoint inhibitors,Crizotinib,278936,RxNorm,mg/kg,169.0,72.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8221,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,987654,PubChem,mg/m2,78.0,
SYNTHETIC-5,DONOR_2222,TREATMENT_8222,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,,cells/kg,151.0,113.0
SYNTHETIC-5,DONOR_2223,TREATMENT_8223,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,RxNorm,g/m2,,129.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8224,Immune checkpoint inhibitors,,987654,RxNorm,,,127.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8225,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8836851,PubChem,cells/kg,110.0,101.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8226,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/m2,74.0,170.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8227,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,,RxNorm,g/m2,81.0,120.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8228,Immune checkpoint inhibitors,Nexavar,278936,PubChem,mg/kg,73.0,79.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8229,Immune checkpoint inhibitors,Cabozantinib,8836851,PubChem,IU/m2,99.0,
SYNTHETIC-5,DONOR_2230,TREATMENT_8230,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,8756456,RxNorm,IU/kg,157.0,75.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8231,Cell-based,,8756456,PubChem,mg/kg,186.0,182.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8232,Cell-based,Herceptin,278936,RxNorm,mg/m2,177.0,50.0
SYNTHETIC-5,DONOR_2233,TREATMENT_8233,Other immunomodulatory substances,Yervoy,987654,PubChem,,50.0,65.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8234,Immune checkpoint inhibitors,Olaparib,239766,NCI Thesaurus,,96.0,139.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8235,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,987654,,IU/m2,148.0,194.0
SYNTHETIC-5,DONOR_2236,TREATMENT_8236,Immune checkpoint inhibitors,Ceritinib,987654,NCI Thesaurus,,120.0,70.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8237,Immune checkpoint inhibitors,Tecentriq,4459876,RxNorm,mg/m2,,115.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8238,Cell-based,Lenvima,987654,RxNorm,mg/kg,115.0,159.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8239,Immune checkpoint inhibitors,Trametinib,987654,PubChem,mg/kg,,102.0
SYNTHETIC-5,DONOR_2240,TREATMENT_8240,,Perjeta,8836851,NCI Thesaurus,IU/m2,142.0,113.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8241,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8836851,NCI Thesaurus,,74.0,66.0
SYNTHETIC-5,DONOR_2242,TREATMENT_8242,Immune checkpoint inhibitors,Yervoy,4459876,PubChem,IU/m2,177.0,68.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8243,Immune checkpoint inhibitors,Tafinlar,4459876,NCI Thesaurus,mg/m2,52.0,
SYNTHETIC-5,DONOR_2244,TREATMENT_8244,Other immunomodulatory substances,Tecentriq,,RxNorm,IU/kg,102.0,70.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8245,,Venetoclax,,,g/m2,,
SYNTHETIC-5,DONOR_2246,TREATMENT_8246,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,RxNorm,,130.0,98.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8247,,Ipilimumab,4459876,,,189.0,173.0
SYNTHETIC-5,DONOR_2248,TREATMENT_8248,,Tecentriq,8836851,,mg/kg,155.0,103.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8249,Other immunomodulatory substances,Inotuzumab ozogamicin,239766,RxNorm,cells/kg,,145.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8250,Other immunomodulatory substances,,8756456,NCI Thesaurus,ug/m2,91.0,164.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8251,Other immunomodulatory substances,Cometriq,8836851,PubChem,IU/kg,,103.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8252,Other immunomodulatory substances,Sorafenib,278936,,cells/kg,104.0,104.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8253,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,mg/kg,162.0,148.0
SYNTHETIC-5,DONOR_2254,TREATMENT_8254,Other immunomodulatory substances,Xalkori,278936,,,200.0,107.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8255,,,,RxNorm,cells/kg,53.0,104.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8256,Other immunomodulatory substances,Venetoclax,278936,RxNorm,g/m2,195.0,150.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8257,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,4459876,PubChem,mg/kg,197.0,77.0
SYNTHETIC-5,DONOR_2258,TREATMENT_8258,Immune checkpoint inhibitors,,8836851,,IU/m2,147.0,66.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8259,,,239766,PubChem,cells/kg,148.0,80.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8260,Other immunomodulatory substances,Brentuximab vedotin,,NCI Thesaurus,ug/m2,,128.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8261,Cell-based,Rituxan,,,g/m2,179.0,119.0
SYNTHETIC-5,DONOR_2262,TREATMENT_8262,Immune checkpoint inhibitors,Kadcyla,239766,,IU/m2,162.0,59.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8263,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,PubChem,mg/m2,153.0,
SYNTHETIC-5,DONOR_2264,TREATMENT_8264,Other immunomodulatory substances,Atezolizumab,987654,NCI Thesaurus,g/m2,149.0,106.0
SYNTHETIC-5,DONOR_2265,TREATMENT_8265,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,278936,NCI Thesaurus,mg/kg,163.0,200.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8266,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,RxNorm,IU/kg,178.0,186.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8267,Immune checkpoint inhibitors,Afatinib,987654,PubChem,mg/kg,90.0,140.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8268,Cell-based,,278936,NCI Thesaurus,,108.0,137.0
SYNTHETIC-5,DONOR_2269,TREATMENT_8269,Cell-based,Mekinist,8836851,PubChem,IU/m2,126.0,
SYNTHETIC-5,DONOR_2270,TREATMENT_8270,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,NCI Thesaurus,,,99.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8271,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,,198.0,162.0
SYNTHETIC-5,DONOR_2272,TREATMENT_8272,Immune checkpoint inhibitors,Alectinib,239766,NCI Thesaurus,ug/m2,118.0,96.0
SYNTHETIC-5,DONOR_2273,TREATMENT_8273,Other immunomodulatory substances,Tecentriq,987654,PubChem,IU/m2,118.0,181.0
SYNTHETIC-5,DONOR_2274,TREATMENT_8274,Cell-based,Xalkori,8756456,PubChem,ug/m2,64.0,98.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8275,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,278936,RxNorm,,,187.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8276,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8836851,NCI Thesaurus,g/m2,,86.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8277,Cell-based,Pembrolizumab,8836851,PubChem,mg/m2,59.0,114.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8278,Other immunomodulatory substances,,,PubChem,,135.0,
SYNTHETIC-5,DONOR_2279,TREATMENT_8279,,Durvalumab,8836851,,IU/kg,183.0,108.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8280,Cell-based,Zejula,278936,RxNorm,,,
SYNTHETIC-5,DONOR_2281,TREATMENT_8281,Immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,cells/kg,158.0,145.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8282,Other immunomodulatory substances,Gazyva,4459876,NCI Thesaurus,mg/m2,57.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_8283,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,239766,RxNorm,IU/kg,74.0,56.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8284,Other immunomodulatory substances,Cobimetinib,278936,PubChem,cells/kg,74.0,
SYNTHETIC-5,DONOR_2285,TREATMENT_8285,Cell-based,Niraparib,278936,NCI Thesaurus,mg/m2,65.0,75.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8286,Other immunomodulatory substances,Necitumumab,278936,NCI Thesaurus,mg/m2,187.0,
SYNTHETIC-5,DONOR_2287,TREATMENT_8287,Cell-based,Keytruda,239766,NCI Thesaurus,IU/kg,,91.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8288,Cell-based,Cotellic,278936,RxNorm,IU/m2,123.0,105.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8289,Immune checkpoint inhibitors,Venetoclax,239766,NCI Thesaurus,,58.0,146.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8290,Cell-based,Yescarta,8836851,PubChem,mg/kg,,97.0
SYNTHETIC-5,DONOR_2291,TREATMENT_8291,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,,mg/kg,108.0,53.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8292,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,,RxNorm,,148.0,190.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8293,Cell-based,Caprelsa,278936,RxNorm,g/m2,197.0,143.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8294,Cell-based,Imfinzi,239766,,,104.0,
SYNTHETIC-5,DONOR_2295,TREATMENT_8295,Cell-based,Daratumumab,8756456,RxNorm,ug/m2,65.0,96.0
SYNTHETIC-5,DONOR_2296,TREATMENT_8296,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,,,81.0,187.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8297,Cell-based,,8756456,NCI Thesaurus,mg/kg,136.0,110.0
SYNTHETIC-5,DONOR_2298,TREATMENT_8298,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,987654,RxNorm,g/m2,132.0,149.0
SYNTHETIC-5,DONOR_2299,TREATMENT_8299,Cell-based,Blinatumomab,8756456,RxNorm,cells/kg,93.0,73.0
SYNTHETIC-5,DONOR_2300,TREATMENT_8300,Other immunomodulatory substances,Alecensa,278936,RxNorm,mg/m2,129.0,67.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8301,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,987654,PubChem,g/m2,185.0,
SYNTHETIC-5,DONOR_2302,TREATMENT_8302,Cell-based,Ceritinib,278936,NCI Thesaurus,g/m2,76.0,113.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8303,Immune checkpoint inhibitors,Venetoclax,8756456,PubChem,,92.0,180.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8304,Other immunomodulatory substances,Cotellic,,NCI Thesaurus,mg/m2,152.0,175.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8305,Other immunomodulatory substances,Nivolumab,,RxNorm,mg/m2,68.0,83.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8306,Cell-based,,4459876,PubChem,mg/kg,136.0,178.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8307,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,RxNorm,IU/m2,,125.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8308,Immune checkpoint inhibitors,Encorafenib,8756456,PubChem,,100.0,191.0
SYNTHETIC-5,DONOR_2309,TREATMENT_8309,Cell-based,Encorafenib,8836851,NCI Thesaurus,ug/m2,125.0,170.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8310,Cell-based,Venclexta,278936,RxNorm,ug/m2,116.0,60.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8311,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,PubChem,ug/m2,,138.0
SYNTHETIC-5,DONOR_2312,TREATMENT_8312,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,mg/kg,,191.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8313,Cell-based,Nivolumab,8756456,RxNorm,,123.0,97.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8314,Immune checkpoint inhibitors,Durvalumab,,RxNorm,,103.0,173.0
SYNTHETIC-5,DONOR_2315,TREATMENT_8315,Cell-based,Lynparza,4459876,RxNorm,g/m2,131.0,72.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8316,Cell-based,Cotellic,,NCI Thesaurus,IU/kg,74.0,117.0
SYNTHETIC-5,DONOR_2317,TREATMENT_8317,Immune checkpoint inhibitors,Tisagenlecleucel,239766,PubChem,IU/kg,,106.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8318,Immune checkpoint inhibitors,Gazyva,,PubChem,g/m2,78.0,109.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8319,Cell-based,Vemurafenib,278936,,mg/m2,104.0,81.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8320,Cell-based,Erlotinib,8836851,PubChem,mg/m2,58.0,97.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8321,Immune checkpoint inhibitors,Ipilimumab,239766,,,157.0,106.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8322,Cell-based,Imfinzi,8756456,PubChem,mg/m2,134.0,
SYNTHETIC-5,DONOR_2323,TREATMENT_8323,Cell-based,Nivolumab,239766,RxNorm,g/m2,187.0,79.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8324,Other immunomodulatory substances,Erlotinib,278936,NCI Thesaurus,,145.0,91.0
SYNTHETIC-5,DONOR_2325,TREATMENT_8325,,Yescarta,4459876,PubChem,IU/kg,94.0,
SYNTHETIC-5,DONOR_2326,TREATMENT_8326,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,,NCI Thesaurus,mg/m2,159.0,111.0
SYNTHETIC-5,DONOR_2327,TREATMENT_8327,Other immunomodulatory substances,Ipilimumab,8756456,,g/m2,73.0,143.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8328,Other immunomodulatory substances,Kymriah,987654,PubChem,IU/kg,90.0,
SYNTHETIC-5,DONOR_2329,TREATMENT_8329,Immune checkpoint inhibitors,Cotellic,987654,NCI Thesaurus,,61.0,168.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8330,Cell-based,Tecentriq,987654,RxNorm,cells/kg,,
SYNTHETIC-5,DONOR_2331,TREATMENT_8331,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,239766,NCI Thesaurus,IU/kg,184.0,
SYNTHETIC-5,DONOR_2332,TREATMENT_8332,Other immunomodulatory substances,,239766,PubChem,IU/m2,149.0,50.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8333,Immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,ug/m2,141.0,143.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8334,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,,62.0,108.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8335,Cell-based,,278936,RxNorm,,90.0,
SYNTHETIC-5,DONOR_2336,TREATMENT_8336,Cell-based,Caprelsa,8756456,RxNorm,mg/kg,96.0,76.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8337,Other immunomodulatory substances,Opdivo,239766,RxNorm,g/m2,119.0,186.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8338,Other immunomodulatory substances,Tecentriq,987654,RxNorm,mg/kg,197.0,158.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8339,Other immunomodulatory substances,Zelboraf,8836851,NCI Thesaurus,IU/m2,148.0,138.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8340,Cell-based,Osimertinib,8756456,PubChem,IU/kg,,186.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8341,Immune checkpoint inhibitors,Cabozantinib,8836851,RxNorm,mg/kg,180.0,102.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8342,,Rituximab,,RxNorm,cells/kg,,194.0
SYNTHETIC-5,DONOR_2343,TREATMENT_8343,Cell-based,Cometriq,278936,PubChem,IU/kg,152.0,56.0
SYNTHETIC-5,DONOR_2344,TREATMENT_8344,Immune checkpoint inhibitors,Mekinist,8756456,NCI Thesaurus,mg/m2,169.0,121.0
SYNTHETIC-5,DONOR_2345,TREATMENT_8345,Immune checkpoint inhibitors,Gazyva,239766,NCI Thesaurus,ug/m2,148.0,116.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8346,Immune checkpoint inhibitors,Caprelsa,278936,RxNorm,ug/m2,166.0,121.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8347,Cell-based,Caprelsa,987654,NCI Thesaurus,g/m2,,86.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8348,Immune checkpoint inhibitors,Rituximab,8836851,,IU/kg,72.0,197.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8349,,Tecentriq,239766,PubChem,cells/kg,198.0,
SYNTHETIC-5,DONOR_2350,TREATMENT_8350,Cell-based,Ceritinib,987654,PubChem,IU/m2,180.0,160.0
SYNTHETIC-5,DONOR_2351,TREATMENT_8351,Cell-based,Erlotinib,987654,PubChem,g/m2,171.0,109.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8352,Other immunomodulatory substances,Kymriah,8756456,,cells/kg,182.0,123.0
SYNTHETIC-5,DONOR_2353,TREATMENT_8353,Cell-based,Ceritinib,8836851,,mg/m2,53.0,72.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8354,Immune checkpoint inhibitors,Ceritinib,239766,NCI Thesaurus,ug/m2,53.0,114.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8355,,Zejula,4459876,NCI Thesaurus,g/m2,60.0,174.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8356,Immune checkpoint inhibitors,Zelboraf,278936,NCI Thesaurus,g/m2,179.0,139.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8357,Other immunomodulatory substances,Darzalex,278936,NCI Thesaurus,IU/m2,120.0,165.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8358,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,,cells/kg,,188.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8359,Other immunomodulatory substances,Atezolizumab,,RxNorm,,127.0,86.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8360,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,278936,,ug/m2,73.0,184.0
SYNTHETIC-5,DONOR_2361,TREATMENT_8361,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2362,TREATMENT_8362,Other immunomodulatory substances,Lynparza,987654,,ug/m2,105.0,144.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8363,Other immunomodulatory substances,Rituxan,987654,RxNorm,g/m2,115.0,200.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8364,Other immunomodulatory substances,Gilteritinib,8756456,RxNorm,g/m2,150.0,83.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8365,Immune checkpoint inhibitors,Tecentriq,4459876,RxNorm,g/m2,159.0,97.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8366,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,4459876,,IU/kg,89.0,187.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8367,Immune checkpoint inhibitors,Enhertu,8756456,PubChem,ug/m2,165.0,180.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8368,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,,,179.0
SYNTHETIC-5,DONOR_2369,TREATMENT_8369,Immune checkpoint inhibitors,Nivolumab,8756456,,,178.0,
SYNTHETIC-5,DONOR_2370,TREATMENT_8370,Immune checkpoint inhibitors,Belantamab,278936,PubChem,mg/kg,148.0,179.0
SYNTHETIC-5,DONOR_2371,TREATMENT_8371,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,,NCI Thesaurus,mg/kg,59.0,
SYNTHETIC-5,DONOR_2372,TREATMENT_8372,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,IU/m2,,105.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8373,Immune checkpoint inhibitors,Tecentriq,8756456,RxNorm,mg/kg,119.0,
SYNTHETIC-5,DONOR_2374,TREATMENT_8374,Immune checkpoint inhibitors,Kadcyla,987654,NCI Thesaurus,cells/kg,81.0,93.0
SYNTHETIC-5,DONOR_2375,TREATMENT_8375,Other immunomodulatory substances,Cobimetinib,239766,PubChem,IU/kg,148.0,92.0
SYNTHETIC-5,DONOR_2376,TREATMENT_8376,Other immunomodulatory substances,Tecentriq,8756456,,mg/m2,84.0,
SYNTHETIC-5,DONOR_2377,TREATMENT_8377,Cell-based,Xalkori,8756456,RxNorm,mg/kg,66.0,182.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8378,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,IU/kg,119.0,83.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8379,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,239766,RxNorm,IU/kg,,63.0
SYNTHETIC-5,DONOR_2380,TREATMENT_8380,Immune checkpoint inhibitors,,987654,,mg/kg,,97.0
SYNTHETIC-5,DONOR_2381,TREATMENT_8381,Immune checkpoint inhibitors,Belantamab,8756456,,IU/kg,150.0,160.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8382,Cell-based,Rituxan,8836851,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2383,TREATMENT_8383,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,278936,NCI Thesaurus,mg/m2,,92.0
SYNTHETIC-5,DONOR_2384,TREATMENT_8384,,,8756456,NCI Thesaurus,,128.0,65.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8385,Cell-based,Yervoy,4459876,NCI Thesaurus,ug/m2,93.0,129.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8386,Immune checkpoint inhibitors,Rucaparib,987654,NCI Thesaurus,IU/m2,,199.0
SYNTHETIC-5,DONOR_2387,TREATMENT_8387,Immune checkpoint inhibitors,Kisqali,8756456,RxNorm,cells/kg,172.0,84.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8388,Immune checkpoint inhibitors,Ibrance,8756456,RxNorm,IU/kg,192.0,58.0
SYNTHETIC-5,DONOR_2389,TREATMENT_8389,,Vandetanib,8836851,PubChem,mg/m2,117.0,196.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8390,Cell-based,Opdivo,8836851,NCI Thesaurus,,167.0,117.0
SYNTHETIC-5,DONOR_2391,TREATMENT_8391,Other immunomodulatory substances,Nivolumab,987654,RxNorm,mg/m2,128.0,91.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8392,Immune checkpoint inhibitors,Tagrisso,8756456,NCI Thesaurus,mg/m2,163.0,65.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8393,Other immunomodulatory substances,Atezolizumab,4459876,,g/m2,71.0,91.0
SYNTHETIC-5,DONOR_2394,TREATMENT_8394,,Encorafenib,,NCI Thesaurus,IU/kg,62.0,85.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8395,Cell-based,Pertuzumab,278936,,cells/kg,69.0,172.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8396,Cell-based,Ceritinib,8836851,RxNorm,mg/kg,158.0,121.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8397,Cell-based,Yervoy,278936,RxNorm,g/m2,126.0,132.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8398,Immune checkpoint inhibitors,Tafinlar,8756456,NCI Thesaurus,mg/m2,,78.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8399,,Ipilimumab,8836851,NCI Thesaurus,mg/m2,189.0,150.0
SYNTHETIC-5,DONOR_2400,TREATMENT_8400,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,cells/kg,110.0,135.0
SYNTHETIC-5,DONOR_2401,TREATMENT_8401,Other immunomodulatory substances,Yervoy,278936,NCI Thesaurus,cells/kg,,136.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8402,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,4459876,PubChem,cells/kg,143.0,69.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8403,Cell-based,Rituximab,,,IU/m2,172.0,58.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8404,Immune checkpoint inhibitors,,278936,,IU/kg,135.0,112.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8405,Cell-based,Pembrolizumab,239766,PubChem,mg/m2,162.0,73.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8406,Other immunomodulatory substances,Tagrisso,,NCI Thesaurus,g/m2,184.0,
SYNTHETIC-5,DONOR_2407,TREATMENT_8407,Cell-based,Binimetinib,,RxNorm,ug/m2,145.0,146.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8408,Cell-based,Lenvatinib,987654,PubChem,cells/kg,155.0,124.0
SYNTHETIC-5,DONOR_2409,TREATMENT_8409,Cell-based,,8756456,PubChem,ug/m2,88.0,77.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8410,Other immunomodulatory substances,Mekinist,987654,,mg/m2,173.0,126.0
SYNTHETIC-5,DONOR_2411,TREATMENT_8411,Immune checkpoint inhibitors,Pembrolizumab,4459876,NCI Thesaurus,g/m2,117.0,173.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8412,Other immunomodulatory substances,Binimetinib,8756456,NCI Thesaurus,g/m2,52.0,119.0
SYNTHETIC-5,DONOR_2413,TREATMENT_8413,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,,cells/kg,66.0,78.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8414,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,8756456,PubChem,IU/kg,110.0,146.0
SYNTHETIC-5,DONOR_2415,TREATMENT_8415,,,278936,PubChem,,54.0,155.0
SYNTHETIC-5,DONOR_2416,TREATMENT_8416,Immune checkpoint inhibitors,Imfinzi,239766,PubChem,mg/kg,138.0,193.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8417,,Blincyto,987654,NCI Thesaurus,mg/kg,102.0,196.0
SYNTHETIC-5,DONOR_2418,TREATMENT_8418,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,RxNorm,,87.0,96.0
SYNTHETIC-5,DONOR_2419,TREATMENT_8419,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,cells/kg,190.0,
SYNTHETIC-5,DONOR_2420,TREATMENT_8420,Immune checkpoint inhibitors,Ipilimumab,8756456,,cells/kg,200.0,68.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8421,Other immunomodulatory substances,Vandetanib,8756456,NCI Thesaurus,cells/kg,121.0,123.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8422,Cell-based,Belantamab,8836851,RxNorm,IU/m2,68.0,120.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8423,Other immunomodulatory substances,Nivolumab,,RxNorm,g/m2,60.0,119.0
SYNTHETIC-5,DONOR_2424,TREATMENT_8424,Cell-based,,8836851,PubChem,ug/m2,57.0,107.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8425,,,239766,NCI Thesaurus,mg/kg,114.0,157.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8426,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,RxNorm,mg/m2,53.0,136.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8427,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,,g/m2,94.0,71.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8428,Other immunomodulatory substances,Keytruda,4459876,RxNorm,cells/kg,,149.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8429,Immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,IU/kg,121.0,80.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8430,Other immunomodulatory substances,Belantamab,8836851,PubChem,IU/kg,68.0,168.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8431,Immune checkpoint inhibitors,,8836851,,cells/kg,160.0,114.0
SYNTHETIC-5,DONOR_2432,TREATMENT_8432,Immune checkpoint inhibitors,Kadcyla,8836851,RxNorm,cells/kg,157.0,167.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8433,Other immunomodulatory substances,Pembrolizumab,239766,NCI Thesaurus,mg/m2,,174.0
SYNTHETIC-5,DONOR_2434,TREATMENT_8434,Other immunomodulatory substances,Dabrafenib,239766,PubChem,mg/m2,177.0,194.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8435,Immune checkpoint inhibitors,Kisqali,8836851,RxNorm,ug/m2,102.0,
SYNTHETIC-5,DONOR_2436,TREATMENT_8436,,Lenvatinib,278936,RxNorm,g/m2,139.0,118.0
SYNTHETIC-5,DONOR_2437,TREATMENT_8437,Other immunomodulatory substances,Blinatumomab,987654,PubChem,,,
SYNTHETIC-5,DONOR_2438,TREATMENT_8438,,,278936,RxNorm,,67.0,118.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8439,Other immunomodulatory substances,Lenvatinib,4459876,RxNorm,cells/kg,76.0,76.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8440,Immune checkpoint inhibitors,Opdivo,8756456,PubChem,cells/kg,,151.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8441,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,8756456,PubChem,IU/m2,162.0,133.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8442,Other immunomodulatory substances,Rituximab,8836851,NCI Thesaurus,IU/m2,52.0,93.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8443,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,IU/kg,,127.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8444,Other immunomodulatory substances,Pembrolizumab,8836851,,cells/kg,168.0,108.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8445,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,,cells/kg,118.0,114.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8446,Cell-based,Darzalex,239766,PubChem,IU/kg,,153.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8447,,Iressa,278936,NCI Thesaurus,IU/kg,198.0,181.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8448,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,8836851,,,,127.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8449,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,239766,NCI Thesaurus,IU/kg,105.0,
SYNTHETIC-5,DONOR_2450,TREATMENT_8450,Other immunomodulatory substances,Opdivo,4459876,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2451,TREATMENT_8451,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,RxNorm,mg/kg,71.0,133.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8452,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,239766,NCI Thesaurus,,194.0,74.0
SYNTHETIC-5,DONOR_2453,TREATMENT_8453,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,,RxNorm,,,126.0
SYNTHETIC-5,DONOR_2454,TREATMENT_8454,Cell-based,Blinatumomab,4459876,PubChem,IU/kg,169.0,51.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8455,Other immunomodulatory substances,,987654,,g/m2,54.0,71.0
SYNTHETIC-5,DONOR_2456,TREATMENT_8456,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,mg/kg,117.0,
SYNTHETIC-5,DONOR_2457,TREATMENT_8457,,Opdivo,8836851,PubChem,IU/kg,,123.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8458,Cell-based,Cometriq,8756456,,g/m2,129.0,177.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8459,Cell-based,Opdivo,239766,NCI Thesaurus,,197.0,
SYNTHETIC-5,DONOR_2460,TREATMENT_8460,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,,193.0,99.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8461,Other immunomodulatory substances,Durvalumab,239766,PubChem,cells/kg,151.0,
SYNTHETIC-5,DONOR_2462,TREATMENT_8462,Cell-based,Pembrolizumab,987654,NCI Thesaurus,IU/m2,127.0,143.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8463,Other immunomodulatory substances,Palbociclib,278936,NCI Thesaurus,g/m2,69.0,197.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8464,Immune checkpoint inhibitors,Yervoy,987654,PubChem,IU/m2,124.0,117.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8465,Cell-based,,8836851,RxNorm,,134.0,
SYNTHETIC-5,DONOR_2466,TREATMENT_8466,Other immunomodulatory substances,Necitumumab,,RxNorm,cells/kg,,187.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8467,Other immunomodulatory substances,,987654,,g/m2,126.0,56.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8468,Other immunomodulatory substances,Lynparza,8836851,RxNorm,,,130.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8469,,Trametinib,4459876,PubChem,IU/m2,,175.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8470,Immune checkpoint inhibitors,Zykadia,4459876,NCI Thesaurus,cells/kg,117.0,136.0
SYNTHETIC-5,DONOR_2471,TREATMENT_8471,Immune checkpoint inhibitors,Tisagenlecleucel,239766,PubChem,,92.0,59.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8472,Immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,,172.0,
SYNTHETIC-5,DONOR_2473,TREATMENT_8473,,,,NCI Thesaurus,IU/kg,54.0,51.0
SYNTHETIC-5,DONOR_2474,TREATMENT_8474,Immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/m2,169.0,151.0
SYNTHETIC-5,DONOR_2475,TREATMENT_8475,Cell-based,Pembrolizumab,278936,NCI Thesaurus,IU/kg,,58.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8476,,Selumitinib,987654,,mg/kg,128.0,195.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8477,,Adcetris,278936,PubChem,mg/m2,,151.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8478,Other immunomodulatory substances,Cotellic,239766,RxNorm,mg/kg,118.0,151.0
SYNTHETIC-5,DONOR_2479,TREATMENT_8479,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,987654,,,197.0,
SYNTHETIC-5,DONOR_2480,TREATMENT_8480,Other immunomodulatory substances,Gefitinib,278936,NCI Thesaurus,mg/m2,61.0,
SYNTHETIC-5,DONOR_2481,TREATMENT_8481,Cell-based,Tarceva,8756456,RxNorm,IU/m2,178.0,
SYNTHETIC-5,DONOR_2482,TREATMENT_8482,Cell-based,Durvalumab,,PubChem,cells/kg,69.0,100.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8483,Immune checkpoint inhibitors,Tecentriq,,RxNorm,mg/m2,132.0,
SYNTHETIC-5,DONOR_2484,TREATMENT_8484,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,RxNorm,mg/m2,191.0,191.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8485,,Palbociclib,987654,PubChem,mg/kg,98.0,109.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8486,Immune checkpoint inhibitors,Rituxan,239766,,ug/m2,105.0,83.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8487,Immune checkpoint inhibitors,Afatinib,8836851,PubChem,mg/kg,175.0,129.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8488,Immune checkpoint inhibitors,Perjeta,8756456,,g/m2,143.0,106.0
SYNTHETIC-5,DONOR_2489,TREATMENT_8489,Other immunomodulatory substances,Keytruda,987654,NCI Thesaurus,cells/kg,103.0,99.0
SYNTHETIC-5,DONOR_2490,TREATMENT_8490,Other immunomodulatory substances,Ado-trastuzumab emtansine,8756456,NCI Thesaurus,,197.0,65.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8491,Cell-based,,,,mg/m2,84.0,
SYNTHETIC-5,DONOR_2492,TREATMENT_8492,Cell-based,,8836851,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2493,TREATMENT_8493,Cell-based,Tafinlar,278936,RxNorm,ug/m2,190.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_8494,Cell-based,Niraparib,4459876,,,182.0,
SYNTHETIC-5,DONOR_2495,TREATMENT_8495,,Keytruda,,RxNorm,mg/m2,107.0,172.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8496,Immune checkpoint inhibitors,Brentuximab vedotin,8836851,PubChem,,95.0,124.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8497,Other immunomodulatory substances,Yervoy,4459876,RxNorm,,124.0,170.0
SYNTHETIC-5,DONOR_2498,TREATMENT_8498,Immune checkpoint inhibitors,Durvalumab,4459876,RxNorm,IU/kg,191.0,69.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8499,Other immunomodulatory substances,Herceptin,987654,RxNorm,IU/m2,126.0,112.0
SYNTHETIC-5,DONOR_2500,TREATMENT_8500,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,,mg/m2,151.0,170.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8501,Immune checkpoint inhibitors,Erlotinib,278936,PubChem,g/m2,63.0,86.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8502,Cell-based,Kadcyla,4459876,PubChem,ug/m2,192.0,
SYNTHETIC-5,DONOR_2003,TREATMENT_8503,,Atezolizumab,4459876,PubChem,g/m2,193.0,50.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8504,Cell-based,Braftovi,8756456,RxNorm,mg/kg,66.0,
SYNTHETIC-5,DONOR_2005,TREATMENT_8505,Cell-based,,8756456,PubChem,mg/kg,152.0,164.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8506,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,PubChem,ug/m2,56.0,59.0
SYNTHETIC-5,DONOR_2007,TREATMENT_8507,Immune checkpoint inhibitors,Vandetanib,,RxNorm,mg/kg,177.0,174.0
SYNTHETIC-5,DONOR_2008,TREATMENT_8508,Immune checkpoint inhibitors,Keytruda,,,g/m2,81.0,157.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8509,,Caprelsa,239766,PubChem,,104.0,156.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8510,Cell-based,,987654,RxNorm,IU/kg,93.0,171.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8511,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,IU/kg,,101.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8512,Cell-based,Yescarta,239766,PubChem,,,134.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8513,Other immunomodulatory substances,Atezolizumab,8756456,,IU/m2,103.0,131.0
SYNTHETIC-5,DONOR_2014,TREATMENT_8514,Immune checkpoint inhibitors,,987654,PubChem,ug/m2,,188.0
SYNTHETIC-5,DONOR_2015,TREATMENT_8515,Other immunomodulatory substances,Durvalumab,239766,RxNorm,mg/kg,,68.0
SYNTHETIC-5,DONOR_2016,TREATMENT_8516,Immune checkpoint inhibitors,Verzenio,278936,RxNorm,,139.0,
SYNTHETIC-5,DONOR_2017,TREATMENT_8517,Immune checkpoint inhibitors,,987654,RxNorm,g/m2,142.0,134.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8518,Immune checkpoint inhibitors,Ceritinib,987654,NCI Thesaurus,,,157.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8519,Other immunomodulatory substances,Ipilimumab,,,cells/kg,63.0,
SYNTHETIC-5,DONOR_2020,TREATMENT_8520,Cell-based,Perjeta,239766,RxNorm,g/m2,52.0,
SYNTHETIC-5,DONOR_2021,TREATMENT_8521,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,RxNorm,IU/m2,102.0,
SYNTHETIC-5,DONOR_2022,TREATMENT_8522,Immune checkpoint inhibitors,,8756456,PubChem,ug/m2,103.0,50.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8523,Immune checkpoint inhibitors,Olaparib,987654,RxNorm,g/m2,56.0,193.0
SYNTHETIC-5,DONOR_2024,TREATMENT_8524,Cell-based,Zejula,,NCI Thesaurus,IU/m2,137.0,200.0
SYNTHETIC-5,DONOR_2025,TREATMENT_8525,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,PubChem,IU/m2,,98.0
SYNTHETIC-5,DONOR_2026,TREATMENT_8526,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,NCI Thesaurus,IU/m2,170.0,102.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8527,Immune checkpoint inhibitors,Keytruda,,PubChem,IU/kg,163.0,84.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8528,Cell-based,,,NCI Thesaurus,cells/kg,102.0,129.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8529,Other immunomodulatory substances,Brentuximab vedotin,4459876,PubChem,g/m2,144.0,66.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8530,Immune checkpoint inhibitors,Rucaparib,4459876,PubChem,IU/kg,130.0,168.0
SYNTHETIC-5,DONOR_2031,TREATMENT_8531,Cell-based,Gazyva,4459876,NCI Thesaurus,mg/m2,,199.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8532,Other immunomodulatory substances,Enhertu,,NCI Thesaurus,IU/m2,176.0,
SYNTHETIC-5,DONOR_2033,TREATMENT_8533,Immune checkpoint inhibitors,Nivolumab,8836851,,cells/kg,133.0,151.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8534,Immune checkpoint inhibitors,Tecentriq,,RxNorm,cells/kg,149.0,174.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8535,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,8756456,NCI Thesaurus,mg/kg,192.0,180.0
SYNTHETIC-5,DONOR_2036,TREATMENT_8536,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/m2,130.0,89.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8537,Immune checkpoint inhibitors,Tecentriq,278936,RxNorm,cells/kg,186.0,
SYNTHETIC-5,DONOR_2038,TREATMENT_8538,Immune checkpoint inhibitors,Alectinib,,,,167.0,112.0
SYNTHETIC-5,DONOR_2039,TREATMENT_8539,Immune checkpoint inhibitors,Nivolumab,8836851,RxNorm,mg/kg,123.0,165.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8540,Cell-based,Sorafenib,4459876,NCI Thesaurus,ug/m2,120.0,57.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8541,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,cells/kg,95.0,
SYNTHETIC-5,DONOR_2042,TREATMENT_8542,Cell-based,Gilteritinib,4459876,RxNorm,g/m2,197.0,101.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8543,Cell-based,Venclexta,239766,RxNorm,,86.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_8544,Other immunomodulatory substances,Atezolizumab,278936,NCI Thesaurus,,68.0,103.0
SYNTHETIC-5,DONOR_2045,TREATMENT_8545,Cell-based,Pembrolizumab,8836851,NCI Thesaurus,,131.0,76.0
SYNTHETIC-5,DONOR_2046,TREATMENT_8546,Immune checkpoint inhibitors,Venclexta,278936,PubChem,mg/kg,78.0,198.0
SYNTHETIC-5,DONOR_2047,TREATMENT_8547,Other immunomodulatory substances,Ipilimumab,4459876,NCI Thesaurus,mg/m2,100.0,166.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8548,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,IU/kg,86.0,74.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8549,Immune checkpoint inhibitors,Rituxan,278936,PubChem,,66.0,62.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8550,,Durvalumab,4459876,RxNorm,cells/kg,,148.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8551,Immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,mg/kg,187.0,104.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8552,Other immunomodulatory substances,Selumitinib,8836851,NCI Thesaurus,,112.0,200.0
SYNTHETIC-5,DONOR_2053,TREATMENT_8553,Other immunomodulatory substances,Gilotrif,8836851,PubChem,mg/kg,195.0,129.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8554,Cell-based,Cometriq,,NCI Thesaurus,g/m2,187.0,88.0
SYNTHETIC-5,DONOR_2055,TREATMENT_8555,Cell-based,Alectinib,239766,NCI Thesaurus,,87.0,50.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8556,,Necitumumab,8836851,PubChem,mg/kg,178.0,76.0
SYNTHETIC-5,DONOR_2057,TREATMENT_8557,Immune checkpoint inhibitors,Erlotinib,8756456,,IU/kg,187.0,
SYNTHETIC-5,DONOR_2058,TREATMENT_8558,,Caprelsa,,PubChem,mg/m2,82.0,82.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8559,Immune checkpoint inhibitors,Pembrolizumab,239766,RxNorm,cells/kg,196.0,136.0
SYNTHETIC-5,DONOR_2060,TREATMENT_8560,Other immunomodulatory substances,Tecentriq,8836851,RxNorm,IU/kg,79.0,142.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8561,Other immunomodulatory substances,Yescarta,987654,NCI Thesaurus,g/m2,78.0,139.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8562,Cell-based,Iressa,8836851,PubChem,mg/kg,,174.0
SYNTHETIC-5,DONOR_2063,TREATMENT_8563,Immune checkpoint inhibitors,Zelboraf,987654,RxNorm,mg/m2,102.0,71.0
SYNTHETIC-5,DONOR_2064,TREATMENT_8564,Other immunomodulatory substances,Lenvatinib,239766,RxNorm,,179.0,
SYNTHETIC-5,DONOR_2065,TREATMENT_8565,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,4459876,NCI Thesaurus,ug/m2,101.0,92.0
SYNTHETIC-5,DONOR_2066,TREATMENT_8566,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,,RxNorm,IU/m2,56.0,169.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8567,Other immunomodulatory substances,Lenvima,8756456,PubChem,,105.0,
SYNTHETIC-5,DONOR_2068,TREATMENT_8568,Other immunomodulatory substances,Xalkori,8756456,PubChem,g/m2,149.0,71.0
SYNTHETIC-5,DONOR_2069,TREATMENT_8569,Cell-based,Darzalex,278936,RxNorm,IU/m2,152.0,
SYNTHETIC-5,DONOR_2070,TREATMENT_8570,Cell-based,Kymriah,8756456,PubChem,IU/m2,92.0,
SYNTHETIC-5,DONOR_2071,TREATMENT_8571,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,PubChem,mg/kg,149.0,151.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8572,,Nivolumab,,PubChem,mg/m2,,105.0
SYNTHETIC-5,DONOR_2073,TREATMENT_8573,Immune checkpoint inhibitors,Tisagenlecleucel,987654,PubChem,mg/m2,68.0,144.0
SYNTHETIC-5,DONOR_2074,TREATMENT_8574,Immune checkpoint inhibitors,Gilteritinib,,PubChem,IU/kg,162.0,171.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8575,Other immunomodulatory substances,Mekinist,278936,,cells/kg,198.0,103.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8576,Other immunomodulatory substances,Rucaparib,239766,,g/m2,139.0,104.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8577,,,,,ug/m2,150.0,
SYNTHETIC-5,DONOR_2078,TREATMENT_8578,Cell-based,Brigatinib,239766,RxNorm,cells/kg,133.0,96.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8579,Other immunomodulatory substances,Tecentriq,,RxNorm,cells/kg,95.0,131.0
SYNTHETIC-5,DONOR_2080,TREATMENT_8580,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,RxNorm,ug/m2,132.0,173.0
SYNTHETIC-5,DONOR_2081,TREATMENT_8581,Cell-based,,239766,PubChem,,122.0,150.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8582,Other immunomodulatory substances,Lynparza,,PubChem,,182.0,163.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8583,,Nivolumab,8756456,RxNorm,ug/m2,,173.0
SYNTHETIC-5,DONOR_2084,TREATMENT_8584,Cell-based,Encorafenib,239766,PubChem,IU/m2,,193.0
SYNTHETIC-5,DONOR_2085,TREATMENT_8585,Other immunomodulatory substances,Lynparza,4459876,RxNorm,,179.0,123.0
SYNTHETIC-5,DONOR_2086,TREATMENT_8586,Cell-based,Keytruda,,RxNorm,cells/kg,89.0,191.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8587,Cell-based,Rituxan,8836851,,IU/kg,,150.0
SYNTHETIC-5,DONOR_2088,TREATMENT_8588,Other immunomodulatory substances,Vemurafenib,4459876,NCI Thesaurus,,171.0,139.0
SYNTHETIC-5,DONOR_2089,TREATMENT_8589,Cell-based,Tecentriq,239766,,ug/m2,82.0,143.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8590,Cell-based,Lenvima,987654,PubChem,ug/m2,,76.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8591,,,4459876,PubChem,mg/m2,121.0,57.0
SYNTHETIC-5,DONOR_2092,TREATMENT_8592,Immune checkpoint inhibitors,Gilotrif,239766,,IU/kg,109.0,188.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8593,Cell-based,Dabrafenib,239766,,IU/kg,153.0,
SYNTHETIC-5,DONOR_2094,TREATMENT_8594,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,IU/m2,,191.0
SYNTHETIC-5,DONOR_2095,TREATMENT_8595,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,,cells/kg,191.0,
SYNTHETIC-5,DONOR_2096,TREATMENT_8596,Other immunomodulatory substances,Olaparib,8836851,,,109.0,72.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8597,Cell-based,Dabrafenib,987654,NCI Thesaurus,,79.0,
SYNTHETIC-5,DONOR_2098,TREATMENT_8598,,Yervoy,987654,,mg/m2,78.0,149.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8599,Cell-based,Vemurafenib,4459876,PubChem,mg/kg,96.0,122.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8600,Other immunomodulatory substances,Inotuzumab ozogamicin,8836851,PubChem,IU/m2,54.0,158.0
SYNTHETIC-5,DONOR_2101,TREATMENT_8601,Immune checkpoint inhibitors,Zelboraf,8836851,RxNorm,IU/m2,140.0,
SYNTHETIC-5,DONOR_2102,TREATMENT_8602,Cell-based,Alunbrig,278936,PubChem,cells/kg,163.0,116.0
SYNTHETIC-5,DONOR_2103,TREATMENT_8603,Other immunomodulatory substances,Trametinib,239766,RxNorm,IU/m2,,62.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8604,,Atezolizumab,8836851,,mg/m2,181.0,143.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8605,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,PubChem,,,188.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8606,,Braftovi,239766,PubChem,IU/m2,161.0,146.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8607,Cell-based,Obinutuzumab,8836851,RxNorm,IU/kg,111.0,
SYNTHETIC-5,DONOR_2108,TREATMENT_8608,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,987654,,mg/kg,172.0,71.0
SYNTHETIC-5,DONOR_2109,TREATMENT_8609,Immune checkpoint inhibitors,,4459876,PubChem,IU/m2,152.0,157.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8610,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,NCI Thesaurus,g/m2,155.0,52.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8611,Cell-based,Dabrafenib,8756456,PubChem,cells/kg,75.0,
SYNTHETIC-5,DONOR_2112,TREATMENT_8612,,Rubraca,987654,,g/m2,92.0,91.0
SYNTHETIC-5,DONOR_2113,TREATMENT_8613,Other immunomodulatory substances,Pexidartinib,278936,RxNorm,IU/kg,195.0,166.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8614,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,PubChem,ug/m2,190.0,
SYNTHETIC-5,DONOR_2115,TREATMENT_8615,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,IU/m2,178.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_8616,Cell-based,Rituximab,,PubChem,ug/m2,160.0,
SYNTHETIC-5,DONOR_2117,TREATMENT_8617,Other immunomodulatory substances,Darzalex,8756456,RxNorm,mg/m2,131.0,193.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8618,,Olaparib,8836851,NCI Thesaurus,mg/kg,84.0,
SYNTHETIC-5,DONOR_2119,TREATMENT_8619,Cell-based,,278936,PubChem,mg/m2,159.0,180.0
SYNTHETIC-5,DONOR_2120,TREATMENT_8620,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,239766,,mg/kg,100.0,57.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8621,Immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,cells/kg,116.0,145.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8622,Immune checkpoint inhibitors,Ribociclib,4459876,NCI Thesaurus,,119.0,
SYNTHETIC-5,DONOR_2123,TREATMENT_8623,Immune checkpoint inhibitors,Atezolizumab,239766,,IU/kg,186.0,156.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8624,Immune checkpoint inhibitors,Alecensa,8756456,PubChem,g/m2,78.0,56.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8625,Other immunomodulatory substances,Herceptin,4459876,PubChem,,104.0,99.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8626,Cell-based,Durvalumab,4459876,PubChem,IU/kg,78.0,176.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8627,Immune checkpoint inhibitors,Blincyto,8756456,PubChem,IU/kg,156.0,
SYNTHETIC-5,DONOR_2128,TREATMENT_8628,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,,80.0,92.0
SYNTHETIC-5,DONOR_2129,TREATMENT_8629,Immune checkpoint inhibitors,Zejula,239766,PubChem,ug/m2,114.0,64.0
SYNTHETIC-5,DONOR_2130,TREATMENT_8630,Other immunomodulatory substances,Rucaparib,4459876,RxNorm,mg/m2,148.0,103.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8631,Immune checkpoint inhibitors,,239766,NCI Thesaurus,g/m2,,96.0
SYNTHETIC-5,DONOR_2132,TREATMENT_8632,Other immunomodulatory substances,Keytruda,,PubChem,IU/kg,189.0,184.0
SYNTHETIC-5,DONOR_2133,TREATMENT_8633,Other immunomodulatory substances,,8756456,RxNorm,cells/kg,196.0,136.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8634,Cell-based,,,NCI Thesaurus,g/m2,188.0,141.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8635,Immune checkpoint inhibitors,Cobimetinib,4459876,NCI Thesaurus,ug/m2,193.0,177.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8636,Cell-based,Xalkori,278936,PubChem,IU/m2,89.0,71.0
SYNTHETIC-5,DONOR_2137,TREATMENT_8637,Immune checkpoint inhibitors,Olaparib,4459876,PubChem,mg/m2,116.0,110.0
SYNTHETIC-5,DONOR_2138,TREATMENT_8638,Immune checkpoint inhibitors,Blincyto,8836851,NCI Thesaurus,g/m2,151.0,179.0
SYNTHETIC-5,DONOR_2139,TREATMENT_8639,Other immunomodulatory substances,Necitumumab,,NCI Thesaurus,cells/kg,80.0,62.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8640,Other immunomodulatory substances,Pembrolizumab,239766,RxNorm,IU/kg,,75.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8641,Cell-based,Perjeta,8756456,PubChem,mg/kg,79.0,
SYNTHETIC-5,DONOR_2142,TREATMENT_8642,,Gilteritinib,8836851,NCI Thesaurus,g/m2,140.0,
SYNTHETIC-5,DONOR_2143,TREATMENT_8643,Cell-based,Rituximab,987654,PubChem,cells/kg,125.0,126.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8644,,Kisqali,8836851,RxNorm,ug/m2,,69.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8645,Immune checkpoint inhibitors,Encorafenib,278936,RxNorm,IU/kg,169.0,63.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8646,Cell-based,Ribociclib,,PubChem,mg/kg,188.0,119.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8647,Immune checkpoint inhibitors,Trametinib,8756456,RxNorm,ug/m2,,51.0
SYNTHETIC-5,DONOR_2148,TREATMENT_8648,Immune checkpoint inhibitors,Yervoy,8836851,,IU/kg,120.0,65.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8649,Cell-based,Rituxan,239766,RxNorm,g/m2,173.0,168.0
SYNTHETIC-5,DONOR_2150,TREATMENT_8650,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,987654,PubChem,ug/m2,101.0,61.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8651,Immune checkpoint inhibitors,Axicabtagene ciloleucel,239766,PubChem,ug/m2,92.0,142.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8652,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,PubChem,cells/kg,200.0,179.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8653,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,278936,PubChem,cells/kg,133.0,175.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8654,Immune checkpoint inhibitors,Herceptin,987654,PubChem,IU/m2,109.0,
SYNTHETIC-5,DONOR_2155,TREATMENT_8655,Immune checkpoint inhibitors,Yervoy,987654,RxNorm,mg/kg,173.0,85.0
SYNTHETIC-5,DONOR_2156,TREATMENT_8656,Other immunomodulatory substances,Tecentriq,239766,RxNorm,mg/kg,168.0,87.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8657,Immune checkpoint inhibitors,Caprelsa,8836851,,,150.0,92.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8658,Cell-based,Axicabtagene ciloleucel,,NCI Thesaurus,,189.0,66.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8659,Other immunomodulatory substances,Caprelsa,,PubChem,IU/m2,66.0,122.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8660,Immune checkpoint inhibitors,Imfinzi,987654,NCI Thesaurus,mg/kg,59.0,
SYNTHETIC-5,DONOR_2161,TREATMENT_8661,Other immunomodulatory substances,Venclexta,239766,PubChem,ug/m2,116.0,86.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8662,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,239766,PubChem,g/m2,150.0,
SYNTHETIC-5,DONOR_2163,TREATMENT_8663,Cell-based,Tecentriq,239766,PubChem,mg/m2,,179.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8664,Immune checkpoint inhibitors,Kymriah,8756456,RxNorm,ug/m2,133.0,81.0
SYNTHETIC-5,DONOR_2165,TREATMENT_8665,Immune checkpoint inhibitors,Belantamab,278936,RxNorm,g/m2,109.0,90.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8666,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,,PubChem,g/m2,,103.0
SYNTHETIC-5,DONOR_2167,TREATMENT_8667,Other immunomodulatory substances,Kadcyla,4459876,PubChem,IU/kg,163.0,176.0
SYNTHETIC-5,DONOR_2168,TREATMENT_8668,,Tafinlar,987654,NCI Thesaurus,mg/kg,141.0,133.0
SYNTHETIC-5,DONOR_2169,TREATMENT_8669,Cell-based,Ipilimumab,987654,RxNorm,ug/m2,88.0,133.0
SYNTHETIC-5,DONOR_2170,TREATMENT_8670,Other immunomodulatory substances,Ipilimumab,278936,NCI Thesaurus,IU/m2,197.0,194.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8671,Cell-based,,278936,PubChem,,194.0,80.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8672,Immune checkpoint inhibitors,Yescarta,8836851,RxNorm,ug/m2,160.0,111.0
SYNTHETIC-5,DONOR_2173,TREATMENT_8673,Immune checkpoint inhibitors,Mekinist,239766,NCI Thesaurus,mg/kg,,77.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8674,Cell-based,Atezolizumab,,PubChem,,135.0,64.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8675,Other immunomodulatory substances,Afatinib,987654,RxNorm,,188.0,107.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8676,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,,103.0,178.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8677,,Fam-trastuzumab deruxtecan-nxki,4459876,PubChem,IU/m2,103.0,129.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8678,Other immunomodulatory substances,Inotuzumab ozogamicin,239766,PubChem,,170.0,199.0
SYNTHETIC-5,DONOR_2179,TREATMENT_8679,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,8836851,NCI Thesaurus,ug/m2,73.0,167.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8680,Cell-based,Selumitinib,,RxNorm,ug/m2,68.0,115.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8681,Immune checkpoint inhibitors,Durvalumab,278936,PubChem,mg/m2,139.0,96.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8682,Immune checkpoint inhibitors,,239766,,g/m2,65.0,54.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8683,Immune checkpoint inhibitors,Daratumumab,239766,,cells/kg,95.0,103.0
SYNTHETIC-5,DONOR_2184,TREATMENT_8684,Cell-based,Copanlisib,987654,PubChem,cells/kg,155.0,78.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8685,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,cells/kg,95.0,189.0
SYNTHETIC-5,DONOR_2186,TREATMENT_8686,Cell-based,Adcetris,239766,NCI Thesaurus,cells/kg,98.0,190.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8687,Other immunomodulatory substances,Palbociclib,987654,NCI Thesaurus,mg/m2,186.0,
SYNTHETIC-5,DONOR_2188,TREATMENT_8688,Other immunomodulatory substances,Ceritinib,278936,RxNorm,mg/m2,136.0,131.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8689,Other immunomodulatory substances,Darzalex,239766,RxNorm,IU/kg,124.0,100.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8690,Cell-based,Perjeta,,PubChem,ug/m2,175.0,155.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8691,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8756456,RxNorm,cells/kg,110.0,
SYNTHETIC-5,DONOR_2192,TREATMENT_8692,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,278936,,IU/kg,194.0,
SYNTHETIC-5,DONOR_2193,TREATMENT_8693,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,IU/m2,157.0,130.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8694,Immune checkpoint inhibitors,Verzenio,987654,NCI Thesaurus,IU/m2,102.0,154.0
SYNTHETIC-5,DONOR_2195,TREATMENT_8695,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,ug/m2,128.0,196.0
SYNTHETIC-5,DONOR_2196,TREATMENT_8696,,Xalkori,8756456,PubChem,mg/m2,181.0,111.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8697,,Yervoy,8836851,PubChem,ug/m2,56.0,170.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8698,Immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,IU/m2,195.0,193.0
SYNTHETIC-5,DONOR_2199,TREATMENT_8699,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,mg/m2,165.0,103.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8700,Immune checkpoint inhibitors,Erlotinib,8756456,PubChem,,156.0,
SYNTHETIC-5,DONOR_2201,TREATMENT_8701,Immune checkpoint inhibitors,Ipilimumab,987654,,mg/kg,87.0,113.0
SYNTHETIC-5,DONOR_2202,TREATMENT_8702,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,239766,RxNorm,mg/m2,105.0,195.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8703,Cell-based,Kisqali,4459876,PubChem,IU/kg,54.0,110.0
SYNTHETIC-5,DONOR_2204,TREATMENT_8704,Immune checkpoint inhibitors,Adcetris,8836851,PubChem,mg/kg,81.0,70.0
SYNTHETIC-5,DONOR_2205,TREATMENT_8705,Cell-based,Verzenio,8836851,PubChem,ug/m2,110.0,169.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8706,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,,PubChem,ug/m2,78.0,71.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8707,Cell-based,Dabrafenib,8836851,NCI Thesaurus,,175.0,120.0
SYNTHETIC-5,DONOR_2208,TREATMENT_8708,Immune checkpoint inhibitors,Cobimetinib,987654,RxNorm,mg/m2,79.0,70.0
SYNTHETIC-5,DONOR_2209,TREATMENT_8709,Cell-based,Alecensa,,,IU/m2,112.0,101.0
SYNTHETIC-5,DONOR_2210,TREATMENT_8710,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,,mg/m2,88.0,194.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8711,Immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,cells/kg,77.0,119.0
SYNTHETIC-5,DONOR_2212,TREATMENT_8712,Other immunomodulatory substances,,278936,RxNorm,,184.0,120.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8713,Other immunomodulatory substances,Lenvima,8836851,RxNorm,g/m2,50.0,159.0
SYNTHETIC-5,DONOR_2214,TREATMENT_8714,,Ipilimumab,239766,NCI Thesaurus,IU/kg,,145.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8715,,Dabrafenib,8756456,NCI Thesaurus,IU/kg,146.0,112.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8716,Other immunomodulatory substances,Xalkori,987654,NCI Thesaurus,mg/m2,166.0,99.0
SYNTHETIC-5,DONOR_2217,TREATMENT_8717,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,RxNorm,,61.0,96.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8718,Immune checkpoint inhibitors,Cometriq,8756456,PubChem,IU/kg,88.0,
SYNTHETIC-5,DONOR_2219,TREATMENT_8719,Other immunomodulatory substances,Niraparib,239766,NCI Thesaurus,mg/m2,,126.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8720,Immune checkpoint inhibitors,Crizotinib,278936,RxNorm,cells/kg,85.0,190.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8721,,Olaparib,8756456,,mg/m2,169.0,156.0
SYNTHETIC-5,DONOR_2222,TREATMENT_8722,Cell-based,Nivolumab,987654,RxNorm,mg/m2,99.0,
SYNTHETIC-5,DONOR_2223,TREATMENT_8723,Cell-based,Gilteritinib,239766,,mg/kg,127.0,90.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8724,Other immunomodulatory substances,Yescarta,8756456,PubChem,IU/kg,55.0,152.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8725,,Tisagenlecleucel,8836851,NCI Thesaurus,IU/m2,162.0,124.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8726,Immune checkpoint inhibitors,Binimetinib,239766,NCI Thesaurus,IU/m2,80.0,141.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8727,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8756456,RxNorm,IU/m2,,81.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8728,Immune checkpoint inhibitors,Verzenio,8836851,RxNorm,IU/kg,77.0,67.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8729,Other immunomodulatory substances,Lenvima,,RxNorm,g/m2,154.0,169.0
SYNTHETIC-5,DONOR_2230,TREATMENT_8730,Cell-based,Gilteritinib,278936,RxNorm,ug/m2,115.0,
SYNTHETIC-5,DONOR_2231,TREATMENT_8731,Other immunomodulatory substances,Ipilimumab,239766,PubChem,cells/kg,84.0,98.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8732,Cell-based,Durvalumab,239766,PubChem,mg/kg,143.0,
SYNTHETIC-5,DONOR_2233,TREATMENT_8733,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,278936,PubChem,mg/kg,52.0,152.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8734,Other immunomodulatory substances,Afatinib,239766,PubChem,cells/kg,103.0,73.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8735,Cell-based,,239766,RxNorm,IU/kg,133.0,73.0
SYNTHETIC-5,DONOR_2236,TREATMENT_8736,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,4459876,NCI Thesaurus,cells/kg,122.0,
SYNTHETIC-5,DONOR_2237,TREATMENT_8737,,Atezolizumab,278936,,mg/m2,,162.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8738,Cell-based,Atezolizumab,8836851,PubChem,ug/m2,93.0,102.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8739,Cell-based,Lenvatinib,987654,,mg/kg,134.0,
SYNTHETIC-5,DONOR_2240,TREATMENT_8740,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,987654,NCI Thesaurus,mg/kg,176.0,81.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8741,Immune checkpoint inhibitors,Vemurafenib,,RxNorm,,138.0,
SYNTHETIC-5,DONOR_2242,TREATMENT_8742,,Venclexta,8836851,PubChem,mg/m2,,79.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8743,Other immunomodulatory substances,Yervoy,8836851,PubChem,ug/m2,172.0,163.0
SYNTHETIC-5,DONOR_2244,TREATMENT_8744,Immune checkpoint inhibitors,Alecensa,987654,NCI Thesaurus,mg/kg,63.0,101.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8745,,Pexidartinib,239766,PubChem,ug/m2,92.0,
SYNTHETIC-5,DONOR_2246,TREATMENT_8746,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/m2,190.0,185.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8747,Other immunomodulatory substances,Zykadia,4459876,RxNorm,mg/kg,65.0,157.0
SYNTHETIC-5,DONOR_2248,TREATMENT_8748,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,,79.0,105.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8749,Other immunomodulatory substances,Zejula,,RxNorm,cells/kg,115.0,121.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8750,Cell-based,Copanlisib,239766,RxNorm,,143.0,96.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8751,Immune checkpoint inhibitors,Afatinib,239766,RxNorm,mg/kg,115.0,96.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8752,Other immunomodulatory substances,Durvalumab,8836851,RxNorm,ug/m2,169.0,145.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8753,Immune checkpoint inhibitors,Crizotinib,987654,RxNorm,g/m2,166.0,
SYNTHETIC-5,DONOR_2254,TREATMENT_8754,Cell-based,Gefitinib,8836851,NCI Thesaurus,,54.0,142.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8755,Cell-based,,8756456,RxNorm,,173.0,132.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8756,Cell-based,Alunbrig,4459876,,ug/m2,195.0,119.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8757,Other immunomodulatory substances,Alunbrig,4459876,PubChem,,,119.0
SYNTHETIC-5,DONOR_2258,TREATMENT_8758,Immune checkpoint inhibitors,Ibrance,8836851,NCI Thesaurus,IU/kg,65.0,133.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8759,Cell-based,Tecentriq,4459876,RxNorm,mg/kg,142.0,70.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8760,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,987654,,g/m2,,134.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8761,Immune checkpoint inhibitors,Zejula,8836851,RxNorm,ug/m2,172.0,
SYNTHETIC-5,DONOR_2262,TREATMENT_8762,,Erlotinib,,PubChem,,99.0,142.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8763,,Imfinzi,8756456,NCI Thesaurus,mg/m2,157.0,187.0
SYNTHETIC-5,DONOR_2264,TREATMENT_8764,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,ug/m2,134.0,
SYNTHETIC-5,DONOR_2265,TREATMENT_8765,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,,74.0,115.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8766,Cell-based,Venetoclax,8756456,NCI Thesaurus,IU/kg,70.0,136.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8767,Cell-based,Tecentriq,8756456,PubChem,ug/m2,101.0,157.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8768,Immune checkpoint inhibitors,Zykadia,8836851,NCI Thesaurus,ug/m2,191.0,187.0
SYNTHETIC-5,DONOR_2269,TREATMENT_8769,Cell-based,Sorafenib,8836851,RxNorm,,136.0,128.0
SYNTHETIC-5,DONOR_2270,TREATMENT_8770,,Gilotrif,8836851,RxNorm,g/m2,64.0,147.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8771,Immune checkpoint inhibitors,Durvalumab,278936,PubChem,ug/m2,134.0,81.0
SYNTHETIC-5,DONOR_2272,TREATMENT_8772,Other immunomodulatory substances,Nivolumab,987654,,ug/m2,185.0,155.0
SYNTHETIC-5,DONOR_2273,TREATMENT_8773,,Verzenio,239766,NCI Thesaurus,,147.0,127.0
SYNTHETIC-5,DONOR_2274,TREATMENT_8774,,,8836851,NCI Thesaurus,mg/m2,,104.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8775,Cell-based,Fam-trastuzumab deruxtecan-nxki,987654,PubChem,IU/kg,196.0,173.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8776,Cell-based,,8836851,PubChem,IU/m2,173.0,129.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8777,Immune checkpoint inhibitors,Alecensa,4459876,PubChem,IU/m2,182.0,92.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8778,Other immunomodulatory substances,Crizotinib,239766,RxNorm,IU/kg,157.0,85.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8779,Cell-based,Alunbrig,8756456,PubChem,g/m2,132.0,187.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8780,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,278936,PubChem,,,200.0
SYNTHETIC-5,DONOR_2281,TREATMENT_8781,Other immunomodulatory substances,Tagrisso,8756456,,cells/kg,167.0,85.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8782,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,4459876,NCI Thesaurus,mg/m2,140.0,127.0
SYNTHETIC-5,DONOR_2283,TREATMENT_8783,Immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,mg/m2,,121.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8784,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8756456,NCI Thesaurus,ug/m2,,128.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8785,Cell-based,,278936,RxNorm,mg/m2,121.0,117.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8786,Immune checkpoint inhibitors,Ribociclib,8836851,NCI Thesaurus,IU/m2,53.0,
SYNTHETIC-5,DONOR_2287,TREATMENT_8787,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,4459876,RxNorm,mg/kg,128.0,83.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8788,Cell-based,,,NCI Thesaurus,mg/m2,102.0,76.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8789,Immune checkpoint inhibitors,Gefitinib,4459876,RxNorm,IU/kg,156.0,122.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8790,Immune checkpoint inhibitors,Zejula,,RxNorm,IU/m2,,93.0
SYNTHETIC-5,DONOR_2291,TREATMENT_8791,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,278936,RxNorm,mg/kg,183.0,190.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8792,Cell-based,Ceritinib,239766,NCI Thesaurus,mg/kg,55.0,101.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8793,,,4459876,PubChem,cells/kg,143.0,87.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8794,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,987654,,g/m2,164.0,
SYNTHETIC-5,DONOR_2295,TREATMENT_8795,Other immunomodulatory substances,,278936,PubChem,mg/m2,170.0,
SYNTHETIC-5,DONOR_2296,TREATMENT_8796,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,987654,PubChem,ug/m2,112.0,197.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8797,Other immunomodulatory substances,Ipilimumab,278936,RxNorm,mg/kg,189.0,57.0
SYNTHETIC-5,DONOR_2298,TREATMENT_8798,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8756456,PubChem,mg/m2,85.0,113.0
SYNTHETIC-5,DONOR_2299,TREATMENT_8799,Other immunomodulatory substances,Gilotrif,4459876,PubChem,mg/kg,188.0,142.0
SYNTHETIC-5,DONOR_2300,TREATMENT_8800,Cell-based,Yervoy,8756456,,ug/m2,95.0,200.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8801,Other immunomodulatory substances,,,PubChem,cells/kg,,122.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8802,Immune checkpoint inhibitors,Lenvatinib,4459876,RxNorm,g/m2,161.0,191.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8803,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,4459876,PubChem,mg/kg,92.0,
SYNTHETIC-5,DONOR_2304,TREATMENT_8804,Cell-based,Abemaciclib,987654,,mg/kg,84.0,102.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8805,Other immunomodulatory substances,Blinatumomab,239766,NCI Thesaurus,cells/kg,95.0,70.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8806,Immune checkpoint inhibitors,Rituxan,987654,NCI Thesaurus,,159.0,133.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8807,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,NCI Thesaurus,,52.0,114.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8808,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8756456,PubChem,IU/m2,64.0,101.0
SYNTHETIC-5,DONOR_2309,TREATMENT_8809,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,mg/kg,94.0,
SYNTHETIC-5,DONOR_2310,TREATMENT_8810,Other immunomodulatory substances,,278936,NCI Thesaurus,mg/kg,59.0,
SYNTHETIC-5,DONOR_2311,TREATMENT_8811,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,987654,NCI Thesaurus,g/m2,56.0,
SYNTHETIC-5,DONOR_2312,TREATMENT_8812,,Ibrance,4459876,NCI Thesaurus,mg/kg,119.0,67.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8813,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,278936,PubChem,IU/m2,198.0,96.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8814,Other immunomodulatory substances,Blincyto,4459876,NCI Thesaurus,g/m2,92.0,
SYNTHETIC-5,DONOR_2315,TREATMENT_8815,Cell-based,Keytruda,8836851,PubChem,mg/kg,115.0,86.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8816,Other immunomodulatory substances,Caprelsa,278936,PubChem,,107.0,
SYNTHETIC-5,DONOR_2317,TREATMENT_8817,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,987654,RxNorm,,,106.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8818,Other immunomodulatory substances,Belantamab,987654,RxNorm,,142.0,90.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8819,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,278936,,,178.0,167.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8820,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,ug/m2,183.0,145.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8821,Cell-based,Necitumumab,239766,PubChem,ug/m2,92.0,79.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8822,Other immunomodulatory substances,Selumitinib,4459876,RxNorm,ug/m2,109.0,119.0
SYNTHETIC-5,DONOR_2323,TREATMENT_8823,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,239766,,ug/m2,170.0,81.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8824,,Selumitinib,8756456,,IU/m2,151.0,122.0
SYNTHETIC-5,DONOR_2325,TREATMENT_8825,Other immunomodulatory substances,Cometriq,,NCI Thesaurus,mg/m2,193.0,113.0
SYNTHETIC-5,DONOR_2326,TREATMENT_8826,Cell-based,Brigatinib,4459876,RxNorm,ug/m2,96.0,144.0
SYNTHETIC-5,DONOR_2327,TREATMENT_8827,Cell-based,Tecentriq,8756456,,mg/m2,69.0,50.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8828,Other immunomodulatory substances,Mekinist,,NCI Thesaurus,mg/m2,191.0,
SYNTHETIC-5,DONOR_2329,TREATMENT_8829,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,ug/m2,67.0,177.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8830,Cell-based,Erlotinib,239766,RxNorm,mg/kg,117.0,95.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8831,,Venetoclax,278936,NCI Thesaurus,cells/kg,177.0,134.0
SYNTHETIC-5,DONOR_2332,TREATMENT_8832,Immune checkpoint inhibitors,Trametinib,987654,RxNorm,mg/kg,142.0,92.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8833,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/m2,111.0,198.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8834,Cell-based,Tagrisso,8836851,RxNorm,mg/m2,,
SYNTHETIC-5,DONOR_2335,TREATMENT_8835,Immune checkpoint inhibitors,Nivolumab,4459876,RxNorm,cells/kg,88.0,
SYNTHETIC-5,DONOR_2336,TREATMENT_8836,Immune checkpoint inhibitors,Opdivo,987654,NCI Thesaurus,g/m2,186.0,79.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8837,Cell-based,Mektovi,4459876,NCI Thesaurus,mg/m2,75.0,127.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8838,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,278936,NCI Thesaurus,mg/kg,134.0,76.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8839,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,ug/m2,169.0,92.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8840,Other immunomodulatory substances,Blinatumomab,239766,RxNorm,mg/kg,,137.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8841,,Trastuzumab,278936,RxNorm,mg/kg,,148.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8842,,Yervoy,4459876,RxNorm,ug/m2,106.0,50.0
SYNTHETIC-5,DONOR_2343,TREATMENT_8843,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,987654,NCI Thesaurus,mg/kg,,54.0
SYNTHETIC-5,DONOR_2344,TREATMENT_8844,Other immunomodulatory substances,Blinatumomab,,RxNorm,mg/m2,164.0,70.0
SYNTHETIC-5,DONOR_2345,TREATMENT_8845,,Verzenio,239766,PubChem,mg/kg,88.0,195.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8846,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,278936,NCI Thesaurus,IU/kg,,198.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8847,Cell-based,Keytruda,239766,RxNorm,,198.0,99.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8848,Immune checkpoint inhibitors,Blinatumomab,278936,,IU/kg,73.0,198.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8849,Other immunomodulatory substances,Darzalex,4459876,RxNorm,ug/m2,157.0,52.0
SYNTHETIC-5,DONOR_2350,TREATMENT_8850,Other immunomodulatory substances,Alectinib,239766,PubChem,g/m2,69.0,
SYNTHETIC-5,DONOR_2351,TREATMENT_8851,Immune checkpoint inhibitors,Enhertu,4459876,NCI Thesaurus,IU/kg,117.0,
SYNTHETIC-5,DONOR_2352,TREATMENT_8852,Immune checkpoint inhibitors,Alunbrig,278936,PubChem,IU/m2,190.0,
SYNTHETIC-5,DONOR_2353,TREATMENT_8853,Immune checkpoint inhibitors,Durvalumab,8756456,RxNorm,cells/kg,154.0,52.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8854,Immune checkpoint inhibitors,Dabrafenib,8756456,RxNorm,mg/kg,92.0,188.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8855,,Braftovi,239766,PubChem,,90.0,143.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8856,,Pertuzumab,239766,,mg/kg,,93.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8857,Cell-based,Imfinzi,987654,RxNorm,IU/m2,152.0,136.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8858,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,,g/m2,,57.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8859,,,4459876,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2360,TREATMENT_8860,Other immunomodulatory substances,Cabozantinib,,NCI Thesaurus,IU/m2,109.0,
SYNTHETIC-5,DONOR_2361,TREATMENT_8861,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8836851,NCI Thesaurus,ug/m2,178.0,160.0
SYNTHETIC-5,DONOR_2362,TREATMENT_8862,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,4459876,NCI Thesaurus,IU/m2,98.0,107.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8863,Cell-based,Pembrolizumab,278936,RxNorm,,174.0,
SYNTHETIC-5,DONOR_2364,TREATMENT_8864,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,8756456,NCI Thesaurus,IU/m2,,186.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8865,,Zejula,987654,RxNorm,,168.0,100.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8866,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,IU/kg,,197.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8867,Other immunomodulatory substances,Opdivo,,,g/m2,182.0,125.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8868,,Yervoy,,NCI Thesaurus,g/m2,65.0,180.0
SYNTHETIC-5,DONOR_2369,TREATMENT_8869,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,987654,RxNorm,IU/m2,,182.0
SYNTHETIC-5,DONOR_2370,TREATMENT_8870,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,987654,RxNorm,mg/m2,168.0,155.0
SYNTHETIC-5,DONOR_2371,TREATMENT_8871,Cell-based,,,RxNorm,ug/m2,181.0,100.0
SYNTHETIC-5,DONOR_2372,TREATMENT_8872,Cell-based,Yervoy,4459876,RxNorm,mg/kg,93.0,104.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8873,Immune checkpoint inhibitors,Binimetinib,278936,PubChem,mg/kg,59.0,164.0
SYNTHETIC-5,DONOR_2374,TREATMENT_8874,Immune checkpoint inhibitors,Alectinib,4459876,PubChem,IU/m2,133.0,155.0
SYNTHETIC-5,DONOR_2375,TREATMENT_8875,Immune checkpoint inhibitors,Opdivo,8836851,PubChem,mg/m2,162.0,169.0
SYNTHETIC-5,DONOR_2376,TREATMENT_8876,,Yervoy,,,IU/kg,143.0,
SYNTHETIC-5,DONOR_2377,TREATMENT_8877,Other immunomodulatory substances,Atezolizumab,278936,,mg/m2,,89.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8878,Other immunomodulatory substances,,987654,NCI Thesaurus,mg/kg,,159.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8879,,Lenvima,8836851,PubChem,ug/m2,89.0,194.0
SYNTHETIC-5,DONOR_2380,TREATMENT_8880,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,PubChem,mg/m2,167.0,56.0
SYNTHETIC-5,DONOR_2381,TREATMENT_8881,Other immunomodulatory substances,Vandetanib,239766,PubChem,IU/kg,61.0,85.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8882,,Yervoy,8756456,RxNorm,IU/m2,,152.0
SYNTHETIC-5,DONOR_2383,TREATMENT_8883,Cell-based,Nivolumab,,PubChem,mg/kg,74.0,186.0
SYNTHETIC-5,DONOR_2384,TREATMENT_8884,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8836851,RxNorm,g/m2,72.0,61.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8885,Other immunomodulatory substances,Abemaciclib,987654,NCI Thesaurus,IU/m2,160.0,128.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8886,Other immunomodulatory substances,Imfinzi,239766,RxNorm,cells/kg,198.0,106.0
SYNTHETIC-5,DONOR_2387,TREATMENT_8887,Immune checkpoint inhibitors,Trametinib,239766,RxNorm,IU/kg,,176.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8888,Immune checkpoint inhibitors,Rubraca,,PubChem,,109.0,94.0
SYNTHETIC-5,DONOR_2389,TREATMENT_8889,Cell-based,Perjeta,8836851,RxNorm,mg/kg,86.0,166.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8890,Cell-based,Trametinib,,NCI Thesaurus,IU/m2,118.0,184.0
SYNTHETIC-5,DONOR_2391,TREATMENT_8891,,Gefitinib,239766,,,178.0,63.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8892,Other immunomodulatory substances,Durvalumab,8836851,NCI Thesaurus,IU/kg,118.0,70.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8893,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,8756456,PubChem,ug/m2,,67.0
SYNTHETIC-5,DONOR_2394,TREATMENT_8894,Other immunomodulatory substances,Palbociclib,987654,RxNorm,mg/m2,51.0,87.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8895,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,,180.0,161.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8896,Cell-based,Gilteritinib,8756456,NCI Thesaurus,cells/kg,90.0,187.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8897,Cell-based,Ipilimumab,987654,NCI Thesaurus,IU/kg,133.0,54.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8898,Other immunomodulatory substances,Ipilimumab,,NCI Thesaurus,mg/m2,,150.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8899,Other immunomodulatory substances,Abemaciclib,8836851,NCI Thesaurus,mg/kg,175.0,
SYNTHETIC-5,DONOR_2400,TREATMENT_8900,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,,mg/m2,88.0,
SYNTHETIC-5,DONOR_2401,TREATMENT_8901,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,278936,NCI Thesaurus,g/m2,79.0,52.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8902,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2403,TREATMENT_8903,,,987654,,,,179.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8904,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,278936,RxNorm,ug/m2,91.0,183.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8905,Cell-based,Blincyto,239766,PubChem,cells/kg,128.0,110.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8906,Immune checkpoint inhibitors,Blinatumomab,4459876,NCI Thesaurus,IU/m2,162.0,113.0
SYNTHETIC-5,DONOR_2407,TREATMENT_8907,Other immunomodulatory substances,Ibrance,8836851,RxNorm,cells/kg,56.0,154.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8908,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,8836851,PubChem,IU/m2,99.0,74.0
SYNTHETIC-5,DONOR_2409,TREATMENT_8909,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,239766,RxNorm,IU/kg,156.0,59.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8910,Cell-based,Ipilimumab,4459876,RxNorm,cells/kg,101.0,193.0
SYNTHETIC-5,DONOR_2411,TREATMENT_8911,Immune checkpoint inhibitors,Trametinib,4459876,PubChem,g/m2,86.0,181.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8912,Other immunomodulatory substances,Cotellic,,PubChem,,188.0,
SYNTHETIC-5,DONOR_2413,TREATMENT_8913,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,PubChem,IU/kg,101.0,
SYNTHETIC-5,DONOR_2414,TREATMENT_8914,Other immunomodulatory substances,Nivolumab,987654,,,,157.0
SYNTHETIC-5,DONOR_2415,TREATMENT_8915,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,239766,RxNorm,cells/kg,,59.0
SYNTHETIC-5,DONOR_2416,TREATMENT_8916,Cell-based,Osimertinib,,NCI Thesaurus,g/m2,161.0,90.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8917,Other immunomodulatory substances,Ipilimumab,987654,RxNorm,cells/kg,,110.0
SYNTHETIC-5,DONOR_2418,TREATMENT_8918,Other immunomodulatory substances,Obinutuzumab,278936,NCI Thesaurus,IU/m2,,53.0
SYNTHETIC-5,DONOR_2419,TREATMENT_8919,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,,mg/kg,,159.0
SYNTHETIC-5,DONOR_2420,TREATMENT_8920,Other immunomodulatory substances,Yervoy,987654,RxNorm,mg/kg,138.0,73.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8921,Other immunomodulatory substances,,239766,PubChem,,,113.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8922,Immune checkpoint inhibitors,,987654,NCI Thesaurus,g/m2,71.0,164.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8923,Other immunomodulatory substances,Durvalumab,8756456,RxNorm,IU/kg,125.0,83.0
SYNTHETIC-5,DONOR_2424,TREATMENT_8924,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,239766,NCI Thesaurus,mg/m2,,133.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8925,Immune checkpoint inhibitors,Trametinib,4459876,PubChem,IU/kg,157.0,59.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8926,Immune checkpoint inhibitors,Selumitinib,,RxNorm,,143.0,68.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8927,Immune checkpoint inhibitors,,8756456,RxNorm,mg/kg,116.0,72.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8928,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,,PubChem,ug/m2,140.0,123.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8929,Other immunomodulatory substances,Yervoy,8756456,PubChem,mg/m2,56.0,
SYNTHETIC-5,DONOR_2430,TREATMENT_8930,Immune checkpoint inhibitors,Abemaciclib,4459876,,mg/kg,182.0,131.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8931,Other immunomodulatory substances,Gilteritinib,8836851,RxNorm,IU/m2,129.0,200.0
SYNTHETIC-5,DONOR_2432,TREATMENT_8932,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,4459876,,,167.0,
SYNTHETIC-5,DONOR_2433,TREATMENT_8933,Immune checkpoint inhibitors,Lenvatinib,239766,,IU/kg,180.0,166.0
SYNTHETIC-5,DONOR_2434,TREATMENT_8934,,,239766,PubChem,mg/m2,139.0,199.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8935,Cell-based,Tecentriq,8836851,RxNorm,IU/kg,122.0,187.0
SYNTHETIC-5,DONOR_2436,TREATMENT_8936,Immune checkpoint inhibitors,Trametinib,8836851,,g/m2,141.0,172.0
SYNTHETIC-5,DONOR_2437,TREATMENT_8937,,Ribociclib,987654,RxNorm,ug/m2,106.0,58.0
SYNTHETIC-5,DONOR_2438,TREATMENT_8938,Immune checkpoint inhibitors,Kisqali,4459876,PubChem,g/m2,116.0,161.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8939,Cell-based,Brigatinib,8836851,NCI Thesaurus,,125.0,
SYNTHETIC-5,DONOR_2440,TREATMENT_8940,,Rituxan,987654,,cells/kg,,71.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8941,,Rituxan,987654,NCI Thesaurus,ug/m2,157.0,157.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8942,,Yervoy,278936,NCI Thesaurus,,177.0,
SYNTHETIC-5,DONOR_2443,TREATMENT_8943,Cell-based,Adcetris,8836851,PubChem,IU/kg,,149.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8944,Immune checkpoint inhibitors,,987654,NCI Thesaurus,g/m2,195.0,168.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8945,Immune checkpoint inhibitors,Daratumumab,278936,,cells/kg,115.0,154.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8946,Other immunomodulatory substances,Encorafenib,,RxNorm,cells/kg,100.0,121.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8947,,Herceptin,8756456,RxNorm,IU/m2,120.0,153.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8948,Other immunomodulatory substances,Tisagenlecleucel,239766,,g/m2,166.0,51.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8949,Other immunomodulatory substances,Nivolumab,8836851,NCI Thesaurus,g/m2,101.0,175.0
SYNTHETIC-5,DONOR_2450,TREATMENT_8950,Other immunomodulatory substances,,4459876,PubChem,IU/m2,158.0,93.0
SYNTHETIC-5,DONOR_2451,TREATMENT_8951,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8836851,NCI Thesaurus,,87.0,185.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8952,Cell-based,Lynparza,987654,RxNorm,ug/m2,173.0,
SYNTHETIC-5,DONOR_2453,TREATMENT_8953,,Vandetanib,8836851,,,85.0,115.0
SYNTHETIC-5,DONOR_2454,TREATMENT_8954,Immune checkpoint inhibitors,Niraparib,4459876,NCI Thesaurus,IU/m2,58.0,
SYNTHETIC-5,DONOR_2455,TREATMENT_8955,Cell-based,Yervoy,8836851,PubChem,ug/m2,,99.0
SYNTHETIC-5,DONOR_2456,TREATMENT_8956,Cell-based,Ceritinib,278936,PubChem,ug/m2,169.0,137.0
SYNTHETIC-5,DONOR_2457,TREATMENT_8957,Other immunomodulatory substances,Belantamab,239766,PubChem,g/m2,,98.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8958,Cell-based,Encorafenib,987654,RxNorm,,80.0,191.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8959,Cell-based,Darzalex,4459876,RxNorm,cells/kg,130.0,184.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8960,Other immunomodulatory substances,Perjeta,987654,PubChem,ug/m2,155.0,
SYNTHETIC-5,DONOR_2461,TREATMENT_8961,Immune checkpoint inhibitors,Crizotinib,278936,RxNorm,IU/m2,91.0,121.0
SYNTHETIC-5,DONOR_2462,TREATMENT_8962,Other immunomodulatory substances,,987654,PubChem,mg/m2,75.0,69.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8963,Other immunomodulatory substances,Adcetris,,RxNorm,mg/m2,69.0,113.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8964,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,8756456,RxNorm,ug/m2,119.0,67.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8965,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,PubChem,IU/kg,114.0,191.0
SYNTHETIC-5,DONOR_2466,TREATMENT_8966,Cell-based,Keytruda,8836851,RxNorm,IU/kg,199.0,159.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8967,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,mg/kg,111.0,158.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8968,Other immunomodulatory substances,Venetoclax,987654,PubChem,ug/m2,96.0,112.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8969,,,8756456,RxNorm,mg/kg,139.0,117.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8970,,Zelboraf,278936,NCI Thesaurus,IU/m2,52.0,
SYNTHETIC-5,DONOR_2471,TREATMENT_8971,Other immunomodulatory substances,Nivolumab,8756456,NCI Thesaurus,IU/m2,,160.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8972,Other immunomodulatory substances,Opdivo,239766,PubChem,mg/m2,,143.0
SYNTHETIC-5,DONOR_2473,TREATMENT_8973,,Herceptin,987654,NCI Thesaurus,mg/kg,112.0,112.0
SYNTHETIC-5,DONOR_2474,TREATMENT_8974,,Olaparib,278936,PubChem,g/m2,77.0,83.0
SYNTHETIC-5,DONOR_2475,TREATMENT_8975,,Rituximab,987654,PubChem,g/m2,111.0,95.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8976,Cell-based,Pertuzumab,4459876,,IU/kg,94.0,109.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8977,,,4459876,RxNorm,IU/kg,195.0,121.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8978,Other immunomodulatory substances,Atezolizumab,278936,PubChem,IU/kg,89.0,163.0
SYNTHETIC-5,DONOR_2479,TREATMENT_8979,Other immunomodulatory substances,Pembrolizumab,,,,183.0,153.0
SYNTHETIC-5,DONOR_2480,TREATMENT_8980,Other immunomodulatory substances,Ibrance,8756456,PubChem,,172.0,125.0
SYNTHETIC-5,DONOR_2481,TREATMENT_8981,Immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,,99.0,82.0
SYNTHETIC-5,DONOR_2482,TREATMENT_8982,Immune checkpoint inhibitors,Nexavar,8836851,RxNorm,mg/kg,191.0,130.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8983,Immune checkpoint inhibitors,,278936,PubChem,mg/m2,171.0,81.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8984,,Tagrisso,239766,PubChem,mg/m2,73.0,85.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8985,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,278936,PubChem,cells/kg,163.0,151.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8986,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,239766,RxNorm,cells/kg,51.0,80.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8987,Cell-based,Rucaparib,278936,,mg/m2,144.0,
SYNTHETIC-5,DONOR_2488,TREATMENT_8988,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,239766,,mg/kg,97.0,
SYNTHETIC-5,DONOR_2489,TREATMENT_8989,Immune checkpoint inhibitors,,278936,NCI Thesaurus,cells/kg,90.0,73.0
SYNTHETIC-5,DONOR_2490,TREATMENT_8990,Cell-based,,987654,RxNorm,g/m2,149.0,116.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8991,Other immunomodulatory substances,Durvalumab,239766,,cells/kg,113.0,99.0
SYNTHETIC-5,DONOR_2492,TREATMENT_8992,Immune checkpoint inhibitors,Brentuximab vedotin,987654,PubChem,mg/kg,122.0,125.0
SYNTHETIC-5,DONOR_2493,TREATMENT_8993,Other immunomodulatory substances,Cometriq,278936,,IU/m2,146.0,180.0
SYNTHETIC-5,DONOR_2494,TREATMENT_8994,,Sorafenib,987654,,g/m2,138.0,
SYNTHETIC-5,DONOR_2495,TREATMENT_8995,Immune checkpoint inhibitors,Keytruda,4459876,NCI Thesaurus,mg/kg,151.0,110.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8996,Cell-based,Herceptin,4459876,RxNorm,,189.0,157.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8997,Immune checkpoint inhibitors,Blincyto,239766,RxNorm,cells/kg,,172.0
SYNTHETIC-5,DONOR_2498,TREATMENT_8998,Other immunomodulatory substances,Afatinib,239766,PubChem,,121.0,117.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8999,Cell-based,Opdivo,4459876,PubChem,cells/kg,,96.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9000,Cell-based,Venclexta,239766,NCI Thesaurus,IU/m2,73.0,75.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9001,Cell-based,Gilotrif,4459876,PubChem,g/m2,164.0,188.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9002,Other immunomodulatory substances,Tecentriq,4459876,RxNorm,IU/m2,160.0,145.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9003,Immune checkpoint inhibitors,Zykadia,239766,RxNorm,g/m2,140.0,174.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9004,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,NCI Thesaurus,ug/m2,,132.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9005,Cell-based,,,NCI Thesaurus,mg/m2,173.0,89.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9006,Cell-based,,,RxNorm,IU/m2,60.0,
SYNTHETIC-5,DONOR_2007,TREATMENT_9007,Cell-based,Kadcyla,239766,PubChem,g/m2,191.0,114.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9008,Cell-based,Brentuximab vedotin,239766,PubChem,IU/kg,,170.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9009,Other immunomodulatory substances,Cotellic,278936,PubChem,mg/m2,143.0,143.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9010,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,RxNorm,,69.0,188.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9011,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,,PubChem,mg/kg,52.0,
SYNTHETIC-5,DONOR_2012,TREATMENT_9012,Cell-based,,987654,PubChem,mg/m2,185.0,91.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9013,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,ug/m2,,135.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9014,Other immunomodulatory substances,Palbociclib,8756456,RxNorm,IU/kg,169.0,
SYNTHETIC-5,DONOR_2015,TREATMENT_9015,,Rituximab,239766,NCI Thesaurus,cells/kg,166.0,151.0
SYNTHETIC-5,DONOR_2016,TREATMENT_9016,Other immunomodulatory substances,Zelboraf,239766,RxNorm,g/m2,116.0,172.0
SYNTHETIC-5,DONOR_2017,TREATMENT_9017,Cell-based,Mekinist,,PubChem,mg/m2,134.0,109.0
SYNTHETIC-5,DONOR_2018,TREATMENT_9018,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,987654,RxNorm,cells/kg,148.0,181.0
SYNTHETIC-5,DONOR_2019,TREATMENT_9019,Immune checkpoint inhibitors,Pertuzumab,8756456,NCI Thesaurus,ug/m2,157.0,
SYNTHETIC-5,DONOR_2020,TREATMENT_9020,,Tagrisso,4459876,PubChem,IU/kg,167.0,171.0
SYNTHETIC-5,DONOR_2021,TREATMENT_9021,Other immunomodulatory substances,Keytruda,,NCI Thesaurus,ug/m2,52.0,171.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9022,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,,,134.0
SYNTHETIC-5,DONOR_2023,TREATMENT_9023,Other immunomodulatory substances,Iressa,8756456,NCI Thesaurus,mg/m2,195.0,197.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9024,,Dabrafenib,4459876,NCI Thesaurus,IU/m2,176.0,122.0
SYNTHETIC-5,DONOR_2025,TREATMENT_9025,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,IU/kg,53.0,86.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9026,Other immunomodulatory substances,Ibrance,,NCI Thesaurus,,,114.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9027,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,8836851,RxNorm,,111.0,182.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9028,Immune checkpoint inhibitors,Afatinib,987654,NCI Thesaurus,g/m2,116.0,188.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9029,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,RxNorm,IU/m2,187.0,78.0
SYNTHETIC-5,DONOR_2030,TREATMENT_9030,Other immunomodulatory substances,Obinutuzumab,239766,RxNorm,ug/m2,101.0,
SYNTHETIC-5,DONOR_2031,TREATMENT_9031,Cell-based,Tecentriq,8836851,,ug/m2,136.0,178.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9032,,Pertuzumab,239766,RxNorm,mg/kg,186.0,70.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9033,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,,NCI Thesaurus,IU/m2,,69.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9034,Immune checkpoint inhibitors,Pertuzumab,8836851,,mg/kg,164.0,121.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9035,Cell-based,Keytruda,278936,NCI Thesaurus,mg/m2,136.0,121.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9036,Immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,mg/kg,135.0,
SYNTHETIC-5,DONOR_2037,TREATMENT_9037,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,,g/m2,61.0,172.0
SYNTHETIC-5,DONOR_2038,TREATMENT_9038,Monoclonal antibodies other than immune checkpoint inhibitors,,,,,180.0,57.0
SYNTHETIC-5,DONOR_2039,TREATMENT_9039,Immune checkpoint inhibitors,Vandetanib,239766,RxNorm,cells/kg,119.0,107.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9040,Cell-based,,239766,PubChem,,167.0,53.0
SYNTHETIC-5,DONOR_2041,TREATMENT_9041,Other immunomodulatory substances,Lenvatinib,4459876,RxNorm,mg/m2,138.0,64.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9042,Cell-based,,4459876,RxNorm,,196.0,163.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9043,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,RxNorm,IU/m2,59.0,130.0
SYNTHETIC-5,DONOR_2044,TREATMENT_9044,Cell-based,Daratumumab,8756456,RxNorm,,88.0,176.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9045,Other immunomodulatory substances,Tafinlar,,RxNorm,mg/kg,135.0,170.0
SYNTHETIC-5,DONOR_2046,TREATMENT_9046,Immune checkpoint inhibitors,Braftovi,8836851,PubChem,IU/m2,55.0,175.0
SYNTHETIC-5,DONOR_2047,TREATMENT_9047,Immune checkpoint inhibitors,Durvalumab,8756456,RxNorm,ug/m2,177.0,
SYNTHETIC-5,DONOR_2048,TREATMENT_9048,Immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,ug/m2,122.0,184.0
SYNTHETIC-5,DONOR_2049,TREATMENT_9049,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,4459876,NCI Thesaurus,IU/kg,76.0,
SYNTHETIC-5,DONOR_2050,TREATMENT_9050,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,RxNorm,,160.0,
SYNTHETIC-5,DONOR_2051,TREATMENT_9051,,Trastuzumab,,,g/m2,196.0,
SYNTHETIC-5,DONOR_2052,TREATMENT_9052,Immune checkpoint inhibitors,Imfinzi,4459876,NCI Thesaurus,ug/m2,143.0,188.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9053,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,4459876,,mg/kg,60.0,82.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9054,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,,RxNorm,mg/kg,168.0,51.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9055,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,278936,RxNorm,ug/m2,85.0,148.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9056,Immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,mg/kg,100.0,194.0
SYNTHETIC-5,DONOR_2057,TREATMENT_9057,,Gazyva,8836851,NCI Thesaurus,IU/kg,61.0,71.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9058,Other immunomodulatory substances,Gefitinib,278936,,mg/m2,100.0,
SYNTHETIC-5,DONOR_2059,TREATMENT_9059,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,NCI Thesaurus,IU/kg,197.0,
SYNTHETIC-5,DONOR_2060,TREATMENT_9060,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,mg/m2,113.0,83.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9061,Other immunomodulatory substances,Pembrolizumab,987654,,IU/kg,,161.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9062,,Rituximab,,NCI Thesaurus,ug/m2,85.0,166.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9063,Other immunomodulatory substances,Selumitinib,4459876,NCI Thesaurus,IU/kg,185.0,72.0
SYNTHETIC-5,DONOR_2064,TREATMENT_9064,,Osimertinib,,,IU/kg,,65.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9065,,Nivolumab,8836851,RxNorm,mg/m2,77.0,84.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9066,Cell-based,Opdivo,4459876,NCI Thesaurus,,105.0,
SYNTHETIC-5,DONOR_2067,TREATMENT_9067,Immune checkpoint inhibitors,Herceptin,987654,RxNorm,,179.0,106.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9068,Other immunomodulatory substances,Lenvima,4459876,,cells/kg,85.0,122.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9069,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,278936,RxNorm,ug/m2,166.0,104.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9070,Other immunomodulatory substances,,8756456,PubChem,IU/kg,189.0,122.0
SYNTHETIC-5,DONOR_2071,TREATMENT_9071,Other immunomodulatory substances,Verzenio,8756456,NCI Thesaurus,mg/kg,,119.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9072,Other immunomodulatory substances,Lynparza,987654,NCI Thesaurus,IU/m2,92.0,188.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9073,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,ug/m2,106.0,
SYNTHETIC-5,DONOR_2074,TREATMENT_9074,Cell-based,Mekinist,239766,,IU/m2,195.0,72.0
SYNTHETIC-5,DONOR_2075,TREATMENT_9075,Immune checkpoint inhibitors,Imfinzi,8756456,PubChem,g/m2,84.0,161.0
SYNTHETIC-5,DONOR_2076,TREATMENT_9076,Cell-based,Adcetris,8756456,NCI Thesaurus,mg/m2,53.0,
SYNTHETIC-5,DONOR_2077,TREATMENT_9077,Immune checkpoint inhibitors,,4459876,PubChem,g/m2,176.0,96.0
SYNTHETIC-5,DONOR_2078,TREATMENT_9078,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,g/m2,88.0,162.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9079,Cell-based,,4459876,PubChem,,,
SYNTHETIC-5,DONOR_2080,TREATMENT_9080,Immune checkpoint inhibitors,Vandetanib,,RxNorm,IU/kg,153.0,144.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9081,Other immunomodulatory substances,Selumitinib,987654,NCI Thesaurus,IU/kg,,178.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9082,Other immunomodulatory substances,Nexavar,239766,RxNorm,,64.0,179.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9083,Immune checkpoint inhibitors,Sorafenib,4459876,PubChem,cells/kg,195.0,168.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9084,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,RxNorm,IU/m2,,132.0
SYNTHETIC-5,DONOR_2085,TREATMENT_9085,Immune checkpoint inhibitors,Durvalumab,8836851,RxNorm,mg/kg,160.0,
SYNTHETIC-5,DONOR_2086,TREATMENT_9086,Cell-based,Durvalumab,8836851,NCI Thesaurus,g/m2,155.0,97.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9087,Other immunomodulatory substances,Yescarta,,NCI Thesaurus,mg/m2,97.0,64.0
SYNTHETIC-5,DONOR_2088,TREATMENT_9088,Immune checkpoint inhibitors,,8836851,PubChem,IU/m2,148.0,
SYNTHETIC-5,DONOR_2089,TREATMENT_9089,Immune checkpoint inhibitors,Tarceva,987654,,g/m2,92.0,
SYNTHETIC-5,DONOR_2090,TREATMENT_9090,Other immunomodulatory substances,Nivolumab,987654,RxNorm,mg/m2,140.0,
SYNTHETIC-5,DONOR_2091,TREATMENT_9091,Cell-based,,8756456,RxNorm,cells/kg,151.0,162.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9092,Other immunomodulatory substances,Verzenio,278936,NCI Thesaurus,cells/kg,182.0,66.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9093,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,,197.0,141.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9094,Other immunomodulatory substances,Selumitinib,278936,RxNorm,IU/m2,111.0,157.0
SYNTHETIC-5,DONOR_2095,TREATMENT_9095,,Nexavar,8836851,RxNorm,g/m2,114.0,95.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9096,Cell-based,Tisagenlecleucel,8756456,RxNorm,mg/m2,182.0,60.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9097,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,PubChem,,187.0,101.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9098,Cell-based,Zykadia,,RxNorm,cells/kg,97.0,132.0
SYNTHETIC-5,DONOR_2099,TREATMENT_9099,Immune checkpoint inhibitors,Sorafenib,8756456,PubChem,cells/kg,161.0,155.0
SYNTHETIC-5,DONOR_2100,TREATMENT_9100,,,4459876,RxNorm,mg/kg,,179.0
SYNTHETIC-5,DONOR_2101,TREATMENT_9101,,Venetoclax,8756456,RxNorm,IU/m2,111.0,102.0
SYNTHETIC-5,DONOR_2102,TREATMENT_9102,Immune checkpoint inhibitors,Yervoy,4459876,RxNorm,mg/m2,,139.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9103,,Tisagenlecleucel,4459876,PubChem,IU/kg,77.0,179.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9104,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,8756456,NCI Thesaurus,,110.0,84.0
SYNTHETIC-5,DONOR_2105,TREATMENT_9105,Cell-based,Cometriq,278936,PubChem,,,154.0
SYNTHETIC-5,DONOR_2106,TREATMENT_9106,,Blincyto,239766,,cells/kg,54.0,161.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9107,,,8836851,,IU/m2,57.0,122.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9108,Cell-based,Niraparib,987654,,mg/m2,189.0,76.0
SYNTHETIC-5,DONOR_2109,TREATMENT_9109,Immune checkpoint inhibitors,Afatinib,278936,PubChem,mg/m2,156.0,146.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9110,Cell-based,Atezolizumab,,PubChem,cells/kg,106.0,59.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9111,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,mg/kg,73.0,192.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9112,Cell-based,,8836851,RxNorm,IU/kg,197.0,148.0
SYNTHETIC-5,DONOR_2113,TREATMENT_9113,Cell-based,Osimertinib,8756456,RxNorm,IU/kg,132.0,
SYNTHETIC-5,DONOR_2114,TREATMENT_9114,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8836851,NCI Thesaurus,cells/kg,,127.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9115,Cell-based,Caprelsa,,,cells/kg,83.0,54.0
SYNTHETIC-5,DONOR_2116,TREATMENT_9116,Other immunomodulatory substances,,278936,RxNorm,IU/kg,170.0,76.0
SYNTHETIC-5,DONOR_2117,TREATMENT_9117,,,987654,NCI Thesaurus,,70.0,165.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9118,,Nexavar,4459876,NCI Thesaurus,mg/m2,171.0,
SYNTHETIC-5,DONOR_2119,TREATMENT_9119,Other immunomodulatory substances,Encorafenib,8836851,NCI Thesaurus,mg/kg,,
SYNTHETIC-5,DONOR_2120,TREATMENT_9120,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8836851,RxNorm,IU/kg,122.0,
SYNTHETIC-5,DONOR_2121,TREATMENT_9121,Immune checkpoint inhibitors,Xalkori,278936,RxNorm,cells/kg,91.0,186.0
SYNTHETIC-5,DONOR_2122,TREATMENT_9122,Other immunomodulatory substances,Atezolizumab,278936,PubChem,cells/kg,147.0,59.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9123,Cell-based,Alecensa,4459876,NCI Thesaurus,cells/kg,93.0,
SYNTHETIC-5,DONOR_2124,TREATMENT_9124,Immune checkpoint inhibitors,,987654,,mg/m2,193.0,
SYNTHETIC-5,DONOR_2125,TREATMENT_9125,Immune checkpoint inhibitors,Necitumumab,987654,,g/m2,130.0,103.0
SYNTHETIC-5,DONOR_2126,TREATMENT_9126,,Abemaciclib,4459876,PubChem,cells/kg,,86.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9127,,Necitumumab,278936,,cells/kg,,59.0
SYNTHETIC-5,DONOR_2128,TREATMENT_9128,Other immunomodulatory substances,,8756456,PubChem,g/m2,150.0,166.0
SYNTHETIC-5,DONOR_2129,TREATMENT_9129,Immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,mg/m2,104.0,
SYNTHETIC-5,DONOR_2130,TREATMENT_9130,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,239766,PubChem,g/m2,123.0,66.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9131,Immune checkpoint inhibitors,Adcetris,8836851,RxNorm,IU/kg,144.0,122.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9132,Immune checkpoint inhibitors,Durvalumab,239766,RxNorm,cells/kg,77.0,83.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9133,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,987654,PubChem,mg/kg,129.0,149.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9134,Other immunomodulatory substances,Kymriah,987654,PubChem,IU/kg,93.0,134.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9135,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,PubChem,ug/m2,191.0,108.0
SYNTHETIC-5,DONOR_2136,TREATMENT_9136,Other immunomodulatory substances,Crizotinib,987654,NCI Thesaurus,IU/m2,163.0,165.0
SYNTHETIC-5,DONOR_2137,TREATMENT_9137,Cell-based,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,mg/m2,111.0,
SYNTHETIC-5,DONOR_2138,TREATMENT_9138,Cell-based,Enhertu,987654,PubChem,cells/kg,182.0,127.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9139,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,cells/kg,87.0,171.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9140,Other immunomodulatory substances,Brigatinib,278936,RxNorm,IU/kg,84.0,139.0
SYNTHETIC-5,DONOR_2141,TREATMENT_9141,Cell-based,Brigatinib,,NCI Thesaurus,mg/m2,186.0,112.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9142,,Herceptin,8836851,RxNorm,IU/m2,198.0,165.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9143,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,,PubChem,mg/m2,154.0,135.0
SYNTHETIC-5,DONOR_2144,TREATMENT_9144,Immune checkpoint inhibitors,,8836851,,IU/kg,115.0,
SYNTHETIC-5,DONOR_2145,TREATMENT_9145,Cell-based,Lenvima,8836851,,IU/m2,119.0,100.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9146,Other immunomodulatory substances,Abemaciclib,4459876,NCI Thesaurus,mg/m2,62.0,
SYNTHETIC-5,DONOR_2147,TREATMENT_9147,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,278936,RxNorm,g/m2,174.0,121.0
SYNTHETIC-5,DONOR_2148,TREATMENT_9148,Other immunomodulatory substances,Selumitinib,278936,,mg/m2,185.0,52.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9149,Immune checkpoint inhibitors,,278936,PubChem,IU/kg,110.0,111.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9150,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,239766,,,99.0,82.0
SYNTHETIC-5,DONOR_2151,TREATMENT_9151,Other immunomodulatory substances,Ceritinib,8756456,PubChem,mg/m2,96.0,80.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9152,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,8836851,PubChem,IU/m2,120.0,94.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9153,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,8836851,RxNorm,cells/kg,68.0,110.0
SYNTHETIC-5,DONOR_2154,TREATMENT_9154,Cell-based,Mekinist,987654,PubChem,g/m2,,100.0
SYNTHETIC-5,DONOR_2155,TREATMENT_9155,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,,ug/m2,171.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_9156,Cell-based,Mektovi,8836851,PubChem,cells/kg,63.0,70.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9157,Other immunomodulatory substances,Alunbrig,239766,,cells/kg,,
SYNTHETIC-5,DONOR_2158,TREATMENT_9158,Immune checkpoint inhibitors,Pembrolizumab,278936,PubChem,IU/m2,84.0,93.0
SYNTHETIC-5,DONOR_2159,TREATMENT_9159,Other immunomodulatory substances,Atezolizumab,239766,NCI Thesaurus,IU/kg,101.0,191.0
SYNTHETIC-5,DONOR_2160,TREATMENT_9160,Other immunomodulatory substances,Ibrance,8756456,PubChem,IU/m2,195.0,121.0
SYNTHETIC-5,DONOR_2161,TREATMENT_9161,Immune checkpoint inhibitors,Daratumumab,8756456,NCI Thesaurus,IU/m2,161.0,150.0
SYNTHETIC-5,DONOR_2162,TREATMENT_9162,Other immunomodulatory substances,Tecentriq,8836851,,g/m2,127.0,109.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9163,Immune checkpoint inhibitors,Cabozantinib,8756456,RxNorm,,,154.0
SYNTHETIC-5,DONOR_2164,TREATMENT_9164,Other immunomodulatory substances,Crizotinib,239766,PubChem,mg/kg,85.0,
SYNTHETIC-5,DONOR_2165,TREATMENT_9165,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,987654,NCI Thesaurus,IU/m2,125.0,186.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9166,Other immunomodulatory substances,Tisagenlecleucel,278936,PubChem,IU/m2,65.0,90.0
SYNTHETIC-5,DONOR_2167,TREATMENT_9167,Immune checkpoint inhibitors,,239766,NCI Thesaurus,mg/kg,,131.0
SYNTHETIC-5,DONOR_2168,TREATMENT_9168,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,,mg/kg,91.0,
SYNTHETIC-5,DONOR_2169,TREATMENT_9169,Other immunomodulatory substances,Belantamab,4459876,PubChem,mg/m2,121.0,192.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9170,Cell-based,Vemurafenib,8836851,RxNorm,IU/kg,193.0,156.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9171,Other immunomodulatory substances,Trametinib,,NCI Thesaurus,g/m2,,86.0
SYNTHETIC-5,DONOR_2172,TREATMENT_9172,Cell-based,Atezolizumab,8756456,PubChem,mg/kg,195.0,126.0
SYNTHETIC-5,DONOR_2173,TREATMENT_9173,Cell-based,Nexavar,987654,NCI Thesaurus,g/m2,66.0,125.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9174,Cell-based,Keytruda,,RxNorm,,89.0,153.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9175,Other immunomodulatory substances,Kisqali,987654,NCI Thesaurus,IU/kg,60.0,194.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9176,Other immunomodulatory substances,Ibrance,,PubChem,mg/kg,176.0,194.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9177,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,NCI Thesaurus,cells/kg,85.0,200.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9178,Other immunomodulatory substances,Tecentriq,987654,RxNorm,,78.0,51.0
SYNTHETIC-5,DONOR_2179,TREATMENT_9179,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,987654,NCI Thesaurus,cells/kg,54.0,147.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9180,Other immunomodulatory substances,Erlotinib,8836851,,IU/kg,111.0,158.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9181,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,278936,RxNorm,,150.0,123.0
SYNTHETIC-5,DONOR_2182,TREATMENT_9182,Other immunomodulatory substances,Yervoy,8756456,PubChem,IU/kg,160.0,139.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9183,Cell-based,Opdivo,8836851,NCI Thesaurus,IU/m2,,165.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9184,Cell-based,Gilteritinib,,NCI Thesaurus,IU/kg,160.0,87.0
SYNTHETIC-5,DONOR_2185,TREATMENT_9185,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,,mg/m2,196.0,150.0
SYNTHETIC-5,DONOR_2186,TREATMENT_9186,Immune checkpoint inhibitors,Pembrolizumab,239766,NCI Thesaurus,IU/kg,,116.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9187,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8756456,,ug/m2,82.0,99.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9188,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,NCI Thesaurus,g/m2,191.0,
SYNTHETIC-5,DONOR_2189,TREATMENT_9189,Other immunomodulatory substances,Rucaparib,278936,NCI Thesaurus,IU/m2,,111.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9190,Other immunomodulatory substances,Nivolumab,8756456,,mg/kg,71.0,60.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9191,Cell-based,Zelboraf,8756456,PubChem,,191.0,137.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9192,Other immunomodulatory substances,Rituximab,278936,RxNorm,IU/m2,112.0,183.0
SYNTHETIC-5,DONOR_2193,TREATMENT_9193,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,mg/m2,105.0,170.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9194,Immune checkpoint inhibitors,Lenvatinib,987654,NCI Thesaurus,mg/m2,167.0,
SYNTHETIC-5,DONOR_2195,TREATMENT_9195,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,,mg/m2,81.0,75.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9196,Immune checkpoint inhibitors,Venetoclax,239766,RxNorm,IU/m2,59.0,53.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9197,Other immunomodulatory substances,Keytruda,8756456,,mg/kg,,102.0
SYNTHETIC-5,DONOR_2198,TREATMENT_9198,Immune checkpoint inhibitors,Vandetanib,278936,,mg/kg,111.0,167.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9199,Immune checkpoint inhibitors,Tisagenlecleucel,8836851,PubChem,IU/m2,63.0,98.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9200,Immune checkpoint inhibitors,Tisagenlecleucel,987654,PubChem,g/m2,199.0,116.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9201,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,ug/m2,165.0,136.0
SYNTHETIC-5,DONOR_2202,TREATMENT_9202,Immune checkpoint inhibitors,Durvalumab,239766,NCI Thesaurus,IU/m2,155.0,94.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9203,,,239766,NCI Thesaurus,ug/m2,,126.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9204,Other immunomodulatory substances,,8756456,PubChem,ug/m2,104.0,
SYNTHETIC-5,DONOR_2205,TREATMENT_9205,Immune checkpoint inhibitors,Nexavar,8836851,,g/m2,,179.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9206,Cell-based,Kymriah,,,mg/kg,89.0,123.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9207,Immune checkpoint inhibitors,Atezolizumab,987654,RxNorm,mg/m2,134.0,129.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9208,,Perjeta,987654,RxNorm,cells/kg,51.0,
SYNTHETIC-5,DONOR_2209,TREATMENT_9209,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,239766,PubChem,ug/m2,56.0,
SYNTHETIC-5,DONOR_2210,TREATMENT_9210,Immune checkpoint inhibitors,Yescarta,8756456,NCI Thesaurus,mg/kg,140.0,
SYNTHETIC-5,DONOR_2211,TREATMENT_9211,,Afatinib,278936,RxNorm,IU/m2,169.0,196.0
SYNTHETIC-5,DONOR_2212,TREATMENT_9212,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,239766,NCI Thesaurus,IU/m2,200.0,63.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9213,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,8756456,RxNorm,IU/kg,189.0,119.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9214,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,RxNorm,IU/m2,62.0,
SYNTHETIC-5,DONOR_2215,TREATMENT_9215,Other immunomodulatory substances,Vemurafenib,4459876,RxNorm,g/m2,117.0,164.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9216,Other immunomodulatory substances,Olaparib,239766,NCI Thesaurus,ug/m2,114.0,
SYNTHETIC-5,DONOR_2217,TREATMENT_9217,Other immunomodulatory substances,Vandetanib,278936,PubChem,g/m2,65.0,130.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9218,Other immunomodulatory substances,Imfinzi,239766,RxNorm,g/m2,118.0,
SYNTHETIC-5,DONOR_2219,TREATMENT_9219,,Kadcyla,278936,NCI Thesaurus,mg/m2,,115.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9220,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8756456,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2221,TREATMENT_9221,Other immunomodulatory substances,Obinutuzumab,,NCI Thesaurus,mg/kg,60.0,108.0
SYNTHETIC-5,DONOR_2222,TREATMENT_9222,Cell-based,Yervoy,8756456,RxNorm,cells/kg,99.0,128.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9223,Cell-based,,4459876,,g/m2,196.0,
SYNTHETIC-5,DONOR_2224,TREATMENT_9224,Cell-based,Imfinzi,239766,PubChem,mg/m2,56.0,108.0
SYNTHETIC-5,DONOR_2225,TREATMENT_9225,Immune checkpoint inhibitors,Copanlisib,239766,NCI Thesaurus,IU/m2,140.0,55.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9226,,Gefitinib,,,g/m2,77.0,137.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9227,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,278936,NCI Thesaurus,IU/m2,98.0,110.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9228,Cell-based,,8836851,RxNorm,IU/kg,96.0,
SYNTHETIC-5,DONOR_2229,TREATMENT_9229,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,278936,NCI Thesaurus,IU/m2,58.0,60.0
SYNTHETIC-5,DONOR_2230,TREATMENT_9230,,Zykadia,8836851,,mg/m2,132.0,174.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9231,Immune checkpoint inhibitors,Tisagenlecleucel,278936,NCI Thesaurus,g/m2,66.0,117.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9232,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,RxNorm,mg/kg,104.0,
SYNTHETIC-5,DONOR_2233,TREATMENT_9233,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8836851,PubChem,,,192.0
SYNTHETIC-5,DONOR_2234,TREATMENT_9234,Immune checkpoint inhibitors,Gilotrif,239766,PubChem,,189.0,133.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9235,Cell-based,Obinutuzumab,8756456,RxNorm,ug/m2,94.0,135.0
SYNTHETIC-5,DONOR_2236,TREATMENT_9236,,Mekinist,,PubChem,,130.0,65.0
SYNTHETIC-5,DONOR_2237,TREATMENT_9237,Immune checkpoint inhibitors,Tagrisso,278936,NCI Thesaurus,ug/m2,192.0,160.0
SYNTHETIC-5,DONOR_2238,TREATMENT_9238,Immune checkpoint inhibitors,Tagrisso,987654,RxNorm,IU/m2,53.0,146.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9239,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,,mg/m2,,139.0
SYNTHETIC-5,DONOR_2240,TREATMENT_9240,Cell-based,Rucaparib,,NCI Thesaurus,ug/m2,86.0,100.0
SYNTHETIC-5,DONOR_2241,TREATMENT_9241,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,mg/m2,91.0,189.0
SYNTHETIC-5,DONOR_2242,TREATMENT_9242,,Abemaciclib,8836851,PubChem,cells/kg,180.0,
SYNTHETIC-5,DONOR_2243,TREATMENT_9243,Other immunomodulatory substances,,,,IU/kg,192.0,157.0
SYNTHETIC-5,DONOR_2244,TREATMENT_9244,Cell-based,Rucaparib,8836851,,,,131.0
SYNTHETIC-5,DONOR_2245,TREATMENT_9245,Cell-based,Tagrisso,278936,NCI Thesaurus,cells/kg,114.0,182.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9246,Other immunomodulatory substances,Rubraca,8836851,PubChem,g/m2,195.0,78.0
SYNTHETIC-5,DONOR_2247,TREATMENT_9247,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,987654,PubChem,,135.0,99.0
SYNTHETIC-5,DONOR_2248,TREATMENT_9248,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,NCI Thesaurus,cells/kg,97.0,85.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9249,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,RxNorm,IU/m2,,79.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9250,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,,IU/m2,59.0,62.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9251,Immune checkpoint inhibitors,Perjeta,239766,NCI Thesaurus,mg/m2,127.0,66.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9252,Cell-based,Tecentriq,8756456,PubChem,cells/kg,183.0,53.0
SYNTHETIC-5,DONOR_2253,TREATMENT_9253,Cell-based,Ipilimumab,987654,PubChem,IU/kg,90.0,102.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9254,Immune checkpoint inhibitors,Brentuximab vedotin,278936,PubChem,IU/m2,197.0,154.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9255,Other immunomodulatory substances,,278936,RxNorm,ug/m2,112.0,137.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9256,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,8836851,NCI Thesaurus,IU/kg,60.0,
SYNTHETIC-5,DONOR_2257,TREATMENT_9257,Immune checkpoint inhibitors,Selumitinib,8836851,NCI Thesaurus,ug/m2,157.0,118.0
SYNTHETIC-5,DONOR_2258,TREATMENT_9258,Immune checkpoint inhibitors,Brigatinib,239766,,IU/kg,156.0,134.0
SYNTHETIC-5,DONOR_2259,TREATMENT_9259,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,4459876,RxNorm,,50.0,79.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9260,,Keytruda,239766,,cells/kg,157.0,71.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9261,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,,PubChem,IU/kg,132.0,179.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9262,Immune checkpoint inhibitors,Pexidartinib,8756456,RxNorm,g/m2,113.0,124.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9263,Other immunomodulatory substances,Crizotinib,239766,NCI Thesaurus,ug/m2,59.0,86.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9264,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,,,mg/kg,110.0,
SYNTHETIC-5,DONOR_2265,TREATMENT_9265,Other immunomodulatory substances,Blincyto,,NCI Thesaurus,,115.0,
SYNTHETIC-5,DONOR_2266,TREATMENT_9266,,Cobimetinib,4459876,NCI Thesaurus,,181.0,
SYNTHETIC-5,DONOR_2267,TREATMENT_9267,Cell-based,Daratumumab,987654,PubChem,ug/m2,106.0,83.0
SYNTHETIC-5,DONOR_2268,TREATMENT_9268,Immune checkpoint inhibitors,Obinutuzumab,278936,PubChem,,56.0,180.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9269,Other immunomodulatory substances,Trastuzumab,987654,NCI Thesaurus,g/m2,,166.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9270,,Opdivo,278936,,,196.0,154.0
SYNTHETIC-5,DONOR_2271,TREATMENT_9271,Other immunomodulatory substances,Opdivo,8836851,NCI Thesaurus,mg/m2,92.0,
SYNTHETIC-5,DONOR_2272,TREATMENT_9272,Immune checkpoint inhibitors,Verzenio,239766,,IU/kg,153.0,
SYNTHETIC-5,DONOR_2273,TREATMENT_9273,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,987654,NCI Thesaurus,,137.0,119.0
SYNTHETIC-5,DONOR_2274,TREATMENT_9274,Cell-based,Tagrisso,,PubChem,IU/m2,,84.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9275,Cell-based,Crizotinib,8756456,PubChem,IU/m2,137.0,120.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9276,Other immunomodulatory substances,Binimetinib,987654,NCI Thesaurus,IU/kg,133.0,52.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9277,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,cells/kg,64.0,99.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9278,Other immunomodulatory substances,Imfinzi,4459876,RxNorm,ug/m2,138.0,130.0
SYNTHETIC-5,DONOR_2279,TREATMENT_9279,Immune checkpoint inhibitors,Mektovi,278936,PubChem,g/m2,92.0,117.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9280,Cell-based,Alecensa,,NCI Thesaurus,mg/m2,,69.0
SYNTHETIC-5,DONOR_2281,TREATMENT_9281,,,,NCI Thesaurus,IU/kg,176.0,200.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9282,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,4459876,PubChem,g/m2,81.0,183.0
SYNTHETIC-5,DONOR_2283,TREATMENT_9283,,Tarceva,987654,,mg/kg,188.0,142.0
SYNTHETIC-5,DONOR_2284,TREATMENT_9284,Other immunomodulatory substances,Yervoy,278936,PubChem,IU/m2,173.0,194.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9285,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,,NCI Thesaurus,IU/kg,164.0,91.0
SYNTHETIC-5,DONOR_2286,TREATMENT_9286,Other immunomodulatory substances,Gazyva,8836851,PubChem,IU/kg,158.0,
SYNTHETIC-5,DONOR_2287,TREATMENT_9287,,Tecentriq,987654,RxNorm,g/m2,119.0,198.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9288,Cell-based,Alectinib,8756456,NCI Thesaurus,g/m2,164.0,92.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9289,Other immunomodulatory substances,Niraparib,8756456,RxNorm,g/m2,109.0,78.0
SYNTHETIC-5,DONOR_2290,TREATMENT_9290,Immune checkpoint inhibitors,Pembrolizumab,239766,NCI Thesaurus,mg/kg,76.0,61.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9291,Cell-based,Osimertinib,987654,NCI Thesaurus,IU/kg,190.0,136.0
SYNTHETIC-5,DONOR_2292,TREATMENT_9292,Cell-based,Yescarta,8756456,,g/m2,183.0,
SYNTHETIC-5,DONOR_2293,TREATMENT_9293,Cell-based,Nivolumab,239766,RxNorm,ug/m2,,59.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9294,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,278936,,IU/m2,98.0,80.0
SYNTHETIC-5,DONOR_2295,TREATMENT_9295,Cell-based,Atezolizumab,8836851,NCI Thesaurus,mg/m2,66.0,
SYNTHETIC-5,DONOR_2296,TREATMENT_9296,Other immunomodulatory substances,,8836851,PubChem,mg/kg,60.0,168.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9297,Other immunomodulatory substances,Niraparib,,NCI Thesaurus,g/m2,67.0,180.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9298,Other immunomodulatory substances,Nivolumab,278936,PubChem,IU/m2,67.0,69.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9299,Immune checkpoint inhibitors,Atezolizumab,,PubChem,IU/kg,151.0,91.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9300,,Sorafenib,8836851,RxNorm,IU/m2,,151.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9301,Immune checkpoint inhibitors,Cotellic,239766,NCI Thesaurus,mg/m2,120.0,117.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9302,Immune checkpoint inhibitors,Obinutuzumab,987654,,IU/m2,187.0,116.0
SYNTHETIC-5,DONOR_2303,TREATMENT_9303,Cell-based,Yervoy,987654,NCI Thesaurus,g/m2,103.0,120.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9304,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,8836851,,cells/kg,124.0,200.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9305,Cell-based,,4459876,PubChem,cells/kg,64.0,158.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9306,Cell-based,Encorafenib,,NCI Thesaurus,mg/kg,83.0,
SYNTHETIC-5,DONOR_2307,TREATMENT_9307,Immune checkpoint inhibitors,Alecensa,,,cells/kg,,57.0
SYNTHETIC-5,DONOR_2308,TREATMENT_9308,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,8756456,NCI Thesaurus,mg/m2,82.0,
SYNTHETIC-5,DONOR_2309,TREATMENT_9309,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,PubChem,cells/kg,196.0,
SYNTHETIC-5,DONOR_2310,TREATMENT_9310,Other immunomodulatory substances,,,PubChem,IU/m2,87.0,109.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9311,Other immunomodulatory substances,Zykadia,8836851,RxNorm,IU/kg,138.0,
SYNTHETIC-5,DONOR_2312,TREATMENT_9312,Immune checkpoint inhibitors,Mekinist,8836851,NCI Thesaurus,mg/m2,50.0,152.0
SYNTHETIC-5,DONOR_2313,TREATMENT_9313,Immune checkpoint inhibitors,Daratumumab,,PubChem,g/m2,93.0,177.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9314,Other immunomodulatory substances,Cobimetinib,4459876,NCI Thesaurus,mg/kg,88.0,81.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9315,Immune checkpoint inhibitors,Verzenio,,,cells/kg,111.0,144.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9316,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2317,TREATMENT_9317,Immune checkpoint inhibitors,Ipilimumab,8756456,,cells/kg,150.0,173.0
SYNTHETIC-5,DONOR_2318,TREATMENT_9318,Other immunomodulatory substances,Nivolumab,987654,RxNorm,g/m2,132.0,151.0
SYNTHETIC-5,DONOR_2319,TREATMENT_9319,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,278936,PubChem,cells/kg,119.0,
SYNTHETIC-5,DONOR_2320,TREATMENT_9320,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,ug/m2,76.0,117.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9321,Other immunomodulatory substances,Trastuzumab,8756456,NCI Thesaurus,mg/m2,,127.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9322,Immune checkpoint inhibitors,,4459876,RxNorm,mg/kg,112.0,133.0
SYNTHETIC-5,DONOR_2323,TREATMENT_9323,Immune checkpoint inhibitors,Atezolizumab,987654,PubChem,mg/m2,68.0,
SYNTHETIC-5,DONOR_2324,TREATMENT_9324,Other immunomodulatory substances,Imfinzi,278936,NCI Thesaurus,IU/kg,110.0,53.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9325,Cell-based,Cabozantinib,278936,PubChem,IU/m2,183.0,92.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9326,Other immunomodulatory substances,Opdivo,8836851,RxNorm,IU/m2,70.0,140.0
SYNTHETIC-5,DONOR_2327,TREATMENT_9327,Cell-based,Abemaciclib,8756456,PubChem,ug/m2,180.0,141.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9328,Cell-based,Gefitinib,8836851,PubChem,ug/m2,146.0,81.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9329,Immune checkpoint inhibitors,Verzenio,4459876,RxNorm,cells/kg,116.0,59.0
SYNTHETIC-5,DONOR_2330,TREATMENT_9330,,Yervoy,,RxNorm,cells/kg,156.0,
SYNTHETIC-5,DONOR_2331,TREATMENT_9331,Cell-based,Olaparib,4459876,RxNorm,,,194.0
SYNTHETIC-5,DONOR_2332,TREATMENT_9332,Cell-based,Durvalumab,8756456,NCI Thesaurus,IU/m2,115.0,60.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9333,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,8756456,RxNorm,cells/kg,84.0,86.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9334,Immune checkpoint inhibitors,Tagrisso,239766,RxNorm,g/m2,103.0,93.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9335,Other immunomodulatory substances,Encorafenib,987654,PubChem,ug/m2,152.0,170.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9336,Immune checkpoint inhibitors,,8756456,PubChem,,76.0,107.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9337,Other immunomodulatory substances,,278936,NCI Thesaurus,g/m2,,136.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9338,Immune checkpoint inhibitors,Opdivo,8756456,PubChem,,141.0,180.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9339,Immune checkpoint inhibitors,Nivolumab,239766,RxNorm,mg/m2,158.0,53.0
SYNTHETIC-5,DONOR_2340,TREATMENT_9340,Immune checkpoint inhibitors,Mektovi,4459876,NCI Thesaurus,g/m2,130.0,
SYNTHETIC-5,DONOR_2341,TREATMENT_9341,Immune checkpoint inhibitors,Obinutuzumab,8756456,RxNorm,mg/kg,123.0,58.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9342,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,,NCI Thesaurus,g/m2,169.0,85.0
SYNTHETIC-5,DONOR_2343,TREATMENT_9343,,Crizotinib,8836851,RxNorm,,146.0,97.0
SYNTHETIC-5,DONOR_2344,TREATMENT_9344,Other immunomodulatory substances,Tafinlar,8836851,NCI Thesaurus,IU/m2,158.0,147.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9345,Immune checkpoint inhibitors,Rituxan,4459876,NCI Thesaurus,mg/kg,190.0,51.0
SYNTHETIC-5,DONOR_2346,TREATMENT_9346,Cell-based,Perjeta,,NCI Thesaurus,IU/kg,92.0,175.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9347,Cell-based,Crizotinib,4459876,PubChem,IU/kg,51.0,125.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9348,Immune checkpoint inhibitors,Gazyva,,RxNorm,mg/m2,,64.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9349,Cell-based,Opdivo,8756456,PubChem,IU/m2,169.0,184.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9350,Immune checkpoint inhibitors,Ceritinib,,NCI Thesaurus,mg/m2,145.0,162.0
SYNTHETIC-5,DONOR_2351,TREATMENT_9351,Immune checkpoint inhibitors,Obinutuzumab,8756456,,mg/m2,157.0,107.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9352,Cell-based,Venclexta,987654,NCI Thesaurus,ug/m2,110.0,121.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9353,Immune checkpoint inhibitors,Mektovi,239766,PubChem,g/m2,,80.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9354,Other immunomodulatory substances,,8756456,NCI Thesaurus,cells/kg,126.0,146.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9355,Cell-based,Rituxan,8836851,,mg/m2,58.0,125.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9356,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,278936,NCI Thesaurus,mg/m2,72.0,77.0
SYNTHETIC-5,DONOR_2357,TREATMENT_9357,,Durvalumab,,,mg/kg,,
SYNTHETIC-5,DONOR_2358,TREATMENT_9358,,Rituximab,,PubChem,mg/m2,143.0,195.0
SYNTHETIC-5,DONOR_2359,TREATMENT_9359,Other immunomodulatory substances,Ipilimumab,8836851,RxNorm,,129.0,146.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9360,,Ceritinib,4459876,NCI Thesaurus,cells/kg,66.0,135.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9361,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,,,53.0,122.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9362,,,239766,RxNorm,mg/kg,,87.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9363,Cell-based,Lynparza,239766,PubChem,cells/kg,155.0,129.0
SYNTHETIC-5,DONOR_2364,TREATMENT_9364,,Blincyto,8756456,RxNorm,ug/m2,192.0,177.0
SYNTHETIC-5,DONOR_2365,TREATMENT_9365,Immune checkpoint inhibitors,Sorafenib,278936,NCI Thesaurus,g/m2,191.0,63.0
SYNTHETIC-5,DONOR_2366,TREATMENT_9366,Immune checkpoint inhibitors,Yescarta,278936,,mg/kg,64.0,170.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9367,Other immunomodulatory substances,Yervoy,8836851,RxNorm,,163.0,181.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9368,Immune checkpoint inhibitors,,,NCI Thesaurus,,69.0,
SYNTHETIC-5,DONOR_2369,TREATMENT_9369,Cell-based,Pexidartinib,278936,PubChem,mg/m2,55.0,158.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9370,Other immunomodulatory substances,Sorafenib,4459876,RxNorm,cells/kg,88.0,51.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9371,Cell-based,,278936,NCI Thesaurus,mg/kg,64.0,148.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9372,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,,IU/kg,118.0,51.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9373,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/m2,,110.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9374,Other immunomodulatory substances,Atezolizumab,987654,PubChem,g/m2,85.0,72.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9375,Immune checkpoint inhibitors,Besponsa,278936,PubChem,IU/m2,128.0,102.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9376,Immune checkpoint inhibitors,Venclexta,278936,NCI Thesaurus,IU/kg,193.0,71.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9377,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,4459876,,,138.0,173.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9378,Immune checkpoint inhibitors,Yescarta,239766,,ug/m2,148.0,170.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9379,Other immunomodulatory substances,Vemurafenib,8756456,NCI Thesaurus,mg/m2,150.0,158.0
SYNTHETIC-5,DONOR_2380,TREATMENT_9380,Other immunomodulatory substances,Durvalumab,4459876,PubChem,IU/kg,174.0,150.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9381,Other immunomodulatory substances,Atezolizumab,239766,RxNorm,,,159.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9382,Other immunomodulatory substances,Nivolumab,8836851,PubChem,IU/kg,109.0,144.0
SYNTHETIC-5,DONOR_2383,TREATMENT_9383,Cell-based,Niraparib,,,,102.0,100.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9384,Cell-based,Rucaparib,239766,PubChem,cells/kg,133.0,53.0
SYNTHETIC-5,DONOR_2385,TREATMENT_9385,Other immunomodulatory substances,Rituxan,8836851,RxNorm,cells/kg,59.0,53.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9386,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,987654,PubChem,IU/kg,199.0,140.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9387,Other immunomodulatory substances,Yervoy,8756456,NCI Thesaurus,,,94.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9388,Cell-based,Palbociclib,,PubChem,IU/kg,,177.0
SYNTHETIC-5,DONOR_2389,TREATMENT_9389,Immune checkpoint inhibitors,Rucaparib,239766,RxNorm,,176.0,
SYNTHETIC-5,DONOR_2390,TREATMENT_9390,Cell-based,Pexidartinib,239766,,IU/kg,142.0,68.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9391,Immune checkpoint inhibitors,Niraparib,,PubChem,g/m2,125.0,124.0
SYNTHETIC-5,DONOR_2392,TREATMENT_9392,Other immunomodulatory substances,Verzenio,4459876,,IU/m2,147.0,130.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9393,Other immunomodulatory substances,Xalkori,8756456,RxNorm,mg/kg,101.0,173.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9394,Cell-based,Ibrance,987654,RxNorm,ug/m2,70.0,
SYNTHETIC-5,DONOR_2395,TREATMENT_9395,Cell-based,,8836851,,mg/m2,161.0,188.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9396,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,278936,NCI Thesaurus,IU/m2,96.0,94.0
SYNTHETIC-5,DONOR_2397,TREATMENT_9397,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2398,TREATMENT_9398,Immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,,,100.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9399,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,4459876,,IU/m2,193.0,100.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9400,Immune checkpoint inhibitors,Cobimetinib,278936,RxNorm,IU/m2,131.0,135.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9401,Immune checkpoint inhibitors,Kadcyla,987654,,mg/kg,53.0,178.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9402,Other immunomodulatory substances,Gilteritinib,8756456,PubChem,g/m2,89.0,84.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9403,,Nexavar,239766,NCI Thesaurus,IU/kg,,92.0
SYNTHETIC-5,DONOR_2404,TREATMENT_9404,Cell-based,Crizotinib,987654,NCI Thesaurus,cells/kg,,57.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9405,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,cells/kg,56.0,137.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9406,Cell-based,Pembrolizumab,4459876,NCI Thesaurus,ug/m2,149.0,
SYNTHETIC-5,DONOR_2407,TREATMENT_9407,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,cells/kg,,189.0
SYNTHETIC-5,DONOR_2408,TREATMENT_9408,Immune checkpoint inhibitors,,987654,RxNorm,g/m2,129.0,
SYNTHETIC-5,DONOR_2409,TREATMENT_9409,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,,RxNorm,,52.0,119.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9410,Other immunomodulatory substances,Ipilimumab,8836851,RxNorm,g/m2,132.0,189.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9411,Other immunomodulatory substances,Verzenio,,,mg/m2,139.0,175.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9412,Immune checkpoint inhibitors,,239766,NCI Thesaurus,IU/m2,153.0,166.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9413,Other immunomodulatory substances,Copanlisib,278936,RxNorm,mg/kg,194.0,84.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9414,Other immunomodulatory substances,Selumitinib,278936,PubChem,g/m2,139.0,156.0
SYNTHETIC-5,DONOR_2415,TREATMENT_9415,Other immunomodulatory substances,,4459876,PubChem,mg/kg,149.0,59.0
SYNTHETIC-5,DONOR_2416,TREATMENT_9416,Immune checkpoint inhibitors,Ribociclib,8756456,NCI Thesaurus,,,132.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9417,Other immunomodulatory substances,,8836851,RxNorm,mg/m2,189.0,118.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9418,Other immunomodulatory substances,Mekinist,239766,RxNorm,IU/kg,,122.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9419,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,g/m2,68.0,91.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9420,,Pembrolizumab,,NCI Thesaurus,cells/kg,104.0,148.0
SYNTHETIC-5,DONOR_2421,TREATMENT_9421,Immune checkpoint inhibitors,Sorafenib,239766,RxNorm,IU/m2,190.0,
SYNTHETIC-5,DONOR_2422,TREATMENT_9422,Immune checkpoint inhibitors,Verzenio,987654,PubChem,mg/m2,85.0,109.0
SYNTHETIC-5,DONOR_2423,TREATMENT_9423,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8756456,PubChem,mg/kg,161.0,
SYNTHETIC-5,DONOR_2424,TREATMENT_9424,Immune checkpoint inhibitors,Ipilimumab,8756456,NCI Thesaurus,g/m2,73.0,195.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9425,Immune checkpoint inhibitors,Tecentriq,8756456,,,186.0,137.0
SYNTHETIC-5,DONOR_2426,TREATMENT_9426,Immune checkpoint inhibitors,Ipilimumab,4459876,NCI Thesaurus,g/m2,91.0,109.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9427,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,RxNorm,,114.0,192.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9428,Other immunomodulatory substances,Axicabtagene ciloleucel,987654,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2429,TREATMENT_9429,Cell-based,Alecensa,8756456,RxNorm,g/m2,117.0,181.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9430,Cell-based,Tecentriq,4459876,RxNorm,,121.0,100.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9431,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,IU/m2,193.0,178.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9432,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,mg/m2,182.0,159.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9433,Immune checkpoint inhibitors,Durvalumab,8756456,,IU/kg,82.0,127.0
SYNTHETIC-5,DONOR_2434,TREATMENT_9434,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,ug/m2,,188.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9435,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,NCI Thesaurus,g/m2,97.0,53.0
SYNTHETIC-5,DONOR_2436,TREATMENT_9436,Other immunomodulatory substances,Pembrolizumab,8756456,NCI Thesaurus,cells/kg,186.0,114.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9437,Other immunomodulatory substances,Sorafenib,239766,RxNorm,mg/kg,95.0,96.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9438,Cell-based,Blinatumomab,4459876,,g/m2,197.0,200.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9439,,Durvalumab,278936,NCI Thesaurus,ug/m2,,90.0
SYNTHETIC-5,DONOR_2440,TREATMENT_9440,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,69.0,
SYNTHETIC-5,DONOR_2441,TREATMENT_9441,,Tecentriq,987654,RxNorm,mg/m2,106.0,163.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9442,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,NCI Thesaurus,IU/kg,139.0,92.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9443,Other immunomodulatory substances,Keytruda,987654,,g/m2,,178.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9444,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,PubChem,IU/kg,180.0,183.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9445,Cell-based,Mekinist,987654,RxNorm,g/m2,56.0,
SYNTHETIC-5,DONOR_2446,TREATMENT_9446,Immune checkpoint inhibitors,Zejula,239766,PubChem,cells/kg,74.0,67.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9447,Other immunomodulatory substances,Cabozantinib,8836851,NCI Thesaurus,mg/kg,167.0,168.0
SYNTHETIC-5,DONOR_2448,TREATMENT_9448,,Pembrolizumab,987654,RxNorm,,78.0,94.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9449,Other immunomodulatory substances,Opdivo,8836851,NCI Thesaurus,g/m2,89.0,76.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9450,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8756456,NCI Thesaurus,ug/m2,96.0,107.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9451,Other immunomodulatory substances,Zejula,278936,RxNorm,mg/kg,57.0,57.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9452,,Nivolumab,,NCI Thesaurus,IU/m2,152.0,
SYNTHETIC-5,DONOR_2453,TREATMENT_9453,Other immunomodulatory substances,Opdivo,8836851,RxNorm,mg/kg,108.0,177.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9454,Immune checkpoint inhibitors,Tecentriq,8836851,PubChem,cells/kg,104.0,
SYNTHETIC-5,DONOR_2455,TREATMENT_9455,Cell-based,Gazyva,278936,,g/m2,197.0,
SYNTHETIC-5,DONOR_2456,TREATMENT_9456,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,278936,,mg/m2,52.0,98.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9457,Cell-based,Kisqali,8836851,,,187.0,78.0
SYNTHETIC-5,DONOR_2458,TREATMENT_9458,Immune checkpoint inhibitors,Binimetinib,4459876,,,,155.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9459,Other immunomodulatory substances,,987654,NCI Thesaurus,,156.0,
SYNTHETIC-5,DONOR_2460,TREATMENT_9460,Other immunomodulatory substances,Enhertu,987654,PubChem,,170.0,195.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9461,Immune checkpoint inhibitors,Yervoy,239766,NCI Thesaurus,IU/m2,132.0,183.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9462,Cell-based,Alunbrig,8836851,NCI Thesaurus,cells/kg,182.0,106.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9463,Other immunomodulatory substances,Lynparza,239766,RxNorm,mg/m2,,
SYNTHETIC-5,DONOR_2464,TREATMENT_9464,Other immunomodulatory substances,,,PubChem,,67.0,142.0
SYNTHETIC-5,DONOR_2465,TREATMENT_9465,Other immunomodulatory substances,Ipilimumab,4459876,NCI Thesaurus,ug/m2,176.0,191.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9466,Cell-based,Atezolizumab,4459876,PubChem,cells/kg,161.0,199.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9467,Other immunomodulatory substances,Keytruda,8756456,PubChem,mg/kg,159.0,66.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9468,Other immunomodulatory substances,Nivolumab,,,,151.0,108.0
SYNTHETIC-5,DONOR_2469,TREATMENT_9469,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8836851,,mg/kg,,76.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9470,Other immunomodulatory substances,Ipilimumab,8756456,,ug/m2,90.0,149.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9471,Immune checkpoint inhibitors,Nexavar,,NCI Thesaurus,IU/m2,199.0,147.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9472,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,987654,RxNorm,mg/m2,118.0,86.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9473,Other immunomodulatory substances,Dabrafenib,4459876,NCI Thesaurus,IU/m2,109.0,175.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9474,Immune checkpoint inhibitors,Tisagenlecleucel,278936,RxNorm,IU/m2,85.0,52.0
SYNTHETIC-5,DONOR_2475,TREATMENT_9475,Immune checkpoint inhibitors,,278936,,,175.0,79.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9476,Other immunomodulatory substances,Kisqali,4459876,RxNorm,,140.0,190.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9477,Cell-based,Ceritinib,4459876,NCI Thesaurus,IU/kg,,151.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9478,,Alectinib,8836851,RxNorm,mg/kg,106.0,120.0
SYNTHETIC-5,DONOR_2479,TREATMENT_9479,Immune checkpoint inhibitors,Zejula,8756456,NCI Thesaurus,,120.0,103.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9480,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,RxNorm,g/m2,173.0,189.0
SYNTHETIC-5,DONOR_2481,TREATMENT_9481,Immune checkpoint inhibitors,Selumitinib,8836851,RxNorm,cells/kg,122.0,176.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9482,Cell-based,Alunbrig,278936,NCI Thesaurus,ug/m2,90.0,
SYNTHETIC-5,DONOR_2483,TREATMENT_9483,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,278936,,mg/m2,60.0,154.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9484,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,4459876,RxNorm,mg/kg,54.0,173.0
SYNTHETIC-5,DONOR_2485,TREATMENT_9485,Immune checkpoint inhibitors,Atezolizumab,8836851,RxNorm,,51.0,179.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9486,Other immunomodulatory substances,Nivolumab,987654,NCI Thesaurus,IU/kg,71.0,182.0
SYNTHETIC-5,DONOR_2487,TREATMENT_9487,Other immunomodulatory substances,Daratumumab,,PubChem,IU/kg,153.0,51.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9488,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,987654,,ug/m2,127.0,
SYNTHETIC-5,DONOR_2489,TREATMENT_9489,Other immunomodulatory substances,,8836851,NCI Thesaurus,cells/kg,164.0,
SYNTHETIC-5,DONOR_2490,TREATMENT_9490,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,4459876,PubChem,mg/kg,166.0,97.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9491,Other immunomodulatory substances,Tecentriq,4459876,,g/m2,,
SYNTHETIC-5,DONOR_2492,TREATMENT_9492,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,8836851,NCI Thesaurus,IU/kg,,143.0
SYNTHETIC-5,DONOR_2493,TREATMENT_9493,Other immunomodulatory substances,Atezolizumab,8756456,NCI Thesaurus,cells/kg,99.0,139.0
SYNTHETIC-5,DONOR_2494,TREATMENT_9494,Immune checkpoint inhibitors,Olaparib,4459876,NCI Thesaurus,g/m2,93.0,152.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9495,Immune checkpoint inhibitors,,278936,RxNorm,IU/m2,193.0,190.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9496,Cell-based,Cabozantinib,,,IU/kg,63.0,
SYNTHETIC-5,DONOR_2497,TREATMENT_9497,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,987654,NCI Thesaurus,ug/m2,191.0,83.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9498,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,NCI Thesaurus,g/m2,54.0,125.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9499,,Opdivo,239766,PubChem,cells/kg,179.0,189.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9500,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,RxNorm,IU/m2,,88.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9501,Cell-based,Tecentriq,8756456,,IU/kg,179.0,141.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9502,,Imfinzi,8756456,RxNorm,g/m2,85.0,193.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9503,Immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,IU/kg,65.0,126.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9504,Other immunomodulatory substances,Xalkori,987654,PubChem,,197.0,133.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9505,Immune checkpoint inhibitors,Alectinib,987654,,cells/kg,92.0,174.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9506,Other immunomodulatory substances,Tecentriq,278936,RxNorm,g/m2,167.0,
SYNTHETIC-5,DONOR_2007,TREATMENT_9507,,Copanlisib,8756456,,,129.0,138.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9508,Immune checkpoint inhibitors,Kymriah,8836851,,mg/m2,66.0,62.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9509,Immune checkpoint inhibitors,Yescarta,239766,RxNorm,g/m2,136.0,93.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9510,Cell-based,Kisqali,4459876,RxNorm,IU/kg,196.0,114.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9511,Other immunomodulatory substances,Perjeta,239766,NCI Thesaurus,IU/m2,191.0,152.0
SYNTHETIC-5,DONOR_2012,TREATMENT_9512,,Inotuzumab ozogamicin,987654,RxNorm,mg/kg,,
SYNTHETIC-5,DONOR_2013,TREATMENT_9513,,Blinatumomab,239766,RxNorm,cells/kg,144.0,150.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9514,Other immunomodulatory substances,Cometriq,987654,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2015,TREATMENT_9515,Immune checkpoint inhibitors,,278936,,cells/kg,130.0,58.0
SYNTHETIC-5,DONOR_2016,TREATMENT_9516,Cell-based,Selumitinib,8836851,PubChem,,,53.0
SYNTHETIC-5,DONOR_2017,TREATMENT_9517,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,239766,NCI Thesaurus,mg/m2,,71.0
SYNTHETIC-5,DONOR_2018,TREATMENT_9518,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,8836851,NCI Thesaurus,cells/kg,166.0,
SYNTHETIC-5,DONOR_2019,TREATMENT_9519,Cell-based,,4459876,PubChem,IU/kg,123.0,118.0
SYNTHETIC-5,DONOR_2020,TREATMENT_9520,Other immunomodulatory substances,,8836851,RxNorm,mg/m2,179.0,183.0
SYNTHETIC-5,DONOR_2021,TREATMENT_9521,Other immunomodulatory substances,Olaparib,4459876,PubChem,mg/kg,165.0,73.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9522,Other immunomodulatory substances,Kymriah,987654,RxNorm,IU/m2,104.0,
SYNTHETIC-5,DONOR_2023,TREATMENT_9523,Other immunomodulatory substances,Pembrolizumab,8836851,RxNorm,ug/m2,,160.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9524,Cell-based,Yervoy,239766,PubChem,IU/m2,161.0,175.0
SYNTHETIC-5,DONOR_2025,TREATMENT_9525,Cell-based,Trametinib,239766,PubChem,cells/kg,109.0,95.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9526,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,RxNorm,mg/kg,,94.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9527,Immune checkpoint inhibitors,Abemaciclib,278936,RxNorm,g/m2,142.0,125.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9528,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,PubChem,IU/m2,125.0,154.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9529,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,NCI Thesaurus,ug/m2,186.0,200.0
SYNTHETIC-5,DONOR_2030,TREATMENT_9530,,,,RxNorm,ug/m2,170.0,80.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9531,,Pembrolizumab,278936,PubChem,ug/m2,179.0,180.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9532,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/m2,165.0,69.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9533,Immune checkpoint inhibitors,Kadcyla,278936,RxNorm,IU/kg,133.0,
SYNTHETIC-5,DONOR_2034,TREATMENT_9534,Immune checkpoint inhibitors,Lenvatinib,8756456,PubChem,mg/m2,162.0,109.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9535,Other immunomodulatory substances,Tisagenlecleucel,4459876,PubChem,g/m2,53.0,80.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9536,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,8836851,PubChem,mg/m2,167.0,81.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9537,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,cells/kg,155.0,65.0
SYNTHETIC-5,DONOR_2038,TREATMENT_9538,Other immunomodulatory substances,Pembrolizumab,4459876,RxNorm,IU/m2,71.0,
SYNTHETIC-5,DONOR_2039,TREATMENT_9539,,Niraparib,4459876,PubChem,IU/m2,118.0,117.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9540,Immune checkpoint inhibitors,Durvalumab,4459876,,mg/m2,170.0,130.0
SYNTHETIC-5,DONOR_2041,TREATMENT_9541,Immune checkpoint inhibitors,Atezolizumab,,RxNorm,ug/m2,,59.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9542,Immune checkpoint inhibitors,Niraparib,8756456,RxNorm,IU/m2,128.0,62.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9543,Other immunomodulatory substances,Rituximab,4459876,,mg/kg,102.0,67.0
SYNTHETIC-5,DONOR_2044,TREATMENT_9544,Cell-based,Lenvatinib,,NCI Thesaurus,ug/m2,111.0,
SYNTHETIC-5,DONOR_2045,TREATMENT_9545,,Perjeta,4459876,PubChem,mg/m2,176.0,
SYNTHETIC-5,DONOR_2046,TREATMENT_9546,Immune checkpoint inhibitors,Besponsa,239766,RxNorm,g/m2,94.0,
SYNTHETIC-5,DONOR_2047,TREATMENT_9547,Other immunomodulatory substances,Gilotrif,987654,NCI Thesaurus,IU/kg,155.0,83.0
SYNTHETIC-5,DONOR_2048,TREATMENT_9548,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,278936,RxNorm,cells/kg,,145.0
SYNTHETIC-5,DONOR_2049,TREATMENT_9549,Cell-based,Braftovi,4459876,NCI Thesaurus,ug/m2,147.0,97.0
SYNTHETIC-5,DONOR_2050,TREATMENT_9550,Cell-based,Necitumumab,8756456,PubChem,mg/m2,,189.0
SYNTHETIC-5,DONOR_2051,TREATMENT_9551,Cell-based,Pembrolizumab,8836851,NCI Thesaurus,g/m2,115.0,178.0
SYNTHETIC-5,DONOR_2052,TREATMENT_9552,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,RxNorm,g/m2,138.0,126.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9553,Other immunomodulatory substances,Trametinib,8836851,PubChem,mg/m2,183.0,98.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9554,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,,NCI Thesaurus,IU/kg,181.0,54.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9555,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,156.0,69.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9556,Other immunomodulatory substances,Encorafenib,987654,PubChem,IU/m2,103.0,
SYNTHETIC-5,DONOR_2057,TREATMENT_9557,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,,NCI Thesaurus,ug/m2,179.0,128.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9558,Other immunomodulatory substances,Erlotinib,278936,,ug/m2,99.0,161.0
SYNTHETIC-5,DONOR_2059,TREATMENT_9559,Cell-based,Enhertu,239766,NCI Thesaurus,IU/kg,,99.0
SYNTHETIC-5,DONOR_2060,TREATMENT_9560,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8756456,RxNorm,mg/kg,,52.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9561,,Pembrolizumab,8756456,PubChem,IU/kg,66.0,167.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9562,,Cometriq,,RxNorm,IU/kg,172.0,112.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9563,Cell-based,Tecentriq,239766,,IU/m2,139.0,166.0
SYNTHETIC-5,DONOR_2064,TREATMENT_9564,Immune checkpoint inhibitors,Durvalumab,987654,RxNorm,IU/m2,155.0,80.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9565,Immune checkpoint inhibitors,Erlotinib,4459876,PubChem,mg/m2,187.0,150.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9566,,Darzalex,278936,NCI Thesaurus,ug/m2,88.0,117.0
SYNTHETIC-5,DONOR_2067,TREATMENT_9567,Immune checkpoint inhibitors,Opdivo,987654,NCI Thesaurus,,56.0,100.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9568,Cell-based,,278936,RxNorm,cells/kg,174.0,128.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9569,Other immunomodulatory substances,,4459876,NCI Thesaurus,ug/m2,90.0,107.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9570,Cell-based,Blincyto,987654,,ug/m2,122.0,100.0
SYNTHETIC-5,DONOR_2071,TREATMENT_9571,Immune checkpoint inhibitors,Rubraca,,RxNorm,IU/m2,57.0,110.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9572,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,PubChem,mg/kg,,145.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9573,Cell-based,Tecentriq,8836851,RxNorm,g/m2,125.0,72.0
SYNTHETIC-5,DONOR_2074,TREATMENT_9574,,Keytruda,278936,RxNorm,IU/m2,155.0,
SYNTHETIC-5,DONOR_2075,TREATMENT_9575,Other immunomodulatory substances,Keytruda,4459876,PubChem,mg/m2,,
SYNTHETIC-5,DONOR_2076,TREATMENT_9576,Other immunomodulatory substances,Iressa,8756456,RxNorm,,83.0,83.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9577,Immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,mg/m2,85.0,155.0
SYNTHETIC-5,DONOR_2078,TREATMENT_9578,Immune checkpoint inhibitors,Olaparib,8836851,NCI Thesaurus,IU/m2,97.0,93.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9579,Other immunomodulatory substances,Vandetanib,278936,RxNorm,mg/kg,156.0,148.0
SYNTHETIC-5,DONOR_2080,TREATMENT_9580,Immune checkpoint inhibitors,Braftovi,278936,,g/m2,155.0,74.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9581,,Rucaparib,987654,NCI Thesaurus,cells/kg,,196.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9582,Other immunomodulatory substances,Tisagenlecleucel,,NCI Thesaurus,mg/kg,105.0,53.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9583,Cell-based,Ribociclib,987654,PubChem,IU/kg,56.0,153.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9584,,,987654,RxNorm,cells/kg,118.0,87.0
SYNTHETIC-5,DONOR_2085,TREATMENT_9585,Immune checkpoint inhibitors,Yervoy,987654,PubChem,cells/kg,77.0,189.0
SYNTHETIC-5,DONOR_2086,TREATMENT_9586,Other immunomodulatory substances,Sorafenib,8836851,NCI Thesaurus,mg/kg,58.0,194.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9587,Immune checkpoint inhibitors,Zejula,4459876,,mg/m2,74.0,68.0
SYNTHETIC-5,DONOR_2088,TREATMENT_9588,Other immunomodulatory substances,Pembrolizumab,8756456,NCI Thesaurus,ug/m2,125.0,113.0
SYNTHETIC-5,DONOR_2089,TREATMENT_9589,Other immunomodulatory substances,Nivolumab,4459876,PubChem,IU/m2,116.0,
SYNTHETIC-5,DONOR_2090,TREATMENT_9590,Immune checkpoint inhibitors,Blinatumomab,987654,RxNorm,IU/m2,131.0,67.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9591,Other immunomodulatory substances,Obinutuzumab,4459876,NCI Thesaurus,IU/kg,140.0,57.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9592,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,,82.0,114.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9593,Immune checkpoint inhibitors,Alunbrig,4459876,,cells/kg,,200.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9594,Immune checkpoint inhibitors,Atezolizumab,278936,RxNorm,cells/kg,157.0,
SYNTHETIC-5,DONOR_2095,TREATMENT_9595,Other immunomodulatory substances,Vemurafenib,278936,RxNorm,mg/kg,54.0,165.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9596,Immune checkpoint inhibitors,Ibrance,4459876,NCI Thesaurus,mg/m2,124.0,108.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9597,Cell-based,,,PubChem,ug/m2,,195.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9598,Other immunomodulatory substances,Lenvatinib,239766,NCI Thesaurus,,118.0,68.0
SYNTHETIC-5,DONOR_2099,TREATMENT_9599,Immune checkpoint inhibitors,Niraparib,8836851,RxNorm,,110.0,122.0
SYNTHETIC-5,DONOR_2100,TREATMENT_9600,,Imfinzi,8756456,PubChem,cells/kg,179.0,142.0
SYNTHETIC-5,DONOR_2101,TREATMENT_9601,Other immunomodulatory substances,Vemurafenib,8836851,PubChem,g/m2,128.0,73.0
SYNTHETIC-5,DONOR_2102,TREATMENT_9602,Other immunomodulatory substances,Selumitinib,8836851,NCI Thesaurus,mg/kg,73.0,188.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9603,Other immunomodulatory substances,Atezolizumab,8836851,RxNorm,,121.0,51.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9604,,Lenvima,4459876,RxNorm,ug/m2,167.0,195.0
SYNTHETIC-5,DONOR_2105,TREATMENT_9605,Other immunomodulatory substances,Zykadia,8836851,NCI Thesaurus,IU/kg,134.0,161.0
SYNTHETIC-5,DONOR_2106,TREATMENT_9606,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,,NCI Thesaurus,,133.0,119.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9607,Immune checkpoint inhibitors,Palbociclib,278936,PubChem,g/m2,56.0,
SYNTHETIC-5,DONOR_2108,TREATMENT_9608,Other immunomodulatory substances,Alecensa,,NCI Thesaurus,mg/m2,138.0,142.0
SYNTHETIC-5,DONOR_2109,TREATMENT_9609,Other immunomodulatory substances,Opdivo,4459876,,mg/kg,145.0,108.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9610,,Gefitinib,8756456,RxNorm,ug/m2,173.0,50.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9611,Cell-based,Venclexta,278936,NCI Thesaurus,,141.0,103.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9612,Other immunomodulatory substances,Gefitinib,987654,,IU/m2,167.0,79.0
SYNTHETIC-5,DONOR_2113,TREATMENT_9613,Immune checkpoint inhibitors,Gilotrif,8836851,,ug/m2,136.0,54.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9614,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8756456,,cells/kg,132.0,173.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9615,Other immunomodulatory substances,Yervoy,987654,RxNorm,cells/kg,50.0,137.0
SYNTHETIC-5,DONOR_2116,TREATMENT_9616,Cell-based,Pexidartinib,,RxNorm,cells/kg,,
SYNTHETIC-5,DONOR_2117,TREATMENT_9617,Immune checkpoint inhibitors,Blinatumomab,239766,PubChem,IU/m2,52.0,149.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9618,,Ribociclib,278936,PubChem,IU/m2,152.0,73.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9619,,Zejula,4459876,NCI Thesaurus,IU/m2,,119.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9620,Immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,mg/m2,119.0,82.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9621,Cell-based,Copanlisib,8756456,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2122,TREATMENT_9622,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,987654,RxNorm,mg/kg,,155.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9623,Cell-based,Brigatinib,278936,PubChem,cells/kg,102.0,54.0
SYNTHETIC-5,DONOR_2124,TREATMENT_9624,Immune checkpoint inhibitors,Mektovi,8756456,PubChem,IU/kg,64.0,165.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9625,Other immunomodulatory substances,Obinutuzumab,4459876,NCI Thesaurus,IU/kg,194.0,
SYNTHETIC-5,DONOR_2126,TREATMENT_9626,Cell-based,,239766,NCI Thesaurus,IU/kg,118.0,149.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9627,Cell-based,Osimertinib,239766,,g/m2,101.0,153.0
SYNTHETIC-5,DONOR_2128,TREATMENT_9628,Cell-based,Pembrolizumab,239766,NCI Thesaurus,cells/kg,84.0,191.0
SYNTHETIC-5,DONOR_2129,TREATMENT_9629,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,,ug/m2,200.0,64.0
SYNTHETIC-5,DONOR_2130,TREATMENT_9630,Other immunomodulatory substances,Pembrolizumab,278936,RxNorm,ug/m2,158.0,108.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9631,Immune checkpoint inhibitors,Adcetris,987654,NCI Thesaurus,IU/kg,,124.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9632,,Vemurafenib,239766,NCI Thesaurus,cells/kg,,149.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9633,Immune checkpoint inhibitors,Atezolizumab,4459876,NCI Thesaurus,mg/kg,176.0,180.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9634,,Pertuzumab,8836851,NCI Thesaurus,cells/kg,199.0,73.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9635,Other immunomodulatory substances,Gilteritinib,987654,PubChem,g/m2,107.0,164.0
SYNTHETIC-5,DONOR_2136,TREATMENT_9636,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,PubChem,IU/kg,163.0,
SYNTHETIC-5,DONOR_2137,TREATMENT_9637,Cell-based,Keytruda,8756456,RxNorm,g/m2,,91.0
SYNTHETIC-5,DONOR_2138,TREATMENT_9638,Other immunomodulatory substances,,4459876,NCI Thesaurus,ug/m2,,149.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9639,Cell-based,Encorafenib,239766,RxNorm,g/m2,59.0,105.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9640,Cell-based,Yervoy,278936,RxNorm,ug/m2,84.0,63.0
SYNTHETIC-5,DONOR_2141,TREATMENT_9641,Immune checkpoint inhibitors,Darzalex,278936,PubChem,mg/m2,153.0,108.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9642,Other immunomodulatory substances,Rucaparib,,NCI Thesaurus,cells/kg,,96.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9643,Other immunomodulatory substances,Alectinib,239766,,IU/kg,,
SYNTHETIC-5,DONOR_2144,TREATMENT_9644,Other immunomodulatory substances,Iressa,987654,RxNorm,ug/m2,132.0,109.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9645,,Pexidartinib,278936,,mg/kg,54.0,197.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9646,Immune checkpoint inhibitors,Atezolizumab,,PubChem,g/m2,116.0,191.0
SYNTHETIC-5,DONOR_2147,TREATMENT_9647,Immune checkpoint inhibitors,Cabozantinib,278936,NCI Thesaurus,mg/kg,102.0,123.0
SYNTHETIC-5,DONOR_2148,TREATMENT_9648,Immune checkpoint inhibitors,Sorafenib,278936,PubChem,g/m2,139.0,65.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9649,Other immunomodulatory substances,Binimetinib,8836851,NCI Thesaurus,IU/kg,159.0,148.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9650,Other immunomodulatory substances,Gilteritinib,4459876,RxNorm,IU/m2,,159.0
SYNTHETIC-5,DONOR_2151,TREATMENT_9651,Other immunomodulatory substances,Ipilimumab,987654,RxNorm,g/m2,,198.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9652,Other immunomodulatory substances,Opdivo,239766,PubChem,cells/kg,185.0,134.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9653,Immune checkpoint inhibitors,Rucaparib,987654,RxNorm,,64.0,
SYNTHETIC-5,DONOR_2154,TREATMENT_9654,,,8756456,,,104.0,168.0
SYNTHETIC-5,DONOR_2155,TREATMENT_9655,,Binimetinib,,,cells/kg,123.0,67.0
SYNTHETIC-5,DONOR_2156,TREATMENT_9656,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,ug/m2,,189.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9657,,,8836851,RxNorm,mg/m2,171.0,121.0
SYNTHETIC-5,DONOR_2158,TREATMENT_9658,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,,NCI Thesaurus,mg/m2,68.0,
SYNTHETIC-5,DONOR_2159,TREATMENT_9659,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,239766,,cells/kg,102.0,54.0
SYNTHETIC-5,DONOR_2160,TREATMENT_9660,Immune checkpoint inhibitors,,987654,,IU/m2,76.0,68.0
SYNTHETIC-5,DONOR_2161,TREATMENT_9661,Cell-based,Alunbrig,8836851,NCI Thesaurus,ug/m2,137.0,199.0
SYNTHETIC-5,DONOR_2162,TREATMENT_9662,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,NCI Thesaurus,ug/m2,,152.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9663,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,PubChem,,74.0,108.0
SYNTHETIC-5,DONOR_2164,TREATMENT_9664,Immune checkpoint inhibitors,Keytruda,987654,PubChem,IU/m2,139.0,101.0
SYNTHETIC-5,DONOR_2165,TREATMENT_9665,Other immunomodulatory substances,,239766,RxNorm,ug/m2,,173.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9666,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,,157.0,
SYNTHETIC-5,DONOR_2167,TREATMENT_9667,Cell-based,Blincyto,987654,PubChem,IU/m2,57.0,151.0
SYNTHETIC-5,DONOR_2168,TREATMENT_9668,,,239766,,ug/m2,190.0,159.0
SYNTHETIC-5,DONOR_2169,TREATMENT_9669,Cell-based,Tagrisso,278936,PubChem,,,139.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9670,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,g/m2,174.0,135.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9671,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,mg/m2,131.0,95.0
SYNTHETIC-5,DONOR_2172,TREATMENT_9672,Cell-based,Pembrolizumab,278936,RxNorm,mg/m2,,124.0
SYNTHETIC-5,DONOR_2173,TREATMENT_9673,Cell-based,Pertuzumab,4459876,RxNorm,IU/m2,61.0,199.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9674,Cell-based,Nivolumab,8836851,RxNorm,ug/m2,184.0,
SYNTHETIC-5,DONOR_2175,TREATMENT_9675,Immune checkpoint inhibitors,Pembrolizumab,8756456,,ug/m2,132.0,99.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9676,Cell-based,Tecentriq,8836851,PubChem,ug/m2,70.0,80.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9677,Cell-based,Erlotinib,987654,PubChem,ug/m2,73.0,76.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9678,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,112.0,189.0
SYNTHETIC-5,DONOR_2179,TREATMENT_9679,Immune checkpoint inhibitors,Mekinist,987654,PubChem,cells/kg,146.0,117.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9680,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,4459876,RxNorm,cells/kg,88.0,139.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9681,Cell-based,Imfinzi,8836851,,g/m2,165.0,125.0
SYNTHETIC-5,DONOR_2182,TREATMENT_9682,Cell-based,,8836851,PubChem,IU/m2,149.0,150.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9683,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,987654,NCI Thesaurus,cells/kg,104.0,98.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9684,Other immunomodulatory substances,Venetoclax,4459876,,ug/m2,183.0,178.0
SYNTHETIC-5,DONOR_2185,TREATMENT_9685,Cell-based,Nivolumab,8756456,NCI Thesaurus,g/m2,109.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_9686,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,NCI Thesaurus,cells/kg,92.0,168.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9687,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,,IU/kg,151.0,82.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9688,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,8836851,RxNorm,cells/kg,104.0,89.0
SYNTHETIC-5,DONOR_2189,TREATMENT_9689,Cell-based,Vemurafenib,278936,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2190,TREATMENT_9690,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,4459876,PubChem,,,164.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9691,Other immunomodulatory substances,Ipilimumab,8756456,PubChem,mg/m2,183.0,118.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9692,Immune checkpoint inhibitors,Gazyva,,NCI Thesaurus,mg/kg,177.0,
SYNTHETIC-5,DONOR_2193,TREATMENT_9693,Cell-based,Brentuximab vedotin,4459876,RxNorm,mg/kg,,58.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9694,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,239766,RxNorm,IU/kg,182.0,
SYNTHETIC-5,DONOR_2195,TREATMENT_9695,,Ipilimumab,8756456,,g/m2,,54.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9696,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8836851,,g/m2,187.0,180.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9697,Cell-based,Keytruda,4459876,RxNorm,IU/kg,192.0,56.0
SYNTHETIC-5,DONOR_2198,TREATMENT_9698,,Adcetris,987654,PubChem,IU/m2,,182.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9699,Immune checkpoint inhibitors,Adcetris,,PubChem,mg/kg,,157.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9700,Other immunomodulatory substances,Ipilimumab,8756456,PubChem,cells/kg,104.0,80.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9701,Immune checkpoint inhibitors,Blincyto,239766,PubChem,IU/m2,,180.0
SYNTHETIC-5,DONOR_2202,TREATMENT_9702,Cell-based,Tagrisso,,NCI Thesaurus,IU/m2,197.0,119.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9703,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,NCI Thesaurus,ug/m2,188.0,69.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9704,Immune checkpoint inhibitors,Lynparza,,NCI Thesaurus,,197.0,
SYNTHETIC-5,DONOR_2205,TREATMENT_9705,Other immunomodulatory substances,Darzalex,278936,,IU/kg,61.0,144.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9706,Immune checkpoint inhibitors,,,PubChem,IU/m2,165.0,
SYNTHETIC-5,DONOR_2207,TREATMENT_9707,Other immunomodulatory substances,Atezolizumab,239766,,IU/kg,95.0,176.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9708,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,ug/m2,,198.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9709,Immune checkpoint inhibitors,Zelboraf,278936,RxNorm,mg/m2,93.0,144.0
SYNTHETIC-5,DONOR_2210,TREATMENT_9710,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8836851,NCI Thesaurus,IU/kg,109.0,64.0
SYNTHETIC-5,DONOR_2211,TREATMENT_9711,Immune checkpoint inhibitors,Crizotinib,,NCI Thesaurus,IU/kg,135.0,140.0
SYNTHETIC-5,DONOR_2212,TREATMENT_9712,Other immunomodulatory substances,Tarceva,8756456,RxNorm,ug/m2,173.0,70.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9713,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8836851,PubChem,mg/m2,168.0,182.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9714,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8836851,,IU/m2,91.0,
SYNTHETIC-5,DONOR_2215,TREATMENT_9715,Other immunomodulatory substances,Blincyto,4459876,NCI Thesaurus,IU/kg,100.0,184.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9716,,Gilteritinib,,PubChem,g/m2,141.0,168.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9717,Immune checkpoint inhibitors,Atezolizumab,278936,PubChem,ug/m2,84.0,60.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9718,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,987654,RxNorm,IU/kg,64.0,187.0
SYNTHETIC-5,DONOR_2219,TREATMENT_9719,Other immunomodulatory substances,Venetoclax,987654,RxNorm,,191.0,70.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9720,Immune checkpoint inhibitors,Ipilimumab,239766,PubChem,mg/m2,187.0,153.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9721,Immune checkpoint inhibitors,Ceritinib,987654,RxNorm,g/m2,,63.0
SYNTHETIC-5,DONOR_2222,TREATMENT_9722,Cell-based,Pembrolizumab,8836851,RxNorm,IU/m2,179.0,164.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9723,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,mg/kg,184.0,193.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9724,Immune checkpoint inhibitors,,8836851,PubChem,ug/m2,112.0,181.0
SYNTHETIC-5,DONOR_2225,TREATMENT_9725,Cell-based,Tecentriq,8836851,NCI Thesaurus,mg/kg,140.0,95.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9726,Immune checkpoint inhibitors,Durvalumab,278936,RxNorm,ug/m2,164.0,133.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9727,Other immunomodulatory substances,Nivolumab,4459876,,IU/kg,133.0,139.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9728,Other immunomodulatory substances,Rituxan,987654,PubChem,mg/m2,191.0,177.0
SYNTHETIC-5,DONOR_2229,TREATMENT_9729,Cell-based,Opdivo,278936,,cells/kg,169.0,
SYNTHETIC-5,DONOR_2230,TREATMENT_9730,Immune checkpoint inhibitors,Blinatumomab,239766,PubChem,mg/m2,197.0,84.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9731,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,987654,NCI Thesaurus,g/m2,92.0,142.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9732,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,987654,,,,159.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9733,Immune checkpoint inhibitors,,,,cells/kg,90.0,
SYNTHETIC-5,DONOR_2234,TREATMENT_9734,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,8756456,NCI Thesaurus,ug/m2,62.0,88.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9735,Cell-based,Yervoy,278936,RxNorm,,121.0,
SYNTHETIC-5,DONOR_2236,TREATMENT_9736,Other immunomodulatory substances,Gilteritinib,278936,NCI Thesaurus,IU/kg,93.0,103.0
SYNTHETIC-5,DONOR_2237,TREATMENT_9737,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,,,IU/m2,157.0,
SYNTHETIC-5,DONOR_2238,TREATMENT_9738,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,g/m2,,71.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9739,Immune checkpoint inhibitors,Alectinib,278936,NCI Thesaurus,g/m2,173.0,
SYNTHETIC-5,DONOR_2240,TREATMENT_9740,Cell-based,,8836851,,cells/kg,84.0,71.0
SYNTHETIC-5,DONOR_2241,TREATMENT_9741,Cell-based,Encorafenib,4459876,,,190.0,197.0
SYNTHETIC-5,DONOR_2242,TREATMENT_9742,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,4459876,RxNorm,IU/m2,77.0,130.0
SYNTHETIC-5,DONOR_2243,TREATMENT_9743,Immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,cells/kg,,
SYNTHETIC-5,DONOR_2244,TREATMENT_9744,Immune checkpoint inhibitors,,8836851,RxNorm,,166.0,
SYNTHETIC-5,DONOR_2245,TREATMENT_9745,Immune checkpoint inhibitors,Nivolumab,4459876,NCI Thesaurus,mg/kg,199.0,137.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9746,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,4459876,NCI Thesaurus,,118.0,55.0
SYNTHETIC-5,DONOR_2247,TREATMENT_9747,Other immunomodulatory substances,Brentuximab vedotin,278936,PubChem,cells/kg,162.0,
SYNTHETIC-5,DONOR_2248,TREATMENT_9748,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,,155.0,55.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9749,Immune checkpoint inhibitors,Selumitinib,987654,PubChem,mg/m2,76.0,147.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9750,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,,RxNorm,,181.0,180.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9751,Cell-based,Vandetanib,278936,NCI Thesaurus,cells/kg,70.0,97.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9752,Other immunomodulatory substances,Abemaciclib,278936,NCI Thesaurus,mg/kg,65.0,
SYNTHETIC-5,DONOR_2253,TREATMENT_9753,Cell-based,Enhertu,987654,,mg/m2,,180.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9754,,Trastuzumab,8836851,NCI Thesaurus,IU/m2,124.0,175.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9755,Other immunomodulatory substances,Osimertinib,278936,PubChem,IU/kg,65.0,162.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9756,Immune checkpoint inhibitors,,,NCI Thesaurus,,55.0,59.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9757,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,,mg/kg,167.0,161.0
SYNTHETIC-5,DONOR_2258,TREATMENT_9758,Immune checkpoint inhibitors,Caprelsa,239766,,ug/m2,169.0,86.0
SYNTHETIC-5,DONOR_2259,TREATMENT_9759,Immune checkpoint inhibitors,Keytruda,239766,RxNorm,g/m2,71.0,135.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9760,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,IU/kg,91.0,88.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9761,Other immunomodulatory substances,Nivolumab,8836851,PubChem,IU/m2,,132.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9762,,Tecentriq,239766,,IU/kg,196.0,195.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9763,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,987654,NCI Thesaurus,g/m2,167.0,140.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9764,Cell-based,Ado-trastuzumab emtansine,278936,PubChem,mg/m2,120.0,157.0
SYNTHETIC-5,DONOR_2265,TREATMENT_9765,Immune checkpoint inhibitors,Gefitinib,278936,PubChem,cells/kg,59.0,
SYNTHETIC-5,DONOR_2266,TREATMENT_9766,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,4459876,RxNorm,mg/m2,,158.0
SYNTHETIC-5,DONOR_2267,TREATMENT_9767,Cell-based,Keytruda,987654,NCI Thesaurus,g/m2,195.0,
SYNTHETIC-5,DONOR_2268,TREATMENT_9768,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2269,TREATMENT_9769,Other immunomodulatory substances,Pembrolizumab,4459876,NCI Thesaurus,IU/m2,82.0,130.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9770,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,IU/m2,152.0,97.0
SYNTHETIC-5,DONOR_2271,TREATMENT_9771,,Vemurafenib,,RxNorm,mg/m2,119.0,109.0
SYNTHETIC-5,DONOR_2272,TREATMENT_9772,Immune checkpoint inhibitors,Daratumumab,987654,PubChem,ug/m2,107.0,113.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9773,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,278936,PubChem,,155.0,77.0
SYNTHETIC-5,DONOR_2274,TREATMENT_9774,Other immunomodulatory substances,Tagrisso,8836851,PubChem,,,158.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9775,Cell-based,Kisqali,8756456,NCI Thesaurus,mg/m2,69.0,139.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9776,,,8836851,PubChem,cells/kg,152.0,81.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9777,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,8756456,NCI Thesaurus,mg/kg,151.0,103.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9778,Cell-based,Mektovi,4459876,PubChem,g/m2,129.0,
SYNTHETIC-5,DONOR_2279,TREATMENT_9779,Cell-based,Gazyva,987654,PubChem,mg/kg,105.0,174.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9780,,Opdivo,4459876,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2281,TREATMENT_9781,Immune checkpoint inhibitors,Vemurafenib,,RxNorm,,112.0,170.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9782,Immune checkpoint inhibitors,Tecentriq,987654,,g/m2,,
SYNTHETIC-5,DONOR_2283,TREATMENT_9783,Other immunomodulatory substances,Durvalumab,,RxNorm,ug/m2,100.0,129.0
SYNTHETIC-5,DONOR_2284,TREATMENT_9784,Cell-based,Ado-trastuzumab emtansine,,PubChem,IU/m2,165.0,167.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9785,Other immunomodulatory substances,Pertuzumab,8836851,NCI Thesaurus,,89.0,
SYNTHETIC-5,DONOR_2286,TREATMENT_9786,,Ipilimumab,,PubChem,ug/m2,,88.0
SYNTHETIC-5,DONOR_2287,TREATMENT_9787,Immune checkpoint inhibitors,Tecentriq,8756456,RxNorm,mg/kg,68.0,107.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9788,Cell-based,,987654,RxNorm,cells/kg,104.0,154.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9789,,Kadcyla,,RxNorm,mg/kg,82.0,99.0
SYNTHETIC-5,DONOR_2290,TREATMENT_9790,Immune checkpoint inhibitors,Pembrolizumab,239766,RxNorm,mg/m2,87.0,165.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9791,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,278936,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2292,TREATMENT_9792,Cell-based,Durvalumab,8836851,NCI Thesaurus,IU/m2,186.0,182.0
SYNTHETIC-5,DONOR_2293,TREATMENT_9793,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,IU/kg,94.0,120.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9794,Cell-based,Herceptin,,NCI Thesaurus,g/m2,,58.0
SYNTHETIC-5,DONOR_2295,TREATMENT_9795,Other immunomodulatory substances,Tecentriq,8836851,NCI Thesaurus,IU/kg,129.0,140.0
SYNTHETIC-5,DONOR_2296,TREATMENT_9796,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,8836851,NCI Thesaurus,IU/kg,135.0,96.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9797,,Ceritinib,239766,RxNorm,cells/kg,153.0,59.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9798,,Opdivo,8756456,NCI Thesaurus,IU/m2,179.0,95.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9799,,Tecentriq,278936,RxNorm,ug/m2,197.0,195.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9800,Immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,cells/kg,85.0,92.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9801,Cell-based,Rucaparib,987654,RxNorm,,131.0,59.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9802,Immune checkpoint inhibitors,Yervoy,987654,PubChem,mg/m2,77.0,131.0
SYNTHETIC-5,DONOR_2303,TREATMENT_9803,Other immunomodulatory substances,Gefitinib,987654,RxNorm,,194.0,114.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9804,Immune checkpoint inhibitors,Belantamab,8756456,RxNorm,cells/kg,,
SYNTHETIC-5,DONOR_2305,TREATMENT_9805,Immune checkpoint inhibitors,Venclexta,239766,NCI Thesaurus,mg/m2,95.0,67.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9806,Other immunomodulatory substances,Venetoclax,8836851,RxNorm,cells/kg,,198.0
SYNTHETIC-5,DONOR_2307,TREATMENT_9807,Cell-based,Opdivo,,RxNorm,cells/kg,135.0,144.0
SYNTHETIC-5,DONOR_2308,TREATMENT_9808,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,NCI Thesaurus,mg/kg,148.0,173.0
SYNTHETIC-5,DONOR_2309,TREATMENT_9809,Immune checkpoint inhibitors,Pembrolizumab,4459876,PubChem,ug/m2,71.0,187.0
SYNTHETIC-5,DONOR_2310,TREATMENT_9810,Other immunomodulatory substances,,8756456,PubChem,,84.0,52.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9811,Other immunomodulatory substances,,8756456,PubChem,IU/m2,63.0,94.0
SYNTHETIC-5,DONOR_2312,TREATMENT_9812,Other immunomodulatory substances,Pembrolizumab,278936,NCI Thesaurus,IU/kg,85.0,114.0
SYNTHETIC-5,DONOR_2313,TREATMENT_9813,Immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,IU/kg,180.0,113.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9814,Immune checkpoint inhibitors,Olaparib,,PubChem,,66.0,97.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9815,Immune checkpoint inhibitors,Rubraca,239766,NCI Thesaurus,,103.0,171.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9816,Cell-based,,8756456,RxNorm,mg/kg,191.0,
SYNTHETIC-5,DONOR_2317,TREATMENT_9817,Other immunomodulatory substances,,4459876,NCI Thesaurus,mg/m2,119.0,
SYNTHETIC-5,DONOR_2318,TREATMENT_9818,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,cells/kg,53.0,
SYNTHETIC-5,DONOR_2319,TREATMENT_9819,Other immunomodulatory substances,Cotellic,239766,RxNorm,IU/m2,118.0,
SYNTHETIC-5,DONOR_2320,TREATMENT_9820,Cell-based,Venclexta,4459876,RxNorm,IU/kg,178.0,85.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9821,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,4459876,PubChem,g/m2,95.0,53.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9822,Other immunomodulatory substances,Ipilimumab,239766,RxNorm,mg/m2,,96.0
SYNTHETIC-5,DONOR_2323,TREATMENT_9823,Cell-based,Blincyto,987654,RxNorm,,134.0,82.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9824,Other immunomodulatory substances,Rituximab,987654,,,,159.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9825,Immune checkpoint inhibitors,Tagrisso,278936,NCI Thesaurus,IU/m2,99.0,152.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9826,Immune checkpoint inhibitors,Adcetris,4459876,NCI Thesaurus,ug/m2,111.0,88.0
SYNTHETIC-5,DONOR_2327,TREATMENT_9827,Immune checkpoint inhibitors,,239766,RxNorm,,76.0,111.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9828,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,8756456,RxNorm,IU/kg,137.0,89.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9829,Cell-based,Selumitinib,8836851,NCI Thesaurus,,82.0,
SYNTHETIC-5,DONOR_2330,TREATMENT_9830,Other immunomodulatory substances,Caprelsa,,,IU/kg,161.0,110.0
SYNTHETIC-5,DONOR_2331,TREATMENT_9831,,Venclexta,,RxNorm,IU/kg,112.0,
SYNTHETIC-5,DONOR_2332,TREATMENT_9832,Immune checkpoint inhibitors,,278936,,,,
SYNTHETIC-5,DONOR_2333,TREATMENT_9833,Immune checkpoint inhibitors,Tisagenlecleucel,,PubChem,ug/m2,149.0,
SYNTHETIC-5,DONOR_2334,TREATMENT_9834,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,239766,NCI Thesaurus,mg/kg,107.0,63.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9835,Other immunomodulatory substances,,8836851,NCI Thesaurus,,163.0,70.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9836,Other immunomodulatory substances,Tecentriq,4459876,,cells/kg,128.0,130.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9837,Immune checkpoint inhibitors,Xalkori,4459876,RxNorm,cells/kg,186.0,139.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9838,Other immunomodulatory substances,,278936,NCI Thesaurus,cells/kg,68.0,154.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9839,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,RxNorm,mg/kg,64.0,135.0
SYNTHETIC-5,DONOR_2340,TREATMENT_9840,Immune checkpoint inhibitors,,239766,,,152.0,68.0
SYNTHETIC-5,DONOR_2341,TREATMENT_9841,Cell-based,Cotellic,8836851,PubChem,mg/kg,183.0,50.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9842,Cell-based,Gilotrif,987654,PubChem,,,99.0
SYNTHETIC-5,DONOR_2343,TREATMENT_9843,Immune checkpoint inhibitors,Pertuzumab,8836851,PubChem,mg/m2,61.0,171.0
SYNTHETIC-5,DONOR_2344,TREATMENT_9844,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,cells/kg,51.0,66.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9845,Cell-based,Rucaparib,278936,RxNorm,IU/m2,,198.0
SYNTHETIC-5,DONOR_2346,TREATMENT_9846,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,PubChem,ug/m2,123.0,197.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9847,,Brigatinib,4459876,NCI Thesaurus,IU/m2,156.0,50.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9848,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,NCI Thesaurus,mg/kg,60.0,148.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9849,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,,176.0,62.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9850,Other immunomodulatory substances,Nivolumab,239766,,g/m2,155.0,
SYNTHETIC-5,DONOR_2351,TREATMENT_9851,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,239766,RxNorm,ug/m2,197.0,167.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9852,Other immunomodulatory substances,Pertuzumab,239766,NCI Thesaurus,mg/kg,132.0,138.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9853,Cell-based,,239766,,ug/m2,61.0,131.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9854,Cell-based,,,PubChem,,,57.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9855,Cell-based,,8836851,PubChem,g/m2,166.0,50.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9856,Cell-based,Atezolizumab,4459876,RxNorm,mg/m2,132.0,82.0
SYNTHETIC-5,DONOR_2357,TREATMENT_9857,Immune checkpoint inhibitors,Selumitinib,4459876,,ug/m2,79.0,104.0
SYNTHETIC-5,DONOR_2358,TREATMENT_9858,Cell-based,Kisqali,278936,RxNorm,,108.0,200.0
SYNTHETIC-5,DONOR_2359,TREATMENT_9859,Other immunomodulatory substances,,987654,,mg/kg,60.0,135.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9860,Immune checkpoint inhibitors,Trastuzumab,8836851,RxNorm,mg/m2,,148.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9861,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,987654,PubChem,,186.0,185.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9862,Immune checkpoint inhibitors,Tecentriq,4459876,PubChem,IU/m2,,144.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9863,Immune checkpoint inhibitors,,8756456,PubChem,IU/kg,95.0,169.0
SYNTHETIC-5,DONOR_2364,TREATMENT_9864,Other immunomodulatory substances,Nivolumab,987654,,,189.0,
SYNTHETIC-5,DONOR_2365,TREATMENT_9865,Immune checkpoint inhibitors,Opdivo,239766,RxNorm,ug/m2,197.0,
SYNTHETIC-5,DONOR_2366,TREATMENT_9866,Immune checkpoint inhibitors,Pexidartinib,987654,RxNorm,ug/m2,99.0,166.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9867,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,278936,RxNorm,g/m2,50.0,58.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9868,Cell-based,Keytruda,987654,NCI Thesaurus,g/m2,160.0,153.0
SYNTHETIC-5,DONOR_2369,TREATMENT_9869,Immune checkpoint inhibitors,Yervoy,4459876,PubChem,IU/kg,112.0,117.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9870,Cell-based,Palbociclib,239766,RxNorm,IU/kg,175.0,156.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9871,Other immunomodulatory substances,Iressa,987654,RxNorm,g/m2,122.0,105.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9872,,Blincyto,239766,RxNorm,mg/m2,167.0,73.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9873,Immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,IU/m2,181.0,174.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9874,Cell-based,Keytruda,8756456,,IU/m2,116.0,97.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9875,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,,PubChem,mg/m2,198.0,122.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9876,,Abemaciclib,8836851,RxNorm,IU/kg,93.0,119.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9877,Cell-based,Herceptin,239766,PubChem,IU/kg,57.0,95.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9878,Immune checkpoint inhibitors,Lynparza,,PubChem,,90.0,
SYNTHETIC-5,DONOR_2379,TREATMENT_9879,Immune checkpoint inhibitors,Ipilimumab,,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2380,TREATMENT_9880,Other immunomodulatory substances,Enhertu,239766,NCI Thesaurus,g/m2,153.0,50.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9881,Other immunomodulatory substances,Dabrafenib,239766,RxNorm,cells/kg,185.0,170.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9882,Cell-based,,278936,RxNorm,,61.0,
SYNTHETIC-5,DONOR_2383,TREATMENT_9883,Immune checkpoint inhibitors,Ibrance,987654,RxNorm,g/m2,163.0,148.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9884,Immune checkpoint inhibitors,Venclexta,239766,NCI Thesaurus,IU/m2,103.0,
SYNTHETIC-5,DONOR_2385,TREATMENT_9885,Other immunomodulatory substances,Imfinzi,8756456,NCI Thesaurus,mg/m2,187.0,123.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9886,,Belantamab,8836851,RxNorm,,103.0,73.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9887,Cell-based,Verzenio,4459876,NCI Thesaurus,IU/m2,78.0,187.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9888,,,4459876,PubChem,mg/kg,180.0,179.0
SYNTHETIC-5,DONOR_2389,TREATMENT_9889,,Tecentriq,4459876,NCI Thesaurus,mg/kg,188.0,
SYNTHETIC-5,DONOR_2390,TREATMENT_9890,Immune checkpoint inhibitors,,987654,PubChem,ug/m2,99.0,97.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9891,,Venclexta,,RxNorm,g/m2,128.0,103.0
SYNTHETIC-5,DONOR_2392,TREATMENT_9892,Cell-based,,987654,RxNorm,,183.0,74.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9893,Immune checkpoint inhibitors,,987654,RxNorm,cells/kg,68.0,119.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9894,Immune checkpoint inhibitors,Abemaciclib,8756456,,,119.0,103.0
SYNTHETIC-5,DONOR_2395,TREATMENT_9895,Immune checkpoint inhibitors,Darzalex,239766,PubChem,ug/m2,,132.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9896,Other immunomodulatory substances,Verzenio,4459876,NCI Thesaurus,IU/kg,,170.0
SYNTHETIC-5,DONOR_2397,TREATMENT_9897,Immune checkpoint inhibitors,Ipilimumab,987654,NCI Thesaurus,mg/m2,,55.0
SYNTHETIC-5,DONOR_2398,TREATMENT_9898,,Afatinib,278936,NCI Thesaurus,IU/m2,164.0,58.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9899,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,239766,NCI Thesaurus,mg/m2,85.0,84.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9900,Other immunomodulatory substances,,,RxNorm,ug/m2,136.0,
SYNTHETIC-5,DONOR_2401,TREATMENT_9901,Other immunomodulatory substances,,,RxNorm,mg/m2,61.0,78.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9902,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,239766,RxNorm,g/m2,98.0,107.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9903,Cell-based,,8756456,PubChem,mg/kg,94.0,122.0
SYNTHETIC-5,DONOR_2404,TREATMENT_9904,Immune checkpoint inhibitors,Rituxan,239766,NCI Thesaurus,ug/m2,194.0,69.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9905,,Pembrolizumab,4459876,RxNorm,IU/kg,155.0,163.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9906,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,278936,PubChem,cells/kg,146.0,81.0
SYNTHETIC-5,DONOR_2407,TREATMENT_9907,Other immunomodulatory substances,,4459876,PubChem,cells/kg,51.0,87.0
SYNTHETIC-5,DONOR_2408,TREATMENT_9908,Immune checkpoint inhibitors,Alectinib,8756456,RxNorm,mg/kg,164.0,155.0
SYNTHETIC-5,DONOR_2409,TREATMENT_9909,Cell-based,Kadcyla,,,IU/m2,155.0,87.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9910,Immune checkpoint inhibitors,Tecentriq,239766,NCI Thesaurus,cells/kg,131.0,103.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9911,Cell-based,Atezolizumab,278936,RxNorm,cells/kg,138.0,199.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9912,Cell-based,Tafinlar,8756456,RxNorm,mg/kg,93.0,77.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9913,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,PubChem,mg/kg,142.0,150.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9914,,,8836851,RxNorm,mg/m2,198.0,191.0
SYNTHETIC-5,DONOR_2415,TREATMENT_9915,Other immunomodulatory substances,Kisqali,239766,,ug/m2,,
SYNTHETIC-5,DONOR_2416,TREATMENT_9916,Other immunomodulatory substances,Keytruda,278936,PubChem,IU/kg,152.0,109.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9917,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,239766,NCI Thesaurus,mg/m2,143.0,72.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9918,,Yervoy,987654,PubChem,g/m2,124.0,179.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9919,Cell-based,Pembrolizumab,,NCI Thesaurus,IU/m2,94.0,181.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9920,,,987654,PubChem,mg/m2,97.0,
SYNTHETIC-5,DONOR_2421,TREATMENT_9921,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,4459876,RxNorm,cells/kg,147.0,
SYNTHETIC-5,DONOR_2422,TREATMENT_9922,Other immunomodulatory substances,Yescarta,,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2423,TREATMENT_9923,Cell-based,Cabozantinib,239766,PubChem,g/m2,66.0,136.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9924,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,,NCI Thesaurus,g/m2,75.0,58.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9925,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,RxNorm,,,
SYNTHETIC-5,DONOR_2426,TREATMENT_9926,Cell-based,Mektovi,278936,RxNorm,ug/m2,81.0,59.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9927,Immune checkpoint inhibitors,Rubraca,987654,,,96.0,65.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9928,Immune checkpoint inhibitors,Mektovi,8836851,PubChem,IU/m2,113.0,
SYNTHETIC-5,DONOR_2429,TREATMENT_9929,Cell-based,Sorafenib,8756456,,IU/kg,137.0,198.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9930,Other immunomodulatory substances,Gazyva,8836851,PubChem,,175.0,121.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9931,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,NCI Thesaurus,ug/m2,87.0,93.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9932,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,8756456,,IU/kg,130.0,129.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9933,Immune checkpoint inhibitors,,4459876,RxNorm,IU/m2,161.0,107.0
SYNTHETIC-5,DONOR_2434,TREATMENT_9934,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,8756456,,,131.0,92.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9935,Other immunomodulatory substances,Yescarta,8836851,NCI Thesaurus,mg/m2,,149.0
SYNTHETIC-5,DONOR_2436,TREATMENT_9936,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,,cells/kg,120.0,
SYNTHETIC-5,DONOR_2437,TREATMENT_9937,,Sorafenib,8836851,NCI Thesaurus,IU/kg,,197.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9938,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,278936,RxNorm,ug/m2,,190.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9939,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,987654,NCI Thesaurus,IU/m2,88.0,136.0
SYNTHETIC-5,DONOR_2440,TREATMENT_9940,Cell-based,Pexidartinib,239766,,IU/kg,,73.0
SYNTHETIC-5,DONOR_2441,TREATMENT_9941,Cell-based,Venclexta,8756456,PubChem,g/m2,165.0,174.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9942,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,278936,RxNorm,g/m2,,184.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9943,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,239766,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2444,TREATMENT_9944,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,4459876,NCI Thesaurus,IU/m2,126.0,200.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9945,Immune checkpoint inhibitors,Belantamab,4459876,PubChem,IU/kg,119.0,116.0
SYNTHETIC-5,DONOR_2446,TREATMENT_9946,Other immunomodulatory substances,Keytruda,278936,PubChem,,134.0,154.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9947,Immune checkpoint inhibitors,Kadcyla,4459876,PubChem,g/m2,,84.0
SYNTHETIC-5,DONOR_2448,TREATMENT_9948,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,4459876,PubChem,g/m2,,176.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9949,Cell-based,Durvalumab,,RxNorm,cells/kg,,82.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9950,Cell-based,,4459876,NCI Thesaurus,mg/kg,133.0,186.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9951,Immune checkpoint inhibitors,,278936,PubChem,ug/m2,129.0,
SYNTHETIC-5,DONOR_2452,TREATMENT_9952,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,,NCI Thesaurus,g/m2,63.0,
SYNTHETIC-5,DONOR_2453,TREATMENT_9953,,Iressa,8836851,,mg/kg,131.0,157.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9954,Immune checkpoint inhibitors,,,RxNorm,ug/m2,149.0,138.0
SYNTHETIC-5,DONOR_2455,TREATMENT_9955,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,NCI Thesaurus,IU/kg,183.0,82.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9956,Immune checkpoint inhibitors,Caprelsa,,,mg/kg,152.0,87.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9957,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8756456,RxNorm,,163.0,159.0
SYNTHETIC-5,DONOR_2458,TREATMENT_9958,Other immunomodulatory substances,,8756456,PubChem,ug/m2,86.0,99.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9959,Immune checkpoint inhibitors,Crizotinib,8756456,,IU/m2,59.0,167.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9960,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,278936,RxNorm,cells/kg,71.0,122.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9961,Other immunomodulatory substances,Rucaparib,987654,RxNorm,g/m2,94.0,153.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9962,Cell-based,Tecentriq,278936,PubChem,IU/m2,99.0,168.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9963,,,8836851,PubChem,cells/kg,,63.0
SYNTHETIC-5,DONOR_2464,TREATMENT_9964,Other immunomodulatory substances,Rubraca,987654,NCI Thesaurus,mg/kg,169.0,62.0
SYNTHETIC-5,DONOR_2465,TREATMENT_9965,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/kg,174.0,109.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9966,Cell-based,Pertuzumab,8756456,,ug/m2,,51.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9967,Immune checkpoint inhibitors,Tafinlar,239766,RxNorm,IU/kg,168.0,178.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9968,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,8756456,RxNorm,mg/m2,171.0,177.0
SYNTHETIC-5,DONOR_2469,TREATMENT_9969,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,mg/kg,95.0,74.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9970,Immune checkpoint inhibitors,Yervoy,,PubChem,IU/m2,101.0,
SYNTHETIC-5,DONOR_2471,TREATMENT_9971,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,4459876,RxNorm,g/m2,128.0,118.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9972,Other immunomodulatory substances,Gilotrif,4459876,RxNorm,mg/m2,105.0,56.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9973,Cell-based,,4459876,PubChem,cells/kg,54.0,140.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9974,Cell-based,,8756456,PubChem,,61.0,
SYNTHETIC-5,DONOR_2475,TREATMENT_9975,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,239766,,IU/kg,,
SYNTHETIC-5,DONOR_2476,TREATMENT_9976,Cell-based,Nivolumab,987654,NCI Thesaurus,mg/m2,94.0,90.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9977,Other immunomodulatory substances,,239766,NCI Thesaurus,IU/kg,150.0,93.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9978,Immune checkpoint inhibitors,Crizotinib,239766,RxNorm,g/m2,106.0,61.0
SYNTHETIC-5,DONOR_2479,TREATMENT_9979,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,278936,RxNorm,ug/m2,62.0,141.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9980,Immune checkpoint inhibitors,Zelboraf,278936,RxNorm,ug/m2,154.0,
SYNTHETIC-5,DONOR_2481,TREATMENT_9981,,Zykadia,239766,PubChem,cells/kg,,126.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9982,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,,,g/m2,130.0,174.0
SYNTHETIC-5,DONOR_2483,TREATMENT_9983,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,,200.0,109.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9984,Cell-based,Pertuzumab,8756456,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2485,TREATMENT_9985,Immune checkpoint inhibitors,Rubraca,8836851,NCI Thesaurus,IU/kg,96.0,
SYNTHETIC-5,DONOR_2486,TREATMENT_9986,Immune checkpoint inhibitors,Pembrolizumab,4459876,,IU/m2,104.0,105.0
SYNTHETIC-5,DONOR_2487,TREATMENT_9987,Cell-based,Nivolumab,8836851,RxNorm,,99.0,144.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9988,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,4459876,NCI Thesaurus,cells/kg,84.0,164.0
SYNTHETIC-5,DONOR_2489,TREATMENT_9989,Immune checkpoint inhibitors,Enhertu,987654,NCI Thesaurus,g/m2,82.0,149.0
SYNTHETIC-5,DONOR_2490,TREATMENT_9990,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,,cells/kg,62.0,188.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9991,Immune checkpoint inhibitors,,987654,PubChem,ug/m2,,138.0
SYNTHETIC-5,DONOR_2492,TREATMENT_9992,Other immunomodulatory substances,,8836851,RxNorm,IU/m2,,172.0
SYNTHETIC-5,DONOR_2493,TREATMENT_9993,Immune checkpoint inhibitors,Nivolumab,4459876,NCI Thesaurus,ug/m2,62.0,183.0
SYNTHETIC-5,DONOR_2494,TREATMENT_9994,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,8836851,RxNorm,cells/kg,80.0,
SYNTHETIC-5,DONOR_2495,TREATMENT_9995,,Ado-trastuzumab emtansine,4459876,NCI Thesaurus,cells/kg,175.0,151.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9996,Cell-based,Cometriq,4459876,PubChem,IU/kg,174.0,106.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9997,Immune checkpoint inhibitors,Pertuzumab,8756456,RxNorm,mg/m2,91.0,172.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9998,Cell-based,Pertuzumab,278936,,mg/kg,94.0,76.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9999,Cell-based,Zejula,239766,RxNorm,cells/kg,147.0,155.0
SYNTHETIC-5,DONOR_2500,TREATMENT_10000,Immune checkpoint inhibitors,Ipilimumab,4459876,,,88.0,165.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8001,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,NCI Thesaurus,,147.0,152.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8002,Immune checkpoint inhibitors,Nivolumab,4459876,,IU/m2,189.0,65.0
SYNTHETIC-5,DONOR_2003,TREATMENT_8003,Immune checkpoint inhibitors,Opdivo,4459876,PubChem,IU/kg,,168.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8004,Cell-based,Nivolumab,239766,,IU/m2,125.0,51.0
SYNTHETIC-5,DONOR_2005,TREATMENT_8005,,Trastuzumab,8756456,NCI Thesaurus,cells/kg,174.0,86.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8006,Immune checkpoint inhibitors,Ribociclib,8836851,NCI Thesaurus,,,182.0
SYNTHETIC-5,DONOR_2007,TREATMENT_8007,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,987654,NCI Thesaurus,cells/kg,70.0,185.0
SYNTHETIC-5,DONOR_2008,TREATMENT_8008,Other immunomodulatory substances,Cotellic,987654,PubChem,,68.0,198.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8009,Cell-based,Copanlisib,,RxNorm,cells/kg,,95.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8010,Immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/kg,62.0,130.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8011,Cell-based,Fam-trastuzumab deruxtecan-nxki,,,ug/m2,50.0,179.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8012,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,4459876,PubChem,IU/kg,120.0,194.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8013,Other immunomodulatory substances,Opdivo,278936,RxNorm,cells/kg,109.0,156.0
SYNTHETIC-5,DONOR_2014,TREATMENT_8014,Immune checkpoint inhibitors,Nivolumab,,NCI Thesaurus,mg/m2,124.0,
SYNTHETIC-5,DONOR_2015,TREATMENT_8015,Immune checkpoint inhibitors,Tecentriq,8836851,PubChem,cells/kg,68.0,
SYNTHETIC-5,DONOR_2016,TREATMENT_8016,Immune checkpoint inhibitors,Atezolizumab,8756456,,mg/m2,117.0,118.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8017,Cell-based,Nivolumab,239766,RxNorm,,156.0,77.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8018,Immune checkpoint inhibitors,Ipilimumab,987654,NCI Thesaurus,,59.0,
SYNTHETIC-5,DONOR_2019,TREATMENT_8019,Cell-based,Afatinib,239766,NCI Thesaurus,mg/m2,128.0,
SYNTHETIC-5,DONOR_2020,TREATMENT_8020,Cell-based,Ipilimumab,4459876,,IU/kg,84.0,99.0
SYNTHETIC-5,DONOR_2021,TREATMENT_8021,Other immunomodulatory substances,Trastuzumab,,NCI Thesaurus,mg/m2,,199.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8022,Other immunomodulatory substances,Yervoy,987654,RxNorm,ug/m2,,146.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8023,,Dabrafenib,4459876,RxNorm,g/m2,55.0,180.0
SYNTHETIC-5,DONOR_2024,TREATMENT_8024,Cell-based,Blincyto,8836851,RxNorm,mg/kg,186.0,
SYNTHETIC-5,DONOR_2025,TREATMENT_8025,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,278936,PubChem,g/m2,164.0,
SYNTHETIC-5,DONOR_2026,TREATMENT_8026,Cell-based,Nivolumab,8756456,PubChem,IU/kg,84.0,152.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8027,,Braftovi,239766,NCI Thesaurus,mg/m2,175.0,181.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8028,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,8836851,PubChem,,,162.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8029,Other immunomodulatory substances,Rituxan,239766,NCI Thesaurus,ug/m2,54.0,98.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8030,Cell-based,Pembrolizumab,8836851,PubChem,,136.0,
SYNTHETIC-5,DONOR_2031,TREATMENT_8031,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,8836851,PubChem,mg/kg,189.0,92.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8032,Immune checkpoint inhibitors,Selumitinib,987654,RxNorm,IU/m2,177.0,186.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8033,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,mg/m2,187.0,156.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8034,Immune checkpoint inhibitors,,239766,,mg/kg,,183.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8035,Other immunomodulatory substances,Zelboraf,987654,PubChem,mg/m2,57.0,168.0
SYNTHETIC-5,DONOR_2036,TREATMENT_8036,Other immunomodulatory substances,Crizotinib,987654,NCI Thesaurus,mg/kg,74.0,
SYNTHETIC-5,DONOR_2037,TREATMENT_8037,Immune checkpoint inhibitors,Abemaciclib,4459876,PubChem,,181.0,109.0
SYNTHETIC-5,DONOR_2038,TREATMENT_8038,,Copanlisib,278936,NCI Thesaurus,g/m2,180.0,122.0
SYNTHETIC-5,DONOR_2039,TREATMENT_8039,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,4459876,RxNorm,ug/m2,,157.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8040,Other immunomodulatory substances,Ado-trastuzumab emtansine,8836851,PubChem,cells/kg,58.0,
SYNTHETIC-5,DONOR_2041,TREATMENT_8041,Other immunomodulatory substances,Yervoy,8756456,NCI Thesaurus,mg/kg,174.0,54.0
SYNTHETIC-5,DONOR_2042,TREATMENT_8042,Cell-based,Tarceva,4459876,NCI Thesaurus,IU/m2,141.0,111.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8043,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,,NCI Thesaurus,IU/m2,146.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_8044,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,,mg/kg,,140.0
SYNTHETIC-5,DONOR_2045,TREATMENT_8045,Immune checkpoint inhibitors,Zejula,278936,NCI Thesaurus,mg/kg,111.0,
SYNTHETIC-5,DONOR_2046,TREATMENT_8046,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,278936,RxNorm,mg/m2,71.0,152.0
SYNTHETIC-5,DONOR_2047,TREATMENT_8047,Other immunomodulatory substances,Belantamab,278936,RxNorm,mg/m2,109.0,145.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8048,,Nivolumab,,PubChem,IU/kg,,106.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8049,Cell-based,Tisagenlecleucel,4459876,NCI Thesaurus,,151.0,61.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8050,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,,144.0,102.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8051,Other immunomodulatory substances,Adcetris,8836851,RxNorm,g/m2,92.0,158.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8052,,Ibrance,8836851,NCI Thesaurus,cells/kg,149.0,70.0
SYNTHETIC-5,DONOR_2053,TREATMENT_8053,Immune checkpoint inhibitors,Sorafenib,,RxNorm,g/m2,,54.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8054,Immune checkpoint inhibitors,Alectinib,8756456,RxNorm,,145.0,173.0
SYNTHETIC-5,DONOR_2055,TREATMENT_8055,Other immunomodulatory substances,Herceptin,4459876,NCI Thesaurus,mg/kg,176.0,161.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8056,Cell-based,Atezolizumab,8836851,,IU/kg,103.0,144.0
SYNTHETIC-5,DONOR_2057,TREATMENT_8057,Cell-based,Ipilimumab,8756456,RxNorm,g/m2,92.0,144.0
SYNTHETIC-5,DONOR_2058,TREATMENT_8058,Immune checkpoint inhibitors,Brigatinib,239766,RxNorm,ug/m2,98.0,69.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8059,Other immunomodulatory substances,Yervoy,8836851,,cells/kg,61.0,53.0
SYNTHETIC-5,DONOR_2060,TREATMENT_8060,,Binimetinib,987654,NCI Thesaurus,IU/m2,51.0,187.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8061,Other immunomodulatory substances,Belantamab,8756456,NCI Thesaurus,ug/m2,81.0,94.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8062,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,8836851,PubChem,,75.0,176.0
SYNTHETIC-5,DONOR_2063,TREATMENT_8063,Cell-based,Darzalex,278936,,mg/kg,,
SYNTHETIC-5,DONOR_2064,TREATMENT_8064,Immune checkpoint inhibitors,Cabozantinib,8836851,PubChem,ug/m2,56.0,125.0
SYNTHETIC-5,DONOR_2065,TREATMENT_8065,Other immunomodulatory substances,Afatinib,4459876,RxNorm,g/m2,62.0,115.0
SYNTHETIC-5,DONOR_2066,TREATMENT_8066,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,ug/m2,76.0,
SYNTHETIC-5,DONOR_2067,TREATMENT_8067,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,g/m2,,80.0
SYNTHETIC-5,DONOR_2068,TREATMENT_8068,Immune checkpoint inhibitors,Opdivo,8836851,PubChem,mg/kg,95.0,154.0
SYNTHETIC-5,DONOR_2069,TREATMENT_8069,Cell-based,Vandetanib,4459876,NCI Thesaurus,mg/m2,60.0,
SYNTHETIC-5,DONOR_2070,TREATMENT_8070,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,8836851,,,168.0,156.0
SYNTHETIC-5,DONOR_2071,TREATMENT_8071,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,8756456,RxNorm,IU/m2,165.0,169.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8072,Immune checkpoint inhibitors,Durvalumab,4459876,RxNorm,IU/m2,174.0,77.0
SYNTHETIC-5,DONOR_2073,TREATMENT_8073,Cell-based,Keytruda,8756456,PubChem,,65.0,
SYNTHETIC-5,DONOR_2074,TREATMENT_8074,Cell-based,Adcetris,4459876,PubChem,IU/kg,116.0,73.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8075,Other immunomodulatory substances,Atezolizumab,4459876,,IU/m2,,189.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8076,Other immunomodulatory substances,Inotuzumab ozogamicin,8836851,RxNorm,ug/m2,176.0,194.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8077,Cell-based,Adcetris,278936,RxNorm,mg/m2,122.0,123.0
SYNTHETIC-5,DONOR_2078,TREATMENT_8078,Immune checkpoint inhibitors,Trametinib,4459876,PubChem,mg/m2,,113.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8079,Cell-based,Gilotrif,239766,NCI Thesaurus,IU/m2,142.0,121.0
SYNTHETIC-5,DONOR_2080,TREATMENT_8080,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,987654,PubChem,IU/kg,,197.0
SYNTHETIC-5,DONOR_2081,TREATMENT_8081,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,278936,PubChem,IU/kg,179.0,80.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8082,Immune checkpoint inhibitors,Vemurafenib,,PubChem,,137.0,152.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8083,Immune checkpoint inhibitors,Yervoy,239766,RxNorm,IU/m2,71.0,91.0
SYNTHETIC-5,DONOR_2084,TREATMENT_8084,Cell-based,Atezolizumab,8756456,RxNorm,cells/kg,128.0,196.0
SYNTHETIC-5,DONOR_2085,TREATMENT_8085,Immune checkpoint inhibitors,Imfinzi,4459876,RxNorm,g/m2,87.0,158.0
SYNTHETIC-5,DONOR_2086,TREATMENT_8086,,Zykadia,278936,NCI Thesaurus,mg/kg,96.0,104.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8087,Cell-based,Yervoy,987654,RxNorm,ug/m2,,199.0
SYNTHETIC-5,DONOR_2088,TREATMENT_8088,Cell-based,Zelboraf,4459876,NCI Thesaurus,ug/m2,153.0,65.0
SYNTHETIC-5,DONOR_2089,TREATMENT_8089,Cell-based,Gilotrif,8836851,PubChem,mg/kg,52.0,
SYNTHETIC-5,DONOR_2090,TREATMENT_8090,Immune checkpoint inhibitors,,4459876,PubChem,ug/m2,,177.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8091,Cell-based,Kadcyla,8756456,NCI Thesaurus,mg/kg,90.0,130.0
SYNTHETIC-5,DONOR_2092,TREATMENT_8092,Immune checkpoint inhibitors,Keytruda,987654,PubChem,ug/m2,65.0,195.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8093,Immune checkpoint inhibitors,,239766,,mg/kg,122.0,
SYNTHETIC-5,DONOR_2094,TREATMENT_8094,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,278936,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2095,TREATMENT_8095,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,,mg/m2,181.0,70.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8096,Cell-based,Brigatinib,8836851,,mg/m2,115.0,77.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8097,Cell-based,Yervoy,278936,PubChem,mg/m2,,192.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8098,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,NCI Thesaurus,mg/kg,189.0,159.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8099,Cell-based,Tecentriq,8756456,PubChem,mg/kg,156.0,
SYNTHETIC-5,DONOR_2100,TREATMENT_8100,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,,59.0,123.0
SYNTHETIC-5,DONOR_2101,TREATMENT_8101,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,RxNorm,,162.0,
SYNTHETIC-5,DONOR_2102,TREATMENT_8102,Immune checkpoint inhibitors,Alecensa,987654,PubChem,mg/kg,91.0,58.0
SYNTHETIC-5,DONOR_2103,TREATMENT_8103,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,,ug/m2,71.0,151.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8104,Other immunomodulatory substances,Cometriq,8836851,,IU/m2,195.0,72.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8105,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,,127.0,54.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8106,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,ug/m2,194.0,83.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8107,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,NCI Thesaurus,g/m2,76.0,95.0
SYNTHETIC-5,DONOR_2108,TREATMENT_8108,Cell-based,,8836851,PubChem,g/m2,165.0,
SYNTHETIC-5,DONOR_2109,TREATMENT_8109,,Atezolizumab,4459876,PubChem,cells/kg,,75.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8110,Other immunomodulatory substances,Zykadia,278936,RxNorm,IU/kg,134.0,172.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8111,Immune checkpoint inhibitors,Obinutuzumab,278936,NCI Thesaurus,,185.0,149.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8112,,Verzenio,239766,RxNorm,,131.0,68.0
SYNTHETIC-5,DONOR_2113,TREATMENT_8113,Cell-based,Enhertu,8756456,NCI Thesaurus,IU/kg,179.0,200.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8114,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,,PubChem,mg/kg,,77.0
SYNTHETIC-5,DONOR_2115,TREATMENT_8115,,,8836851,RxNorm,g/m2,,123.0
SYNTHETIC-5,DONOR_2116,TREATMENT_8116,Cell-based,,8756456,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2117,TREATMENT_8117,Cell-based,,4459876,RxNorm,mg/m2,193.0,80.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8118,Immune checkpoint inhibitors,Besponsa,987654,PubChem,mg/kg,195.0,
SYNTHETIC-5,DONOR_2119,TREATMENT_8119,Immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,ug/m2,188.0,
SYNTHETIC-5,DONOR_2120,TREATMENT_8120,Immune checkpoint inhibitors,Ribociclib,8836851,PubChem,mg/kg,,50.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8121,Cell-based,Atezolizumab,278936,RxNorm,ug/m2,144.0,51.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8122,Other immunomodulatory substances,Blincyto,239766,PubChem,mg/kg,179.0,157.0
SYNTHETIC-5,DONOR_2123,TREATMENT_8123,Immune checkpoint inhibitors,Cabozantinib,987654,NCI Thesaurus,,175.0,87.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8124,Cell-based,Verzenio,8836851,PubChem,ug/m2,162.0,167.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8125,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,278936,,mg/m2,,96.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8126,Other immunomodulatory substances,Rituxan,987654,PubChem,,,148.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8127,Cell-based,Yescarta,,PubChem,IU/kg,153.0,67.0
SYNTHETIC-5,DONOR_2128,TREATMENT_8128,Other immunomodulatory substances,Kymriah,4459876,NCI Thesaurus,mg/m2,,125.0
SYNTHETIC-5,DONOR_2129,TREATMENT_8129,,,,,mg/kg,169.0,89.0
SYNTHETIC-5,DONOR_2130,TREATMENT_8130,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,987654,RxNorm,cells/kg,53.0,150.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8131,Cell-based,Tisagenlecleucel,8756456,,,65.0,
SYNTHETIC-5,DONOR_2132,TREATMENT_8132,Cell-based,Tecentriq,8836851,PubChem,mg/kg,166.0,98.0
SYNTHETIC-5,DONOR_2133,TREATMENT_8133,,Kisqali,8756456,NCI Thesaurus,,128.0,
SYNTHETIC-5,DONOR_2134,TREATMENT_8134,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,mg/kg,,194.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8135,,Rubraca,278936,,ug/m2,117.0,179.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8136,Cell-based,Mektovi,8756456,RxNorm,ug/m2,163.0,156.0
SYNTHETIC-5,DONOR_2137,TREATMENT_8137,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,239766,,IU/m2,161.0,
SYNTHETIC-5,DONOR_2138,TREATMENT_8138,,Trastuzumab,8756456,,IU/m2,62.0,145.0
SYNTHETIC-5,DONOR_2139,TREATMENT_8139,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,RxNorm,IU/kg,,184.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8140,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,8836851,NCI Thesaurus,mg/kg,144.0,79.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8141,Immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,ug/m2,73.0,190.0
SYNTHETIC-5,DONOR_2142,TREATMENT_8142,,Keytruda,278936,NCI Thesaurus,,169.0,73.0
SYNTHETIC-5,DONOR_2143,TREATMENT_8143,Cell-based,Belantamab,987654,NCI Thesaurus,IU/m2,110.0,126.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8144,Immune checkpoint inhibitors,Enhertu,8756456,PubChem,mg/m2,188.0,155.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8145,Immune checkpoint inhibitors,Durvalumab,,RxNorm,IU/m2,182.0,
SYNTHETIC-5,DONOR_2146,TREATMENT_8146,Cell-based,Mektovi,8836851,RxNorm,ug/m2,92.0,74.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8147,Immune checkpoint inhibitors,Ribociclib,239766,,,115.0,181.0
SYNTHETIC-5,DONOR_2148,TREATMENT_8148,Immune checkpoint inhibitors,Vandetanib,4459876,,,67.0,104.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8149,Immune checkpoint inhibitors,Besponsa,987654,,g/m2,148.0,183.0
SYNTHETIC-5,DONOR_2150,TREATMENT_8150,Immune checkpoint inhibitors,Necitumumab,4459876,RxNorm,ug/m2,,178.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8151,Immune checkpoint inhibitors,Perjeta,4459876,NCI Thesaurus,ug/m2,123.0,106.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8152,Cell-based,Atezolizumab,8836851,RxNorm,,161.0,63.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8153,,Blincyto,987654,NCI Thesaurus,mg/m2,,65.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8154,Other immunomodulatory substances,Olaparib,8756456,PubChem,mg/kg,139.0,154.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8155,Other immunomodulatory substances,Tagrisso,8756456,NCI Thesaurus,mg/kg,144.0,81.0
SYNTHETIC-5,DONOR_2156,TREATMENT_8156,Cell-based,Brentuximab vedotin,239766,PubChem,,174.0,69.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8157,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8836851,PubChem,,138.0,196.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8158,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,4459876,PubChem,IU/m2,110.0,151.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8159,Cell-based,Blinatumomab,8756456,RxNorm,mg/kg,51.0,59.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8160,Other immunomodulatory substances,,278936,,g/m2,80.0,140.0
SYNTHETIC-5,DONOR_2161,TREATMENT_8161,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,239766,PubChem,g/m2,54.0,129.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8162,,Perjeta,987654,PubChem,IU/kg,148.0,190.0
SYNTHETIC-5,DONOR_2163,TREATMENT_8163,Other immunomodulatory substances,Imfinzi,4459876,PubChem,g/m2,173.0,162.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8164,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,4459876,NCI Thesaurus,ug/m2,113.0,
SYNTHETIC-5,DONOR_2165,TREATMENT_8165,,Daratumumab,8836851,PubChem,g/m2,,
SYNTHETIC-5,DONOR_2166,TREATMENT_8166,,Belantamab,8836851,PubChem,mg/m2,164.0,
SYNTHETIC-5,DONOR_2167,TREATMENT_8167,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,cells/kg,199.0,158.0
SYNTHETIC-5,DONOR_2168,TREATMENT_8168,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,987654,,IU/m2,,151.0
SYNTHETIC-5,DONOR_2169,TREATMENT_8169,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,g/m2,62.0,
SYNTHETIC-5,DONOR_2170,TREATMENT_8170,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,90.0,153.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8171,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,8756456,PubChem,IU/kg,90.0,135.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8172,,Enhertu,8836851,PubChem,IU/m2,72.0,62.0
SYNTHETIC-5,DONOR_2173,TREATMENT_8173,Immune checkpoint inhibitors,Blinatumomab,278936,NCI Thesaurus,,103.0,72.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8174,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,987654,RxNorm,IU/m2,144.0,199.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8175,,Alectinib,8836851,PubChem,ug/m2,153.0,102.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8176,Cell-based,Cabozantinib,8756456,PubChem,,122.0,74.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8177,Immune checkpoint inhibitors,Rituximab,8836851,PubChem,g/m2,80.0,68.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8178,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,PubChem,g/m2,194.0,191.0
SYNTHETIC-5,DONOR_2179,TREATMENT_8179,Immune checkpoint inhibitors,Cobimetinib,4459876,PubChem,,,70.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8180,,,,,ug/m2,197.0,142.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8181,Immune checkpoint inhibitors,Daratumumab,239766,PubChem,,177.0,113.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8182,Cell-based,Gilotrif,,PubChem,IU/m2,167.0,56.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8183,,Pembrolizumab,239766,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2184,TREATMENT_8184,Immune checkpoint inhibitors,Rituxan,987654,RxNorm,,109.0,96.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8185,Cell-based,Copanlisib,4459876,NCI Thesaurus,,152.0,153.0
SYNTHETIC-5,DONOR_2186,TREATMENT_8186,Cell-based,Blincyto,,NCI Thesaurus,,89.0,178.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8187,Cell-based,Besponsa,278936,RxNorm,mg/m2,128.0,168.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8188,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,,RxNorm,IU/kg,194.0,189.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8189,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,278936,NCI Thesaurus,cells/kg,104.0,85.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8190,,Durvalumab,8756456,PubChem,,194.0,61.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8191,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,RxNorm,mg/m2,89.0,77.0
SYNTHETIC-5,DONOR_2192,TREATMENT_8192,Cell-based,Gilotrif,,RxNorm,mg/kg,116.0,
SYNTHETIC-5,DONOR_2193,TREATMENT_8193,Immune checkpoint inhibitors,Nivolumab,278936,PubChem,mg/kg,148.0,76.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8194,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8836851,PubChem,,71.0,70.0
SYNTHETIC-5,DONOR_2195,TREATMENT_8195,,Zykadia,8836851,RxNorm,g/m2,66.0,57.0
SYNTHETIC-5,DONOR_2196,TREATMENT_8196,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,4459876,NCI Thesaurus,,110.0,75.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8197,Immune checkpoint inhibitors,Opdivo,,RxNorm,ug/m2,121.0,109.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8198,Cell-based,Yescarta,987654,PubChem,mg/m2,96.0,113.0
SYNTHETIC-5,DONOR_2199,TREATMENT_8199,Other immunomodulatory substances,,4459876,RxNorm,g/m2,167.0,99.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8200,Other immunomodulatory substances,Atezolizumab,239766,NCI Thesaurus,mg/kg,124.0,148.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8201,Immune checkpoint inhibitors,Yervoy,8756456,RxNorm,IU/m2,199.0,
SYNTHETIC-5,DONOR_2202,TREATMENT_8202,,Gilotrif,278936,,IU/m2,192.0,118.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8203,Immune checkpoint inhibitors,Atezolizumab,4459876,,g/m2,144.0,94.0
SYNTHETIC-5,DONOR_2204,TREATMENT_8204,Cell-based,,8836851,RxNorm,g/m2,106.0,142.0
SYNTHETIC-5,DONOR_2205,TREATMENT_8205,Immune checkpoint inhibitors,Opdivo,8836851,PubChem,cells/kg,122.0,82.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8206,Other immunomodulatory substances,Darzalex,278936,NCI Thesaurus,IU/kg,55.0,
SYNTHETIC-5,DONOR_2207,TREATMENT_8207,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,NCI Thesaurus,,132.0,
SYNTHETIC-5,DONOR_2208,TREATMENT_8208,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,ug/m2,63.0,
SYNTHETIC-5,DONOR_2209,TREATMENT_8209,Cell-based,Opdivo,4459876,PubChem,cells/kg,106.0,94.0
SYNTHETIC-5,DONOR_2210,TREATMENT_8210,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8836851,RxNorm,cells/kg,59.0,149.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8211,Immune checkpoint inhibitors,Tafinlar,278936,NCI Thesaurus,cells/kg,135.0,175.0
SYNTHETIC-5,DONOR_2212,TREATMENT_8212,Other immunomodulatory substances,Atezolizumab,239766,,IU/kg,,179.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8213,Cell-based,Zelboraf,8756456,,g/m2,93.0,157.0
SYNTHETIC-5,DONOR_2214,TREATMENT_8214,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,239766,RxNorm,ug/m2,93.0,156.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8215,Immune checkpoint inhibitors,Abemaciclib,8836851,RxNorm,cells/kg,137.0,75.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8216,,Alecensa,987654,RxNorm,ug/m2,91.0,57.0
SYNTHETIC-5,DONOR_2217,TREATMENT_8217,Cell-based,Braftovi,8756456,NCI Thesaurus,,134.0,142.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8218,Immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,cells/kg,100.0,118.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8219,Other immunomodulatory substances,Blinatumomab,239766,PubChem,ug/m2,150.0,182.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8220,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,cells/kg,176.0,57.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8221,Immune checkpoint inhibitors,Erlotinib,239766,RxNorm,mg/kg,56.0,170.0
SYNTHETIC-5,DONOR_2222,TREATMENT_8222,Immune checkpoint inhibitors,Nivolumab,278936,PubChem,IU/kg,141.0,79.0
SYNTHETIC-5,DONOR_2223,TREATMENT_8223,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,987654,,mg/m2,57.0,162.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8224,Other immunomodulatory substances,Brigatinib,8756456,PubChem,mg/m2,182.0,185.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8225,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,RxNorm,IU/kg,177.0,176.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8226,Immune checkpoint inhibitors,,8836851,PubChem,,64.0,50.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8227,Other immunomodulatory substances,Mekinist,8756456,RxNorm,ug/m2,113.0,
SYNTHETIC-5,DONOR_2228,TREATMENT_8228,Other immunomodulatory substances,,987654,NCI Thesaurus,IU/m2,96.0,163.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8229,Cell-based,Opdivo,4459876,PubChem,IU/kg,53.0,
SYNTHETIC-5,DONOR_2230,TREATMENT_8230,Cell-based,Opdivo,,,mg/m2,105.0,137.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8231,Cell-based,Pembrolizumab,987654,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2232,TREATMENT_8232,Cell-based,,239766,RxNorm,ug/m2,122.0,118.0
SYNTHETIC-5,DONOR_2233,TREATMENT_8233,Immune checkpoint inhibitors,Gazyva,8836851,PubChem,,146.0,85.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8234,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,278936,NCI Thesaurus,g/m2,149.0,148.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8235,Immune checkpoint inhibitors,Pertuzumab,239766,PubChem,,106.0,
SYNTHETIC-5,DONOR_2236,TREATMENT_8236,Cell-based,Tecentriq,8756456,NCI Thesaurus,IU/kg,59.0,154.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8237,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,4459876,RxNorm,ug/m2,199.0,160.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8238,,Zelboraf,,RxNorm,,94.0,182.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8239,Immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,mg/kg,183.0,104.0
SYNTHETIC-5,DONOR_2240,TREATMENT_8240,Cell-based,Lenvima,278936,RxNorm,ug/m2,139.0,193.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8241,Immune checkpoint inhibitors,,987654,PubChem,,75.0,
SYNTHETIC-5,DONOR_2242,TREATMENT_8242,Other immunomodulatory substances,Durvalumab,8836851,PubChem,,64.0,190.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8243,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,239766,,mg/m2,,104.0
SYNTHETIC-5,DONOR_2244,TREATMENT_8244,Cell-based,Trastuzumab,8756456,,mg/m2,194.0,68.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8245,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,239766,RxNorm,g/m2,123.0,124.0
SYNTHETIC-5,DONOR_2246,TREATMENT_8246,Cell-based,Keytruda,278936,PubChem,cells/kg,89.0,89.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8247,Other immunomodulatory substances,Kisqali,,RxNorm,,174.0,110.0
SYNTHETIC-5,DONOR_2248,TREATMENT_8248,Immune checkpoint inhibitors,Keytruda,239766,,IU/kg,57.0,189.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8249,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8836851,NCI Thesaurus,,130.0,83.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8250,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,PubChem,IU/kg,,116.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8251,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,IU/m2,,149.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8252,Cell-based,Yervoy,,,mg/m2,,117.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8253,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,987654,RxNorm,IU/kg,79.0,131.0
SYNTHETIC-5,DONOR_2254,TREATMENT_8254,Immune checkpoint inhibitors,Ipilimumab,278936,RxNorm,IU/m2,113.0,171.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8255,Other immunomodulatory substances,Ipilimumab,987654,PubChem,g/m2,199.0,93.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8256,Immune checkpoint inhibitors,Gilotrif,4459876,NCI Thesaurus,mg/kg,,104.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8257,Other immunomodulatory substances,Atezolizumab,987654,NCI Thesaurus,ug/m2,175.0,
SYNTHETIC-5,DONOR_2258,TREATMENT_8258,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,NCI Thesaurus,IU/kg,100.0,177.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8259,Cell-based,,987654,,IU/kg,146.0,106.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8260,Immune checkpoint inhibitors,Rucaparib,278936,PubChem,mg/m2,197.0,57.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8261,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,RxNorm,mg/kg,137.0,
SYNTHETIC-5,DONOR_2262,TREATMENT_8262,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,PubChem,mg/kg,79.0,200.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8263,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,mg/m2,57.0,
SYNTHETIC-5,DONOR_2264,TREATMENT_8264,Other immunomodulatory substances,,8756456,NCI Thesaurus,IU/kg,181.0,177.0
SYNTHETIC-5,DONOR_2265,TREATMENT_8265,Other immunomodulatory substances,Trametinib,278936,PubChem,IU/kg,158.0,56.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8266,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,PubChem,,192.0,130.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8267,Cell-based,Verzenio,8836851,PubChem,IU/m2,,151.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8268,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,4459876,RxNorm,mg/kg,101.0,100.0
SYNTHETIC-5,DONOR_2269,TREATMENT_8269,,Tafinlar,8756456,PubChem,IU/m2,74.0,
SYNTHETIC-5,DONOR_2270,TREATMENT_8270,Cell-based,Kisqali,987654,,IU/m2,106.0,148.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8271,Immune checkpoint inhibitors,Tagrisso,4459876,PubChem,mg/kg,53.0,
SYNTHETIC-5,DONOR_2272,TREATMENT_8272,Other immunomodulatory substances,Yervoy,278936,PubChem,,61.0,186.0
SYNTHETIC-5,DONOR_2273,TREATMENT_8273,Immune checkpoint inhibitors,Tecentriq,4459876,,IU/m2,,99.0
SYNTHETIC-5,DONOR_2274,TREATMENT_8274,Immune checkpoint inhibitors,,4459876,RxNorm,mg/m2,,146.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8275,Cell-based,Opdivo,8836851,NCI Thesaurus,ug/m2,151.0,183.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8276,,,8836851,RxNorm,ug/m2,130.0,
SYNTHETIC-5,DONOR_2277,TREATMENT_8277,Immune checkpoint inhibitors,Besponsa,,NCI Thesaurus,,71.0,134.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8278,Other immunomodulatory substances,Ibrance,239766,NCI Thesaurus,IU/kg,140.0,84.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8279,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,278936,PubChem,mg/m2,139.0,136.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8280,Cell-based,Ipilimumab,987654,PubChem,ug/m2,194.0,169.0
SYNTHETIC-5,DONOR_2281,TREATMENT_8281,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,RxNorm,cells/kg,133.0,51.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8282,Cell-based,Axicabtagene ciloleucel,278936,NCI Thesaurus,IU/m2,81.0,138.0
SYNTHETIC-5,DONOR_2283,TREATMENT_8283,Cell-based,Pembrolizumab,8756456,NCI Thesaurus,IU/m2,200.0,179.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8284,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,4459876,NCI Thesaurus,cells/kg,136.0,150.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8285,Cell-based,Herceptin,8756456,NCI Thesaurus,cells/kg,79.0,159.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8286,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,,mg/m2,,
SYNTHETIC-5,DONOR_2287,TREATMENT_8287,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,4459876,PubChem,cells/kg,125.0,180.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8288,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,NCI Thesaurus,g/m2,196.0,100.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8289,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,239766,PubChem,mg/kg,138.0,55.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8290,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,PubChem,cells/kg,175.0,
SYNTHETIC-5,DONOR_2291,TREATMENT_8291,,Tecentriq,4459876,RxNorm,IU/m2,166.0,86.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8292,Other immunomodulatory substances,Ipilimumab,239766,PubChem,,178.0,58.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8293,Immune checkpoint inhibitors,Olaparib,8756456,NCI Thesaurus,cells/kg,,78.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8294,Immune checkpoint inhibitors,Yervoy,239766,PubChem,ug/m2,121.0,134.0
SYNTHETIC-5,DONOR_2295,TREATMENT_8295,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,278936,,mg/m2,61.0,174.0
SYNTHETIC-5,DONOR_2296,TREATMENT_8296,,Ado-trastuzumab emtansine,8836851,NCI Thesaurus,mg/m2,146.0,165.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8297,Cell-based,Opdivo,278936,RxNorm,cells/kg,114.0,
SYNTHETIC-5,DONOR_2298,TREATMENT_8298,Cell-based,Nivolumab,8756456,PubChem,ug/m2,182.0,
SYNTHETIC-5,DONOR_2299,TREATMENT_8299,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,239766,RxNorm,IU/kg,131.0,73.0
SYNTHETIC-5,DONOR_2300,TREATMENT_8300,Other immunomodulatory substances,,239766,NCI Thesaurus,,167.0,162.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8301,Immune checkpoint inhibitors,,4459876,RxNorm,mg/kg,189.0,55.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8302,Other immunomodulatory substances,Osimertinib,987654,NCI Thesaurus,mg/m2,172.0,73.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8303,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,,RxNorm,,85.0,138.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8304,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,4459876,NCI Thesaurus,g/m2,,94.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8305,Cell-based,,239766,NCI Thesaurus,,164.0,107.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8306,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,,ug/m2,86.0,143.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8307,Other immunomodulatory substances,Perjeta,239766,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2308,TREATMENT_8308,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,278936,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2309,TREATMENT_8309,Cell-based,Tagrisso,8756456,PubChem,ug/m2,,103.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8310,Cell-based,Gazyva,8756456,PubChem,mg/m2,172.0,188.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8311,Immune checkpoint inhibitors,Lynparza,8836851,,IU/kg,,
SYNTHETIC-5,DONOR_2312,TREATMENT_8312,,Tarceva,8836851,PubChem,g/m2,188.0,
SYNTHETIC-5,DONOR_2313,TREATMENT_8313,Other immunomodulatory substances,Copanlisib,8756456,NCI Thesaurus,mg/m2,70.0,160.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8314,,,278936,RxNorm,g/m2,,182.0
SYNTHETIC-5,DONOR_2315,TREATMENT_8315,,Ipilimumab,,NCI Thesaurus,IU/kg,194.0,101.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8316,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,278936,PubChem,IU/m2,156.0,102.0
SYNTHETIC-5,DONOR_2317,TREATMENT_8317,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,4459876,PubChem,IU/m2,167.0,
SYNTHETIC-5,DONOR_2318,TREATMENT_8318,Other immunomodulatory substances,Mektovi,987654,,IU/m2,186.0,120.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8319,Other immunomodulatory substances,Abemaciclib,239766,PubChem,g/m2,116.0,138.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8320,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,4459876,NCI Thesaurus,,94.0,177.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8321,Cell-based,Mekinist,8756456,RxNorm,g/m2,79.0,169.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8322,Other immunomodulatory substances,Adcetris,278936,RxNorm,mg/kg,,186.0
SYNTHETIC-5,DONOR_2323,TREATMENT_8323,Other immunomodulatory substances,Nivolumab,,NCI Thesaurus,IU/kg,142.0,167.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8324,Immune checkpoint inhibitors,Nivolumab,4459876,PubChem,IU/m2,184.0,59.0
SYNTHETIC-5,DONOR_2325,TREATMENT_8325,Cell-based,Cometriq,278936,NCI Thesaurus,g/m2,118.0,116.0
SYNTHETIC-5,DONOR_2326,TREATMENT_8326,Other immunomodulatory substances,,4459876,RxNorm,,56.0,157.0
SYNTHETIC-5,DONOR_2327,TREATMENT_8327,Other immunomodulatory substances,Tisagenlecleucel,4459876,NCI Thesaurus,mg/kg,93.0,198.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8328,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,987654,,cells/kg,68.0,113.0
SYNTHETIC-5,DONOR_2329,TREATMENT_8329,Immune checkpoint inhibitors,Rituximab,278936,PubChem,cells/kg,,76.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8330,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,239766,RxNorm,,92.0,122.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8331,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,278936,RxNorm,cells/kg,200.0,
SYNTHETIC-5,DONOR_2332,TREATMENT_8332,Immune checkpoint inhibitors,Zykadia,8756456,PubChem,IU/kg,125.0,118.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8333,Cell-based,Alunbrig,239766,PubChem,,178.0,
SYNTHETIC-5,DONOR_2334,TREATMENT_8334,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,,145.0,197.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8335,,Gilotrif,4459876,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2336,TREATMENT_8336,Immune checkpoint inhibitors,Ribociclib,239766,,IU/kg,198.0,128.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8337,Other immunomodulatory substances,Caprelsa,8836851,NCI Thesaurus,IU/m2,,160.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8338,Cell-based,Tafinlar,4459876,RxNorm,mg/m2,132.0,113.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8339,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,PubChem,IU/m2,104.0,87.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8340,Cell-based,Daratumumab,,RxNorm,IU/m2,108.0,61.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8341,Other immunomodulatory substances,Herceptin,987654,NCI Thesaurus,cells/kg,50.0,152.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8342,Other immunomodulatory substances,Alecensa,8836851,NCI Thesaurus,ug/m2,199.0,
SYNTHETIC-5,DONOR_2343,TREATMENT_8343,Cell-based,Tisagenlecleucel,8836851,NCI Thesaurus,mg/kg,186.0,
SYNTHETIC-5,DONOR_2344,TREATMENT_8344,Immune checkpoint inhibitors,Opdivo,987654,,ug/m2,121.0,
SYNTHETIC-5,DONOR_2345,TREATMENT_8345,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,8836851,,IU/kg,127.0,133.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8346,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,239766,,mg/m2,186.0,72.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8347,Cell-based,Mektovi,4459876,PubChem,,165.0,151.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8348,Cell-based,Zejula,8836851,,ug/m2,195.0,99.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8349,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,RxNorm,,,109.0
SYNTHETIC-5,DONOR_2350,TREATMENT_8350,Immune checkpoint inhibitors,Yervoy,239766,NCI Thesaurus,mg/m2,127.0,122.0
SYNTHETIC-5,DONOR_2351,TREATMENT_8351,Other immunomodulatory substances,Pertuzumab,8836851,PubChem,cells/kg,99.0,187.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8352,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,mg/kg,170.0,
SYNTHETIC-5,DONOR_2353,TREATMENT_8353,Cell-based,Alunbrig,987654,NCI Thesaurus,g/m2,122.0,189.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8354,Cell-based,Selumitinib,987654,RxNorm,IU/m2,52.0,79.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8355,Immune checkpoint inhibitors,Obinutuzumab,4459876,,IU/m2,138.0,95.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8356,Immune checkpoint inhibitors,Rubraca,4459876,RxNorm,IU/kg,102.0,136.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8357,Other immunomodulatory substances,Nexavar,4459876,NCI Thesaurus,ug/m2,97.0,152.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8358,Immune checkpoint inhibitors,Trametinib,987654,PubChem,ug/m2,88.0,156.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8359,Immune checkpoint inhibitors,Rucaparib,8836851,RxNorm,IU/m2,,78.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8360,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,987654,PubChem,ug/m2,154.0,133.0
SYNTHETIC-5,DONOR_2361,TREATMENT_8361,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,4459876,PubChem,cells/kg,,162.0
SYNTHETIC-5,DONOR_2362,TREATMENT_8362,,Durvalumab,8756456,PubChem,IU/m2,60.0,154.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8363,Other immunomodulatory substances,Keytruda,987654,PubChem,ug/m2,181.0,159.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8364,Other immunomodulatory substances,Blinatumomab,239766,NCI Thesaurus,ug/m2,192.0,105.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8365,Other immunomodulatory substances,Palbociclib,239766,,mg/m2,84.0,71.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8366,Other immunomodulatory substances,Ipilimumab,278936,NCI Thesaurus,g/m2,163.0,95.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8367,,Olaparib,278936,PubChem,IU/m2,102.0,196.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8368,Cell-based,Rituxan,4459876,RxNorm,mg/kg,111.0,159.0
SYNTHETIC-5,DONOR_2369,TREATMENT_8369,,Adcetris,987654,PubChem,IU/m2,164.0,65.0
SYNTHETIC-5,DONOR_2370,TREATMENT_8370,,,987654,NCI Thesaurus,ug/m2,162.0,123.0
SYNTHETIC-5,DONOR_2371,TREATMENT_8371,Immune checkpoint inhibitors,Gilteritinib,8836851,NCI Thesaurus,mg/kg,138.0,186.0
SYNTHETIC-5,DONOR_2372,TREATMENT_8372,Immune checkpoint inhibitors,Tafinlar,278936,RxNorm,g/m2,180.0,84.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8373,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,,PubChem,IU/m2,,110.0
SYNTHETIC-5,DONOR_2374,TREATMENT_8374,Immune checkpoint inhibitors,Gefitinib,239766,RxNorm,mg/kg,134.0,68.0
SYNTHETIC-5,DONOR_2375,TREATMENT_8375,Immune checkpoint inhibitors,Keytruda,278936,,IU/kg,192.0,
SYNTHETIC-5,DONOR_2376,TREATMENT_8376,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,PubChem,,72.0,
SYNTHETIC-5,DONOR_2377,TREATMENT_8377,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,239766,,IU/m2,166.0,189.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8378,Cell-based,,8836851,NCI Thesaurus,,146.0,85.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8379,Other immunomodulatory substances,Cometriq,8836851,PubChem,,150.0,155.0
SYNTHETIC-5,DONOR_2380,TREATMENT_8380,Cell-based,Blinatumomab,278936,PubChem,,189.0,114.0
SYNTHETIC-5,DONOR_2381,TREATMENT_8381,Cell-based,Brigatinib,8756456,,IU/m2,95.0,135.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8382,Immune checkpoint inhibitors,Nivolumab,278936,,ug/m2,180.0,108.0
SYNTHETIC-5,DONOR_2383,TREATMENT_8383,Other immunomodulatory substances,,8836851,RxNorm,,127.0,159.0
SYNTHETIC-5,DONOR_2384,TREATMENT_8384,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,,NCI Thesaurus,,156.0,79.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8385,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,IU/m2,152.0,166.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8386,Other immunomodulatory substances,Yervoy,278936,NCI Thesaurus,mg/kg,66.0,84.0
SYNTHETIC-5,DONOR_2387,TREATMENT_8387,Immune checkpoint inhibitors,Rubraca,8756456,NCI Thesaurus,mg/m2,72.0,57.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8388,Cell-based,Durvalumab,278936,RxNorm,mg/m2,64.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_8389,,Yervoy,8756456,NCI Thesaurus,g/m2,101.0,
SYNTHETIC-5,DONOR_2390,TREATMENT_8390,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,987654,RxNorm,mg/m2,195.0,
SYNTHETIC-5,DONOR_2391,TREATMENT_8391,Immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,cells/kg,114.0,53.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8392,Immune checkpoint inhibitors,Venetoclax,4459876,PubChem,,,
SYNTHETIC-5,DONOR_2393,TREATMENT_8393,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,239766,NCI Thesaurus,g/m2,56.0,
SYNTHETIC-5,DONOR_2394,TREATMENT_8394,Cell-based,Opdivo,8756456,PubChem,IU/m2,178.0,150.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8395,Other immunomodulatory substances,Pertuzumab,8756456,PubChem,,166.0,128.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8396,Other immunomodulatory substances,Ipilimumab,278936,NCI Thesaurus,,155.0,
SYNTHETIC-5,DONOR_2397,TREATMENT_8397,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,RxNorm,IU/kg,193.0,
SYNTHETIC-5,DONOR_2398,TREATMENT_8398,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,IU/kg,176.0,195.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8399,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,4459876,NCI Thesaurus,IU/kg,77.0,124.0
SYNTHETIC-5,DONOR_2400,TREATMENT_8400,Immune checkpoint inhibitors,Vandetanib,4459876,NCI Thesaurus,,117.0,132.0
SYNTHETIC-5,DONOR_2401,TREATMENT_8401,Cell-based,Dabrafenib,8756456,PubChem,ug/m2,,111.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8402,Immune checkpoint inhibitors,Axicabtagene ciloleucel,,RxNorm,IU/kg,69.0,94.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8403,Immune checkpoint inhibitors,Herceptin,8756456,PubChem,ug/m2,185.0,162.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8404,Cell-based,Gilteritinib,8756456,NCI Thesaurus,g/m2,80.0,77.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8405,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,278936,,,112.0,79.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8406,Immune checkpoint inhibitors,Alectinib,987654,PubChem,mg/m2,116.0,194.0
SYNTHETIC-5,DONOR_2407,TREATMENT_8407,Cell-based,Yescarta,4459876,NCI Thesaurus,,117.0,127.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8408,Cell-based,Adcetris,239766,NCI Thesaurus,mg/m2,57.0,
SYNTHETIC-5,DONOR_2409,TREATMENT_8409,Cell-based,Lenvima,,,g/m2,185.0,82.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8410,Immune checkpoint inhibitors,Gefitinib,,RxNorm,mg/kg,174.0,
SYNTHETIC-5,DONOR_2411,TREATMENT_8411,,Lenvatinib,278936,NCI Thesaurus,g/m2,74.0,180.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8412,Other immunomodulatory substances,Durvalumab,278936,NCI Thesaurus,IU/kg,76.0,95.0
SYNTHETIC-5,DONOR_2413,TREATMENT_8413,,,239766,PubChem,IU/kg,55.0,189.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8414,,Nivolumab,239766,NCI Thesaurus,,80.0,
SYNTHETIC-5,DONOR_2415,TREATMENT_8415,Cell-based,Tecentriq,8756456,PubChem,ug/m2,188.0,
SYNTHETIC-5,DONOR_2416,TREATMENT_8416,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,987654,RxNorm,g/m2,166.0,
SYNTHETIC-5,DONOR_2417,TREATMENT_8417,Immune checkpoint inhibitors,Nexavar,278936,PubChem,IU/kg,158.0,114.0
SYNTHETIC-5,DONOR_2418,TREATMENT_8418,Other immunomodulatory substances,,,RxNorm,mg/m2,189.0,
SYNTHETIC-5,DONOR_2419,TREATMENT_8419,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,IU/kg,145.0,
SYNTHETIC-5,DONOR_2420,TREATMENT_8420,Immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,IU/m2,,192.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8421,,Binimetinib,8756456,RxNorm,IU/m2,145.0,173.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8422,Cell-based,Tisagenlecleucel,239766,NCI Thesaurus,mg/m2,175.0,84.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8423,Other immunomodulatory substances,Xalkori,8756456,PubChem,,108.0,
SYNTHETIC-5,DONOR_2424,TREATMENT_8424,Other immunomodulatory substances,Herceptin,278936,,,63.0,157.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8425,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,,NCI Thesaurus,mg/m2,,167.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8426,Cell-based,Adcetris,8756456,RxNorm,IU/m2,130.0,169.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8427,Other immunomodulatory substances,,8836851,NCI Thesaurus,IU/kg,145.0,169.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8428,Other immunomodulatory substances,Adcetris,8756456,PubChem,mg/m2,86.0,97.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8429,,,4459876,PubChem,cells/kg,131.0,119.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8430,,Vemurafenib,8756456,RxNorm,mg/m2,53.0,90.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8431,Immune checkpoint inhibitors,Cobimetinib,8756456,PubChem,g/m2,,
SYNTHETIC-5,DONOR_2432,TREATMENT_8432,Immune checkpoint inhibitors,Imfinzi,,PubChem,IU/kg,120.0,146.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8433,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,,mg/kg,88.0,126.0
SYNTHETIC-5,DONOR_2434,TREATMENT_8434,Cell-based,Ipilimumab,,,mg/m2,125.0,162.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8435,Cell-based,Ipilimumab,4459876,NCI Thesaurus,ug/m2,122.0,86.0
SYNTHETIC-5,DONOR_2436,TREATMENT_8436,Cell-based,Trametinib,,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2437,TREATMENT_8437,Immune checkpoint inhibitors,,,NCI Thesaurus,g/m2,94.0,106.0
SYNTHETIC-5,DONOR_2438,TREATMENT_8438,Cell-based,Durvalumab,278936,,mg/m2,191.0,79.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8439,Other immunomodulatory substances,Tecentriq,4459876,NCI Thesaurus,cells/kg,142.0,92.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8440,Cell-based,Sorafenib,8836851,PubChem,mg/kg,102.0,143.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8441,Immune checkpoint inhibitors,Kisqali,4459876,RxNorm,ug/m2,135.0,159.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8442,,Alectinib,,PubChem,g/m2,184.0,103.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8443,Immune checkpoint inhibitors,Tagrisso,,RxNorm,cells/kg,131.0,143.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8444,Immune checkpoint inhibitors,Crizotinib,8836851,NCI Thesaurus,IU/kg,115.0,178.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8445,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8836851,RxNorm,mg/m2,141.0,106.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8446,Cell-based,Ipilimumab,239766,NCI Thesaurus,IU/m2,97.0,51.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8447,Other immunomodulatory substances,Opdivo,8836851,PubChem,mg/m2,89.0,144.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8448,Cell-based,Trastuzumab,239766,,IU/kg,,
SYNTHETIC-5,DONOR_2449,TREATMENT_8449,,Erlotinib,239766,RxNorm,mg/kg,173.0,
SYNTHETIC-5,DONOR_2450,TREATMENT_8450,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,RxNorm,cells/kg,150.0,93.0
SYNTHETIC-5,DONOR_2451,TREATMENT_8451,Immune checkpoint inhibitors,Gazyva,987654,PubChem,mg/m2,142.0,195.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8452,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,8836851,,cells/kg,141.0,86.0
SYNTHETIC-5,DONOR_2453,TREATMENT_8453,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,IU/m2,150.0,153.0
SYNTHETIC-5,DONOR_2454,TREATMENT_8454,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,4459876,NCI Thesaurus,IU/m2,147.0,175.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8455,Immune checkpoint inhibitors,Niraparib,987654,PubChem,g/m2,52.0,119.0
SYNTHETIC-5,DONOR_2456,TREATMENT_8456,Other immunomodulatory substances,Opdivo,4459876,NCI Thesaurus,mg/m2,184.0,
SYNTHETIC-5,DONOR_2457,TREATMENT_8457,Immune checkpoint inhibitors,Axicabtagene ciloleucel,987654,PubChem,g/m2,170.0,138.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8458,,Alectinib,4459876,,cells/kg,161.0,
SYNTHETIC-5,DONOR_2459,TREATMENT_8459,Other immunomodulatory substances,Tisagenlecleucel,8836851,NCI Thesaurus,cells/kg,172.0,95.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8460,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,cells/kg,72.0,113.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8461,Immune checkpoint inhibitors,Braftovi,8836851,NCI Thesaurus,mg/m2,85.0,
SYNTHETIC-5,DONOR_2462,TREATMENT_8462,Cell-based,Enhertu,8756456,RxNorm,ug/m2,165.0,106.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8463,Other immunomodulatory substances,Erlotinib,,,g/m2,134.0,143.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8464,,Afatinib,8756456,RxNorm,mg/kg,148.0,107.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8465,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,987654,RxNorm,mg/kg,,
SYNTHETIC-5,DONOR_2466,TREATMENT_8466,Immune checkpoint inhibitors,,278936,RxNorm,,172.0,147.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8467,,Zelboraf,239766,,mg/m2,182.0,
SYNTHETIC-5,DONOR_2468,TREATMENT_8468,Other immunomodulatory substances,,278936,RxNorm,,77.0,191.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8469,Other immunomodulatory substances,Gefitinib,8756456,NCI Thesaurus,,165.0,
SYNTHETIC-5,DONOR_2470,TREATMENT_8470,Other immunomodulatory substances,Tecentriq,4459876,PubChem,mg/m2,111.0,
SYNTHETIC-5,DONOR_2471,TREATMENT_8471,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8836851,RxNorm,IU/m2,90.0,137.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8472,Cell-based,Ipilimumab,987654,RxNorm,ug/m2,,150.0
SYNTHETIC-5,DONOR_2473,TREATMENT_8473,Immune checkpoint inhibitors,Olaparib,4459876,,IU/m2,75.0,146.0
SYNTHETIC-5,DONOR_2474,TREATMENT_8474,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,PubChem,,107.0,143.0
SYNTHETIC-5,DONOR_2475,TREATMENT_8475,Immune checkpoint inhibitors,Verzenio,8756456,PubChem,mg/m2,59.0,104.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8476,Cell-based,Opdivo,,PubChem,g/m2,186.0,151.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8477,Other immunomodulatory substances,,,NCI Thesaurus,mg/m2,,81.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8478,Other immunomodulatory substances,Opdivo,,,g/m2,,169.0
SYNTHETIC-5,DONOR_2479,TREATMENT_8479,Other immunomodulatory substances,Kisqali,8836851,RxNorm,ug/m2,165.0,169.0
SYNTHETIC-5,DONOR_2480,TREATMENT_8480,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,,NCI Thesaurus,IU/kg,175.0,98.0
SYNTHETIC-5,DONOR_2481,TREATMENT_8481,,Osimertinib,8756456,RxNorm,mg/m2,187.0,51.0
SYNTHETIC-5,DONOR_2482,TREATMENT_8482,,Lenvatinib,4459876,,g/m2,102.0,95.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8483,Cell-based,Keytruda,278936,PubChem,mg/m2,137.0,155.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8484,Immune checkpoint inhibitors,Darzalex,8756456,,mg/kg,199.0,53.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8485,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,RxNorm,IU/m2,198.0,188.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8486,Other immunomodulatory substances,Yescarta,987654,NCI Thesaurus,cells/kg,185.0,98.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8487,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,4459876,RxNorm,mg/kg,190.0,162.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8488,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,PubChem,,,193.0
SYNTHETIC-5,DONOR_2489,TREATMENT_8489,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,g/m2,77.0,62.0
SYNTHETIC-5,DONOR_2490,TREATMENT_8490,Other immunomodulatory substances,Gefitinib,278936,RxNorm,IU/m2,69.0,106.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8491,Immune checkpoint inhibitors,Keytruda,987654,PubChem,,183.0,159.0
SYNTHETIC-5,DONOR_2492,TREATMENT_8492,Other immunomodulatory substances,Yescarta,278936,PubChem,mg/m2,139.0,
SYNTHETIC-5,DONOR_2493,TREATMENT_8493,,Rubraca,8836851,NCI Thesaurus,g/m2,,171.0
SYNTHETIC-5,DONOR_2494,TREATMENT_8494,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,mg/m2,133.0,
SYNTHETIC-5,DONOR_2495,TREATMENT_8495,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,278936,PubChem,mg/m2,,78.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8496,Immune checkpoint inhibitors,Trastuzumab,278936,PubChem,,101.0,106.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8497,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,239766,RxNorm,,97.0,
SYNTHETIC-5,DONOR_2498,TREATMENT_8498,Cell-based,Ceritinib,4459876,RxNorm,mg/kg,57.0,161.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8499,Immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,ug/m2,97.0,176.0
SYNTHETIC-5,DONOR_2500,TREATMENT_8500,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,8836851,NCI Thesaurus,cells/kg,,169.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8501,,Lynparza,,PubChem,,,91.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8502,Immune checkpoint inhibitors,,278936,PubChem,IU/m2,158.0,174.0
SYNTHETIC-5,DONOR_2003,TREATMENT_8503,Immune checkpoint inhibitors,Yervoy,8836851,NCI Thesaurus,,50.0,134.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8504,,Tecentriq,278936,RxNorm,,132.0,157.0
SYNTHETIC-5,DONOR_2005,TREATMENT_8505,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,IU/kg,189.0,105.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8506,Immune checkpoint inhibitors,Rubraca,8836851,RxNorm,IU/kg,117.0,78.0
SYNTHETIC-5,DONOR_2007,TREATMENT_8507,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,IU/kg,141.0,105.0
SYNTHETIC-5,DONOR_2008,TREATMENT_8508,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8756456,PubChem,,114.0,175.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8509,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,PubChem,mg/kg,76.0,188.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8510,Cell-based,Tarceva,4459876,PubChem,cells/kg,53.0,151.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8511,Cell-based,Tarceva,239766,PubChem,mg/kg,118.0,
SYNTHETIC-5,DONOR_2012,TREATMENT_8512,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,278936,PubChem,,95.0,
SYNTHETIC-5,DONOR_2013,TREATMENT_8513,Immune checkpoint inhibitors,,239766,PubChem,mg/kg,124.0,51.0
SYNTHETIC-5,DONOR_2014,TREATMENT_8514,Other immunomodulatory substances,Abemaciclib,4459876,RxNorm,,66.0,168.0
SYNTHETIC-5,DONOR_2015,TREATMENT_8515,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,ug/m2,147.0,106.0
SYNTHETIC-5,DONOR_2016,TREATMENT_8516,Cell-based,Encorafenib,8756456,NCI Thesaurus,IU/m2,,137.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8517,Other immunomodulatory substances,Trastuzumab,,PubChem,IU/m2,68.0,69.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8518,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,ug/m2,,61.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8519,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,RxNorm,ug/m2,,103.0
SYNTHETIC-5,DONOR_2020,TREATMENT_8520,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,NCI Thesaurus,IU/kg,,116.0
SYNTHETIC-5,DONOR_2021,TREATMENT_8521,Immune checkpoint inhibitors,,8756456,PubChem,,164.0,191.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8522,Other immunomodulatory substances,Cabozantinib,278936,PubChem,g/m2,173.0,98.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8523,,,239766,,mg/kg,151.0,59.0
SYNTHETIC-5,DONOR_2024,TREATMENT_8524,Other immunomodulatory substances,Lenvima,8836851,PubChem,mg/m2,84.0,
SYNTHETIC-5,DONOR_2025,TREATMENT_8525,Immune checkpoint inhibitors,Rubraca,,RxNorm,cells/kg,53.0,
SYNTHETIC-5,DONOR_2026,TREATMENT_8526,Cell-based,Blinatumomab,239766,NCI Thesaurus,IU/m2,192.0,176.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8527,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,RxNorm,IU/m2,,177.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8528,Immune checkpoint inhibitors,Atezolizumab,278936,NCI Thesaurus,IU/m2,147.0,
SYNTHETIC-5,DONOR_2029,TREATMENT_8529,Other immunomodulatory substances,Pembrolizumab,239766,RxNorm,mg/kg,60.0,194.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8530,Other immunomodulatory substances,Opdivo,8836851,,cells/kg,136.0,
SYNTHETIC-5,DONOR_2031,TREATMENT_8531,Immune checkpoint inhibitors,,239766,PubChem,mg/m2,87.0,76.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8532,Other immunomodulatory substances,Opdivo,278936,RxNorm,g/m2,184.0,133.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8533,Cell-based,,278936,PubChem,ug/m2,,127.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8534,Immune checkpoint inhibitors,Tarceva,,RxNorm,mg/m2,62.0,168.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8535,Immune checkpoint inhibitors,Zykadia,,PubChem,cells/kg,186.0,
SYNTHETIC-5,DONOR_2036,TREATMENT_8536,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,PubChem,g/m2,89.0,136.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8537,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,PubChem,,57.0,75.0
SYNTHETIC-5,DONOR_2038,TREATMENT_8538,Cell-based,Mektovi,4459876,RxNorm,,77.0,54.0
SYNTHETIC-5,DONOR_2039,TREATMENT_8539,Other immunomodulatory substances,Ceritinib,987654,NCI Thesaurus,mg/m2,123.0,65.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8540,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,4459876,PubChem,IU/m2,134.0,162.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8541,Other immunomodulatory substances,Opdivo,,NCI Thesaurus,ug/m2,158.0,141.0
SYNTHETIC-5,DONOR_2042,TREATMENT_8542,Other immunomodulatory substances,,8836851,RxNorm,,191.0,141.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8543,Cell-based,Atezolizumab,8756456,NCI Thesaurus,IU/kg,154.0,76.0
SYNTHETIC-5,DONOR_2044,TREATMENT_8544,Immune checkpoint inhibitors,Atezolizumab,4459876,,ug/m2,184.0,162.0
SYNTHETIC-5,DONOR_2045,TREATMENT_8545,Immune checkpoint inhibitors,Trametinib,8756456,PubChem,ug/m2,176.0,89.0
SYNTHETIC-5,DONOR_2046,TREATMENT_8546,Immune checkpoint inhibitors,Trastuzumab,239766,NCI Thesaurus,,190.0,54.0
SYNTHETIC-5,DONOR_2047,TREATMENT_8547,Cell-based,Niraparib,8836851,NCI Thesaurus,g/m2,84.0,114.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8548,,Pembrolizumab,278936,NCI Thesaurus,IU/kg,160.0,129.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8549,Cell-based,Rituxan,8756456,PubChem,mg/m2,88.0,85.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8550,Cell-based,Blinatumomab,8836851,NCI Thesaurus,IU/m2,165.0,166.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8551,Cell-based,Perjeta,278936,PubChem,IU/kg,117.0,92.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8552,Cell-based,Besponsa,987654,RxNorm,,,138.0
SYNTHETIC-5,DONOR_2053,TREATMENT_8553,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,IU/kg,146.0,171.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8554,Immune checkpoint inhibitors,Ceritinib,,PubChem,,192.0,141.0
SYNTHETIC-5,DONOR_2055,TREATMENT_8555,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,mg/kg,65.0,198.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8556,Cell-based,Rituxan,4459876,PubChem,ug/m2,144.0,
SYNTHETIC-5,DONOR_2057,TREATMENT_8557,Cell-based,Yervoy,987654,NCI Thesaurus,mg/kg,108.0,68.0
SYNTHETIC-5,DONOR_2058,TREATMENT_8558,,Pexidartinib,239766,PubChem,,117.0,59.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8559,Other immunomodulatory substances,Copanlisib,8836851,RxNorm,mg/m2,94.0,71.0
SYNTHETIC-5,DONOR_2060,TREATMENT_8560,Cell-based,,,NCI Thesaurus,cells/kg,171.0,200.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8561,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,mg/m2,161.0,160.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8562,Cell-based,Binimetinib,239766,NCI Thesaurus,cells/kg,189.0,126.0
SYNTHETIC-5,DONOR_2063,TREATMENT_8563,Other immunomodulatory substances,Alectinib,987654,RxNorm,g/m2,178.0,78.0
SYNTHETIC-5,DONOR_2064,TREATMENT_8564,,Ipilimumab,4459876,RxNorm,g/m2,190.0,148.0
SYNTHETIC-5,DONOR_2065,TREATMENT_8565,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,239766,RxNorm,ug/m2,,145.0
SYNTHETIC-5,DONOR_2066,TREATMENT_8566,Cell-based,Crizotinib,,RxNorm,ug/m2,78.0,60.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8567,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,8836851,RxNorm,IU/kg,120.0,124.0
SYNTHETIC-5,DONOR_2068,TREATMENT_8568,,,8836851,,IU/m2,116.0,125.0
SYNTHETIC-5,DONOR_2069,TREATMENT_8569,Cell-based,,4459876,,ug/m2,132.0,62.0
SYNTHETIC-5,DONOR_2070,TREATMENT_8570,Immune checkpoint inhibitors,Gazyva,8756456,PubChem,IU/m2,136.0,
SYNTHETIC-5,DONOR_2071,TREATMENT_8571,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,RxNorm,cells/kg,106.0,123.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8572,Cell-based,Nivolumab,8836851,PubChem,,,133.0
SYNTHETIC-5,DONOR_2073,TREATMENT_8573,,Ipilimumab,,PubChem,g/m2,165.0,
SYNTHETIC-5,DONOR_2074,TREATMENT_8574,Other immunomodulatory substances,Perjeta,8836851,RxNorm,ug/m2,111.0,50.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8575,Immune checkpoint inhibitors,Ipilimumab,8836851,NCI Thesaurus,IU/kg,176.0,86.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8576,Other immunomodulatory substances,Ado-trastuzumab emtansine,,,,59.0,154.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8577,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,987654,NCI Thesaurus,g/m2,112.0,61.0
SYNTHETIC-5,DONOR_2078,TREATMENT_8578,Other immunomodulatory substances,Yervoy,278936,,mg/m2,,50.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8579,,Kymriah,8836851,RxNorm,mg/m2,78.0,
SYNTHETIC-5,DONOR_2080,TREATMENT_8580,Immune checkpoint inhibitors,,8836851,,IU/m2,112.0,173.0
SYNTHETIC-5,DONOR_2081,TREATMENT_8581,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,4459876,NCI Thesaurus,mg/kg,152.0,
SYNTHETIC-5,DONOR_2082,TREATMENT_8582,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,,NCI Thesaurus,ug/m2,103.0,143.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8583,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,239766,PubChem,g/m2,,98.0
SYNTHETIC-5,DONOR_2084,TREATMENT_8584,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,8836851,RxNorm,,142.0,150.0
SYNTHETIC-5,DONOR_2085,TREATMENT_8585,Immune checkpoint inhibitors,Alectinib,987654,NCI Thesaurus,,87.0,
SYNTHETIC-5,DONOR_2086,TREATMENT_8586,,Ibrance,278936,,mg/m2,181.0,171.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8587,Other immunomodulatory substances,Gazyva,4459876,PubChem,IU/m2,167.0,
SYNTHETIC-5,DONOR_2088,TREATMENT_8588,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,8836851,NCI Thesaurus,mg/kg,136.0,129.0
SYNTHETIC-5,DONOR_2089,TREATMENT_8589,Other immunomodulatory substances,Imfinzi,8756456,PubChem,cells/kg,,74.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8590,Cell-based,Opdivo,8836851,PubChem,cells/kg,,80.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8591,Other immunomodulatory substances,Rituximab,4459876,NCI Thesaurus,ug/m2,127.0,
SYNTHETIC-5,DONOR_2092,TREATMENT_8592,Other immunomodulatory substances,,,RxNorm,mg/m2,72.0,118.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8593,Cell-based,Vandetanib,4459876,NCI Thesaurus,,95.0,152.0
SYNTHETIC-5,DONOR_2094,TREATMENT_8594,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,987654,PubChem,mg/kg,82.0,76.0
SYNTHETIC-5,DONOR_2095,TREATMENT_8595,,Rucaparib,,PubChem,cells/kg,131.0,171.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8596,Cell-based,Erlotinib,239766,RxNorm,IU/kg,111.0,105.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8597,Other immunomodulatory substances,Durvalumab,987654,,g/m2,53.0,194.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8598,Immune checkpoint inhibitors,Sorafenib,,,g/m2,157.0,193.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8599,,Tafinlar,8756456,NCI Thesaurus,mg/kg,,123.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8600,Cell-based,Rubraca,278936,NCI Thesaurus,mg/kg,166.0,
SYNTHETIC-5,DONOR_2101,TREATMENT_8601,Immune checkpoint inhibitors,Pertuzumab,4459876,NCI Thesaurus,IU/m2,55.0,62.0
SYNTHETIC-5,DONOR_2102,TREATMENT_8602,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,RxNorm,mg/m2,135.0,190.0
SYNTHETIC-5,DONOR_2103,TREATMENT_8603,Immune checkpoint inhibitors,Venclexta,8756456,,g/m2,,151.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8604,,Rucaparib,239766,NCI Thesaurus,IU/kg,170.0,57.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8605,Other immunomodulatory substances,,8836851,RxNorm,g/m2,93.0,69.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8606,Other immunomodulatory substances,Trastuzumab,239766,RxNorm,cells/kg,107.0,113.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8607,,Lenvatinib,239766,NCI Thesaurus,g/m2,143.0,58.0
SYNTHETIC-5,DONOR_2108,TREATMENT_8608,Cell-based,Vemurafenib,8836851,,mg/m2,198.0,154.0
SYNTHETIC-5,DONOR_2109,TREATMENT_8609,Immune checkpoint inhibitors,Verzenio,987654,NCI Thesaurus,cells/kg,177.0,149.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8610,Immune checkpoint inhibitors,Tisagenlecleucel,278936,PubChem,IU/kg,74.0,124.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8611,Immune checkpoint inhibitors,Ipilimumab,4459876,,IU/m2,,195.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8612,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,239766,RxNorm,g/m2,191.0,167.0
SYNTHETIC-5,DONOR_2113,TREATMENT_8613,Immune checkpoint inhibitors,Tagrisso,987654,PubChem,IU/m2,150.0,82.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8614,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,cells/kg,181.0,
SYNTHETIC-5,DONOR_2115,TREATMENT_8615,Cell-based,Crizotinib,8756456,RxNorm,mg/kg,136.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_8616,Cell-based,Kadcyla,8756456,PubChem,g/m2,86.0,109.0
SYNTHETIC-5,DONOR_2117,TREATMENT_8617,Immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,cells/kg,136.0,135.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8618,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,ug/m2,,
SYNTHETIC-5,DONOR_2119,TREATMENT_8619,Immune checkpoint inhibitors,Xalkori,239766,NCI Thesaurus,IU/kg,131.0,101.0
SYNTHETIC-5,DONOR_2120,TREATMENT_8620,Other immunomodulatory substances,Abemaciclib,,NCI Thesaurus,g/m2,126.0,85.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8621,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,987654,PubChem,,120.0,197.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8622,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8756456,PubChem,cells/kg,182.0,151.0
SYNTHETIC-5,DONOR_2123,TREATMENT_8623,Cell-based,Lynparza,4459876,NCI Thesaurus,g/m2,142.0,
SYNTHETIC-5,DONOR_2124,TREATMENT_8624,Immune checkpoint inhibitors,,278936,PubChem,cells/kg,180.0,151.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8625,Other immunomodulatory substances,Cabozantinib,987654,,ug/m2,115.0,187.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8626,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8756456,PubChem,IU/kg,97.0,95.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8627,,Kisqali,239766,PubChem,mg/kg,151.0,53.0
SYNTHETIC-5,DONOR_2128,TREATMENT_8628,,Trametinib,,PubChem,g/m2,,108.0
SYNTHETIC-5,DONOR_2129,TREATMENT_8629,Immune checkpoint inhibitors,Erlotinib,278936,PubChem,IU/kg,64.0,127.0
SYNTHETIC-5,DONOR_2130,TREATMENT_8630,Cell-based,Keytruda,239766,RxNorm,IU/m2,198.0,117.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8631,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,8836851,RxNorm,mg/kg,120.0,150.0
SYNTHETIC-5,DONOR_2132,TREATMENT_8632,Cell-based,Alectinib,987654,RxNorm,mg/kg,106.0,182.0
SYNTHETIC-5,DONOR_2133,TREATMENT_8633,Other immunomodulatory substances,Alunbrig,278936,PubChem,g/m2,199.0,85.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8634,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8836851,NCI Thesaurus,,75.0,115.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8635,Cell-based,Lenvatinib,987654,RxNorm,IU/kg,150.0,151.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8636,Cell-based,Copanlisib,,NCI Thesaurus,g/m2,,174.0
SYNTHETIC-5,DONOR_2137,TREATMENT_8637,,Yescarta,987654,PubChem,IU/m2,170.0,58.0
SYNTHETIC-5,DONOR_2138,TREATMENT_8638,Other immunomodulatory substances,Tecentriq,987654,PubChem,IU/m2,,102.0
SYNTHETIC-5,DONOR_2139,TREATMENT_8639,Other immunomodulatory substances,Gilteritinib,8756456,PubChem,g/m2,,169.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8640,,Keytruda,987654,RxNorm,g/m2,175.0,58.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8641,Cell-based,Blincyto,8836851,RxNorm,g/m2,187.0,191.0
SYNTHETIC-5,DONOR_2142,TREATMENT_8642,Immune checkpoint inhibitors,Kisqali,,,mg/kg,,168.0
SYNTHETIC-5,DONOR_2143,TREATMENT_8643,Other immunomodulatory substances,Cabozantinib,8836851,,IU/kg,,132.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8644,Immune checkpoint inhibitors,Olaparib,239766,NCI Thesaurus,,,57.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8645,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,987654,PubChem,ug/m2,129.0,94.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8646,Immune checkpoint inhibitors,Yervoy,8756456,PubChem,mg/m2,65.0,193.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8647,Cell-based,Atezolizumab,8756456,PubChem,cells/kg,72.0,
SYNTHETIC-5,DONOR_2148,TREATMENT_8648,Immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,NCI Thesaurus,cells/kg,78.0,125.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8649,,Tecentriq,239766,PubChem,mg/kg,192.0,119.0
SYNTHETIC-5,DONOR_2150,TREATMENT_8650,Other immunomodulatory substances,,8836851,PubChem,IU/kg,,106.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8651,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,4459876,RxNorm,,162.0,75.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8652,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,239766,NCI Thesaurus,ug/m2,110.0,80.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8653,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,8836851,RxNorm,mg/kg,169.0,
SYNTHETIC-5,DONOR_2154,TREATMENT_8654,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,,RxNorm,g/m2,128.0,138.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8655,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,,IU/m2,88.0,190.0
SYNTHETIC-5,DONOR_2156,TREATMENT_8656,Other immunomodulatory substances,Pembrolizumab,278936,RxNorm,g/m2,102.0,83.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8657,Immune checkpoint inhibitors,Brentuximab vedotin,4459876,PubChem,mg/kg,72.0,125.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8658,Cell-based,Brentuximab vedotin,8756456,RxNorm,IU/kg,60.0,195.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8659,Other immunomodulatory substances,Pembrolizumab,8756456,NCI Thesaurus,g/m2,99.0,158.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8660,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8756456,PubChem,mg/m2,195.0,
SYNTHETIC-5,DONOR_2161,TREATMENT_8661,Immune checkpoint inhibitors,,987654,PubChem,g/m2,79.0,
SYNTHETIC-5,DONOR_2162,TREATMENT_8662,Other immunomodulatory substances,Ipilimumab,239766,PubChem,,133.0,125.0
SYNTHETIC-5,DONOR_2163,TREATMENT_8663,Immune checkpoint inhibitors,Trametinib,8756456,NCI Thesaurus,,193.0,112.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8664,Immune checkpoint inhibitors,Cometriq,239766,RxNorm,,106.0,
SYNTHETIC-5,DONOR_2165,TREATMENT_8665,Immune checkpoint inhibitors,Atezolizumab,8836851,RxNorm,cells/kg,,114.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8666,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,NCI Thesaurus,g/m2,184.0,84.0
SYNTHETIC-5,DONOR_2167,TREATMENT_8667,Cell-based,Tecentriq,4459876,RxNorm,ug/m2,174.0,198.0
SYNTHETIC-5,DONOR_2168,TREATMENT_8668,Other immunomodulatory substances,Binimetinib,987654,,cells/kg,118.0,
SYNTHETIC-5,DONOR_2169,TREATMENT_8669,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8756456,RxNorm,,,59.0
SYNTHETIC-5,DONOR_2170,TREATMENT_8670,Immune checkpoint inhibitors,Vandetanib,,,IU/kg,161.0,
SYNTHETIC-5,DONOR_2171,TREATMENT_8671,Cell-based,Kymriah,8836851,PubChem,g/m2,89.0,65.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8672,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2173,TREATMENT_8673,Cell-based,Alecensa,278936,NCI Thesaurus,cells/kg,,71.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8674,Immune checkpoint inhibitors,Palbociclib,987654,PubChem,ug/m2,115.0,164.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8675,Cell-based,Keytruda,4459876,PubChem,ug/m2,181.0,129.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8676,Other immunomodulatory substances,Pembrolizumab,278936,RxNorm,mg/m2,125.0,100.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8677,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,,PubChem,mg/kg,182.0,65.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8678,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,278936,,g/m2,75.0,
SYNTHETIC-5,DONOR_2179,TREATMENT_8679,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,239766,PubChem,cells/kg,95.0,85.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8680,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,8836851,RxNorm,ug/m2,,110.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8681,Cell-based,Pembrolizumab,4459876,RxNorm,g/m2,145.0,
SYNTHETIC-5,DONOR_2182,TREATMENT_8682,Other immunomodulatory substances,Crizotinib,4459876,RxNorm,g/m2,105.0,190.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8683,Other immunomodulatory substances,Ado-trastuzumab emtansine,8756456,,cells/kg,159.0,189.0
SYNTHETIC-5,DONOR_2184,TREATMENT_8684,Cell-based,Kymriah,278936,PubChem,ug/m2,75.0,109.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8685,Cell-based,Braftovi,4459876,RxNorm,mg/m2,102.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_8686,Cell-based,Atezolizumab,8756456,NCI Thesaurus,mg/kg,167.0,67.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8687,Immune checkpoint inhibitors,Gazyva,987654,,mg/m2,91.0,172.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8688,Cell-based,Tecentriq,987654,NCI Thesaurus,g/m2,,94.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8689,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,PubChem,,168.0,157.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8690,Immune checkpoint inhibitors,,239766,RxNorm,ug/m2,126.0,
SYNTHETIC-5,DONOR_2191,TREATMENT_8691,Other immunomodulatory substances,Tecentriq,278936,PubChem,ug/m2,,196.0
SYNTHETIC-5,DONOR_2192,TREATMENT_8692,Immune checkpoint inhibitors,Kymriah,,RxNorm,,130.0,145.0
SYNTHETIC-5,DONOR_2193,TREATMENT_8693,Other immunomodulatory substances,,,RxNorm,IU/kg,168.0,171.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8694,Immune checkpoint inhibitors,Ibrance,278936,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2195,TREATMENT_8695,Immune checkpoint inhibitors,Tarceva,8836851,,ug/m2,164.0,
SYNTHETIC-5,DONOR_2196,TREATMENT_8696,Other immunomodulatory substances,Caprelsa,4459876,PubChem,g/m2,129.0,168.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8697,,Venetoclax,239766,PubChem,cells/kg,172.0,100.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8698,Immune checkpoint inhibitors,Gilotrif,278936,PubChem,mg/m2,,
SYNTHETIC-5,DONOR_2199,TREATMENT_8699,,Erlotinib,239766,PubChem,ug/m2,77.0,52.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8700,,Tecentriq,4459876,RxNorm,mg/m2,183.0,65.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8701,Other immunomodulatory substances,Vandetanib,,NCI Thesaurus,mg/kg,190.0,69.0
SYNTHETIC-5,DONOR_2202,TREATMENT_8702,Other immunomodulatory substances,Zejula,278936,RxNorm,IU/kg,98.0,124.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8703,Other immunomodulatory substances,Kymriah,278936,RxNorm,IU/kg,162.0,179.0
SYNTHETIC-5,DONOR_2204,TREATMENT_8704,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,IU/kg,97.0,65.0
SYNTHETIC-5,DONOR_2205,TREATMENT_8705,Cell-based,Erlotinib,987654,RxNorm,ug/m2,79.0,146.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8706,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,239766,RxNorm,mg/m2,186.0,177.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8707,Other immunomodulatory substances,Perjeta,987654,RxNorm,mg/m2,155.0,
SYNTHETIC-5,DONOR_2208,TREATMENT_8708,Other immunomodulatory substances,Abemaciclib,239766,NCI Thesaurus,ug/m2,104.0,54.0
SYNTHETIC-5,DONOR_2209,TREATMENT_8709,Other immunomodulatory substances,Tafinlar,239766,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2210,TREATMENT_8710,Other immunomodulatory substances,Tisagenlecleucel,278936,,g/m2,142.0,191.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8711,Cell-based,Rituxan,,,ug/m2,95.0,61.0
SYNTHETIC-5,DONOR_2212,TREATMENT_8712,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,PubChem,IU/m2,193.0,148.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8713,Cell-based,Gazyva,239766,RxNorm,mg/m2,97.0,150.0
SYNTHETIC-5,DONOR_2214,TREATMENT_8714,Immune checkpoint inhibitors,Imfinzi,239766,NCI Thesaurus,mg/m2,56.0,57.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8715,Other immunomodulatory substances,Tecentriq,278936,RxNorm,IU/m2,181.0,186.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8716,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,ug/m2,160.0,110.0
SYNTHETIC-5,DONOR_2217,TREATMENT_8717,Cell-based,Cabozantinib,4459876,PubChem,ug/m2,130.0,58.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8718,Other immunomodulatory substances,Ceritinib,8756456,RxNorm,mg/kg,74.0,177.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8719,,Rituximab,239766,RxNorm,mg/kg,113.0,119.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8720,,Atezolizumab,278936,PubChem,mg/kg,99.0,74.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8721,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,RxNorm,,188.0,173.0
SYNTHETIC-5,DONOR_2222,TREATMENT_8722,Immune checkpoint inhibitors,Braftovi,278936,PubChem,IU/kg,192.0,174.0
SYNTHETIC-5,DONOR_2223,TREATMENT_8723,Other immunomodulatory substances,Cobimetinib,8756456,,mg/m2,136.0,131.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8724,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,8836851,RxNorm,g/m2,58.0,157.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8725,Immune checkpoint inhibitors,Selumitinib,4459876,NCI Thesaurus,ug/m2,147.0,183.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8726,,Verzenio,8836851,NCI Thesaurus,mg/kg,154.0,76.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8727,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,239766,,g/m2,168.0,162.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8728,Immune checkpoint inhibitors,Iressa,8756456,RxNorm,g/m2,121.0,67.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8729,,Kadcyla,239766,RxNorm,cells/kg,136.0,102.0
SYNTHETIC-5,DONOR_2230,TREATMENT_8730,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,g/m2,53.0,66.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8731,Cell-based,Tagrisso,278936,PubChem,IU/kg,132.0,193.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8732,Other immunomodulatory substances,Nivolumab,239766,,,73.0,175.0
SYNTHETIC-5,DONOR_2233,TREATMENT_8733,Other immunomodulatory substances,Vandetanib,8836851,PubChem,IU/m2,,119.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8734,Cell-based,Tagrisso,8756456,RxNorm,,126.0,86.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8735,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,,RxNorm,IU/m2,,180.0
SYNTHETIC-5,DONOR_2236,TREATMENT_8736,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,,PubChem,,190.0,198.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8737,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,239766,NCI Thesaurus,IU/m2,93.0,125.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8738,,,,RxNorm,cells/kg,166.0,55.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8739,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,278936,,g/m2,65.0,
SYNTHETIC-5,DONOR_2240,TREATMENT_8740,Immune checkpoint inhibitors,Inotuzumab ozogamicin,987654,PubChem,IU/kg,120.0,149.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8741,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,987654,RxNorm,IU/kg,,157.0
SYNTHETIC-5,DONOR_2242,TREATMENT_8742,,Ado-trastuzumab emtansine,239766,PubChem,cells/kg,177.0,71.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8743,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,IU/kg,194.0,
SYNTHETIC-5,DONOR_2244,TREATMENT_8744,Other immunomodulatory substances,Tecentriq,4459876,RxNorm,ug/m2,184.0,98.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8745,Other immunomodulatory substances,Daratumumab,239766,PubChem,cells/kg,65.0,
SYNTHETIC-5,DONOR_2246,TREATMENT_8746,Immune checkpoint inhibitors,Durvalumab,8756456,PubChem,g/m2,93.0,199.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8747,Immune checkpoint inhibitors,Herceptin,987654,NCI Thesaurus,mg/m2,,
SYNTHETIC-5,DONOR_2248,TREATMENT_8748,Cell-based,Ipilimumab,278936,NCI Thesaurus,mg/m2,187.0,131.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8749,Immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,mg/kg,92.0,119.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8750,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,mg/kg,67.0,158.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8751,Other immunomodulatory substances,Durvalumab,8836851,PubChem,ug/m2,170.0,64.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8752,Immune checkpoint inhibitors,,8756456,RxNorm,IU/kg,,145.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8753,Immune checkpoint inhibitors,Lynparza,4459876,,mg/m2,,93.0
SYNTHETIC-5,DONOR_2254,TREATMENT_8754,Cell-based,Lenvima,8756456,RxNorm,,72.0,73.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8755,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,8836851,NCI Thesaurus,,98.0,193.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8756,Immune checkpoint inhibitors,Pertuzumab,,NCI Thesaurus,cells/kg,,147.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8757,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,,NCI Thesaurus,g/m2,188.0,
SYNTHETIC-5,DONOR_2258,TREATMENT_8758,Cell-based,Alecensa,8756456,PubChem,mg/m2,143.0,192.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8759,,Inotuzumab ozogamicin,8836851,RxNorm,mg/m2,139.0,108.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8760,Other immunomodulatory substances,Kymriah,4459876,RxNorm,cells/kg,172.0,151.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8761,Other immunomodulatory substances,Kisqali,4459876,RxNorm,IU/kg,86.0,138.0
SYNTHETIC-5,DONOR_2262,TREATMENT_8762,Immune checkpoint inhibitors,,278936,NCI Thesaurus,g/m2,198.0,171.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8763,Immune checkpoint inhibitors,,8836851,PubChem,IU/m2,,
SYNTHETIC-5,DONOR_2264,TREATMENT_8764,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,RxNorm,g/m2,142.0,62.0
SYNTHETIC-5,DONOR_2265,TREATMENT_8765,Cell-based,Tecentriq,987654,PubChem,g/m2,177.0,74.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8766,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,239766,,cells/kg,155.0,99.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8767,Cell-based,Brigatinib,987654,NCI Thesaurus,ug/m2,190.0,90.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8768,,Durvalumab,4459876,NCI Thesaurus,mg/m2,162.0,199.0
SYNTHETIC-5,DONOR_2269,TREATMENT_8769,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8756456,NCI Thesaurus,IU/kg,52.0,87.0
SYNTHETIC-5,DONOR_2270,TREATMENT_8770,,Lenvatinib,239766,NCI Thesaurus,cells/kg,74.0,109.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8771,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,PubChem,g/m2,,123.0
SYNTHETIC-5,DONOR_2272,TREATMENT_8772,Cell-based,Niraparib,8836851,NCI Thesaurus,g/m2,153.0,
SYNTHETIC-5,DONOR_2273,TREATMENT_8773,Immune checkpoint inhibitors,Necitumumab,,NCI Thesaurus,ug/m2,129.0,84.0
SYNTHETIC-5,DONOR_2274,TREATMENT_8774,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,NCI Thesaurus,IU/m2,148.0,78.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8775,Other immunomodulatory substances,Imfinzi,987654,,cells/kg,119.0,129.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8776,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,278936,,ug/m2,122.0,60.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8777,Cell-based,Binimetinib,239766,NCI Thesaurus,IU/m2,79.0,
SYNTHETIC-5,DONOR_2278,TREATMENT_8778,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8836851,PubChem,cells/kg,187.0,65.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8779,Other immunomodulatory substances,Encorafenib,278936,RxNorm,mg/kg,,96.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8780,Immune checkpoint inhibitors,Lynparza,278936,,cells/kg,66.0,95.0
SYNTHETIC-5,DONOR_2281,TREATMENT_8781,Immune checkpoint inhibitors,Kymriah,239766,PubChem,,80.0,78.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8782,Other immunomodulatory substances,Pexidartinib,239766,NCI Thesaurus,mg/kg,,182.0
SYNTHETIC-5,DONOR_2283,TREATMENT_8783,Cell-based,Opdivo,8756456,PubChem,,72.0,50.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8784,Immune checkpoint inhibitors,Pembrolizumab,239766,NCI Thesaurus,IU/m2,132.0,150.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8785,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,mg/kg,73.0,149.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8786,Other immunomodulatory substances,Trastuzumab,,NCI Thesaurus,ug/m2,187.0,65.0
SYNTHETIC-5,DONOR_2287,TREATMENT_8787,Immune checkpoint inhibitors,Belantamab,8836851,RxNorm,cells/kg,79.0,110.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8788,Cell-based,Opdivo,,NCI Thesaurus,IU/kg,76.0,176.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8789,Cell-based,Binimetinib,987654,RxNorm,mg/kg,156.0,111.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8790,Other immunomodulatory substances,Gilotrif,8836851,,,100.0,124.0
SYNTHETIC-5,DONOR_2291,TREATMENT_8791,Cell-based,,,NCI Thesaurus,IU/kg,100.0,109.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8792,Immune checkpoint inhibitors,Sorafenib,,NCI Thesaurus,cells/kg,57.0,74.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8793,,Opdivo,,PubChem,IU/m2,167.0,196.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8794,Immune checkpoint inhibitors,Xalkori,239766,NCI Thesaurus,,73.0,161.0
SYNTHETIC-5,DONOR_2295,TREATMENT_8795,Immune checkpoint inhibitors,,,RxNorm,,175.0,
SYNTHETIC-5,DONOR_2296,TREATMENT_8796,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,mg/m2,110.0,71.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8797,Cell-based,Kisqali,8836851,PubChem,IU/m2,181.0,
SYNTHETIC-5,DONOR_2298,TREATMENT_8798,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,PubChem,IU/kg,120.0,104.0
SYNTHETIC-5,DONOR_2299,TREATMENT_8799,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,RxNorm,,186.0,
SYNTHETIC-5,DONOR_2300,TREATMENT_8800,Immune checkpoint inhibitors,Opdivo,,RxNorm,,136.0,119.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8801,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,987654,PubChem,ug/m2,133.0,134.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8802,Cell-based,Yervoy,278936,NCI Thesaurus,ug/m2,56.0,88.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8803,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,,RxNorm,cells/kg,79.0,164.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8804,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,8756456,,mg/kg,,64.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8805,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,239766,NCI Thesaurus,IU/m2,172.0,95.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8806,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,,PubChem,g/m2,177.0,143.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8807,,Tagrisso,987654,NCI Thesaurus,,97.0,63.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8808,,Pembrolizumab,987654,RxNorm,IU/kg,90.0,116.0
SYNTHETIC-5,DONOR_2309,TREATMENT_8809,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,RxNorm,ug/m2,122.0,85.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8810,Cell-based,Nivolumab,,RxNorm,IU/kg,,148.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8811,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,4459876,RxNorm,cells/kg,,165.0
SYNTHETIC-5,DONOR_2312,TREATMENT_8812,Immune checkpoint inhibitors,,278936,,cells/kg,75.0,169.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8813,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,,181.0,161.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8814,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,ug/m2,88.0,54.0
SYNTHETIC-5,DONOR_2315,TREATMENT_8815,Immune checkpoint inhibitors,Atezolizumab,,RxNorm,IU/kg,62.0,69.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8816,Other immunomodulatory substances,Blinatumomab,278936,PubChem,IU/m2,,153.0
SYNTHETIC-5,DONOR_2317,TREATMENT_8817,Other immunomodulatory substances,Pertuzumab,239766,NCI Thesaurus,cells/kg,167.0,182.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8818,Cell-based,Opdivo,4459876,RxNorm,cells/kg,191.0,155.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8819,,Besponsa,4459876,PubChem,ug/m2,74.0,
SYNTHETIC-5,DONOR_2320,TREATMENT_8820,Other immunomodulatory substances,Zejula,8836851,RxNorm,mg/kg,107.0,109.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8821,,Lenvima,4459876,RxNorm,mg/m2,87.0,157.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8822,Cell-based,Verzenio,987654,PubChem,g/m2,121.0,
SYNTHETIC-5,DONOR_2323,TREATMENT_8823,,Encorafenib,,,IU/kg,,193.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8824,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,8756456,NCI Thesaurus,cells/kg,137.0,
SYNTHETIC-5,DONOR_2325,TREATMENT_8825,Immune checkpoint inhibitors,Yescarta,987654,RxNorm,g/m2,79.0,199.0
SYNTHETIC-5,DONOR_2326,TREATMENT_8826,Immune checkpoint inhibitors,Yervoy,8836851,RxNorm,mg/m2,69.0,
SYNTHETIC-5,DONOR_2327,TREATMENT_8827,Immune checkpoint inhibitors,Braftovi,239766,NCI Thesaurus,,95.0,183.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8828,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,cells/kg,134.0,67.0
SYNTHETIC-5,DONOR_2329,TREATMENT_8829,Cell-based,Zejula,8836851,NCI Thesaurus,cells/kg,167.0,178.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8830,Other immunomodulatory substances,Tecentriq,8756456,RxNorm,IU/m2,63.0,129.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8831,Cell-based,Cobimetinib,8836851,PubChem,,115.0,166.0
SYNTHETIC-5,DONOR_2332,TREATMENT_8832,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,NCI Thesaurus,mg/kg,,90.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8833,Cell-based,,239766,PubChem,mg/kg,105.0,170.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8834,Immune checkpoint inhibitors,Keytruda,4459876,PubChem,mg/m2,,146.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8835,Other immunomodulatory substances,Mektovi,8756456,,IU/kg,138.0,76.0
SYNTHETIC-5,DONOR_2336,TREATMENT_8836,Immune checkpoint inhibitors,,,RxNorm,mg/m2,149.0,79.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8837,Other immunomodulatory substances,Kisqali,4459876,RxNorm,ug/m2,158.0,125.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8838,Other immunomodulatory substances,Binimetinib,987654,NCI Thesaurus,g/m2,194.0,53.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8839,Other immunomodulatory substances,Cobimetinib,239766,PubChem,mg/kg,161.0,108.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8840,Immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,mg/m2,131.0,102.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8841,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,987654,PubChem,cells/kg,179.0,86.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8842,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,RxNorm,cells/kg,,104.0
SYNTHETIC-5,DONOR_2343,TREATMENT_8843,Immune checkpoint inhibitors,Imfinzi,278936,PubChem,IU/kg,143.0,110.0
SYNTHETIC-5,DONOR_2344,TREATMENT_8844,Cell-based,Ipilimumab,4459876,NCI Thesaurus,mg/m2,175.0,
SYNTHETIC-5,DONOR_2345,TREATMENT_8845,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,PubChem,mg/m2,139.0,98.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8846,Cell-based,Pembrolizumab,4459876,,mg/m2,,193.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8847,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,PubChem,cells/kg,134.0,96.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8848,Other immunomodulatory substances,Zykadia,8756456,NCI Thesaurus,mg/kg,160.0,69.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8849,Other immunomodulatory substances,Herceptin,,NCI Thesaurus,,60.0,109.0
SYNTHETIC-5,DONOR_2350,TREATMENT_8850,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,278936,RxNorm,cells/kg,185.0,
SYNTHETIC-5,DONOR_2351,TREATMENT_8851,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,987654,PubChem,IU/kg,53.0,198.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8852,,,8836851,RxNorm,ug/m2,153.0,180.0
SYNTHETIC-5,DONOR_2353,TREATMENT_8853,Immune checkpoint inhibitors,Perjeta,4459876,PubChem,,128.0,167.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8854,Immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,IU/m2,199.0,72.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8855,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,278936,PubChem,mg/kg,153.0,114.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8856,Cell-based,Gilteritinib,8836851,NCI Thesaurus,,125.0,145.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8857,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,8756456,RxNorm,IU/m2,108.0,186.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8858,Other immunomodulatory substances,Nexavar,,RxNorm,cells/kg,123.0,181.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8859,Other immunomodulatory substances,Afatinib,987654,NCI Thesaurus,ug/m2,75.0,191.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8860,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,RxNorm,ug/m2,177.0,123.0
SYNTHETIC-5,DONOR_2361,TREATMENT_8861,Cell-based,Iressa,278936,,,144.0,191.0
SYNTHETIC-5,DONOR_2362,TREATMENT_8862,Cell-based,Nivolumab,,,g/m2,78.0,121.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8863,Cell-based,Crizotinib,239766,PubChem,cells/kg,84.0,111.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8864,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,4459876,RxNorm,ug/m2,,140.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8865,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,IU/m2,97.0,66.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8866,Immune checkpoint inhibitors,Cabozantinib,239766,RxNorm,g/m2,112.0,92.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8867,Immune checkpoint inhibitors,Keytruda,4459876,NCI Thesaurus,g/m2,107.0,164.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8868,Cell-based,Ceritinib,8756456,RxNorm,,136.0,
SYNTHETIC-5,DONOR_2369,TREATMENT_8869,Other immunomodulatory substances,Tecentriq,239766,RxNorm,IU/m2,77.0,105.0
SYNTHETIC-5,DONOR_2370,TREATMENT_8870,,Gilteritinib,239766,RxNorm,mg/kg,,126.0
SYNTHETIC-5,DONOR_2371,TREATMENT_8871,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,PubChem,mg/kg,59.0,
SYNTHETIC-5,DONOR_2372,TREATMENT_8872,Immune checkpoint inhibitors,Tisagenlecleucel,,RxNorm,IU/m2,,161.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8873,Immune checkpoint inhibitors,Herceptin,239766,PubChem,IU/m2,96.0,
SYNTHETIC-5,DONOR_2374,TREATMENT_8874,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,987654,NCI Thesaurus,g/m2,65.0,165.0
SYNTHETIC-5,DONOR_2375,TREATMENT_8875,Immune checkpoint inhibitors,Ibrance,278936,,ug/m2,96.0,132.0
SYNTHETIC-5,DONOR_2376,TREATMENT_8876,,Alunbrig,987654,NCI Thesaurus,cells/kg,145.0,
SYNTHETIC-5,DONOR_2377,TREATMENT_8877,Cell-based,Verzenio,4459876,NCI Thesaurus,ug/m2,131.0,189.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8878,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,PubChem,mg/m2,67.0,133.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8879,Other immunomodulatory substances,Niraparib,,,mg/kg,172.0,
SYNTHETIC-5,DONOR_2380,TREATMENT_8880,Cell-based,,278936,RxNorm,IU/kg,96.0,
SYNTHETIC-5,DONOR_2381,TREATMENT_8881,Other immunomodulatory substances,Gilteritinib,278936,,IU/m2,131.0,142.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8882,Other immunomodulatory substances,Cometriq,987654,NCI Thesaurus,mg/m2,166.0,92.0
SYNTHETIC-5,DONOR_2383,TREATMENT_8883,Immune checkpoint inhibitors,,8756456,RxNorm,IU/kg,165.0,
SYNTHETIC-5,DONOR_2384,TREATMENT_8884,Cell-based,Perjeta,239766,NCI Thesaurus,g/m2,117.0,75.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8885,Other immunomodulatory substances,Olaparib,278936,NCI Thesaurus,,75.0,
SYNTHETIC-5,DONOR_2386,TREATMENT_8886,Cell-based,Mektovi,239766,NCI Thesaurus,,100.0,
SYNTHETIC-5,DONOR_2387,TREATMENT_8887,Cell-based,Tafinlar,,PubChem,,108.0,171.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8888,Other immunomodulatory substances,Ipilimumab,278936,NCI Thesaurus,ug/m2,68.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_8889,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,,PubChem,mg/m2,,197.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8890,Immune checkpoint inhibitors,Gilotrif,,RxNorm,mg/m2,64.0,62.0
SYNTHETIC-5,DONOR_2391,TREATMENT_8891,Immune checkpoint inhibitors,Copanlisib,,PubChem,IU/kg,190.0,
SYNTHETIC-5,DONOR_2392,TREATMENT_8892,Other immunomodulatory substances,Ribociclib,987654,PubChem,IU/m2,100.0,121.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8893,Other immunomodulatory substances,Tecentriq,8836851,NCI Thesaurus,mg/kg,123.0,
SYNTHETIC-5,DONOR_2394,TREATMENT_8894,Other immunomodulatory substances,Ipilimumab,4459876,,mg/m2,104.0,179.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8895,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,IU/m2,188.0,94.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8896,,Necitumumab,8836851,PubChem,mg/m2,,149.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8897,Immune checkpoint inhibitors,Keytruda,4459876,RxNorm,g/m2,156.0,98.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8898,Cell-based,Cabozantinib,987654,PubChem,ug/m2,,72.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8899,Immune checkpoint inhibitors,,987654,RxNorm,IU/m2,198.0,
SYNTHETIC-5,DONOR_2400,TREATMENT_8900,Immune checkpoint inhibitors,,278936,NCI Thesaurus,mg/m2,,
SYNTHETIC-5,DONOR_2401,TREATMENT_8901,Other immunomodulatory substances,,,PubChem,cells/kg,72.0,164.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8902,Other immunomodulatory substances,,8756456,NCI Thesaurus,g/m2,106.0,114.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8903,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,239766,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2404,TREATMENT_8904,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,4459876,,mg/m2,67.0,175.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8905,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,,NCI Thesaurus,mg/m2,,
SYNTHETIC-5,DONOR_2406,TREATMENT_8906,Immune checkpoint inhibitors,Iressa,8756456,NCI Thesaurus,ug/m2,133.0,
SYNTHETIC-5,DONOR_2407,TREATMENT_8907,Cell-based,Enhertu,4459876,NCI Thesaurus,cells/kg,177.0,99.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8908,Cell-based,Ribociclib,4459876,NCI Thesaurus,mg/kg,200.0,187.0
SYNTHETIC-5,DONOR_2409,TREATMENT_8909,Other immunomodulatory substances,Yervoy,239766,,IU/kg,81.0,150.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8910,Cell-based,,8836851,NCI Thesaurus,g/m2,,163.0
SYNTHETIC-5,DONOR_2411,TREATMENT_8911,Cell-based,,987654,RxNorm,IU/kg,,154.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8912,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,278936,PubChem,g/m2,199.0,148.0
SYNTHETIC-5,DONOR_2413,TREATMENT_8913,,Durvalumab,278936,RxNorm,g/m2,103.0,159.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8914,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,IU/m2,91.0,148.0
SYNTHETIC-5,DONOR_2415,TREATMENT_8915,Immune checkpoint inhibitors,Durvalumab,8756456,,cells/kg,171.0,197.0
SYNTHETIC-5,DONOR_2416,TREATMENT_8916,,,8836851,PubChem,g/m2,89.0,134.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8917,Immune checkpoint inhibitors,Alunbrig,8756456,,IU/kg,,115.0
SYNTHETIC-5,DONOR_2418,TREATMENT_8918,Other immunomodulatory substances,Tagrisso,4459876,,IU/kg,62.0,167.0
SYNTHETIC-5,DONOR_2419,TREATMENT_8919,Cell-based,,,NCI Thesaurus,g/m2,105.0,136.0
SYNTHETIC-5,DONOR_2420,TREATMENT_8920,Cell-based,Niraparib,278936,RxNorm,IU/kg,161.0,123.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8921,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,239766,PubChem,,62.0,159.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8922,Immune checkpoint inhibitors,Binimetinib,239766,NCI Thesaurus,,,111.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8923,Immune checkpoint inhibitors,,8756456,RxNorm,,147.0,140.0
SYNTHETIC-5,DONOR_2424,TREATMENT_8924,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,RxNorm,,,71.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8925,Other immunomodulatory substances,Cotellic,8836851,RxNorm,IU/m2,197.0,178.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8926,Cell-based,Cometriq,,NCI Thesaurus,cells/kg,,176.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8927,Cell-based,Lynparza,8836851,PubChem,,145.0,172.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8928,Other immunomodulatory substances,Atezolizumab,8836851,,IU/m2,88.0,109.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8929,Immune checkpoint inhibitors,Cometriq,8756456,NCI Thesaurus,IU/kg,82.0,75.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8930,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,,g/m2,190.0,
SYNTHETIC-5,DONOR_2431,TREATMENT_8931,Other immunomodulatory substances,Axicabtagene ciloleucel,,NCI Thesaurus,,158.0,
SYNTHETIC-5,DONOR_2432,TREATMENT_8932,Cell-based,Pembrolizumab,239766,RxNorm,IU/m2,,179.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8933,Immune checkpoint inhibitors,Durvalumab,239766,PubChem,mg/kg,133.0,103.0
SYNTHETIC-5,DONOR_2434,TREATMENT_8934,Cell-based,Zejula,4459876,PubChem,,58.0,85.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8935,Other immunomodulatory substances,Tecentriq,239766,NCI Thesaurus,IU/kg,198.0,
SYNTHETIC-5,DONOR_2436,TREATMENT_8936,Cell-based,Yervoy,,NCI Thesaurus,mg/kg,194.0,105.0
SYNTHETIC-5,DONOR_2437,TREATMENT_8937,Immune checkpoint inhibitors,Imfinzi,987654,NCI Thesaurus,ug/m2,67.0,126.0
SYNTHETIC-5,DONOR_2438,TREATMENT_8938,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8836851,NCI Thesaurus,mg/m2,,132.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8939,Cell-based,Gazyva,8836851,RxNorm,,,91.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8940,,Obinutuzumab,8756456,PubChem,mg/m2,73.0,104.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8941,Cell-based,Lenvima,,NCI Thesaurus,IU/kg,195.0,92.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8942,Cell-based,Yervoy,987654,PubChem,g/m2,61.0,129.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8943,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,4459876,PubChem,ug/m2,199.0,89.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8944,Cell-based,Venetoclax,987654,NCI Thesaurus,mg/kg,157.0,196.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8945,Cell-based,Necitumumab,239766,,g/m2,82.0,187.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8946,Cell-based,Vemurafenib,4459876,,IU/m2,199.0,57.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8947,Immune checkpoint inhibitors,Imfinzi,8836851,NCI Thesaurus,g/m2,199.0,
SYNTHETIC-5,DONOR_2448,TREATMENT_8948,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8836851,PubChem,ug/m2,101.0,56.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8949,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,239766,RxNorm,mg/kg,144.0,144.0
SYNTHETIC-5,DONOR_2450,TREATMENT_8950,Cell-based,Rubraca,987654,RxNorm,IU/m2,125.0,100.0
SYNTHETIC-5,DONOR_2451,TREATMENT_8951,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,g/m2,,90.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8952,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,RxNorm,mg/kg,55.0,
SYNTHETIC-5,DONOR_2453,TREATMENT_8953,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,,mg/m2,,
SYNTHETIC-5,DONOR_2454,TREATMENT_8954,Other immunomodulatory substances,Opdivo,239766,PubChem,cells/kg,70.0,51.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8955,Cell-based,,278936,PubChem,ug/m2,175.0,
SYNTHETIC-5,DONOR_2456,TREATMENT_8956,,Caprelsa,239766,,mg/kg,81.0,
SYNTHETIC-5,DONOR_2457,TREATMENT_8957,Other immunomodulatory substances,Yervoy,8836851,RxNorm,IU/m2,103.0,57.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8958,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,987654,PubChem,mg/kg,150.0,79.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8959,Other immunomodulatory substances,Cabozantinib,8836851,,ug/m2,150.0,193.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8960,,Alectinib,278936,PubChem,IU/m2,142.0,127.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8961,Cell-based,Mektovi,4459876,PubChem,,182.0,71.0
SYNTHETIC-5,DONOR_2462,TREATMENT_8962,Cell-based,Sorafenib,278936,RxNorm,ug/m2,176.0,55.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8963,Cell-based,Rituximab,239766,PubChem,ug/m2,,92.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8964,Cell-based,Pembrolizumab,,RxNorm,,148.0,130.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8965,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,,NCI Thesaurus,g/m2,90.0,
SYNTHETIC-5,DONOR_2466,TREATMENT_8966,Cell-based,Imfinzi,278936,NCI Thesaurus,,69.0,123.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8967,,Tecentriq,239766,NCI Thesaurus,mg/kg,171.0,196.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8968,Other immunomodulatory substances,,,PubChem,,120.0,110.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8969,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,987654,PubChem,ug/m2,179.0,50.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8970,Cell-based,,8756456,RxNorm,g/m2,50.0,196.0
SYNTHETIC-5,DONOR_2471,TREATMENT_8971,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,4459876,PubChem,ug/m2,176.0,185.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8972,Immune checkpoint inhibitors,Durvalumab,239766,PubChem,g/m2,194.0,
SYNTHETIC-5,DONOR_2473,TREATMENT_8973,Other immunomodulatory substances,Obinutuzumab,8756456,NCI Thesaurus,IU/kg,174.0,
SYNTHETIC-5,DONOR_2474,TREATMENT_8974,Cell-based,Venetoclax,239766,NCI Thesaurus,ug/m2,184.0,147.0
SYNTHETIC-5,DONOR_2475,TREATMENT_8975,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,8756456,NCI Thesaurus,IU/kg,192.0,174.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8976,Cell-based,Keytruda,8756456,PubChem,ug/m2,135.0,
SYNTHETIC-5,DONOR_2477,TREATMENT_8977,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,,PubChem,,138.0,147.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8978,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,987654,RxNorm,ug/m2,101.0,
SYNTHETIC-5,DONOR_2479,TREATMENT_8979,,Yervoy,8756456,RxNorm,IU/kg,176.0,114.0
SYNTHETIC-5,DONOR_2480,TREATMENT_8980,Other immunomodulatory substances,Durvalumab,987654,PubChem,,139.0,149.0
SYNTHETIC-5,DONOR_2481,TREATMENT_8981,Other immunomodulatory substances,Cotellic,4459876,,ug/m2,143.0,94.0
SYNTHETIC-5,DONOR_2482,TREATMENT_8982,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,ug/m2,,91.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8983,,Opdivo,239766,NCI Thesaurus,ug/m2,197.0,141.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8984,Immune checkpoint inhibitors,Kymriah,8756456,NCI Thesaurus,ug/m2,96.0,189.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8985,Other immunomodulatory substances,Tecentriq,278936,RxNorm,,115.0,119.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8986,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,cells/kg,52.0,
SYNTHETIC-5,DONOR_2487,TREATMENT_8987,Other immunomodulatory substances,Opdivo,4459876,RxNorm,mg/kg,183.0,182.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8988,Other immunomodulatory substances,Iressa,,PubChem,IU/m2,52.0,118.0
SYNTHETIC-5,DONOR_2489,TREATMENT_8989,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,ug/m2,196.0,
SYNTHETIC-5,DONOR_2490,TREATMENT_8990,,Ipilimumab,278936,NCI Thesaurus,ug/m2,171.0,123.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8991,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,278936,,ug/m2,166.0,78.0
SYNTHETIC-5,DONOR_2492,TREATMENT_8992,,Vemurafenib,8836851,RxNorm,g/m2,138.0,92.0
SYNTHETIC-5,DONOR_2493,TREATMENT_8993,,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,cells/kg,174.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_8994,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8756456,NCI Thesaurus,IU/m2,128.0,155.0
SYNTHETIC-5,DONOR_2495,TREATMENT_8995,Cell-based,Cometriq,4459876,NCI Thesaurus,g/m2,62.0,144.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8996,Immune checkpoint inhibitors,Pembrolizumab,987654,PubChem,mg/kg,166.0,169.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8997,Cell-based,Ipilimumab,4459876,NCI Thesaurus,cells/kg,65.0,192.0
SYNTHETIC-5,DONOR_2498,TREATMENT_8998,Immune checkpoint inhibitors,Pembrolizumab,278936,PubChem,,147.0,59.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8999,,Atezolizumab,4459876,PubChem,IU/m2,180.0,55.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9000,Cell-based,Gilteritinib,,,cells/kg,156.0,62.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9001,Immune checkpoint inhibitors,Iressa,987654,PubChem,g/m2,111.0,
SYNTHETIC-5,DONOR_2002,TREATMENT_9002,Immune checkpoint inhibitors,Gefitinib,239766,RxNorm,,174.0,115.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9003,,Pembrolizumab,8836851,RxNorm,cells/kg,137.0,67.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9004,Other immunomodulatory substances,Trametinib,8756456,NCI Thesaurus,g/m2,,196.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9005,,Besponsa,239766,PubChem,g/m2,,153.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9006,Immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,g/m2,181.0,154.0
SYNTHETIC-5,DONOR_2007,TREATMENT_9007,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,8756456,NCI Thesaurus,IU/kg,174.0,180.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9008,Immune checkpoint inhibitors,,278936,,cells/kg,101.0,104.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9009,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,mg/kg,,198.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9010,Cell-based,Afatinib,8836851,,,,174.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9011,Immune checkpoint inhibitors,Keytruda,987654,,cells/kg,158.0,121.0
SYNTHETIC-5,DONOR_2012,TREATMENT_9012,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,NCI Thesaurus,g/m2,132.0,166.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9013,Cell-based,Niraparib,987654,,cells/kg,177.0,183.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9014,Other immunomodulatory substances,Rucaparib,278936,RxNorm,IU/m2,73.0,154.0
SYNTHETIC-5,DONOR_2015,TREATMENT_9015,Immune checkpoint inhibitors,Selumitinib,,PubChem,g/m2,156.0,157.0
SYNTHETIC-5,DONOR_2016,TREATMENT_9016,Cell-based,Imfinzi,4459876,PubChem,,161.0,185.0
SYNTHETIC-5,DONOR_2017,TREATMENT_9017,Cell-based,Perjeta,8756456,,IU/kg,111.0,156.0
SYNTHETIC-5,DONOR_2018,TREATMENT_9018,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,PubChem,IU/kg,192.0,169.0
SYNTHETIC-5,DONOR_2019,TREATMENT_9019,Cell-based,Tecentriq,987654,RxNorm,IU/kg,,177.0
SYNTHETIC-5,DONOR_2020,TREATMENT_9020,Cell-based,Caprelsa,,,g/m2,107.0,174.0
SYNTHETIC-5,DONOR_2021,TREATMENT_9021,Immune checkpoint inhibitors,Keytruda,987654,PubChem,,128.0,122.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9022,,Opdivo,8756456,NCI Thesaurus,mg/kg,195.0,
SYNTHETIC-5,DONOR_2023,TREATMENT_9023,Cell-based,Atezolizumab,8756456,NCI Thesaurus,,,88.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9024,Immune checkpoint inhibitors,Vandetanib,278936,NCI Thesaurus,,,
SYNTHETIC-5,DONOR_2025,TREATMENT_9025,Other immunomodulatory substances,Ipilimumab,8756456,PubChem,cells/kg,69.0,58.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9026,Immune checkpoint inhibitors,,278936,RxNorm,mg/m2,76.0,50.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9027,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,mg/m2,196.0,53.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9028,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,g/m2,193.0,54.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9029,Cell-based,Imfinzi,8756456,NCI Thesaurus,ug/m2,192.0,120.0
SYNTHETIC-5,DONOR_2030,TREATMENT_9030,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,8836851,PubChem,mg/kg,50.0,75.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9031,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,,185.0,177.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9032,,Inotuzumab ozogamicin,,,cells/kg,82.0,
SYNTHETIC-5,DONOR_2033,TREATMENT_9033,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,,RxNorm,mg/m2,,87.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9034,Other immunomodulatory substances,Atezolizumab,4459876,NCI Thesaurus,mg/kg,162.0,93.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9035,Cell-based,Pembrolizumab,278936,,,132.0,189.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9036,,Gilteritinib,278936,RxNorm,IU/m2,82.0,121.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9037,Other immunomodulatory substances,,987654,PubChem,IU/kg,125.0,
SYNTHETIC-5,DONOR_2038,TREATMENT_9038,Cell-based,Opdivo,239766,RxNorm,cells/kg,175.0,185.0
SYNTHETIC-5,DONOR_2039,TREATMENT_9039,Cell-based,Brentuximab vedotin,4459876,PubChem,mg/kg,,60.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9040,Cell-based,,987654,NCI Thesaurus,ug/m2,166.0,110.0
SYNTHETIC-5,DONOR_2041,TREATMENT_9041,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,RxNorm,IU/m2,175.0,156.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9042,Cell-based,Atezolizumab,239766,RxNorm,mg/kg,151.0,165.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9043,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,4459876,NCI Thesaurus,cells/kg,71.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_9044,,Perjeta,,PubChem,mg/kg,124.0,68.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9045,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,4459876,PubChem,IU/m2,149.0,
SYNTHETIC-5,DONOR_2046,TREATMENT_9046,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,PubChem,,186.0,55.0
SYNTHETIC-5,DONOR_2047,TREATMENT_9047,Other immunomodulatory substances,Tisagenlecleucel,8756456,NCI Thesaurus,mg/m2,80.0,179.0
SYNTHETIC-5,DONOR_2048,TREATMENT_9048,Immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/kg,187.0,132.0
SYNTHETIC-5,DONOR_2049,TREATMENT_9049,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,ug/m2,182.0,124.0
SYNTHETIC-5,DONOR_2050,TREATMENT_9050,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,IU/kg,80.0,
SYNTHETIC-5,DONOR_2051,TREATMENT_9051,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,IU/m2,,190.0
SYNTHETIC-5,DONOR_2052,TREATMENT_9052,Other immunomodulatory substances,Tecentriq,8836851,,mg/m2,139.0,
SYNTHETIC-5,DONOR_2053,TREATMENT_9053,Immune checkpoint inhibitors,Durvalumab,,PubChem,ug/m2,64.0,163.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9054,Immune checkpoint inhibitors,,278936,NCI Thesaurus,IU/m2,81.0,135.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9055,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,239766,RxNorm,mg/kg,135.0,92.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9056,Cell-based,Besponsa,278936,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2057,TREATMENT_9057,Other immunomodulatory substances,Alecensa,4459876,,ug/m2,98.0,74.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9058,,,987654,RxNorm,IU/m2,169.0,
SYNTHETIC-5,DONOR_2059,TREATMENT_9059,Cell-based,Gilotrif,278936,PubChem,IU/kg,150.0,127.0
SYNTHETIC-5,DONOR_2060,TREATMENT_9060,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,ug/m2,143.0,
SYNTHETIC-5,DONOR_2061,TREATMENT_9061,Immune checkpoint inhibitors,Rubraca,,PubChem,,187.0,163.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9062,Immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,cells/kg,96.0,198.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9063,Cell-based,Ribociclib,8756456,PubChem,IU/kg,60.0,
SYNTHETIC-5,DONOR_2064,TREATMENT_9064,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,cells/kg,,167.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9065,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,IU/m2,50.0,176.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9066,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,cells/kg,178.0,113.0
SYNTHETIC-5,DONOR_2067,TREATMENT_9067,Cell-based,Alectinib,987654,RxNorm,IU/m2,71.0,
SYNTHETIC-5,DONOR_2068,TREATMENT_9068,Immune checkpoint inhibitors,Crizotinib,239766,PubChem,,122.0,108.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9069,Immune checkpoint inhibitors,Abemaciclib,8756456,NCI Thesaurus,IU/m2,148.0,95.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9070,Cell-based,Enhertu,8756456,RxNorm,,169.0,
SYNTHETIC-5,DONOR_2071,TREATMENT_9071,Cell-based,Nivolumab,8756456,RxNorm,ug/m2,191.0,150.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9072,,Dabrafenib,987654,RxNorm,mg/m2,,53.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9073,Cell-based,Nivolumab,278936,PubChem,cells/kg,110.0,
SYNTHETIC-5,DONOR_2074,TREATMENT_9074,Other immunomodulatory substances,Niraparib,,,mg/m2,183.0,73.0
SYNTHETIC-5,DONOR_2075,TREATMENT_9075,Other immunomodulatory substances,Alecensa,4459876,NCI Thesaurus,g/m2,67.0,
SYNTHETIC-5,DONOR_2076,TREATMENT_9076,Immune checkpoint inhibitors,Ribociclib,278936,NCI Thesaurus,IU/m2,118.0,107.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9077,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,8756456,RxNorm,ug/m2,183.0,
SYNTHETIC-5,DONOR_2078,TREATMENT_9078,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,987654,PubChem,ug/m2,88.0,99.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9079,Cell-based,Pembrolizumab,278936,PubChem,mg/m2,198.0,
SYNTHETIC-5,DONOR_2080,TREATMENT_9080,Other immunomodulatory substances,,8836851,RxNorm,IU/m2,,97.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9081,Other immunomodulatory substances,Rituximab,239766,RxNorm,IU/kg,,81.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9082,Other immunomodulatory substances,Nivolumab,8756456,NCI Thesaurus,g/m2,156.0,133.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9083,Immune checkpoint inhibitors,Yervoy,278936,PubChem,mg/kg,165.0,
SYNTHETIC-5,DONOR_2084,TREATMENT_9084,Other immunomodulatory substances,Gazyva,8836851,NCI Thesaurus,IU/m2,65.0,140.0
SYNTHETIC-5,DONOR_2085,TREATMENT_9085,,Osimertinib,278936,RxNorm,IU/m2,190.0,171.0
SYNTHETIC-5,DONOR_2086,TREATMENT_9086,Immune checkpoint inhibitors,,8836851,PubChem,IU/m2,,100.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9087,Cell-based,,8756456,NCI Thesaurus,IU/m2,154.0,101.0
SYNTHETIC-5,DONOR_2088,TREATMENT_9088,Other immunomodulatory substances,Atezolizumab,4459876,NCI Thesaurus,ug/m2,185.0,
SYNTHETIC-5,DONOR_2089,TREATMENT_9089,Cell-based,Besponsa,987654,PubChem,mg/kg,152.0,154.0
SYNTHETIC-5,DONOR_2090,TREATMENT_9090,Other immunomodulatory substances,Imfinzi,8756456,,IU/m2,104.0,73.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9091,Cell-based,Herceptin,4459876,RxNorm,mg/kg,,73.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9092,Cell-based,Opdivo,987654,RxNorm,ug/m2,70.0,67.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9093,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,,NCI Thesaurus,cells/kg,153.0,65.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9094,Other immunomodulatory substances,Enhertu,239766,PubChem,IU/kg,185.0,141.0
SYNTHETIC-5,DONOR_2095,TREATMENT_9095,Immune checkpoint inhibitors,,987654,RxNorm,IU/kg,180.0,135.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9096,Cell-based,Nivolumab,278936,PubChem,IU/kg,81.0,86.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9097,Immune checkpoint inhibitors,Binimetinib,8836851,PubChem,mg/kg,,149.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9098,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8756456,RxNorm,IU/m2,72.0,85.0
SYNTHETIC-5,DONOR_2099,TREATMENT_9099,Immune checkpoint inhibitors,Rituxan,8836851,NCI Thesaurus,mg/kg,130.0,146.0
SYNTHETIC-5,DONOR_2100,TREATMENT_9100,Immune checkpoint inhibitors,Venclexta,987654,,mg/kg,,
SYNTHETIC-5,DONOR_2101,TREATMENT_9101,Immune checkpoint inhibitors,Pexidartinib,8756456,NCI Thesaurus,mg/kg,153.0,
SYNTHETIC-5,DONOR_2102,TREATMENT_9102,Other immunomodulatory substances,Yescarta,278936,RxNorm,mg/m2,,73.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9103,Other immunomodulatory substances,Palbociclib,,,,189.0,80.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9104,Other immunomodulatory substances,Tisagenlecleucel,8756456,RxNorm,ug/m2,118.0,
SYNTHETIC-5,DONOR_2105,TREATMENT_9105,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,987654,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2106,TREATMENT_9106,Cell-based,Xalkori,239766,PubChem,mg/kg,191.0,181.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9107,Other immunomodulatory substances,,,NCI Thesaurus,mg/kg,168.0,124.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9108,Other immunomodulatory substances,Belantamab,987654,PubChem,IU/kg,173.0,
SYNTHETIC-5,DONOR_2109,TREATMENT_9109,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,4459876,NCI Thesaurus,IU/kg,,96.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9110,Cell-based,,278936,NCI Thesaurus,IU/m2,,135.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9111,,Brentuximab vedotin,4459876,NCI Thesaurus,IU/kg,,169.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9112,Cell-based,Olaparib,239766,RxNorm,mg/m2,158.0,124.0
SYNTHETIC-5,DONOR_2113,TREATMENT_9113,Immune checkpoint inhibitors,Alectinib,8756456,RxNorm,g/m2,,110.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9114,,Trastuzumab,8836851,PubChem,mg/kg,147.0,183.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9115,,,239766,NCI Thesaurus,,154.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_9116,Other immunomodulatory substances,Keytruda,,RxNorm,mg/m2,150.0,96.0
SYNTHETIC-5,DONOR_2117,TREATMENT_9117,Immune checkpoint inhibitors,Tagrisso,,PubChem,mg/m2,110.0,138.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9118,Other immunomodulatory substances,Selumitinib,8836851,RxNorm,IU/kg,,69.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9119,Other immunomodulatory substances,Mekinist,239766,PubChem,IU/m2,110.0,74.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9120,,Nivolumab,987654,,ug/m2,188.0,56.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9121,Cell-based,Keytruda,278936,NCI Thesaurus,mg/m2,52.0,117.0
SYNTHETIC-5,DONOR_2122,TREATMENT_9122,Other immunomodulatory substances,Brigatinib,987654,PubChem,g/m2,92.0,196.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9123,Cell-based,Vandetanib,239766,NCI Thesaurus,,,157.0
SYNTHETIC-5,DONOR_2124,TREATMENT_9124,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,278936,NCI Thesaurus,,,124.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9125,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,NCI Thesaurus,mg/kg,198.0,168.0
SYNTHETIC-5,DONOR_2126,TREATMENT_9126,Cell-based,Alectinib,8756456,RxNorm,ug/m2,,84.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9127,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,4459876,RxNorm,cells/kg,85.0,
SYNTHETIC-5,DONOR_2128,TREATMENT_9128,Cell-based,,8836851,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2129,TREATMENT_9129,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,278936,,mg/m2,180.0,149.0
SYNTHETIC-5,DONOR_2130,TREATMENT_9130,Cell-based,Fam-trastuzumab deruxtecan-nxki,8836851,,g/m2,59.0,200.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9131,Cell-based,Tecentriq,4459876,RxNorm,,85.0,115.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9132,Other immunomodulatory substances,,8836851,RxNorm,ug/m2,,101.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9133,Other immunomodulatory substances,,239766,PubChem,ug/m2,142.0,79.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9134,Cell-based,Tarceva,987654,NCI Thesaurus,g/m2,121.0,194.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9135,Other immunomodulatory substances,Dabrafenib,8836851,RxNorm,mg/kg,77.0,
SYNTHETIC-5,DONOR_2136,TREATMENT_9136,Other immunomodulatory substances,Pexidartinib,239766,,,168.0,149.0
SYNTHETIC-5,DONOR_2137,TREATMENT_9137,Immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,g/m2,58.0,125.0
SYNTHETIC-5,DONOR_2138,TREATMENT_9138,Immune checkpoint inhibitors,Gilteritinib,4459876,RxNorm,ug/m2,92.0,167.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9139,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,,,54.0,132.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9140,Immune checkpoint inhibitors,Tarceva,278936,RxNorm,g/m2,,140.0
SYNTHETIC-5,DONOR_2141,TREATMENT_9141,Cell-based,Alunbrig,8756456,PubChem,g/m2,,137.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9142,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,IU/m2,,58.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9143,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,8756456,RxNorm,mg/kg,137.0,
SYNTHETIC-5,DONOR_2144,TREATMENT_9144,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,8756456,RxNorm,mg/m2,120.0,114.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9145,Other immunomodulatory substances,,,NCI Thesaurus,cells/kg,,106.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9146,Cell-based,Perjeta,239766,,IU/m2,80.0,
SYNTHETIC-5,DONOR_2147,TREATMENT_9147,Other immunomodulatory substances,Cometriq,987654,PubChem,IU/kg,71.0,129.0
SYNTHETIC-5,DONOR_2148,TREATMENT_9148,Other immunomodulatory substances,Niraparib,4459876,RxNorm,IU/kg,182.0,173.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9149,Immune checkpoint inhibitors,Blincyto,4459876,RxNorm,g/m2,131.0,94.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9150,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,cells/kg,,
SYNTHETIC-5,DONOR_2151,TREATMENT_9151,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,8756456,PubChem,mg/m2,136.0,109.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9152,Other immunomodulatory substances,Yervoy,8756456,PubChem,mg/kg,124.0,152.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9153,Immune checkpoint inhibitors,Necitumumab,,NCI Thesaurus,ug/m2,181.0,200.0
SYNTHETIC-5,DONOR_2154,TREATMENT_9154,Immune checkpoint inhibitors,,8756456,RxNorm,,168.0,157.0
SYNTHETIC-5,DONOR_2155,TREATMENT_9155,Cell-based,Ipilimumab,8836851,,mg/m2,126.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_9156,Other immunomodulatory substances,Tecentriq,4459876,RxNorm,mg/m2,173.0,101.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9157,Cell-based,Venclexta,239766,RxNorm,IU/kg,66.0,159.0
SYNTHETIC-5,DONOR_2158,TREATMENT_9158,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,987654,,cells/kg,107.0,
SYNTHETIC-5,DONOR_2159,TREATMENT_9159,,Keytruda,239766,RxNorm,mg/m2,160.0,125.0
SYNTHETIC-5,DONOR_2160,TREATMENT_9160,Cell-based,Brigatinib,8756456,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2161,TREATMENT_9161,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,NCI Thesaurus,IU/m2,145.0,169.0
SYNTHETIC-5,DONOR_2162,TREATMENT_9162,Other immunomodulatory substances,,4459876,NCI Thesaurus,IU/m2,125.0,168.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9163,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8836851,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2164,TREATMENT_9164,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,PubChem,mg/kg,131.0,
SYNTHETIC-5,DONOR_2165,TREATMENT_9165,Other immunomodulatory substances,Crizotinib,4459876,RxNorm,g/m2,75.0,150.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9166,Immune checkpoint inhibitors,Zejula,4459876,NCI Thesaurus,mg/m2,183.0,126.0
SYNTHETIC-5,DONOR_2167,TREATMENT_9167,Immune checkpoint inhibitors,,278936,NCI Thesaurus,cells/kg,196.0,
SYNTHETIC-5,DONOR_2168,TREATMENT_9168,Other immunomodulatory substances,,987654,,ug/m2,166.0,
SYNTHETIC-5,DONOR_2169,TREATMENT_9169,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,987654,PubChem,mg/kg,84.0,85.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9170,,Rucaparib,4459876,PubChem,cells/kg,122.0,71.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9171,Immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,mg/kg,,159.0
SYNTHETIC-5,DONOR_2172,TREATMENT_9172,Immune checkpoint inhibitors,Gazyva,,PubChem,IU/kg,187.0,128.0
SYNTHETIC-5,DONOR_2173,TREATMENT_9173,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/kg,122.0,107.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9174,,Alecensa,8756456,PubChem,mg/m2,69.0,196.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9175,Cell-based,Ibrance,,RxNorm,IU/kg,125.0,108.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9176,Cell-based,Yervoy,8836851,,,144.0,
SYNTHETIC-5,DONOR_2177,TREATMENT_9177,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,mg/kg,93.0,148.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9178,Cell-based,Yervoy,,RxNorm,mg/m2,57.0,51.0
SYNTHETIC-5,DONOR_2179,TREATMENT_9179,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,g/m2,54.0,161.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9180,Other immunomodulatory substances,Enhertu,239766,PubChem,mg/m2,174.0,200.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9181,Other immunomodulatory substances,Pertuzumab,4459876,RxNorm,IU/kg,162.0,71.0
SYNTHETIC-5,DONOR_2182,TREATMENT_9182,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,,NCI Thesaurus,IU/kg,57.0,81.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9183,,Erlotinib,4459876,RxNorm,IU/kg,,200.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9184,Other immunomodulatory substances,Durvalumab,8836851,PubChem,mg/kg,185.0,
SYNTHETIC-5,DONOR_2185,TREATMENT_9185,Other immunomodulatory substances,Olaparib,,RxNorm,ug/m2,118.0,180.0
SYNTHETIC-5,DONOR_2186,TREATMENT_9186,Immune checkpoint inhibitors,Zelboraf,8836851,NCI Thesaurus,mg/kg,,199.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9187,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,4459876,NCI Thesaurus,IU/m2,147.0,104.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9188,Immune checkpoint inhibitors,Lynparza,8756456,,ug/m2,77.0,159.0
SYNTHETIC-5,DONOR_2189,TREATMENT_9189,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,239766,RxNorm,cells/kg,63.0,117.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9190,Other immunomodulatory substances,Mekinist,8756456,NCI Thesaurus,g/m2,149.0,183.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9191,Cell-based,Lenvatinib,,RxNorm,,192.0,161.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9192,Other immunomodulatory substances,Besponsa,8836851,,IU/m2,,
SYNTHETIC-5,DONOR_2193,TREATMENT_9193,Other immunomodulatory substances,Perjeta,4459876,,,63.0,155.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9194,Other immunomodulatory substances,Caprelsa,239766,NCI Thesaurus,mg/kg,,71.0
SYNTHETIC-5,DONOR_2195,TREATMENT_9195,Immune checkpoint inhibitors,Kisqali,4459876,PubChem,,130.0,58.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9196,Cell-based,Pembrolizumab,8836851,RxNorm,IU/m2,79.0,150.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9197,Cell-based,Pembrolizumab,4459876,RxNorm,mg/kg,61.0,
SYNTHETIC-5,DONOR_2198,TREATMENT_9198,Immune checkpoint inhibitors,Iressa,8756456,,,102.0,194.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9199,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,278936,PubChem,IU/kg,58.0,76.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9200,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,RxNorm,g/m2,,138.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9201,,Yervoy,,NCI Thesaurus,mg/kg,57.0,173.0
SYNTHETIC-5,DONOR_2202,TREATMENT_9202,Other immunomodulatory substances,Yervoy,4459876,,mg/m2,172.0,80.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9203,Cell-based,Zejula,8836851,RxNorm,mg/kg,78.0,123.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9204,,Dabrafenib,8836851,RxNorm,,,80.0
SYNTHETIC-5,DONOR_2205,TREATMENT_9205,Immune checkpoint inhibitors,Atezolizumab,4459876,,,82.0,187.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9206,Cell-based,Abemaciclib,8756456,NCI Thesaurus,IU/m2,,54.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9207,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,RxNorm,mg/kg,196.0,146.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9208,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,987654,PubChem,IU/kg,141.0,53.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9209,,,239766,NCI Thesaurus,mg/m2,58.0,63.0
SYNTHETIC-5,DONOR_2210,TREATMENT_9210,,Copanlisib,239766,RxNorm,,159.0,163.0
SYNTHETIC-5,DONOR_2211,TREATMENT_9211,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,4459876,PubChem,,138.0,110.0
SYNTHETIC-5,DONOR_2212,TREATMENT_9212,Cell-based,,4459876,RxNorm,mg/kg,196.0,111.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9213,Other immunomodulatory substances,Lenvatinib,8756456,PubChem,IU/m2,50.0,160.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9214,Immune checkpoint inhibitors,Tecentriq,278936,RxNorm,mg/kg,143.0,101.0
SYNTHETIC-5,DONOR_2215,TREATMENT_9215,Cell-based,,,NCI Thesaurus,IU/m2,111.0,122.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9216,,Cometriq,278936,RxNorm,mg/kg,,54.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9217,Other immunomodulatory substances,Rubraca,239766,RxNorm,mg/kg,73.0,136.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9218,,Nexavar,8756456,NCI Thesaurus,mg/m2,67.0,85.0
SYNTHETIC-5,DONOR_2219,TREATMENT_9219,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,NCI Thesaurus,g/m2,,71.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9220,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,cells/kg,144.0,191.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9221,,Lenvatinib,278936,PubChem,IU/kg,101.0,197.0
SYNTHETIC-5,DONOR_2222,TREATMENT_9222,Other immunomodulatory substances,Nivolumab,239766,NCI Thesaurus,,140.0,199.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9223,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,4459876,RxNorm,IU/m2,,59.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9224,,Trastuzumab,278936,NCI Thesaurus,g/m2,106.0,193.0
SYNTHETIC-5,DONOR_2225,TREATMENT_9225,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,RxNorm,IU/m2,192.0,117.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9226,,Dabrafenib,4459876,PubChem,,,
SYNTHETIC-5,DONOR_2227,TREATMENT_9227,Immune checkpoint inhibitors,Tisagenlecleucel,8756456,RxNorm,IU/kg,175.0,95.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9228,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,IU/m2,,173.0
SYNTHETIC-5,DONOR_2229,TREATMENT_9229,Immune checkpoint inhibitors,Rituximab,278936,RxNorm,g/m2,104.0,118.0
SYNTHETIC-5,DONOR_2230,TREATMENT_9230,Other immunomodulatory substances,Atezolizumab,8836851,PubChem,mg/kg,198.0,192.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9231,,Inotuzumab ozogamicin,8836851,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2232,TREATMENT_9232,Immune checkpoint inhibitors,Sorafenib,,RxNorm,mg/m2,198.0,128.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9233,Other immunomodulatory substances,Vemurafenib,278936,NCI Thesaurus,mg/m2,127.0,115.0
SYNTHETIC-5,DONOR_2234,TREATMENT_9234,Other immunomodulatory substances,,,NCI Thesaurus,IU/kg,130.0,143.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9235,Other immunomodulatory substances,Adcetris,8756456,PubChem,,97.0,108.0
SYNTHETIC-5,DONOR_2236,TREATMENT_9236,Other immunomodulatory substances,Ipilimumab,4459876,RxNorm,mg/m2,141.0,
SYNTHETIC-5,DONOR_2237,TREATMENT_9237,Immune checkpoint inhibitors,,239766,RxNorm,,68.0,128.0
SYNTHETIC-5,DONOR_2238,TREATMENT_9238,,Fam-trastuzumab deruxtecan-nxki,278936,,cells/kg,99.0,143.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9239,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,PubChem,mg/m2,,80.0
SYNTHETIC-5,DONOR_2240,TREATMENT_9240,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,PubChem,ug/m2,171.0,
SYNTHETIC-5,DONOR_2241,TREATMENT_9241,Immune checkpoint inhibitors,Daratumumab,278936,NCI Thesaurus,ug/m2,95.0,
SYNTHETIC-5,DONOR_2242,TREATMENT_9242,,Atezolizumab,278936,PubChem,ug/m2,176.0,
SYNTHETIC-5,DONOR_2243,TREATMENT_9243,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,987654,NCI Thesaurus,cells/kg,134.0,122.0
SYNTHETIC-5,DONOR_2244,TREATMENT_9244,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,ug/m2,81.0,
SYNTHETIC-5,DONOR_2245,TREATMENT_9245,Cell-based,Tecentriq,,PubChem,IU/kg,104.0,193.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9246,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8756456,NCI Thesaurus,g/m2,164.0,183.0
SYNTHETIC-5,DONOR_2247,TREATMENT_9247,Other immunomodulatory substances,Lynparza,,PubChem,cells/kg,141.0,57.0
SYNTHETIC-5,DONOR_2248,TREATMENT_9248,Immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,,,159.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9249,Immune checkpoint inhibitors,Osimertinib,239766,NCI Thesaurus,mg/kg,,83.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9250,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,PubChem,IU/m2,61.0,187.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9251,,Imfinzi,8756456,PubChem,mg/kg,158.0,129.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9252,Other immunomodulatory substances,Blinatumomab,,PubChem,,111.0,
SYNTHETIC-5,DONOR_2253,TREATMENT_9253,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8836851,RxNorm,,,61.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9254,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,mg/m2,,94.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9255,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,,mg/m2,131.0,142.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9256,Other immunomodulatory substances,Durvalumab,278936,,g/m2,,199.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9257,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,,,mg/kg,158.0,126.0
SYNTHETIC-5,DONOR_2258,TREATMENT_9258,Cell-based,Tecentriq,239766,,ug/m2,192.0,188.0
SYNTHETIC-5,DONOR_2259,TREATMENT_9259,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,,IU/kg,55.0,139.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9260,Other immunomodulatory substances,Tisagenlecleucel,987654,PubChem,mg/kg,122.0,56.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9261,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,8836851,PubChem,IU/m2,197.0,95.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9262,Immune checkpoint inhibitors,Alecensa,4459876,,IU/m2,66.0,150.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9263,Other immunomodulatory substances,Zykadia,8836851,RxNorm,mg/kg,74.0,119.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9264,Other immunomodulatory substances,Perjeta,278936,NCI Thesaurus,mg/m2,113.0,94.0
SYNTHETIC-5,DONOR_2265,TREATMENT_9265,Cell-based,Lenvima,,PubChem,IU/kg,111.0,154.0
SYNTHETIC-5,DONOR_2266,TREATMENT_9266,,Tecentriq,987654,RxNorm,,71.0,138.0
SYNTHETIC-5,DONOR_2267,TREATMENT_9267,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,RxNorm,mg/m2,164.0,114.0
SYNTHETIC-5,DONOR_2268,TREATMENT_9268,Immune checkpoint inhibitors,Venetoclax,8836851,PubChem,g/m2,93.0,71.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9269,Other immunomodulatory substances,Pembrolizumab,239766,NCI Thesaurus,,62.0,74.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9270,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,278936,NCI Thesaurus,IU/m2,118.0,186.0
SYNTHETIC-5,DONOR_2271,TREATMENT_9271,Other immunomodulatory substances,,239766,,,56.0,61.0
SYNTHETIC-5,DONOR_2272,TREATMENT_9272,,Kadcyla,239766,PubChem,,61.0,144.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9273,Cell-based,Binimetinib,278936,RxNorm,IU/kg,140.0,123.0
SYNTHETIC-5,DONOR_2274,TREATMENT_9274,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,,,IU/kg,136.0,186.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9275,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,8836851,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2276,TREATMENT_9276,Cell-based,Ipilimumab,278936,NCI Thesaurus,ug/m2,79.0,
SYNTHETIC-5,DONOR_2277,TREATMENT_9277,Other immunomodulatory substances,Keytruda,987654,PubChem,,90.0,75.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9278,Other immunomodulatory substances,Venetoclax,278936,RxNorm,IU/kg,,100.0
SYNTHETIC-5,DONOR_2279,TREATMENT_9279,Cell-based,Tecentriq,278936,NCI Thesaurus,mg/kg,94.0,135.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9280,,Tecentriq,8836851,RxNorm,ug/m2,,148.0
SYNTHETIC-5,DONOR_2281,TREATMENT_9281,,Pembrolizumab,4459876,RxNorm,IU/m2,79.0,84.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9282,Cell-based,Blincyto,987654,NCI Thesaurus,mg/kg,81.0,138.0
SYNTHETIC-5,DONOR_2283,TREATMENT_9283,Immune checkpoint inhibitors,Opdivo,239766,RxNorm,,81.0,195.0
SYNTHETIC-5,DONOR_2284,TREATMENT_9284,Cell-based,Abemaciclib,239766,PubChem,IU/kg,188.0,90.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9285,Other immunomodulatory substances,Atezolizumab,8756456,NCI Thesaurus,g/m2,75.0,149.0
SYNTHETIC-5,DONOR_2286,TREATMENT_9286,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/kg,126.0,109.0
SYNTHETIC-5,DONOR_2287,TREATMENT_9287,Immune checkpoint inhibitors,Alunbrig,8836851,NCI Thesaurus,cells/kg,,65.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9288,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,PubChem,cells/kg,186.0,110.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9289,Other immunomodulatory substances,,278936,RxNorm,IU/m2,71.0,62.0
SYNTHETIC-5,DONOR_2290,TREATMENT_9290,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,239766,RxNorm,,193.0,155.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9291,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,NCI Thesaurus,IU/m2,149.0,191.0
SYNTHETIC-5,DONOR_2292,TREATMENT_9292,,Pertuzumab,278936,RxNorm,,180.0,
SYNTHETIC-5,DONOR_2293,TREATMENT_9293,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,8756456,NCI Thesaurus,IU/kg,,95.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9294,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,239766,RxNorm,cells/kg,180.0,125.0
SYNTHETIC-5,DONOR_2295,TREATMENT_9295,Immune checkpoint inhibitors,Atezolizumab,278936,NCI Thesaurus,ug/m2,61.0,150.0
SYNTHETIC-5,DONOR_2296,TREATMENT_9296,Immune checkpoint inhibitors,Mektovi,4459876,PubChem,,199.0,193.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9297,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,4459876,RxNorm,cells/kg,57.0,111.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9298,Immune checkpoint inhibitors,Kisqali,8836851,PubChem,,,187.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9299,Cell-based,Erlotinib,278936,PubChem,g/m2,,196.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9300,Immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,mg/m2,164.0,168.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9301,,Atezolizumab,,RxNorm,IU/m2,97.0,166.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9302,Other immunomodulatory substances,Sorafenib,4459876,PubChem,mg/kg,126.0,
SYNTHETIC-5,DONOR_2303,TREATMENT_9303,Other immunomodulatory substances,Pertuzumab,8836851,PubChem,,85.0,107.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9304,,Alunbrig,,PubChem,,109.0,147.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9305,Cell-based,Olaparib,8836851,NCI Thesaurus,IU/kg,,194.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9306,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,239766,NCI Thesaurus,cells/kg,148.0,126.0
SYNTHETIC-5,DONOR_2307,TREATMENT_9307,,Ipilimumab,8836851,RxNorm,mg/kg,92.0,161.0
SYNTHETIC-5,DONOR_2308,TREATMENT_9308,Other immunomodulatory substances,Gefitinib,4459876,NCI Thesaurus,mg/kg,108.0,
SYNTHETIC-5,DONOR_2309,TREATMENT_9309,Cell-based,Rucaparib,987654,RxNorm,mg/kg,,54.0
SYNTHETIC-5,DONOR_2310,TREATMENT_9310,,Yervoy,4459876,PubChem,ug/m2,170.0,129.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9311,Immune checkpoint inhibitors,Opdivo,,PubChem,IU/m2,60.0,142.0
SYNTHETIC-5,DONOR_2312,TREATMENT_9312,Cell-based,Nivolumab,,,ug/m2,192.0,109.0
SYNTHETIC-5,DONOR_2313,TREATMENT_9313,Other immunomodulatory substances,Pembrolizumab,278936,PubChem,cells/kg,132.0,190.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9314,Cell-based,Braftovi,239766,NCI Thesaurus,,157.0,181.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9315,,Vandetanib,,NCI Thesaurus,cells/kg,161.0,182.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9316,Immune checkpoint inhibitors,Keytruda,987654,RxNorm,g/m2,176.0,90.0
SYNTHETIC-5,DONOR_2317,TREATMENT_9317,Cell-based,Cabozantinib,,NCI Thesaurus,IU/m2,,130.0
SYNTHETIC-5,DONOR_2318,TREATMENT_9318,Immune checkpoint inhibitors,Gazyva,8836851,,ug/m2,136.0,163.0
SYNTHETIC-5,DONOR_2319,TREATMENT_9319,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,4459876,PubChem,IU/kg,94.0,120.0
SYNTHETIC-5,DONOR_2320,TREATMENT_9320,,Venclexta,278936,RxNorm,ug/m2,173.0,101.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9321,Immune checkpoint inhibitors,Venetoclax,278936,,g/m2,62.0,58.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9322,Cell-based,Tecentriq,,PubChem,cells/kg,177.0,152.0
SYNTHETIC-5,DONOR_2323,TREATMENT_9323,,Tarceva,239766,,mg/m2,89.0,181.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9324,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,987654,PubChem,mg/m2,61.0,151.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9325,Other immunomodulatory substances,,278936,RxNorm,cells/kg,,102.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9326,Other immunomodulatory substances,Belantamab,4459876,,mg/m2,156.0,
SYNTHETIC-5,DONOR_2327,TREATMENT_9327,Other immunomodulatory substances,Cobimetinib,987654,RxNorm,,149.0,118.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9328,Other immunomodulatory substances,Atezolizumab,278936,NCI Thesaurus,IU/m2,137.0,54.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9329,Cell-based,Tecentriq,8756456,,mg/kg,88.0,
SYNTHETIC-5,DONOR_2330,TREATMENT_9330,Other immunomodulatory substances,,278936,RxNorm,,,
SYNTHETIC-5,DONOR_2331,TREATMENT_9331,Cell-based,Alecensa,4459876,RxNorm,,137.0,126.0
SYNTHETIC-5,DONOR_2332,TREATMENT_9332,,Kisqali,8756456,NCI Thesaurus,,74.0,161.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9333,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,239766,,g/m2,172.0,63.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9334,Cell-based,Perjeta,4459876,PubChem,IU/kg,160.0,118.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9335,Cell-based,Blinatumomab,278936,PubChem,cells/kg,115.0,90.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9336,Other immunomodulatory substances,Cobimetinib,4459876,PubChem,,103.0,196.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9337,,Keytruda,278936,PubChem,IU/kg,,86.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9338,,Gilteritinib,987654,PubChem,mg/m2,98.0,
SYNTHETIC-5,DONOR_2339,TREATMENT_9339,Immune checkpoint inhibitors,Alunbrig,278936,NCI Thesaurus,mg/kg,132.0,
SYNTHETIC-5,DONOR_2340,TREATMENT_9340,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,,mg/kg,130.0,166.0
SYNTHETIC-5,DONOR_2341,TREATMENT_9341,Cell-based,Braftovi,4459876,PubChem,cells/kg,,
SYNTHETIC-5,DONOR_2342,TREATMENT_9342,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,mg/m2,137.0,
SYNTHETIC-5,DONOR_2343,TREATMENT_9343,Immune checkpoint inhibitors,Venetoclax,239766,NCI Thesaurus,ug/m2,125.0,74.0
SYNTHETIC-5,DONOR_2344,TREATMENT_9344,,,8836851,RxNorm,mg/m2,,115.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9345,Other immunomodulatory substances,Axicabtagene ciloleucel,4459876,PubChem,mg/m2,195.0,
SYNTHETIC-5,DONOR_2346,TREATMENT_9346,Immune checkpoint inhibitors,Gilteritinib,4459876,RxNorm,IU/m2,,148.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9347,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,987654,,mg/kg,,
SYNTHETIC-5,DONOR_2348,TREATMENT_9348,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,239766,NCI Thesaurus,cells/kg,178.0,175.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9349,Immune checkpoint inhibitors,Vemurafenib,8836851,PubChem,mg/kg,72.0,187.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9350,Other immunomodulatory substances,Kisqali,278936,NCI Thesaurus,g/m2,148.0,120.0
SYNTHETIC-5,DONOR_2351,TREATMENT_9351,Cell-based,Durvalumab,987654,NCI Thesaurus,ug/m2,118.0,99.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9352,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,,RxNorm,ug/m2,93.0,167.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9353,Immune checkpoint inhibitors,Ipilimumab,4459876,NCI Thesaurus,,105.0,100.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9354,Cell-based,Durvalumab,278936,,ug/m2,71.0,137.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9355,Immune checkpoint inhibitors,Nivolumab,278936,,mg/m2,99.0,118.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9356,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,8836851,PubChem,IU/m2,99.0,194.0
SYNTHETIC-5,DONOR_2357,TREATMENT_9357,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,8836851,RxNorm,g/m2,53.0,75.0
SYNTHETIC-5,DONOR_2358,TREATMENT_9358,Cell-based,Durvalumab,278936,NCI Thesaurus,mg/m2,94.0,
SYNTHETIC-5,DONOR_2359,TREATMENT_9359,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,239766,NCI Thesaurus,IU/kg,167.0,107.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9360,Other immunomodulatory substances,Nivolumab,4459876,,IU/kg,192.0,162.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9361,,Olaparib,239766,PubChem,g/m2,,127.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9362,Cell-based,Pembrolizumab,987654,PubChem,g/m2,179.0,86.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9363,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,,mg/m2,50.0,81.0
SYNTHETIC-5,DONOR_2364,TREATMENT_9364,Other immunomodulatory substances,Tecentriq,8836851,NCI Thesaurus,mg/m2,80.0,178.0
SYNTHETIC-5,DONOR_2365,TREATMENT_9365,Other immunomodulatory substances,,8836851,RxNorm,mg/m2,141.0,158.0
SYNTHETIC-5,DONOR_2366,TREATMENT_9366,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,NCI Thesaurus,,181.0,129.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9367,Immune checkpoint inhibitors,Kisqali,,RxNorm,cells/kg,68.0,142.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9368,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,g/m2,53.0,111.0
SYNTHETIC-5,DONOR_2369,TREATMENT_9369,Other immunomodulatory substances,Pexidartinib,239766,,cells/kg,199.0,182.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9370,Immune checkpoint inhibitors,Trastuzumab,239766,PubChem,,91.0,134.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9371,Immune checkpoint inhibitors,Gefitinib,8756456,PubChem,mg/kg,58.0,111.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9372,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/m2,,85.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9373,Immune checkpoint inhibitors,,4459876,PubChem,IU/m2,83.0,122.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9374,,Pexidartinib,,RxNorm,,148.0,102.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9375,Immune checkpoint inhibitors,Crizotinib,278936,RxNorm,ug/m2,164.0,118.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9376,Cell-based,Braftovi,987654,NCI Thesaurus,g/m2,59.0,70.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9377,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,,RxNorm,cells/kg,116.0,121.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9378,,Belantamab,,PubChem,,183.0,129.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9379,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,987654,RxNorm,mg/kg,187.0,
SYNTHETIC-5,DONOR_2380,TREATMENT_9380,Other immunomodulatory substances,Pembrolizumab,,PubChem,,,106.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9381,Cell-based,Blinatumomab,8836851,PubChem,cells/kg,,107.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9382,Immune checkpoint inhibitors,Alectinib,8836851,RxNorm,cells/kg,,105.0
SYNTHETIC-5,DONOR_2383,TREATMENT_9383,,,4459876,NCI Thesaurus,ug/m2,144.0,79.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9384,Immune checkpoint inhibitors,Venclexta,4459876,,mg/m2,56.0,124.0
SYNTHETIC-5,DONOR_2385,TREATMENT_9385,,Zelboraf,8756456,PubChem,,95.0,64.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9386,Cell-based,,8756456,,g/m2,70.0,174.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9387,Immune checkpoint inhibitors,Gefitinib,8836851,,,190.0,
SYNTHETIC-5,DONOR_2388,TREATMENT_9388,Cell-based,Atezolizumab,278936,RxNorm,,122.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_9389,Other immunomodulatory substances,,4459876,PubChem,ug/m2,200.0,103.0
SYNTHETIC-5,DONOR_2390,TREATMENT_9390,Cell-based,,,RxNorm,ug/m2,112.0,86.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9391,Other immunomodulatory substances,Alectinib,8756456,RxNorm,mg/m2,66.0,54.0
SYNTHETIC-5,DONOR_2392,TREATMENT_9392,Cell-based,Brigatinib,239766,RxNorm,ug/m2,124.0,156.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9393,Other immunomodulatory substances,Gilotrif,239766,RxNorm,mg/m2,122.0,75.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9394,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,4459876,,cells/kg,196.0,70.0
SYNTHETIC-5,DONOR_2395,TREATMENT_9395,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,,,70.0,138.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9396,Cell-based,,987654,NCI Thesaurus,g/m2,97.0,
SYNTHETIC-5,DONOR_2397,TREATMENT_9397,Cell-based,Cobimetinib,278936,PubChem,mg/m2,52.0,137.0
SYNTHETIC-5,DONOR_2398,TREATMENT_9398,Cell-based,Blinatumomab,8756456,NCI Thesaurus,,114.0,56.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9399,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,mg/m2,134.0,128.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9400,,Caprelsa,239766,RxNorm,,182.0,95.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9401,Other immunomodulatory substances,Blincyto,278936,,mg/kg,,
SYNTHETIC-5,DONOR_2402,TREATMENT_9402,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,,mg/m2,130.0,184.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9403,Cell-based,Venetoclax,278936,RxNorm,,88.0,
SYNTHETIC-5,DONOR_2404,TREATMENT_9404,Cell-based,Zelboraf,4459876,RxNorm,cells/kg,142.0,148.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9405,Cell-based,Yervoy,8836851,,g/m2,139.0,65.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9406,Other immunomodulatory substances,Gazyva,8836851,NCI Thesaurus,mg/m2,,122.0
SYNTHETIC-5,DONOR_2407,TREATMENT_9407,Cell-based,Copanlisib,987654,NCI Thesaurus,g/m2,80.0,62.0
SYNTHETIC-5,DONOR_2408,TREATMENT_9408,Immune checkpoint inhibitors,Xalkori,8756456,,IU/kg,121.0,58.0
SYNTHETIC-5,DONOR_2409,TREATMENT_9409,Other immunomodulatory substances,,4459876,PubChem,ug/m2,143.0,92.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9410,Cell-based,Keytruda,8836851,PubChem,cells/kg,113.0,152.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9411,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,4459876,RxNorm,IU/m2,59.0,179.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9412,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,278936,RxNorm,IU/kg,181.0,154.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9413,Cell-based,Crizotinib,278936,PubChem,cells/kg,58.0,113.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9414,Cell-based,Vandetanib,,RxNorm,mg/kg,174.0,148.0
SYNTHETIC-5,DONOR_2415,TREATMENT_9415,Other immunomodulatory substances,Olaparib,987654,PubChem,g/m2,174.0,68.0
SYNTHETIC-5,DONOR_2416,TREATMENT_9416,Cell-based,Daratumumab,4459876,PubChem,IU/m2,132.0,177.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9417,Cell-based,Ipilimumab,,PubChem,ug/m2,200.0,150.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9418,,Pertuzumab,,PubChem,mg/m2,168.0,184.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9419,Cell-based,Gefitinib,,RxNorm,IU/kg,153.0,129.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9420,,,,PubChem,IU/m2,112.0,98.0
SYNTHETIC-5,DONOR_2421,TREATMENT_9421,Immune checkpoint inhibitors,Dabrafenib,239766,RxNorm,IU/kg,196.0,
SYNTHETIC-5,DONOR_2422,TREATMENT_9422,Cell-based,Vandetanib,8836851,,IU/kg,177.0,
SYNTHETIC-5,DONOR_2423,TREATMENT_9423,Immune checkpoint inhibitors,Rituxan,,NCI Thesaurus,IU/kg,170.0,87.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9424,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,987654,NCI Thesaurus,ug/m2,125.0,
SYNTHETIC-5,DONOR_2425,TREATMENT_9425,Cell-based,,,RxNorm,IU/m2,109.0,157.0
SYNTHETIC-5,DONOR_2426,TREATMENT_9426,Other immunomodulatory substances,Pembrolizumab,,NCI Thesaurus,mg/m2,182.0,105.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9427,Immune checkpoint inhibitors,Kadcyla,8836851,NCI Thesaurus,cells/kg,190.0,
SYNTHETIC-5,DONOR_2428,TREATMENT_9428,Other immunomodulatory substances,Tecentriq,8836851,PubChem,,51.0,
SYNTHETIC-5,DONOR_2429,TREATMENT_9429,Other immunomodulatory substances,Abemaciclib,278936,PubChem,IU/m2,,74.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9430,Other immunomodulatory substances,Atezolizumab,8756456,NCI Thesaurus,cells/kg,,74.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9431,Immune checkpoint inhibitors,Imfinzi,278936,PubChem,cells/kg,107.0,200.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9432,Cell-based,Dabrafenib,278936,,cells/kg,103.0,111.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9433,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8756456,NCI Thesaurus,g/m2,128.0,143.0
SYNTHETIC-5,DONOR_2434,TREATMENT_9434,Cell-based,Gazyva,987654,RxNorm,ug/m2,97.0,
SYNTHETIC-5,DONOR_2435,TREATMENT_9435,Cell-based,Opdivo,4459876,RxNorm,cells/kg,63.0,
SYNTHETIC-5,DONOR_2436,TREATMENT_9436,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,8836851,RxNorm,mg/m2,,190.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9437,Cell-based,,,NCI Thesaurus,IU/kg,132.0,150.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9438,,Necitumumab,987654,NCI Thesaurus,IU/m2,74.0,139.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9439,Cell-based,Keytruda,4459876,PubChem,IU/kg,146.0,
SYNTHETIC-5,DONOR_2440,TREATMENT_9440,Cell-based,Herceptin,239766,PubChem,g/m2,160.0,145.0
SYNTHETIC-5,DONOR_2441,TREATMENT_9441,Immune checkpoint inhibitors,Lenvima,,,ug/m2,114.0,105.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9442,,,987654,RxNorm,,104.0,51.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9443,Other immunomodulatory substances,Yervoy,278936,PubChem,g/m2,197.0,195.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9444,Immune checkpoint inhibitors,Pexidartinib,987654,PubChem,mg/kg,62.0,136.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9445,Immune checkpoint inhibitors,Keytruda,8756456,PubChem,,102.0,68.0
SYNTHETIC-5,DONOR_2446,TREATMENT_9446,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,ug/m2,103.0,72.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9447,Cell-based,Enhertu,8756456,NCI Thesaurus,cells/kg,185.0,124.0
SYNTHETIC-5,DONOR_2448,TREATMENT_9448,,Encorafenib,4459876,NCI Thesaurus,IU/m2,190.0,64.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9449,Other immunomodulatory substances,Kymriah,8836851,RxNorm,IU/m2,135.0,
SYNTHETIC-5,DONOR_2450,TREATMENT_9450,Other immunomodulatory substances,Kisqali,,PubChem,g/m2,122.0,116.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9451,Other immunomodulatory substances,Pembrolizumab,239766,NCI Thesaurus,,130.0,138.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9452,Cell-based,Copanlisib,8836851,RxNorm,IU/m2,,88.0
SYNTHETIC-5,DONOR_2453,TREATMENT_9453,Immune checkpoint inhibitors,Ribociclib,278936,NCI Thesaurus,ug/m2,158.0,133.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9454,Immune checkpoint inhibitors,Afatinib,8756456,RxNorm,g/m2,187.0,
SYNTHETIC-5,DONOR_2455,TREATMENT_9455,Cell-based,Atezolizumab,8756456,PubChem,mg/m2,156.0,54.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9456,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,cells/kg,,
SYNTHETIC-5,DONOR_2457,TREATMENT_9457,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,8756456,NCI Thesaurus,ug/m2,142.0,83.0
SYNTHETIC-5,DONOR_2458,TREATMENT_9458,Immune checkpoint inhibitors,Mekinist,8756456,RxNorm,IU/m2,55.0,90.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9459,Immune checkpoint inhibitors,Cotellic,8756456,RxNorm,IU/m2,164.0,199.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9460,Other immunomodulatory substances,Gilotrif,8756456,RxNorm,IU/m2,69.0,
SYNTHETIC-5,DONOR_2461,TREATMENT_9461,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,278936,NCI Thesaurus,cells/kg,102.0,157.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9462,Other immunomodulatory substances,Obinutuzumab,239766,RxNorm,g/m2,179.0,162.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9463,Other immunomodulatory substances,Keytruda,278936,RxNorm,IU/kg,,102.0
SYNTHETIC-5,DONOR_2464,TREATMENT_9464,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,NCI Thesaurus,mg/kg,152.0,
SYNTHETIC-5,DONOR_2465,TREATMENT_9465,Immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,g/m2,,129.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9466,Other immunomodulatory substances,Zykadia,987654,PubChem,mg/kg,187.0,185.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9467,Cell-based,Opdivo,239766,RxNorm,g/m2,179.0,123.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9468,Immune checkpoint inhibitors,Besponsa,4459876,,ug/m2,54.0,64.0
SYNTHETIC-5,DONOR_2469,TREATMENT_9469,Cell-based,Mekinist,8756456,NCI Thesaurus,,92.0,82.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9470,Other immunomodulatory substances,,4459876,PubChem,IU/kg,143.0,180.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9471,Cell-based,Dabrafenib,,RxNorm,mg/kg,,86.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9472,,Cotellic,8756456,PubChem,mg/m2,177.0,50.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9473,Immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,,72.0,66.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9474,,Opdivo,239766,NCI Thesaurus,ug/m2,190.0,106.0
SYNTHETIC-5,DONOR_2475,TREATMENT_9475,,Gazyva,,NCI Thesaurus,cells/kg,113.0,99.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9476,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,,175.0,86.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9477,Cell-based,Dabrafenib,278936,NCI Thesaurus,IU/kg,196.0,144.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9478,Other immunomodulatory substances,Durvalumab,278936,RxNorm,IU/m2,83.0,
SYNTHETIC-5,DONOR_2479,TREATMENT_9479,,Daratumumab,239766,,,74.0,
SYNTHETIC-5,DONOR_2480,TREATMENT_9480,Cell-based,Tafinlar,239766,PubChem,g/m2,179.0,170.0
SYNTHETIC-5,DONOR_2481,TREATMENT_9481,Other immunomodulatory substances,Inotuzumab ozogamicin,,,ug/m2,139.0,148.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9482,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,4459876,RxNorm,g/m2,147.0,196.0
SYNTHETIC-5,DONOR_2483,TREATMENT_9483,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,278936,NCI Thesaurus,mg/kg,145.0,95.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9484,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,,PubChem,g/m2,92.0,70.0
SYNTHETIC-5,DONOR_2485,TREATMENT_9485,Immune checkpoint inhibitors,Ipilimumab,8756456,RxNorm,,,58.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9486,,Zejula,,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2487,TREATMENT_9487,Cell-based,,278936,PubChem,,170.0,125.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9488,Immune checkpoint inhibitors,Niraparib,,NCI Thesaurus,cells/kg,,161.0
SYNTHETIC-5,DONOR_2489,TREATMENT_9489,Other immunomodulatory substances,Alunbrig,8836851,PubChem,g/m2,149.0,68.0
SYNTHETIC-5,DONOR_2490,TREATMENT_9490,Cell-based,Durvalumab,,NCI Thesaurus,IU/kg,71.0,92.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9491,Cell-based,Keytruda,239766,NCI Thesaurus,IU/m2,113.0,115.0
SYNTHETIC-5,DONOR_2492,TREATMENT_9492,Other immunomodulatory substances,Tafinlar,239766,RxNorm,,153.0,76.0
SYNTHETIC-5,DONOR_2493,TREATMENT_9493,Other immunomodulatory substances,Daratumumab,4459876,RxNorm,IU/kg,185.0,69.0
SYNTHETIC-5,DONOR_2494,TREATMENT_9494,Other immunomodulatory substances,Blinatumomab,987654,NCI Thesaurus,IU/kg,69.0,107.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9495,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,,RxNorm,mg/kg,181.0,86.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9496,Other immunomodulatory substances,,239766,PubChem,,91.0,106.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9497,Other immunomodulatory substances,Adcetris,987654,RxNorm,g/m2,176.0,166.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9498,Cell-based,,4459876,RxNorm,mg/m2,58.0,185.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9499,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,4459876,PubChem,cells/kg,129.0,89.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9500,,Niraparib,4459876,PubChem,mg/m2,132.0,190.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9501,Immune checkpoint inhibitors,Gefitinib,4459876,NCI Thesaurus,cells/kg,51.0,178.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9502,Other immunomodulatory substances,Yescarta,4459876,NCI Thesaurus,mg/kg,52.0,132.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9503,Cell-based,,8836851,NCI Thesaurus,g/m2,169.0,94.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9504,,Rubraca,8756456,PubChem,mg/m2,168.0,152.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9505,Immune checkpoint inhibitors,,239766,NCI Thesaurus,IU/kg,60.0,55.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9506,,Durvalumab,,PubChem,mg/kg,,196.0
SYNTHETIC-5,DONOR_2007,TREATMENT_9507,Immune checkpoint inhibitors,Nexavar,8836851,RxNorm,g/m2,169.0,176.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9508,Other immunomodulatory substances,Braftovi,987654,RxNorm,mg/kg,151.0,147.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9509,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,4459876,NCI Thesaurus,ug/m2,128.0,174.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9510,Other immunomodulatory substances,Tafinlar,8836851,NCI Thesaurus,IU/m2,,95.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9511,Other immunomodulatory substances,Rituxan,987654,PubChem,ug/m2,115.0,
SYNTHETIC-5,DONOR_2012,TREATMENT_9512,Cell-based,Darzalex,,NCI Thesaurus,mg/kg,,53.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9513,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,PubChem,mg/kg,182.0,79.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9514,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,278936,PubChem,cells/kg,189.0,124.0
SYNTHETIC-5,DONOR_2015,TREATMENT_9515,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,8836851,NCI Thesaurus,mg/m2,103.0,102.0
SYNTHETIC-5,DONOR_2016,TREATMENT_9516,Other immunomodulatory substances,Palbociclib,,NCI Thesaurus,mg/m2,87.0,
SYNTHETIC-5,DONOR_2017,TREATMENT_9517,Other immunomodulatory substances,,987654,PubChem,cells/kg,,
SYNTHETIC-5,DONOR_2018,TREATMENT_9518,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,239766,RxNorm,cells/kg,112.0,50.0
SYNTHETIC-5,DONOR_2019,TREATMENT_9519,Cell-based,Olaparib,239766,RxNorm,IU/kg,92.0,
SYNTHETIC-5,DONOR_2020,TREATMENT_9520,Other immunomodulatory substances,Alecensa,278936,RxNorm,mg/kg,60.0,179.0
SYNTHETIC-5,DONOR_2021,TREATMENT_9521,,Yervoy,,RxNorm,mg/m2,180.0,143.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9522,Cell-based,Herceptin,239766,RxNorm,cells/kg,,83.0
SYNTHETIC-5,DONOR_2023,TREATMENT_9523,Cell-based,Vandetanib,4459876,RxNorm,cells/kg,147.0,116.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9524,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,,,,123.0,
SYNTHETIC-5,DONOR_2025,TREATMENT_9525,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,PubChem,g/m2,51.0,58.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9526,,,239766,,mg/m2,133.0,61.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9527,,Axicabtagene ciloleucel,8756456,,IU/m2,144.0,
SYNTHETIC-5,DONOR_2028,TREATMENT_9528,Cell-based,Gilteritinib,8836851,RxNorm,,61.0,80.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9529,Other immunomodulatory substances,Rituximab,8836851,NCI Thesaurus,g/m2,108.0,
SYNTHETIC-5,DONOR_2030,TREATMENT_9530,Cell-based,Alectinib,8756456,RxNorm,,177.0,142.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9531,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,g/m2,121.0,197.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9532,Other immunomodulatory substances,Dabrafenib,8756456,,mg/kg,137.0,67.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9533,Other immunomodulatory substances,Pembrolizumab,8756456,RxNorm,IU/kg,126.0,137.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9534,Cell-based,Sorafenib,4459876,PubChem,mg/m2,199.0,70.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9535,Cell-based,Zykadia,987654,,IU/m2,128.0,137.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9536,Other immunomodulatory substances,Venclexta,,NCI Thesaurus,,198.0,129.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9537,Immune checkpoint inhibitors,Yervoy,987654,PubChem,ug/m2,,146.0
SYNTHETIC-5,DONOR_2038,TREATMENT_9538,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,8836851,,IU/m2,98.0,124.0
SYNTHETIC-5,DONOR_2039,TREATMENT_9539,Other immunomodulatory substances,Sorafenib,4459876,NCI Thesaurus,IU/kg,,110.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9540,Immune checkpoint inhibitors,Atezolizumab,8756456,PubChem,ug/m2,62.0,138.0
SYNTHETIC-5,DONOR_2041,TREATMENT_9541,,,8836851,PubChem,ug/m2,,111.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9542,Immune checkpoint inhibitors,Gazyva,239766,PubChem,mg/kg,106.0,63.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9543,Other immunomodulatory substances,Kisqali,278936,,mg/kg,112.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_9544,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8756456,RxNorm,IU/kg,,59.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9545,Other immunomodulatory substances,Vemurafenib,8836851,RxNorm,cells/kg,171.0,170.0
SYNTHETIC-5,DONOR_2046,TREATMENT_9546,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,8836851,,mg/m2,139.0,
SYNTHETIC-5,DONOR_2047,TREATMENT_9547,,Vandetanib,239766,NCI Thesaurus,g/m2,,140.0
SYNTHETIC-5,DONOR_2048,TREATMENT_9548,Other immunomodulatory substances,Ibrance,4459876,RxNorm,IU/m2,116.0,
SYNTHETIC-5,DONOR_2049,TREATMENT_9549,,Blinatumomab,4459876,NCI Thesaurus,ug/m2,,
SYNTHETIC-5,DONOR_2050,TREATMENT_9550,Cell-based,Lenvima,239766,RxNorm,ug/m2,81.0,142.0
SYNTHETIC-5,DONOR_2051,TREATMENT_9551,,,8756456,PubChem,cells/kg,167.0,191.0
SYNTHETIC-5,DONOR_2052,TREATMENT_9552,,Imfinzi,239766,PubChem,mg/kg,110.0,126.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9553,Immune checkpoint inhibitors,Ibrance,8836851,PubChem,IU/kg,172.0,72.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9554,Immune checkpoint inhibitors,Atezolizumab,,PubChem,g/m2,58.0,102.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9555,Other immunomodulatory substances,Perjeta,8836851,NCI Thesaurus,IU/kg,,181.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9556,Cell-based,,278936,,,114.0,106.0
SYNTHETIC-5,DONOR_2057,TREATMENT_9557,Other immunomodulatory substances,Pembrolizumab,,PubChem,IU/kg,78.0,76.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9558,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,ug/m2,189.0,
SYNTHETIC-5,DONOR_2059,TREATMENT_9559,Other immunomodulatory substances,Gilteritinib,987654,PubChem,mg/kg,,193.0
SYNTHETIC-5,DONOR_2060,TREATMENT_9560,Cell-based,Mektovi,8836851,,IU/kg,101.0,154.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9561,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,4459876,PubChem,mg/m2,,136.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9562,,Caprelsa,8756456,NCI Thesaurus,g/m2,,114.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9563,Cell-based,Keytruda,239766,PubChem,mg/kg,161.0,119.0
SYNTHETIC-5,DONOR_2064,TREATMENT_9564,Immune checkpoint inhibitors,Nivolumab,8836851,,IU/kg,137.0,106.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9565,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,239766,PubChem,mg/kg,192.0,105.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9566,Immune checkpoint inhibitors,Imfinzi,278936,,g/m2,179.0,191.0
SYNTHETIC-5,DONOR_2067,TREATMENT_9567,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,8756456,NCI Thesaurus,mg/kg,,54.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9568,,Durvalumab,8836851,PubChem,IU/m2,64.0,100.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9569,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,cells/kg,98.0,135.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9570,Cell-based,Verzenio,8756456,PubChem,IU/m2,51.0,59.0
SYNTHETIC-5,DONOR_2071,TREATMENT_9571,Cell-based,Rucaparib,8756456,PubChem,,72.0,192.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9572,Other immunomodulatory substances,Yescarta,239766,NCI Thesaurus,cells/kg,94.0,62.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9573,Immune checkpoint inhibitors,Tagrisso,987654,NCI Thesaurus,IU/m2,,185.0
SYNTHETIC-5,DONOR_2074,TREATMENT_9574,Other immunomodulatory substances,Tarceva,8836851,NCI Thesaurus,ug/m2,189.0,
SYNTHETIC-5,DONOR_2075,TREATMENT_9575,Cell-based,Rituximab,239766,NCI Thesaurus,g/m2,61.0,
SYNTHETIC-5,DONOR_2076,TREATMENT_9576,Cell-based,Atezolizumab,239766,,,140.0,91.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9577,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,PubChem,mg/m2,,149.0
SYNTHETIC-5,DONOR_2078,TREATMENT_9578,Immune checkpoint inhibitors,Atezolizumab,987654,PubChem,,124.0,126.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9579,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8836851,PubChem,IU/kg,190.0,77.0
SYNTHETIC-5,DONOR_2080,TREATMENT_9580,,,8836851,NCI Thesaurus,mg/m2,88.0,73.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9581,Other immunomodulatory substances,Necitumumab,4459876,,,109.0,181.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9582,Cell-based,Gefitinib,,NCI Thesaurus,,107.0,99.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9583,Immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,IU/kg,,84.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9584,,,8836851,RxNorm,g/m2,80.0,199.0
SYNTHETIC-5,DONOR_2085,TREATMENT_9585,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,g/m2,77.0,103.0
SYNTHETIC-5,DONOR_2086,TREATMENT_9586,Immune checkpoint inhibitors,Tarceva,,NCI Thesaurus,IU/m2,64.0,61.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9587,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,987654,NCI Thesaurus,,194.0,
SYNTHETIC-5,DONOR_2088,TREATMENT_9588,Other immunomodulatory substances,Nivolumab,278936,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2089,TREATMENT_9589,,Ipilimumab,239766,RxNorm,,,
SYNTHETIC-5,DONOR_2090,TREATMENT_9590,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,278936,NCI Thesaurus,ug/m2,124.0,120.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9591,Cell-based,Olaparib,8756456,NCI Thesaurus,g/m2,,183.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9592,Cell-based,Brigatinib,8756456,PubChem,IU/m2,181.0,128.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9593,Immune checkpoint inhibitors,Ibrance,278936,NCI Thesaurus,g/m2,164.0,61.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9594,Cell-based,Alunbrig,8756456,PubChem,IU/kg,194.0,159.0
SYNTHETIC-5,DONOR_2095,TREATMENT_9595,,,8756456,NCI Thesaurus,IU/m2,,89.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9596,Other immunomodulatory substances,Darzalex,4459876,,mg/m2,131.0,169.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9597,Immune checkpoint inhibitors,Nivolumab,239766,PubChem,IU/kg,65.0,85.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9598,Other immunomodulatory substances,Nexavar,278936,NCI Thesaurus,g/m2,146.0,176.0
SYNTHETIC-5,DONOR_2099,TREATMENT_9599,Immune checkpoint inhibitors,Tisagenlecleucel,8836851,RxNorm,IU/m2,,171.0
SYNTHETIC-5,DONOR_2100,TREATMENT_9600,Immune checkpoint inhibitors,Belantamab,8836851,RxNorm,,79.0,196.0
SYNTHETIC-5,DONOR_2101,TREATMENT_9601,Immune checkpoint inhibitors,Inotuzumab ozogamicin,278936,,cells/kg,104.0,58.0
SYNTHETIC-5,DONOR_2102,TREATMENT_9602,Cell-based,Yervoy,987654,NCI Thesaurus,,100.0,76.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9603,Other immunomodulatory substances,Tagrisso,8756456,RxNorm,,101.0,151.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9604,Immune checkpoint inhibitors,,239766,,IU/kg,119.0,161.0
SYNTHETIC-5,DONOR_2105,TREATMENT_9605,Immune checkpoint inhibitors,,8756456,RxNorm,ug/m2,124.0,108.0
SYNTHETIC-5,DONOR_2106,TREATMENT_9606,,Rubraca,8756456,PubChem,g/m2,176.0,102.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9607,Immune checkpoint inhibitors,Rucaparib,8756456,PubChem,mg/m2,161.0,198.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9608,Cell-based,Venclexta,4459876,PubChem,cells/kg,51.0,133.0
SYNTHETIC-5,DONOR_2109,TREATMENT_9609,Cell-based,Herceptin,278936,PubChem,cells/kg,118.0,
SYNTHETIC-5,DONOR_2110,TREATMENT_9610,Cell-based,,239766,,mg/kg,134.0,188.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9611,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,8836851,NCI Thesaurus,cells/kg,89.0,51.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9612,Immune checkpoint inhibitors,Atezolizumab,8836851,RxNorm,,52.0,
SYNTHETIC-5,DONOR_2113,TREATMENT_9613,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,239766,PubChem,mg/kg,107.0,104.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9614,Cell-based,Rucaparib,,RxNorm,IU/m2,96.0,178.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9615,Cell-based,,987654,NCI Thesaurus,g/m2,,100.0
SYNTHETIC-5,DONOR_2116,TREATMENT_9616,Immune checkpoint inhibitors,Blincyto,,,cells/kg,178.0,98.0
SYNTHETIC-5,DONOR_2117,TREATMENT_9617,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,PubChem,mg/m2,179.0,94.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9618,Immune checkpoint inhibitors,,239766,NCI Thesaurus,ug/m2,139.0,133.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9619,Cell-based,Tisagenlecleucel,,NCI Thesaurus,ug/m2,199.0,93.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9620,Cell-based,Perjeta,239766,RxNorm,mg/kg,117.0,72.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9621,Immune checkpoint inhibitors,Pembrolizumab,8756456,RxNorm,mg/kg,126.0,
SYNTHETIC-5,DONOR_2122,TREATMENT_9622,Immune checkpoint inhibitors,Binimetinib,987654,RxNorm,cells/kg,93.0,
SYNTHETIC-5,DONOR_2123,TREATMENT_9623,Immune checkpoint inhibitors,Obinutuzumab,,RxNorm,,59.0,130.0
SYNTHETIC-5,DONOR_2124,TREATMENT_9624,Other immunomodulatory substances,,239766,RxNorm,ug/m2,185.0,52.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9625,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,,PubChem,IU/kg,156.0,100.0
SYNTHETIC-5,DONOR_2126,TREATMENT_9626,Other immunomodulatory substances,,4459876,NCI Thesaurus,IU/kg,90.0,61.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9627,Immune checkpoint inhibitors,Kisqali,4459876,PubChem,ug/m2,94.0,98.0
SYNTHETIC-5,DONOR_2128,TREATMENT_9628,Cell-based,Durvalumab,987654,PubChem,,,142.0
SYNTHETIC-5,DONOR_2129,TREATMENT_9629,Other immunomodulatory substances,Durvalumab,8756456,RxNorm,mg/m2,,
SYNTHETIC-5,DONOR_2130,TREATMENT_9630,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,RxNorm,IU/m2,187.0,146.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9631,Cell-based,Tecentriq,,RxNorm,mg/kg,124.0,121.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9632,,Tecentriq,8836851,NCI Thesaurus,IU/m2,153.0,102.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9633,Other immunomodulatory substances,Nexavar,4459876,,,,146.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9634,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,4459876,PubChem,mg/m2,177.0,151.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9635,Immune checkpoint inhibitors,Trametinib,8756456,RxNorm,IU/m2,161.0,52.0
SYNTHETIC-5,DONOR_2136,TREATMENT_9636,Other immunomodulatory substances,Lynparza,4459876,NCI Thesaurus,ug/m2,187.0,76.0
SYNTHETIC-5,DONOR_2137,TREATMENT_9637,Other immunomodulatory substances,Olaparib,239766,NCI Thesaurus,IU/m2,51.0,
SYNTHETIC-5,DONOR_2138,TREATMENT_9638,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,,PubChem,g/m2,117.0,111.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9639,Cell-based,Vandetanib,,NCI Thesaurus,cells/kg,197.0,158.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9640,Cell-based,Gefitinib,987654,PubChem,ug/m2,,162.0
SYNTHETIC-5,DONOR_2141,TREATMENT_9641,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,278936,NCI Thesaurus,ug/m2,138.0,135.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9642,Immune checkpoint inhibitors,Atezolizumab,,PubChem,g/m2,111.0,159.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9643,Other immunomodulatory substances,Dabrafenib,987654,RxNorm,ug/m2,185.0,164.0
SYNTHETIC-5,DONOR_2144,TREATMENT_9644,Immune checkpoint inhibitors,Caprelsa,987654,PubChem,ug/m2,74.0,82.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9645,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,4459876,NCI Thesaurus,g/m2,159.0,112.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9646,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,NCI Thesaurus,mg/m2,65.0,102.0
SYNTHETIC-5,DONOR_2147,TREATMENT_9647,,Zelboraf,8756456,RxNorm,,134.0,
SYNTHETIC-5,DONOR_2148,TREATMENT_9648,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,NCI Thesaurus,cells/kg,133.0,106.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9649,,Tecentriq,987654,PubChem,g/m2,137.0,172.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9650,Cell-based,Caprelsa,8756456,RxNorm,mg/kg,190.0,99.0
SYNTHETIC-5,DONOR_2151,TREATMENT_9651,Immune checkpoint inhibitors,Besponsa,278936,NCI Thesaurus,ug/m2,196.0,140.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9652,Immune checkpoint inhibitors,Braftovi,8836851,NCI Thesaurus,,,
SYNTHETIC-5,DONOR_2153,TREATMENT_9653,Immune checkpoint inhibitors,,987654,RxNorm,IU/m2,55.0,190.0
SYNTHETIC-5,DONOR_2154,TREATMENT_9654,Cell-based,Cotellic,8756456,RxNorm,IU/kg,97.0,
SYNTHETIC-5,DONOR_2155,TREATMENT_9655,Cell-based,Afatinib,4459876,RxNorm,g/m2,137.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_9656,,Belantamab,8836851,NCI Thesaurus,IU/kg,166.0,
SYNTHETIC-5,DONOR_2157,TREATMENT_9657,,Darzalex,987654,RxNorm,mg/m2,186.0,
SYNTHETIC-5,DONOR_2158,TREATMENT_9658,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,8756456,PubChem,cells/kg,77.0,
SYNTHETIC-5,DONOR_2159,TREATMENT_9659,,Herceptin,4459876,NCI Thesaurus,,124.0,166.0
SYNTHETIC-5,DONOR_2160,TREATMENT_9660,Other immunomodulatory substances,Ipilimumab,4459876,PubChem,g/m2,173.0,141.0
SYNTHETIC-5,DONOR_2161,TREATMENT_9661,Immune checkpoint inhibitors,,987654,NCI Thesaurus,cells/kg,72.0,
SYNTHETIC-5,DONOR_2162,TREATMENT_9662,,Blinatumomab,8836851,NCI Thesaurus,mg/kg,,65.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9663,,Dabrafenib,,RxNorm,mg/m2,53.0,118.0
SYNTHETIC-5,DONOR_2164,TREATMENT_9664,Cell-based,Enhertu,4459876,,mg/kg,79.0,176.0
SYNTHETIC-5,DONOR_2165,TREATMENT_9665,Other immunomodulatory substances,Selumitinib,278936,,mg/m2,165.0,58.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9666,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,PubChem,g/m2,57.0,80.0
SYNTHETIC-5,DONOR_2167,TREATMENT_9667,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,239766,NCI Thesaurus,IU/m2,117.0,154.0
SYNTHETIC-5,DONOR_2168,TREATMENT_9668,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,IU/kg,131.0,50.0
SYNTHETIC-5,DONOR_2169,TREATMENT_9669,Cell-based,Afatinib,987654,PubChem,ug/m2,172.0,99.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9670,Immune checkpoint inhibitors,Tafinlar,,RxNorm,mg/m2,190.0,130.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9671,Immune checkpoint inhibitors,Vemurafenib,8836851,RxNorm,cells/kg,112.0,162.0
SYNTHETIC-5,DONOR_2172,TREATMENT_9672,Immune checkpoint inhibitors,,,NCI Thesaurus,g/m2,105.0,
SYNTHETIC-5,DONOR_2173,TREATMENT_9673,Other immunomodulatory substances,Encorafenib,278936,RxNorm,ug/m2,162.0,69.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9674,Other immunomodulatory substances,Opdivo,4459876,NCI Thesaurus,mg/kg,61.0,63.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9675,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,RxNorm,,98.0,79.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9676,Other immunomodulatory substances,Pembrolizumab,,NCI Thesaurus,IU/kg,58.0,119.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9677,Immune checkpoint inhibitors,,,RxNorm,cells/kg,,124.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9678,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,239766,RxNorm,g/m2,51.0,122.0
SYNTHETIC-5,DONOR_2179,TREATMENT_9679,Other immunomodulatory substances,Pembrolizumab,987654,,IU/m2,183.0,173.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9680,Immune checkpoint inhibitors,Verzenio,987654,PubChem,cells/kg,53.0,61.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9681,,Opdivo,8836851,PubChem,mg/kg,51.0,
SYNTHETIC-5,DONOR_2182,TREATMENT_9682,Cell-based,Ipilimumab,4459876,PubChem,cells/kg,,
SYNTHETIC-5,DONOR_2183,TREATMENT_9683,,Erlotinib,,,IU/m2,174.0,166.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9684,Other immunomodulatory substances,Pertuzumab,8836851,NCI Thesaurus,cells/kg,,
SYNTHETIC-5,DONOR_2185,TREATMENT_9685,Other immunomodulatory substances,,987654,RxNorm,ug/m2,70.0,135.0
SYNTHETIC-5,DONOR_2186,TREATMENT_9686,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,8836851,,IU/m2,,143.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9687,Cell-based,Axicabtagene ciloleucel,278936,RxNorm,,167.0,105.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9688,Cell-based,Keytruda,8756456,,,98.0,
SYNTHETIC-5,DONOR_2189,TREATMENT_9689,,Selumitinib,8756456,RxNorm,cells/kg,64.0,150.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9690,,Imfinzi,278936,RxNorm,g/m2,164.0,109.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9691,,Rituxan,8836851,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2192,TREATMENT_9692,Other immunomodulatory substances,Yervoy,8836851,PubChem,mg/kg,86.0,
SYNTHETIC-5,DONOR_2193,TREATMENT_9693,Immune checkpoint inhibitors,Obinutuzumab,987654,RxNorm,mg/m2,176.0,187.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9694,Cell-based,Fam-trastuzumab deruxtecan-nxki,8756456,NCI Thesaurus,IU/kg,72.0,105.0
SYNTHETIC-5,DONOR_2195,TREATMENT_9695,Cell-based,,4459876,PubChem,ug/m2,180.0,184.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9696,Other immunomodulatory substances,Copanlisib,8756456,PubChem,,135.0,173.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9697,Other immunomodulatory substances,Darzalex,8756456,RxNorm,ug/m2,148.0,
SYNTHETIC-5,DONOR_2198,TREATMENT_9698,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,8756456,RxNorm,mg/m2,,193.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9699,Cell-based,Cabozantinib,278936,PubChem,cells/kg,87.0,91.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9700,Other immunomodulatory substances,Durvalumab,987654,RxNorm,g/m2,59.0,139.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9701,Immune checkpoint inhibitors,Adcetris,8756456,NCI Thesaurus,g/m2,156.0,
SYNTHETIC-5,DONOR_2202,TREATMENT_9702,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,RxNorm,cells/kg,119.0,162.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9703,,Herceptin,,RxNorm,cells/kg,102.0,
SYNTHETIC-5,DONOR_2204,TREATMENT_9704,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,4459876,RxNorm,mg/kg,101.0,123.0
SYNTHETIC-5,DONOR_2205,TREATMENT_9705,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,cells/kg,113.0,
SYNTHETIC-5,DONOR_2206,TREATMENT_9706,,Cabozantinib,987654,RxNorm,ug/m2,114.0,182.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9707,Other immunomodulatory substances,,8756456,NCI Thesaurus,cells/kg,,77.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9708,Immune checkpoint inhibitors,Erlotinib,987654,RxNorm,mg/m2,80.0,185.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9709,,Crizotinib,,PubChem,,67.0,120.0
SYNTHETIC-5,DONOR_2210,TREATMENT_9710,Cell-based,,239766,NCI Thesaurus,cells/kg,,163.0
SYNTHETIC-5,DONOR_2211,TREATMENT_9711,Cell-based,Pembrolizumab,8836851,NCI Thesaurus,,109.0,
SYNTHETIC-5,DONOR_2212,TREATMENT_9712,,Herceptin,278936,RxNorm,ug/m2,162.0,101.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9713,Cell-based,Braftovi,8756456,NCI Thesaurus,,106.0,156.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9714,Cell-based,Pexidartinib,239766,,cells/kg,71.0,147.0
SYNTHETIC-5,DONOR_2215,TREATMENT_9715,Cell-based,Lenvima,4459876,PubChem,mg/m2,148.0,148.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9716,Cell-based,Atezolizumab,278936,NCI Thesaurus,,151.0,186.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9717,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,cells/kg,,85.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9718,Cell-based,Keytruda,4459876,RxNorm,mg/m2,150.0,82.0
SYNTHETIC-5,DONOR_2219,TREATMENT_9719,,Nivolumab,8756456,PubChem,,50.0,128.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9720,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,278936,RxNorm,,111.0,102.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9721,Cell-based,Alunbrig,987654,PubChem,cells/kg,133.0,
SYNTHETIC-5,DONOR_2222,TREATMENT_9722,Cell-based,Trastuzumab,,PubChem,mg/kg,149.0,
SYNTHETIC-5,DONOR_2223,TREATMENT_9723,,Herceptin,987654,RxNorm,g/m2,103.0,116.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9724,Immune checkpoint inhibitors,Tecentriq,239766,NCI Thesaurus,ug/m2,124.0,
SYNTHETIC-5,DONOR_2225,TREATMENT_9725,,Keytruda,4459876,,cells/kg,192.0,134.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9726,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,NCI Thesaurus,IU/kg,142.0,163.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9727,Immune checkpoint inhibitors,Opdivo,8836851,PubChem,mg/kg,158.0,197.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9728,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,,PubChem,IU/kg,90.0,
SYNTHETIC-5,DONOR_2229,TREATMENT_9729,Cell-based,Herceptin,4459876,PubChem,,55.0,163.0
SYNTHETIC-5,DONOR_2230,TREATMENT_9730,Immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,mg/m2,178.0,65.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9731,Cell-based,Nivolumab,987654,PubChem,g/m2,173.0,188.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9732,Cell-based,Axicabtagene ciloleucel,4459876,RxNorm,ug/m2,124.0,82.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9733,Immune checkpoint inhibitors,Opdivo,987654,NCI Thesaurus,cells/kg,111.0,52.0
SYNTHETIC-5,DONOR_2234,TREATMENT_9734,Other immunomodulatory substances,Nivolumab,987654,NCI Thesaurus,cells/kg,57.0,81.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9735,Immune checkpoint inhibitors,Atezolizumab,8756456,PubChem,g/m2,,185.0
SYNTHETIC-5,DONOR_2236,TREATMENT_9736,Other immunomodulatory substances,Yescarta,987654,NCI Thesaurus,g/m2,168.0,
SYNTHETIC-5,DONOR_2237,TREATMENT_9737,Cell-based,Axicabtagene ciloleucel,8836851,PubChem,mg/kg,187.0,121.0
SYNTHETIC-5,DONOR_2238,TREATMENT_9738,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,4459876,RxNorm,mg/kg,113.0,131.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9739,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,987654,NCI Thesaurus,IU/m2,117.0,94.0
SYNTHETIC-5,DONOR_2240,TREATMENT_9740,Cell-based,Durvalumab,987654,NCI Thesaurus,cells/kg,84.0,109.0
SYNTHETIC-5,DONOR_2241,TREATMENT_9741,,Binimetinib,,NCI Thesaurus,,160.0,105.0
SYNTHETIC-5,DONOR_2242,TREATMENT_9742,Cell-based,Atezolizumab,239766,,IU/m2,122.0,101.0
SYNTHETIC-5,DONOR_2243,TREATMENT_9743,Cell-based,Cometriq,,NCI Thesaurus,,58.0,172.0
SYNTHETIC-5,DONOR_2244,TREATMENT_9744,,Tarceva,8756456,RxNorm,g/m2,,101.0
SYNTHETIC-5,DONOR_2245,TREATMENT_9745,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,ug/m2,108.0,92.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9746,,Abemaciclib,239766,,cells/kg,157.0,
SYNTHETIC-5,DONOR_2247,TREATMENT_9747,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,987654,,cells/kg,,63.0
SYNTHETIC-5,DONOR_2248,TREATMENT_9748,Other immunomodulatory substances,,4459876,RxNorm,g/m2,81.0,197.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9749,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,mg/m2,185.0,152.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9750,,Tecentriq,987654,NCI Thesaurus,mg/kg,,59.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9751,Cell-based,Atezolizumab,278936,,mg/m2,68.0,
SYNTHETIC-5,DONOR_2252,TREATMENT_9752,Cell-based,Binimetinib,8836851,,mg/kg,97.0,166.0
SYNTHETIC-5,DONOR_2253,TREATMENT_9753,Immune checkpoint inhibitors,Pembrolizumab,278936,,IU/m2,141.0,183.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9754,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,mg/kg,184.0,52.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9755,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8836851,NCI Thesaurus,mg/m2,76.0,191.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9756,Cell-based,Pembrolizumab,,RxNorm,IU/kg,159.0,76.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9757,Immune checkpoint inhibitors,Gilotrif,8756456,PubChem,,193.0,128.0
SYNTHETIC-5,DONOR_2258,TREATMENT_9758,Cell-based,Obinutuzumab,,RxNorm,IU/kg,176.0,52.0
SYNTHETIC-5,DONOR_2259,TREATMENT_9759,Cell-based,Fam-trastuzumab deruxtecan-nxki,278936,RxNorm,IU/kg,159.0,192.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9760,Immune checkpoint inhibitors,Yervoy,8756456,,,94.0,127.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9761,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,PubChem,IU/kg,69.0,164.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9762,Other immunomodulatory substances,Caprelsa,8836851,RxNorm,g/m2,103.0,144.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9763,,Zelboraf,278936,RxNorm,mg/kg,,165.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9764,Immune checkpoint inhibitors,,4459876,PubChem,IU/kg,,121.0
SYNTHETIC-5,DONOR_2265,TREATMENT_9765,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,239766,RxNorm,mg/kg,185.0,57.0
SYNTHETIC-5,DONOR_2266,TREATMENT_9766,Other immunomodulatory substances,Afatinib,8756456,PubChem,mg/kg,,66.0
SYNTHETIC-5,DONOR_2267,TREATMENT_9767,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,278936,,mg/kg,70.0,177.0
SYNTHETIC-5,DONOR_2268,TREATMENT_9768,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,mg/kg,,126.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9769,Other immunomodulatory substances,Darzalex,8756456,PubChem,cells/kg,,141.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9770,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,NCI Thesaurus,,95.0,153.0
SYNTHETIC-5,DONOR_2271,TREATMENT_9771,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,239766,PubChem,g/m2,150.0,185.0
SYNTHETIC-5,DONOR_2272,TREATMENT_9772,Cell-based,Opdivo,,NCI Thesaurus,,,128.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9773,Immune checkpoint inhibitors,Tecentriq,239766,RxNorm,,59.0,111.0
SYNTHETIC-5,DONOR_2274,TREATMENT_9774,Other immunomodulatory substances,,4459876,PubChem,cells/kg,131.0,192.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9775,,Venetoclax,8756456,PubChem,IU/m2,151.0,88.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9776,,Gilotrif,8756456,,cells/kg,74.0,88.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9777,Immune checkpoint inhibitors,Gazyva,987654,,cells/kg,101.0,158.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9778,Immune checkpoint inhibitors,Iressa,278936,RxNorm,mg/m2,,71.0
SYNTHETIC-5,DONOR_2279,TREATMENT_9779,Other immunomodulatory substances,Yervoy,4459876,PubChem,cells/kg,,86.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9780,Other immunomodulatory substances,Imfinzi,278936,PubChem,cells/kg,,66.0
SYNTHETIC-5,DONOR_2281,TREATMENT_9781,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8836851,RxNorm,mg/m2,,184.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9782,Other immunomodulatory substances,Trastuzumab,987654,NCI Thesaurus,IU/m2,97.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_9783,Cell-based,Fam-trastuzumab deruxtecan-nxki,278936,PubChem,mg/m2,174.0,
SYNTHETIC-5,DONOR_2284,TREATMENT_9784,,Yervoy,,NCI Thesaurus,mg/kg,165.0,135.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9785,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,987654,NCI Thesaurus,cells/kg,120.0,152.0
SYNTHETIC-5,DONOR_2286,TREATMENT_9786,Other immunomodulatory substances,Kadcyla,8756456,RxNorm,g/m2,,
SYNTHETIC-5,DONOR_2287,TREATMENT_9787,Cell-based,Gilteritinib,239766,NCI Thesaurus,ug/m2,147.0,120.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9788,,Pembrolizumab,,,mg/m2,50.0,139.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9789,Other immunomodulatory substances,Cabozantinib,4459876,NCI Thesaurus,mg/kg,68.0,
SYNTHETIC-5,DONOR_2290,TREATMENT_9790,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,987654,PubChem,mg/m2,132.0,
SYNTHETIC-5,DONOR_2291,TREATMENT_9791,Other immunomodulatory substances,,,RxNorm,g/m2,196.0,141.0
SYNTHETIC-5,DONOR_2292,TREATMENT_9792,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,987654,NCI Thesaurus,IU/kg,141.0,194.0
SYNTHETIC-5,DONOR_2293,TREATMENT_9793,Immune checkpoint inhibitors,Rituxan,8836851,NCI Thesaurus,g/m2,59.0,167.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9794,Cell-based,,278936,,,85.0,
SYNTHETIC-5,DONOR_2295,TREATMENT_9795,,,8836851,NCI Thesaurus,IU/kg,106.0,93.0
SYNTHETIC-5,DONOR_2296,TREATMENT_9796,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,g/m2,,200.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9797,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,,cells/kg,90.0,
SYNTHETIC-5,DONOR_2298,TREATMENT_9798,Immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/m2,53.0,51.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9799,Immune checkpoint inhibitors,Niraparib,239766,,IU/m2,165.0,64.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9800,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,RxNorm,IU/kg,73.0,135.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9801,Other immunomodulatory substances,Gefitinib,239766,RxNorm,mg/m2,166.0,76.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9802,Other immunomodulatory substances,,4459876,,IU/kg,86.0,105.0
SYNTHETIC-5,DONOR_2303,TREATMENT_9803,Cell-based,Palbociclib,239766,PubChem,mg/m2,165.0,166.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9804,Immune checkpoint inhibitors,Tarceva,278936,RxNorm,ug/m2,,148.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9805,,Rubraca,4459876,RxNorm,ug/m2,79.0,71.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9806,Cell-based,Binimetinib,,NCI Thesaurus,g/m2,84.0,154.0
SYNTHETIC-5,DONOR_2307,TREATMENT_9807,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,4459876,RxNorm,mg/kg,162.0,112.0
SYNTHETIC-5,DONOR_2308,TREATMENT_9808,Immune checkpoint inhibitors,,239766,PubChem,g/m2,74.0,
SYNTHETIC-5,DONOR_2309,TREATMENT_9809,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,cells/kg,51.0,67.0
SYNTHETIC-5,DONOR_2310,TREATMENT_9810,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,RxNorm,cells/kg,69.0,190.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9811,Immune checkpoint inhibitors,Nivolumab,8756456,,IU/kg,129.0,
SYNTHETIC-5,DONOR_2312,TREATMENT_9812,Cell-based,Keytruda,8756456,PubChem,,110.0,
SYNTHETIC-5,DONOR_2313,TREATMENT_9813,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,278936,PubChem,IU/m2,143.0,175.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9814,Cell-based,Ipilimumab,239766,NCI Thesaurus,g/m2,153.0,157.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9815,Other immunomodulatory substances,Opdivo,8836851,NCI Thesaurus,,128.0,169.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9816,Cell-based,Abemaciclib,278936,RxNorm,cells/kg,,122.0
SYNTHETIC-5,DONOR_2317,TREATMENT_9817,,Blincyto,278936,RxNorm,mg/m2,150.0,
SYNTHETIC-5,DONOR_2318,TREATMENT_9818,Cell-based,Gazyva,8756456,RxNorm,IU/m2,,58.0
SYNTHETIC-5,DONOR_2319,TREATMENT_9819,Other immunomodulatory substances,,239766,RxNorm,cells/kg,199.0,183.0
SYNTHETIC-5,DONOR_2320,TREATMENT_9820,Other immunomodulatory substances,Brentuximab vedotin,8836851,,g/m2,66.0,186.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9821,Immune checkpoint inhibitors,Lynparza,8756456,PubChem,IU/m2,66.0,127.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9822,Immune checkpoint inhibitors,,,RxNorm,cells/kg,168.0,165.0
SYNTHETIC-5,DONOR_2323,TREATMENT_9823,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,278936,,IU/kg,177.0,180.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9824,Cell-based,,239766,NCI Thesaurus,,129.0,55.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9825,,Zelboraf,987654,,ug/m2,163.0,151.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9826,Immune checkpoint inhibitors,Adcetris,278936,,cells/kg,76.0,77.0
SYNTHETIC-5,DONOR_2327,TREATMENT_9827,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,987654,NCI Thesaurus,IU/m2,62.0,142.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9828,Other immunomodulatory substances,Abemaciclib,278936,NCI Thesaurus,IU/kg,,194.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9829,Cell-based,Mekinist,239766,PubChem,cells/kg,132.0,80.0
SYNTHETIC-5,DONOR_2330,TREATMENT_9830,Immune checkpoint inhibitors,,278936,NCI Thesaurus,IU/m2,74.0,173.0
SYNTHETIC-5,DONOR_2331,TREATMENT_9831,Immune checkpoint inhibitors,Yervoy,4459876,RxNorm,ug/m2,83.0,
SYNTHETIC-5,DONOR_2332,TREATMENT_9832,Immune checkpoint inhibitors,Pembrolizumab,4459876,NCI Thesaurus,ug/m2,140.0,133.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9833,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,RxNorm,,110.0,196.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9834,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,8756456,RxNorm,,185.0,116.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9835,Cell-based,Copanlisib,,RxNorm,,72.0,200.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9836,Cell-based,Cobimetinib,8756456,,mg/kg,93.0,124.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9837,Immune checkpoint inhibitors,Tisagenlecleucel,278936,PubChem,mg/kg,192.0,105.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9838,Other immunomodulatory substances,,8836851,PubChem,ug/m2,197.0,83.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9839,Immune checkpoint inhibitors,Brentuximab vedotin,8756456,,,143.0,150.0
SYNTHETIC-5,DONOR_2340,TREATMENT_9840,,Rubraca,8756456,RxNorm,mg/kg,129.0,
SYNTHETIC-5,DONOR_2341,TREATMENT_9841,Immune checkpoint inhibitors,Cabozantinib,,PubChem,IU/kg,,56.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9842,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,278936,PubChem,mg/kg,160.0,101.0
SYNTHETIC-5,DONOR_2343,TREATMENT_9843,,Crizotinib,987654,RxNorm,cells/kg,53.0,78.0
SYNTHETIC-5,DONOR_2344,TREATMENT_9844,Cell-based,,987654,NCI Thesaurus,ug/m2,,
SYNTHETIC-5,DONOR_2345,TREATMENT_9845,Immune checkpoint inhibitors,Rubraca,4459876,PubChem,,151.0,198.0
SYNTHETIC-5,DONOR_2346,TREATMENT_9846,Other immunomodulatory substances,,8756456,NCI Thesaurus,IU/m2,198.0,90.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9847,Other immunomodulatory substances,,4459876,NCI Thesaurus,cells/kg,122.0,117.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9848,Immune checkpoint inhibitors,Necitumumab,,RxNorm,IU/kg,,179.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9849,,Adcetris,8756456,NCI Thesaurus,IU/m2,150.0,124.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9850,Other immunomodulatory substances,Nivolumab,4459876,NCI Thesaurus,mg/m2,154.0,103.0
SYNTHETIC-5,DONOR_2351,TREATMENT_9851,Other immunomodulatory substances,Brentuximab vedotin,239766,PubChem,IU/m2,123.0,157.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9852,Other immunomodulatory substances,Cabozantinib,278936,RxNorm,IU/m2,126.0,191.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9853,Other immunomodulatory substances,Afatinib,4459876,PubChem,,131.0,190.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9854,,Durvalumab,,RxNorm,ug/m2,63.0,159.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9855,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,NCI Thesaurus,IU/kg,,
SYNTHETIC-5,DONOR_2356,TREATMENT_9856,Immune checkpoint inhibitors,Durvalumab,239766,RxNorm,g/m2,72.0,181.0
SYNTHETIC-5,DONOR_2357,TREATMENT_9857,Immune checkpoint inhibitors,Pertuzumab,987654,RxNorm,g/m2,83.0,53.0
SYNTHETIC-5,DONOR_2358,TREATMENT_9858,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,,94.0,
SYNTHETIC-5,DONOR_2359,TREATMENT_9859,,Atezolizumab,8756456,PubChem,IU/m2,76.0,133.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9860,Cell-based,,8836851,NCI Thesaurus,IU/m2,111.0,188.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9861,,Cobimetinib,278936,PubChem,g/m2,,122.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9862,Other immunomodulatory substances,Rucaparib,8836851,RxNorm,mg/kg,108.0,187.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9863,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,IU/m2,173.0,
SYNTHETIC-5,DONOR_2364,TREATMENT_9864,Immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,IU/m2,,163.0
SYNTHETIC-5,DONOR_2365,TREATMENT_9865,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,RxNorm,IU/kg,,91.0
SYNTHETIC-5,DONOR_2366,TREATMENT_9866,Other immunomodulatory substances,,,PubChem,mg/m2,64.0,193.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9867,Cell-based,Durvalumab,987654,PubChem,ug/m2,76.0,91.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9868,Immune checkpoint inhibitors,Atezolizumab,987654,PubChem,IU/kg,136.0,140.0
SYNTHETIC-5,DONOR_2369,TREATMENT_9869,Immune checkpoint inhibitors,,278936,RxNorm,ug/m2,123.0,104.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9870,Cell-based,Palbociclib,8836851,PubChem,g/m2,54.0,169.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9871,Immune checkpoint inhibitors,Abemaciclib,987654,,g/m2,98.0,159.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9872,,Keytruda,8836851,PubChem,IU/kg,155.0,126.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9873,Cell-based,Keytruda,8836851,RxNorm,IU/m2,93.0,99.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9874,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8836851,PubChem,mg/kg,61.0,183.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9875,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8836851,,g/m2,108.0,80.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9876,,,,RxNorm,cells/kg,112.0,119.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9877,,,278936,RxNorm,cells/kg,65.0,131.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9878,Other immunomodulatory substances,Sorafenib,8836851,NCI Thesaurus,g/m2,68.0,196.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9879,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,987654,RxNorm,IU/m2,61.0,150.0
SYNTHETIC-5,DONOR_2380,TREATMENT_9880,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,,IU/kg,91.0,145.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9881,Other immunomodulatory substances,Obinutuzumab,8836851,NCI Thesaurus,g/m2,128.0,173.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9882,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,IU/kg,182.0,
SYNTHETIC-5,DONOR_2383,TREATMENT_9883,Other immunomodulatory substances,Ipilimumab,8836851,,IU/kg,,
SYNTHETIC-5,DONOR_2384,TREATMENT_9884,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,mg/kg,122.0,
SYNTHETIC-5,DONOR_2385,TREATMENT_9885,Cell-based,Zejula,239766,RxNorm,,61.0,135.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9886,Cell-based,Fam-trastuzumab deruxtecan-nxki,278936,NCI Thesaurus,IU/m2,101.0,125.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9887,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,4459876,NCI Thesaurus,cells/kg,182.0,107.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9888,Cell-based,Pembrolizumab,987654,RxNorm,cells/kg,136.0,167.0
SYNTHETIC-5,DONOR_2389,TREATMENT_9889,Cell-based,Cometriq,,NCI Thesaurus,cells/kg,156.0,176.0
SYNTHETIC-5,DONOR_2390,TREATMENT_9890,Cell-based,Daratumumab,8836851,RxNorm,IU/kg,,175.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9891,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,IU/m2,174.0,
SYNTHETIC-5,DONOR_2392,TREATMENT_9892,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,RxNorm,,132.0,180.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9893,Other immunomodulatory substances,Opdivo,4459876,RxNorm,,139.0,103.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9894,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,278936,RxNorm,IU/m2,179.0,158.0
SYNTHETIC-5,DONOR_2395,TREATMENT_9895,Immune checkpoint inhibitors,Tafinlar,,RxNorm,IU/m2,,84.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9896,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,4459876,,cells/kg,97.0,196.0
SYNTHETIC-5,DONOR_2397,TREATMENT_9897,Other immunomodulatory substances,,278936,PubChem,IU/m2,59.0,
SYNTHETIC-5,DONOR_2398,TREATMENT_9898,,Belantamab,8836851,NCI Thesaurus,mg/kg,74.0,165.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9899,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,PubChem,mg/kg,168.0,145.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9900,Other immunomodulatory substances,,8836851,PubChem,IU/kg,51.0,194.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9901,Other immunomodulatory substances,Perjeta,239766,PubChem,mg/kg,128.0,64.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9902,Other immunomodulatory substances,Herceptin,4459876,RxNorm,IU/kg,,59.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9903,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,RxNorm,g/m2,161.0,70.0
SYNTHETIC-5,DONOR_2404,TREATMENT_9904,Immune checkpoint inhibitors,Kadcyla,987654,,,79.0,155.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9905,,Inotuzumab ozogamicin,987654,PubChem,IU/kg,151.0,140.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9906,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,8836851,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2407,TREATMENT_9907,Other immunomodulatory substances,Tisagenlecleucel,8836851,NCI Thesaurus,mg/m2,,78.0
SYNTHETIC-5,DONOR_2408,TREATMENT_9908,Other immunomodulatory substances,Opdivo,239766,PubChem,IU/m2,126.0,
SYNTHETIC-5,DONOR_2409,TREATMENT_9909,Immune checkpoint inhibitors,Imfinzi,8756456,NCI Thesaurus,,103.0,155.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9910,Cell-based,,239766,,,165.0,113.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9911,,Palbociclib,239766,NCI Thesaurus,IU/m2,180.0,89.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9912,Cell-based,Tagrisso,4459876,NCI Thesaurus,,176.0,70.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9913,Cell-based,Kymriah,239766,NCI Thesaurus,mg/m2,115.0,65.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9914,Other immunomodulatory substances,Olaparib,4459876,,ug/m2,131.0,138.0
SYNTHETIC-5,DONOR_2415,TREATMENT_9915,,Tarceva,8756456,PubChem,,194.0,180.0
SYNTHETIC-5,DONOR_2416,TREATMENT_9916,Immune checkpoint inhibitors,,,NCI Thesaurus,,150.0,
SYNTHETIC-5,DONOR_2417,TREATMENT_9917,Other immunomodulatory substances,Venetoclax,239766,NCI Thesaurus,,,93.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9918,Cell-based,Durvalumab,4459876,PubChem,g/m2,65.0,180.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9919,Cell-based,,4459876,,,144.0,92.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9920,Other immunomodulatory substances,Rituximab,987654,RxNorm,mg/kg,186.0,115.0
SYNTHETIC-5,DONOR_2421,TREATMENT_9921,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,,52.0,193.0
SYNTHETIC-5,DONOR_2422,TREATMENT_9922,Cell-based,Durvalumab,278936,PubChem,ug/m2,195.0,97.0
SYNTHETIC-5,DONOR_2423,TREATMENT_9923,Cell-based,Herceptin,987654,RxNorm,mg/m2,115.0,187.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9924,Other immunomodulatory substances,Ibrance,8836851,NCI Thesaurus,g/m2,60.0,80.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9925,Cell-based,,987654,,ug/m2,115.0,102.0
SYNTHETIC-5,DONOR_2426,TREATMENT_9926,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,8836851,NCI Thesaurus,mg/m2,84.0,
SYNTHETIC-5,DONOR_2427,TREATMENT_9927,Immune checkpoint inhibitors,Trametinib,4459876,NCI Thesaurus,mg/m2,130.0,158.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9928,Cell-based,Durvalumab,987654,NCI Thesaurus,ug/m2,102.0,50.0
SYNTHETIC-5,DONOR_2429,TREATMENT_9929,Cell-based,Besponsa,278936,PubChem,,100.0,
SYNTHETIC-5,DONOR_2430,TREATMENT_9930,Cell-based,Keytruda,8756456,RxNorm,IU/kg,,183.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9931,Cell-based,Cotellic,8756456,PubChem,ug/m2,100.0,69.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9932,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,PubChem,IU/m2,177.0,59.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9933,Immune checkpoint inhibitors,Crizotinib,987654,RxNorm,mg/m2,64.0,112.0
SYNTHETIC-5,DONOR_2434,TREATMENT_9934,Cell-based,Ceritinib,4459876,NCI Thesaurus,ug/m2,158.0,144.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9935,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,4459876,PubChem,mg/m2,80.0,
SYNTHETIC-5,DONOR_2436,TREATMENT_9936,Cell-based,Ribociclib,239766,NCI Thesaurus,IU/kg,76.0,106.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9937,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,987654,,IU/m2,183.0,109.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9938,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,,IU/kg,78.0,159.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9939,Other immunomodulatory substances,Imfinzi,278936,PubChem,IU/m2,140.0,80.0
SYNTHETIC-5,DONOR_2440,TREATMENT_9940,Other immunomodulatory substances,Trastuzumab,278936,NCI Thesaurus,IU/m2,56.0,
SYNTHETIC-5,DONOR_2441,TREATMENT_9941,,Obinutuzumab,4459876,RxNorm,IU/m2,179.0,72.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9942,Cell-based,Copanlisib,239766,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2443,TREATMENT_9943,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,mg/m2,155.0,135.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9944,,Ceritinib,,PubChem,,60.0,165.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9945,Other immunomodulatory substances,Venetoclax,987654,PubChem,g/m2,106.0,84.0
SYNTHETIC-5,DONOR_2446,TREATMENT_9946,Immune checkpoint inhibitors,Dabrafenib,8836851,NCI Thesaurus,,174.0,136.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9947,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,PubChem,IU/kg,159.0,193.0
SYNTHETIC-5,DONOR_2448,TREATMENT_9948,,Nexavar,278936,RxNorm,IU/kg,,65.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9949,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,PubChem,IU/m2,151.0,148.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9950,Immune checkpoint inhibitors,Opdivo,4459876,RxNorm,g/m2,,160.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9951,Immune checkpoint inhibitors,Atezolizumab,8836851,,IU/kg,99.0,144.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9952,Other immunomodulatory substances,Zykadia,8756456,PubChem,mg/m2,84.0,
SYNTHETIC-5,DONOR_2453,TREATMENT_9953,Other immunomodulatory substances,Keytruda,239766,PubChem,mg/kg,95.0,144.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9954,Immune checkpoint inhibitors,Blinatumomab,278936,PubChem,g/m2,135.0,180.0
SYNTHETIC-5,DONOR_2455,TREATMENT_9955,Cell-based,Yescarta,4459876,PubChem,mg/m2,132.0,147.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9956,Other immunomodulatory substances,Caprelsa,8836851,,IU/m2,181.0,181.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9957,Cell-based,,987654,,IU/m2,116.0,
SYNTHETIC-5,DONOR_2458,TREATMENT_9958,Immune checkpoint inhibitors,Kisqali,987654,RxNorm,mg/m2,99.0,
SYNTHETIC-5,DONOR_2459,TREATMENT_9959,Immune checkpoint inhibitors,Copanlisib,,,,,181.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9960,Immune checkpoint inhibitors,Opdivo,278936,PubChem,,149.0,151.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9961,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,239766,RxNorm,IU/kg,113.0,182.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9962,Immune checkpoint inhibitors,Vandetanib,278936,NCI Thesaurus,,,146.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9963,Other immunomodulatory substances,Durvalumab,,RxNorm,mg/kg,122.0,180.0
SYNTHETIC-5,DONOR_2464,TREATMENT_9964,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,,57.0,163.0
SYNTHETIC-5,DONOR_2465,TREATMENT_9965,Cell-based,Vandetanib,,RxNorm,IU/m2,161.0,60.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9966,Other immunomodulatory substances,Mektovi,8756456,RxNorm,,170.0,133.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9967,Cell-based,Opdivo,239766,PubChem,mg/kg,,66.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9968,Immune checkpoint inhibitors,Olaparib,278936,NCI Thesaurus,mg/m2,170.0,79.0
SYNTHETIC-5,DONOR_2469,TREATMENT_9969,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,RxNorm,ug/m2,175.0,101.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9970,Cell-based,Nivolumab,4459876,PubChem,IU/m2,105.0,86.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9971,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2472,TREATMENT_9972,Other immunomodulatory substances,Iressa,4459876,PubChem,ug/m2,126.0,92.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9973,Other immunomodulatory substances,,8756456,PubChem,IU/m2,140.0,196.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9974,Immune checkpoint inhibitors,Durvalumab,,PubChem,g/m2,119.0,161.0
SYNTHETIC-5,DONOR_2475,TREATMENT_9975,Immune checkpoint inhibitors,Pembrolizumab,987654,RxNorm,IU/m2,69.0,143.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9976,Cell-based,Ipilimumab,8836851,PubChem,ug/m2,57.0,71.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9977,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,PubChem,,191.0,84.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9978,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,,IU/kg,189.0,
SYNTHETIC-5,DONOR_2479,TREATMENT_9979,Immune checkpoint inhibitors,Venclexta,4459876,PubChem,mg/m2,147.0,164.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9980,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,4459876,PubChem,g/m2,143.0,
SYNTHETIC-5,DONOR_2481,TREATMENT_9981,Other immunomodulatory substances,Pexidartinib,8836851,NCI Thesaurus,ug/m2,103.0,77.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9982,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,IU/kg,71.0,162.0
SYNTHETIC-5,DONOR_2483,TREATMENT_9983,Immune checkpoint inhibitors,Gilteritinib,,RxNorm,IU/m2,134.0,90.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9984,Immune checkpoint inhibitors,Besponsa,,PubChem,cells/kg,99.0,
SYNTHETIC-5,DONOR_2485,TREATMENT_9985,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,239766,NCI Thesaurus,ug/m2,150.0,99.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9986,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,239766,PubChem,IU/kg,57.0,173.0
SYNTHETIC-5,DONOR_2487,TREATMENT_9987,Immune checkpoint inhibitors,Cotellic,4459876,NCI Thesaurus,,,161.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9988,Immune checkpoint inhibitors,,987654,NCI Thesaurus,cells/kg,,125.0
SYNTHETIC-5,DONOR_2489,TREATMENT_9989,Immune checkpoint inhibitors,Daratumumab,239766,NCI Thesaurus,ug/m2,124.0,123.0
SYNTHETIC-5,DONOR_2490,TREATMENT_9990,Other immunomodulatory substances,Gilteritinib,987654,,mg/kg,,97.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9991,Cell-based,,278936,RxNorm,mg/kg,139.0,106.0
SYNTHETIC-5,DONOR_2492,TREATMENT_9992,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,278936,NCI Thesaurus,IU/m2,57.0,88.0
SYNTHETIC-5,DONOR_2493,TREATMENT_9993,Other immunomodulatory substances,Perjeta,8836851,,cells/kg,68.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_9994,Cell-based,Yervoy,8756456,PubChem,IU/kg,95.0,157.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9995,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,g/m2,135.0,139.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9996,Immune checkpoint inhibitors,Brentuximab vedotin,8836851,NCI Thesaurus,mg/kg,71.0,155.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9997,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,239766,NCI Thesaurus,cells/kg,147.0,
SYNTHETIC-5,DONOR_2498,TREATMENT_9998,Cell-based,Alecensa,4459876,NCI Thesaurus,IU/kg,107.0,169.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9999,Cell-based,Yervoy,987654,RxNorm,g/m2,104.0,124.0
SYNTHETIC-5,DONOR_2500,TREATMENT_10000,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,4459876,,IU/m2,,56.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8001,Cell-based,Ipilimumab,4459876,RxNorm,IU/kg,173.0,158.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8002,Immune checkpoint inhibitors,Yervoy,8836851,NCI Thesaurus,IU/m2,168.0,183.0
SYNTHETIC-5,DONOR_2003,TREATMENT_8003,Cell-based,Encorafenib,4459876,NCI Thesaurus,mg/m2,122.0,
SYNTHETIC-5,DONOR_2004,TREATMENT_8004,Cell-based,Ipilimumab,8756456,PubChem,,165.0,51.0
SYNTHETIC-5,DONOR_2005,TREATMENT_8005,Other immunomodulatory substances,Cabozantinib,278936,PubChem,,151.0,155.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8006,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,IU/m2,162.0,
SYNTHETIC-5,DONOR_2007,TREATMENT_8007,Other immunomodulatory substances,Opdivo,8836851,PubChem,,,143.0
SYNTHETIC-5,DONOR_2008,TREATMENT_8008,Immune checkpoint inhibitors,,239766,RxNorm,g/m2,143.0,163.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8009,Other immunomodulatory substances,Ipilimumab,239766,NCI Thesaurus,g/m2,183.0,83.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8010,Cell-based,Tecentriq,4459876,NCI Thesaurus,IU/kg,181.0,170.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8011,Cell-based,Zejula,,PubChem,IU/m2,154.0,137.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8012,Cell-based,Herceptin,8836851,NCI Thesaurus,ug/m2,83.0,111.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8013,Cell-based,Ipilimumab,,RxNorm,g/m2,168.0,139.0
SYNTHETIC-5,DONOR_2014,TREATMENT_8014,Cell-based,,239766,NCI Thesaurus,cells/kg,186.0,85.0
SYNTHETIC-5,DONOR_2015,TREATMENT_8015,Other immunomodulatory substances,Nexavar,239766,NCI Thesaurus,IU/m2,183.0,
SYNTHETIC-5,DONOR_2016,TREATMENT_8016,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,cells/kg,122.0,152.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8017,Other immunomodulatory substances,Verzenio,278936,PubChem,cells/kg,136.0,171.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8018,Other immunomodulatory substances,Gazyva,239766,NCI Thesaurus,cells/kg,177.0,79.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8019,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8836851,RxNorm,mg/m2,172.0,194.0
SYNTHETIC-5,DONOR_2020,TREATMENT_8020,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,987654,RxNorm,cells/kg,119.0,55.0
SYNTHETIC-5,DONOR_2021,TREATMENT_8021,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,987654,RxNorm,mg/kg,59.0,132.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8022,Other immunomodulatory substances,Ado-trastuzumab emtansine,239766,PubChem,g/m2,129.0,65.0
SYNTHETIC-5,DONOR_2023,TREATMENT_8023,Other immunomodulatory substances,Tecentriq,987654,NCI Thesaurus,cells/kg,169.0,191.0
SYNTHETIC-5,DONOR_2024,TREATMENT_8024,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,mg/kg,175.0,111.0
SYNTHETIC-5,DONOR_2025,TREATMENT_8025,Cell-based,Nivolumab,239766,PubChem,ug/m2,61.0,149.0
SYNTHETIC-5,DONOR_2026,TREATMENT_8026,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,,PubChem,IU/m2,,110.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8027,,Durvalumab,4459876,RxNorm,ug/m2,86.0,148.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8028,Immune checkpoint inhibitors,Keytruda,4459876,NCI Thesaurus,mg/m2,177.0,157.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8029,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,,,114.0,122.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8030,Other immunomodulatory substances,Erlotinib,8756456,PubChem,mg/kg,138.0,73.0
SYNTHETIC-5,DONOR_2031,TREATMENT_8031,Cell-based,Tecentriq,278936,NCI Thesaurus,cells/kg,109.0,144.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8032,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,mg/kg,199.0,86.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8033,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,RxNorm,IU/kg,173.0,72.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8034,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,mg/m2,200.0,118.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8035,Cell-based,Nivolumab,239766,RxNorm,,91.0,63.0
SYNTHETIC-5,DONOR_2036,TREATMENT_8036,Cell-based,Iressa,8836851,NCI Thesaurus,mg/kg,172.0,183.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8037,Immune checkpoint inhibitors,Kadcyla,278936,RxNorm,mg/m2,96.0,122.0
SYNTHETIC-5,DONOR_2038,TREATMENT_8038,Immune checkpoint inhibitors,Niraparib,,NCI Thesaurus,ug/m2,186.0,
SYNTHETIC-5,DONOR_2039,TREATMENT_8039,Immune checkpoint inhibitors,Alectinib,8756456,NCI Thesaurus,IU/kg,104.0,94.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8040,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,PubChem,mg/m2,188.0,81.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8041,Other immunomodulatory substances,Lenvatinib,,NCI Thesaurus,ug/m2,126.0,
SYNTHETIC-5,DONOR_2042,TREATMENT_8042,Other immunomodulatory substances,,278936,RxNorm,mg/m2,107.0,190.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8043,Immune checkpoint inhibitors,Abemaciclib,,PubChem,IU/m2,,62.0
SYNTHETIC-5,DONOR_2044,TREATMENT_8044,Immune checkpoint inhibitors,Durvalumab,8756456,NCI Thesaurus,cells/kg,63.0,
SYNTHETIC-5,DONOR_2045,TREATMENT_8045,Other immunomodulatory substances,Yervoy,8836851,NCI Thesaurus,mg/m2,50.0,87.0
SYNTHETIC-5,DONOR_2046,TREATMENT_8046,Other immunomodulatory substances,Nivolumab,987654,PubChem,g/m2,84.0,120.0
SYNTHETIC-5,DONOR_2047,TREATMENT_8047,Cell-based,Lenvatinib,4459876,PubChem,IU/m2,153.0,160.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8048,Immune checkpoint inhibitors,Yescarta,8756456,PubChem,ug/m2,123.0,179.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8049,Cell-based,Sorafenib,8756456,PubChem,mg/kg,65.0,140.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8050,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,239766,RxNorm,IU/m2,131.0,177.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8051,Other immunomodulatory substances,Palbociclib,8836851,RxNorm,IU/kg,112.0,139.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8052,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,4459876,,cells/kg,55.0,
SYNTHETIC-5,DONOR_2053,TREATMENT_8053,Other immunomodulatory substances,,987654,RxNorm,mg/m2,84.0,162.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8054,,Keytruda,8756456,RxNorm,IU/kg,152.0,
SYNTHETIC-5,DONOR_2055,TREATMENT_8055,Cell-based,Ribociclib,,PubChem,cells/kg,122.0,121.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8056,Immune checkpoint inhibitors,Tisagenlecleucel,239766,PubChem,IU/kg,152.0,
SYNTHETIC-5,DONOR_2057,TREATMENT_8057,Immune checkpoint inhibitors,Atezolizumab,278936,RxNorm,mg/m2,171.0,142.0
SYNTHETIC-5,DONOR_2058,TREATMENT_8058,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8836851,RxNorm,cells/kg,90.0,94.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8059,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,239766,NCI Thesaurus,IU/kg,110.0,194.0
SYNTHETIC-5,DONOR_2060,TREATMENT_8060,Cell-based,Alecensa,278936,PubChem,,187.0,107.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8061,,Nexavar,,RxNorm,mg/kg,100.0,102.0
SYNTHETIC-5,DONOR_2062,TREATMENT_8062,Cell-based,Alectinib,8756456,RxNorm,mg/m2,126.0,172.0
SYNTHETIC-5,DONOR_2063,TREATMENT_8063,Other immunomodulatory substances,Lynparza,8836851,RxNorm,IU/m2,98.0,105.0
SYNTHETIC-5,DONOR_2064,TREATMENT_8064,Cell-based,Nexavar,8836851,NCI Thesaurus,mg/kg,186.0,
SYNTHETIC-5,DONOR_2065,TREATMENT_8065,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8756456,RxNorm,g/m2,141.0,192.0
SYNTHETIC-5,DONOR_2066,TREATMENT_8066,Cell-based,Copanlisib,239766,NCI Thesaurus,g/m2,,169.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8067,Other immunomodulatory substances,,987654,PubChem,cells/kg,187.0,98.0
SYNTHETIC-5,DONOR_2068,TREATMENT_8068,,Nivolumab,8756456,NCI Thesaurus,cells/kg,74.0,
SYNTHETIC-5,DONOR_2069,TREATMENT_8069,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,8756456,,ug/m2,119.0,85.0
SYNTHETIC-5,DONOR_2070,TREATMENT_8070,Cell-based,Atezolizumab,278936,,ug/m2,147.0,172.0
SYNTHETIC-5,DONOR_2071,TREATMENT_8071,Immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,IU/kg,,
SYNTHETIC-5,DONOR_2072,TREATMENT_8072,Other immunomodulatory substances,Keytruda,8756456,,g/m2,,60.0
SYNTHETIC-5,DONOR_2073,TREATMENT_8073,Immune checkpoint inhibitors,Yervoy,8836851,NCI Thesaurus,IU/m2,196.0,
SYNTHETIC-5,DONOR_2074,TREATMENT_8074,Cell-based,Yervoy,8836851,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2075,TREATMENT_8075,Cell-based,Ipilimumab,,NCI Thesaurus,,78.0,113.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8076,,Trastuzumab,8756456,NCI Thesaurus,g/m2,170.0,167.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8077,Immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,mg/kg,146.0,50.0
SYNTHETIC-5,DONOR_2078,TREATMENT_8078,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,8836851,RxNorm,,56.0,76.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8079,Immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,cells/kg,196.0,191.0
SYNTHETIC-5,DONOR_2080,TREATMENT_8080,Immune checkpoint inhibitors,Vemurafenib,4459876,,IU/kg,,82.0
SYNTHETIC-5,DONOR_2081,TREATMENT_8081,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,IU/m2,,86.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8082,,,4459876,NCI Thesaurus,ug/m2,196.0,128.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8083,Cell-based,Caprelsa,8756456,RxNorm,,,120.0
SYNTHETIC-5,DONOR_2084,TREATMENT_8084,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,4459876,RxNorm,mg/kg,,174.0
SYNTHETIC-5,DONOR_2085,TREATMENT_8085,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,mg/m2,88.0,112.0
SYNTHETIC-5,DONOR_2086,TREATMENT_8086,Other immunomodulatory substances,Durvalumab,239766,PubChem,mg/m2,163.0,150.0
SYNTHETIC-5,DONOR_2087,TREATMENT_8087,Other immunomodulatory substances,Alunbrig,987654,PubChem,IU/kg,143.0,88.0
SYNTHETIC-5,DONOR_2088,TREATMENT_8088,Immune checkpoint inhibitors,Lenvima,239766,,cells/kg,74.0,
SYNTHETIC-5,DONOR_2089,TREATMENT_8089,Immune checkpoint inhibitors,Atezolizumab,8836851,NCI Thesaurus,cells/kg,83.0,177.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8090,,Pertuzumab,8756456,NCI Thesaurus,mg/m2,196.0,144.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8091,Other immunomodulatory substances,Imfinzi,8756456,PubChem,g/m2,79.0,117.0
SYNTHETIC-5,DONOR_2092,TREATMENT_8092,Other immunomodulatory substances,Besponsa,8836851,,cells/kg,55.0,141.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8093,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,NCI Thesaurus,,96.0,
SYNTHETIC-5,DONOR_2094,TREATMENT_8094,Other immunomodulatory substances,Opdivo,987654,NCI Thesaurus,ug/m2,109.0,136.0
SYNTHETIC-5,DONOR_2095,TREATMENT_8095,Cell-based,Atezolizumab,278936,PubChem,cells/kg,164.0,89.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8096,Immune checkpoint inhibitors,Afatinib,239766,NCI Thesaurus,cells/kg,134.0,156.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8097,Other immunomodulatory substances,Axicabtagene ciloleucel,8836851,PubChem,IU/m2,104.0,173.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8098,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,IU/kg,174.0,50.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8099,Cell-based,Lynparza,8756456,PubChem,,101.0,140.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8100,Cell-based,Tecentriq,239766,NCI Thesaurus,IU/kg,105.0,80.0
SYNTHETIC-5,DONOR_2101,TREATMENT_8101,Cell-based,Adcetris,4459876,NCI Thesaurus,g/m2,156.0,188.0
SYNTHETIC-5,DONOR_2102,TREATMENT_8102,Other immunomodulatory substances,,278936,NCI Thesaurus,IU/kg,,52.0
SYNTHETIC-5,DONOR_2103,TREATMENT_8103,,Rubraca,278936,PubChem,ug/m2,51.0,69.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8104,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,RxNorm,IU/kg,78.0,164.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8105,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,,,cells/kg,,65.0
SYNTHETIC-5,DONOR_2106,TREATMENT_8106,Cell-based,Durvalumab,8756456,RxNorm,IU/m2,70.0,92.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8107,Immune checkpoint inhibitors,Zejula,987654,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2108,TREATMENT_8108,Immune checkpoint inhibitors,Selumitinib,4459876,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2109,TREATMENT_8109,Cell-based,Herceptin,8836851,,ug/m2,62.0,131.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8110,Other immunomodulatory substances,Kymriah,8756456,NCI Thesaurus,ug/m2,139.0,94.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8111,Other immunomodulatory substances,Tisagenlecleucel,987654,NCI Thesaurus,IU/kg,96.0,95.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8112,Other immunomodulatory substances,Nivolumab,987654,PubChem,mg/m2,79.0,
SYNTHETIC-5,DONOR_2113,TREATMENT_8113,Other immunomodulatory substances,Yervoy,,,mg/kg,118.0,129.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8114,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8836851,PubChem,mg/m2,63.0,
SYNTHETIC-5,DONOR_2115,TREATMENT_8115,Immune checkpoint inhibitors,Osimertinib,278936,PubChem,cells/kg,65.0,76.0
SYNTHETIC-5,DONOR_2116,TREATMENT_8116,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,987654,PubChem,IU/kg,,117.0
SYNTHETIC-5,DONOR_2117,TREATMENT_8117,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,8836851,RxNorm,g/m2,144.0,69.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8118,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,278936,NCI Thesaurus,IU/m2,170.0,163.0
SYNTHETIC-5,DONOR_2119,TREATMENT_8119,Immune checkpoint inhibitors,Brentuximab vedotin,4459876,RxNorm,ug/m2,114.0,106.0
SYNTHETIC-5,DONOR_2120,TREATMENT_8120,Other immunomodulatory substances,Xalkori,987654,PubChem,g/m2,71.0,188.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8121,Immune checkpoint inhibitors,Imfinzi,8756456,,,63.0,
SYNTHETIC-5,DONOR_2122,TREATMENT_8122,Other immunomodulatory substances,Pembrolizumab,278936,,ug/m2,177.0,
SYNTHETIC-5,DONOR_2123,TREATMENT_8123,Other immunomodulatory substances,Herceptin,8756456,NCI Thesaurus,mg/kg,,190.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8124,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,4459876,NCI Thesaurus,IU/m2,73.0,101.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8125,Immune checkpoint inhibitors,Pembrolizumab,278936,,mg/m2,185.0,194.0
SYNTHETIC-5,DONOR_2126,TREATMENT_8126,Other immunomodulatory substances,Inotuzumab ozogamicin,987654,NCI Thesaurus,mg/m2,91.0,177.0
SYNTHETIC-5,DONOR_2127,TREATMENT_8127,Immune checkpoint inhibitors,Ribociclib,8836851,NCI Thesaurus,mg/kg,93.0,138.0
SYNTHETIC-5,DONOR_2128,TREATMENT_8128,Immune checkpoint inhibitors,Adcetris,987654,PubChem,,78.0,
SYNTHETIC-5,DONOR_2129,TREATMENT_8129,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,987654,RxNorm,,134.0,88.0
SYNTHETIC-5,DONOR_2130,TREATMENT_8130,,,278936,,ug/m2,83.0,156.0
SYNTHETIC-5,DONOR_2131,TREATMENT_8131,Cell-based,Sorafenib,278936,NCI Thesaurus,g/m2,177.0,198.0
SYNTHETIC-5,DONOR_2132,TREATMENT_8132,,Adcetris,,,,73.0,154.0
SYNTHETIC-5,DONOR_2133,TREATMENT_8133,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,278936,NCI Thesaurus,ug/m2,200.0,195.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8134,Other immunomodulatory substances,Tarceva,4459876,PubChem,mg/m2,119.0,138.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8135,Other immunomodulatory substances,Vandetanib,987654,RxNorm,IU/m2,150.0,181.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8136,Other immunomodulatory substances,Niraparib,8756456,,g/m2,123.0,78.0
SYNTHETIC-5,DONOR_2137,TREATMENT_8137,Immune checkpoint inhibitors,Enhertu,987654,NCI Thesaurus,cells/kg,85.0,170.0
SYNTHETIC-5,DONOR_2138,TREATMENT_8138,Cell-based,Braftovi,8756456,NCI Thesaurus,cells/kg,184.0,111.0
SYNTHETIC-5,DONOR_2139,TREATMENT_8139,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,239766,,cells/kg,164.0,60.0
SYNTHETIC-5,DONOR_2140,TREATMENT_8140,,Braftovi,,NCI Thesaurus,cells/kg,76.0,50.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8141,Immune checkpoint inhibitors,Rucaparib,987654,PubChem,cells/kg,,100.0
SYNTHETIC-5,DONOR_2142,TREATMENT_8142,Cell-based,,278936,NCI Thesaurus,ug/m2,176.0,120.0
SYNTHETIC-5,DONOR_2143,TREATMENT_8143,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,239766,,mg/kg,178.0,120.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8144,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,4459876,NCI Thesaurus,IU/m2,126.0,130.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8145,,Tagrisso,239766,PubChem,mg/m2,143.0,181.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8146,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,239766,RxNorm,ug/m2,157.0,58.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8147,Other immunomodulatory substances,Iressa,4459876,,IU/m2,82.0,123.0
SYNTHETIC-5,DONOR_2148,TREATMENT_8148,Other immunomodulatory substances,Binimetinib,4459876,PubChem,IU/kg,70.0,85.0
SYNTHETIC-5,DONOR_2149,TREATMENT_8149,Other immunomodulatory substances,,239766,RxNorm,,88.0,
SYNTHETIC-5,DONOR_2150,TREATMENT_8150,Cell-based,Copanlisib,278936,RxNorm,mg/m2,142.0,113.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8151,Cell-based,Ipilimumab,278936,RxNorm,,,
SYNTHETIC-5,DONOR_2152,TREATMENT_8152,Cell-based,Trametinib,987654,NCI Thesaurus,,,171.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8153,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,4459876,PubChem,,115.0,196.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8154,Cell-based,Selumitinib,239766,NCI Thesaurus,g/m2,115.0,111.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8155,,,239766,PubChem,IU/m2,189.0,96.0
SYNTHETIC-5,DONOR_2156,TREATMENT_8156,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,,RxNorm,cells/kg,,133.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8157,Immune checkpoint inhibitors,Yervoy,278936,,mg/m2,,
SYNTHETIC-5,DONOR_2158,TREATMENT_8158,,Pembrolizumab,987654,,IU/m2,91.0,174.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8159,Other immunomodulatory substances,Atezolizumab,8836851,NCI Thesaurus,mg/kg,126.0,177.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8160,Immune checkpoint inhibitors,Besponsa,4459876,NCI Thesaurus,,111.0,136.0
SYNTHETIC-5,DONOR_2161,TREATMENT_8161,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,PubChem,g/m2,185.0,146.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8162,Immune checkpoint inhibitors,Niraparib,987654,RxNorm,IU/m2,154.0,
SYNTHETIC-5,DONOR_2163,TREATMENT_8163,Other immunomodulatory substances,,8836851,PubChem,,,71.0
SYNTHETIC-5,DONOR_2164,TREATMENT_8164,Other immunomodulatory substances,Zelboraf,987654,RxNorm,IU/kg,115.0,120.0
SYNTHETIC-5,DONOR_2165,TREATMENT_8165,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,987654,,IU/kg,176.0,123.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8166,Other immunomodulatory substances,Trametinib,8836851,PubChem,cells/kg,,125.0
SYNTHETIC-5,DONOR_2167,TREATMENT_8167,Cell-based,Opdivo,4459876,RxNorm,IU/kg,52.0,74.0
SYNTHETIC-5,DONOR_2168,TREATMENT_8168,Cell-based,Durvalumab,987654,RxNorm,mg/kg,109.0,
SYNTHETIC-5,DONOR_2169,TREATMENT_8169,Immune checkpoint inhibitors,,278936,RxNorm,g/m2,141.0,172.0
SYNTHETIC-5,DONOR_2170,TREATMENT_8170,Immune checkpoint inhibitors,Tecentriq,,PubChem,cells/kg,85.0,150.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8171,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2172,TREATMENT_8172,Other immunomodulatory substances,Yescarta,,RxNorm,IU/m2,177.0,159.0
SYNTHETIC-5,DONOR_2173,TREATMENT_8173,Cell-based,Trametinib,987654,PubChem,IU/m2,54.0,133.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8174,Other immunomodulatory substances,Palbociclib,4459876,RxNorm,mg/m2,102.0,
SYNTHETIC-5,DONOR_2175,TREATMENT_8175,,,4459876,RxNorm,mg/m2,169.0,97.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8176,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,,132.0,139.0
SYNTHETIC-5,DONOR_2177,TREATMENT_8177,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,987654,RxNorm,g/m2,170.0,141.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8178,Immune checkpoint inhibitors,Blincyto,8836851,NCI Thesaurus,IU/kg,153.0,51.0
SYNTHETIC-5,DONOR_2179,TREATMENT_8179,,Pembrolizumab,278936,PubChem,mg/kg,97.0,173.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8180,Other immunomodulatory substances,,4459876,PubChem,ug/m2,105.0,74.0
SYNTHETIC-5,DONOR_2181,TREATMENT_8181,Other immunomodulatory substances,Alectinib,8756456,,,73.0,181.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8182,Cell-based,Keytruda,987654,RxNorm,g/m2,68.0,199.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8183,,Trastuzumab,8836851,RxNorm,IU/kg,174.0,82.0
SYNTHETIC-5,DONOR_2184,TREATMENT_8184,Immune checkpoint inhibitors,Rubraca,278936,PubChem,IU/m2,193.0,139.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8185,Other immunomodulatory substances,Ibrance,278936,RxNorm,mg/m2,101.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_8186,Immune checkpoint inhibitors,Sorafenib,987654,PubChem,IU/m2,,140.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8187,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,239766,NCI Thesaurus,ug/m2,,57.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8188,,Pexidartinib,278936,RxNorm,,75.0,
SYNTHETIC-5,DONOR_2189,TREATMENT_8189,Immune checkpoint inhibitors,Gefitinib,278936,,mg/m2,194.0,129.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8190,Other immunomodulatory substances,Yervoy,278936,RxNorm,,115.0,158.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8191,Cell-based,Fam-trastuzumab deruxtecan-nxki,8756456,PubChem,cells/kg,51.0,166.0
SYNTHETIC-5,DONOR_2192,TREATMENT_8192,Cell-based,Blinatumomab,8756456,NCI Thesaurus,g/m2,95.0,104.0
SYNTHETIC-5,DONOR_2193,TREATMENT_8193,Cell-based,Tecentriq,278936,,ug/m2,90.0,200.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8194,Other immunomodulatory substances,Rituximab,239766,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2195,TREATMENT_8195,Other immunomodulatory substances,Blinatumomab,278936,NCI Thesaurus,cells/kg,,59.0
SYNTHETIC-5,DONOR_2196,TREATMENT_8196,Cell-based,Dabrafenib,278936,PubChem,IU/kg,130.0,83.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8197,Other immunomodulatory substances,Cotellic,239766,RxNorm,ug/m2,,134.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8198,Cell-based,Vandetanib,278936,NCI Thesaurus,mg/m2,,110.0
SYNTHETIC-5,DONOR_2199,TREATMENT_8199,Immune checkpoint inhibitors,Keytruda,4459876,RxNorm,IU/kg,77.0,138.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8200,,Cabozantinib,,RxNorm,cells/kg,138.0,109.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8201,Immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,g/m2,56.0,139.0
SYNTHETIC-5,DONOR_2202,TREATMENT_8202,Other immunomodulatory substances,Mektovi,239766,PubChem,mg/kg,,83.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8203,Immune checkpoint inhibitors,Kadcyla,4459876,NCI Thesaurus,IU/m2,,61.0
SYNTHETIC-5,DONOR_2204,TREATMENT_8204,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,cells/kg,123.0,157.0
SYNTHETIC-5,DONOR_2205,TREATMENT_8205,Other immunomodulatory substances,Yescarta,239766,NCI Thesaurus,g/m2,182.0,89.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8206,Other immunomodulatory substances,Keytruda,278936,NCI Thesaurus,g/m2,109.0,121.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8207,Cell-based,Copanlisib,987654,PubChem,mg/kg,115.0,188.0
SYNTHETIC-5,DONOR_2208,TREATMENT_8208,Immune checkpoint inhibitors,Blinatumomab,278936,NCI Thesaurus,cells/kg,111.0,
SYNTHETIC-5,DONOR_2209,TREATMENT_8209,Other immunomodulatory substances,Axicabtagene ciloleucel,8836851,RxNorm,IU/kg,183.0,143.0
SYNTHETIC-5,DONOR_2210,TREATMENT_8210,Other immunomodulatory substances,Atezolizumab,278936,RxNorm,cells/kg,,174.0
SYNTHETIC-5,DONOR_2211,TREATMENT_8211,Other immunomodulatory substances,,239766,PubChem,cells/kg,159.0,190.0
SYNTHETIC-5,DONOR_2212,TREATMENT_8212,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,ug/m2,139.0,171.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8213,Immune checkpoint inhibitors,Cobimetinib,987654,RxNorm,IU/m2,144.0,
SYNTHETIC-5,DONOR_2214,TREATMENT_8214,Other immunomodulatory substances,Tagrisso,8836851,NCI Thesaurus,cells/kg,,119.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8215,,Brentuximab vedotin,4459876,NCI Thesaurus,IU/kg,145.0,
SYNTHETIC-5,DONOR_2216,TREATMENT_8216,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,8756456,NCI Thesaurus,IU/kg,94.0,131.0
SYNTHETIC-5,DONOR_2217,TREATMENT_8217,Other immunomodulatory substances,Opdivo,278936,NCI Thesaurus,g/m2,113.0,73.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8218,Immune checkpoint inhibitors,Imfinzi,4459876,PubChem,IU/m2,,142.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8219,Other immunomodulatory substances,Cabozantinib,278936,,,145.0,68.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8220,Cell-based,Gilotrif,8836851,PubChem,g/m2,111.0,183.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8221,,Gilteritinib,,PubChem,ug/m2,121.0,
SYNTHETIC-5,DONOR_2222,TREATMENT_8222,,Yervoy,278936,RxNorm,,174.0,
SYNTHETIC-5,DONOR_2223,TREATMENT_8223,Cell-based,Ipilimumab,239766,RxNorm,mg/m2,58.0,145.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8224,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,4459876,NCI Thesaurus,g/m2,112.0,103.0
SYNTHETIC-5,DONOR_2225,TREATMENT_8225,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,987654,PubChem,ug/m2,,177.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8226,,Herceptin,278936,PubChem,mg/kg,152.0,152.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8227,Cell-based,Kisqali,239766,,,52.0,189.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8228,Other immunomodulatory substances,,239766,RxNorm,cells/kg,75.0,
SYNTHETIC-5,DONOR_2229,TREATMENT_8229,Cell-based,Binimetinib,4459876,NCI Thesaurus,,190.0,
SYNTHETIC-5,DONOR_2230,TREATMENT_8230,Cell-based,Caprelsa,987654,RxNorm,cells/kg,56.0,83.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8231,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,987654,PubChem,IU/m2,190.0,172.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8232,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,mg/kg,51.0,147.0
SYNTHETIC-5,DONOR_2233,TREATMENT_8233,Immune checkpoint inhibitors,Alunbrig,8836851,NCI Thesaurus,,89.0,133.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8234,Other immunomodulatory substances,,987654,PubChem,mg/m2,,120.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8235,Other immunomodulatory substances,Lynparza,239766,,cells/kg,111.0,184.0
SYNTHETIC-5,DONOR_2236,TREATMENT_8236,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,IU/m2,135.0,157.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8237,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,278936,PubChem,g/m2,90.0,
SYNTHETIC-5,DONOR_2238,TREATMENT_8238,Immune checkpoint inhibitors,Tagrisso,8756456,RxNorm,IU/kg,178.0,
SYNTHETIC-5,DONOR_2239,TREATMENT_8239,,Rubraca,8836851,NCI Thesaurus,cells/kg,176.0,103.0
SYNTHETIC-5,DONOR_2240,TREATMENT_8240,Other immunomodulatory substances,Zejula,8836851,PubChem,g/m2,91.0,
SYNTHETIC-5,DONOR_2241,TREATMENT_8241,Cell-based,Axicabtagene ciloleucel,8836851,NCI Thesaurus,IU/m2,106.0,74.0
SYNTHETIC-5,DONOR_2242,TREATMENT_8242,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8836851,RxNorm,ug/m2,147.0,83.0
SYNTHETIC-5,DONOR_2243,TREATMENT_8243,Other immunomodulatory substances,Ceritinib,8756456,RxNorm,g/m2,71.0,68.0
SYNTHETIC-5,DONOR_2244,TREATMENT_8244,Other immunomodulatory substances,,239766,NCI Thesaurus,IU/m2,87.0,118.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8245,Immune checkpoint inhibitors,Inotuzumab ozogamicin,8756456,PubChem,ug/m2,161.0,149.0
SYNTHETIC-5,DONOR_2246,TREATMENT_8246,Immune checkpoint inhibitors,Encorafenib,278936,RxNorm,IU/m2,198.0,51.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8247,Cell-based,,4459876,PubChem,cells/kg,135.0,55.0
SYNTHETIC-5,DONOR_2248,TREATMENT_8248,Immune checkpoint inhibitors,Opdivo,239766,,g/m2,155.0,121.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8249,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,4459876,RxNorm,mg/m2,,176.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8250,Cell-based,Ipilimumab,278936,NCI Thesaurus,mg/m2,,72.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8251,Cell-based,Tagrisso,8836851,PubChem,ug/m2,79.0,182.0
SYNTHETIC-5,DONOR_2252,TREATMENT_8252,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,,mg/kg,,192.0
SYNTHETIC-5,DONOR_2253,TREATMENT_8253,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,,PubChem,ug/m2,84.0,
SYNTHETIC-5,DONOR_2254,TREATMENT_8254,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8836851,RxNorm,,117.0,91.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8255,Cell-based,Daratumumab,8756456,NCI Thesaurus,mg/kg,83.0,165.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8256,Immune checkpoint inhibitors,Yervoy,278936,PubChem,IU/m2,74.0,150.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8257,Cell-based,Cotellic,8836851,RxNorm,g/m2,123.0,170.0
SYNTHETIC-5,DONOR_2258,TREATMENT_8258,Cell-based,Ipilimumab,987654,NCI Thesaurus,IU/kg,95.0,97.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8259,Cell-based,Obinutuzumab,8756456,,ug/m2,133.0,51.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8260,Immune checkpoint inhibitors,Afatinib,8836851,PubChem,cells/kg,183.0,126.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8261,Immune checkpoint inhibitors,Durvalumab,4459876,PubChem,,83.0,196.0
SYNTHETIC-5,DONOR_2262,TREATMENT_8262,Cell-based,Tecentriq,,NCI Thesaurus,cells/kg,193.0,86.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8263,,Nivolumab,4459876,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2264,TREATMENT_8264,Other immunomodulatory substances,Nivolumab,278936,RxNorm,IU/kg,129.0,91.0
SYNTHETIC-5,DONOR_2265,TREATMENT_8265,Cell-based,Mektovi,987654,NCI Thesaurus,IU/m2,64.0,103.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8266,Cell-based,,987654,NCI Thesaurus,ug/m2,178.0,119.0
SYNTHETIC-5,DONOR_2267,TREATMENT_8267,Other immunomodulatory substances,Rituximab,4459876,PubChem,cells/kg,175.0,140.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8268,Cell-based,Belantamab,8756456,RxNorm,mg/m2,,145.0
SYNTHETIC-5,DONOR_2269,TREATMENT_8269,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,IU/m2,96.0,194.0
SYNTHETIC-5,DONOR_2270,TREATMENT_8270,Cell-based,Atezolizumab,987654,NCI Thesaurus,g/m2,,106.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8271,Other immunomodulatory substances,Encorafenib,239766,NCI Thesaurus,cells/kg,152.0,148.0
SYNTHETIC-5,DONOR_2272,TREATMENT_8272,Cell-based,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,g/m2,200.0,158.0
SYNTHETIC-5,DONOR_2273,TREATMENT_8273,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8756456,NCI Thesaurus,ug/m2,98.0,113.0
SYNTHETIC-5,DONOR_2274,TREATMENT_8274,Cell-based,Rubraca,,NCI Thesaurus,IU/m2,59.0,197.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8275,,Durvalumab,239766,PubChem,IU/kg,73.0,195.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8276,Other immunomodulatory substances,Opdivo,8836851,RxNorm,IU/kg,65.0,93.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8277,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8756456,NCI Thesaurus,ug/m2,,179.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8278,,Opdivo,8836851,PubChem,mg/kg,148.0,130.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8279,Other immunomodulatory substances,Verzenio,8756456,NCI Thesaurus,,129.0,148.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8280,Cell-based,Pexidartinib,987654,RxNorm,cells/kg,87.0,
SYNTHETIC-5,DONOR_2281,TREATMENT_8281,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,239766,RxNorm,ug/m2,148.0,99.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8282,Immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,mg/m2,,158.0
SYNTHETIC-5,DONOR_2283,TREATMENT_8283,Cell-based,,8756456,PubChem,ug/m2,104.0,80.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8284,,Sorafenib,239766,NCI Thesaurus,mg/m2,136.0,132.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8285,,,8836851,,IU/m2,71.0,189.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8286,Other immunomodulatory substances,Axicabtagene ciloleucel,4459876,NCI Thesaurus,IU/m2,89.0,184.0
SYNTHETIC-5,DONOR_2287,TREATMENT_8287,,Yescarta,8756456,RxNorm,IU/kg,190.0,122.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8288,Other immunomodulatory substances,Axicabtagene ciloleucel,278936,PubChem,g/m2,169.0,58.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8289,Cell-based,Xalkori,278936,NCI Thesaurus,IU/kg,178.0,103.0
SYNTHETIC-5,DONOR_2290,TREATMENT_8290,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8756456,PubChem,IU/m2,195.0,
SYNTHETIC-5,DONOR_2291,TREATMENT_8291,Immune checkpoint inhibitors,Zelboraf,987654,NCI Thesaurus,cells/kg,67.0,197.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8292,Immune checkpoint inhibitors,Atezolizumab,,PubChem,ug/m2,71.0,181.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8293,Other immunomodulatory substances,Kisqali,8836851,,mg/m2,180.0,188.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8294,Other immunomodulatory substances,Opdivo,,,IU/m2,108.0,
SYNTHETIC-5,DONOR_2295,TREATMENT_8295,Cell-based,Inotuzumab ozogamicin,239766,RxNorm,ug/m2,189.0,
SYNTHETIC-5,DONOR_2296,TREATMENT_8296,Cell-based,Tecentriq,278936,,IU/m2,152.0,130.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8297,,Venclexta,8836851,PubChem,g/m2,158.0,184.0
SYNTHETIC-5,DONOR_2298,TREATMENT_8298,Immune checkpoint inhibitors,Nivolumab,8836851,PubChem,cells/kg,,75.0
SYNTHETIC-5,DONOR_2299,TREATMENT_8299,Cell-based,Tecentriq,239766,PubChem,,56.0,110.0
SYNTHETIC-5,DONOR_2300,TREATMENT_8300,Immune checkpoint inhibitors,Besponsa,987654,,cells/kg,,141.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8301,Other immunomodulatory substances,,,PubChem,mg/m2,150.0,157.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8302,Immune checkpoint inhibitors,Cabozantinib,8756456,PubChem,cells/kg,174.0,76.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8303,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,ug/m2,79.0,109.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8304,Cell-based,Tecentriq,239766,NCI Thesaurus,IU/m2,,63.0
SYNTHETIC-5,DONOR_2305,TREATMENT_8305,Other immunomodulatory substances,Belantamab,987654,RxNorm,mg/m2,89.0,127.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8306,Other immunomodulatory substances,Venetoclax,8836851,PubChem,mg/m2,74.0,149.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8307,Cell-based,Yervoy,4459876,PubChem,mg/m2,133.0,68.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8308,,Tecentriq,239766,PubChem,mg/kg,140.0,177.0
SYNTHETIC-5,DONOR_2309,TREATMENT_8309,Immune checkpoint inhibitors,Mektovi,,NCI Thesaurus,g/m2,174.0,53.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8310,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,,,ug/m2,124.0,184.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8311,Cell-based,Gazyva,,NCI Thesaurus,mg/kg,50.0,185.0
SYNTHETIC-5,DONOR_2312,TREATMENT_8312,Other immunomodulatory substances,Nexavar,8836851,,mg/m2,132.0,67.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8313,,Perjeta,4459876,PubChem,,162.0,100.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8314,Other immunomodulatory substances,Gazyva,278936,RxNorm,IU/kg,199.0,175.0
SYNTHETIC-5,DONOR_2315,TREATMENT_8315,,Keytruda,,RxNorm,,178.0,176.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8316,Other immunomodulatory substances,Osimertinib,987654,NCI Thesaurus,ug/m2,67.0,
SYNTHETIC-5,DONOR_2317,TREATMENT_8317,Other immunomodulatory substances,Mekinist,278936,NCI Thesaurus,IU/kg,111.0,58.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8318,Immune checkpoint inhibitors,Ipilimumab,239766,PubChem,IU/kg,70.0,111.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8319,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,NCI Thesaurus,mg/m2,168.0,88.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8320,Immune checkpoint inhibitors,Venetoclax,278936,NCI Thesaurus,ug/m2,,115.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8321,Other immunomodulatory substances,Rucaparib,8836851,PubChem,mg/kg,,128.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8322,,,278936,NCI Thesaurus,IU/kg,50.0,
SYNTHETIC-5,DONOR_2323,TREATMENT_8323,Immune checkpoint inhibitors,Afatinib,278936,PubChem,mg/kg,144.0,55.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8324,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,278936,NCI Thesaurus,IU/m2,193.0,93.0
SYNTHETIC-5,DONOR_2325,TREATMENT_8325,Cell-based,,8756456,NCI Thesaurus,IU/kg,116.0,51.0
SYNTHETIC-5,DONOR_2326,TREATMENT_8326,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8756456,PubChem,mg/m2,103.0,124.0
SYNTHETIC-5,DONOR_2327,TREATMENT_8327,Other immunomodulatory substances,Verzenio,,NCI Thesaurus,ug/m2,146.0,
SYNTHETIC-5,DONOR_2328,TREATMENT_8328,Cell-based,,4459876,RxNorm,mg/m2,53.0,131.0
SYNTHETIC-5,DONOR_2329,TREATMENT_8329,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,4459876,PubChem,g/m2,184.0,185.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8330,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/kg,56.0,76.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8331,Immune checkpoint inhibitors,Rubraca,239766,PubChem,ug/m2,,143.0
SYNTHETIC-5,DONOR_2332,TREATMENT_8332,,Atezolizumab,278936,PubChem,,78.0,181.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8333,Other immunomodulatory substances,Ibrance,,RxNorm,mg/m2,108.0,71.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8334,Other immunomodulatory substances,Pertuzumab,278936,NCI Thesaurus,cells/kg,59.0,103.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8335,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,4459876,PubChem,mg/m2,123.0,
SYNTHETIC-5,DONOR_2336,TREATMENT_8336,Other immunomodulatory substances,Lenvima,239766,PubChem,mg/m2,,186.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8337,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,278936,,ug/m2,154.0,65.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8338,Cell-based,Zykadia,8836851,PubChem,ug/m2,84.0,82.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8339,Other immunomodulatory substances,Blincyto,8756456,,IU/m2,132.0,142.0
SYNTHETIC-5,DONOR_2340,TREATMENT_8340,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,8756456,RxNorm,ug/m2,59.0,67.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8341,Cell-based,Kymriah,8836851,PubChem,g/m2,179.0,175.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8342,,,8836851,NCI Thesaurus,,166.0,58.0
SYNTHETIC-5,DONOR_2343,TREATMENT_8343,Other immunomodulatory substances,Opdivo,987654,RxNorm,IU/m2,125.0,111.0
SYNTHETIC-5,DONOR_2344,TREATMENT_8344,Cell-based,Kadcyla,278936,NCI Thesaurus,mg/kg,159.0,53.0
SYNTHETIC-5,DONOR_2345,TREATMENT_8345,Cell-based,Palbociclib,4459876,NCI Thesaurus,,182.0,118.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8346,Cell-based,Trametinib,4459876,PubChem,IU/m2,199.0,167.0
SYNTHETIC-5,DONOR_2347,TREATMENT_8347,Other immunomodulatory substances,Ipilimumab,239766,NCI Thesaurus,IU/kg,129.0,
SYNTHETIC-5,DONOR_2348,TREATMENT_8348,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,ug/m2,,
SYNTHETIC-5,DONOR_2349,TREATMENT_8349,,,,,g/m2,106.0,
SYNTHETIC-5,DONOR_2350,TREATMENT_8350,Cell-based,,8836851,PubChem,cells/kg,,57.0
SYNTHETIC-5,DONOR_2351,TREATMENT_8351,Cell-based,Durvalumab,,NCI Thesaurus,mg/m2,141.0,173.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8352,Immune checkpoint inhibitors,,,PubChem,IU/kg,197.0,140.0
SYNTHETIC-5,DONOR_2353,TREATMENT_8353,Immune checkpoint inhibitors,Tarceva,239766,NCI Thesaurus,,99.0,80.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8354,,Axicabtagene ciloleucel,,NCI Thesaurus,IU/kg,122.0,93.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8355,,Nivolumab,4459876,RxNorm,mg/kg,187.0,149.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8356,Other immunomodulatory substances,Erlotinib,239766,NCI Thesaurus,g/m2,100.0,172.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8357,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,987654,RxNorm,,188.0,176.0
SYNTHETIC-5,DONOR_2358,TREATMENT_8358,Cell-based,Ado-trastuzumab emtansine,,RxNorm,mg/m2,79.0,94.0
SYNTHETIC-5,DONOR_2359,TREATMENT_8359,Cell-based,Blinatumomab,,PubChem,mg/kg,184.0,71.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8360,,Ipilimumab,8836851,RxNorm,mg/m2,100.0,120.0
SYNTHETIC-5,DONOR_2361,TREATMENT_8361,Other immunomodulatory substances,Gilotrif,278936,NCI Thesaurus,IU/m2,160.0,
SYNTHETIC-5,DONOR_2362,TREATMENT_8362,Immune checkpoint inhibitors,,987654,RxNorm,,166.0,50.0
SYNTHETIC-5,DONOR_2363,TREATMENT_8363,Cell-based,,4459876,NCI Thesaurus,IU/kg,,110.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8364,Cell-based,Gazyva,239766,PubChem,IU/m2,181.0,
SYNTHETIC-5,DONOR_2365,TREATMENT_8365,Cell-based,Nivolumab,8836851,RxNorm,,162.0,146.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8366,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,,,151.0,77.0
SYNTHETIC-5,DONOR_2367,TREATMENT_8367,Immune checkpoint inhibitors,Nivolumab,,,cells/kg,64.0,151.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8368,,Ipilimumab,987654,,mg/m2,126.0,53.0
SYNTHETIC-5,DONOR_2369,TREATMENT_8369,Cell-based,Imfinzi,239766,NCI Thesaurus,cells/kg,,188.0
SYNTHETIC-5,DONOR_2370,TREATMENT_8370,Cell-based,Durvalumab,987654,RxNorm,mg/m2,109.0,169.0
SYNTHETIC-5,DONOR_2371,TREATMENT_8371,Other immunomodulatory substances,Niraparib,8836851,,IU/kg,54.0,99.0
SYNTHETIC-5,DONOR_2372,TREATMENT_8372,Other immunomodulatory substances,Imfinzi,987654,NCI Thesaurus,IU/kg,128.0,
SYNTHETIC-5,DONOR_2373,TREATMENT_8373,,Tagrisso,987654,NCI Thesaurus,mg/m2,188.0,70.0
SYNTHETIC-5,DONOR_2374,TREATMENT_8374,Immune checkpoint inhibitors,Crizotinib,4459876,PubChem,IU/kg,119.0,
SYNTHETIC-5,DONOR_2375,TREATMENT_8375,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,278936,RxNorm,mg/m2,73.0,136.0
SYNTHETIC-5,DONOR_2376,TREATMENT_8376,Other immunomodulatory substances,Obinutuzumab,8756456,PubChem,,124.0,95.0
SYNTHETIC-5,DONOR_2377,TREATMENT_8377,Immune checkpoint inhibitors,Selumitinib,4459876,RxNorm,mg/m2,79.0,73.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8378,Cell-based,Pertuzumab,987654,PubChem,mg/m2,154.0,174.0
SYNTHETIC-5,DONOR_2379,TREATMENT_8379,Other immunomodulatory substances,Gazyva,8836851,PubChem,IU/m2,137.0,
SYNTHETIC-5,DONOR_2380,TREATMENT_8380,Other immunomodulatory substances,Ibrance,8756456,RxNorm,IU/m2,135.0,192.0
SYNTHETIC-5,DONOR_2381,TREATMENT_8381,Other immunomodulatory substances,Pembrolizumab,278936,RxNorm,IU/kg,159.0,76.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8382,Other immunomodulatory substances,Tisagenlecleucel,987654,RxNorm,ug/m2,191.0,75.0
SYNTHETIC-5,DONOR_2383,TREATMENT_8383,Other immunomodulatory substances,Cobimetinib,987654,PubChem,IU/kg,73.0,62.0
SYNTHETIC-5,DONOR_2384,TREATMENT_8384,Immune checkpoint inhibitors,Blincyto,4459876,RxNorm,cells/kg,191.0,189.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8385,Cell-based,Lynparza,239766,,,,120.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8386,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,987654,NCI Thesaurus,g/m2,71.0,59.0
SYNTHETIC-5,DONOR_2387,TREATMENT_8387,Cell-based,Axicabtagene ciloleucel,987654,PubChem,mg/kg,81.0,137.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8388,,Nivolumab,239766,NCI Thesaurus,g/m2,112.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_8389,Immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,,112.0,174.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8390,Immune checkpoint inhibitors,Pembrolizumab,239766,RxNorm,IU/m2,160.0,
SYNTHETIC-5,DONOR_2391,TREATMENT_8391,Immune checkpoint inhibitors,Gilteritinib,239766,RxNorm,,71.0,59.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8392,Cell-based,Ribociclib,8836851,NCI Thesaurus,mg/m2,76.0,57.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8393,Cell-based,Inotuzumab ozogamicin,4459876,RxNorm,,80.0,139.0
SYNTHETIC-5,DONOR_2394,TREATMENT_8394,Other immunomodulatory substances,Brentuximab vedotin,239766,RxNorm,g/m2,168.0,153.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8395,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8756456,NCI Thesaurus,,121.0,54.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8396,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,IU/kg,149.0,167.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8397,Immune checkpoint inhibitors,Imfinzi,239766,,IU/kg,140.0,180.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8398,,Besponsa,239766,RxNorm,IU/m2,75.0,
SYNTHETIC-5,DONOR_2399,TREATMENT_8399,Immune checkpoint inhibitors,Nivolumab,987654,,IU/m2,53.0,110.0
SYNTHETIC-5,DONOR_2400,TREATMENT_8400,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,RxNorm,IU/m2,184.0,169.0
SYNTHETIC-5,DONOR_2401,TREATMENT_8401,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8756456,RxNorm,IU/kg,133.0,190.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8402,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,,mg/kg,68.0,98.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8403,Other immunomodulatory substances,Durvalumab,987654,PubChem,cells/kg,,73.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8404,Other immunomodulatory substances,Blinatumomab,278936,,cells/kg,,181.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8405,Cell-based,Selumitinib,987654,NCI Thesaurus,g/m2,,127.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8406,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,IU/m2,159.0,187.0
SYNTHETIC-5,DONOR_2407,TREATMENT_8407,Cell-based,,8836851,PubChem,IU/m2,165.0,108.0
SYNTHETIC-5,DONOR_2408,TREATMENT_8408,Immune checkpoint inhibitors,,8756456,RxNorm,,90.0,194.0
SYNTHETIC-5,DONOR_2409,TREATMENT_8409,Cell-based,Rubraca,8836851,RxNorm,,,179.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8410,Cell-based,Olaparib,,PubChem,cells/kg,143.0,197.0
SYNTHETIC-5,DONOR_2411,TREATMENT_8411,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,239766,,cells/kg,92.0,131.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8412,Cell-based,Nivolumab,,NCI Thesaurus,g/m2,58.0,62.0
SYNTHETIC-5,DONOR_2413,TREATMENT_8413,Cell-based,Nivolumab,278936,,IU/m2,174.0,176.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8414,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,,RxNorm,ug/m2,128.0,89.0
SYNTHETIC-5,DONOR_2415,TREATMENT_8415,Immune checkpoint inhibitors,Blincyto,,PubChem,ug/m2,180.0,
SYNTHETIC-5,DONOR_2416,TREATMENT_8416,Other immunomodulatory substances,Pembrolizumab,,PubChem,ug/m2,55.0,112.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8417,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,4459876,PubChem,mg/m2,84.0,
SYNTHETIC-5,DONOR_2418,TREATMENT_8418,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,987654,NCI Thesaurus,mg/m2,79.0,113.0
SYNTHETIC-5,DONOR_2419,TREATMENT_8419,Other immunomodulatory substances,Encorafenib,278936,PubChem,,139.0,194.0
SYNTHETIC-5,DONOR_2420,TREATMENT_8420,Immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,ug/m2,70.0,119.0
SYNTHETIC-5,DONOR_2421,TREATMENT_8421,Other immunomodulatory substances,Yescarta,4459876,NCI Thesaurus,cells/kg,190.0,198.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8422,Immune checkpoint inhibitors,Pembrolizumab,239766,NCI Thesaurus,IU/m2,180.0,88.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8423,Cell-based,,8836851,NCI Thesaurus,cells/kg,,146.0
SYNTHETIC-5,DONOR_2424,TREATMENT_8424,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,PubChem,IU/m2,,149.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8425,Immune checkpoint inhibitors,Iressa,278936,NCI Thesaurus,,103.0,85.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8426,Other immunomodulatory substances,Gazyva,8756456,PubChem,IU/m2,164.0,162.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8427,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,g/m2,89.0,118.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8428,Cell-based,Cometriq,8756456,RxNorm,,152.0,
SYNTHETIC-5,DONOR_2429,TREATMENT_8429,Immune checkpoint inhibitors,Obinutuzumab,4459876,PubChem,g/m2,,81.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8430,Immune checkpoint inhibitors,Gilotrif,,RxNorm,cells/kg,115.0,102.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8431,Cell-based,Ipilimumab,,,IU/m2,163.0,
SYNTHETIC-5,DONOR_2432,TREATMENT_8432,,Abemaciclib,4459876,PubChem,,69.0,124.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8433,Immune checkpoint inhibitors,Obinutuzumab,4459876,NCI Thesaurus,cells/kg,77.0,198.0
SYNTHETIC-5,DONOR_2434,TREATMENT_8434,Other immunomodulatory substances,Opdivo,987654,NCI Thesaurus,IU/m2,145.0,
SYNTHETIC-5,DONOR_2435,TREATMENT_8435,Immune checkpoint inhibitors,Vemurafenib,8836851,NCI Thesaurus,IU/kg,76.0,
SYNTHETIC-5,DONOR_2436,TREATMENT_8436,Other immunomodulatory substances,Mekinist,239766,,mg/kg,93.0,
SYNTHETIC-5,DONOR_2437,TREATMENT_8437,Immune checkpoint inhibitors,Zejula,239766,RxNorm,cells/kg,,
SYNTHETIC-5,DONOR_2438,TREATMENT_8438,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,IU/m2,155.0,183.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8439,,Imfinzi,,PubChem,IU/kg,117.0,153.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8440,,Pembrolizumab,8836851,NCI Thesaurus,cells/kg,,59.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8441,Cell-based,Binimetinib,8756456,RxNorm,mg/kg,172.0,116.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8442,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,987654,RxNorm,cells/kg,113.0,193.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8443,Immune checkpoint inhibitors,Opdivo,8756456,,mg/kg,,119.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8444,Cell-based,Imfinzi,4459876,RxNorm,g/m2,107.0,193.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8445,Cell-based,Pembrolizumab,987654,PubChem,,91.0,182.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8446,Other immunomodulatory substances,Olaparib,8836851,,mg/m2,,162.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8447,Immune checkpoint inhibitors,Necitumumab,,NCI Thesaurus,cells/kg,146.0,182.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8448,Other immunomodulatory substances,,4459876,NCI Thesaurus,mg/m2,,156.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8449,Other immunomodulatory substances,Inotuzumab ozogamicin,278936,PubChem,cells/kg,122.0,82.0
SYNTHETIC-5,DONOR_2450,TREATMENT_8450,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,4459876,RxNorm,g/m2,146.0,94.0
SYNTHETIC-5,DONOR_2451,TREATMENT_8451,Cell-based,Rituximab,987654,PubChem,ug/m2,165.0,82.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8452,Cell-based,Binimetinib,8836851,RxNorm,g/m2,122.0,151.0
SYNTHETIC-5,DONOR_2453,TREATMENT_8453,Other immunomodulatory substances,,8836851,PubChem,mg/m2,171.0,198.0
SYNTHETIC-5,DONOR_2454,TREATMENT_8454,Other immunomodulatory substances,Brigatinib,8836851,RxNorm,IU/kg,57.0,171.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8455,Immune checkpoint inhibitors,Dabrafenib,987654,,IU/kg,151.0,98.0
SYNTHETIC-5,DONOR_2456,TREATMENT_8456,Other immunomodulatory substances,Opdivo,987654,PubChem,,,
SYNTHETIC-5,DONOR_2457,TREATMENT_8457,Other immunomodulatory substances,Alunbrig,8756456,NCI Thesaurus,IU/m2,,56.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8458,Other immunomodulatory substances,Selumitinib,278936,NCI Thesaurus,,,177.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8459,Cell-based,Besponsa,278936,,IU/kg,168.0,67.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8460,Immune checkpoint inhibitors,Yervoy,8836851,RxNorm,mg/kg,126.0,99.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8461,Cell-based,Cometriq,8836851,NCI Thesaurus,IU/m2,,139.0
SYNTHETIC-5,DONOR_2462,TREATMENT_8462,Immune checkpoint inhibitors,Mektovi,8756456,PubChem,IU/m2,66.0,149.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8463,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,,,cells/kg,74.0,66.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8464,Immune checkpoint inhibitors,Atezolizumab,8836851,NCI Thesaurus,,,107.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8465,Other immunomodulatory substances,Selumitinib,8836851,NCI Thesaurus,,165.0,188.0
SYNTHETIC-5,DONOR_2466,TREATMENT_8466,Immune checkpoint inhibitors,Gazyva,278936,RxNorm,IU/kg,,120.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8467,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,mg/m2,96.0,149.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8468,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,RxNorm,ug/m2,127.0,175.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8469,Immune checkpoint inhibitors,Pembrolizumab,,RxNorm,cells/kg,165.0,178.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8470,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,RxNorm,mg/kg,,169.0
SYNTHETIC-5,DONOR_2471,TREATMENT_8471,Cell-based,Imfinzi,278936,PubChem,,75.0,81.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8472,Other immunomodulatory substances,Pembrolizumab,987654,PubChem,cells/kg,124.0,137.0
SYNTHETIC-5,DONOR_2473,TREATMENT_8473,Other immunomodulatory substances,Opdivo,,RxNorm,IU/kg,192.0,90.0
SYNTHETIC-5,DONOR_2474,TREATMENT_8474,,Pembrolizumab,278936,NCI Thesaurus,cells/kg,,
SYNTHETIC-5,DONOR_2475,TREATMENT_8475,Other immunomodulatory substances,Besponsa,4459876,RxNorm,cells/kg,93.0,74.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8476,Other immunomodulatory substances,Ipilimumab,4459876,PubChem,IU/kg,82.0,115.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8477,Other immunomodulatory substances,Braftovi,239766,PubChem,mg/kg,155.0,102.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8478,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,g/m2,110.0,188.0
SYNTHETIC-5,DONOR_2479,TREATMENT_8479,Other immunomodulatory substances,,,PubChem,IU/kg,63.0,101.0
SYNTHETIC-5,DONOR_2480,TREATMENT_8480,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,,RxNorm,IU/kg,57.0,
SYNTHETIC-5,DONOR_2481,TREATMENT_8481,Other immunomodulatory substances,Pembrolizumab,4459876,,mg/kg,83.0,177.0
SYNTHETIC-5,DONOR_2482,TREATMENT_8482,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,,RxNorm,mg/m2,199.0,194.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8483,Cell-based,Abemaciclib,239766,RxNorm,cells/kg,164.0,84.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8484,Immune checkpoint inhibitors,Tecentriq,239766,NCI Thesaurus,ug/m2,,72.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8485,Other immunomodulatory substances,Opdivo,8756456,PubChem,cells/kg,101.0,79.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8486,Other immunomodulatory substances,,278936,PubChem,,,157.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8487,Cell-based,Copanlisib,4459876,RxNorm,IU/kg,155.0,76.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8488,Cell-based,,,PubChem,,123.0,116.0
SYNTHETIC-5,DONOR_2489,TREATMENT_8489,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,987654,PubChem,,125.0,72.0
SYNTHETIC-5,DONOR_2490,TREATMENT_8490,Other immunomodulatory substances,Imfinzi,8836851,PubChem,cells/kg,112.0,158.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8491,Cell-based,,4459876,NCI Thesaurus,,145.0,
SYNTHETIC-5,DONOR_2492,TREATMENT_8492,Immune checkpoint inhibitors,Ibrance,239766,NCI Thesaurus,mg/kg,55.0,118.0
SYNTHETIC-5,DONOR_2493,TREATMENT_8493,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8836851,NCI Thesaurus,g/m2,181.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_8494,Other immunomodulatory substances,Yervoy,8756456,,mg/m2,134.0,72.0
SYNTHETIC-5,DONOR_2495,TREATMENT_8495,,Tarceva,8756456,PubChem,ug/m2,,174.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8496,Immune checkpoint inhibitors,,987654,PubChem,IU/kg,54.0,
SYNTHETIC-5,DONOR_2497,TREATMENT_8497,Other immunomodulatory substances,Mekinist,239766,NCI Thesaurus,,,56.0
SYNTHETIC-5,DONOR_2498,TREATMENT_8498,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,,RxNorm,,144.0,175.0
SYNTHETIC-5,DONOR_2499,TREATMENT_8499,Immune checkpoint inhibitors,,4459876,RxNorm,cells/kg,84.0,
SYNTHETIC-5,DONOR_2500,TREATMENT_8500,Other immunomodulatory substances,Keytruda,4459876,RxNorm,mg/kg,97.0,104.0
SYNTHETIC-5,DONOR_2001,TREATMENT_8501,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,,RxNorm,,124.0,140.0
SYNTHETIC-5,DONOR_2002,TREATMENT_8502,Immune checkpoint inhibitors,,8756456,PubChem,g/m2,88.0,
SYNTHETIC-5,DONOR_2003,TREATMENT_8503,Immune checkpoint inhibitors,Gazyva,,PubChem,IU/kg,136.0,170.0
SYNTHETIC-5,DONOR_2004,TREATMENT_8504,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,g/m2,,129.0
SYNTHETIC-5,DONOR_2005,TREATMENT_8505,,Gazyva,278936,RxNorm,IU/kg,87.0,170.0
SYNTHETIC-5,DONOR_2006,TREATMENT_8506,,Opdivo,278936,RxNorm,ug/m2,175.0,149.0
SYNTHETIC-5,DONOR_2007,TREATMENT_8507,Cell-based,Nivolumab,,PubChem,IU/m2,175.0,
SYNTHETIC-5,DONOR_2008,TREATMENT_8508,Other immunomodulatory substances,Herceptin,239766,,IU/kg,113.0,144.0
SYNTHETIC-5,DONOR_2009,TREATMENT_8509,Cell-based,Tisagenlecleucel,278936,PubChem,,118.0,87.0
SYNTHETIC-5,DONOR_2010,TREATMENT_8510,Immune checkpoint inhibitors,,4459876,,,,99.0
SYNTHETIC-5,DONOR_2011,TREATMENT_8511,Other immunomodulatory substances,Mektovi,8836851,RxNorm,mg/m2,191.0,179.0
SYNTHETIC-5,DONOR_2012,TREATMENT_8512,Immune checkpoint inhibitors,Keytruda,8836851,,IU/kg,162.0,82.0
SYNTHETIC-5,DONOR_2013,TREATMENT_8513,Immune checkpoint inhibitors,Crizotinib,,RxNorm,,,
SYNTHETIC-5,DONOR_2014,TREATMENT_8514,Other immunomodulatory substances,Adcetris,8836851,RxNorm,IU/m2,85.0,
SYNTHETIC-5,DONOR_2015,TREATMENT_8515,Other immunomodulatory substances,Opdivo,4459876,,mg/m2,137.0,184.0
SYNTHETIC-5,DONOR_2016,TREATMENT_8516,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,RxNorm,,65.0,133.0
SYNTHETIC-5,DONOR_2017,TREATMENT_8517,Cell-based,Blinatumomab,278936,PubChem,g/m2,142.0,62.0
SYNTHETIC-5,DONOR_2018,TREATMENT_8518,Cell-based,Erlotinib,987654,PubChem,IU/kg,105.0,101.0
SYNTHETIC-5,DONOR_2019,TREATMENT_8519,Cell-based,,8836851,NCI Thesaurus,mg/kg,165.0,108.0
SYNTHETIC-5,DONOR_2020,TREATMENT_8520,Other immunomodulatory substances,Atezolizumab,987654,RxNorm,mg/kg,,110.0
SYNTHETIC-5,DONOR_2021,TREATMENT_8521,Other immunomodulatory substances,Rituxan,,PubChem,g/m2,51.0,192.0
SYNTHETIC-5,DONOR_2022,TREATMENT_8522,Cell-based,Opdivo,278936,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2023,TREATMENT_8523,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,,PubChem,,82.0,150.0
SYNTHETIC-5,DONOR_2024,TREATMENT_8524,Immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/kg,95.0,158.0
SYNTHETIC-5,DONOR_2025,TREATMENT_8525,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,mg/kg,59.0,53.0
SYNTHETIC-5,DONOR_2026,TREATMENT_8526,Immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,IU/m2,137.0,61.0
SYNTHETIC-5,DONOR_2027,TREATMENT_8527,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,278936,,ug/m2,193.0,125.0
SYNTHETIC-5,DONOR_2028,TREATMENT_8528,Immune checkpoint inhibitors,Cotellic,278936,RxNorm,ug/m2,57.0,134.0
SYNTHETIC-5,DONOR_2029,TREATMENT_8529,Cell-based,Nivolumab,987654,,g/m2,141.0,76.0
SYNTHETIC-5,DONOR_2030,TREATMENT_8530,Immune checkpoint inhibitors,Yervoy,8756456,NCI Thesaurus,IU/m2,197.0,151.0
SYNTHETIC-5,DONOR_2031,TREATMENT_8531,Immune checkpoint inhibitors,Opdivo,4459876,RxNorm,IU/kg,77.0,156.0
SYNTHETIC-5,DONOR_2032,TREATMENT_8532,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,ug/m2,54.0,164.0
SYNTHETIC-5,DONOR_2033,TREATMENT_8533,Immune checkpoint inhibitors,Vemurafenib,8836851,NCI Thesaurus,mg/kg,152.0,147.0
SYNTHETIC-5,DONOR_2034,TREATMENT_8534,,,8836851,PubChem,mg/kg,76.0,88.0
SYNTHETIC-5,DONOR_2035,TREATMENT_8535,Other immunomodulatory substances,Keytruda,8836851,PubChem,mg/kg,,139.0
SYNTHETIC-5,DONOR_2036,TREATMENT_8536,Other immunomodulatory substances,Ipilimumab,8836851,RxNorm,g/m2,163.0,186.0
SYNTHETIC-5,DONOR_2037,TREATMENT_8537,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,RxNorm,,,197.0
SYNTHETIC-5,DONOR_2038,TREATMENT_8538,Immune checkpoint inhibitors,Braftovi,4459876,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2039,TREATMENT_8539,Other immunomodulatory substances,Ipilimumab,8756456,RxNorm,,173.0,66.0
SYNTHETIC-5,DONOR_2040,TREATMENT_8540,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,PubChem,mg/kg,,160.0
SYNTHETIC-5,DONOR_2041,TREATMENT_8541,Immune checkpoint inhibitors,Ceritinib,278936,PubChem,cells/kg,134.0,169.0
SYNTHETIC-5,DONOR_2042,TREATMENT_8542,Cell-based,Vemurafenib,278936,PubChem,IU/m2,100.0,129.0
SYNTHETIC-5,DONOR_2043,TREATMENT_8543,Cell-based,Inotuzumab ozogamicin,8756456,RxNorm,mg/kg,138.0,105.0
SYNTHETIC-5,DONOR_2044,TREATMENT_8544,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8756456,PubChem,cells/kg,195.0,
SYNTHETIC-5,DONOR_2045,TREATMENT_8545,Immune checkpoint inhibitors,Ipilimumab,278936,RxNorm,ug/m2,,142.0
SYNTHETIC-5,DONOR_2046,TREATMENT_8546,Immune checkpoint inhibitors,Pembrolizumab,8756456,PubChem,cells/kg,95.0,136.0
SYNTHETIC-5,DONOR_2047,TREATMENT_8547,Cell-based,Alunbrig,987654,PubChem,mg/m2,149.0,143.0
SYNTHETIC-5,DONOR_2048,TREATMENT_8548,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,,ug/m2,,63.0
SYNTHETIC-5,DONOR_2049,TREATMENT_8549,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,239766,RxNorm,mg/m2,99.0,131.0
SYNTHETIC-5,DONOR_2050,TREATMENT_8550,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,ug/m2,184.0,172.0
SYNTHETIC-5,DONOR_2051,TREATMENT_8551,Immune checkpoint inhibitors,,278936,PubChem,mg/kg,148.0,102.0
SYNTHETIC-5,DONOR_2052,TREATMENT_8552,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,PubChem,mg/kg,97.0,123.0
SYNTHETIC-5,DONOR_2053,TREATMENT_8553,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,239766,RxNorm,IU/kg,173.0,171.0
SYNTHETIC-5,DONOR_2054,TREATMENT_8554,Cell-based,Gilteritinib,4459876,,IU/kg,,163.0
SYNTHETIC-5,DONOR_2055,TREATMENT_8555,Cell-based,Trametinib,239766,RxNorm,cells/kg,139.0,167.0
SYNTHETIC-5,DONOR_2056,TREATMENT_8556,Other immunomodulatory substances,Mekinist,8756456,PubChem,IU/kg,89.0,
SYNTHETIC-5,DONOR_2057,TREATMENT_8557,Cell-based,,,NCI Thesaurus,ug/m2,65.0,
SYNTHETIC-5,DONOR_2058,TREATMENT_8558,Immune checkpoint inhibitors,Abemaciclib,278936,RxNorm,IU/m2,142.0,194.0
SYNTHETIC-5,DONOR_2059,TREATMENT_8559,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,4459876,PubChem,IU/kg,144.0,52.0
SYNTHETIC-5,DONOR_2060,TREATMENT_8560,Other immunomodulatory substances,Rituximab,,RxNorm,IU/kg,71.0,119.0
SYNTHETIC-5,DONOR_2061,TREATMENT_8561,Other immunomodulatory substances,Tisagenlecleucel,,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2062,TREATMENT_8562,Cell-based,Tagrisso,8836851,RxNorm,mg/m2,,73.0
SYNTHETIC-5,DONOR_2063,TREATMENT_8563,Other immunomodulatory substances,Adcetris,987654,NCI Thesaurus,mg/kg,189.0,153.0
SYNTHETIC-5,DONOR_2064,TREATMENT_8564,Immune checkpoint inhibitors,Nivolumab,8836851,,mg/m2,,125.0
SYNTHETIC-5,DONOR_2065,TREATMENT_8565,Cell-based,Vemurafenib,8756456,,IU/kg,159.0,
SYNTHETIC-5,DONOR_2066,TREATMENT_8566,Immune checkpoint inhibitors,Opdivo,8756456,RxNorm,IU/kg,177.0,199.0
SYNTHETIC-5,DONOR_2067,TREATMENT_8567,Cell-based,,239766,NCI Thesaurus,,130.0,88.0
SYNTHETIC-5,DONOR_2068,TREATMENT_8568,,Nexavar,8756456,PubChem,,197.0,109.0
SYNTHETIC-5,DONOR_2069,TREATMENT_8569,Cell-based,,4459876,PubChem,g/m2,,59.0
SYNTHETIC-5,DONOR_2070,TREATMENT_8570,,Alecensa,239766,PubChem,mg/kg,76.0,85.0
SYNTHETIC-5,DONOR_2071,TREATMENT_8571,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,987654,PubChem,,58.0,172.0
SYNTHETIC-5,DONOR_2072,TREATMENT_8572,Immune checkpoint inhibitors,Zejula,239766,PubChem,cells/kg,88.0,
SYNTHETIC-5,DONOR_2073,TREATMENT_8573,Immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,cells/kg,,188.0
SYNTHETIC-5,DONOR_2074,TREATMENT_8574,Other immunomodulatory substances,Caprelsa,239766,,,155.0,152.0
SYNTHETIC-5,DONOR_2075,TREATMENT_8575,Other immunomodulatory substances,Zykadia,239766,NCI Thesaurus,ug/m2,,164.0
SYNTHETIC-5,DONOR_2076,TREATMENT_8576,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,,,cells/kg,,167.0
SYNTHETIC-5,DONOR_2077,TREATMENT_8577,Other immunomodulatory substances,Cabozantinib,,PubChem,ug/m2,186.0,
SYNTHETIC-5,DONOR_2078,TREATMENT_8578,,Kisqali,278936,PubChem,IU/kg,,60.0
SYNTHETIC-5,DONOR_2079,TREATMENT_8579,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,987654,PubChem,IU/m2,95.0,110.0
SYNTHETIC-5,DONOR_2080,TREATMENT_8580,,Yervoy,,,IU/m2,99.0,88.0
SYNTHETIC-5,DONOR_2081,TREATMENT_8581,Cell-based,Opdivo,8836851,PubChem,mg/kg,103.0,157.0
SYNTHETIC-5,DONOR_2082,TREATMENT_8582,Cell-based,Tecentriq,239766,NCI Thesaurus,,104.0,178.0
SYNTHETIC-5,DONOR_2083,TREATMENT_8583,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,mg/m2,137.0,152.0
SYNTHETIC-5,DONOR_2084,TREATMENT_8584,Other immunomodulatory substances,Keytruda,,PubChem,ug/m2,111.0,66.0
SYNTHETIC-5,DONOR_2085,TREATMENT_8585,Cell-based,Gefitinib,,RxNorm,g/m2,188.0,156.0
SYNTHETIC-5,DONOR_2086,TREATMENT_8586,Cell-based,Zykadia,,RxNorm,mg/m2,105.0,
SYNTHETIC-5,DONOR_2087,TREATMENT_8587,,Abemaciclib,8836851,PubChem,ug/m2,115.0,182.0
SYNTHETIC-5,DONOR_2088,TREATMENT_8588,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,987654,,cells/kg,85.0,175.0
SYNTHETIC-5,DONOR_2089,TREATMENT_8589,Immune checkpoint inhibitors,Nexavar,8836851,,,163.0,63.0
SYNTHETIC-5,DONOR_2090,TREATMENT_8590,Immune checkpoint inhibitors,Nivolumab,987654,RxNorm,,,187.0
SYNTHETIC-5,DONOR_2091,TREATMENT_8591,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,PubChem,ug/m2,158.0,149.0
SYNTHETIC-5,DONOR_2092,TREATMENT_8592,Cell-based,Palbociclib,4459876,PubChem,cells/kg,73.0,85.0
SYNTHETIC-5,DONOR_2093,TREATMENT_8593,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,PubChem,mg/m2,192.0,138.0
SYNTHETIC-5,DONOR_2094,TREATMENT_8594,Cell-based,Brigatinib,239766,NCI Thesaurus,,179.0,117.0
SYNTHETIC-5,DONOR_2095,TREATMENT_8595,Immune checkpoint inhibitors,Keytruda,8836851,NCI Thesaurus,g/m2,107.0,159.0
SYNTHETIC-5,DONOR_2096,TREATMENT_8596,Other immunomodulatory substances,Cotellic,239766,PubChem,ug/m2,,111.0
SYNTHETIC-5,DONOR_2097,TREATMENT_8597,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,8756456,PubChem,ug/m2,85.0,173.0
SYNTHETIC-5,DONOR_2098,TREATMENT_8598,Other immunomodulatory substances,Enhertu,8836851,RxNorm,g/m2,87.0,65.0
SYNTHETIC-5,DONOR_2099,TREATMENT_8599,Cell-based,Opdivo,4459876,,,127.0,131.0
SYNTHETIC-5,DONOR_2100,TREATMENT_8600,Cell-based,Ceritinib,987654,,cells/kg,,
SYNTHETIC-5,DONOR_2101,TREATMENT_8601,Immune checkpoint inhibitors,Pertuzumab,278936,PubChem,g/m2,116.0,107.0
SYNTHETIC-5,DONOR_2102,TREATMENT_8602,Cell-based,Atezolizumab,8836851,NCI Thesaurus,IU/kg,182.0,133.0
SYNTHETIC-5,DONOR_2103,TREATMENT_8603,Cell-based,Tagrisso,239766,PubChem,cells/kg,115.0,119.0
SYNTHETIC-5,DONOR_2104,TREATMENT_8604,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,g/m2,176.0,138.0
SYNTHETIC-5,DONOR_2105,TREATMENT_8605,Immune checkpoint inhibitors,Alunbrig,4459876,PubChem,mg/kg,148.0,
SYNTHETIC-5,DONOR_2106,TREATMENT_8606,Cell-based,,987654,RxNorm,IU/m2,58.0,69.0
SYNTHETIC-5,DONOR_2107,TREATMENT_8607,Cell-based,Opdivo,278936,NCI Thesaurus,IU/kg,72.0,69.0
SYNTHETIC-5,DONOR_2108,TREATMENT_8608,Other immunomodulatory substances,Cabozantinib,278936,RxNorm,cells/kg,,174.0
SYNTHETIC-5,DONOR_2109,TREATMENT_8609,Other immunomodulatory substances,Zykadia,,PubChem,mg/kg,139.0,87.0
SYNTHETIC-5,DONOR_2110,TREATMENT_8610,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8836851,RxNorm,ug/m2,87.0,84.0
SYNTHETIC-5,DONOR_2111,TREATMENT_8611,Cell-based,,4459876,RxNorm,IU/kg,117.0,110.0
SYNTHETIC-5,DONOR_2112,TREATMENT_8612,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,PubChem,ug/m2,134.0,185.0
SYNTHETIC-5,DONOR_2113,TREATMENT_8613,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,mg/m2,164.0,182.0
SYNTHETIC-5,DONOR_2114,TREATMENT_8614,,Enhertu,4459876,PubChem,g/m2,161.0,151.0
SYNTHETIC-5,DONOR_2115,TREATMENT_8615,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,278936,PubChem,,134.0,111.0
SYNTHETIC-5,DONOR_2116,TREATMENT_8616,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,8756456,PubChem,cells/kg,102.0,132.0
SYNTHETIC-5,DONOR_2117,TREATMENT_8617,Cell-based,Ribociclib,4459876,PubChem,IU/m2,125.0,166.0
SYNTHETIC-5,DONOR_2118,TREATMENT_8618,Immune checkpoint inhibitors,Cobimetinib,8836851,RxNorm,mg/kg,141.0,93.0
SYNTHETIC-5,DONOR_2119,TREATMENT_8619,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,mg/kg,99.0,56.0
SYNTHETIC-5,DONOR_2120,TREATMENT_8620,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,,g/m2,199.0,98.0
SYNTHETIC-5,DONOR_2121,TREATMENT_8621,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,4459876,PubChem,cells/kg,,196.0
SYNTHETIC-5,DONOR_2122,TREATMENT_8622,,Kisqali,278936,RxNorm,ug/m2,95.0,116.0
SYNTHETIC-5,DONOR_2123,TREATMENT_8623,Immune checkpoint inhibitors,Keytruda,8836851,NCI Thesaurus,g/m2,101.0,177.0
SYNTHETIC-5,DONOR_2124,TREATMENT_8624,Other immunomodulatory substances,Kymriah,987654,RxNorm,mg/m2,,51.0
SYNTHETIC-5,DONOR_2125,TREATMENT_8625,Cell-based,Atezolizumab,987654,PubChem,cells/kg,183.0,
SYNTHETIC-5,DONOR_2126,TREATMENT_8626,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,239766,NCI Thesaurus,,,
SYNTHETIC-5,DONOR_2127,TREATMENT_8627,Immune checkpoint inhibitors,Copanlisib,8836851,PubChem,mg/m2,103.0,
SYNTHETIC-5,DONOR_2128,TREATMENT_8628,Cell-based,Blinatumomab,239766,,mg/m2,84.0,
SYNTHETIC-5,DONOR_2129,TREATMENT_8629,Other immunomodulatory substances,Ipilimumab,8836851,,ug/m2,61.0,84.0
SYNTHETIC-5,DONOR_2130,TREATMENT_8630,Other immunomodulatory substances,Zykadia,8836851,NCI Thesaurus,mg/kg,121.0,
SYNTHETIC-5,DONOR_2131,TREATMENT_8631,Other immunomodulatory substances,Daratumumab,8756456,,IU/m2,156.0,189.0
SYNTHETIC-5,DONOR_2132,TREATMENT_8632,,Lenvatinib,8756456,,IU/kg,,
SYNTHETIC-5,DONOR_2133,TREATMENT_8633,,Atezolizumab,987654,PubChem,IU/m2,67.0,174.0
SYNTHETIC-5,DONOR_2134,TREATMENT_8634,Immune checkpoint inhibitors,Cotellic,8756456,PubChem,g/m2,,196.0
SYNTHETIC-5,DONOR_2135,TREATMENT_8635,Immune checkpoint inhibitors,Ipilimumab,8836851,,mg/m2,121.0,76.0
SYNTHETIC-5,DONOR_2136,TREATMENT_8636,Cell-based,Ibrance,4459876,RxNorm,g/m2,61.0,192.0
SYNTHETIC-5,DONOR_2137,TREATMENT_8637,Immune checkpoint inhibitors,Gilotrif,,RxNorm,IU/kg,74.0,65.0
SYNTHETIC-5,DONOR_2138,TREATMENT_8638,Cell-based,Darzalex,,PubChem,ug/m2,174.0,53.0
SYNTHETIC-5,DONOR_2139,TREATMENT_8639,Other immunomodulatory substances,Trametinib,239766,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2140,TREATMENT_8640,Cell-based,Adcetris,8756456,RxNorm,mg/kg,172.0,107.0
SYNTHETIC-5,DONOR_2141,TREATMENT_8641,Other immunomodulatory substances,Cabozantinib,8836851,NCI Thesaurus,,182.0,
SYNTHETIC-5,DONOR_2142,TREATMENT_8642,,Crizotinib,987654,PubChem,IU/m2,181.0,93.0
SYNTHETIC-5,DONOR_2143,TREATMENT_8643,Immune checkpoint inhibitors,,987654,NCI Thesaurus,g/m2,184.0,132.0
SYNTHETIC-5,DONOR_2144,TREATMENT_8644,Other immunomodulatory substances,Olaparib,8756456,RxNorm,ug/m2,,109.0
SYNTHETIC-5,DONOR_2145,TREATMENT_8645,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8756456,NCI Thesaurus,ug/m2,66.0,129.0
SYNTHETIC-5,DONOR_2146,TREATMENT_8646,Cell-based,Ado-trastuzumab emtansine,987654,RxNorm,g/m2,193.0,106.0
SYNTHETIC-5,DONOR_2147,TREATMENT_8647,Immune checkpoint inhibitors,Venclexta,278936,NCI Thesaurus,mg/m2,58.0,138.0
SYNTHETIC-5,DONOR_2148,TREATMENT_8648,Immune checkpoint inhibitors,Atezolizumab,,PubChem,ug/m2,,
SYNTHETIC-5,DONOR_2149,TREATMENT_8649,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,8836851,PubChem,g/m2,64.0,
SYNTHETIC-5,DONOR_2150,TREATMENT_8650,Other immunomodulatory substances,Erlotinib,278936,RxNorm,g/m2,197.0,123.0
SYNTHETIC-5,DONOR_2151,TREATMENT_8651,,Blincyto,278936,NCI Thesaurus,ug/m2,134.0,136.0
SYNTHETIC-5,DONOR_2152,TREATMENT_8652,,Yervoy,4459876,RxNorm,IU/m2,183.0,158.0
SYNTHETIC-5,DONOR_2153,TREATMENT_8653,Immune checkpoint inhibitors,Rituxan,4459876,,ug/m2,60.0,74.0
SYNTHETIC-5,DONOR_2154,TREATMENT_8654,Other immunomodulatory substances,Xalkori,8756456,,IU/m2,97.0,187.0
SYNTHETIC-5,DONOR_2155,TREATMENT_8655,Cell-based,Lenvatinib,987654,PubChem,,160.0,
SYNTHETIC-5,DONOR_2156,TREATMENT_8656,Immune checkpoint inhibitors,Opdivo,8756456,,,77.0,127.0
SYNTHETIC-5,DONOR_2157,TREATMENT_8657,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,,97.0,160.0
SYNTHETIC-5,DONOR_2158,TREATMENT_8658,,Ribociclib,239766,RxNorm,mg/m2,115.0,138.0
SYNTHETIC-5,DONOR_2159,TREATMENT_8659,Other immunomodulatory substances,Trametinib,987654,NCI Thesaurus,IU/kg,104.0,191.0
SYNTHETIC-5,DONOR_2160,TREATMENT_8660,Cell-based,Sorafenib,8756456,RxNorm,IU/kg,100.0,138.0
SYNTHETIC-5,DONOR_2161,TREATMENT_8661,Cell-based,,987654,PubChem,mg/m2,105.0,78.0
SYNTHETIC-5,DONOR_2162,TREATMENT_8662,Immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,mg/m2,64.0,160.0
SYNTHETIC-5,DONOR_2163,TREATMENT_8663,Cell-based,Trastuzumab,8756456,RxNorm,cells/kg,198.0,
SYNTHETIC-5,DONOR_2164,TREATMENT_8664,Cell-based,Erlotinib,8836851,NCI Thesaurus,IU/m2,69.0,103.0
SYNTHETIC-5,DONOR_2165,TREATMENT_8665,,Afatinib,987654,RxNorm,cells/kg,187.0,138.0
SYNTHETIC-5,DONOR_2166,TREATMENT_8666,Immune checkpoint inhibitors,Ipilimumab,987654,RxNorm,IU/kg,,83.0
SYNTHETIC-5,DONOR_2167,TREATMENT_8667,Other immunomodulatory substances,Afatinib,239766,PubChem,mg/m2,136.0,
SYNTHETIC-5,DONOR_2168,TREATMENT_8668,,Tagrisso,8756456,NCI Thesaurus,g/m2,64.0,139.0
SYNTHETIC-5,DONOR_2169,TREATMENT_8669,Cell-based,Lynparza,8836851,RxNorm,ug/m2,112.0,185.0
SYNTHETIC-5,DONOR_2170,TREATMENT_8670,Other immunomodulatory substances,Cabozantinib,278936,PubChem,IU/kg,,126.0
SYNTHETIC-5,DONOR_2171,TREATMENT_8671,Immune checkpoint inhibitors,Nivolumab,278936,NCI Thesaurus,g/m2,,184.0
SYNTHETIC-5,DONOR_2172,TREATMENT_8672,Cell-based,Kadcyla,8836851,PubChem,mg/m2,,
SYNTHETIC-5,DONOR_2173,TREATMENT_8673,Cell-based,Tecentriq,8836851,RxNorm,IU/m2,79.0,95.0
SYNTHETIC-5,DONOR_2174,TREATMENT_8674,Immune checkpoint inhibitors,Imfinzi,278936,RxNorm,,131.0,72.0
SYNTHETIC-5,DONOR_2175,TREATMENT_8675,Immune checkpoint inhibitors,Ribociclib,278936,NCI Thesaurus,,83.0,110.0
SYNTHETIC-5,DONOR_2176,TREATMENT_8676,Other immunomodulatory substances,Yervoy,8756456,NCI Thesaurus,ug/m2,126.0,
SYNTHETIC-5,DONOR_2177,TREATMENT_8677,Other immunomodulatory substances,Keytruda,987654,RxNorm,IU/m2,137.0,138.0
SYNTHETIC-5,DONOR_2178,TREATMENT_8678,Cell-based,Durvalumab,8756456,NCI Thesaurus,cells/kg,,179.0
SYNTHETIC-5,DONOR_2179,TREATMENT_8679,Cell-based,Copanlisib,8756456,NCI Thesaurus,mg/m2,144.0,143.0
SYNTHETIC-5,DONOR_2180,TREATMENT_8680,Cell-based,Braftovi,,PubChem,mg/kg,116.0,
SYNTHETIC-5,DONOR_2181,TREATMENT_8681,Immune checkpoint inhibitors,Axicabtagene ciloleucel,,RxNorm,IU/kg,176.0,54.0
SYNTHETIC-5,DONOR_2182,TREATMENT_8682,Other immunomodulatory substances,Opdivo,239766,PubChem,mg/m2,200.0,157.0
SYNTHETIC-5,DONOR_2183,TREATMENT_8683,Immune checkpoint inhibitors,Ribociclib,,RxNorm,g/m2,198.0,
SYNTHETIC-5,DONOR_2184,TREATMENT_8684,Other immunomodulatory substances,,8836851,RxNorm,IU/kg,157.0,84.0
SYNTHETIC-5,DONOR_2185,TREATMENT_8685,Immune checkpoint inhibitors,Opdivo,4459876,RxNorm,IU/kg,98.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_8686,Other immunomodulatory substances,Afatinib,8836851,PubChem,IU/kg,,166.0
SYNTHETIC-5,DONOR_2187,TREATMENT_8687,Cell-based,Obinutuzumab,4459876,NCI Thesaurus,mg/kg,135.0,142.0
SYNTHETIC-5,DONOR_2188,TREATMENT_8688,Other immunomodulatory substances,Pembrolizumab,278936,RxNorm,g/m2,120.0,98.0
SYNTHETIC-5,DONOR_2189,TREATMENT_8689,Cell-based,Pexidartinib,239766,PubChem,cells/kg,69.0,81.0
SYNTHETIC-5,DONOR_2190,TREATMENT_8690,Immune checkpoint inhibitors,Adcetris,987654,NCI Thesaurus,mg/m2,174.0,140.0
SYNTHETIC-5,DONOR_2191,TREATMENT_8691,Cell-based,Rubraca,4459876,,mg/kg,116.0,
SYNTHETIC-5,DONOR_2192,TREATMENT_8692,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,239766,NCI Thesaurus,IU/m2,129.0,98.0
SYNTHETIC-5,DONOR_2193,TREATMENT_8693,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,8836851,PubChem,IU/m2,190.0,104.0
SYNTHETIC-5,DONOR_2194,TREATMENT_8694,,Blincyto,8836851,,IU/kg,,148.0
SYNTHETIC-5,DONOR_2195,TREATMENT_8695,Cell-based,Erlotinib,8756456,,g/m2,153.0,91.0
SYNTHETIC-5,DONOR_2196,TREATMENT_8696,Immune checkpoint inhibitors,Pembrolizumab,,RxNorm,,96.0,188.0
SYNTHETIC-5,DONOR_2197,TREATMENT_8697,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,278936,NCI Thesaurus,mg/kg,119.0,96.0
SYNTHETIC-5,DONOR_2198,TREATMENT_8698,,Imfinzi,8756456,NCI Thesaurus,ug/m2,164.0,58.0
SYNTHETIC-5,DONOR_2199,TREATMENT_8699,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,987654,RxNorm,ug/m2,181.0,69.0
SYNTHETIC-5,DONOR_2200,TREATMENT_8700,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,278936,NCI Thesaurus,cells/kg,69.0,162.0
SYNTHETIC-5,DONOR_2201,TREATMENT_8701,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2202,TREATMENT_8702,Cell-based,,8756456,RxNorm,mg/kg,,111.0
SYNTHETIC-5,DONOR_2203,TREATMENT_8703,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,PubChem,,147.0,127.0
SYNTHETIC-5,DONOR_2204,TREATMENT_8704,Other immunomodulatory substances,Ribociclib,8836851,RxNorm,mg/kg,81.0,177.0
SYNTHETIC-5,DONOR_2205,TREATMENT_8705,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,278936,PubChem,mg/kg,174.0,56.0
SYNTHETIC-5,DONOR_2206,TREATMENT_8706,Other immunomodulatory substances,Alectinib,8836851,NCI Thesaurus,,106.0,176.0
SYNTHETIC-5,DONOR_2207,TREATMENT_8707,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,RxNorm,g/m2,193.0,71.0
SYNTHETIC-5,DONOR_2208,TREATMENT_8708,Other immunomodulatory substances,Imfinzi,8836851,NCI Thesaurus,g/m2,125.0,91.0
SYNTHETIC-5,DONOR_2209,TREATMENT_8709,,Opdivo,987654,RxNorm,IU/m2,178.0,188.0
SYNTHETIC-5,DONOR_2210,TREATMENT_8710,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,mg/kg,85.0,
SYNTHETIC-5,DONOR_2211,TREATMENT_8711,Immune checkpoint inhibitors,Obinutuzumab,8756456,RxNorm,mg/kg,153.0,
SYNTHETIC-5,DONOR_2212,TREATMENT_8712,Immune checkpoint inhibitors,Yervoy,278936,RxNorm,g/m2,152.0,147.0
SYNTHETIC-5,DONOR_2213,TREATMENT_8713,Cell-based,Sorafenib,239766,NCI Thesaurus,ug/m2,69.0,135.0
SYNTHETIC-5,DONOR_2214,TREATMENT_8714,Other immunomodulatory substances,Tafinlar,239766,RxNorm,IU/kg,,155.0
SYNTHETIC-5,DONOR_2215,TREATMENT_8715,Other immunomodulatory substances,Brentuximab vedotin,278936,PubChem,mg/kg,74.0,77.0
SYNTHETIC-5,DONOR_2216,TREATMENT_8716,Other immunomodulatory substances,Keytruda,278936,PubChem,IU/kg,180.0,140.0
SYNTHETIC-5,DONOR_2217,TREATMENT_8717,Immune checkpoint inhibitors,Keytruda,278936,,,,170.0
SYNTHETIC-5,DONOR_2218,TREATMENT_8718,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,987654,NCI Thesaurus,IU/m2,,87.0
SYNTHETIC-5,DONOR_2219,TREATMENT_8719,Cell-based,Dabrafenib,8836851,PubChem,mg/m2,122.0,101.0
SYNTHETIC-5,DONOR_2220,TREATMENT_8720,Immune checkpoint inhibitors,Ipilimumab,,RxNorm,ug/m2,58.0,134.0
SYNTHETIC-5,DONOR_2221,TREATMENT_8721,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,RxNorm,IU/kg,170.0,167.0
SYNTHETIC-5,DONOR_2222,TREATMENT_8722,Cell-based,,4459876,PubChem,mg/m2,189.0,135.0
SYNTHETIC-5,DONOR_2223,TREATMENT_8723,Immune checkpoint inhibitors,Yescarta,987654,PubChem,IU/m2,121.0,132.0
SYNTHETIC-5,DONOR_2224,TREATMENT_8724,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,RxNorm,mg/kg,93.0,
SYNTHETIC-5,DONOR_2225,TREATMENT_8725,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,NCI Thesaurus,,167.0,142.0
SYNTHETIC-5,DONOR_2226,TREATMENT_8726,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8756456,RxNorm,cells/kg,170.0,61.0
SYNTHETIC-5,DONOR_2227,TREATMENT_8727,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,,mg/m2,58.0,55.0
SYNTHETIC-5,DONOR_2228,TREATMENT_8728,Cell-based,Atezolizumab,278936,NCI Thesaurus,IU/kg,75.0,116.0
SYNTHETIC-5,DONOR_2229,TREATMENT_8729,Cell-based,Yervoy,987654,NCI Thesaurus,ug/m2,76.0,194.0
SYNTHETIC-5,DONOR_2230,TREATMENT_8730,Other immunomodulatory substances,Lenvatinib,8836851,PubChem,,199.0,50.0
SYNTHETIC-5,DONOR_2231,TREATMENT_8731,Cell-based,Zykadia,8836851,PubChem,ug/m2,135.0,168.0
SYNTHETIC-5,DONOR_2232,TREATMENT_8732,,Atezolizumab,278936,,ug/m2,117.0,187.0
SYNTHETIC-5,DONOR_2233,TREATMENT_8733,Immune checkpoint inhibitors,Cobimetinib,987654,RxNorm,cells/kg,178.0,50.0
SYNTHETIC-5,DONOR_2234,TREATMENT_8734,,Copanlisib,987654,NCI Thesaurus,IU/kg,159.0,109.0
SYNTHETIC-5,DONOR_2235,TREATMENT_8735,Other immunomodulatory substances,,239766,PubChem,mg/m2,,75.0
SYNTHETIC-5,DONOR_2236,TREATMENT_8736,Cell-based,,278936,PubChem,mg/m2,50.0,198.0
SYNTHETIC-5,DONOR_2237,TREATMENT_8737,Other immunomodulatory substances,,278936,PubChem,cells/kg,52.0,137.0
SYNTHETIC-5,DONOR_2238,TREATMENT_8738,Cell-based,Daratumumab,8836851,NCI Thesaurus,ug/m2,172.0,159.0
SYNTHETIC-5,DONOR_2239,TREATMENT_8739,Immune checkpoint inhibitors,Kymriah,8836851,RxNorm,mg/kg,131.0,166.0
SYNTHETIC-5,DONOR_2240,TREATMENT_8740,Other immunomodulatory substances,Brigatinib,,NCI Thesaurus,,120.0,79.0
SYNTHETIC-5,DONOR_2241,TREATMENT_8741,Other immunomodulatory substances,,278936,RxNorm,IU/kg,100.0,139.0
SYNTHETIC-5,DONOR_2242,TREATMENT_8742,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8836851,,mg/kg,112.0,
SYNTHETIC-5,DONOR_2243,TREATMENT_8743,Cell-based,Niraparib,239766,NCI Thesaurus,IU/kg,200.0,124.0
SYNTHETIC-5,DONOR_2244,TREATMENT_8744,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,NCI Thesaurus,mg/kg,99.0,50.0
SYNTHETIC-5,DONOR_2245,TREATMENT_8745,Immune checkpoint inhibitors,Inotuzumab ozogamicin,,NCI Thesaurus,cells/kg,61.0,128.0
SYNTHETIC-5,DONOR_2246,TREATMENT_8746,Other immunomodulatory substances,Copanlisib,8836851,RxNorm,,190.0,110.0
SYNTHETIC-5,DONOR_2247,TREATMENT_8747,Cell-based,Pexidartinib,239766,PubChem,mg/m2,,195.0
SYNTHETIC-5,DONOR_2248,TREATMENT_8748,Cell-based,,8756456,RxNorm,mg/kg,185.0,111.0
SYNTHETIC-5,DONOR_2249,TREATMENT_8749,Other immunomodulatory substances,Blinatumomab,8836851,NCI Thesaurus,cells/kg,161.0,146.0
SYNTHETIC-5,DONOR_2250,TREATMENT_8750,Other immunomodulatory substances,Cometriq,987654,,cells/kg,65.0,98.0
SYNTHETIC-5,DONOR_2251,TREATMENT_8751,Immune checkpoint inhibitors,Gilteritinib,8756456,RxNorm,ug/m2,194.0,
SYNTHETIC-5,DONOR_2252,TREATMENT_8752,Cell-based,,987654,NCI Thesaurus,mg/kg,,
SYNTHETIC-5,DONOR_2253,TREATMENT_8753,Cell-based,Blinatumomab,278936,NCI Thesaurus,ug/m2,53.0,145.0
SYNTHETIC-5,DONOR_2254,TREATMENT_8754,Cell-based,Atezolizumab,278936,RxNorm,ug/m2,60.0,125.0
SYNTHETIC-5,DONOR_2255,TREATMENT_8755,Cell-based,Venclexta,239766,PubChem,ug/m2,151.0,144.0
SYNTHETIC-5,DONOR_2256,TREATMENT_8756,,,,PubChem,cells/kg,69.0,191.0
SYNTHETIC-5,DONOR_2257,TREATMENT_8757,Cell-based,Atezolizumab,278936,PubChem,,97.0,180.0
SYNTHETIC-5,DONOR_2258,TREATMENT_8758,Cell-based,Opdivo,278936,NCI Thesaurus,g/m2,164.0,152.0
SYNTHETIC-5,DONOR_2259,TREATMENT_8759,,Nexavar,,,IU/m2,,73.0
SYNTHETIC-5,DONOR_2260,TREATMENT_8760,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8836851,RxNorm,cells/kg,117.0,78.0
SYNTHETIC-5,DONOR_2261,TREATMENT_8761,Other immunomodulatory substances,Atezolizumab,987654,PubChem,,169.0,107.0
SYNTHETIC-5,DONOR_2262,TREATMENT_8762,Immune checkpoint inhibitors,Atezolizumab,278936,PubChem,IU/m2,69.0,166.0
SYNTHETIC-5,DONOR_2263,TREATMENT_8763,Other immunomodulatory substances,Yervoy,4459876,PubChem,IU/kg,102.0,177.0
SYNTHETIC-5,DONOR_2264,TREATMENT_8764,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,g/m2,79.0,156.0
SYNTHETIC-5,DONOR_2265,TREATMENT_8765,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,8756456,PubChem,cells/kg,,189.0
SYNTHETIC-5,DONOR_2266,TREATMENT_8766,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,278936,PubChem,,188.0,
SYNTHETIC-5,DONOR_2267,TREATMENT_8767,Other immunomodulatory substances,Venclexta,,,mg/m2,121.0,95.0
SYNTHETIC-5,DONOR_2268,TREATMENT_8768,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,239766,NCI Thesaurus,cells/kg,134.0,
SYNTHETIC-5,DONOR_2269,TREATMENT_8769,Other immunomodulatory substances,Dabrafenib,239766,,mg/m2,75.0,139.0
SYNTHETIC-5,DONOR_2270,TREATMENT_8770,Immune checkpoint inhibitors,Atezolizumab,4459876,,IU/kg,76.0,195.0
SYNTHETIC-5,DONOR_2271,TREATMENT_8771,Immune checkpoint inhibitors,Olaparib,,RxNorm,mg/kg,91.0,
SYNTHETIC-5,DONOR_2272,TREATMENT_8772,Cell-based,Ceritinib,,PubChem,IU/m2,112.0,191.0
SYNTHETIC-5,DONOR_2273,TREATMENT_8773,Other immunomodulatory substances,Imfinzi,,NCI Thesaurus,IU/m2,96.0,143.0
SYNTHETIC-5,DONOR_2274,TREATMENT_8774,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,278936,NCI Thesaurus,g/m2,92.0,140.0
SYNTHETIC-5,DONOR_2275,TREATMENT_8775,Immune checkpoint inhibitors,Ribociclib,8836851,NCI Thesaurus,cells/kg,112.0,77.0
SYNTHETIC-5,DONOR_2276,TREATMENT_8776,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,4459876,PubChem,g/m2,148.0,156.0
SYNTHETIC-5,DONOR_2277,TREATMENT_8777,Immune checkpoint inhibitors,Ipilimumab,,PubChem,mg/m2,170.0,108.0
SYNTHETIC-5,DONOR_2278,TREATMENT_8778,Other immunomodulatory substances,Braftovi,4459876,NCI Thesaurus,,185.0,185.0
SYNTHETIC-5,DONOR_2279,TREATMENT_8779,Immune checkpoint inhibitors,Daratumumab,8756456,,cells/kg,146.0,176.0
SYNTHETIC-5,DONOR_2280,TREATMENT_8780,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,,PubChem,g/m2,,158.0
SYNTHETIC-5,DONOR_2281,TREATMENT_8781,Other immunomodulatory substances,Keytruda,278936,PubChem,ug/m2,150.0,71.0
SYNTHETIC-5,DONOR_2282,TREATMENT_8782,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,,RxNorm,cells/kg,,
SYNTHETIC-5,DONOR_2283,TREATMENT_8783,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,,,111.0,103.0
SYNTHETIC-5,DONOR_2284,TREATMENT_8784,,Tecentriq,239766,RxNorm,,57.0,157.0
SYNTHETIC-5,DONOR_2285,TREATMENT_8785,Other immunomodulatory substances,,239766,PubChem,,,118.0
SYNTHETIC-5,DONOR_2286,TREATMENT_8786,Immune checkpoint inhibitors,Cometriq,8836851,PubChem,g/m2,181.0,119.0
SYNTHETIC-5,DONOR_2287,TREATMENT_8787,Immune checkpoint inhibitors,Venetoclax,,,IU/kg,,98.0
SYNTHETIC-5,DONOR_2288,TREATMENT_8788,Cell-based,Perjeta,239766,RxNorm,mg/kg,,119.0
SYNTHETIC-5,DONOR_2289,TREATMENT_8789,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,278936,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2290,TREATMENT_8790,Immune checkpoint inhibitors,Herceptin,987654,PubChem,mg/kg,88.0,76.0
SYNTHETIC-5,DONOR_2291,TREATMENT_8791,Other immunomodulatory substances,Mektovi,987654,,ug/m2,140.0,170.0
SYNTHETIC-5,DONOR_2292,TREATMENT_8792,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,,RxNorm,mg/kg,186.0,146.0
SYNTHETIC-5,DONOR_2293,TREATMENT_8793,Cell-based,Nivolumab,239766,RxNorm,ug/m2,,193.0
SYNTHETIC-5,DONOR_2294,TREATMENT_8794,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,278936,PubChem,ug/m2,56.0,114.0
SYNTHETIC-5,DONOR_2295,TREATMENT_8795,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,RxNorm,,63.0,170.0
SYNTHETIC-5,DONOR_2296,TREATMENT_8796,Immune checkpoint inhibitors,Gazyva,239766,RxNorm,mg/m2,177.0,68.0
SYNTHETIC-5,DONOR_2297,TREATMENT_8797,Other immunomodulatory substances,Sorafenib,,PubChem,IU/kg,121.0,194.0
SYNTHETIC-5,DONOR_2298,TREATMENT_8798,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,NCI Thesaurus,ug/m2,,
SYNTHETIC-5,DONOR_2299,TREATMENT_8799,Immune checkpoint inhibitors,Vemurafenib,8756456,NCI Thesaurus,,,
SYNTHETIC-5,DONOR_2300,TREATMENT_8800,Immune checkpoint inhibitors,Caprelsa,4459876,,ug/m2,158.0,67.0
SYNTHETIC-5,DONOR_2301,TREATMENT_8801,Immune checkpoint inhibitors,Erlotinib,987654,NCI Thesaurus,cells/kg,,107.0
SYNTHETIC-5,DONOR_2302,TREATMENT_8802,Other immunomodulatory substances,Keytruda,,PubChem,IU/m2,,70.0
SYNTHETIC-5,DONOR_2303,TREATMENT_8803,Immune checkpoint inhibitors,Enhertu,4459876,RxNorm,cells/kg,151.0,137.0
SYNTHETIC-5,DONOR_2304,TREATMENT_8804,Other immunomodulatory substances,Erlotinib,987654,RxNorm,mg/m2,91.0,
SYNTHETIC-5,DONOR_2305,TREATMENT_8805,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8756456,NCI Thesaurus,IU/m2,166.0,155.0
SYNTHETIC-5,DONOR_2306,TREATMENT_8806,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,,RxNorm,mg/kg,76.0,130.0
SYNTHETIC-5,DONOR_2307,TREATMENT_8807,Other immunomodulatory substances,Brigatinib,987654,NCI Thesaurus,cells/kg,178.0,90.0
SYNTHETIC-5,DONOR_2308,TREATMENT_8808,Immune checkpoint inhibitors,Atezolizumab,278936,RxNorm,g/m2,158.0,
SYNTHETIC-5,DONOR_2309,TREATMENT_8809,Immune checkpoint inhibitors,Tecentriq,987654,RxNorm,,76.0,151.0
SYNTHETIC-5,DONOR_2310,TREATMENT_8810,Cell-based,Keytruda,8836851,PubChem,mg/m2,130.0,113.0
SYNTHETIC-5,DONOR_2311,TREATMENT_8811,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8756456,RxNorm,g/m2,157.0,104.0
SYNTHETIC-5,DONOR_2312,TREATMENT_8812,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,278936,PubChem,,139.0,105.0
SYNTHETIC-5,DONOR_2313,TREATMENT_8813,Cell-based,Tecentriq,987654,PubChem,IU/kg,168.0,116.0
SYNTHETIC-5,DONOR_2314,TREATMENT_8814,Immune checkpoint inhibitors,,4459876,PubChem,IU/m2,193.0,65.0
SYNTHETIC-5,DONOR_2315,TREATMENT_8815,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,g/m2,74.0,93.0
SYNTHETIC-5,DONOR_2316,TREATMENT_8816,Cell-based,Pembrolizumab,278936,PubChem,cells/kg,146.0,
SYNTHETIC-5,DONOR_2317,TREATMENT_8817,Other immunomodulatory substances,Alunbrig,8756456,RxNorm,,64.0,106.0
SYNTHETIC-5,DONOR_2318,TREATMENT_8818,Cell-based,Imfinzi,8836851,RxNorm,g/m2,127.0,152.0
SYNTHETIC-5,DONOR_2319,TREATMENT_8819,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,53.0,73.0
SYNTHETIC-5,DONOR_2320,TREATMENT_8820,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,239766,NCI Thesaurus,cells/kg,148.0,99.0
SYNTHETIC-5,DONOR_2321,TREATMENT_8821,Other immunomodulatory substances,Sorafenib,987654,PubChem,mg/kg,172.0,90.0
SYNTHETIC-5,DONOR_2322,TREATMENT_8822,Other immunomodulatory substances,Osimertinib,4459876,NCI Thesaurus,mg/kg,156.0,151.0
SYNTHETIC-5,DONOR_2323,TREATMENT_8823,Immune checkpoint inhibitors,,239766,PubChem,cells/kg,71.0,162.0
SYNTHETIC-5,DONOR_2324,TREATMENT_8824,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,,RxNorm,IU/m2,62.0,180.0
SYNTHETIC-5,DONOR_2325,TREATMENT_8825,Cell-based,Mekinist,8836851,PubChem,mg/m2,188.0,89.0
SYNTHETIC-5,DONOR_2326,TREATMENT_8826,,Zejula,8836851,NCI Thesaurus,,98.0,
SYNTHETIC-5,DONOR_2327,TREATMENT_8827,Other immunomodulatory substances,Atezolizumab,239766,RxNorm,IU/kg,158.0,119.0
SYNTHETIC-5,DONOR_2328,TREATMENT_8828,Cell-based,Perjeta,4459876,RxNorm,g/m2,68.0,57.0
SYNTHETIC-5,DONOR_2329,TREATMENT_8829,Other immunomodulatory substances,Mekinist,8756456,NCI Thesaurus,IU/kg,136.0,139.0
SYNTHETIC-5,DONOR_2330,TREATMENT_8830,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,PubChem,ug/m2,53.0,96.0
SYNTHETIC-5,DONOR_2331,TREATMENT_8831,,Mekinist,987654,RxNorm,IU/m2,51.0,106.0
SYNTHETIC-5,DONOR_2332,TREATMENT_8832,Immune checkpoint inhibitors,Lenvima,4459876,RxNorm,IU/kg,62.0,90.0
SYNTHETIC-5,DONOR_2333,TREATMENT_8833,Immune checkpoint inhibitors,Obinutuzumab,278936,RxNorm,,,119.0
SYNTHETIC-5,DONOR_2334,TREATMENT_8834,Cell-based,Selumitinib,,RxNorm,mg/kg,139.0,91.0
SYNTHETIC-5,DONOR_2335,TREATMENT_8835,Immune checkpoint inhibitors,Besponsa,4459876,RxNorm,,,75.0
SYNTHETIC-5,DONOR_2336,TREATMENT_8836,Other immunomodulatory substances,Ado-trastuzumab emtansine,278936,PubChem,IU/kg,,102.0
SYNTHETIC-5,DONOR_2337,TREATMENT_8837,Cell-based,Opdivo,987654,RxNorm,IU/kg,116.0,68.0
SYNTHETIC-5,DONOR_2338,TREATMENT_8838,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,278936,RxNorm,IU/kg,69.0,66.0
SYNTHETIC-5,DONOR_2339,TREATMENT_8839,Immune checkpoint inhibitors,Tecentriq,8836851,,mg/kg,108.0,
SYNTHETIC-5,DONOR_2340,TREATMENT_8840,Immune checkpoint inhibitors,Kisqali,987654,RxNorm,,57.0,50.0
SYNTHETIC-5,DONOR_2341,TREATMENT_8841,Cell-based,Besponsa,8836851,PubChem,,51.0,180.0
SYNTHETIC-5,DONOR_2342,TREATMENT_8842,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,987654,,g/m2,147.0,
SYNTHETIC-5,DONOR_2343,TREATMENT_8843,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,987654,RxNorm,mg/kg,51.0,57.0
SYNTHETIC-5,DONOR_2344,TREATMENT_8844,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,NCI Thesaurus,,111.0,93.0
SYNTHETIC-5,DONOR_2345,TREATMENT_8845,,Nivolumab,,PubChem,ug/m2,,169.0
SYNTHETIC-5,DONOR_2346,TREATMENT_8846,Cell-based,Yescarta,8836851,NCI Thesaurus,,,
SYNTHETIC-5,DONOR_2347,TREATMENT_8847,Immune checkpoint inhibitors,Besponsa,278936,NCI Thesaurus,g/m2,57.0,200.0
SYNTHETIC-5,DONOR_2348,TREATMENT_8848,Cell-based,,278936,,IU/kg,162.0,181.0
SYNTHETIC-5,DONOR_2349,TREATMENT_8849,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,g/m2,162.0,178.0
SYNTHETIC-5,DONOR_2350,TREATMENT_8850,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,278936,PubChem,IU/m2,146.0,81.0
SYNTHETIC-5,DONOR_2351,TREATMENT_8851,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,,IU/m2,105.0,157.0
SYNTHETIC-5,DONOR_2352,TREATMENT_8852,Immune checkpoint inhibitors,Nivolumab,,RxNorm,IU/kg,,78.0
SYNTHETIC-5,DONOR_2353,TREATMENT_8853,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,RxNorm,mg/m2,180.0,174.0
SYNTHETIC-5,DONOR_2354,TREATMENT_8854,Immune checkpoint inhibitors,Trametinib,987654,,mg/m2,144.0,94.0
SYNTHETIC-5,DONOR_2355,TREATMENT_8855,Immune checkpoint inhibitors,Tafinlar,4459876,PubChem,mg/m2,117.0,101.0
SYNTHETIC-5,DONOR_2356,TREATMENT_8856,,Tafinlar,8836851,NCI Thesaurus,cells/kg,66.0,68.0
SYNTHETIC-5,DONOR_2357,TREATMENT_8857,Cell-based,Adcetris,8756456,PubChem,cells/kg,65.0,
SYNTHETIC-5,DONOR_2358,TREATMENT_8858,Immune checkpoint inhibitors,Binimetinib,8756456,RxNorm,IU/kg,189.0,
SYNTHETIC-5,DONOR_2359,TREATMENT_8859,Cell-based,Durvalumab,987654,RxNorm,IU/kg,89.0,120.0
SYNTHETIC-5,DONOR_2360,TREATMENT_8860,Immune checkpoint inhibitors,Pertuzumab,278936,RxNorm,cells/kg,143.0,
SYNTHETIC-5,DONOR_2361,TREATMENT_8861,Cell-based,,8836851,PubChem,IU/m2,145.0,
SYNTHETIC-5,DONOR_2362,TREATMENT_8862,Other immunomodulatory substances,Gefitinib,8836851,RxNorm,cells/kg,161.0,
SYNTHETIC-5,DONOR_2363,TREATMENT_8863,Other immunomodulatory substances,,987654,NCI Thesaurus,cells/kg,121.0,160.0
SYNTHETIC-5,DONOR_2364,TREATMENT_8864,Immune checkpoint inhibitors,Mektovi,278936,,mg/kg,,93.0
SYNTHETIC-5,DONOR_2365,TREATMENT_8865,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,PubChem,mg/m2,123.0,161.0
SYNTHETIC-5,DONOR_2366,TREATMENT_8866,Immune checkpoint inhibitors,,278936,NCI Thesaurus,cells/kg,93.0,
SYNTHETIC-5,DONOR_2367,TREATMENT_8867,Immune checkpoint inhibitors,Brentuximab vedotin,987654,NCI Thesaurus,mg/m2,98.0,113.0
SYNTHETIC-5,DONOR_2368,TREATMENT_8868,Immune checkpoint inhibitors,Rituximab,278936,PubChem,cells/kg,117.0,198.0
SYNTHETIC-5,DONOR_2369,TREATMENT_8869,,Vemurafenib,4459876,RxNorm,cells/kg,197.0,
SYNTHETIC-5,DONOR_2370,TREATMENT_8870,,Rituxan,239766,NCI Thesaurus,IU/m2,136.0,
SYNTHETIC-5,DONOR_2371,TREATMENT_8871,Other immunomodulatory substances,Alectinib,4459876,NCI Thesaurus,cells/kg,145.0,158.0
SYNTHETIC-5,DONOR_2372,TREATMENT_8872,Immune checkpoint inhibitors,Gilteritinib,8836851,,mg/kg,180.0,66.0
SYNTHETIC-5,DONOR_2373,TREATMENT_8873,Immune checkpoint inhibitors,Pembrolizumab,,NCI Thesaurus,IU/m2,109.0,143.0
SYNTHETIC-5,DONOR_2374,TREATMENT_8874,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,239766,PubChem,g/m2,174.0,157.0
SYNTHETIC-5,DONOR_2375,TREATMENT_8875,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,,,g/m2,176.0,
SYNTHETIC-5,DONOR_2376,TREATMENT_8876,Cell-based,,278936,RxNorm,IU/m2,,87.0
SYNTHETIC-5,DONOR_2377,TREATMENT_8877,Other immunomodulatory substances,Kymriah,8756456,PubChem,IU/m2,,151.0
SYNTHETIC-5,DONOR_2378,TREATMENT_8878,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,PubChem,cells/kg,198.0,
SYNTHETIC-5,DONOR_2379,TREATMENT_8879,Cell-based,Trametinib,8836851,,ug/m2,185.0,107.0
SYNTHETIC-5,DONOR_2380,TREATMENT_8880,,Opdivo,239766,,mg/kg,87.0,142.0
SYNTHETIC-5,DONOR_2381,TREATMENT_8881,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,cells/kg,85.0,56.0
SYNTHETIC-5,DONOR_2382,TREATMENT_8882,Other immunomodulatory substances,Binimetinib,,NCI Thesaurus,mg/kg,69.0,
SYNTHETIC-5,DONOR_2383,TREATMENT_8883,Cell-based,Obinutuzumab,278936,NCI Thesaurus,cells/kg,150.0,
SYNTHETIC-5,DONOR_2384,TREATMENT_8884,,Tafinlar,8836851,PubChem,cells/kg,157.0,51.0
SYNTHETIC-5,DONOR_2385,TREATMENT_8885,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,,PubChem,cells/kg,105.0,83.0
SYNTHETIC-5,DONOR_2386,TREATMENT_8886,Cell-based,Zelboraf,8756456,RxNorm,cells/kg,79.0,191.0
SYNTHETIC-5,DONOR_2387,TREATMENT_8887,Immune checkpoint inhibitors,Erlotinib,8756456,NCI Thesaurus,g/m2,,133.0
SYNTHETIC-5,DONOR_2388,TREATMENT_8888,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8836851,RxNorm,g/m2,150.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_8889,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,8836851,RxNorm,,114.0,87.0
SYNTHETIC-5,DONOR_2390,TREATMENT_8890,Cell-based,,8836851,PubChem,g/m2,132.0,166.0
SYNTHETIC-5,DONOR_2391,TREATMENT_8891,Other immunomodulatory substances,Yescarta,4459876,PubChem,mg/m2,102.0,154.0
SYNTHETIC-5,DONOR_2392,TREATMENT_8892,Other immunomodulatory substances,Ipilimumab,278936,RxNorm,mg/kg,195.0,88.0
SYNTHETIC-5,DONOR_2393,TREATMENT_8893,Other immunomodulatory substances,Nivolumab,8756456,NCI Thesaurus,mg/kg,79.0,70.0
SYNTHETIC-5,DONOR_2394,TREATMENT_8894,,Blincyto,,PubChem,mg/m2,70.0,150.0
SYNTHETIC-5,DONOR_2395,TREATMENT_8895,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,g/m2,67.0,174.0
SYNTHETIC-5,DONOR_2396,TREATMENT_8896,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,NCI Thesaurus,IU/m2,82.0,83.0
SYNTHETIC-5,DONOR_2397,TREATMENT_8897,,,278936,RxNorm,cells/kg,76.0,102.0
SYNTHETIC-5,DONOR_2398,TREATMENT_8898,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,cells/kg,108.0,107.0
SYNTHETIC-5,DONOR_2399,TREATMENT_8899,Cell-based,,,RxNorm,mg/m2,185.0,57.0
SYNTHETIC-5,DONOR_2400,TREATMENT_8900,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,cells/kg,132.0,176.0
SYNTHETIC-5,DONOR_2401,TREATMENT_8901,Other immunomodulatory substances,Alecensa,278936,NCI Thesaurus,,182.0,119.0
SYNTHETIC-5,DONOR_2402,TREATMENT_8902,Other immunomodulatory substances,,278936,RxNorm,IU/kg,125.0,93.0
SYNTHETIC-5,DONOR_2403,TREATMENT_8903,Other immunomodulatory substances,Zejula,987654,PubChem,cells/kg,176.0,121.0
SYNTHETIC-5,DONOR_2404,TREATMENT_8904,Other immunomodulatory substances,,,RxNorm,ug/m2,132.0,154.0
SYNTHETIC-5,DONOR_2405,TREATMENT_8905,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,PubChem,ug/m2,,180.0
SYNTHETIC-5,DONOR_2406,TREATMENT_8906,Other immunomodulatory substances,,987654,,IU/kg,,184.0
SYNTHETIC-5,DONOR_2407,TREATMENT_8907,Cell-based,Yervoy,278936,RxNorm,mg/kg,117.0,
SYNTHETIC-5,DONOR_2408,TREATMENT_8908,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,RxNorm,IU/m2,67.0,88.0
SYNTHETIC-5,DONOR_2409,TREATMENT_8909,Immune checkpoint inhibitors,Obinutuzumab,278936,NCI Thesaurus,IU/m2,,162.0
SYNTHETIC-5,DONOR_2410,TREATMENT_8910,,Atezolizumab,8756456,PubChem,IU/m2,139.0,145.0
SYNTHETIC-5,DONOR_2411,TREATMENT_8911,Immune checkpoint inhibitors,,8756456,RxNorm,IU/m2,125.0,118.0
SYNTHETIC-5,DONOR_2412,TREATMENT_8912,Other immunomodulatory substances,Lynparza,8836851,RxNorm,,,
SYNTHETIC-5,DONOR_2413,TREATMENT_8913,Immune checkpoint inhibitors,Lynparza,987654,NCI Thesaurus,mg/kg,117.0,158.0
SYNTHETIC-5,DONOR_2414,TREATMENT_8914,Immune checkpoint inhibitors,Niraparib,,PubChem,cells/kg,,
SYNTHETIC-5,DONOR_2415,TREATMENT_8915,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,4459876,PubChem,cells/kg,193.0,64.0
SYNTHETIC-5,DONOR_2416,TREATMENT_8916,Cell-based,Zykadia,8756456,RxNorm,IU/m2,116.0,164.0
SYNTHETIC-5,DONOR_2417,TREATMENT_8917,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,IU/kg,153.0,
SYNTHETIC-5,DONOR_2418,TREATMENT_8918,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,cells/kg,64.0,126.0
SYNTHETIC-5,DONOR_2419,TREATMENT_8919,,Atezolizumab,239766,PubChem,cells/kg,89.0,78.0
SYNTHETIC-5,DONOR_2420,TREATMENT_8920,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,mg/kg,172.0,
SYNTHETIC-5,DONOR_2421,TREATMENT_8921,Immune checkpoint inhibitors,Binimetinib,8836851,,IU/kg,,145.0
SYNTHETIC-5,DONOR_2422,TREATMENT_8922,Immune checkpoint inhibitors,Zykadia,239766,RxNorm,,135.0,120.0
SYNTHETIC-5,DONOR_2423,TREATMENT_8923,Cell-based,Lenvima,8756456,NCI Thesaurus,mg/kg,190.0,169.0
SYNTHETIC-5,DONOR_2424,TREATMENT_8924,Cell-based,,8836851,,IU/kg,107.0,172.0
SYNTHETIC-5,DONOR_2425,TREATMENT_8925,,Fam-trastuzumab deruxtecan-nxki,8756456,RxNorm,cells/kg,116.0,64.0
SYNTHETIC-5,DONOR_2426,TREATMENT_8926,Cell-based,Osimertinib,4459876,RxNorm,cells/kg,115.0,131.0
SYNTHETIC-5,DONOR_2427,TREATMENT_8927,,Pexidartinib,278936,PubChem,mg/kg,70.0,99.0
SYNTHETIC-5,DONOR_2428,TREATMENT_8928,Immune checkpoint inhibitors,Belantamab,278936,PubChem,mg/kg,111.0,167.0
SYNTHETIC-5,DONOR_2429,TREATMENT_8929,Other immunomodulatory substances,Blincyto,8836851,RxNorm,mg/kg,121.0,180.0
SYNTHETIC-5,DONOR_2430,TREATMENT_8930,Immune checkpoint inhibitors,Opdivo,278936,,g/m2,96.0,123.0
SYNTHETIC-5,DONOR_2431,TREATMENT_8931,Cell-based,Osimertinib,987654,NCI Thesaurus,ug/m2,193.0,59.0
SYNTHETIC-5,DONOR_2432,TREATMENT_8932,Immune checkpoint inhibitors,Yescarta,4459876,PubChem,mg/kg,73.0,165.0
SYNTHETIC-5,DONOR_2433,TREATMENT_8933,Other immunomodulatory substances,Tafinlar,8836851,RxNorm,IU/kg,161.0,
SYNTHETIC-5,DONOR_2434,TREATMENT_8934,Other immunomodulatory substances,Blinatumomab,,,cells/kg,101.0,80.0
SYNTHETIC-5,DONOR_2435,TREATMENT_8935,Other immunomodulatory substances,Tecentriq,278936,NCI Thesaurus,,96.0,98.0
SYNTHETIC-5,DONOR_2436,TREATMENT_8936,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8756456,NCI Thesaurus,mg/m2,157.0,
SYNTHETIC-5,DONOR_2437,TREATMENT_8937,,Vandetanib,4459876,PubChem,IU/m2,153.0,127.0
SYNTHETIC-5,DONOR_2438,TREATMENT_8938,Immune checkpoint inhibitors,Yervoy,239766,,ug/m2,122.0,79.0
SYNTHETIC-5,DONOR_2439,TREATMENT_8939,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,,NCI Thesaurus,mg/kg,,132.0
SYNTHETIC-5,DONOR_2440,TREATMENT_8940,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,PubChem,mg/m2,187.0,104.0
SYNTHETIC-5,DONOR_2441,TREATMENT_8941,Cell-based,Ipilimumab,987654,NCI Thesaurus,ug/m2,100.0,158.0
SYNTHETIC-5,DONOR_2442,TREATMENT_8942,Other immunomodulatory substances,,8836851,NCI Thesaurus,mg/m2,148.0,116.0
SYNTHETIC-5,DONOR_2443,TREATMENT_8943,Cell-based,Tagrisso,987654,NCI Thesaurus,mg/kg,152.0,89.0
SYNTHETIC-5,DONOR_2444,TREATMENT_8944,Other immunomodulatory substances,Durvalumab,239766,NCI Thesaurus,mg/m2,172.0,54.0
SYNTHETIC-5,DONOR_2445,TREATMENT_8945,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,8756456,RxNorm,mg/m2,91.0,104.0
SYNTHETIC-5,DONOR_2446,TREATMENT_8946,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,8836851,PubChem,IU/m2,198.0,101.0
SYNTHETIC-5,DONOR_2447,TREATMENT_8947,Immune checkpoint inhibitors,Nivolumab,,PubChem,cells/kg,200.0,129.0
SYNTHETIC-5,DONOR_2448,TREATMENT_8948,,Pembrolizumab,987654,RxNorm,mg/kg,161.0,66.0
SYNTHETIC-5,DONOR_2449,TREATMENT_8949,Other immunomodulatory substances,Obinutuzumab,4459876,PubChem,ug/m2,82.0,
SYNTHETIC-5,DONOR_2450,TREATMENT_8950,Other immunomodulatory substances,Axicabtagene ciloleucel,239766,,,154.0,
SYNTHETIC-5,DONOR_2451,TREATMENT_8951,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,mg/m2,,122.0
SYNTHETIC-5,DONOR_2452,TREATMENT_8952,,Verzenio,987654,NCI Thesaurus,ug/m2,178.0,80.0
SYNTHETIC-5,DONOR_2453,TREATMENT_8953,Immune checkpoint inhibitors,Abemaciclib,239766,,ug/m2,195.0,171.0
SYNTHETIC-5,DONOR_2454,TREATMENT_8954,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,,mg/kg,182.0,136.0
SYNTHETIC-5,DONOR_2455,TREATMENT_8955,Immune checkpoint inhibitors,Ibrance,4459876,,IU/kg,137.0,144.0
SYNTHETIC-5,DONOR_2456,TREATMENT_8956,Cell-based,Opdivo,4459876,,IU/m2,141.0,186.0
SYNTHETIC-5,DONOR_2457,TREATMENT_8957,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,RxNorm,,79.0,123.0
SYNTHETIC-5,DONOR_2458,TREATMENT_8958,Cell-based,Cobimetinib,987654,RxNorm,g/m2,172.0,125.0
SYNTHETIC-5,DONOR_2459,TREATMENT_8959,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,RxNorm,IU/m2,93.0,156.0
SYNTHETIC-5,DONOR_2460,TREATMENT_8960,Cell-based,Tecentriq,278936,NCI Thesaurus,cells/kg,146.0,173.0
SYNTHETIC-5,DONOR_2461,TREATMENT_8961,Immune checkpoint inhibitors,Inotuzumab ozogamicin,278936,NCI Thesaurus,mg/kg,149.0,83.0
SYNTHETIC-5,DONOR_2462,TREATMENT_8962,Cell-based,Durvalumab,8836851,NCI Thesaurus,mg/kg,,163.0
SYNTHETIC-5,DONOR_2463,TREATMENT_8963,,Nivolumab,278936,,g/m2,136.0,86.0
SYNTHETIC-5,DONOR_2464,TREATMENT_8964,Other immunomodulatory substances,Yervoy,239766,PubChem,mg/kg,136.0,76.0
SYNTHETIC-5,DONOR_2465,TREATMENT_8965,Immune checkpoint inhibitors,Atezolizumab,987654,PubChem,IU/m2,63.0,177.0
SYNTHETIC-5,DONOR_2466,TREATMENT_8966,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,987654,,IU/m2,52.0,197.0
SYNTHETIC-5,DONOR_2467,TREATMENT_8967,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,239766,PubChem,g/m2,188.0,95.0
SYNTHETIC-5,DONOR_2468,TREATMENT_8968,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,PubChem,,184.0,146.0
SYNTHETIC-5,DONOR_2469,TREATMENT_8969,Cell-based,Imfinzi,239766,RxNorm,cells/kg,,197.0
SYNTHETIC-5,DONOR_2470,TREATMENT_8970,Immune checkpoint inhibitors,Nivolumab,239766,PubChem,IU/m2,97.0,
SYNTHETIC-5,DONOR_2471,TREATMENT_8971,Cell-based,Ipilimumab,,,mg/m2,64.0,155.0
SYNTHETIC-5,DONOR_2472,TREATMENT_8972,Cell-based,Opdivo,8836851,NCI Thesaurus,g/m2,75.0,176.0
SYNTHETIC-5,DONOR_2473,TREATMENT_8973,Immune checkpoint inhibitors,,239766,RxNorm,,77.0,
SYNTHETIC-5,DONOR_2474,TREATMENT_8974,Immune checkpoint inhibitors,Enhertu,8836851,PubChem,,190.0,162.0
SYNTHETIC-5,DONOR_2475,TREATMENT_8975,Other immunomodulatory substances,Mektovi,239766,RxNorm,cells/kg,,164.0
SYNTHETIC-5,DONOR_2476,TREATMENT_8976,Other immunomodulatory substances,Rubraca,,RxNorm,IU/m2,,125.0
SYNTHETIC-5,DONOR_2477,TREATMENT_8977,Cell-based,Braftovi,8836851,RxNorm,ug/m2,135.0,100.0
SYNTHETIC-5,DONOR_2478,TREATMENT_8978,Immune checkpoint inhibitors,Lenvima,8836851,RxNorm,,161.0,137.0
SYNTHETIC-5,DONOR_2479,TREATMENT_8979,Immune checkpoint inhibitors,Ipilimumab,8756456,RxNorm,mg/m2,56.0,
SYNTHETIC-5,DONOR_2480,TREATMENT_8980,Immune checkpoint inhibitors,Selumitinib,987654,PubChem,g/m2,121.0,71.0
SYNTHETIC-5,DONOR_2481,TREATMENT_8981,Immune checkpoint inhibitors,Crizotinib,987654,NCI Thesaurus,,198.0,
SYNTHETIC-5,DONOR_2482,TREATMENT_8982,Other immunomodulatory substances,,8756456,PubChem,cells/kg,133.0,123.0
SYNTHETIC-5,DONOR_2483,TREATMENT_8983,Cell-based,,8836851,NCI Thesaurus,,124.0,59.0
SYNTHETIC-5,DONOR_2484,TREATMENT_8984,Immune checkpoint inhibitors,Durvalumab,278936,RxNorm,,144.0,54.0
SYNTHETIC-5,DONOR_2485,TREATMENT_8985,Cell-based,,4459876,RxNorm,ug/m2,51.0,53.0
SYNTHETIC-5,DONOR_2486,TREATMENT_8986,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,,NCI Thesaurus,cells/kg,100.0,122.0
SYNTHETIC-5,DONOR_2487,TREATMENT_8987,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8836851,PubChem,IU/m2,74.0,106.0
SYNTHETIC-5,DONOR_2488,TREATMENT_8988,Immune checkpoint inhibitors,Lenvatinib,239766,NCI Thesaurus,,69.0,
SYNTHETIC-5,DONOR_2489,TREATMENT_8989,Other immunomodulatory substances,Gilteritinib,278936,NCI Thesaurus,mg/m2,195.0,189.0
SYNTHETIC-5,DONOR_2490,TREATMENT_8990,Other immunomodulatory substances,Vandetanib,278936,PubChem,mg/m2,188.0,76.0
SYNTHETIC-5,DONOR_2491,TREATMENT_8991,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,,NCI Thesaurus,IU/kg,,183.0
SYNTHETIC-5,DONOR_2492,TREATMENT_8992,Cell-based,Daratumumab,8756456,PubChem,IU/kg,53.0,171.0
SYNTHETIC-5,DONOR_2493,TREATMENT_8993,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,cells/kg,180.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_8994,Cell-based,,8836851,RxNorm,IU/m2,93.0,130.0
SYNTHETIC-5,DONOR_2495,TREATMENT_8995,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,,NCI Thesaurus,mg/m2,149.0,108.0
SYNTHETIC-5,DONOR_2496,TREATMENT_8996,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,8836851,,g/m2,183.0,175.0
SYNTHETIC-5,DONOR_2497,TREATMENT_8997,Immune checkpoint inhibitors,Gilotrif,987654,RxNorm,g/m2,50.0,
SYNTHETIC-5,DONOR_2498,TREATMENT_8998,,Rucaparib,8756456,,mg/kg,,
SYNTHETIC-5,DONOR_2499,TREATMENT_8999,Immune checkpoint inhibitors,Tarceva,4459876,PubChem,ug/m2,79.0,51.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9000,Other immunomodulatory substances,Mekinist,987654,,cells/kg,,138.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9001,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,278936,NCI Thesaurus,IU/m2,119.0,89.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9002,Immune checkpoint inhibitors,Venclexta,8756456,PubChem,IU/kg,129.0,155.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9003,Immune checkpoint inhibitors,Obinutuzumab,,RxNorm,,,
SYNTHETIC-5,DONOR_2004,TREATMENT_9004,Other immunomodulatory substances,Verzenio,278936,RxNorm,mg/m2,107.0,170.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9005,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,cells/kg,189.0,165.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9006,Other immunomodulatory substances,Cometriq,278936,RxNorm,mg/m2,,190.0
SYNTHETIC-5,DONOR_2007,TREATMENT_9007,Cell-based,Nexavar,8756456,RxNorm,mg/m2,,60.0
SYNTHETIC-5,DONOR_2008,TREATMENT_9008,,Opdivo,239766,NCI Thesaurus,cells/kg,88.0,147.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9009,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,RxNorm,g/m2,174.0,110.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9010,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,8756456,RxNorm,,177.0,158.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9011,Other immunomodulatory substances,,8836851,,cells/kg,61.0,72.0
SYNTHETIC-5,DONOR_2012,TREATMENT_9012,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,8836851,RxNorm,IU/kg,78.0,162.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9013,Cell-based,Durvalumab,4459876,NCI Thesaurus,g/m2,65.0,195.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9014,Cell-based,Belantamab,8836851,PubChem,,82.0,63.0
SYNTHETIC-5,DONOR_2015,TREATMENT_9015,Other immunomodulatory substances,,278936,NCI Thesaurus,IU/kg,117.0,110.0
SYNTHETIC-5,DONOR_2016,TREATMENT_9016,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,g/m2,97.0,196.0
SYNTHETIC-5,DONOR_2017,TREATMENT_9017,Other immunomodulatory substances,Erlotinib,4459876,,g/m2,113.0,
SYNTHETIC-5,DONOR_2018,TREATMENT_9018,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,239766,RxNorm,,200.0,111.0
SYNTHETIC-5,DONOR_2019,TREATMENT_9019,Other immunomodulatory substances,Cobimetinib,987654,RxNorm,mg/m2,121.0,117.0
SYNTHETIC-5,DONOR_2020,TREATMENT_9020,Immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,mg/kg,196.0,61.0
SYNTHETIC-5,DONOR_2021,TREATMENT_9021,Immune checkpoint inhibitors,Ipilimumab,239766,PubChem,g/m2,,173.0
SYNTHETIC-5,DONOR_2022,TREATMENT_9022,Cell-based,Rubraca,8756456,NCI Thesaurus,mg/m2,,66.0
SYNTHETIC-5,DONOR_2023,TREATMENT_9023,Other immunomodulatory substances,Perjeta,8756456,RxNorm,ug/m2,182.0,66.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9024,,Atezolizumab,987654,NCI Thesaurus,g/m2,,151.0
SYNTHETIC-5,DONOR_2025,TREATMENT_9025,Other immunomodulatory substances,Keytruda,8836851,,,54.0,142.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9026,Immune checkpoint inhibitors,Niraparib,278936,,ug/m2,75.0,
SYNTHETIC-5,DONOR_2027,TREATMENT_9027,Other immunomodulatory substances,Pembrolizumab,8836851,PubChem,ug/m2,70.0,87.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9028,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,IU/m2,74.0,57.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9029,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,PubChem,IU/kg,85.0,184.0
SYNTHETIC-5,DONOR_2030,TREATMENT_9030,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8836851,NCI Thesaurus,cells/kg,52.0,61.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9031,Other immunomodulatory substances,Perjeta,8756456,PubChem,,71.0,115.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9032,Immune checkpoint inhibitors,Crizotinib,987654,RxNorm,g/m2,,158.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9033,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,PubChem,cells/kg,126.0,81.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9034,Immune checkpoint inhibitors,Gilteritinib,987654,RxNorm,IU/kg,194.0,162.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9035,Other immunomodulatory substances,Zelboraf,,,mg/kg,123.0,138.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9036,Immune checkpoint inhibitors,Adcetris,987654,NCI Thesaurus,cells/kg,139.0,164.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9037,Immune checkpoint inhibitors,Cometriq,,PubChem,g/m2,171.0,81.0
SYNTHETIC-5,DONOR_2038,TREATMENT_9038,Other immunomodulatory substances,Nivolumab,278936,,,136.0,136.0
SYNTHETIC-5,DONOR_2039,TREATMENT_9039,,Opdivo,987654,RxNorm,,135.0,174.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9040,,Gazyva,239766,NCI Thesaurus,cells/kg,198.0,
SYNTHETIC-5,DONOR_2041,TREATMENT_9041,Other immunomodulatory substances,Keytruda,8756456,RxNorm,IU/m2,143.0,186.0
SYNTHETIC-5,DONOR_2042,TREATMENT_9042,,Atezolizumab,,NCI Thesaurus,mg/kg,80.0,126.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9043,Immune checkpoint inhibitors,Kisqali,8836851,,IU/m2,174.0,118.0
SYNTHETIC-5,DONOR_2044,TREATMENT_9044,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,239766,NCI Thesaurus,ug/m2,104.0,80.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9045,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,PubChem,cells/kg,143.0,140.0
SYNTHETIC-5,DONOR_2046,TREATMENT_9046,,Tecentriq,987654,,IU/kg,153.0,181.0
SYNTHETIC-5,DONOR_2047,TREATMENT_9047,,Durvalumab,,RxNorm,cells/kg,194.0,
SYNTHETIC-5,DONOR_2048,TREATMENT_9048,Other immunomodulatory substances,Enhertu,239766,NCI Thesaurus,cells/kg,,
SYNTHETIC-5,DONOR_2049,TREATMENT_9049,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,,PubChem,IU/kg,140.0,
SYNTHETIC-5,DONOR_2050,TREATMENT_9050,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,987654,PubChem,ug/m2,81.0,
SYNTHETIC-5,DONOR_2051,TREATMENT_9051,Other immunomodulatory substances,,,,ug/m2,121.0,149.0
SYNTHETIC-5,DONOR_2052,TREATMENT_9052,Other immunomodulatory substances,Keytruda,4459876,RxNorm,mg/kg,149.0,194.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9053,Immune checkpoint inhibitors,Rubraca,278936,PubChem,IU/m2,179.0,191.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9054,Immune checkpoint inhibitors,Iressa,8756456,NCI Thesaurus,g/m2,101.0,172.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9055,Other immunomodulatory substances,Ipilimumab,987654,,IU/m2,144.0,190.0
SYNTHETIC-5,DONOR_2056,TREATMENT_9056,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,278936,PubChem,cells/kg,,65.0
SYNTHETIC-5,DONOR_2057,TREATMENT_9057,Immune checkpoint inhibitors,Rituxan,8756456,NCI Thesaurus,mg/kg,103.0,119.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9058,Other immunomodulatory substances,,278936,RxNorm,IU/m2,148.0,125.0
SYNTHETIC-5,DONOR_2059,TREATMENT_9059,,Necitumumab,8836851,PubChem,ug/m2,168.0,
SYNTHETIC-5,DONOR_2060,TREATMENT_9060,Immune checkpoint inhibitors,Cabozantinib,4459876,RxNorm,mg/kg,125.0,104.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9061,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,,,119.0,110.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9062,Other immunomodulatory substances,Pexidartinib,4459876,PubChem,cells/kg,,169.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9063,Immune checkpoint inhibitors,Keytruda,239766,PubChem,mg/m2,159.0,85.0
SYNTHETIC-5,DONOR_2064,TREATMENT_9064,Cell-based,Cobimetinib,4459876,PubChem,cells/kg,106.0,119.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9065,Other immunomodulatory substances,Tecentriq,239766,RxNorm,mg/kg,145.0,104.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9066,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,,PubChem,IU/m2,131.0,135.0
SYNTHETIC-5,DONOR_2067,TREATMENT_9067,Immune checkpoint inhibitors,Alunbrig,987654,PubChem,cells/kg,158.0,187.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9068,Cell-based,Ribociclib,,NCI Thesaurus,cells/kg,168.0,136.0
SYNTHETIC-5,DONOR_2069,TREATMENT_9069,Other immunomodulatory substances,Atezolizumab,4459876,PubChem,cells/kg,,162.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9070,,,987654,RxNorm,cells/kg,114.0,
SYNTHETIC-5,DONOR_2071,TREATMENT_9071,Immune checkpoint inhibitors,Kadcyla,,NCI Thesaurus,,81.0,186.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9072,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,,NCI Thesaurus,,108.0,110.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9073,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,278936,PubChem,,161.0,118.0
SYNTHETIC-5,DONOR_2074,TREATMENT_9074,Immune checkpoint inhibitors,Adcetris,,RxNorm,g/m2,119.0,151.0
SYNTHETIC-5,DONOR_2075,TREATMENT_9075,Immune checkpoint inhibitors,Durvalumab,239766,PubChem,g/m2,135.0,68.0
SYNTHETIC-5,DONOR_2076,TREATMENT_9076,Cell-based,Nivolumab,987654,NCI Thesaurus,mg/kg,144.0,98.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9077,Other immunomodulatory substances,Blinatumomab,4459876,NCI Thesaurus,mg/kg,87.0,128.0
SYNTHETIC-5,DONOR_2078,TREATMENT_9078,Other immunomodulatory substances,Darzalex,239766,NCI Thesaurus,ug/m2,126.0,88.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9079,,Brentuximab vedotin,4459876,RxNorm,IU/kg,165.0,70.0
SYNTHETIC-5,DONOR_2080,TREATMENT_9080,Other immunomodulatory substances,,239766,NCI Thesaurus,mg/kg,181.0,91.0
SYNTHETIC-5,DONOR_2081,TREATMENT_9081,Immune checkpoint inhibitors,Crizotinib,239766,NCI Thesaurus,IU/m2,98.0,179.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9082,Cell-based,Nivolumab,4459876,NCI Thesaurus,,122.0,
SYNTHETIC-5,DONOR_2083,TREATMENT_9083,Other immunomodulatory substances,Zejula,8836851,NCI Thesaurus,cells/kg,75.0,59.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9084,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,ug/m2,135.0,102.0
SYNTHETIC-5,DONOR_2085,TREATMENT_9085,,Tecentriq,987654,,cells/kg,64.0,
SYNTHETIC-5,DONOR_2086,TREATMENT_9086,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8836851,RxNorm,,106.0,84.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9087,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,PubChem,IU/m2,175.0,121.0
SYNTHETIC-5,DONOR_2088,TREATMENT_9088,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,987654,RxNorm,IU/kg,82.0,57.0
SYNTHETIC-5,DONOR_2089,TREATMENT_9089,Other immunomodulatory substances,Olaparib,239766,PubChem,,153.0,110.0
SYNTHETIC-5,DONOR_2090,TREATMENT_9090,Cell-based,Axicabtagene ciloleucel,8756456,PubChem,IU/kg,,155.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9091,Other immunomodulatory substances,Nivolumab,278936,,g/m2,56.0,65.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9092,Other immunomodulatory substances,Gazyva,987654,RxNorm,IU/m2,66.0,195.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9093,Cell-based,Trastuzumab,4459876,PubChem,cells/kg,117.0,87.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9094,Immune checkpoint inhibitors,Crizotinib,987654,NCI Thesaurus,,106.0,80.0
SYNTHETIC-5,DONOR_2095,TREATMENT_9095,Other immunomodulatory substances,Alecensa,8756456,,,181.0,
SYNTHETIC-5,DONOR_2096,TREATMENT_9096,Cell-based,Opdivo,278936,RxNorm,,109.0,56.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9097,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,IU/kg,156.0,141.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9098,Cell-based,Atezolizumab,4459876,RxNorm,IU/m2,,
SYNTHETIC-5,DONOR_2099,TREATMENT_9099,Other immunomodulatory substances,Alecensa,239766,,ug/m2,151.0,156.0
SYNTHETIC-5,DONOR_2100,TREATMENT_9100,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,g/m2,106.0,
SYNTHETIC-5,DONOR_2101,TREATMENT_9101,Immune checkpoint inhibitors,,239766,RxNorm,mg/m2,126.0,96.0
SYNTHETIC-5,DONOR_2102,TREATMENT_9102,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,,NCI Thesaurus,,152.0,100.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9103,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8756456,NCI Thesaurus,,157.0,140.0
SYNTHETIC-5,DONOR_2104,TREATMENT_9104,,Kadcyla,4459876,PubChem,ug/m2,66.0,145.0
SYNTHETIC-5,DONOR_2105,TREATMENT_9105,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,PubChem,IU/m2,,57.0
SYNTHETIC-5,DONOR_2106,TREATMENT_9106,Immune checkpoint inhibitors,Nivolumab,8836851,RxNorm,IU/kg,123.0,90.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9107,,Alectinib,987654,NCI Thesaurus,ug/m2,93.0,59.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9108,Immune checkpoint inhibitors,,4459876,PubChem,mg/kg,93.0,155.0
SYNTHETIC-5,DONOR_2109,TREATMENT_9109,Immune checkpoint inhibitors,Rituximab,,PubChem,,158.0,196.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9110,Other immunomodulatory substances,Durvalumab,239766,NCI Thesaurus,cells/kg,140.0,
SYNTHETIC-5,DONOR_2111,TREATMENT_9111,,Tecentriq,987654,RxNorm,cells/kg,59.0,178.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9112,Immune checkpoint inhibitors,Kymriah,239766,PubChem,IU/m2,165.0,56.0
SYNTHETIC-5,DONOR_2113,TREATMENT_9113,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,PubChem,mg/kg,,103.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9114,Cell-based,Xalkori,987654,PubChem,cells/kg,187.0,80.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9115,Other immunomodulatory substances,Opdivo,278936,,mg/kg,145.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_9116,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,,PubChem,,63.0,69.0
SYNTHETIC-5,DONOR_2117,TREATMENT_9117,Other immunomodulatory substances,Copanlisib,987654,NCI Thesaurus,IU/m2,143.0,89.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9118,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8836851,PubChem,IU/kg,126.0,59.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9119,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,8836851,PubChem,ug/m2,137.0,105.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9120,Immune checkpoint inhibitors,,8756456,RxNorm,g/m2,148.0,195.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9121,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,278936,,cells/kg,174.0,57.0
SYNTHETIC-5,DONOR_2122,TREATMENT_9122,Cell-based,Selumitinib,,,IU/kg,,62.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9123,Cell-based,Pembrolizumab,278936,RxNorm,mg/kg,69.0,
SYNTHETIC-5,DONOR_2124,TREATMENT_9124,Other immunomodulatory substances,Yervoy,278936,NCI Thesaurus,,139.0,82.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9125,Immune checkpoint inhibitors,Crizotinib,8836851,PubChem,IU/kg,122.0,
SYNTHETIC-5,DONOR_2126,TREATMENT_9126,Other immunomodulatory substances,,4459876,,mg/kg,75.0,158.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9127,Other immunomodulatory substances,Lenvima,,NCI Thesaurus,mg/kg,183.0,
SYNTHETIC-5,DONOR_2128,TREATMENT_9128,Other immunomodulatory substances,Belantamab,987654,NCI Thesaurus,ug/m2,,109.0
SYNTHETIC-5,DONOR_2129,TREATMENT_9129,Cell-based,Durvalumab,8836851,RxNorm,IU/kg,188.0,88.0
SYNTHETIC-5,DONOR_2130,TREATMENT_9130,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,4459876,NCI Thesaurus,IU/m2,128.0,
SYNTHETIC-5,DONOR_2131,TREATMENT_9131,Immune checkpoint inhibitors,Cometriq,239766,NCI Thesaurus,IU/kg,118.0,58.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9132,Other immunomodulatory substances,Niraparib,8756456,RxNorm,IU/kg,173.0,66.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9133,Cell-based,Vemurafenib,4459876,,g/m2,192.0,194.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9134,,Ipilimumab,8836851,,ug/m2,147.0,88.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9135,Other immunomodulatory substances,,,RxNorm,ug/m2,146.0,140.0
SYNTHETIC-5,DONOR_2136,TREATMENT_9136,Immune checkpoint inhibitors,Afatinib,8836851,NCI Thesaurus,IU/m2,90.0,147.0
SYNTHETIC-5,DONOR_2137,TREATMENT_9137,,Nivolumab,8756456,RxNorm,ug/m2,118.0,181.0
SYNTHETIC-5,DONOR_2138,TREATMENT_9138,Other immunomodulatory substances,Vemurafenib,,PubChem,cells/kg,116.0,186.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9139,Immune checkpoint inhibitors,Opdivo,278936,PubChem,g/m2,200.0,184.0
SYNTHETIC-5,DONOR_2140,TREATMENT_9140,Cell-based,,8836851,PubChem,,,
SYNTHETIC-5,DONOR_2141,TREATMENT_9141,Immune checkpoint inhibitors,,,,mg/kg,,170.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9142,Immune checkpoint inhibitors,Zejula,239766,PubChem,g/m2,78.0,198.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9143,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,mg/kg,54.0,196.0
SYNTHETIC-5,DONOR_2144,TREATMENT_9144,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,8836851,NCI Thesaurus,mg/m2,95.0,112.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9145,,Cometriq,4459876,PubChem,g/m2,148.0,61.0
SYNTHETIC-5,DONOR_2146,TREATMENT_9146,Cell-based,Cotellic,987654,PubChem,g/m2,77.0,187.0
SYNTHETIC-5,DONOR_2147,TREATMENT_9147,Immune checkpoint inhibitors,Olaparib,8836851,PubChem,IU/m2,135.0,
SYNTHETIC-5,DONOR_2148,TREATMENT_9148,,Imfinzi,8836851,,ug/m2,,66.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9149,Cell-based,Alecensa,,,IU/m2,195.0,
SYNTHETIC-5,DONOR_2150,TREATMENT_9150,,Pembrolizumab,8756456,PubChem,,161.0,192.0
SYNTHETIC-5,DONOR_2151,TREATMENT_9151,Cell-based,Lenvatinib,987654,RxNorm,ug/m2,189.0,110.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9152,Immune checkpoint inhibitors,Belantamab,8756456,NCI Thesaurus,mg/kg,186.0,172.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9153,Cell-based,Trastuzumab,239766,PubChem,mg/m2,161.0,184.0
SYNTHETIC-5,DONOR_2154,TREATMENT_9154,,Belantamab,239766,RxNorm,cells/kg,183.0,131.0
SYNTHETIC-5,DONOR_2155,TREATMENT_9155,,Venclexta,4459876,RxNorm,cells/kg,59.0,189.0
SYNTHETIC-5,DONOR_2156,TREATMENT_9156,Immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,mg/kg,156.0,107.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9157,,Vandetanib,8836851,PubChem,mg/m2,,
SYNTHETIC-5,DONOR_2158,TREATMENT_9158,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,4459876,,IU/kg,147.0,116.0
SYNTHETIC-5,DONOR_2159,TREATMENT_9159,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,278936,PubChem,cells/kg,107.0,
SYNTHETIC-5,DONOR_2160,TREATMENT_9160,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,197.0,
SYNTHETIC-5,DONOR_2161,TREATMENT_9161,Other immunomodulatory substances,Erlotinib,,RxNorm,mg/m2,168.0,191.0
SYNTHETIC-5,DONOR_2162,TREATMENT_9162,Immune checkpoint inhibitors,Keytruda,987654,PubChem,IU/m2,191.0,195.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9163,Other immunomodulatory substances,Opdivo,4459876,NCI Thesaurus,IU/kg,96.0,80.0
SYNTHETIC-5,DONOR_2164,TREATMENT_9164,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8756456,NCI Thesaurus,IU/kg,93.0,177.0
SYNTHETIC-5,DONOR_2165,TREATMENT_9165,Other immunomodulatory substances,,8836851,RxNorm,mg/m2,92.0,153.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9166,,Zelboraf,987654,NCI Thesaurus,cells/kg,141.0,
SYNTHETIC-5,DONOR_2167,TREATMENT_9167,Immune checkpoint inhibitors,Gazyva,987654,,IU/kg,,114.0
SYNTHETIC-5,DONOR_2168,TREATMENT_9168,Immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,g/m2,127.0,54.0
SYNTHETIC-5,DONOR_2169,TREATMENT_9169,Other immunomodulatory substances,,8836851,PubChem,IU/kg,,122.0
SYNTHETIC-5,DONOR_2170,TREATMENT_9170,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,4459876,RxNorm,cells/kg,181.0,153.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9171,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,mg/kg,113.0,
SYNTHETIC-5,DONOR_2172,TREATMENT_9172,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,PubChem,IU/m2,134.0,61.0
SYNTHETIC-5,DONOR_2173,TREATMENT_9173,Other immunomodulatory substances,Keytruda,278936,NCI Thesaurus,mg/kg,135.0,132.0
SYNTHETIC-5,DONOR_2174,TREATMENT_9174,Cell-based,Blincyto,8756456,PubChem,,190.0,151.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9175,Cell-based,Trastuzumab,278936,RxNorm,mg/m2,89.0,184.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9176,,Obinutuzumab,987654,PubChem,cells/kg,155.0,192.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9177,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8756456,PubChem,mg/m2,172.0,79.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9178,Other immunomodulatory substances,Yervoy,,PubChem,ug/m2,132.0,195.0
SYNTHETIC-5,DONOR_2179,TREATMENT_9179,Other immunomodulatory substances,Olaparib,8836851,RxNorm,,126.0,163.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9180,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,4459876,,cells/kg,,123.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9181,Other immunomodulatory substances,Pembrolizumab,4459876,NCI Thesaurus,IU/m2,110.0,
SYNTHETIC-5,DONOR_2182,TREATMENT_9182,Other immunomodulatory substances,Tecentriq,8756456,PubChem,,92.0,126.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9183,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,RxNorm,,92.0,
SYNTHETIC-5,DONOR_2184,TREATMENT_9184,Cell-based,Crizotinib,,PubChem,g/m2,,135.0
SYNTHETIC-5,DONOR_2185,TREATMENT_9185,Other immunomodulatory substances,,4459876,NCI Thesaurus,,149.0,
SYNTHETIC-5,DONOR_2186,TREATMENT_9186,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,8756456,PubChem,g/m2,156.0,152.0
SYNTHETIC-5,DONOR_2187,TREATMENT_9187,Immune checkpoint inhibitors,Pembrolizumab,4459876,RxNorm,ug/m2,85.0,177.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9188,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,987654,PubChem,,53.0,147.0
SYNTHETIC-5,DONOR_2189,TREATMENT_9189,Other immunomodulatory substances,Yervoy,239766,RxNorm,mg/m2,,152.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9190,,Cometriq,278936,PubChem,mg/m2,149.0,120.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9191,Immune checkpoint inhibitors,Imfinzi,239766,PubChem,mg/kg,159.0,161.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9192,,Yescarta,4459876,,IU/m2,120.0,181.0
SYNTHETIC-5,DONOR_2193,TREATMENT_9193,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,278936,NCI Thesaurus,mg/kg,151.0,112.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9194,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,239766,NCI Thesaurus,cells/kg,120.0,151.0
SYNTHETIC-5,DONOR_2195,TREATMENT_9195,,Rubraca,,,g/m2,145.0,78.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9196,Other immunomodulatory substances,Necitumumab,8756456,NCI Thesaurus,IU/kg,91.0,
SYNTHETIC-5,DONOR_2197,TREATMENT_9197,Immune checkpoint inhibitors,Zejula,4459876,RxNorm,g/m2,167.0,136.0
SYNTHETIC-5,DONOR_2198,TREATMENT_9198,Cell-based,Iressa,987654,RxNorm,IU/kg,,102.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9199,Cell-based,Cometriq,239766,,IU/m2,104.0,182.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9200,Other immunomodulatory substances,,8836851,PubChem,cells/kg,168.0,112.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9201,,Pexidartinib,8836851,RxNorm,mg/m2,195.0,85.0
SYNTHETIC-5,DONOR_2202,TREATMENT_9202,Cell-based,Mektovi,8756456,NCI Thesaurus,,62.0,70.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9203,Cell-based,,8756456,NCI Thesaurus,cells/kg,110.0,119.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9204,Immune checkpoint inhibitors,Kymriah,8836851,PubChem,mg/kg,69.0,60.0
SYNTHETIC-5,DONOR_2205,TREATMENT_9205,Cell-based,Yescarta,987654,RxNorm,mg/kg,193.0,196.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9206,,Trastuzumab,4459876,RxNorm,mg/m2,191.0,171.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9207,Immune checkpoint inhibitors,Imfinzi,8756456,PubChem,g/m2,169.0,191.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9208,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,PubChem,mg/m2,64.0,169.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9209,Immune checkpoint inhibitors,Yescarta,8836851,PubChem,,83.0,164.0
SYNTHETIC-5,DONOR_2210,TREATMENT_9210,Other immunomodulatory substances,,987654,RxNorm,g/m2,118.0,161.0
SYNTHETIC-5,DONOR_2211,TREATMENT_9211,Immune checkpoint inhibitors,Durvalumab,,PubChem,mg/m2,,184.0
SYNTHETIC-5,DONOR_2212,TREATMENT_9212,Cell-based,,239766,PubChem,ug/m2,68.0,186.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9213,Immune checkpoint inhibitors,Perjeta,,,mg/m2,,93.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9214,,Obinutuzumab,8836851,RxNorm,g/m2,133.0,80.0
SYNTHETIC-5,DONOR_2215,TREATMENT_9215,,,8756456,NCI Thesaurus,mg/kg,79.0,92.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9216,,,8756456,NCI Thesaurus,mg/kg,107.0,126.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9217,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,,PubChem,mg/m2,144.0,195.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9218,Cell-based,Opdivo,,PubChem,mg/m2,121.0,
SYNTHETIC-5,DONOR_2219,TREATMENT_9219,Cell-based,,4459876,RxNorm,,108.0,64.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9220,,Daratumumab,8756456,RxNorm,ug/m2,91.0,118.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9221,Immune checkpoint inhibitors,Cobimetinib,4459876,NCI Thesaurus,,74.0,
SYNTHETIC-5,DONOR_2222,TREATMENT_9222,Immune checkpoint inhibitors,Rucaparib,239766,RxNorm,mg/m2,137.0,68.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9223,Immune checkpoint inhibitors,,,PubChem,IU/m2,139.0,102.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9224,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,8756456,NCI Thesaurus,cells/kg,70.0,181.0
SYNTHETIC-5,DONOR_2225,TREATMENT_9225,Other immunomodulatory substances,Niraparib,278936,RxNorm,cells/kg,,102.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9226,Immune checkpoint inhibitors,Crizotinib,4459876,RxNorm,IU/kg,124.0,136.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9227,Immune checkpoint inhibitors,Osimertinib,4459876,PubChem,cells/kg,178.0,93.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9228,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,987654,NCI Thesaurus,g/m2,95.0,118.0
SYNTHETIC-5,DONOR_2229,TREATMENT_9229,Cell-based,Durvalumab,,PubChem,cells/kg,183.0,130.0
SYNTHETIC-5,DONOR_2230,TREATMENT_9230,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,278936,NCI Thesaurus,,85.0,112.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9231,,Cobimetinib,8756456,PubChem,IU/m2,,169.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9232,Other immunomodulatory substances,Keytruda,278936,RxNorm,ug/m2,70.0,176.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9233,Other immunomodulatory substances,Tarceva,8756456,RxNorm,IU/kg,161.0,
SYNTHETIC-5,DONOR_2234,TREATMENT_9234,Other immunomodulatory substances,,239766,PubChem,IU/m2,97.0,79.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9235,Immune checkpoint inhibitors,Ipilimumab,239766,PubChem,,,126.0
SYNTHETIC-5,DONOR_2236,TREATMENT_9236,Immune checkpoint inhibitors,Cabozantinib,239766,PubChem,IU/m2,110.0,
SYNTHETIC-5,DONOR_2237,TREATMENT_9237,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,RxNorm,mg/kg,112.0,112.0
SYNTHETIC-5,DONOR_2238,TREATMENT_9238,Cell-based,Gilotrif,,NCI Thesaurus,,63.0,162.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9239,Other immunomodulatory substances,Vandetanib,,RxNorm,IU/m2,51.0,86.0
SYNTHETIC-5,DONOR_2240,TREATMENT_9240,Other immunomodulatory substances,Xalkori,987654,RxNorm,IU/m2,114.0,117.0
SYNTHETIC-5,DONOR_2241,TREATMENT_9241,Other immunomodulatory substances,Keytruda,8756456,NCI Thesaurus,mg/m2,195.0,172.0
SYNTHETIC-5,DONOR_2242,TREATMENT_9242,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,ug/m2,130.0,
SYNTHETIC-5,DONOR_2243,TREATMENT_9243,Other immunomodulatory substances,Trastuzumab,8756456,,IU/kg,,70.0
SYNTHETIC-5,DONOR_2244,TREATMENT_9244,Cell-based,,4459876,RxNorm,g/m2,56.0,131.0
SYNTHETIC-5,DONOR_2245,TREATMENT_9245,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/kg,88.0,100.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9246,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,NCI Thesaurus,,160.0,
SYNTHETIC-5,DONOR_2247,TREATMENT_9247,Immune checkpoint inhibitors,Durvalumab,4459876,,,179.0,
SYNTHETIC-5,DONOR_2248,TREATMENT_9248,,Yervoy,987654,RxNorm,ug/m2,90.0,
SYNTHETIC-5,DONOR_2249,TREATMENT_9249,Cell-based,,239766,NCI Thesaurus,IU/kg,178.0,130.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9250,Cell-based,Fam-trastuzumab deruxtecan-nxki,4459876,PubChem,,62.0,111.0
SYNTHETIC-5,DONOR_2251,TREATMENT_9251,Immune checkpoint inhibitors,Ribociclib,8836851,RxNorm,cells/kg,184.0,157.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9252,Other immunomodulatory substances,,987654,,IU/kg,68.0,52.0
SYNTHETIC-5,DONOR_2253,TREATMENT_9253,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,IU/m2,179.0,120.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9254,Immune checkpoint inhibitors,Iressa,239766,,mg/kg,163.0,55.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9255,Cell-based,Gilotrif,987654,PubChem,IU/m2,104.0,100.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9256,Cell-based,Pexidartinib,987654,PubChem,mg/kg,195.0,92.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9257,Other immunomodulatory substances,Pexidartinib,987654,,,101.0,
SYNTHETIC-5,DONOR_2258,TREATMENT_9258,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,mg/kg,,142.0
SYNTHETIC-5,DONOR_2259,TREATMENT_9259,Cell-based,Alectinib,239766,PubChem,cells/kg,86.0,150.0
SYNTHETIC-5,DONOR_2260,TREATMENT_9260,Other immunomodulatory substances,Crizotinib,8836851,PubChem,mg/kg,69.0,124.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9261,Cell-based,Yervoy,987654,PubChem,mg/m2,122.0,95.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9262,,Trametinib,278936,PubChem,cells/kg,90.0,98.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9263,Other immunomodulatory substances,Copanlisib,,,mg/kg,169.0,115.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9264,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,,ug/m2,,193.0
SYNTHETIC-5,DONOR_2265,TREATMENT_9265,Immune checkpoint inhibitors,Xalkori,278936,,g/m2,101.0,62.0
SYNTHETIC-5,DONOR_2266,TREATMENT_9266,Cell-based,Atezolizumab,4459876,NCI Thesaurus,IU/kg,149.0,108.0
SYNTHETIC-5,DONOR_2267,TREATMENT_9267,Other immunomodulatory substances,Opdivo,,NCI Thesaurus,mg/m2,87.0,170.0
SYNTHETIC-5,DONOR_2268,TREATMENT_9268,Immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,ug/m2,,113.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9269,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,,RxNorm,cells/kg,99.0,74.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9270,,,8756456,NCI Thesaurus,IU/kg,80.0,
SYNTHETIC-5,DONOR_2271,TREATMENT_9271,,Olaparib,8756456,NCI Thesaurus,,159.0,159.0
SYNTHETIC-5,DONOR_2272,TREATMENT_9272,Other immunomodulatory substances,Keytruda,,PubChem,cells/kg,97.0,154.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9273,Immune checkpoint inhibitors,Rucaparib,4459876,NCI Thesaurus,,59.0,
SYNTHETIC-5,DONOR_2274,TREATMENT_9274,Cell-based,Yervoy,,,g/m2,185.0,
SYNTHETIC-5,DONOR_2275,TREATMENT_9275,Other immunomodulatory substances,Crizotinib,987654,RxNorm,,198.0,76.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9276,Cell-based,Ibrance,4459876,NCI Thesaurus,mg/kg,191.0,174.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9277,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,ug/m2,,193.0
SYNTHETIC-5,DONOR_2278,TREATMENT_9278,,Inotuzumab ozogamicin,239766,RxNorm,ug/m2,160.0,180.0
SYNTHETIC-5,DONOR_2279,TREATMENT_9279,Cell-based,Pembrolizumab,8836851,RxNorm,mg/m2,75.0,150.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9280,Cell-based,Alecensa,4459876,NCI Thesaurus,IU/m2,193.0,
SYNTHETIC-5,DONOR_2281,TREATMENT_9281,Other immunomodulatory substances,,239766,NCI Thesaurus,ug/m2,108.0,93.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9282,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,,,IU/kg,167.0,
SYNTHETIC-5,DONOR_2283,TREATMENT_9283,Immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,IU/kg,81.0,
SYNTHETIC-5,DONOR_2284,TREATMENT_9284,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,mg/kg,60.0,152.0
SYNTHETIC-5,DONOR_2285,TREATMENT_9285,Cell-based,Enhertu,4459876,RxNorm,g/m2,167.0,
SYNTHETIC-5,DONOR_2286,TREATMENT_9286,Immune checkpoint inhibitors,,8756456,RxNorm,,181.0,128.0
SYNTHETIC-5,DONOR_2287,TREATMENT_9287,Immune checkpoint inhibitors,Dabrafenib,8756456,RxNorm,g/m2,171.0,
SYNTHETIC-5,DONOR_2288,TREATMENT_9288,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,239766,NCI Thesaurus,cells/kg,176.0,53.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9289,,Mekinist,,NCI Thesaurus,mg/kg,144.0,125.0
SYNTHETIC-5,DONOR_2290,TREATMENT_9290,,Gilotrif,278936,PubChem,IU/m2,192.0,167.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9291,Cell-based,Blincyto,,,IU/m2,63.0,171.0
SYNTHETIC-5,DONOR_2292,TREATMENT_9292,Immune checkpoint inhibitors,,239766,RxNorm,mg/kg,130.0,135.0
SYNTHETIC-5,DONOR_2293,TREATMENT_9293,,,987654,,mg/kg,97.0,105.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9294,Cell-based,Gilteritinib,239766,NCI Thesaurus,,,152.0
SYNTHETIC-5,DONOR_2295,TREATMENT_9295,Cell-based,,278936,NCI Thesaurus,IU/m2,159.0,
SYNTHETIC-5,DONOR_2296,TREATMENT_9296,Immune checkpoint inhibitors,Trastuzumab,278936,NCI Thesaurus,IU/m2,144.0,50.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9297,Immune checkpoint inhibitors,Tarceva,,RxNorm,g/m2,157.0,100.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9298,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8836851,RxNorm,,,
SYNTHETIC-5,DONOR_2299,TREATMENT_9299,Cell-based,Durvalumab,239766,PubChem,g/m2,141.0,169.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9300,Immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,ug/m2,76.0,
SYNTHETIC-5,DONOR_2301,TREATMENT_9301,Immune checkpoint inhibitors,Rituximab,239766,NCI Thesaurus,mg/kg,62.0,108.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9302,Immune checkpoint inhibitors,Verzenio,4459876,PubChem,g/m2,,69.0
SYNTHETIC-5,DONOR_2303,TREATMENT_9303,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,278936,PubChem,cells/kg,180.0,
SYNTHETIC-5,DONOR_2304,TREATMENT_9304,Other immunomodulatory substances,Alunbrig,8836851,RxNorm,g/m2,164.0,114.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9305,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,239766,NCI Thesaurus,ug/m2,180.0,97.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9306,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,239766,NCI Thesaurus,IU/kg,158.0,51.0
SYNTHETIC-5,DONOR_2307,TREATMENT_9307,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,278936,NCI Thesaurus,mg/kg,,51.0
SYNTHETIC-5,DONOR_2308,TREATMENT_9308,Immune checkpoint inhibitors,Venetoclax,8756456,NCI Thesaurus,mg/m2,144.0,69.0
SYNTHETIC-5,DONOR_2309,TREATMENT_9309,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,,RxNorm,mg/m2,,155.0
SYNTHETIC-5,DONOR_2310,TREATMENT_9310,Cell-based,Dabrafenib,,PubChem,mg/m2,121.0,105.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9311,Cell-based,Opdivo,987654,NCI Thesaurus,g/m2,161.0,113.0
SYNTHETIC-5,DONOR_2312,TREATMENT_9312,Other immunomodulatory substances,,987654,PubChem,cells/kg,126.0,
SYNTHETIC-5,DONOR_2313,TREATMENT_9313,Other immunomodulatory substances,Adcetris,278936,RxNorm,mg/kg,193.0,135.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9314,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,PubChem,ug/m2,,102.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9315,Cell-based,Keytruda,,NCI Thesaurus,mg/m2,65.0,158.0
SYNTHETIC-5,DONOR_2316,TREATMENT_9316,Cell-based,,278936,PubChem,cells/kg,,97.0
SYNTHETIC-5,DONOR_2317,TREATMENT_9317,Other immunomodulatory substances,Pexidartinib,8756456,PubChem,mg/m2,,70.0
SYNTHETIC-5,DONOR_2318,TREATMENT_9318,Immune checkpoint inhibitors,Crizotinib,,RxNorm,ug/m2,60.0,75.0
SYNTHETIC-5,DONOR_2319,TREATMENT_9319,Other immunomodulatory substances,Dabrafenib,987654,RxNorm,cells/kg,97.0,151.0
SYNTHETIC-5,DONOR_2320,TREATMENT_9320,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,239766,,g/m2,79.0,
SYNTHETIC-5,DONOR_2321,TREATMENT_9321,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,,,191.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9322,Immune checkpoint inhibitors,Sorafenib,,PubChem,mg/kg,161.0,125.0
SYNTHETIC-5,DONOR_2323,TREATMENT_9323,Cell-based,Kadcyla,278936,NCI Thesaurus,ug/m2,155.0,176.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9324,Immune checkpoint inhibitors,Zykadia,278936,RxNorm,mg/m2,121.0,
SYNTHETIC-5,DONOR_2325,TREATMENT_9325,Cell-based,Pembrolizumab,8836851,PubChem,mg/m2,161.0,
SYNTHETIC-5,DONOR_2326,TREATMENT_9326,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,987654,NCI Thesaurus,g/m2,187.0,
SYNTHETIC-5,DONOR_2327,TREATMENT_9327,Other immunomodulatory substances,Inotuzumab ozogamicin,8756456,NCI Thesaurus,g/m2,161.0,170.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9328,Cell-based,Keytruda,8836851,RxNorm,cells/kg,135.0,64.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9329,Other immunomodulatory substances,,4459876,RxNorm,mg/m2,94.0,84.0
SYNTHETIC-5,DONOR_2330,TREATMENT_9330,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,RxNorm,ug/m2,,51.0
SYNTHETIC-5,DONOR_2331,TREATMENT_9331,Cell-based,Durvalumab,,NCI Thesaurus,ug/m2,138.0,130.0
SYNTHETIC-5,DONOR_2332,TREATMENT_9332,,Pertuzumab,,PubChem,mg/kg,195.0,152.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9333,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,mg/m2,98.0,142.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9334,Cell-based,Besponsa,4459876,PubChem,IU/kg,90.0,145.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9335,,Ipilimumab,8836851,NCI Thesaurus,IU/kg,86.0,196.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9336,Other immunomodulatory substances,Axicabtagene ciloleucel,4459876,PubChem,mg/m2,124.0,196.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9337,Immune checkpoint inhibitors,Enhertu,987654,NCI Thesaurus,ug/m2,74.0,127.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9338,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,NCI Thesaurus,cells/kg,61.0,119.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9339,Cell-based,,,NCI Thesaurus,ug/m2,65.0,
SYNTHETIC-5,DONOR_2340,TREATMENT_9340,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,NCI Thesaurus,mg/kg,,
SYNTHETIC-5,DONOR_2341,TREATMENT_9341,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,987654,,cells/kg,59.0,115.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9342,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,mg/kg,95.0,
SYNTHETIC-5,DONOR_2343,TREATMENT_9343,Cell-based,Crizotinib,8756456,RxNorm,g/m2,,97.0
SYNTHETIC-5,DONOR_2344,TREATMENT_9344,Other immunomodulatory substances,Trametinib,8756456,NCI Thesaurus,ug/m2,200.0,76.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9345,Immune checkpoint inhibitors,Ipilimumab,8836851,,mg/m2,69.0,130.0
SYNTHETIC-5,DONOR_2346,TREATMENT_9346,Cell-based,Ibrance,,NCI Thesaurus,,65.0,184.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9347,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,278936,RxNorm,ug/m2,113.0,81.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9348,Other immunomodulatory substances,Trastuzumab,8756456,PubChem,g/m2,63.0,108.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9349,Other immunomodulatory substances,Nexavar,987654,PubChem,cells/kg,64.0,58.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9350,Immune checkpoint inhibitors,Ibrance,239766,PubChem,,104.0,148.0
SYNTHETIC-5,DONOR_2351,TREATMENT_9351,Immune checkpoint inhibitors,Gazyva,4459876,RxNorm,mg/m2,134.0,150.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9352,Other immunomodulatory substances,Inotuzumab ozogamicin,,RxNorm,mg/kg,84.0,
SYNTHETIC-5,DONOR_2353,TREATMENT_9353,Other immunomodulatory substances,Opdivo,987654,PubChem,IU/kg,92.0,63.0
SYNTHETIC-5,DONOR_2354,TREATMENT_9354,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,PubChem,mg/kg,,
SYNTHETIC-5,DONOR_2355,TREATMENT_9355,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,PubChem,g/m2,60.0,166.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9356,Other immunomodulatory substances,Kymriah,8756456,PubChem,cells/kg,112.0,
SYNTHETIC-5,DONOR_2357,TREATMENT_9357,Immune checkpoint inhibitors,Gilteritinib,8836851,NCI Thesaurus,mg/kg,93.0,106.0
SYNTHETIC-5,DONOR_2358,TREATMENT_9358,Other immunomodulatory substances,Pertuzumab,,PubChem,cells/kg,130.0,126.0
SYNTHETIC-5,DONOR_2359,TREATMENT_9359,Immune checkpoint inhibitors,Cabozantinib,8836851,,mg/kg,,60.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9360,Cell-based,Afatinib,,NCI Thesaurus,,58.0,85.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9361,Immune checkpoint inhibitors,Tecentriq,8836851,RxNorm,IU/kg,106.0,119.0
SYNTHETIC-5,DONOR_2362,TREATMENT_9362,Immune checkpoint inhibitors,Braftovi,8756456,RxNorm,ug/m2,186.0,
SYNTHETIC-5,DONOR_2363,TREATMENT_9363,,Yervoy,278936,,mg/m2,,165.0
SYNTHETIC-5,DONOR_2364,TREATMENT_9364,Other immunomodulatory substances,Pembrolizumab,4459876,PubChem,cells/kg,146.0,
SYNTHETIC-5,DONOR_2365,TREATMENT_9365,Immune checkpoint inhibitors,Durvalumab,278936,NCI Thesaurus,,58.0,153.0
SYNTHETIC-5,DONOR_2366,TREATMENT_9366,Other immunomodulatory substances,Adcetris,4459876,PubChem,,72.0,190.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9367,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,,NCI Thesaurus,,93.0,
SYNTHETIC-5,DONOR_2368,TREATMENT_9368,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,,192.0,91.0
SYNTHETIC-5,DONOR_2369,TREATMENT_9369,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,,NCI Thesaurus,g/m2,198.0,167.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9370,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,239766,NCI Thesaurus,ug/m2,147.0,148.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9371,Cell-based,,8756456,NCI Thesaurus,IU/m2,110.0,152.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9372,Immune checkpoint inhibitors,Gilteritinib,278936,,mg/kg,,148.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9373,Other immunomodulatory substances,Besponsa,,PubChem,ug/m2,178.0,
SYNTHETIC-5,DONOR_2374,TREATMENT_9374,Other immunomodulatory substances,Palbociclib,8836851,PubChem,cells/kg,135.0,
SYNTHETIC-5,DONOR_2375,TREATMENT_9375,Other immunomodulatory substances,Lenvatinib,987654,NCI Thesaurus,IU/m2,112.0,152.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9376,Immune checkpoint inhibitors,Abemaciclib,278936,NCI Thesaurus,ug/m2,,189.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9377,Other immunomodulatory substances,Nexavar,8756456,PubChem,mg/kg,78.0,57.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9378,Other immunomodulatory substances,Besponsa,8756456,NCI Thesaurus,mg/m2,195.0,81.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9379,Other immunomodulatory substances,Yervoy,8756456,PubChem,IU/kg,,182.0
SYNTHETIC-5,DONOR_2380,TREATMENT_9380,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,4459876,PubChem,IU/m2,,120.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9381,,Lenvima,8756456,PubChem,IU/m2,194.0,87.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9382,Immune checkpoint inhibitors,Obinutuzumab,8756456,NCI Thesaurus,cells/kg,,131.0
SYNTHETIC-5,DONOR_2383,TREATMENT_9383,Other immunomodulatory substances,Opdivo,4459876,PubChem,IU/kg,,140.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9384,Cell-based,Necitumumab,987654,NCI Thesaurus,cells/kg,163.0,
SYNTHETIC-5,DONOR_2385,TREATMENT_9385,Other immunomodulatory substances,Yervoy,8836851,PubChem,IU/kg,130.0,110.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9386,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,cells/kg,126.0,148.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9387,Other immunomodulatory substances,Ado-trastuzumab emtansine,4459876,PubChem,,129.0,197.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9388,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,987654,PubChem,mg/kg,157.0,
SYNTHETIC-5,DONOR_2389,TREATMENT_9389,Cell-based,Rubraca,8836851,PubChem,mg/m2,88.0,
SYNTHETIC-5,DONOR_2390,TREATMENT_9390,Immune checkpoint inhibitors,Alunbrig,8756456,RxNorm,mg/kg,120.0,163.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9391,Immune checkpoint inhibitors,Alectinib,8756456,RxNorm,IU/kg,79.0,118.0
SYNTHETIC-5,DONOR_2392,TREATMENT_9392,Cell-based,Durvalumab,239766,RxNorm,IU/kg,185.0,175.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9393,Other immunomodulatory substances,Atezolizumab,239766,NCI Thesaurus,,57.0,139.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9394,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,g/m2,155.0,
SYNTHETIC-5,DONOR_2395,TREATMENT_9395,Immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,mg/kg,,
SYNTHETIC-5,DONOR_2396,TREATMENT_9396,Other immunomodulatory substances,Atezolizumab,8756456,PubChem,IU/m2,166.0,106.0
SYNTHETIC-5,DONOR_2397,TREATMENT_9397,Cell-based,Ipilimumab,8756456,PubChem,cells/kg,,169.0
SYNTHETIC-5,DONOR_2398,TREATMENT_9398,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,,cells/kg,160.0,107.0
SYNTHETIC-5,DONOR_2399,TREATMENT_9399,Other immunomodulatory substances,,,NCI Thesaurus,IU/kg,136.0,125.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9400,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,,cells/kg,96.0,82.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9401,Other immunomodulatory substances,Tagrisso,4459876,NCI Thesaurus,mg/kg,,78.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9402,Cell-based,Yervoy,8756456,PubChem,mg/m2,71.0,58.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9403,Other immunomodulatory substances,Ipilimumab,,RxNorm,ug/m2,60.0,
SYNTHETIC-5,DONOR_2404,TREATMENT_9404,Cell-based,Perjeta,987654,RxNorm,IU/kg,147.0,145.0
SYNTHETIC-5,DONOR_2405,TREATMENT_9405,Other immunomodulatory substances,Keytruda,8756456,PubChem,mg/m2,,183.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9406,Cell-based,Yescarta,239766,RxNorm,,177.0,113.0
SYNTHETIC-5,DONOR_2407,TREATMENT_9407,Cell-based,Opdivo,8836851,RxNorm,g/m2,69.0,
SYNTHETIC-5,DONOR_2408,TREATMENT_9408,Cell-based,Cobimetinib,,RxNorm,,88.0,123.0
SYNTHETIC-5,DONOR_2409,TREATMENT_9409,Cell-based,Adcetris,278936,RxNorm,,106.0,88.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9410,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,cells/kg,66.0,111.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9411,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,,RxNorm,mg/kg,112.0,160.0
SYNTHETIC-5,DONOR_2412,TREATMENT_9412,Immune checkpoint inhibitors,Yervoy,8836851,,IU/kg,89.0,180.0
SYNTHETIC-5,DONOR_2413,TREATMENT_9413,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,cells/kg,118.0,148.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9414,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,8836851,,ug/m2,56.0,
SYNTHETIC-5,DONOR_2415,TREATMENT_9415,Other immunomodulatory substances,Verzenio,987654,RxNorm,g/m2,,125.0
SYNTHETIC-5,DONOR_2416,TREATMENT_9416,Immune checkpoint inhibitors,Niraparib,8756456,RxNorm,,105.0,163.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9417,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,IU/kg,196.0,62.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9418,,Ipilimumab,8756456,RxNorm,IU/kg,73.0,177.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9419,Other immunomodulatory substances,,,RxNorm,IU/m2,79.0,120.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9420,Immune checkpoint inhibitors,Vemurafenib,,RxNorm,,,69.0
SYNTHETIC-5,DONOR_2421,TREATMENT_9421,Cell-based,,987654,PubChem,g/m2,178.0,127.0
SYNTHETIC-5,DONOR_2422,TREATMENT_9422,,Keytruda,4459876,NCI Thesaurus,mg/m2,114.0,173.0
SYNTHETIC-5,DONOR_2423,TREATMENT_9423,Cell-based,Rucaparib,987654,,g/m2,94.0,108.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9424,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,4459876,PubChem,ug/m2,196.0,144.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9425,Immune checkpoint inhibitors,,4459876,,ug/m2,108.0,142.0
SYNTHETIC-5,DONOR_2426,TREATMENT_9426,Cell-based,Gazyva,278936,,mg/m2,63.0,60.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9427,Other immunomodulatory substances,Alunbrig,8836851,PubChem,cells/kg,61.0,63.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9428,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,NCI Thesaurus,cells/kg,58.0,157.0
SYNTHETIC-5,DONOR_2429,TREATMENT_9429,Immune checkpoint inhibitors,Pertuzumab,239766,PubChem,IU/m2,97.0,89.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9430,Other immunomodulatory substances,Venclexta,8836851,NCI Thesaurus,mg/m2,133.0,130.0
SYNTHETIC-5,DONOR_2431,TREATMENT_9431,Other immunomodulatory substances,,278936,PubChem,mg/m2,70.0,90.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9432,Other immunomodulatory substances,Ipilimumab,987654,NCI Thesaurus,mg/m2,106.0,53.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9433,Other immunomodulatory substances,Palbociclib,,PubChem,IU/m2,,148.0
SYNTHETIC-5,DONOR_2434,TREATMENT_9434,Immune checkpoint inhibitors,Trastuzumab,987654,RxNorm,g/m2,109.0,135.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9435,Immune checkpoint inhibitors,Ibrance,8756456,RxNorm,mg/kg,,199.0
SYNTHETIC-5,DONOR_2436,TREATMENT_9436,,Ipilimumab,8756456,RxNorm,mg/m2,122.0,184.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9437,Other immunomodulatory substances,Mektovi,4459876,PubChem,IU/kg,181.0,65.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9438,Cell-based,Keytruda,,,mg/m2,155.0,171.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9439,Cell-based,Opdivo,239766,,mg/kg,,110.0
SYNTHETIC-5,DONOR_2440,TREATMENT_9440,Immune checkpoint inhibitors,Gilteritinib,987654,PubChem,cells/kg,74.0,62.0
SYNTHETIC-5,DONOR_2441,TREATMENT_9441,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,4459876,RxNorm,mg/kg,160.0,164.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9442,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,239766,NCI Thesaurus,ug/m2,175.0,132.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9443,,,239766,PubChem,ug/m2,67.0,101.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9444,Cell-based,Osimertinib,4459876,,g/m2,117.0,74.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9445,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,,g/m2,165.0,193.0
SYNTHETIC-5,DONOR_2446,TREATMENT_9446,,Rubraca,278936,RxNorm,IU/m2,,89.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9447,Other immunomodulatory substances,Kadcyla,278936,PubChem,g/m2,118.0,
SYNTHETIC-5,DONOR_2448,TREATMENT_9448,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,PubChem,IU/kg,111.0,184.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9449,Other immunomodulatory substances,Yervoy,239766,PubChem,IU/m2,116.0,62.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9450,Cell-based,Enhertu,278936,RxNorm,cells/kg,128.0,191.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9451,Other immunomodulatory substances,,8836851,RxNorm,g/m2,197.0,136.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9452,Cell-based,Tisagenlecleucel,278936,,ug/m2,182.0,192.0
SYNTHETIC-5,DONOR_2453,TREATMENT_9453,Immune checkpoint inhibitors,Belantamab,278936,PubChem,,154.0,
SYNTHETIC-5,DONOR_2454,TREATMENT_9454,Cell-based,Kadcyla,,RxNorm,IU/m2,110.0,92.0
SYNTHETIC-5,DONOR_2455,TREATMENT_9455,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,8836851,NCI Thesaurus,cells/kg,,152.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9456,Other immunomodulatory substances,,278936,,,138.0,126.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9457,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,mg/m2,126.0,
SYNTHETIC-5,DONOR_2458,TREATMENT_9458,Immune checkpoint inhibitors,Niraparib,278936,NCI Thesaurus,ug/m2,146.0,170.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9459,Other immunomodulatory substances,Blincyto,239766,NCI Thesaurus,mg/m2,127.0,115.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9460,Other immunomodulatory substances,Sorafenib,8756456,PubChem,IU/kg,,184.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9461,Cell-based,Gazyva,8836851,,IU/m2,185.0,55.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9462,Immune checkpoint inhibitors,Imfinzi,8756456,RxNorm,mg/m2,93.0,
SYNTHETIC-5,DONOR_2463,TREATMENT_9463,Cell-based,Tisagenlecleucel,278936,PubChem,cells/kg,137.0,105.0
SYNTHETIC-5,DONOR_2464,TREATMENT_9464,Other immunomodulatory substances,Daratumumab,987654,,mg/kg,171.0,114.0
SYNTHETIC-5,DONOR_2465,TREATMENT_9465,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,IU/kg,66.0,73.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9466,Other immunomodulatory substances,Trametinib,239766,PubChem,IU/m2,71.0,84.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9467,Other immunomodulatory substances,Atezolizumab,4459876,,mg/m2,73.0,83.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9468,Cell-based,,8756456,PubChem,g/m2,,
SYNTHETIC-5,DONOR_2469,TREATMENT_9469,Immune checkpoint inhibitors,Opdivo,239766,PubChem,mg/kg,53.0,
SYNTHETIC-5,DONOR_2470,TREATMENT_9470,,,,RxNorm,g/m2,,165.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9471,Cell-based,Abemaciclib,239766,RxNorm,ug/m2,,172.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9472,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,278936,RxNorm,IU/kg,,88.0
SYNTHETIC-5,DONOR_2473,TREATMENT_9473,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,mg/kg,138.0,
SYNTHETIC-5,DONOR_2474,TREATMENT_9474,Immune checkpoint inhibitors,Ipilimumab,987654,,,158.0,
SYNTHETIC-5,DONOR_2475,TREATMENT_9475,Other immunomodulatory substances,Osimertinib,8836851,RxNorm,mg/m2,76.0,84.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9476,Cell-based,Xalkori,4459876,PubChem,,63.0,124.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9477,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,PubChem,mg/kg,129.0,83.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9478,Other immunomodulatory substances,Gazyva,239766,PubChem,mg/m2,110.0,137.0
SYNTHETIC-5,DONOR_2479,TREATMENT_9479,Immune checkpoint inhibitors,Tecentriq,987654,,IU/m2,182.0,198.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9480,Other immunomodulatory substances,Axicabtagene ciloleucel,278936,PubChem,,104.0,197.0
SYNTHETIC-5,DONOR_2481,TREATMENT_9481,,Adcetris,,RxNorm,g/m2,74.0,200.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9482,Cell-based,Durvalumab,239766,PubChem,g/m2,157.0,85.0
SYNTHETIC-5,DONOR_2483,TREATMENT_9483,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,8836851,RxNorm,cells/kg,79.0,160.0
SYNTHETIC-5,DONOR_2484,TREATMENT_9484,Other immunomodulatory substances,Yervoy,8836851,,IU/m2,138.0,55.0
SYNTHETIC-5,DONOR_2485,TREATMENT_9485,Cell-based,Yervoy,8756456,RxNorm,IU/m2,,160.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9486,Other immunomodulatory substances,Trametinib,8836851,PubChem,mg/m2,131.0,77.0
SYNTHETIC-5,DONOR_2487,TREATMENT_9487,Cell-based,Lenvima,4459876,NCI Thesaurus,IU/kg,153.0,126.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9488,Cell-based,Nivolumab,987654,NCI Thesaurus,mg/kg,185.0,167.0
SYNTHETIC-5,DONOR_2489,TREATMENT_9489,Cell-based,Tisagenlecleucel,8836851,NCI Thesaurus,g/m2,184.0,145.0
SYNTHETIC-5,DONOR_2490,TREATMENT_9490,Cell-based,Alectinib,987654,RxNorm,IU/m2,106.0,152.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9491,Other immunomodulatory substances,Cotellic,278936,RxNorm,,,
SYNTHETIC-5,DONOR_2492,TREATMENT_9492,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,8836851,,mg/kg,176.0,179.0
SYNTHETIC-5,DONOR_2493,TREATMENT_9493,Other immunomodulatory substances,Blinatumomab,278936,,mg/kg,50.0,
SYNTHETIC-5,DONOR_2494,TREATMENT_9494,Other immunomodulatory substances,Zejula,278936,,mg/m2,180.0,136.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9495,Other immunomodulatory substances,Selumitinib,8756456,NCI Thesaurus,,65.0,84.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9496,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,987654,,g/m2,166.0,117.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9497,Immune checkpoint inhibitors,Tecentriq,278936,RxNorm,ug/m2,157.0,188.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9498,,Lynparza,8756456,PubChem,,172.0,174.0
SYNTHETIC-5,DONOR_2499,TREATMENT_9499,Cell-based,Keytruda,987654,PubChem,cells/kg,,98.0
SYNTHETIC-5,DONOR_2500,TREATMENT_9500,Other immunomodulatory substances,Trastuzumab,987654,NCI Thesaurus,cells/kg,50.0,125.0
SYNTHETIC-5,DONOR_2001,TREATMENT_9501,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,987654,RxNorm,mg/m2,,107.0
SYNTHETIC-5,DONOR_2002,TREATMENT_9502,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,mg/kg,,114.0
SYNTHETIC-5,DONOR_2003,TREATMENT_9503,Immune checkpoint inhibitors,Brentuximab vedotin,4459876,NCI Thesaurus,IU/kg,96.0,118.0
SYNTHETIC-5,DONOR_2004,TREATMENT_9504,Cell-based,Ibrance,4459876,RxNorm,g/m2,170.0,155.0
SYNTHETIC-5,DONOR_2005,TREATMENT_9505,Immune checkpoint inhibitors,Enhertu,239766,PubChem,ug/m2,142.0,105.0
SYNTHETIC-5,DONOR_2006,TREATMENT_9506,Other immunomodulatory substances,Erlotinib,987654,NCI Thesaurus,IU/kg,106.0,103.0
SYNTHETIC-5,DONOR_2007,TREATMENT_9507,Other immunomodulatory substances,Kisqali,8756456,NCI Thesaurus,cells/kg,119.0,
SYNTHETIC-5,DONOR_2008,TREATMENT_9508,Cell-based,Ipilimumab,4459876,PubChem,IU/m2,109.0,104.0
SYNTHETIC-5,DONOR_2009,TREATMENT_9509,Cell-based,Alectinib,987654,RxNorm,mg/kg,138.0,141.0
SYNTHETIC-5,DONOR_2010,TREATMENT_9510,,Cotellic,8836851,PubChem,,64.0,188.0
SYNTHETIC-5,DONOR_2011,TREATMENT_9511,Immune checkpoint inhibitors,Belantamab,8756456,PubChem,g/m2,62.0,126.0
SYNTHETIC-5,DONOR_2012,TREATMENT_9512,Immune checkpoint inhibitors,Axicabtagene ciloleucel,987654,,mg/m2,195.0,80.0
SYNTHETIC-5,DONOR_2013,TREATMENT_9513,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,mg/kg,77.0,127.0
SYNTHETIC-5,DONOR_2014,TREATMENT_9514,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,RxNorm,IU/kg,,126.0
SYNTHETIC-5,DONOR_2015,TREATMENT_9515,Other immunomodulatory substances,Perjeta,8756456,NCI Thesaurus,IU/m2,,
SYNTHETIC-5,DONOR_2016,TREATMENT_9516,Cell-based,Gilteritinib,987654,PubChem,ug/m2,108.0,188.0
SYNTHETIC-5,DONOR_2017,TREATMENT_9517,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,239766,PubChem,IU/m2,88.0,
SYNTHETIC-5,DONOR_2018,TREATMENT_9518,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,239766,NCI Thesaurus,mg/kg,66.0,78.0
SYNTHETIC-5,DONOR_2019,TREATMENT_9519,Other immunomodulatory substances,Iressa,4459876,RxNorm,IU/m2,98.0,109.0
SYNTHETIC-5,DONOR_2020,TREATMENT_9520,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,239766,RxNorm,ug/m2,,
SYNTHETIC-5,DONOR_2021,TREATMENT_9521,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,,cells/kg,181.0,
SYNTHETIC-5,DONOR_2022,TREATMENT_9522,Cell-based,Alunbrig,4459876,,ug/m2,198.0,61.0
SYNTHETIC-5,DONOR_2023,TREATMENT_9523,Other immunomodulatory substances,Nexavar,8836851,PubChem,ug/m2,143.0,140.0
SYNTHETIC-5,DONOR_2024,TREATMENT_9524,Other immunomodulatory substances,Zejula,987654,NCI Thesaurus,mg/kg,76.0,80.0
SYNTHETIC-5,DONOR_2025,TREATMENT_9525,Immune checkpoint inhibitors,Cometriq,239766,PubChem,mg/m2,,98.0
SYNTHETIC-5,DONOR_2026,TREATMENT_9526,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,8756456,PubChem,IU/m2,,95.0
SYNTHETIC-5,DONOR_2027,TREATMENT_9527,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,cells/kg,50.0,61.0
SYNTHETIC-5,DONOR_2028,TREATMENT_9528,,Tarceva,278936,NCI Thesaurus,cells/kg,125.0,153.0
SYNTHETIC-5,DONOR_2029,TREATMENT_9529,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,,,78.0,
SYNTHETIC-5,DONOR_2030,TREATMENT_9530,Cell-based,,,NCI Thesaurus,ug/m2,94.0,151.0
SYNTHETIC-5,DONOR_2031,TREATMENT_9531,Cell-based,Yervoy,4459876,PubChem,IU/m2,57.0,83.0
SYNTHETIC-5,DONOR_2032,TREATMENT_9532,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,mg/m2,120.0,167.0
SYNTHETIC-5,DONOR_2033,TREATMENT_9533,Cell-based,Lenvima,987654,NCI Thesaurus,cells/kg,166.0,189.0
SYNTHETIC-5,DONOR_2034,TREATMENT_9534,Cell-based,Daratumumab,239766,PubChem,g/m2,136.0,133.0
SYNTHETIC-5,DONOR_2035,TREATMENT_9535,,Pembrolizumab,4459876,RxNorm,mg/kg,191.0,118.0
SYNTHETIC-5,DONOR_2036,TREATMENT_9536,Other immunomodulatory substances,Xalkori,8836851,PubChem,g/m2,155.0,68.0
SYNTHETIC-5,DONOR_2037,TREATMENT_9537,Cell-based,Besponsa,,NCI Thesaurus,IU/m2,160.0,
SYNTHETIC-5,DONOR_2038,TREATMENT_9538,,Kymriah,239766,NCI Thesaurus,mg/kg,111.0,135.0
SYNTHETIC-5,DONOR_2039,TREATMENT_9539,,Atezolizumab,8756456,NCI Thesaurus,,87.0,115.0
SYNTHETIC-5,DONOR_2040,TREATMENT_9540,,Tecentriq,4459876,PubChem,mg/kg,94.0,
SYNTHETIC-5,DONOR_2041,TREATMENT_9541,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,mg/m2,56.0,
SYNTHETIC-5,DONOR_2042,TREATMENT_9542,Immune checkpoint inhibitors,Durvalumab,239766,RxNorm,ug/m2,78.0,112.0
SYNTHETIC-5,DONOR_2043,TREATMENT_9543,,Pexidartinib,8756456,,,140.0,
SYNTHETIC-5,DONOR_2044,TREATMENT_9544,Cell-based,Opdivo,987654,RxNorm,ug/m2,120.0,51.0
SYNTHETIC-5,DONOR_2045,TREATMENT_9545,Other immunomodulatory substances,,4459876,NCI Thesaurus,IU/m2,102.0,114.0
SYNTHETIC-5,DONOR_2046,TREATMENT_9546,Cell-based,Durvalumab,4459876,PubChem,ug/m2,170.0,120.0
SYNTHETIC-5,DONOR_2047,TREATMENT_9547,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,239766,PubChem,ug/m2,,154.0
SYNTHETIC-5,DONOR_2048,TREATMENT_9548,Other immunomodulatory substances,Pembrolizumab,,RxNorm,mg/m2,63.0,172.0
SYNTHETIC-5,DONOR_2049,TREATMENT_9549,Cell-based,Pembrolizumab,239766,,IU/m2,,64.0
SYNTHETIC-5,DONOR_2050,TREATMENT_9550,Other immunomodulatory substances,Pembrolizumab,,PubChem,cells/kg,,168.0
SYNTHETIC-5,DONOR_2051,TREATMENT_9551,Immune checkpoint inhibitors,Darzalex,,PubChem,IU/m2,196.0,
SYNTHETIC-5,DONOR_2052,TREATMENT_9552,,Lenvatinib,8756456,PubChem,mg/m2,143.0,77.0
SYNTHETIC-5,DONOR_2053,TREATMENT_9553,Cell-based,Nivolumab,,,ug/m2,190.0,190.0
SYNTHETIC-5,DONOR_2054,TREATMENT_9554,Cell-based,Pembrolizumab,239766,PubChem,ug/m2,91.0,96.0
SYNTHETIC-5,DONOR_2055,TREATMENT_9555,,Gefitinib,239766,PubChem,mg/m2,192.0,
SYNTHETIC-5,DONOR_2056,TREATMENT_9556,Cell-based,Opdivo,4459876,RxNorm,mg/kg,143.0,134.0
SYNTHETIC-5,DONOR_2057,TREATMENT_9557,Immune checkpoint inhibitors,Venclexta,278936,NCI Thesaurus,mg/m2,191.0,168.0
SYNTHETIC-5,DONOR_2058,TREATMENT_9558,Cell-based,Durvalumab,8836851,,cells/kg,176.0,190.0
SYNTHETIC-5,DONOR_2059,TREATMENT_9559,Other immunomodulatory substances,Gilotrif,987654,NCI Thesaurus,cells/kg,120.0,177.0
SYNTHETIC-5,DONOR_2060,TREATMENT_9560,,Gilteritinib,239766,RxNorm,IU/kg,119.0,100.0
SYNTHETIC-5,DONOR_2061,TREATMENT_9561,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,4459876,PubChem,IU/m2,101.0,73.0
SYNTHETIC-5,DONOR_2062,TREATMENT_9562,Cell-based,Palbociclib,278936,NCI Thesaurus,IU/m2,178.0,127.0
SYNTHETIC-5,DONOR_2063,TREATMENT_9563,Immune checkpoint inhibitors,Obinutuzumab,,NCI Thesaurus,cells/kg,136.0,109.0
SYNTHETIC-5,DONOR_2064,TREATMENT_9564,Cell-based,Axicabtagene ciloleucel,8756456,NCI Thesaurus,mg/m2,150.0,78.0
SYNTHETIC-5,DONOR_2065,TREATMENT_9565,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,mg/m2,151.0,139.0
SYNTHETIC-5,DONOR_2066,TREATMENT_9566,Cell-based,Rituximab,239766,PubChem,g/m2,148.0,72.0
SYNTHETIC-5,DONOR_2067,TREATMENT_9567,Immune checkpoint inhibitors,Selumitinib,987654,PubChem,mg/m2,110.0,195.0
SYNTHETIC-5,DONOR_2068,TREATMENT_9568,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8836851,PubChem,IU/m2,200.0,
SYNTHETIC-5,DONOR_2069,TREATMENT_9569,Immune checkpoint inhibitors,Xalkori,,NCI Thesaurus,cells/kg,74.0,176.0
SYNTHETIC-5,DONOR_2070,TREATMENT_9570,Immune checkpoint inhibitors,Nivolumab,8756456,,mg/kg,177.0,135.0
SYNTHETIC-5,DONOR_2071,TREATMENT_9571,Cell-based,Ipilimumab,8836851,PubChem,ug/m2,97.0,159.0
SYNTHETIC-5,DONOR_2072,TREATMENT_9572,Immune checkpoint inhibitors,Lenvima,,PubChem,IU/m2,109.0,195.0
SYNTHETIC-5,DONOR_2073,TREATMENT_9573,Immune checkpoint inhibitors,Abemaciclib,4459876,NCI Thesaurus,mg/kg,81.0,103.0
SYNTHETIC-5,DONOR_2074,TREATMENT_9574,Cell-based,Ribociclib,987654,,IU/m2,135.0,135.0
SYNTHETIC-5,DONOR_2075,TREATMENT_9575,Cell-based,Pertuzumab,4459876,RxNorm,IU/kg,77.0,74.0
SYNTHETIC-5,DONOR_2076,TREATMENT_9576,Immune checkpoint inhibitors,Copanlisib,4459876,,IU/m2,150.0,172.0
SYNTHETIC-5,DONOR_2077,TREATMENT_9577,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,g/m2,146.0,139.0
SYNTHETIC-5,DONOR_2078,TREATMENT_9578,Immune checkpoint inhibitors,Yescarta,239766,,,167.0,131.0
SYNTHETIC-5,DONOR_2079,TREATMENT_9579,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,987654,PubChem,mg/m2,173.0,
SYNTHETIC-5,DONOR_2080,TREATMENT_9580,Other immunomodulatory substances,,987654,PubChem,,163.0,
SYNTHETIC-5,DONOR_2081,TREATMENT_9581,Cell-based,Ribociclib,239766,RxNorm,g/m2,,82.0
SYNTHETIC-5,DONOR_2082,TREATMENT_9582,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/kg,,131.0
SYNTHETIC-5,DONOR_2083,TREATMENT_9583,Immune checkpoint inhibitors,Trastuzumab,239766,NCI Thesaurus,cells/kg,129.0,89.0
SYNTHETIC-5,DONOR_2084,TREATMENT_9584,Cell-based,Cotellic,987654,,,,92.0
SYNTHETIC-5,DONOR_2085,TREATMENT_9585,Other immunomodulatory substances,Alecensa,8836851,,cells/kg,,136.0
SYNTHETIC-5,DONOR_2086,TREATMENT_9586,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,IU/m2,100.0,136.0
SYNTHETIC-5,DONOR_2087,TREATMENT_9587,Cell-based,Mekinist,,,,142.0,180.0
SYNTHETIC-5,DONOR_2088,TREATMENT_9588,Immune checkpoint inhibitors,Opdivo,8756456,,mg/kg,194.0,91.0
SYNTHETIC-5,DONOR_2089,TREATMENT_9589,Other immunomodulatory substances,,,PubChem,cells/kg,,120.0
SYNTHETIC-5,DONOR_2090,TREATMENT_9590,Other immunomodulatory substances,Pexidartinib,239766,PubChem,IU/kg,89.0,60.0
SYNTHETIC-5,DONOR_2091,TREATMENT_9591,,Lenvima,8756456,RxNorm,mg/kg,116.0,141.0
SYNTHETIC-5,DONOR_2092,TREATMENT_9592,Immune checkpoint inhibitors,,,PubChem,mg/m2,89.0,84.0
SYNTHETIC-5,DONOR_2093,TREATMENT_9593,,Iressa,8756456,PubChem,,140.0,132.0
SYNTHETIC-5,DONOR_2094,TREATMENT_9594,Immune checkpoint inhibitors,Tisagenlecleucel,,NCI Thesaurus,mg/m2,94.0,96.0
SYNTHETIC-5,DONOR_2095,TREATMENT_9595,Other immunomodulatory substances,Atezolizumab,278936,PubChem,IU/m2,98.0,161.0
SYNTHETIC-5,DONOR_2096,TREATMENT_9596,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,4459876,PubChem,mg/m2,136.0,112.0
SYNTHETIC-5,DONOR_2097,TREATMENT_9597,Other immunomodulatory substances,Vemurafenib,239766,NCI Thesaurus,ug/m2,175.0,187.0
SYNTHETIC-5,DONOR_2098,TREATMENT_9598,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,8756456,RxNorm,g/m2,135.0,114.0
SYNTHETIC-5,DONOR_2099,TREATMENT_9599,,Brentuximab vedotin,,PubChem,mg/kg,,128.0
SYNTHETIC-5,DONOR_2100,TREATMENT_9600,Cell-based,Zejula,987654,PubChem,IU/kg,101.0,196.0
SYNTHETIC-5,DONOR_2101,TREATMENT_9601,,Abemaciclib,239766,NCI Thesaurus,ug/m2,77.0,
SYNTHETIC-5,DONOR_2102,TREATMENT_9602,Cell-based,Cometriq,278936,NCI Thesaurus,ug/m2,136.0,126.0
SYNTHETIC-5,DONOR_2103,TREATMENT_9603,Immune checkpoint inhibitors,Atezolizumab,278936,RxNorm,cells/kg,114.0,
SYNTHETIC-5,DONOR_2104,TREATMENT_9604,Other immunomodulatory substances,,278936,RxNorm,mg/m2,59.0,
SYNTHETIC-5,DONOR_2105,TREATMENT_9605,Immune checkpoint inhibitors,Kadcyla,8756456,NCI Thesaurus,g/m2,78.0,144.0
SYNTHETIC-5,DONOR_2106,TREATMENT_9606,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,RxNorm,IU/kg,116.0,131.0
SYNTHETIC-5,DONOR_2107,TREATMENT_9607,Cell-based,,8836851,PubChem,ug/m2,78.0,76.0
SYNTHETIC-5,DONOR_2108,TREATMENT_9608,Immune checkpoint inhibitors,Encorafenib,,PubChem,IU/kg,196.0,120.0
SYNTHETIC-5,DONOR_2109,TREATMENT_9609,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,278936,,,72.0,165.0
SYNTHETIC-5,DONOR_2110,TREATMENT_9610,Immune checkpoint inhibitors,Imfinzi,239766,RxNorm,,134.0,190.0
SYNTHETIC-5,DONOR_2111,TREATMENT_9611,Cell-based,Trametinib,239766,,ug/m2,52.0,98.0
SYNTHETIC-5,DONOR_2112,TREATMENT_9612,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,987654,NCI Thesaurus,cells/kg,185.0,186.0
SYNTHETIC-5,DONOR_2113,TREATMENT_9613,Cell-based,Daratumumab,278936,PubChem,ug/m2,94.0,164.0
SYNTHETIC-5,DONOR_2114,TREATMENT_9614,Other immunomodulatory substances,Perjeta,987654,PubChem,ug/m2,92.0,91.0
SYNTHETIC-5,DONOR_2115,TREATMENT_9615,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,4459876,RxNorm,mg/kg,118.0,
SYNTHETIC-5,DONOR_2116,TREATMENT_9616,Cell-based,Necitumumab,239766,PubChem,IU/kg,,155.0
SYNTHETIC-5,DONOR_2117,TREATMENT_9617,,,4459876,,IU/kg,178.0,52.0
SYNTHETIC-5,DONOR_2118,TREATMENT_9618,Other immunomodulatory substances,Atezolizumab,,NCI Thesaurus,IU/m2,102.0,121.0
SYNTHETIC-5,DONOR_2119,TREATMENT_9619,Other immunomodulatory substances,,239766,PubChem,,184.0,73.0
SYNTHETIC-5,DONOR_2120,TREATMENT_9620,Cell-based,Palbociclib,,RxNorm,mg/kg,72.0,87.0
SYNTHETIC-5,DONOR_2121,TREATMENT_9621,Immune checkpoint inhibitors,,8756456,PubChem,mg/kg,50.0,200.0
SYNTHETIC-5,DONOR_2122,TREATMENT_9622,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,4459876,NCI Thesaurus,g/m2,147.0,68.0
SYNTHETIC-5,DONOR_2123,TREATMENT_9623,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,cells/kg,170.0,73.0
SYNTHETIC-5,DONOR_2124,TREATMENT_9624,Immune checkpoint inhibitors,Caprelsa,8836851,,cells/kg,149.0,134.0
SYNTHETIC-5,DONOR_2125,TREATMENT_9625,Immune checkpoint inhibitors,Tecentriq,8756456,PubChem,,64.0,173.0
SYNTHETIC-5,DONOR_2126,TREATMENT_9626,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,cells/kg,93.0,117.0
SYNTHETIC-5,DONOR_2127,TREATMENT_9627,Immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,,162.0,
SYNTHETIC-5,DONOR_2128,TREATMENT_9628,Other immunomodulatory substances,,,,,173.0,
SYNTHETIC-5,DONOR_2129,TREATMENT_9629,Cell-based,Ado-trastuzumab emtansine,,NCI Thesaurus,mg/m2,57.0,102.0
SYNTHETIC-5,DONOR_2130,TREATMENT_9630,,Yervoy,8836851,RxNorm,mg/m2,105.0,192.0
SYNTHETIC-5,DONOR_2131,TREATMENT_9631,Immune checkpoint inhibitors,Tecentriq,278936,PubChem,,,55.0
SYNTHETIC-5,DONOR_2132,TREATMENT_9632,,Blinatumomab,278936,NCI Thesaurus,IU/m2,57.0,117.0
SYNTHETIC-5,DONOR_2133,TREATMENT_9633,Other immunomodulatory substances,Durvalumab,8756456,NCI Thesaurus,ug/m2,96.0,157.0
SYNTHETIC-5,DONOR_2134,TREATMENT_9634,Other immunomodulatory substances,Vemurafenib,8836851,PubChem,,190.0,130.0
SYNTHETIC-5,DONOR_2135,TREATMENT_9635,Immune checkpoint inhibitors,Venetoclax,8756456,RxNorm,ug/m2,54.0,138.0
SYNTHETIC-5,DONOR_2136,TREATMENT_9636,Other immunomodulatory substances,Keytruda,987654,RxNorm,IU/m2,,89.0
SYNTHETIC-5,DONOR_2137,TREATMENT_9637,Immune checkpoint inhibitors,Daratumumab,278936,RxNorm,IU/m2,108.0,60.0
SYNTHETIC-5,DONOR_2138,TREATMENT_9638,,Cobimetinib,239766,NCI Thesaurus,IU/kg,90.0,168.0
SYNTHETIC-5,DONOR_2139,TREATMENT_9639,,Xalkori,987654,NCI Thesaurus,IU/m2,138.0,
SYNTHETIC-5,DONOR_2140,TREATMENT_9640,Other immunomodulatory substances,Atezolizumab,987654,NCI Thesaurus,IU/m2,142.0,184.0
SYNTHETIC-5,DONOR_2141,TREATMENT_9641,Cell-based,,8756456,NCI Thesaurus,IU/kg,109.0,184.0
SYNTHETIC-5,DONOR_2142,TREATMENT_9642,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,NCI Thesaurus,mg/m2,157.0,87.0
SYNTHETIC-5,DONOR_2143,TREATMENT_9643,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,,,125.0
SYNTHETIC-5,DONOR_2144,TREATMENT_9644,Other immunomodulatory substances,Nivolumab,,RxNorm,,,166.0
SYNTHETIC-5,DONOR_2145,TREATMENT_9645,Immune checkpoint inhibitors,Binimetinib,278936,PubChem,cells/kg,123.0,
SYNTHETIC-5,DONOR_2146,TREATMENT_9646,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,987654,PubChem,g/m2,67.0,97.0
SYNTHETIC-5,DONOR_2147,TREATMENT_9647,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,g/m2,169.0,126.0
SYNTHETIC-5,DONOR_2148,TREATMENT_9648,Cell-based,Erlotinib,,,mg/kg,75.0,190.0
SYNTHETIC-5,DONOR_2149,TREATMENT_9649,Immune checkpoint inhibitors,Axicabtagene ciloleucel,987654,NCI Thesaurus,IU/m2,183.0,142.0
SYNTHETIC-5,DONOR_2150,TREATMENT_9650,Other immunomodulatory substances,,278936,,IU/m2,97.0,86.0
SYNTHETIC-5,DONOR_2151,TREATMENT_9651,Immune checkpoint inhibitors,Imfinzi,239766,PubChem,IU/m2,56.0,143.0
SYNTHETIC-5,DONOR_2152,TREATMENT_9652,Cell-based,,4459876,NCI Thesaurus,IU/kg,131.0,99.0
SYNTHETIC-5,DONOR_2153,TREATMENT_9653,Other immunomodulatory substances,Nivolumab,,PubChem,ug/m2,96.0,154.0
SYNTHETIC-5,DONOR_2154,TREATMENT_9654,Other immunomodulatory substances,Zykadia,8756456,RxNorm,g/m2,105.0,182.0
SYNTHETIC-5,DONOR_2155,TREATMENT_9655,Other immunomodulatory substances,,4459876,PubChem,ug/m2,186.0,143.0
SYNTHETIC-5,DONOR_2156,TREATMENT_9656,Cell-based,Yervoy,4459876,,ug/m2,,120.0
SYNTHETIC-5,DONOR_2157,TREATMENT_9657,Immune checkpoint inhibitors,Yescarta,8836851,RxNorm,cells/kg,,89.0
SYNTHETIC-5,DONOR_2158,TREATMENT_9658,Other immunomodulatory substances,Tecentriq,,PubChem,,145.0,126.0
SYNTHETIC-5,DONOR_2159,TREATMENT_9659,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,987654,NCI Thesaurus,ug/m2,58.0,169.0
SYNTHETIC-5,DONOR_2160,TREATMENT_9660,Other immunomodulatory substances,Binimetinib,987654,RxNorm,IU/m2,74.0,
SYNTHETIC-5,DONOR_2161,TREATMENT_9661,Cell-based,Gazyva,8836851,NCI Thesaurus,g/m2,122.0,80.0
SYNTHETIC-5,DONOR_2162,TREATMENT_9662,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,239766,PubChem,,,60.0
SYNTHETIC-5,DONOR_2163,TREATMENT_9663,,Nivolumab,8756456,NCI Thesaurus,IU/kg,57.0,
SYNTHETIC-5,DONOR_2164,TREATMENT_9664,Cell-based,,278936,NCI Thesaurus,g/m2,198.0,198.0
SYNTHETIC-5,DONOR_2165,TREATMENT_9665,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8836851,PubChem,IU/kg,165.0,171.0
SYNTHETIC-5,DONOR_2166,TREATMENT_9666,,Mekinist,239766,NCI Thesaurus,ug/m2,,147.0
SYNTHETIC-5,DONOR_2167,TREATMENT_9667,Other immunomodulatory substances,,8756456,PubChem,mg/m2,76.0,
SYNTHETIC-5,DONOR_2168,TREATMENT_9668,Immune checkpoint inhibitors,Tisagenlecleucel,8836851,RxNorm,cells/kg,69.0,106.0
SYNTHETIC-5,DONOR_2169,TREATMENT_9669,Other immunomodulatory substances,Mektovi,987654,RxNorm,,125.0,
SYNTHETIC-5,DONOR_2170,TREATMENT_9670,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,278936,PubChem,g/m2,124.0,100.0
SYNTHETIC-5,DONOR_2171,TREATMENT_9671,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,987654,NCI Thesaurus,ug/m2,142.0,
SYNTHETIC-5,DONOR_2172,TREATMENT_9672,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8836851,,g/m2,,150.0
SYNTHETIC-5,DONOR_2173,TREATMENT_9673,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,,RxNorm,IU/m2,199.0,
SYNTHETIC-5,DONOR_2174,TREATMENT_9674,Other immunomodulatory substances,Atezolizumab,8756456,NCI Thesaurus,mg/kg,127.0,110.0
SYNTHETIC-5,DONOR_2175,TREATMENT_9675,,Nivolumab,8756456,PubChem,mg/m2,70.0,182.0
SYNTHETIC-5,DONOR_2176,TREATMENT_9676,Other immunomodulatory substances,Yervoy,239766,PubChem,IU/m2,97.0,172.0
SYNTHETIC-5,DONOR_2177,TREATMENT_9677,Other immunomodulatory substances,Dabrafenib,987654,NCI Thesaurus,ug/m2,88.0,87.0
SYNTHETIC-5,DONOR_2178,TREATMENT_9678,Immune checkpoint inhibitors,Inotuzumab ozogamicin,4459876,NCI Thesaurus,,160.0,196.0
SYNTHETIC-5,DONOR_2179,TREATMENT_9679,,Yervoy,8836851,,ug/m2,191.0,162.0
SYNTHETIC-5,DONOR_2180,TREATMENT_9680,,Atezolizumab,8756456,NCI Thesaurus,cells/kg,184.0,190.0
SYNTHETIC-5,DONOR_2181,TREATMENT_9681,Immune checkpoint inhibitors,Xalkori,4459876,PubChem,g/m2,,70.0
SYNTHETIC-5,DONOR_2182,TREATMENT_9682,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,239766,PubChem,IU/kg,171.0,121.0
SYNTHETIC-5,DONOR_2183,TREATMENT_9683,,Durvalumab,278936,,IU/kg,74.0,189.0
SYNTHETIC-5,DONOR_2184,TREATMENT_9684,Other immunomodulatory substances,Binimetinib,4459876,NCI Thesaurus,cells/kg,102.0,157.0
SYNTHETIC-5,DONOR_2185,TREATMENT_9685,Immune checkpoint inhibitors,Dabrafenib,,PubChem,IU/kg,136.0,160.0
SYNTHETIC-5,DONOR_2186,TREATMENT_9686,Immune checkpoint inhibitors,,8756456,PubChem,IU/kg,138.0,
SYNTHETIC-5,DONOR_2187,TREATMENT_9687,,Perjeta,8756456,RxNorm,g/m2,62.0,164.0
SYNTHETIC-5,DONOR_2188,TREATMENT_9688,Immune checkpoint inhibitors,Alunbrig,8756456,NCI Thesaurus,mg/m2,,193.0
SYNTHETIC-5,DONOR_2189,TREATMENT_9689,Immune checkpoint inhibitors,Inotuzumab ozogamicin,8756456,NCI Thesaurus,ug/m2,106.0,58.0
SYNTHETIC-5,DONOR_2190,TREATMENT_9690,,Blincyto,,PubChem,IU/m2,146.0,156.0
SYNTHETIC-5,DONOR_2191,TREATMENT_9691,Cell-based,Nivolumab,,NCI Thesaurus,,73.0,180.0
SYNTHETIC-5,DONOR_2192,TREATMENT_9692,,Abemaciclib,278936,PubChem,ug/m2,,123.0
SYNTHETIC-5,DONOR_2193,TREATMENT_9693,Immune checkpoint inhibitors,Encorafenib,4459876,NCI Thesaurus,,161.0,96.0
SYNTHETIC-5,DONOR_2194,TREATMENT_9694,Immune checkpoint inhibitors,,8836851,RxNorm,ug/m2,,92.0
SYNTHETIC-5,DONOR_2195,TREATMENT_9695,Other immunomodulatory substances,,987654,PubChem,IU/m2,161.0,124.0
SYNTHETIC-5,DONOR_2196,TREATMENT_9696,Immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,cells/kg,95.0,64.0
SYNTHETIC-5,DONOR_2197,TREATMENT_9697,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,4459876,,mg/m2,84.0,64.0
SYNTHETIC-5,DONOR_2198,TREATMENT_9698,Other immunomodulatory substances,Tecentriq,8756456,RxNorm,cells/kg,174.0,50.0
SYNTHETIC-5,DONOR_2199,TREATMENT_9699,Other immunomodulatory substances,Nivolumab,278936,,IU/m2,173.0,104.0
SYNTHETIC-5,DONOR_2200,TREATMENT_9700,Immune checkpoint inhibitors,Ibrance,987654,NCI Thesaurus,mg/m2,133.0,112.0
SYNTHETIC-5,DONOR_2201,TREATMENT_9701,Cell-based,Durvalumab,8836851,PubChem,,105.0,70.0
SYNTHETIC-5,DONOR_2202,TREATMENT_9702,Other immunomodulatory substances,Herceptin,239766,RxNorm,IU/m2,171.0,197.0
SYNTHETIC-5,DONOR_2203,TREATMENT_9703,Other immunomodulatory substances,Imfinzi,8756456,RxNorm,mg/kg,75.0,158.0
SYNTHETIC-5,DONOR_2204,TREATMENT_9704,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,IU/kg,,160.0
SYNTHETIC-5,DONOR_2205,TREATMENT_9705,Other immunomodulatory substances,,8836851,PubChem,mg/m2,72.0,172.0
SYNTHETIC-5,DONOR_2206,TREATMENT_9706,Cell-based,,,RxNorm,mg/m2,88.0,97.0
SYNTHETIC-5,DONOR_2207,TREATMENT_9707,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,,NCI Thesaurus,IU/kg,95.0,130.0
SYNTHETIC-5,DONOR_2208,TREATMENT_9708,Other immunomodulatory substances,Imfinzi,278936,PubChem,IU/kg,,53.0
SYNTHETIC-5,DONOR_2209,TREATMENT_9709,Cell-based,Yervoy,8756456,NCI Thesaurus,mg/m2,187.0,200.0
SYNTHETIC-5,DONOR_2210,TREATMENT_9710,Cell-based,Xalkori,4459876,NCI Thesaurus,mg/kg,62.0,54.0
SYNTHETIC-5,DONOR_2211,TREATMENT_9711,,Pertuzumab,239766,,,181.0,114.0
SYNTHETIC-5,DONOR_2212,TREATMENT_9712,Other immunomodulatory substances,Adcetris,4459876,NCI Thesaurus,ug/m2,186.0,53.0
SYNTHETIC-5,DONOR_2213,TREATMENT_9713,Other immunomodulatory substances,Pembrolizumab,8756456,,mg/m2,106.0,53.0
SYNTHETIC-5,DONOR_2214,TREATMENT_9714,Immune checkpoint inhibitors,Gazyva,987654,PubChem,cells/kg,107.0,71.0
SYNTHETIC-5,DONOR_2215,TREATMENT_9715,Cell-based,Opdivo,4459876,NCI Thesaurus,,86.0,198.0
SYNTHETIC-5,DONOR_2216,TREATMENT_9716,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,PubChem,,133.0,146.0
SYNTHETIC-5,DONOR_2217,TREATMENT_9717,Immune checkpoint inhibitors,Palbociclib,8836851,PubChem,mg/m2,99.0,66.0
SYNTHETIC-5,DONOR_2218,TREATMENT_9718,Cell-based,,987654,PubChem,mg/m2,142.0,192.0
SYNTHETIC-5,DONOR_2219,TREATMENT_9719,Immune checkpoint inhibitors,,8836851,,IU/kg,189.0,169.0
SYNTHETIC-5,DONOR_2220,TREATMENT_9720,,Venetoclax,987654,RxNorm,g/m2,147.0,60.0
SYNTHETIC-5,DONOR_2221,TREATMENT_9721,Immune checkpoint inhibitors,Lenvima,8836851,RxNorm,mg/m2,96.0,
SYNTHETIC-5,DONOR_2222,TREATMENT_9722,Cell-based,Sorafenib,987654,PubChem,IU/m2,141.0,193.0
SYNTHETIC-5,DONOR_2223,TREATMENT_9723,,Brentuximab vedotin,8836851,NCI Thesaurus,IU/kg,162.0,199.0
SYNTHETIC-5,DONOR_2224,TREATMENT_9724,Immune checkpoint inhibitors,,987654,PubChem,IU/kg,50.0,70.0
SYNTHETIC-5,DONOR_2225,TREATMENT_9725,Cell-based,Niraparib,8756456,,IU/kg,184.0,121.0
SYNTHETIC-5,DONOR_2226,TREATMENT_9726,Other immunomodulatory substances,Ipilimumab,239766,PubChem,,140.0,109.0
SYNTHETIC-5,DONOR_2227,TREATMENT_9727,,Osimertinib,278936,NCI Thesaurus,g/m2,165.0,135.0
SYNTHETIC-5,DONOR_2228,TREATMENT_9728,,Alunbrig,8836851,PubChem,mg/m2,57.0,84.0
SYNTHETIC-5,DONOR_2229,TREATMENT_9729,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,IU/kg,59.0,
SYNTHETIC-5,DONOR_2230,TREATMENT_9730,Immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,mg/kg,115.0,88.0
SYNTHETIC-5,DONOR_2231,TREATMENT_9731,Immune checkpoint inhibitors,Palbociclib,8756456,RxNorm,IU/kg,53.0,190.0
SYNTHETIC-5,DONOR_2232,TREATMENT_9732,Other immunomodulatory substances,Pembrolizumab,4459876,RxNorm,cells/kg,106.0,157.0
SYNTHETIC-5,DONOR_2233,TREATMENT_9733,Cell-based,Iressa,8756456,RxNorm,mg/m2,118.0,123.0
SYNTHETIC-5,DONOR_2234,TREATMENT_9734,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,,PubChem,mg/kg,,73.0
SYNTHETIC-5,DONOR_2235,TREATMENT_9735,Immune checkpoint inhibitors,Pembrolizumab,8756456,NCI Thesaurus,cells/kg,148.0,81.0
SYNTHETIC-5,DONOR_2236,TREATMENT_9736,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,4459876,RxNorm,mg/kg,151.0,184.0
SYNTHETIC-5,DONOR_2237,TREATMENT_9737,,,278936,RxNorm,IU/m2,93.0,134.0
SYNTHETIC-5,DONOR_2238,TREATMENT_9738,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,987654,NCI Thesaurus,cells/kg,167.0,119.0
SYNTHETIC-5,DONOR_2239,TREATMENT_9739,Other immunomodulatory substances,Atezolizumab,8756456,RxNorm,IU/kg,139.0,70.0
SYNTHETIC-5,DONOR_2240,TREATMENT_9740,Other immunomodulatory substances,Ipilimumab,8836851,RxNorm,cells/kg,136.0,
SYNTHETIC-5,DONOR_2241,TREATMENT_9741,Immune checkpoint inhibitors,Alecensa,,RxNorm,IU/m2,154.0,
SYNTHETIC-5,DONOR_2242,TREATMENT_9742,Other immunomodulatory substances,Mektovi,8836851,NCI Thesaurus,mg/kg,,163.0
SYNTHETIC-5,DONOR_2243,TREATMENT_9743,Other immunomodulatory substances,Niraparib,239766,PubChem,,181.0,
SYNTHETIC-5,DONOR_2244,TREATMENT_9744,Cell-based,,987654,RxNorm,mg/m2,133.0,83.0
SYNTHETIC-5,DONOR_2245,TREATMENT_9745,Other immunomodulatory substances,Zelboraf,239766,,ug/m2,,61.0
SYNTHETIC-5,DONOR_2246,TREATMENT_9746,Immune checkpoint inhibitors,Lenvima,8836851,RxNorm,g/m2,121.0,
SYNTHETIC-5,DONOR_2247,TREATMENT_9747,Cell-based,Blincyto,,PubChem,g/m2,131.0,98.0
SYNTHETIC-5,DONOR_2248,TREATMENT_9748,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,987654,PubChem,IU/kg,96.0,86.0
SYNTHETIC-5,DONOR_2249,TREATMENT_9749,Cell-based,Nexavar,,RxNorm,g/m2,124.0,102.0
SYNTHETIC-5,DONOR_2250,TREATMENT_9750,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,278936,,g/m2,159.0,
SYNTHETIC-5,DONOR_2251,TREATMENT_9751,Other immunomodulatory substances,Opdivo,,NCI Thesaurus,ug/m2,144.0,167.0
SYNTHETIC-5,DONOR_2252,TREATMENT_9752,Cell-based,Osimertinib,278936,PubChem,mg/m2,167.0,76.0
SYNTHETIC-5,DONOR_2253,TREATMENT_9753,Cell-based,Tecentriq,278936,PubChem,IU/kg,130.0,194.0
SYNTHETIC-5,DONOR_2254,TREATMENT_9754,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,PubChem,mg/m2,56.0,188.0
SYNTHETIC-5,DONOR_2255,TREATMENT_9755,Cell-based,Keytruda,8836851,NCI Thesaurus,g/m2,158.0,85.0
SYNTHETIC-5,DONOR_2256,TREATMENT_9756,Cell-based,Kymriah,8756456,PubChem,cells/kg,78.0,158.0
SYNTHETIC-5,DONOR_2257,TREATMENT_9757,Cell-based,Nivolumab,987654,NCI Thesaurus,g/m2,124.0,141.0
SYNTHETIC-5,DONOR_2258,TREATMENT_9758,Cell-based,Herceptin,8836851,NCI Thesaurus,g/m2,155.0,
SYNTHETIC-5,DONOR_2259,TREATMENT_9759,Immune checkpoint inhibitors,Yervoy,987654,RxNorm,ug/m2,162.0,
SYNTHETIC-5,DONOR_2260,TREATMENT_9760,Other immunomodulatory substances,Rucaparib,278936,PubChem,,81.0,68.0
SYNTHETIC-5,DONOR_2261,TREATMENT_9761,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,278936,RxNorm,,54.0,174.0
SYNTHETIC-5,DONOR_2262,TREATMENT_9762,,Ceritinib,987654,RxNorm,IU/m2,125.0,57.0
SYNTHETIC-5,DONOR_2263,TREATMENT_9763,Immune checkpoint inhibitors,Tecentriq,4459876,PubChem,cells/kg,174.0,71.0
SYNTHETIC-5,DONOR_2264,TREATMENT_9764,Cell-based,Mektovi,239766,PubChem,mg/m2,64.0,151.0
SYNTHETIC-5,DONOR_2265,TREATMENT_9765,Cell-based,Rubraca,239766,RxNorm,IU/kg,126.0,124.0
SYNTHETIC-5,DONOR_2266,TREATMENT_9766,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,191.0,
SYNTHETIC-5,DONOR_2267,TREATMENT_9767,,Nivolumab,239766,PubChem,cells/kg,125.0,121.0
SYNTHETIC-5,DONOR_2268,TREATMENT_9768,Cell-based,Opdivo,278936,PubChem,IU/m2,66.0,50.0
SYNTHETIC-5,DONOR_2269,TREATMENT_9769,Cell-based,Binimetinib,987654,NCI Thesaurus,mg/m2,173.0,118.0
SYNTHETIC-5,DONOR_2270,TREATMENT_9770,Cell-based,Rituxan,278936,RxNorm,IU/kg,84.0,
SYNTHETIC-5,DONOR_2271,TREATMENT_9771,Cell-based,,8836851,NCI Thesaurus,cells/kg,172.0,175.0
SYNTHETIC-5,DONOR_2272,TREATMENT_9772,Other immunomodulatory substances,Keytruda,,NCI Thesaurus,mg/m2,133.0,78.0
SYNTHETIC-5,DONOR_2273,TREATMENT_9773,Cell-based,Ibrance,8756456,NCI Thesaurus,g/m2,108.0,172.0
SYNTHETIC-5,DONOR_2274,TREATMENT_9774,Immune checkpoint inhibitors,Atezolizumab,8756456,NCI Thesaurus,,140.0,172.0
SYNTHETIC-5,DONOR_2275,TREATMENT_9775,Cell-based,Brigatinib,239766,PubChem,IU/m2,163.0,95.0
SYNTHETIC-5,DONOR_2276,TREATMENT_9776,Other immunomodulatory substances,Opdivo,4459876,RxNorm,mg/m2,,134.0
SYNTHETIC-5,DONOR_2277,TREATMENT_9777,Cell-based,Erlotinib,239766,NCI Thesaurus,g/m2,,
SYNTHETIC-5,DONOR_2278,TREATMENT_9778,Cell-based,Alecensa,8756456,PubChem,cells/kg,180.0,181.0
SYNTHETIC-5,DONOR_2279,TREATMENT_9779,Cell-based,Nivolumab,987654,NCI Thesaurus,ug/m2,,141.0
SYNTHETIC-5,DONOR_2280,TREATMENT_9780,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,987654,RxNorm,cells/kg,62.0,160.0
SYNTHETIC-5,DONOR_2281,TREATMENT_9781,Cell-based,Sorafenib,278936,RxNorm,IU/m2,188.0,108.0
SYNTHETIC-5,DONOR_2282,TREATMENT_9782,Cell-based,Pembrolizumab,8836851,NCI Thesaurus,IU/m2,135.0,144.0
SYNTHETIC-5,DONOR_2283,TREATMENT_9783,Cell-based,,8756456,RxNorm,,83.0,
SYNTHETIC-5,DONOR_2284,TREATMENT_9784,Immune checkpoint inhibitors,Durvalumab,8756456,NCI Thesaurus,IU/kg,110.0,
SYNTHETIC-5,DONOR_2285,TREATMENT_9785,Immune checkpoint inhibitors,Nivolumab,,RxNorm,,150.0,73.0
SYNTHETIC-5,DONOR_2286,TREATMENT_9786,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,278936,RxNorm,,56.0,
SYNTHETIC-5,DONOR_2287,TREATMENT_9787,,Rituxan,8836851,RxNorm,IU/kg,82.0,174.0
SYNTHETIC-5,DONOR_2288,TREATMENT_9788,Cell-based,Imfinzi,8756456,NCI Thesaurus,mg/m2,,180.0
SYNTHETIC-5,DONOR_2289,TREATMENT_9789,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,987654,PubChem,cells/kg,199.0,181.0
SYNTHETIC-5,DONOR_2290,TREATMENT_9790,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,4459876,NCI Thesaurus,,196.0,64.0
SYNTHETIC-5,DONOR_2291,TREATMENT_9791,Other immunomodulatory substances,,8756456,PubChem,mg/m2,198.0,187.0
SYNTHETIC-5,DONOR_2292,TREATMENT_9792,Cell-based,Blinatumomab,4459876,NCI Thesaurus,mg/kg,172.0,95.0
SYNTHETIC-5,DONOR_2293,TREATMENT_9793,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,8836851,RxNorm,g/m2,,191.0
SYNTHETIC-5,DONOR_2294,TREATMENT_9794,Immune checkpoint inhibitors,,278936,PubChem,IU/kg,135.0,
SYNTHETIC-5,DONOR_2295,TREATMENT_9795,Other immunomodulatory substances,,278936,NCI Thesaurus,IU/m2,,66.0
SYNTHETIC-5,DONOR_2296,TREATMENT_9796,Immune checkpoint inhibitors,Kymriah,987654,NCI Thesaurus,cells/kg,,92.0
SYNTHETIC-5,DONOR_2297,TREATMENT_9797,Immune checkpoint inhibitors,,239766,,g/m2,,149.0
SYNTHETIC-5,DONOR_2298,TREATMENT_9798,,Adcetris,,RxNorm,IU/kg,156.0,179.0
SYNTHETIC-5,DONOR_2299,TREATMENT_9799,Immune checkpoint inhibitors,Rituxan,,PubChem,,126.0,138.0
SYNTHETIC-5,DONOR_2300,TREATMENT_9800,Cell-based,,987654,RxNorm,cells/kg,141.0,105.0
SYNTHETIC-5,DONOR_2301,TREATMENT_9801,Cell-based,Tecentriq,8836851,RxNorm,mg/kg,192.0,100.0
SYNTHETIC-5,DONOR_2302,TREATMENT_9802,Cell-based,Pembrolizumab,8756456,,IU/m2,,130.0
SYNTHETIC-5,DONOR_2303,TREATMENT_9803,Other immunomodulatory substances,Pembrolizumab,239766,PubChem,ug/m2,114.0,128.0
SYNTHETIC-5,DONOR_2304,TREATMENT_9804,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8756456,,IU/m2,119.0,114.0
SYNTHETIC-5,DONOR_2305,TREATMENT_9805,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,278936,PubChem,mg/kg,123.0,177.0
SYNTHETIC-5,DONOR_2306,TREATMENT_9806,Cell-based,Yescarta,4459876,,ug/m2,,183.0
SYNTHETIC-5,DONOR_2307,TREATMENT_9807,,Kymriah,239766,PubChem,mg/m2,193.0,163.0
SYNTHETIC-5,DONOR_2308,TREATMENT_9808,,Gilteritinib,8756456,PubChem,mg/kg,89.0,59.0
SYNTHETIC-5,DONOR_2309,TREATMENT_9809,Cell-based,Pembrolizumab,,RxNorm,ug/m2,135.0,111.0
SYNTHETIC-5,DONOR_2310,TREATMENT_9810,Other immunomodulatory substances,Keytruda,278936,NCI Thesaurus,IU/kg,,141.0
SYNTHETIC-5,DONOR_2311,TREATMENT_9811,Immune checkpoint inhibitors,Selumitinib,8836851,PubChem,IU/kg,,
SYNTHETIC-5,DONOR_2312,TREATMENT_9812,Cell-based,Caprelsa,4459876,PubChem,IU/m2,,181.0
SYNTHETIC-5,DONOR_2313,TREATMENT_9813,Other immunomodulatory substances,Selumitinib,278936,RxNorm,cells/kg,131.0,60.0
SYNTHETIC-5,DONOR_2314,TREATMENT_9814,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,987654,NCI Thesaurus,IU/m2,83.0,196.0
SYNTHETIC-5,DONOR_2315,TREATMENT_9815,Other immunomodulatory substances,Opdivo,987654,,mg/kg,168.0,
SYNTHETIC-5,DONOR_2316,TREATMENT_9816,Cell-based,Besponsa,,NCI Thesaurus,g/m2,199.0,173.0
SYNTHETIC-5,DONOR_2317,TREATMENT_9817,Other immunomodulatory substances,Ribociclib,239766,PubChem,,155.0,128.0
SYNTHETIC-5,DONOR_2318,TREATMENT_9818,,Adcetris,987654,,mg/m2,171.0,180.0
SYNTHETIC-5,DONOR_2319,TREATMENT_9819,Immune checkpoint inhibitors,Selumitinib,4459876,NCI Thesaurus,ug/m2,,181.0
SYNTHETIC-5,DONOR_2320,TREATMENT_9820,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,PubChem,cells/kg,133.0,195.0
SYNTHETIC-5,DONOR_2321,TREATMENT_9821,Immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,93.0,200.0
SYNTHETIC-5,DONOR_2322,TREATMENT_9822,Immune checkpoint inhibitors,Blincyto,4459876,,ug/m2,136.0,
SYNTHETIC-5,DONOR_2323,TREATMENT_9823,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,4459876,,mg/kg,83.0,151.0
SYNTHETIC-5,DONOR_2324,TREATMENT_9824,Cell-based,Binimetinib,,,,178.0,187.0
SYNTHETIC-5,DONOR_2325,TREATMENT_9825,Other immunomodulatory substances,Alectinib,8836851,NCI Thesaurus,cells/kg,145.0,50.0
SYNTHETIC-5,DONOR_2326,TREATMENT_9826,Cell-based,Tecentriq,8756456,NCI Thesaurus,cells/kg,178.0,73.0
SYNTHETIC-5,DONOR_2327,TREATMENT_9827,Cell-based,Pembrolizumab,8836851,NCI Thesaurus,ug/m2,122.0,152.0
SYNTHETIC-5,DONOR_2328,TREATMENT_9828,Other immunomodulatory substances,Belantamab,239766,RxNorm,cells/kg,181.0,116.0
SYNTHETIC-5,DONOR_2329,TREATMENT_9829,Other immunomodulatory substances,Kisqali,,RxNorm,mg/kg,182.0,163.0
SYNTHETIC-5,DONOR_2330,TREATMENT_9830,Other immunomodulatory substances,Palbociclib,239766,,IU/m2,,177.0
SYNTHETIC-5,DONOR_2331,TREATMENT_9831,Immune checkpoint inhibitors,Ibrance,,PubChem,mg/m2,195.0,86.0
SYNTHETIC-5,DONOR_2332,TREATMENT_9832,Other immunomodulatory substances,Alunbrig,239766,,ug/m2,159.0,80.0
SYNTHETIC-5,DONOR_2333,TREATMENT_9833,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,987654,NCI Thesaurus,cells/kg,191.0,100.0
SYNTHETIC-5,DONOR_2334,TREATMENT_9834,Cell-based,Zelboraf,239766,NCI Thesaurus,cells/kg,80.0,84.0
SYNTHETIC-5,DONOR_2335,TREATMENT_9835,Cell-based,Adcetris,987654,RxNorm,cells/kg,73.0,124.0
SYNTHETIC-5,DONOR_2336,TREATMENT_9836,Other immunomodulatory substances,Yervoy,987654,PubChem,g/m2,175.0,144.0
SYNTHETIC-5,DONOR_2337,TREATMENT_9837,,,8756456,PubChem,g/m2,,121.0
SYNTHETIC-5,DONOR_2338,TREATMENT_9838,Cell-based,Olaparib,239766,RxNorm,ug/m2,,107.0
SYNTHETIC-5,DONOR_2339,TREATMENT_9839,Cell-based,Niraparib,4459876,RxNorm,mg/m2,105.0,166.0
SYNTHETIC-5,DONOR_2340,TREATMENT_9840,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,g/m2,55.0,164.0
SYNTHETIC-5,DONOR_2341,TREATMENT_9841,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,278936,NCI Thesaurus,IU/kg,86.0,132.0
SYNTHETIC-5,DONOR_2342,TREATMENT_9842,Other immunomodulatory substances,Adcetris,8836851,NCI Thesaurus,IU/kg,189.0,53.0
SYNTHETIC-5,DONOR_2343,TREATMENT_9843,Cell-based,Encorafenib,8756456,PubChem,mg/m2,,
SYNTHETIC-5,DONOR_2344,TREATMENT_9844,Immune checkpoint inhibitors,Mekinist,8756456,RxNorm,,67.0,183.0
SYNTHETIC-5,DONOR_2345,TREATMENT_9845,Immune checkpoint inhibitors,Cotellic,8756456,NCI Thesaurus,ug/m2,79.0,
SYNTHETIC-5,DONOR_2346,TREATMENT_9846,Other immunomodulatory substances,Afatinib,987654,NCI Thesaurus,,,132.0
SYNTHETIC-5,DONOR_2347,TREATMENT_9847,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,,137.0,155.0
SYNTHETIC-5,DONOR_2348,TREATMENT_9848,Other immunomodulatory substances,Tecentriq,8836851,RxNorm,IU/kg,102.0,130.0
SYNTHETIC-5,DONOR_2349,TREATMENT_9849,,Pembrolizumab,239766,,g/m2,,112.0
SYNTHETIC-5,DONOR_2350,TREATMENT_9850,Other immunomodulatory substances,Opdivo,4459876,RxNorm,mg/kg,106.0,123.0
SYNTHETIC-5,DONOR_2351,TREATMENT_9851,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8836851,RxNorm,IU/m2,171.0,59.0
SYNTHETIC-5,DONOR_2352,TREATMENT_9852,Other immunomodulatory substances,Yescarta,8756456,RxNorm,mg/m2,137.0,53.0
SYNTHETIC-5,DONOR_2353,TREATMENT_9853,Other immunomodulatory substances,Tarceva,278936,,ug/m2,110.0,
SYNTHETIC-5,DONOR_2354,TREATMENT_9854,Immune checkpoint inhibitors,Opdivo,8836851,NCI Thesaurus,g/m2,89.0,100.0
SYNTHETIC-5,DONOR_2355,TREATMENT_9855,Immune checkpoint inhibitors,Zelboraf,4459876,,cells/kg,,119.0
SYNTHETIC-5,DONOR_2356,TREATMENT_9856,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,278936,RxNorm,mg/kg,71.0,176.0
SYNTHETIC-5,DONOR_2357,TREATMENT_9857,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,RxNorm,mg/m2,183.0,
SYNTHETIC-5,DONOR_2358,TREATMENT_9858,Immune checkpoint inhibitors,Lenvima,239766,NCI Thesaurus,,180.0,
SYNTHETIC-5,DONOR_2359,TREATMENT_9859,,Braftovi,8756456,,ug/m2,,196.0
SYNTHETIC-5,DONOR_2360,TREATMENT_9860,Immune checkpoint inhibitors,Daratumumab,,RxNorm,ug/m2,98.0,199.0
SYNTHETIC-5,DONOR_2361,TREATMENT_9861,,,239766,NCI Thesaurus,mg/kg,,
SYNTHETIC-5,DONOR_2362,TREATMENT_9862,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,ug/m2,,167.0
SYNTHETIC-5,DONOR_2363,TREATMENT_9863,Other immunomodulatory substances,Palbociclib,8756456,PubChem,IU/m2,98.0,90.0
SYNTHETIC-5,DONOR_2364,TREATMENT_9864,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,278936,NCI Thesaurus,ug/m2,165.0,92.0
SYNTHETIC-5,DONOR_2365,TREATMENT_9865,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,239766,,IU/m2,113.0,126.0
SYNTHETIC-5,DONOR_2366,TREATMENT_9866,Immune checkpoint inhibitors,Mekinist,987654,RxNorm,cells/kg,100.0,55.0
SYNTHETIC-5,DONOR_2367,TREATMENT_9867,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,PubChem,IU/kg,150.0,99.0
SYNTHETIC-5,DONOR_2368,TREATMENT_9868,,Nivolumab,239766,RxNorm,IU/m2,123.0,
SYNTHETIC-5,DONOR_2369,TREATMENT_9869,Other immunomodulatory substances,Cotellic,4459876,NCI Thesaurus,ug/m2,113.0,76.0
SYNTHETIC-5,DONOR_2370,TREATMENT_9870,Immune checkpoint inhibitors,Herceptin,987654,RxNorm,IU/kg,96.0,197.0
SYNTHETIC-5,DONOR_2371,TREATMENT_9871,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,,NCI Thesaurus,IU/kg,188.0,81.0
SYNTHETIC-5,DONOR_2372,TREATMENT_9872,Immune checkpoint inhibitors,,8836851,,IU/m2,178.0,143.0
SYNTHETIC-5,DONOR_2373,TREATMENT_9873,Immune checkpoint inhibitors,Olaparib,4459876,NCI Thesaurus,IU/kg,84.0,67.0
SYNTHETIC-5,DONOR_2374,TREATMENT_9874,Other immunomodulatory substances,,8756456,NCI Thesaurus,,83.0,99.0
SYNTHETIC-5,DONOR_2375,TREATMENT_9875,Immune checkpoint inhibitors,Kymriah,8836851,,mg/m2,148.0,159.0
SYNTHETIC-5,DONOR_2376,TREATMENT_9876,Immune checkpoint inhibitors,Xalkori,8836851,RxNorm,g/m2,184.0,143.0
SYNTHETIC-5,DONOR_2377,TREATMENT_9877,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,,PubChem,IU/kg,,127.0
SYNTHETIC-5,DONOR_2378,TREATMENT_9878,Cell-based,Tagrisso,4459876,RxNorm,g/m2,139.0,152.0
SYNTHETIC-5,DONOR_2379,TREATMENT_9879,Other immunomodulatory substances,Vandetanib,987654,NCI Thesaurus,ug/m2,200.0,112.0
SYNTHETIC-5,DONOR_2380,TREATMENT_9880,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,239766,NCI Thesaurus,cells/kg,155.0,126.0
SYNTHETIC-5,DONOR_2381,TREATMENT_9881,,,,NCI Thesaurus,,135.0,169.0
SYNTHETIC-5,DONOR_2382,TREATMENT_9882,,Tecentriq,4459876,NCI Thesaurus,IU/m2,78.0,105.0
SYNTHETIC-5,DONOR_2383,TREATMENT_9883,Cell-based,Keytruda,4459876,PubChem,,142.0,178.0
SYNTHETIC-5,DONOR_2384,TREATMENT_9884,Other immunomodulatory substances,Tecentriq,8836851,NCI Thesaurus,,131.0,123.0
SYNTHETIC-5,DONOR_2385,TREATMENT_9885,Immune checkpoint inhibitors,Ipilimumab,278936,PubChem,mg/kg,112.0,137.0
SYNTHETIC-5,DONOR_2386,TREATMENT_9886,Immune checkpoint inhibitors,Cobimetinib,8836851,PubChem,g/m2,163.0,112.0
SYNTHETIC-5,DONOR_2387,TREATMENT_9887,Immune checkpoint inhibitors,Brentuximab vedotin,8756456,NCI Thesaurus,cells/kg,,159.0
SYNTHETIC-5,DONOR_2388,TREATMENT_9888,Other immunomodulatory substances,Pexidartinib,,NCI Thesaurus,mg/kg,144.0,75.0
SYNTHETIC-5,DONOR_2389,TREATMENT_9889,,Keytruda,987654,RxNorm,g/m2,121.0,51.0
SYNTHETIC-5,DONOR_2390,TREATMENT_9890,Immune checkpoint inhibitors,Alecensa,987654,PubChem,ug/m2,183.0,94.0
SYNTHETIC-5,DONOR_2391,TREATMENT_9891,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,PubChem,g/m2,56.0,112.0
SYNTHETIC-5,DONOR_2392,TREATMENT_9892,Other immunomodulatory substances,Mekinist,8756456,NCI Thesaurus,ug/m2,77.0,150.0
SYNTHETIC-5,DONOR_2393,TREATMENT_9893,Cell-based,Durvalumab,239766,RxNorm,ug/m2,133.0,172.0
SYNTHETIC-5,DONOR_2394,TREATMENT_9894,,Atezolizumab,8756456,PubChem,IU/m2,,183.0
SYNTHETIC-5,DONOR_2395,TREATMENT_9895,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,239766,RxNorm,IU/kg,148.0,62.0
SYNTHETIC-5,DONOR_2396,TREATMENT_9896,,Erlotinib,278936,RxNorm,cells/kg,,199.0
SYNTHETIC-5,DONOR_2397,TREATMENT_9897,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,RxNorm,ug/m2,77.0,136.0
SYNTHETIC-5,DONOR_2398,TREATMENT_9898,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,278936,RxNorm,mg/kg,55.0,
SYNTHETIC-5,DONOR_2399,TREATMENT_9899,,Brigatinib,4459876,PubChem,ug/m2,77.0,122.0
SYNTHETIC-5,DONOR_2400,TREATMENT_9900,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,RxNorm,mg/kg,136.0,160.0
SYNTHETIC-5,DONOR_2401,TREATMENT_9901,Cell-based,Zejula,8836851,RxNorm,IU/kg,182.0,171.0
SYNTHETIC-5,DONOR_2402,TREATMENT_9902,Cell-based,Vemurafenib,8836851,NCI Thesaurus,ug/m2,143.0,171.0
SYNTHETIC-5,DONOR_2403,TREATMENT_9903,,Atezolizumab,4459876,RxNorm,,169.0,69.0
SYNTHETIC-5,DONOR_2404,TREATMENT_9904,Immune checkpoint inhibitors,Cometriq,987654,,g/m2,,
SYNTHETIC-5,DONOR_2405,TREATMENT_9905,Cell-based,Afatinib,8836851,PubChem,,144.0,57.0
SYNTHETIC-5,DONOR_2406,TREATMENT_9906,Immune checkpoint inhibitors,Cometriq,239766,NCI Thesaurus,IU/m2,134.0,139.0
SYNTHETIC-5,DONOR_2407,TREATMENT_9907,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,4459876,PubChem,cells/kg,146.0,66.0
SYNTHETIC-5,DONOR_2408,TREATMENT_9908,,Cabozantinib,239766,PubChem,ug/m2,167.0,85.0
SYNTHETIC-5,DONOR_2409,TREATMENT_9909,Immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/m2,92.0,50.0
SYNTHETIC-5,DONOR_2410,TREATMENT_9910,Cell-based,Palbociclib,987654,PubChem,cells/kg,190.0,155.0
SYNTHETIC-5,DONOR_2411,TREATMENT_9911,Other immunomodulatory substances,Gilteritinib,987654,NCI Thesaurus,mg/m2,50.0,
SYNTHETIC-5,DONOR_2412,TREATMENT_9912,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,239766,PubChem,g/m2,119.0,
SYNTHETIC-5,DONOR_2413,TREATMENT_9913,Cell-based,Tarceva,987654,RxNorm,cells/kg,143.0,180.0
SYNTHETIC-5,DONOR_2414,TREATMENT_9914,Other immunomodulatory substances,Opdivo,239766,PubChem,ug/m2,193.0,88.0
SYNTHETIC-5,DONOR_2415,TREATMENT_9915,Immune checkpoint inhibitors,Xalkori,8756456,RxNorm,IU/m2,158.0,130.0
SYNTHETIC-5,DONOR_2416,TREATMENT_9916,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,IU/m2,189.0,193.0
SYNTHETIC-5,DONOR_2417,TREATMENT_9917,Other immunomodulatory substances,Mekinist,987654,NCI Thesaurus,g/m2,87.0,159.0
SYNTHETIC-5,DONOR_2418,TREATMENT_9918,Immune checkpoint inhibitors,Opdivo,8836851,PubChem,,77.0,141.0
SYNTHETIC-5,DONOR_2419,TREATMENT_9919,Cell-based,Tafinlar,4459876,NCI Thesaurus,,164.0,130.0
SYNTHETIC-5,DONOR_2420,TREATMENT_9920,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,,mg/m2,182.0,50.0
SYNTHETIC-5,DONOR_2421,TREATMENT_9921,Cell-based,Olaparib,987654,PubChem,IU/kg,105.0,157.0
SYNTHETIC-5,DONOR_2422,TREATMENT_9922,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,PubChem,g/m2,74.0,182.0
SYNTHETIC-5,DONOR_2423,TREATMENT_9923,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,8836851,NCI Thesaurus,mg/m2,,53.0
SYNTHETIC-5,DONOR_2424,TREATMENT_9924,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8756456,RxNorm,g/m2,,147.0
SYNTHETIC-5,DONOR_2425,TREATMENT_9925,Other immunomodulatory substances,Ipilimumab,,NCI Thesaurus,,64.0,
SYNTHETIC-5,DONOR_2426,TREATMENT_9926,Other immunomodulatory substances,,8756456,NCI Thesaurus,IU/kg,,121.0
SYNTHETIC-5,DONOR_2427,TREATMENT_9927,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,PubChem,g/m2,189.0,123.0
SYNTHETIC-5,DONOR_2428,TREATMENT_9928,Cell-based,Mektovi,239766,,g/m2,99.0,190.0
SYNTHETIC-5,DONOR_2429,TREATMENT_9929,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,,cells/kg,,146.0
SYNTHETIC-5,DONOR_2430,TREATMENT_9930,Immune checkpoint inhibitors,Keytruda,239766,PubChem,mg/m2,182.0,
SYNTHETIC-5,DONOR_2431,TREATMENT_9931,Other immunomodulatory substances,Lenvima,239766,RxNorm,mg/m2,140.0,156.0
SYNTHETIC-5,DONOR_2432,TREATMENT_9932,,Tarceva,8836851,RxNorm,,176.0,150.0
SYNTHETIC-5,DONOR_2433,TREATMENT_9933,Cell-based,Crizotinib,,PubChem,IU/kg,,104.0
SYNTHETIC-5,DONOR_2434,TREATMENT_9934,Immune checkpoint inhibitors,Lenvima,,RxNorm,ug/m2,78.0,113.0
SYNTHETIC-5,DONOR_2435,TREATMENT_9935,Cell-based,Imfinzi,,RxNorm,g/m2,158.0,87.0
SYNTHETIC-5,DONOR_2436,TREATMENT_9936,Other immunomodulatory substances,Mektovi,4459876,PubChem,,89.0,87.0
SYNTHETIC-5,DONOR_2437,TREATMENT_9937,Immune checkpoint inhibitors,Vemurafenib,8756456,PubChem,,186.0,138.0
SYNTHETIC-5,DONOR_2438,TREATMENT_9938,Immune checkpoint inhibitors,Axicabtagene ciloleucel,239766,NCI Thesaurus,IU/m2,85.0,88.0
SYNTHETIC-5,DONOR_2439,TREATMENT_9939,,Cotellic,4459876,NCI Thesaurus,mg/kg,75.0,
SYNTHETIC-5,DONOR_2440,TREATMENT_9940,Immune checkpoint inhibitors,Venetoclax,8756456,,IU/kg,134.0,82.0
SYNTHETIC-5,DONOR_2441,TREATMENT_9941,Other immunomodulatory substances,Nivolumab,239766,RxNorm,mg/kg,154.0,149.0
SYNTHETIC-5,DONOR_2442,TREATMENT_9942,Cell-based,Nivolumab,8836851,PubChem,g/m2,181.0,192.0
SYNTHETIC-5,DONOR_2443,TREATMENT_9943,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,PubChem,IU/m2,,59.0
SYNTHETIC-5,DONOR_2444,TREATMENT_9944,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,,RxNorm,IU/m2,198.0,168.0
SYNTHETIC-5,DONOR_2445,TREATMENT_9945,Other immunomodulatory substances,Afatinib,987654,RxNorm,IU/m2,164.0,
SYNTHETIC-5,DONOR_2446,TREATMENT_9946,Immune checkpoint inhibitors,Opdivo,278936,RxNorm,mg/kg,170.0,141.0
SYNTHETIC-5,DONOR_2447,TREATMENT_9947,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,278936,PubChem,mg/m2,,174.0
SYNTHETIC-5,DONOR_2448,TREATMENT_9948,Other immunomodulatory substances,Daratumumab,239766,NCI Thesaurus,,123.0,83.0
SYNTHETIC-5,DONOR_2449,TREATMENT_9949,Other immunomodulatory substances,Pexidartinib,278936,,mg/m2,156.0,188.0
SYNTHETIC-5,DONOR_2450,TREATMENT_9950,Immune checkpoint inhibitors,Binimetinib,987654,,mg/m2,174.0,124.0
SYNTHETIC-5,DONOR_2451,TREATMENT_9951,Immune checkpoint inhibitors,Mekinist,239766,,g/m2,100.0,96.0
SYNTHETIC-5,DONOR_2452,TREATMENT_9952,Cell-based,Alunbrig,239766,NCI Thesaurus,ug/m2,189.0,
SYNTHETIC-5,DONOR_2453,TREATMENT_9953,Cell-based,Pexidartinib,8756456,NCI Thesaurus,,85.0,196.0
SYNTHETIC-5,DONOR_2454,TREATMENT_9954,Cell-based,Durvalumab,8836851,PubChem,g/m2,191.0,151.0
SYNTHETIC-5,DONOR_2455,TREATMENT_9955,Cell-based,Lenvima,8756456,,cells/kg,65.0,97.0
SYNTHETIC-5,DONOR_2456,TREATMENT_9956,Other immunomodulatory substances,,4459876,RxNorm,,71.0,158.0
SYNTHETIC-5,DONOR_2457,TREATMENT_9957,Other immunomodulatory substances,Binimetinib,8836851,PubChem,cells/kg,,111.0
SYNTHETIC-5,DONOR_2458,TREATMENT_9958,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,RxNorm,ug/m2,152.0,175.0
SYNTHETIC-5,DONOR_2459,TREATMENT_9959,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,IU/m2,107.0,190.0
SYNTHETIC-5,DONOR_2460,TREATMENT_9960,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,987654,NCI Thesaurus,IU/kg,52.0,50.0
SYNTHETIC-5,DONOR_2461,TREATMENT_9961,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,8836851,NCI Thesaurus,mg/kg,87.0,78.0
SYNTHETIC-5,DONOR_2462,TREATMENT_9962,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,mg/kg,67.0,200.0
SYNTHETIC-5,DONOR_2463,TREATMENT_9963,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,RxNorm,ug/m2,142.0,64.0
SYNTHETIC-5,DONOR_2464,TREATMENT_9964,Immune checkpoint inhibitors,Afatinib,239766,,mg/kg,149.0,81.0
SYNTHETIC-5,DONOR_2465,TREATMENT_9965,Other immunomodulatory substances,Kadcyla,239766,PubChem,mg/kg,68.0,150.0
SYNTHETIC-5,DONOR_2466,TREATMENT_9966,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,239766,PubChem,cells/kg,145.0,182.0
SYNTHETIC-5,DONOR_2467,TREATMENT_9967,Cell-based,Durvalumab,4459876,PubChem,mg/kg,131.0,106.0
SYNTHETIC-5,DONOR_2468,TREATMENT_9968,Other immunomodulatory substances,Encorafenib,8836851,NCI Thesaurus,mg/m2,,198.0
SYNTHETIC-5,DONOR_2469,TREATMENT_9969,,Daratumumab,278936,RxNorm,mg/m2,63.0,148.0
SYNTHETIC-5,DONOR_2470,TREATMENT_9970,Cell-based,Cotellic,239766,RxNorm,mg/m2,94.0,135.0
SYNTHETIC-5,DONOR_2471,TREATMENT_9971,,Trametinib,239766,PubChem,mg/m2,176.0,90.0
SYNTHETIC-5,DONOR_2472,TREATMENT_9972,Immune checkpoint inhibitors,Trastuzumab,8756456,NCI Thesaurus,,97.0,
SYNTHETIC-5,DONOR_2473,TREATMENT_9973,Immune checkpoint inhibitors,Gilotrif,4459876,PubChem,IU/kg,188.0,175.0
SYNTHETIC-5,DONOR_2474,TREATMENT_9974,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8756456,RxNorm,ug/m2,163.0,
SYNTHETIC-5,DONOR_2475,TREATMENT_9975,,Tecentriq,,PubChem,IU/m2,111.0,102.0
SYNTHETIC-5,DONOR_2476,TREATMENT_9976,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,4459876,PubChem,g/m2,151.0,136.0
SYNTHETIC-5,DONOR_2477,TREATMENT_9977,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,PubChem,IU/m2,103.0,89.0
SYNTHETIC-5,DONOR_2478,TREATMENT_9978,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,RxNorm,mg/kg,,185.0
SYNTHETIC-5,DONOR_2479,TREATMENT_9979,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,mg/kg,,115.0
SYNTHETIC-5,DONOR_2480,TREATMENT_9980,Immune checkpoint inhibitors,Ipilimumab,987654,RxNorm,g/m2,128.0,124.0
SYNTHETIC-5,DONOR_2481,TREATMENT_9981,Cell-based,Tarceva,239766,NCI Thesaurus,,,158.0
SYNTHETIC-5,DONOR_2482,TREATMENT_9982,Immune checkpoint inhibitors,,8836851,RxNorm,mg/m2,,163.0
SYNTHETIC-5,DONOR_2483,TREATMENT_9983,Other immunomodulatory substances,Opdivo,,NCI Thesaurus,ug/m2,,
SYNTHETIC-5,DONOR_2484,TREATMENT_9984,Cell-based,Yervoy,8756456,,mg/m2,111.0,97.0
SYNTHETIC-5,DONOR_2485,TREATMENT_9985,Other immunomodulatory substances,,278936,,IU/kg,,193.0
SYNTHETIC-5,DONOR_2486,TREATMENT_9986,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,278936,NCI Thesaurus,,115.0,191.0
SYNTHETIC-5,DONOR_2487,TREATMENT_9987,Immune checkpoint inhibitors,,987654,RxNorm,mg/m2,55.0,110.0
SYNTHETIC-5,DONOR_2488,TREATMENT_9988,Other immunomodulatory substances,Blinatumomab,,NCI Thesaurus,cells/kg,102.0,
SYNTHETIC-5,DONOR_2489,TREATMENT_9989,Immune checkpoint inhibitors,Nexavar,4459876,NCI Thesaurus,g/m2,154.0,145.0
SYNTHETIC-5,DONOR_2490,TREATMENT_9990,,Tisagenlecleucel,,PubChem,IU/kg,149.0,79.0
SYNTHETIC-5,DONOR_2491,TREATMENT_9991,Other immunomodulatory substances,Osimertinib,8756456,RxNorm,ug/m2,107.0,92.0
SYNTHETIC-5,DONOR_2492,TREATMENT_9992,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,cells/kg,,
SYNTHETIC-5,DONOR_2493,TREATMENT_9993,Immune checkpoint inhibitors,Mekinist,,,IU/kg,130.0,92.0
SYNTHETIC-5,DONOR_2494,TREATMENT_9994,Cell-based,,278936,RxNorm,mg/kg,95.0,132.0
SYNTHETIC-5,DONOR_2495,TREATMENT_9995,Immune checkpoint inhibitors,Pexidartinib,278936,RxNorm,cells/kg,154.0,61.0
SYNTHETIC-5,DONOR_2496,TREATMENT_9996,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,IU/m2,177.0,115.0
SYNTHETIC-5,DONOR_2497,TREATMENT_9997,Cell-based,Opdivo,239766,RxNorm,IU/kg,60.0,156.0
SYNTHETIC-5,DONOR_2498,TREATMENT_9998,Cell-based,Encorafenib,987654,NCI Thesaurus,IU/kg,153.0,
SYNTHETIC-5,DONOR_2499,TREATMENT_9999,Immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/m2,197.0,185.0
SYNTHETIC-5,DONOR_2500,TREATMENT_10000,Cell-based,Ribociclib,4459876,NCI Thesaurus,g/m2,101.0,
SYNTHETIC-6,DONOR_2501,TREATMENT_10001,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,IU/m2,,
SYNTHETIC-6,DONOR_2502,TREATMENT_10002,Cell-based,Blincyto,239766,,,194.0,131.0
SYNTHETIC-6,DONOR_2503,TREATMENT_10003,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,RxNorm,g/m2,94.0,
SYNTHETIC-6,DONOR_2504,TREATMENT_10004,Other immunomodulatory substances,Encorafenib,8756456,,IU/kg,197.0,166.0
SYNTHETIC-6,DONOR_2505,TREATMENT_10005,Other immunomodulatory substances,Tisagenlecleucel,278936,PubChem,IU/m2,97.0,115.0
SYNTHETIC-6,DONOR_2506,TREATMENT_10006,Immune checkpoint inhibitors,Ipilimumab,239766,RxNorm,,153.0,84.0
SYNTHETIC-6,DONOR_2507,TREATMENT_10007,Other immunomodulatory substances,Yervoy,987654,PubChem,IU/kg,188.0,89.0
SYNTHETIC-6,DONOR_2508,TREATMENT_10008,,Tecentriq,239766,NCI Thesaurus,cells/kg,183.0,143.0
SYNTHETIC-6,DONOR_2509,TREATMENT_10009,Cell-based,Opdivo,987654,PubChem,,67.0,64.0
SYNTHETIC-6,DONOR_2510,TREATMENT_10010,Immune checkpoint inhibitors,Ribociclib,8756456,NCI Thesaurus,,51.0,
SYNTHETIC-6,DONOR_2511,TREATMENT_10011,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,NCI Thesaurus,mg/m2,99.0,112.0
SYNTHETIC-6,DONOR_2512,TREATMENT_10012,Cell-based,Blincyto,8836851,NCI Thesaurus,mg/kg,180.0,110.0
SYNTHETIC-6,DONOR_2513,TREATMENT_10013,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,987654,RxNorm,mg/kg,148.0,69.0
SYNTHETIC-6,DONOR_2514,TREATMENT_10014,Cell-based,Iressa,,PubChem,,,148.0
SYNTHETIC-6,DONOR_2515,TREATMENT_10015,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,IU/m2,100.0,177.0
SYNTHETIC-6,DONOR_2516,TREATMENT_10016,Immune checkpoint inhibitors,,987654,RxNorm,ug/m2,69.0,188.0
SYNTHETIC-6,DONOR_2517,TREATMENT_10017,,Braftovi,278936,NCI Thesaurus,ug/m2,115.0,162.0
SYNTHETIC-6,DONOR_2518,TREATMENT_10018,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/kg,,85.0
SYNTHETIC-6,DONOR_2519,TREATMENT_10019,Other immunomodulatory substances,,8756456,,mg/m2,57.0,199.0
SYNTHETIC-6,DONOR_2520,TREATMENT_10020,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,RxNorm,,179.0,87.0
SYNTHETIC-6,DONOR_2521,TREATMENT_10021,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,987654,PubChem,mg/kg,196.0,
SYNTHETIC-6,DONOR_2522,TREATMENT_10022,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,4459876,RxNorm,ug/m2,117.0,76.0
SYNTHETIC-6,DONOR_2523,TREATMENT_10023,Immune checkpoint inhibitors,Zykadia,8756456,NCI Thesaurus,ug/m2,140.0,148.0
SYNTHETIC-6,DONOR_2524,TREATMENT_10024,Other immunomodulatory substances,Atezolizumab,987654,,g/m2,126.0,
SYNTHETIC-6,DONOR_2525,TREATMENT_10025,Immune checkpoint inhibitors,,239766,NCI Thesaurus,mg/m2,194.0,73.0
SYNTHETIC-6,DONOR_2526,TREATMENT_10026,Immune checkpoint inhibitors,Crizotinib,239766,,cells/kg,127.0,116.0
SYNTHETIC-6,DONOR_2527,TREATMENT_10027,Other immunomodulatory substances,Copanlisib,8836851,PubChem,,133.0,125.0
SYNTHETIC-6,DONOR_2528,TREATMENT_10028,Immune checkpoint inhibitors,Rituximab,278936,,,73.0,61.0
SYNTHETIC-6,DONOR_2529,TREATMENT_10029,Other immunomodulatory substances,Herceptin,8756456,NCI Thesaurus,g/m2,128.0,104.0
SYNTHETIC-6,DONOR_2530,TREATMENT_10030,Immune checkpoint inhibitors,Besponsa,8836851,PubChem,,165.0,132.0
SYNTHETIC-6,DONOR_2531,TREATMENT_10031,Immune checkpoint inhibitors,Caprelsa,8756456,PubChem,mg/m2,179.0,126.0
SYNTHETIC-6,DONOR_2532,TREATMENT_10032,Cell-based,Ipilimumab,278936,,ug/m2,,135.0
SYNTHETIC-6,DONOR_2533,TREATMENT_10033,,Vandetanib,278936,PubChem,,70.0,59.0
SYNTHETIC-6,DONOR_2534,TREATMENT_10034,Cell-based,Opdivo,,NCI Thesaurus,IU/m2,,168.0
SYNTHETIC-6,DONOR_2535,TREATMENT_10035,Cell-based,Abemaciclib,8836851,PubChem,IU/m2,191.0,182.0
SYNTHETIC-6,DONOR_2536,TREATMENT_10036,,Daratumumab,987654,NCI Thesaurus,,181.0,199.0
SYNTHETIC-6,DONOR_2537,TREATMENT_10037,Other immunomodulatory substances,Atezolizumab,278936,PubChem,IU/m2,198.0,134.0
SYNTHETIC-6,DONOR_2538,TREATMENT_10038,,Pembrolizumab,987654,PubChem,IU/m2,98.0,
SYNTHETIC-6,DONOR_2539,TREATMENT_10039,Cell-based,Venclexta,4459876,NCI Thesaurus,g/m2,154.0,138.0
SYNTHETIC-6,DONOR_2540,TREATMENT_10040,Cell-based,Zykadia,8836851,PubChem,cells/kg,133.0,157.0
SYNTHETIC-6,DONOR_2541,TREATMENT_10041,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8836851,RxNorm,,132.0,115.0
SYNTHETIC-6,DONOR_2542,TREATMENT_10042,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,239766,NCI Thesaurus,mg/kg,197.0,
SYNTHETIC-6,DONOR_2543,TREATMENT_10043,Other immunomodulatory substances,Ribociclib,239766,,cells/kg,151.0,61.0
SYNTHETIC-6,DONOR_2544,TREATMENT_10044,Immune checkpoint inhibitors,Nivolumab,8756456,PubChem,IU/kg,172.0,178.0
SYNTHETIC-6,DONOR_2545,TREATMENT_10045,Cell-based,Sorafenib,8756456,NCI Thesaurus,,55.0,80.0
SYNTHETIC-6,DONOR_2546,TREATMENT_10046,Cell-based,,8756456,NCI Thesaurus,IU/kg,54.0,54.0
SYNTHETIC-6,DONOR_2547,TREATMENT_10047,Cell-based,Rubraca,278936,PubChem,,116.0,102.0
SYNTHETIC-6,DONOR_2548,TREATMENT_10048,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,239766,NCI Thesaurus,cells/kg,194.0,182.0
SYNTHETIC-6,DONOR_2549,TREATMENT_10049,Cell-based,Opdivo,278936,,mg/m2,51.0,
SYNTHETIC-6,DONOR_2550,TREATMENT_10050,Other immunomodulatory substances,Tecentriq,278936,PubChem,IU/m2,148.0,117.0
SYNTHETIC-6,DONOR_2551,TREATMENT_10051,Other immunomodulatory substances,,4459876,RxNorm,g/m2,66.0,92.0
SYNTHETIC-6,DONOR_2552,TREATMENT_10052,,Tecentriq,4459876,PubChem,mg/m2,74.0,129.0
SYNTHETIC-6,DONOR_2553,TREATMENT_10053,Other immunomodulatory substances,Yervoy,987654,NCI Thesaurus,IU/kg,68.0,76.0
SYNTHETIC-6,DONOR_2554,TREATMENT_10054,Other immunomodulatory substances,Gefitinib,239766,RxNorm,IU/kg,182.0,137.0
SYNTHETIC-6,DONOR_2555,TREATMENT_10055,Other immunomodulatory substances,Blinatumomab,278936,RxNorm,IU/kg,135.0,188.0
SYNTHETIC-6,DONOR_2556,TREATMENT_10056,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,NCI Thesaurus,g/m2,79.0,191.0
SYNTHETIC-6,DONOR_2557,TREATMENT_10057,Cell-based,Alecensa,278936,PubChem,mg/kg,172.0,200.0
SYNTHETIC-6,DONOR_2558,TREATMENT_10058,Immune checkpoint inhibitors,Opdivo,278936,PubChem,IU/m2,190.0,149.0
SYNTHETIC-6,DONOR_2559,TREATMENT_10059,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,IU/kg,97.0,130.0
SYNTHETIC-6,DONOR_2560,TREATMENT_10060,Cell-based,Alecensa,8836851,PubChem,,,58.0
SYNTHETIC-6,DONOR_2561,TREATMENT_10061,Immune checkpoint inhibitors,,239766,NCI Thesaurus,IU/m2,,152.0
SYNTHETIC-6,DONOR_2562,TREATMENT_10062,Immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,IU/kg,55.0,
SYNTHETIC-6,DONOR_2563,TREATMENT_10063,Cell-based,Nivolumab,987654,NCI Thesaurus,mg/kg,200.0,153.0
SYNTHETIC-6,DONOR_2564,TREATMENT_10064,Other immunomodulatory substances,Caprelsa,,NCI Thesaurus,IU/m2,,155.0
SYNTHETIC-6,DONOR_2565,TREATMENT_10065,Immune checkpoint inhibitors,,987654,NCI Thesaurus,mg/m2,200.0,86.0
SYNTHETIC-6,DONOR_2566,TREATMENT_10066,Cell-based,Nivolumab,8756456,NCI Thesaurus,mg/kg,128.0,
SYNTHETIC-6,DONOR_2567,TREATMENT_10067,Other immunomodulatory substances,Imfinzi,987654,PubChem,,149.0,109.0
SYNTHETIC-6,DONOR_2568,TREATMENT_10068,Other immunomodulatory substances,Ribociclib,239766,RxNorm,,129.0,171.0
SYNTHETIC-6,DONOR_2569,TREATMENT_10069,Other immunomodulatory substances,Zejula,8756456,NCI Thesaurus,IU/m2,195.0,129.0
SYNTHETIC-6,DONOR_2570,TREATMENT_10070,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8756456,NCI Thesaurus,,163.0,
SYNTHETIC-6,DONOR_2571,TREATMENT_10071,Cell-based,,987654,RxNorm,mg/m2,122.0,189.0
SYNTHETIC-6,DONOR_2572,TREATMENT_10072,Cell-based,Dabrafenib,987654,NCI Thesaurus,IU/m2,51.0,166.0
SYNTHETIC-6,DONOR_2573,TREATMENT_10073,Cell-based,Atezolizumab,,PubChem,ug/m2,135.0,199.0
SYNTHETIC-6,DONOR_2574,TREATMENT_10074,Immune checkpoint inhibitors,Blinatumomab,987654,,cells/kg,167.0,142.0
SYNTHETIC-6,DONOR_2575,TREATMENT_10075,Immune checkpoint inhibitors,Tagrisso,4459876,PubChem,cells/kg,84.0,199.0
SYNTHETIC-6,DONOR_2576,TREATMENT_10076,Cell-based,Nivolumab,8836851,NCI Thesaurus,,143.0,140.0
SYNTHETIC-6,DONOR_2577,TREATMENT_10077,Other immunomodulatory substances,Pembrolizumab,239766,RxNorm,IU/m2,90.0,
SYNTHETIC-6,DONOR_2578,TREATMENT_10078,Immune checkpoint inhibitors,Tecentriq,,NCI Thesaurus,mg/m2,181.0,92.0
SYNTHETIC-6,DONOR_2579,TREATMENT_10079,Immune checkpoint inhibitors,Obinutuzumab,8836851,RxNorm,IU/kg,58.0,151.0
SYNTHETIC-6,DONOR_2580,TREATMENT_10080,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,,,148.0
SYNTHETIC-6,DONOR_2581,TREATMENT_10081,Cell-based,Enhertu,987654,RxNorm,IU/m2,139.0,124.0
SYNTHETIC-6,DONOR_2582,TREATMENT_10082,Monoclonal antibodies other than immune checkpoint inhibitors,,,PubChem,,189.0,103.0
SYNTHETIC-6,DONOR_2583,TREATMENT_10083,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,8836851,RxNorm,cells/kg,,80.0
SYNTHETIC-6,DONOR_2584,TREATMENT_10084,Immune checkpoint inhibitors,Tecentriq,4459876,RxNorm,IU/m2,198.0,116.0
SYNTHETIC-6,DONOR_2585,TREATMENT_10085,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,,PubChem,cells/kg,63.0,101.0
SYNTHETIC-6,DONOR_2586,TREATMENT_10086,Cell-based,Inotuzumab ozogamicin,8756456,PubChem,g/m2,132.0,149.0
SYNTHETIC-6,DONOR_2587,TREATMENT_10087,Other immunomodulatory substances,Caprelsa,,PubChem,IU/m2,114.0,50.0
SYNTHETIC-6,DONOR_2588,TREATMENT_10088,Cell-based,Axicabtagene ciloleucel,4459876,RxNorm,IU/m2,173.0,
SYNTHETIC-6,DONOR_2589,TREATMENT_10089,Cell-based,,239766,RxNorm,IU/m2,130.0,80.0
SYNTHETIC-6,DONOR_2590,TREATMENT_10090,,Tarceva,4459876,NCI Thesaurus,g/m2,159.0,153.0
SYNTHETIC-6,DONOR_2591,TREATMENT_10091,,,8756456,NCI Thesaurus,ug/m2,141.0,182.0
SYNTHETIC-6,DONOR_2592,TREATMENT_10092,Other immunomodulatory substances,Atezolizumab,8756456,RxNorm,mg/kg,67.0,139.0
SYNTHETIC-6,DONOR_2593,TREATMENT_10093,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,RxNorm,ug/m2,87.0,105.0
SYNTHETIC-6,DONOR_2594,TREATMENT_10094,Immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,RxNorm,mg/kg,128.0,185.0
SYNTHETIC-6,DONOR_2595,TREATMENT_10095,Immune checkpoint inhibitors,Pembrolizumab,987654,PubChem,ug/m2,134.0,
SYNTHETIC-6,DONOR_2596,TREATMENT_10096,Cell-based,,,PubChem,g/m2,115.0,139.0
SYNTHETIC-6,DONOR_2597,TREATMENT_10097,Other immunomodulatory substances,Zelboraf,987654,PubChem,ug/m2,,149.0
SYNTHETIC-6,DONOR_2598,TREATMENT_10098,Cell-based,Niraparib,4459876,PubChem,mg/kg,126.0,176.0
SYNTHETIC-6,DONOR_2599,TREATMENT_10099,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,987654,NCI Thesaurus,ug/m2,91.0,51.0
SYNTHETIC-6,DONOR_2600,TREATMENT_10100,Cell-based,Zejula,239766,,g/m2,78.0,89.0
SYNTHETIC-6,DONOR_2601,TREATMENT_10101,Immune checkpoint inhibitors,Osimertinib,987654,RxNorm,IU/kg,150.0,74.0
SYNTHETIC-6,DONOR_2602,TREATMENT_10102,Cell-based,Necitumumab,239766,RxNorm,ug/m2,165.0,108.0
SYNTHETIC-6,DONOR_2603,TREATMENT_10103,Cell-based,Palbociclib,8756456,RxNorm,cells/kg,,137.0
SYNTHETIC-6,DONOR_2604,TREATMENT_10104,Immune checkpoint inhibitors,Blinatumomab,987654,NCI Thesaurus,ug/m2,,141.0
SYNTHETIC-6,DONOR_2605,TREATMENT_10105,Other immunomodulatory substances,Tecentriq,278936,NCI Thesaurus,ug/m2,126.0,
SYNTHETIC-6,DONOR_2606,TREATMENT_10106,Other immunomodulatory substances,Kymriah,239766,NCI Thesaurus,IU/kg,74.0,183.0
SYNTHETIC-6,DONOR_2607,TREATMENT_10107,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,8756456,RxNorm,IU/kg,195.0,141.0
SYNTHETIC-6,DONOR_2608,TREATMENT_10108,Cell-based,Gazyva,8756456,PubChem,IU/m2,189.0,153.0
SYNTHETIC-6,DONOR_2609,TREATMENT_10109,Other immunomodulatory substances,Cabozantinib,239766,RxNorm,,163.0,
SYNTHETIC-6,DONOR_2610,TREATMENT_10110,Immune checkpoint inhibitors,,8836851,RxNorm,mg/kg,179.0,80.0
SYNTHETIC-6,DONOR_2611,TREATMENT_10111,Cell-based,Osimertinib,8836851,NCI Thesaurus,,140.0,123.0
SYNTHETIC-6,DONOR_2612,TREATMENT_10112,,Belantamab,987654,,ug/m2,,54.0
SYNTHETIC-6,DONOR_2613,TREATMENT_10113,Other immunomodulatory substances,Caprelsa,8756456,NCI Thesaurus,ug/m2,64.0,165.0
SYNTHETIC-6,DONOR_2614,TREATMENT_10114,Other immunomodulatory substances,Dabrafenib,278936,RxNorm,,,158.0
SYNTHETIC-6,DONOR_2615,TREATMENT_10115,Other immunomodulatory substances,Tisagenlecleucel,278936,NCI Thesaurus,cells/kg,110.0,108.0
SYNTHETIC-6,DONOR_2616,TREATMENT_10116,Cell-based,Gazyva,239766,NCI Thesaurus,mg/m2,139.0,63.0
SYNTHETIC-6,DONOR_2617,TREATMENT_10117,Cell-based,,239766,PubChem,cells/kg,186.0,183.0
SYNTHETIC-6,DONOR_2618,TREATMENT_10118,Other immunomodulatory substances,Braftovi,4459876,PubChem,IU/m2,185.0,
SYNTHETIC-6,DONOR_2619,TREATMENT_10119,Cell-based,Yervoy,278936,NCI Thesaurus,,129.0,59.0
SYNTHETIC-6,DONOR_2620,TREATMENT_10120,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8756456,NCI Thesaurus,IU/kg,174.0,134.0
SYNTHETIC-6,DONOR_2621,TREATMENT_10121,,Opdivo,8756456,PubChem,,193.0,67.0
SYNTHETIC-6,DONOR_2622,TREATMENT_10122,Immune checkpoint inhibitors,,8836851,PubChem,ug/m2,177.0,
SYNTHETIC-6,DONOR_2623,TREATMENT_10123,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,4459876,RxNorm,IU/m2,120.0,187.0
SYNTHETIC-6,DONOR_2624,TREATMENT_10124,Other immunomodulatory substances,Pertuzumab,8836851,RxNorm,mg/m2,109.0,181.0
SYNTHETIC-6,DONOR_2625,TREATMENT_10125,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,NCI Thesaurus,mg/m2,99.0,136.0
SYNTHETIC-6,DONOR_2626,TREATMENT_10126,,,987654,NCI Thesaurus,g/m2,52.0,156.0
SYNTHETIC-6,DONOR_2627,TREATMENT_10127,Immune checkpoint inhibitors,Atezolizumab,8836851,RxNorm,mg/m2,108.0,94.0
SYNTHETIC-6,DONOR_2628,TREATMENT_10128,Other immunomodulatory substances,Binimetinib,8836851,RxNorm,mg/m2,128.0,124.0
SYNTHETIC-6,DONOR_2629,TREATMENT_10129,Other immunomodulatory substances,Venclexta,278936,RxNorm,cells/kg,78.0,172.0
SYNTHETIC-6,DONOR_2630,TREATMENT_10130,Immune checkpoint inhibitors,Lenvima,239766,RxNorm,IU/kg,86.0,197.0
SYNTHETIC-6,DONOR_2631,TREATMENT_10131,,Nivolumab,8836851,RxNorm,,94.0,
SYNTHETIC-6,DONOR_2632,TREATMENT_10132,Immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,mg/kg,181.0,56.0
SYNTHETIC-6,DONOR_2633,TREATMENT_10133,Other immunomodulatory substances,Alectinib,8836851,,cells/kg,169.0,105.0
SYNTHETIC-6,DONOR_2634,TREATMENT_10134,Immune checkpoint inhibitors,Darzalex,4459876,NCI Thesaurus,ug/m2,125.0,127.0
SYNTHETIC-6,DONOR_2635,TREATMENT_10135,Immune checkpoint inhibitors,Pexidartinib,8836851,NCI Thesaurus,g/m2,167.0,116.0
SYNTHETIC-6,DONOR_2636,TREATMENT_10136,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,8836851,NCI Thesaurus,mg/kg,,200.0
SYNTHETIC-6,DONOR_2637,TREATMENT_10137,Cell-based,Brentuximab vedotin,987654,PubChem,IU/kg,195.0,
SYNTHETIC-6,DONOR_2638,TREATMENT_10138,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,mg/kg,200.0,89.0
SYNTHETIC-6,DONOR_2639,TREATMENT_10139,,Atezolizumab,,RxNorm,IU/kg,136.0,159.0
SYNTHETIC-6,DONOR_2640,TREATMENT_10140,Immune checkpoint inhibitors,Yescarta,8756456,RxNorm,,83.0,191.0
SYNTHETIC-6,DONOR_2641,TREATMENT_10141,Immune checkpoint inhibitors,,4459876,NCI Thesaurus,ug/m2,144.0,70.0
SYNTHETIC-6,DONOR_2642,TREATMENT_10142,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,4459876,RxNorm,mg/kg,,184.0
SYNTHETIC-6,DONOR_2643,TREATMENT_10143,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,4459876,RxNorm,IU/m2,104.0,153.0
SYNTHETIC-6,DONOR_2644,TREATMENT_10144,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,,NCI Thesaurus,cells/kg,,93.0
SYNTHETIC-6,DONOR_2645,TREATMENT_10145,,Pexidartinib,4459876,NCI Thesaurus,ug/m2,104.0,115.0
SYNTHETIC-6,DONOR_2646,TREATMENT_10146,,Kadcyla,4459876,,g/m2,,133.0
SYNTHETIC-6,DONOR_2647,TREATMENT_10147,Cell-based,Belantamab,239766,PubChem,,91.0,84.0
SYNTHETIC-6,DONOR_2648,TREATMENT_10148,Cell-based,Zelboraf,278936,PubChem,g/m2,181.0,
SYNTHETIC-6,DONOR_2649,TREATMENT_10149,Monoclonal antibodies other than immune checkpoint inhibitors,Nexavar,278936,NCI Thesaurus,IU/kg,138.0,181.0
SYNTHETIC-6,DONOR_2650,TREATMENT_10150,Other immunomodulatory substances,Tisagenlecleucel,239766,NCI Thesaurus,,172.0,151.0
SYNTHETIC-6,DONOR_2651,TREATMENT_10151,Other immunomodulatory substances,Nivolumab,4459876,NCI Thesaurus,,100.0,93.0
SYNTHETIC-6,DONOR_2652,TREATMENT_10152,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,8836851,RxNorm,mg/kg,129.0,
SYNTHETIC-6,DONOR_2653,TREATMENT_10153,Cell-based,Yescarta,,NCI Thesaurus,,101.0,174.0
SYNTHETIC-6,DONOR_2654,TREATMENT_10154,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,4459876,NCI Thesaurus,cells/kg,133.0,
SYNTHETIC-6,DONOR_2655,TREATMENT_10155,Immune checkpoint inhibitors,Yervoy,987654,PubChem,IU/kg,161.0,
SYNTHETIC-6,DONOR_2656,TREATMENT_10156,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,987654,PubChem,ug/m2,53.0,181.0
SYNTHETIC-6,DONOR_2657,TREATMENT_10157,Immune checkpoint inhibitors,Enhertu,239766,,mg/kg,194.0,186.0
SYNTHETIC-6,DONOR_2658,TREATMENT_10158,,Tecentriq,4459876,RxNorm,g/m2,168.0,
SYNTHETIC-6,DONOR_2659,TREATMENT_10159,Cell-based,Kadcyla,278936,NCI Thesaurus,IU/m2,193.0,176.0
SYNTHETIC-6,DONOR_2660,TREATMENT_10160,Immune checkpoint inhibitors,Obinutuzumab,278936,,cells/kg,116.0,138.0
SYNTHETIC-6,DONOR_2661,TREATMENT_10161,Immune checkpoint inhibitors,Lenvima,8836851,NCI Thesaurus,IU/m2,85.0,117.0
SYNTHETIC-6,DONOR_2662,TREATMENT_10162,,Verzenio,239766,NCI Thesaurus,,180.0,89.0
SYNTHETIC-6,DONOR_2663,TREATMENT_10163,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8836851,RxNorm,g/m2,108.0,115.0
SYNTHETIC-6,DONOR_2664,TREATMENT_10164,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,NCI Thesaurus,mg/m2,76.0,89.0
SYNTHETIC-6,DONOR_2665,TREATMENT_10165,,Lenvatinib,239766,NCI Thesaurus,mg/m2,125.0,51.0
SYNTHETIC-6,DONOR_2666,TREATMENT_10166,,Alunbrig,8756456,,ug/m2,,
SYNTHETIC-6,DONOR_2667,TREATMENT_10167,Immune checkpoint inhibitors,Zykadia,8756456,NCI Thesaurus,ug/m2,138.0,62.0
SYNTHETIC-6,DONOR_2668,TREATMENT_10168,Other immunomodulatory substances,Lenvatinib,278936,,IU/m2,81.0,132.0
SYNTHETIC-6,DONOR_2669,TREATMENT_10169,Cell-based,Adcetris,987654,PubChem,ug/m2,72.0,
SYNTHETIC-6,DONOR_2670,TREATMENT_10170,Immune checkpoint inhibitors,Perjeta,4459876,RxNorm,,,125.0
SYNTHETIC-6,DONOR_2671,TREATMENT_10171,Cell-based,Pembrolizumab,239766,RxNorm,ug/m2,66.0,79.0
SYNTHETIC-6,DONOR_2672,TREATMENT_10172,Immune checkpoint inhibitors,Copanlisib,278936,RxNorm,g/m2,176.0,198.0
SYNTHETIC-6,DONOR_2673,TREATMENT_10173,Other immunomodulatory substances,Erlotinib,,RxNorm,mg/m2,,127.0
SYNTHETIC-6,DONOR_2674,TREATMENT_10174,Other immunomodulatory substances,,8836851,NCI Thesaurus,g/m2,,142.0
SYNTHETIC-6,DONOR_2675,TREATMENT_10175,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,4459876,,cells/kg,95.0,
SYNTHETIC-6,DONOR_2676,TREATMENT_10176,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,4459876,PubChem,mg/m2,149.0,
SYNTHETIC-6,DONOR_2677,TREATMENT_10177,Immune checkpoint inhibitors,Pembrolizumab,278936,PubChem,,58.0,163.0
SYNTHETIC-6,DONOR_2678,TREATMENT_10178,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,cells/kg,136.0,161.0
SYNTHETIC-6,DONOR_2679,TREATMENT_10179,Other immunomodulatory substances,Tecentriq,987654,PubChem,cells/kg,72.0,67.0
SYNTHETIC-6,DONOR_2680,TREATMENT_10180,Immune checkpoint inhibitors,Kadcyla,278936,PubChem,mg/m2,108.0,76.0
SYNTHETIC-6,DONOR_2681,TREATMENT_10181,Other immunomodulatory substances,Yescarta,,,cells/kg,122.0,
SYNTHETIC-6,DONOR_2682,TREATMENT_10182,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,PubChem,IU/m2,168.0,57.0
SYNTHETIC-6,DONOR_2683,TREATMENT_10183,Cell-based,Cometriq,,NCI Thesaurus,IU/m2,,132.0
SYNTHETIC-6,DONOR_2684,TREATMENT_10184,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,8836851,PubChem,ug/m2,123.0,131.0
SYNTHETIC-6,DONOR_2685,TREATMENT_10185,Other immunomodulatory substances,Caprelsa,239766,NCI Thesaurus,cells/kg,71.0,93.0
SYNTHETIC-6,DONOR_2686,TREATMENT_10186,Cell-based,Tecentriq,8756456,NCI Thesaurus,cells/kg,106.0,114.0
SYNTHETIC-6,DONOR_2687,TREATMENT_10187,,Rubraca,239766,RxNorm,g/m2,122.0,50.0
SYNTHETIC-6,DONOR_2688,TREATMENT_10188,Cell-based,Nexavar,8836851,,mg/m2,135.0,196.0
SYNTHETIC-6,DONOR_2689,TREATMENT_10189,,Braftovi,987654,RxNorm,cells/kg,148.0,
SYNTHETIC-6,DONOR_2690,TREATMENT_10190,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,mg/m2,76.0,153.0
SYNTHETIC-6,DONOR_2691,TREATMENT_10191,Other immunomodulatory substances,,8836851,PubChem,cells/kg,102.0,134.0
SYNTHETIC-6,DONOR_2692,TREATMENT_10192,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,987654,NCI Thesaurus,mg/m2,144.0,89.0
SYNTHETIC-6,DONOR_2693,TREATMENT_10193,,Erlotinib,8756456,NCI Thesaurus,,138.0,
SYNTHETIC-6,DONOR_2694,TREATMENT_10194,Immune checkpoint inhibitors,Tecentriq,4459876,,ug/m2,54.0,94.0
SYNTHETIC-6,DONOR_2695,TREATMENT_10195,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,mg/m2,184.0,180.0
SYNTHETIC-6,DONOR_2696,TREATMENT_10196,Other immunomodulatory substances,Pembrolizumab,4459876,PubChem,,175.0,
SYNTHETIC-6,DONOR_2697,TREATMENT_10197,,Cometriq,987654,,cells/kg,180.0,83.0
SYNTHETIC-6,DONOR_2698,TREATMENT_10198,Cell-based,Rituxan,4459876,PubChem,ug/m2,177.0,156.0
SYNTHETIC-6,DONOR_2699,TREATMENT_10199,,Gazyva,278936,RxNorm,IU/kg,134.0,89.0
SYNTHETIC-6,DONOR_2700,TREATMENT_10200,Immune checkpoint inhibitors,Atezolizumab,278936,PubChem,ug/m2,159.0,136.0
SYNTHETIC-6,DONOR_2701,TREATMENT_10201,Other immunomodulatory substances,Tisagenlecleucel,8756456,NCI Thesaurus,mg/m2,54.0,180.0
SYNTHETIC-6,DONOR_2702,TREATMENT_10202,,,,NCI Thesaurus,,152.0,80.0
SYNTHETIC-6,DONOR_2703,TREATMENT_10203,Immune checkpoint inhibitors,Trastuzumab,,NCI Thesaurus,,131.0,
SYNTHETIC-6,DONOR_2704,TREATMENT_10204,Other immunomodulatory substances,Pembrolizumab,278936,RxNorm,g/m2,,172.0
SYNTHETIC-6,DONOR_2705,TREATMENT_10205,Cell-based,Lenvima,278936,,mg/m2,197.0,95.0
SYNTHETIC-6,DONOR_2706,TREATMENT_10206,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,987654,RxNorm,IU/m2,147.0,200.0
SYNTHETIC-6,DONOR_2707,TREATMENT_10207,Immune checkpoint inhibitors,Opdivo,987654,RxNorm,mg/m2,187.0,140.0
SYNTHETIC-6,DONOR_2708,TREATMENT_10208,Other immunomodulatory substances,Obinutuzumab,4459876,,ug/m2,160.0,52.0
SYNTHETIC-6,DONOR_2709,TREATMENT_10209,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,RxNorm,mg/kg,,172.0
SYNTHETIC-6,DONOR_2710,TREATMENT_10210,Cell-based,Palbociclib,278936,,mg/kg,,146.0
SYNTHETIC-6,DONOR_2711,TREATMENT_10211,Cell-based,Inotuzumab ozogamicin,,RxNorm,IU/m2,,
SYNTHETIC-6,DONOR_2712,TREATMENT_10212,Cell-based,,278936,,,,135.0
SYNTHETIC-6,DONOR_2713,TREATMENT_10213,Cell-based,Zejula,4459876,RxNorm,mg/kg,194.0,145.0
SYNTHETIC-6,DONOR_2714,TREATMENT_10214,,Atezolizumab,278936,NCI Thesaurus,mg/kg,62.0,171.0
SYNTHETIC-6,DONOR_2715,TREATMENT_10215,Immune checkpoint inhibitors,Tisagenlecleucel,,NCI Thesaurus,mg/m2,,152.0
SYNTHETIC-6,DONOR_2716,TREATMENT_10216,Cell-based,Zejula,4459876,,,52.0,52.0
SYNTHETIC-6,DONOR_2717,TREATMENT_10217,Cell-based,Cotellic,239766,PubChem,IU/m2,,173.0
SYNTHETIC-6,DONOR_2718,TREATMENT_10218,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,987654,PubChem,g/m2,72.0,172.0
SYNTHETIC-6,DONOR_2719,TREATMENT_10219,,Pembrolizumab,239766,NCI Thesaurus,IU/m2,141.0,116.0
SYNTHETIC-6,DONOR_2720,TREATMENT_10220,Cell-based,Brigatinib,8836851,RxNorm,mg/m2,167.0,77.0
SYNTHETIC-6,DONOR_2721,TREATMENT_10221,Immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/kg,106.0,160.0
SYNTHETIC-6,DONOR_2722,TREATMENT_10222,Other immunomodulatory substances,Palbociclib,278936,,g/m2,123.0,166.0
SYNTHETIC-6,DONOR_2723,TREATMENT_10223,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,4459876,NCI Thesaurus,mg/m2,191.0,189.0
SYNTHETIC-6,DONOR_2724,TREATMENT_10224,Cell-based,,4459876,PubChem,IU/m2,177.0,
SYNTHETIC-6,DONOR_2725,TREATMENT_10225,Immune checkpoint inhibitors,,239766,RxNorm,cells/kg,83.0,60.0
SYNTHETIC-6,DONOR_2726,TREATMENT_10226,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,239766,PubChem,g/m2,,51.0
SYNTHETIC-6,DONOR_2727,TREATMENT_10227,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,,IU/m2,82.0,86.0
SYNTHETIC-6,DONOR_2728,TREATMENT_10228,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,,IU/m2,55.0,50.0
SYNTHETIC-6,DONOR_2729,TREATMENT_10229,Cell-based,Tisagenlecleucel,8756456,NCI Thesaurus,ug/m2,,56.0
SYNTHETIC-6,DONOR_2730,TREATMENT_10230,Cell-based,Ribociclib,8836851,RxNorm,cells/kg,81.0,84.0
SYNTHETIC-6,DONOR_2731,TREATMENT_10231,Immune checkpoint inhibitors,Nexavar,987654,NCI Thesaurus,IU/m2,,
SYNTHETIC-6,DONOR_2732,TREATMENT_10232,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,4459876,RxNorm,,78.0,86.0
SYNTHETIC-6,DONOR_2733,TREATMENT_10233,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,NCI Thesaurus,g/m2,,119.0
SYNTHETIC-6,DONOR_2734,TREATMENT_10234,Cell-based,Verzenio,4459876,NCI Thesaurus,,,156.0
SYNTHETIC-6,DONOR_2735,TREATMENT_10235,Immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,mg/m2,,131.0
SYNTHETIC-6,DONOR_2736,TREATMENT_10236,,Yervoy,4459876,RxNorm,mg/m2,166.0,142.0
SYNTHETIC-6,DONOR_2737,TREATMENT_10237,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,987654,RxNorm,g/m2,196.0,179.0
SYNTHETIC-6,DONOR_2738,TREATMENT_10238,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8836851,PubChem,mg/kg,178.0,107.0
SYNTHETIC-6,DONOR_2739,TREATMENT_10239,Cell-based,Braftovi,239766,PubChem,cells/kg,53.0,
SYNTHETIC-6,DONOR_2740,TREATMENT_10240,Immune checkpoint inhibitors,Zykadia,239766,PubChem,mg/kg,173.0,120.0
SYNTHETIC-6,DONOR_2741,TREATMENT_10241,Monoclonal antibodies other than immune checkpoint inhibitors,,,,IU/m2,,195.0
SYNTHETIC-6,DONOR_2742,TREATMENT_10242,Other immunomodulatory substances,Imfinzi,8836851,RxNorm,IU/m2,136.0,159.0
SYNTHETIC-6,DONOR_2743,TREATMENT_10243,Immune checkpoint inhibitors,Tagrisso,4459876,PubChem,IU/m2,63.0,174.0
SYNTHETIC-6,DONOR_2744,TREATMENT_10244,Cell-based,,8756456,NCI Thesaurus,IU/kg,181.0,149.0
SYNTHETIC-6,DONOR_2745,TREATMENT_10245,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,RxNorm,cells/kg,186.0,72.0
SYNTHETIC-6,DONOR_2746,TREATMENT_10246,Immune checkpoint inhibitors,Gazyva,239766,RxNorm,mg/kg,142.0,67.0
SYNTHETIC-6,DONOR_2747,TREATMENT_10247,,Lynparza,4459876,RxNorm,mg/kg,90.0,181.0
SYNTHETIC-6,DONOR_2748,TREATMENT_10248,Other immunomodulatory substances,Nexavar,4459876,RxNorm,cells/kg,199.0,162.0
SYNTHETIC-6,DONOR_2749,TREATMENT_10249,Immune checkpoint inhibitors,Belantamab,278936,RxNorm,,111.0,157.0
SYNTHETIC-6,DONOR_2750,TREATMENT_10250,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,4459876,NCI Thesaurus,,169.0,134.0
SYNTHETIC-6,DONOR_2751,TREATMENT_10251,Immune checkpoint inhibitors,Vemurafenib,278936,RxNorm,mg/kg,62.0,130.0
SYNTHETIC-6,DONOR_2752,TREATMENT_10252,Immune checkpoint inhibitors,Yervoy,8836851,RxNorm,g/m2,,
SYNTHETIC-6,DONOR_2753,TREATMENT_10253,Immune checkpoint inhibitors,Ribociclib,,,g/m2,187.0,
SYNTHETIC-6,DONOR_2754,TREATMENT_10254,Other immunomodulatory substances,Nivolumab,8836851,PubChem,mg/m2,148.0,153.0
SYNTHETIC-6,DONOR_2755,TREATMENT_10255,Cell-based,,,PubChem,ug/m2,133.0,95.0
SYNTHETIC-6,DONOR_2756,TREATMENT_10256,Other immunomodulatory substances,,278936,PubChem,g/m2,198.0,86.0
SYNTHETIC-6,DONOR_2757,TREATMENT_10257,,Mektovi,239766,NCI Thesaurus,cells/kg,126.0,
SYNTHETIC-6,DONOR_2758,TREATMENT_10258,Other immunomodulatory substances,Durvalumab,8836851,NCI Thesaurus,mg/m2,64.0,159.0
SYNTHETIC-6,DONOR_2759,TREATMENT_10259,Cell-based,Venetoclax,8756456,PubChem,ug/m2,158.0,150.0
SYNTHETIC-6,DONOR_2760,TREATMENT_10260,Cell-based,Cotellic,987654,RxNorm,g/m2,112.0,199.0
SYNTHETIC-6,DONOR_2761,TREATMENT_10261,Other immunomodulatory substances,Tisagenlecleucel,278936,RxNorm,mg/kg,106.0,172.0
SYNTHETIC-6,DONOR_2762,TREATMENT_10262,Other immunomodulatory substances,Trastuzumab,8836851,PubChem,mg/kg,,113.0
SYNTHETIC-6,DONOR_2763,TREATMENT_10263,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,239766,PubChem,IU/m2,175.0,
SYNTHETIC-6,DONOR_2764,TREATMENT_10264,Immune checkpoint inhibitors,Keytruda,,PubChem,IU/kg,115.0,166.0
SYNTHETIC-6,DONOR_2765,TREATMENT_10265,Immune checkpoint inhibitors,Cabozantinib,8756456,PubChem,ug/m2,126.0,192.0
SYNTHETIC-6,DONOR_2766,TREATMENT_10266,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,ug/m2,185.0,128.0
SYNTHETIC-6,DONOR_2767,TREATMENT_10267,Other immunomodulatory substances,,8836851,RxNorm,IU/m2,153.0,57.0
SYNTHETIC-6,DONOR_2768,TREATMENT_10268,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,8756456,,mg/m2,167.0,142.0
SYNTHETIC-6,DONOR_2769,TREATMENT_10269,Immune checkpoint inhibitors,,8756456,PubChem,IU/m2,85.0,130.0
SYNTHETIC-6,DONOR_2770,TREATMENT_10270,Cell-based,Tisagenlecleucel,4459876,RxNorm,g/m2,86.0,154.0
SYNTHETIC-6,DONOR_2771,TREATMENT_10271,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,987654,RxNorm,mg/kg,177.0,52.0
SYNTHETIC-6,DONOR_2772,TREATMENT_10272,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,PubChem,cells/kg,121.0,
SYNTHETIC-6,DONOR_2773,TREATMENT_10273,Cell-based,Zejula,8836851,PubChem,IU/m2,76.0,157.0
SYNTHETIC-6,DONOR_2774,TREATMENT_10274,Other immunomodulatory substances,,8756456,RxNorm,mg/kg,169.0,104.0
SYNTHETIC-6,DONOR_2775,TREATMENT_10275,Other immunomodulatory substances,Copanlisib,239766,PubChem,g/m2,99.0,
SYNTHETIC-6,DONOR_2776,TREATMENT_10276,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,,137.0,176.0
SYNTHETIC-6,DONOR_2777,TREATMENT_10277,Other immunomodulatory substances,Kadcyla,239766,,g/m2,98.0,
SYNTHETIC-6,DONOR_2778,TREATMENT_10278,Cell-based,Binimetinib,8836851,,mg/kg,67.0,184.0
SYNTHETIC-6,DONOR_2779,TREATMENT_10279,Immune checkpoint inhibitors,Pertuzumab,,RxNorm,,175.0,131.0
SYNTHETIC-6,DONOR_2780,TREATMENT_10280,Other immunomodulatory substances,Ipilimumab,278936,PubChem,ug/m2,91.0,111.0
SYNTHETIC-6,DONOR_2781,TREATMENT_10281,Immune checkpoint inhibitors,Pembrolizumab,987654,PubChem,cells/kg,90.0,133.0
SYNTHETIC-6,DONOR_2782,TREATMENT_10282,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,PubChem,ug/m2,158.0,150.0
SYNTHETIC-6,DONOR_2783,TREATMENT_10283,Immune checkpoint inhibitors,Tisagenlecleucel,278936,,IU/kg,193.0,
SYNTHETIC-6,DONOR_2784,TREATMENT_10284,Immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,,53.0,173.0
SYNTHETIC-6,DONOR_2785,TREATMENT_10285,Immune checkpoint inhibitors,Yescarta,278936,,cells/kg,,65.0
SYNTHETIC-6,DONOR_2786,TREATMENT_10286,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,g/m2,146.0,58.0
SYNTHETIC-6,DONOR_2787,TREATMENT_10287,Other immunomodulatory substances,Tecentriq,239766,PubChem,IU/kg,159.0,81.0
SYNTHETIC-6,DONOR_2788,TREATMENT_10288,Immune checkpoint inhibitors,Zykadia,278936,PubChem,g/m2,138.0,
SYNTHETIC-6,DONOR_2789,TREATMENT_10289,Immune checkpoint inhibitors,,8836851,,,61.0,75.0
SYNTHETIC-6,DONOR_2790,TREATMENT_10290,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,4459876,,IU/m2,143.0,146.0
SYNTHETIC-6,DONOR_2791,TREATMENT_10291,Other immunomodulatory substances,Binimetinib,239766,RxNorm,mg/kg,,104.0
SYNTHETIC-6,DONOR_2792,TREATMENT_10292,Immune checkpoint inhibitors,Opdivo,8836851,NCI Thesaurus,IU/m2,119.0,165.0
SYNTHETIC-6,DONOR_2793,TREATMENT_10293,Immune checkpoint inhibitors,Rubraca,239766,RxNorm,mg/m2,57.0,70.0
SYNTHETIC-6,DONOR_2794,TREATMENT_10294,Immune checkpoint inhibitors,Lenvima,278936,,mg/kg,78.0,126.0
SYNTHETIC-6,DONOR_2795,TREATMENT_10295,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,,NCI Thesaurus,mg/m2,61.0,69.0
SYNTHETIC-6,DONOR_2796,TREATMENT_10296,Cell-based,Erlotinib,4459876,PubChem,ug/m2,,191.0
SYNTHETIC-6,DONOR_2797,TREATMENT_10297,Cell-based,Selumitinib,4459876,RxNorm,IU/m2,,
SYNTHETIC-6,DONOR_2798,TREATMENT_10298,Immune checkpoint inhibitors,,4459876,,mg/m2,92.0,159.0
SYNTHETIC-6,DONOR_2799,TREATMENT_10299,Immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,mg/m2,143.0,103.0
SYNTHETIC-6,DONOR_2800,TREATMENT_10300,Immune checkpoint inhibitors,Gefitinib,8756456,RxNorm,g/m2,129.0,81.0
SYNTHETIC-6,DONOR_2801,TREATMENT_10301,Cell-based,Brentuximab vedotin,8756456,NCI Thesaurus,IU/m2,,122.0
SYNTHETIC-6,DONOR_2802,TREATMENT_10302,Other immunomodulatory substances,,239766,NCI Thesaurus,ug/m2,142.0,66.0
SYNTHETIC-6,DONOR_2803,TREATMENT_10303,,,278936,,IU/m2,83.0,170.0
SYNTHETIC-6,DONOR_2804,TREATMENT_10304,Immune checkpoint inhibitors,Atezolizumab,8756456,RxNorm,g/m2,154.0,71.0
SYNTHETIC-6,DONOR_2805,TREATMENT_10305,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,278936,PubChem,IU/kg,129.0,
SYNTHETIC-6,DONOR_2806,TREATMENT_10306,Other immunomodulatory substances,,239766,RxNorm,ug/m2,169.0,148.0
SYNTHETIC-6,DONOR_2807,TREATMENT_10307,Other immunomodulatory substances,Tafinlar,278936,,cells/kg,102.0,
SYNTHETIC-6,DONOR_2808,TREATMENT_10308,Cell-based,Yervoy,278936,PubChem,mg/kg,,188.0
SYNTHETIC-6,DONOR_2809,TREATMENT_10309,Cell-based,Rucaparib,4459876,RxNorm,g/m2,151.0,102.0
SYNTHETIC-6,DONOR_2810,TREATMENT_10310,Immune checkpoint inhibitors,Lenvima,987654,NCI Thesaurus,ug/m2,,
SYNTHETIC-6,DONOR_2811,TREATMENT_10311,Other immunomodulatory substances,Inotuzumab ozogamicin,,RxNorm,IU/kg,61.0,
SYNTHETIC-6,DONOR_2812,TREATMENT_10312,Cell-based,Abemaciclib,,NCI Thesaurus,cells/kg,,137.0
SYNTHETIC-6,DONOR_2813,TREATMENT_10313,,,,PubChem,,,123.0
SYNTHETIC-6,DONOR_2814,TREATMENT_10314,Immune checkpoint inhibitors,Tecentriq,987654,,g/m2,76.0,147.0
SYNTHETIC-6,DONOR_2815,TREATMENT_10315,Other immunomodulatory substances,Sorafenib,987654,PubChem,mg/m2,85.0,
SYNTHETIC-6,DONOR_2816,TREATMENT_10316,Other immunomodulatory substances,Braftovi,8756456,PubChem,g/m2,178.0,78.0
SYNTHETIC-6,DONOR_2817,TREATMENT_10317,Cell-based,Caprelsa,,PubChem,mg/kg,174.0,104.0
SYNTHETIC-6,DONOR_2818,TREATMENT_10318,Cell-based,Rituxan,8756456,PubChem,,165.0,81.0
SYNTHETIC-6,DONOR_2819,TREATMENT_10319,Immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,mg/m2,174.0,51.0
SYNTHETIC-6,DONOR_2820,TREATMENT_10320,Other immunomodulatory substances,Nivolumab,278936,NCI Thesaurus,IU/kg,110.0,194.0
SYNTHETIC-6,DONOR_2821,TREATMENT_10321,Cell-based,Yervoy,,PubChem,IU/kg,146.0,93.0
SYNTHETIC-6,DONOR_2822,TREATMENT_10322,Other immunomodulatory substances,Blincyto,8756456,PubChem,IU/m2,115.0,53.0
SYNTHETIC-6,DONOR_2823,TREATMENT_10323,Immune checkpoint inhibitors,Tisagenlecleucel,8756456,NCI Thesaurus,,154.0,161.0
SYNTHETIC-6,DONOR_2824,TREATMENT_10324,Cell-based,Keytruda,239766,,IU/kg,178.0,53.0
SYNTHETIC-6,DONOR_2825,TREATMENT_10325,Cell-based,Yervoy,987654,PubChem,mg/kg,127.0,106.0
SYNTHETIC-6,DONOR_2826,TREATMENT_10326,Other immunomodulatory substances,Olaparib,8756456,RxNorm,ug/m2,113.0,114.0
SYNTHETIC-6,DONOR_2827,TREATMENT_10327,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,PubChem,IU/m2,164.0,
SYNTHETIC-6,DONOR_2828,TREATMENT_10328,Other immunomodulatory substances,Cabozantinib,278936,NCI Thesaurus,mg/m2,60.0,70.0
SYNTHETIC-6,DONOR_2829,TREATMENT_10329,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,ug/m2,86.0,82.0
SYNTHETIC-6,DONOR_2830,TREATMENT_10330,Cell-based,Gazyva,,,mg/m2,151.0,
SYNTHETIC-6,DONOR_2831,TREATMENT_10331,Cell-based,Nivolumab,239766,,ug/m2,110.0,180.0
SYNTHETIC-6,DONOR_2832,TREATMENT_10332,Other immunomodulatory substances,Alecensa,4459876,PubChem,IU/m2,148.0,182.0
SYNTHETIC-6,DONOR_2833,TREATMENT_10333,Immune checkpoint inhibitors,,987654,RxNorm,IU/kg,95.0,71.0
SYNTHETIC-6,DONOR_2834,TREATMENT_10334,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,IU/kg,80.0,58.0
SYNTHETIC-6,DONOR_2835,TREATMENT_10335,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,239766,PubChem,g/m2,179.0,108.0
SYNTHETIC-6,DONOR_2836,TREATMENT_10336,Cell-based,Vemurafenib,,,g/m2,103.0,115.0
SYNTHETIC-6,DONOR_2837,TREATMENT_10337,Cell-based,Gilotrif,8836851,NCI Thesaurus,mg/m2,,
SYNTHETIC-6,DONOR_2838,TREATMENT_10338,Cell-based,Imfinzi,,RxNorm,IU/kg,164.0,161.0
SYNTHETIC-6,DONOR_2839,TREATMENT_10339,Immune checkpoint inhibitors,Durvalumab,239766,,IU/kg,152.0,184.0
SYNTHETIC-6,DONOR_2840,TREATMENT_10340,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,,RxNorm,g/m2,,
SYNTHETIC-6,DONOR_2841,TREATMENT_10341,Immune checkpoint inhibitors,Tagrisso,8836851,RxNorm,ug/m2,,
SYNTHETIC-6,DONOR_2842,TREATMENT_10342,Other immunomodulatory substances,Verzenio,239766,RxNorm,,130.0,
SYNTHETIC-6,DONOR_2843,TREATMENT_10343,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,4459876,PubChem,mg/kg,155.0,115.0
SYNTHETIC-6,DONOR_2844,TREATMENT_10344,Cell-based,Ipilimumab,,,mg/kg,53.0,68.0
SYNTHETIC-6,DONOR_2845,TREATMENT_10345,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8836851,PubChem,mg/m2,123.0,103.0
SYNTHETIC-6,DONOR_2846,TREATMENT_10346,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8836851,RxNorm,g/m2,52.0,185.0
SYNTHETIC-6,DONOR_2847,TREATMENT_10347,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,mg/kg,,81.0
SYNTHETIC-6,DONOR_2848,TREATMENT_10348,,Pexidartinib,8756456,PubChem,,143.0,127.0
SYNTHETIC-6,DONOR_2849,TREATMENT_10349,Immune checkpoint inhibitors,Inotuzumab ozogamicin,278936,PubChem,g/m2,129.0,66.0
SYNTHETIC-6,DONOR_2850,TREATMENT_10350,Immune checkpoint inhibitors,Blincyto,4459876,RxNorm,mg/m2,180.0,82.0
SYNTHETIC-6,DONOR_2851,TREATMENT_10351,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,PubChem,cells/kg,101.0,195.0
SYNTHETIC-6,DONOR_2852,TREATMENT_10352,Immune checkpoint inhibitors,Alectinib,8836851,,,133.0,197.0
SYNTHETIC-6,DONOR_2853,TREATMENT_10353,Other immunomodulatory substances,Rituxan,987654,PubChem,g/m2,198.0,103.0
SYNTHETIC-6,DONOR_2854,TREATMENT_10354,Cell-based,Yescarta,278936,NCI Thesaurus,IU/kg,88.0,
SYNTHETIC-6,DONOR_2855,TREATMENT_10355,Immune checkpoint inhibitors,Atezolizumab,,PubChem,cells/kg,108.0,169.0
SYNTHETIC-6,DONOR_2856,TREATMENT_10356,Cell-based,Enhertu,239766,NCI Thesaurus,,109.0,
SYNTHETIC-6,DONOR_2857,TREATMENT_10357,Other immunomodulatory substances,Gilotrif,8836851,,,122.0,146.0
SYNTHETIC-6,DONOR_2858,TREATMENT_10358,Immune checkpoint inhibitors,Kymriah,,PubChem,mg/m2,,166.0
SYNTHETIC-6,DONOR_2859,TREATMENT_10359,Immune checkpoint inhibitors,,8756456,RxNorm,,94.0,89.0
SYNTHETIC-6,DONOR_2860,TREATMENT_10360,Immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,mg/kg,110.0,152.0
SYNTHETIC-6,DONOR_2861,TREATMENT_10361,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,8836851,,mg/kg,169.0,151.0
SYNTHETIC-6,DONOR_2862,TREATMENT_10362,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8836851,RxNorm,cells/kg,186.0,131.0
SYNTHETIC-6,DONOR_2863,TREATMENT_10363,Immune checkpoint inhibitors,Kisqali,4459876,,g/m2,58.0,98.0
SYNTHETIC-6,DONOR_2864,TREATMENT_10364,Other immunomodulatory substances,Durvalumab,278936,PubChem,IU/kg,70.0,156.0
SYNTHETIC-6,DONOR_2865,TREATMENT_10365,Other immunomodulatory substances,Rubraca,239766,RxNorm,cells/kg,170.0,57.0
SYNTHETIC-6,DONOR_2866,TREATMENT_10366,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,cells/kg,126.0,158.0
SYNTHETIC-6,DONOR_2867,TREATMENT_10367,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,PubChem,IU/m2,112.0,123.0
SYNTHETIC-6,DONOR_2868,TREATMENT_10368,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8756456,RxNorm,cells/kg,177.0,
SYNTHETIC-6,DONOR_2869,TREATMENT_10369,Other immunomodulatory substances,Axicabtagene ciloleucel,987654,PubChem,mg/m2,184.0,157.0
SYNTHETIC-6,DONOR_2870,TREATMENT_10370,Other immunomodulatory substances,,278936,RxNorm,mg/kg,66.0,181.0
SYNTHETIC-6,DONOR_2871,TREATMENT_10371,Cell-based,Nexavar,8836851,RxNorm,,,170.0
SYNTHETIC-6,DONOR_2872,TREATMENT_10372,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,987654,,,,197.0
SYNTHETIC-6,DONOR_2873,TREATMENT_10373,Other immunomodulatory substances,Sorafenib,,PubChem,IU/kg,123.0,190.0
SYNTHETIC-6,DONOR_2874,TREATMENT_10374,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,IU/kg,,83.0
SYNTHETIC-6,DONOR_2875,TREATMENT_10375,Other immunomodulatory substances,Mektovi,278936,RxNorm,cells/kg,,
SYNTHETIC-6,DONOR_2876,TREATMENT_10376,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,278936,NCI Thesaurus,,186.0,104.0
SYNTHETIC-6,DONOR_2877,TREATMENT_10377,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,,ug/m2,183.0,
SYNTHETIC-6,DONOR_2878,TREATMENT_10378,Other immunomodulatory substances,Daratumumab,,RxNorm,cells/kg,82.0,168.0
SYNTHETIC-6,DONOR_2879,TREATMENT_10379,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8756456,NCI Thesaurus,ug/m2,,167.0
SYNTHETIC-6,DONOR_2880,TREATMENT_10380,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,278936,NCI Thesaurus,IU/kg,103.0,77.0
SYNTHETIC-6,DONOR_2881,TREATMENT_10381,,Blinatumomab,987654,RxNorm,,138.0,
SYNTHETIC-6,DONOR_2882,TREATMENT_10382,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,PubChem,mg/kg,154.0,
SYNTHETIC-6,DONOR_2883,TREATMENT_10383,Other immunomodulatory substances,Yervoy,987654,PubChem,mg/m2,159.0,184.0
SYNTHETIC-6,DONOR_2884,TREATMENT_10384,Other immunomodulatory substances,Lynparza,239766,NCI Thesaurus,cells/kg,198.0,103.0
SYNTHETIC-6,DONOR_2885,TREATMENT_10385,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,g/m2,63.0,154.0
SYNTHETIC-6,DONOR_2886,TREATMENT_10386,,Blincyto,,RxNorm,mg/m2,,62.0
SYNTHETIC-6,DONOR_2887,TREATMENT_10387,Cell-based,Durvalumab,8836851,PubChem,,,
SYNTHETIC-6,DONOR_2888,TREATMENT_10388,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,278936,NCI Thesaurus,mg/kg,192.0,
SYNTHETIC-6,DONOR_2889,TREATMENT_10389,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,,PubChem,g/m2,55.0,104.0
SYNTHETIC-6,DONOR_2890,TREATMENT_10390,,Sorafenib,987654,NCI Thesaurus,mg/m2,196.0,64.0
SYNTHETIC-6,DONOR_2891,TREATMENT_10391,Cell-based,Yervoy,,,cells/kg,116.0,164.0
SYNTHETIC-6,DONOR_2892,TREATMENT_10392,,Selumitinib,8756456,NCI Thesaurus,cells/kg,154.0,66.0
SYNTHETIC-6,DONOR_2893,TREATMENT_10393,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8836851,PubChem,g/m2,142.0,191.0
SYNTHETIC-6,DONOR_2894,TREATMENT_10394,Cell-based,Cometriq,4459876,RxNorm,cells/kg,181.0,82.0
SYNTHETIC-6,DONOR_2895,TREATMENT_10395,,Yervoy,4459876,PubChem,cells/kg,104.0,
SYNTHETIC-6,DONOR_2896,TREATMENT_10396,,,,NCI Thesaurus,IU/m2,87.0,50.0
SYNTHETIC-6,DONOR_2897,TREATMENT_10397,Other immunomodulatory substances,Kymriah,278936,RxNorm,IU/kg,129.0,128.0
SYNTHETIC-6,DONOR_2898,TREATMENT_10398,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,4459876,,mg/kg,160.0,
SYNTHETIC-6,DONOR_2899,TREATMENT_10399,Immune checkpoint inhibitors,Sorafenib,239766,NCI Thesaurus,ug/m2,173.0,81.0
SYNTHETIC-6,DONOR_2900,TREATMENT_10400,,Enhertu,8756456,RxNorm,ug/m2,197.0,178.0
SYNTHETIC-6,DONOR_2901,TREATMENT_10401,Cell-based,Pertuzumab,4459876,NCI Thesaurus,cells/kg,153.0,81.0
SYNTHETIC-6,DONOR_2902,TREATMENT_10402,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,987654,RxNorm,,,200.0
SYNTHETIC-6,DONOR_2903,TREATMENT_10403,Cell-based,,239766,PubChem,IU/kg,112.0,104.0
SYNTHETIC-6,DONOR_2904,TREATMENT_10404,,Mektovi,8756456,PubChem,ug/m2,62.0,188.0
SYNTHETIC-6,DONOR_2905,TREATMENT_10405,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,4459876,PubChem,,100.0,191.0
SYNTHETIC-6,DONOR_2906,TREATMENT_10406,Immune checkpoint inhibitors,Sorafenib,8836851,PubChem,mg/kg,157.0,60.0
SYNTHETIC-6,DONOR_2907,TREATMENT_10407,Other immunomodulatory substances,Alecensa,987654,NCI Thesaurus,g/m2,196.0,177.0
SYNTHETIC-6,DONOR_2908,TREATMENT_10408,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,239766,RxNorm,ug/m2,135.0,
SYNTHETIC-6,DONOR_2909,TREATMENT_10409,Immune checkpoint inhibitors,Daratumumab,8836851,RxNorm,mg/kg,,
SYNTHETIC-6,DONOR_2910,TREATMENT_10410,Immune checkpoint inhibitors,Trametinib,8836851,,mg/kg,62.0,72.0
SYNTHETIC-6,DONOR_2911,TREATMENT_10411,,Yervoy,278936,PubChem,cells/kg,72.0,53.0
SYNTHETIC-6,DONOR_2912,TREATMENT_10412,Cell-based,,8836851,NCI Thesaurus,ug/m2,100.0,174.0
SYNTHETIC-6,DONOR_2913,TREATMENT_10413,Other immunomodulatory substances,Pembrolizumab,987654,NCI Thesaurus,IU/m2,174.0,106.0
SYNTHETIC-6,DONOR_2914,TREATMENT_10414,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,4459876,NCI Thesaurus,mg/kg,134.0,167.0
SYNTHETIC-6,DONOR_2915,TREATMENT_10415,Immune checkpoint inhibitors,Nivolumab,4459876,NCI Thesaurus,IU/kg,,55.0
SYNTHETIC-6,DONOR_2916,TREATMENT_10416,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,PubChem,mg/m2,157.0,133.0
SYNTHETIC-6,DONOR_2917,TREATMENT_10417,Immune checkpoint inhibitors,Erlotinib,8756456,RxNorm,IU/kg,102.0,166.0
SYNTHETIC-6,DONOR_2918,TREATMENT_10418,Other immunomodulatory substances,Encorafenib,4459876,PubChem,mg/m2,178.0,
SYNTHETIC-6,DONOR_2919,TREATMENT_10419,Immune checkpoint inhibitors,Rucaparib,278936,RxNorm,g/m2,103.0,101.0
SYNTHETIC-6,DONOR_2920,TREATMENT_10420,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,,NCI Thesaurus,mg/kg,68.0,
SYNTHETIC-6,DONOR_2921,TREATMENT_10421,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,NCI Thesaurus,,,137.0
SYNTHETIC-6,DONOR_2922,TREATMENT_10422,,,4459876,PubChem,cells/kg,146.0,
SYNTHETIC-6,DONOR_2923,TREATMENT_10423,Other immunomodulatory substances,Nivolumab,239766,RxNorm,mg/kg,99.0,92.0
SYNTHETIC-6,DONOR_2924,TREATMENT_10424,Cell-based,,8836851,PubChem,mg/m2,107.0,92.0
SYNTHETIC-6,DONOR_2925,TREATMENT_10425,Other immunomodulatory substances,Encorafenib,8756456,NCI Thesaurus,,59.0,159.0
SYNTHETIC-6,DONOR_2926,TREATMENT_10426,Cell-based,Niraparib,987654,RxNorm,g/m2,91.0,123.0
SYNTHETIC-6,DONOR_2927,TREATMENT_10427,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,239766,PubChem,g/m2,166.0,68.0
SYNTHETIC-6,DONOR_2928,TREATMENT_10428,,Encorafenib,4459876,,,60.0,159.0
SYNTHETIC-6,DONOR_2929,TREATMENT_10429,Cell-based,Kisqali,239766,RxNorm,cells/kg,,
SYNTHETIC-6,DONOR_2930,TREATMENT_10430,,Herceptin,8836851,RxNorm,mg/m2,128.0,158.0
SYNTHETIC-6,DONOR_2931,TREATMENT_10431,Other immunomodulatory substances,,278936,,IU/kg,160.0,124.0
SYNTHETIC-6,DONOR_2932,TREATMENT_10432,Cell-based,Verzenio,987654,PubChem,,76.0,119.0
SYNTHETIC-6,DONOR_2933,TREATMENT_10433,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8836851,,cells/kg,56.0,72.0
SYNTHETIC-6,DONOR_2934,TREATMENT_10434,Other immunomodulatory substances,Kisqali,,PubChem,,85.0,178.0
SYNTHETIC-6,DONOR_2935,TREATMENT_10435,Cell-based,Axicabtagene ciloleucel,8756456,PubChem,IU/kg,108.0,
SYNTHETIC-6,DONOR_2936,TREATMENT_10436,Other immunomodulatory substances,,8836851,NCI Thesaurus,IU/kg,64.0,129.0
SYNTHETIC-6,DONOR_2937,TREATMENT_10437,Immune checkpoint inhibitors,Kadcyla,278936,RxNorm,ug/m2,149.0,121.0
SYNTHETIC-6,DONOR_2938,TREATMENT_10438,Other immunomodulatory substances,Atezolizumab,8756456,RxNorm,IU/kg,169.0,171.0
SYNTHETIC-6,DONOR_2939,TREATMENT_10439,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,,116.0,
SYNTHETIC-6,DONOR_2940,TREATMENT_10440,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,8756456,NCI Thesaurus,IU/m2,163.0,107.0
SYNTHETIC-6,DONOR_2941,TREATMENT_10441,Cell-based,Yescarta,278936,RxNorm,mg/m2,190.0,164.0
SYNTHETIC-6,DONOR_2942,TREATMENT_10442,Other immunomodulatory substances,Pexidartinib,8756456,NCI Thesaurus,cells/kg,162.0,
SYNTHETIC-6,DONOR_2943,TREATMENT_10443,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,PubChem,ug/m2,106.0,80.0
SYNTHETIC-6,DONOR_2944,TREATMENT_10444,Immune checkpoint inhibitors,Nivolumab,987654,PubChem,ug/m2,186.0,170.0
SYNTHETIC-6,DONOR_2945,TREATMENT_10445,Cell-based,Blinatumomab,8836851,NCI Thesaurus,,132.0,119.0
SYNTHETIC-6,DONOR_2946,TREATMENT_10446,,Afatinib,8836851,PubChem,ug/m2,60.0,187.0
SYNTHETIC-6,DONOR_2947,TREATMENT_10447,Immune checkpoint inhibitors,Pembrolizumab,8836851,,ug/m2,101.0,141.0
SYNTHETIC-6,DONOR_2948,TREATMENT_10448,Cell-based,Ipilimumab,987654,RxNorm,,120.0,86.0
SYNTHETIC-6,DONOR_2949,TREATMENT_10449,Immune checkpoint inhibitors,Dabrafenib,239766,,IU/m2,55.0,
SYNTHETIC-6,DONOR_2950,TREATMENT_10450,Other immunomodulatory substances,Obinutuzumab,8756456,NCI Thesaurus,IU/kg,134.0,198.0
SYNTHETIC-6,DONOR_2951,TREATMENT_10451,,Nivolumab,987654,RxNorm,,86.0,126.0
SYNTHETIC-6,DONOR_2952,TREATMENT_10452,,Tecentriq,278936,,,151.0,63.0
SYNTHETIC-6,DONOR_2953,TREATMENT_10453,Immune checkpoint inhibitors,Ipilimumab,239766,PubChem,mg/m2,68.0,179.0
SYNTHETIC-6,DONOR_2954,TREATMENT_10454,Other immunomodulatory substances,Rituximab,,NCI Thesaurus,mg/kg,139.0,130.0
SYNTHETIC-6,DONOR_2955,TREATMENT_10455,Cell-based,Crizotinib,8756456,NCI Thesaurus,IU/m2,193.0,172.0
SYNTHETIC-6,DONOR_2956,TREATMENT_10456,Immune checkpoint inhibitors,Rituxan,8756456,NCI Thesaurus,g/m2,94.0,
SYNTHETIC-6,DONOR_2957,TREATMENT_10457,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,8836851,,mg/kg,166.0,82.0
SYNTHETIC-6,DONOR_2958,TREATMENT_10458,Other immunomodulatory substances,Encorafenib,239766,RxNorm,mg/m2,71.0,186.0
SYNTHETIC-6,DONOR_2959,TREATMENT_10459,,Mektovi,4459876,PubChem,g/m2,,130.0
SYNTHETIC-6,DONOR_2960,TREATMENT_10460,Cell-based,Nivolumab,239766,,mg/m2,134.0,160.0
SYNTHETIC-6,DONOR_2961,TREATMENT_10461,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,,mg/m2,161.0,186.0
SYNTHETIC-6,DONOR_2962,TREATMENT_10462,Immune checkpoint inhibitors,Zelboraf,278936,PubChem,g/m2,86.0,
SYNTHETIC-6,DONOR_2963,TREATMENT_10463,Cell-based,,4459876,PubChem,ug/m2,173.0,105.0
SYNTHETIC-6,DONOR_2964,TREATMENT_10464,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,NCI Thesaurus,mg/m2,187.0,
SYNTHETIC-6,DONOR_2965,TREATMENT_10465,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8836851,,mg/m2,169.0,122.0
SYNTHETIC-6,DONOR_2966,TREATMENT_10466,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,RxNorm,mg/m2,57.0,120.0
SYNTHETIC-6,DONOR_2967,TREATMENT_10467,Cell-based,Dabrafenib,987654,PubChem,cells/kg,80.0,
SYNTHETIC-6,DONOR_2968,TREATMENT_10468,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,239766,NCI Thesaurus,IU/m2,,90.0
SYNTHETIC-6,DONOR_2969,TREATMENT_10469,Cell-based,Tecentriq,239766,PubChem,ug/m2,,
SYNTHETIC-6,DONOR_2970,TREATMENT_10470,Immune checkpoint inhibitors,Opdivo,239766,RxNorm,,,149.0
SYNTHETIC-6,DONOR_2971,TREATMENT_10471,Cell-based,Ribociclib,4459876,,ug/m2,117.0,172.0
SYNTHETIC-6,DONOR_2972,TREATMENT_10472,Other immunomodulatory substances,Yescarta,8836851,PubChem,mg/kg,79.0,174.0
SYNTHETIC-6,DONOR_2973,TREATMENT_10473,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,987654,NCI Thesaurus,ug/m2,164.0,
SYNTHETIC-6,DONOR_2974,TREATMENT_10474,Immune checkpoint inhibitors,Keytruda,8756456,RxNorm,mg/m2,65.0,71.0
SYNTHETIC-6,DONOR_2975,TREATMENT_10475,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,239766,PubChem,,62.0,
SYNTHETIC-6,DONOR_2976,TREATMENT_10476,Cell-based,,987654,NCI Thesaurus,,125.0,155.0
SYNTHETIC-6,DONOR_2977,TREATMENT_10477,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,278936,RxNorm,IU/m2,97.0,56.0
SYNTHETIC-6,DONOR_2978,TREATMENT_10478,Immune checkpoint inhibitors,Yervoy,8756456,NCI Thesaurus,g/m2,148.0,
SYNTHETIC-6,DONOR_2979,TREATMENT_10479,,Yervoy,278936,PubChem,cells/kg,183.0,191.0
SYNTHETIC-6,DONOR_2980,TREATMENT_10480,Cell-based,Niraparib,987654,NCI Thesaurus,IU/m2,87.0,78.0
SYNTHETIC-6,DONOR_2981,TREATMENT_10481,Immune checkpoint inhibitors,Nivolumab,239766,,ug/m2,,110.0
SYNTHETIC-6,DONOR_2982,TREATMENT_10482,Cell-based,Inotuzumab ozogamicin,8836851,PubChem,IU/kg,177.0,
SYNTHETIC-6,DONOR_2983,TREATMENT_10483,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,987654,NCI Thesaurus,,98.0,87.0
SYNTHETIC-6,DONOR_2984,TREATMENT_10484,Immune checkpoint inhibitors,Yescarta,4459876,RxNorm,IU/kg,106.0,90.0
SYNTHETIC-6,DONOR_2985,TREATMENT_10485,Cell-based,,8836851,RxNorm,mg/kg,177.0,169.0
SYNTHETIC-6,DONOR_2986,TREATMENT_10486,Other immunomodulatory substances,,239766,RxNorm,mg/kg,121.0,76.0
SYNTHETIC-6,DONOR_2987,TREATMENT_10487,Other immunomodulatory substances,Ipilimumab,8836851,RxNorm,,,105.0
SYNTHETIC-6,DONOR_2988,TREATMENT_10488,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,RxNorm,IU/m2,,85.0
SYNTHETIC-6,DONOR_2989,TREATMENT_10489,Cell-based,Lenvima,8836851,NCI Thesaurus,mg/m2,,64.0
SYNTHETIC-6,DONOR_2990,TREATMENT_10490,Immune checkpoint inhibitors,Tisagenlecleucel,239766,,IU/m2,84.0,138.0
SYNTHETIC-6,DONOR_2991,TREATMENT_10491,Other immunomodulatory substances,Dabrafenib,987654,NCI Thesaurus,cells/kg,109.0,190.0
SYNTHETIC-6,DONOR_2992,TREATMENT_10492,Other immunomodulatory substances,Pembrolizumab,239766,NCI Thesaurus,IU/kg,200.0,156.0
SYNTHETIC-6,DONOR_2993,TREATMENT_10493,,Brentuximab vedotin,8836851,PubChem,mg/m2,187.0,108.0
SYNTHETIC-6,DONOR_2994,TREATMENT_10494,Cell-based,Tafinlar,8836851,RxNorm,,128.0,159.0
SYNTHETIC-6,DONOR_2995,TREATMENT_10495,Other immunomodulatory substances,Tecentriq,8756456,,g/m2,87.0,156.0
SYNTHETIC-6,DONOR_2996,TREATMENT_10496,Other immunomodulatory substances,Tecentriq,987654,RxNorm,cells/kg,61.0,60.0
SYNTHETIC-6,DONOR_2997,TREATMENT_10497,Immune checkpoint inhibitors,Gilotrif,278936,RxNorm,g/m2,115.0,59.0
SYNTHETIC-6,DONOR_2998,TREATMENT_10498,Immune checkpoint inhibitors,Alecensa,278936,PubChem,,56.0,170.0
SYNTHETIC-6,DONOR_2999,TREATMENT_10499,Cell-based,Opdivo,,,IU/kg,188.0,102.0
SYNTHETIC-6,DONOR_3000,TREATMENT_10500,Immune checkpoint inhibitors,Iressa,8756456,NCI Thesaurus,IU/kg,161.0,103.0
SYNTHETIC-6,DONOR_2501,TREATMENT_10501,,Ado-trastuzumab emtansine,,RxNorm,,91.0,187.0
SYNTHETIC-6,DONOR_2502,TREATMENT_10502,Cell-based,,987654,NCI Thesaurus,mg/m2,151.0,179.0
SYNTHETIC-6,DONOR_2503,TREATMENT_10503,Immune checkpoint inhibitors,Lenvima,8756456,RxNorm,cells/kg,,115.0
SYNTHETIC-6,DONOR_2504,TREATMENT_10504,Other immunomodulatory substances,Enhertu,987654,,IU/m2,190.0,90.0
SYNTHETIC-6,DONOR_2505,TREATMENT_10505,Immune checkpoint inhibitors,Yescarta,,NCI Thesaurus,IU/m2,,165.0
SYNTHETIC-6,DONOR_2506,TREATMENT_10506,Cell-based,Trastuzumab,278936,,cells/kg,66.0,
SYNTHETIC-6,DONOR_2507,TREATMENT_10507,Cell-based,Gefitinib,8756456,PubChem,ug/m2,191.0,
SYNTHETIC-6,DONOR_2508,TREATMENT_10508,Immune checkpoint inhibitors,Osimertinib,8836851,RxNorm,g/m2,151.0,190.0
SYNTHETIC-6,DONOR_2509,TREATMENT_10509,Cell-based,Imfinzi,8756456,NCI Thesaurus,g/m2,190.0,159.0
SYNTHETIC-6,DONOR_2510,TREATMENT_10510,Immune checkpoint inhibitors,Rituximab,8836851,NCI Thesaurus,,,139.0
SYNTHETIC-6,DONOR_2511,TREATMENT_10511,Immune checkpoint inhibitors,Dabrafenib,4459876,NCI Thesaurus,,159.0,200.0
SYNTHETIC-6,DONOR_2512,TREATMENT_10512,Immune checkpoint inhibitors,Abemaciclib,4459876,NCI Thesaurus,ug/m2,116.0,50.0
SYNTHETIC-6,DONOR_2513,TREATMENT_10513,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,NCI Thesaurus,IU/m2,57.0,
SYNTHETIC-6,DONOR_2514,TREATMENT_10514,Immune checkpoint inhibitors,Caprelsa,987654,NCI Thesaurus,,77.0,160.0
SYNTHETIC-6,DONOR_2515,TREATMENT_10515,Immune checkpoint inhibitors,Tafinlar,,PubChem,IU/m2,,108.0
SYNTHETIC-6,DONOR_2516,TREATMENT_10516,Immune checkpoint inhibitors,Tecentriq,8756456,PubChem,cells/kg,95.0,115.0
SYNTHETIC-6,DONOR_2517,TREATMENT_10517,Cell-based,Afatinib,4459876,PubChem,IU/kg,197.0,97.0
SYNTHETIC-6,DONOR_2518,TREATMENT_10518,Other immunomodulatory substances,Lynparza,4459876,PubChem,mg/kg,,
SYNTHETIC-6,DONOR_2519,TREATMENT_10519,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,4459876,PubChem,mg/m2,,126.0
SYNTHETIC-6,DONOR_2520,TREATMENT_10520,Immune checkpoint inhibitors,Zelboraf,239766,PubChem,IU/m2,101.0,192.0
SYNTHETIC-6,DONOR_2521,TREATMENT_10521,Immune checkpoint inhibitors,Pembrolizumab,8836851,RxNorm,mg/kg,169.0,182.0
SYNTHETIC-6,DONOR_2522,TREATMENT_10522,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,4459876,PubChem,IU/kg,132.0,161.0
SYNTHETIC-6,DONOR_2523,TREATMENT_10523,Immune checkpoint inhibitors,Besponsa,987654,NCI Thesaurus,cells/kg,189.0,82.0
SYNTHETIC-6,DONOR_2524,TREATMENT_10524,Immune checkpoint inhibitors,Abemaciclib,4459876,NCI Thesaurus,,,
SYNTHETIC-6,DONOR_2525,TREATMENT_10525,Immune checkpoint inhibitors,Opdivo,8756456,RxNorm,ug/m2,,
SYNTHETIC-6,DONOR_2526,TREATMENT_10526,Other immunomodulatory substances,Darzalex,4459876,PubChem,mg/m2,194.0,131.0
SYNTHETIC-6,DONOR_2527,TREATMENT_10527,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,RxNorm,g/m2,79.0,180.0
SYNTHETIC-6,DONOR_2528,TREATMENT_10528,Other immunomodulatory substances,Ipilimumab,8836851,NCI Thesaurus,cells/kg,184.0,155.0
SYNTHETIC-6,DONOR_2529,TREATMENT_10529,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,cells/kg,143.0,107.0
SYNTHETIC-6,DONOR_2530,TREATMENT_10530,,Cometriq,4459876,RxNorm,IU/kg,196.0,55.0
SYNTHETIC-6,DONOR_2531,TREATMENT_10531,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,,RxNorm,,90.0,146.0
SYNTHETIC-6,DONOR_2532,TREATMENT_10532,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,4459876,NCI Thesaurus,ug/m2,52.0,59.0
SYNTHETIC-6,DONOR_2533,TREATMENT_10533,Other immunomodulatory substances,Vandetanib,278936,NCI Thesaurus,mg/m2,130.0,192.0
SYNTHETIC-6,DONOR_2534,TREATMENT_10534,Other immunomodulatory substances,Lenvatinib,8756456,NCI Thesaurus,ug/m2,94.0,54.0
SYNTHETIC-6,DONOR_2535,TREATMENT_10535,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,4459876,PubChem,,51.0,146.0
SYNTHETIC-6,DONOR_2536,TREATMENT_10536,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,239766,RxNorm,g/m2,102.0,151.0
SYNTHETIC-6,DONOR_2537,TREATMENT_10537,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,ug/m2,88.0,136.0
SYNTHETIC-6,DONOR_2538,TREATMENT_10538,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,ug/m2,87.0,
SYNTHETIC-6,DONOR_2539,TREATMENT_10539,Immune checkpoint inhibitors,Lenvatinib,987654,PubChem,mg/kg,,127.0
SYNTHETIC-6,DONOR_2540,TREATMENT_10540,Cell-based,Rucaparib,8756456,NCI Thesaurus,ug/m2,68.0,70.0
SYNTHETIC-6,DONOR_2541,TREATMENT_10541,Other immunomodulatory substances,Alecensa,8836851,RxNorm,mg/kg,57.0,76.0
SYNTHETIC-6,DONOR_2542,TREATMENT_10542,Immune checkpoint inhibitors,Rubraca,8836851,PubChem,IU/m2,,63.0
SYNTHETIC-6,DONOR_2543,TREATMENT_10543,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,8836851,PubChem,mg/kg,,73.0
SYNTHETIC-6,DONOR_2544,TREATMENT_10544,Cell-based,Pembrolizumab,4459876,PubChem,mg/m2,179.0,68.0
SYNTHETIC-6,DONOR_2545,TREATMENT_10545,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,278936,PubChem,mg/m2,110.0,
SYNTHETIC-6,DONOR_2546,TREATMENT_10546,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,4459876,RxNorm,mg/m2,197.0,174.0
SYNTHETIC-6,DONOR_2547,TREATMENT_10547,Other immunomodulatory substances,Brigatinib,,RxNorm,mg/kg,193.0,131.0
SYNTHETIC-6,DONOR_2548,TREATMENT_10548,,Alecensa,239766,PubChem,IU/kg,,
SYNTHETIC-6,DONOR_2549,TREATMENT_10549,,Venetoclax,,NCI Thesaurus,mg/m2,138.0,189.0
SYNTHETIC-6,DONOR_2550,TREATMENT_10550,Other immunomodulatory substances,Adcetris,239766,,g/m2,174.0,156.0
SYNTHETIC-6,DONOR_2551,TREATMENT_10551,Cell-based,,239766,NCI Thesaurus,IU/kg,187.0,79.0
SYNTHETIC-6,DONOR_2552,TREATMENT_10552,Cell-based,,239766,NCI Thesaurus,,98.0,126.0
SYNTHETIC-6,DONOR_2553,TREATMENT_10553,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,987654,,ug/m2,83.0,163.0
SYNTHETIC-6,DONOR_2554,TREATMENT_10554,Other immunomodulatory substances,Afatinib,4459876,NCI Thesaurus,cells/kg,72.0,
SYNTHETIC-6,DONOR_2555,TREATMENT_10555,Other immunomodulatory substances,Pertuzumab,278936,NCI Thesaurus,g/m2,179.0,108.0
SYNTHETIC-6,DONOR_2556,TREATMENT_10556,Other immunomodulatory substances,Vandetanib,8836851,PubChem,,140.0,160.0
SYNTHETIC-6,DONOR_2557,TREATMENT_10557,Cell-based,Copanlisib,239766,PubChem,,174.0,71.0
SYNTHETIC-6,DONOR_2558,TREATMENT_10558,Immune checkpoint inhibitors,Darzalex,8756456,NCI Thesaurus,IU/kg,102.0,158.0
SYNTHETIC-6,DONOR_2559,TREATMENT_10559,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,mg/kg,122.0,130.0
SYNTHETIC-6,DONOR_2560,TREATMENT_10560,Immune checkpoint inhibitors,Ceritinib,4459876,PubChem,ug/m2,175.0,126.0
SYNTHETIC-6,DONOR_2561,TREATMENT_10561,Immune checkpoint inhibitors,Zejula,8756456,NCI Thesaurus,mg/m2,198.0,128.0
SYNTHETIC-6,DONOR_2562,TREATMENT_10562,Cell-based,Opdivo,278936,RxNorm,cells/kg,187.0,126.0
SYNTHETIC-6,DONOR_2563,TREATMENT_10563,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,,IU/m2,,69.0
SYNTHETIC-6,DONOR_2564,TREATMENT_10564,Other immunomodulatory substances,Niraparib,278936,,IU/m2,151.0,194.0
SYNTHETIC-6,DONOR_2565,TREATMENT_10565,Other immunomodulatory substances,Gilotrif,278936,PubChem,g/m2,,154.0
SYNTHETIC-6,DONOR_2566,TREATMENT_10566,Other immunomodulatory substances,Pembrolizumab,278936,NCI Thesaurus,IU/kg,52.0,195.0
SYNTHETIC-6,DONOR_2567,TREATMENT_10567,Cell-based,Kymriah,,RxNorm,g/m2,148.0,95.0
SYNTHETIC-6,DONOR_2568,TREATMENT_10568,,,278936,RxNorm,IU/m2,188.0,99.0
SYNTHETIC-6,DONOR_2569,TREATMENT_10569,Cell-based,Zelboraf,4459876,NCI Thesaurus,IU/kg,179.0,79.0
SYNTHETIC-6,DONOR_2570,TREATMENT_10570,Cell-based,Darzalex,8756456,RxNorm,IU/kg,,188.0
SYNTHETIC-6,DONOR_2571,TREATMENT_10571,Other immunomodulatory substances,Perjeta,8836851,RxNorm,mg/m2,169.0,143.0
SYNTHETIC-6,DONOR_2572,TREATMENT_10572,Immune checkpoint inhibitors,Cobimetinib,4459876,RxNorm,ug/m2,67.0,137.0
SYNTHETIC-6,DONOR_2573,TREATMENT_10573,Other immunomodulatory substances,Cotellic,278936,PubChem,IU/kg,138.0,133.0
SYNTHETIC-6,DONOR_2574,TREATMENT_10574,Immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,58.0,140.0
SYNTHETIC-6,DONOR_2575,TREATMENT_10575,Cell-based,Dabrafenib,8756456,RxNorm,cells/kg,121.0,
SYNTHETIC-6,DONOR_2576,TREATMENT_10576,Cell-based,,239766,NCI Thesaurus,IU/m2,113.0,117.0
SYNTHETIC-6,DONOR_2577,TREATMENT_10577,Other immunomodulatory substances,Mektovi,4459876,RxNorm,cells/kg,125.0,63.0
SYNTHETIC-6,DONOR_2578,TREATMENT_10578,Immune checkpoint inhibitors,Tisagenlecleucel,8836851,RxNorm,ug/m2,83.0,110.0
SYNTHETIC-6,DONOR_2579,TREATMENT_10579,Other immunomodulatory substances,Enhertu,,RxNorm,ug/m2,133.0,189.0
SYNTHETIC-6,DONOR_2580,TREATMENT_10580,Cell-based,Alunbrig,4459876,RxNorm,mg/m2,53.0,181.0
SYNTHETIC-6,DONOR_2581,TREATMENT_10581,Other immunomodulatory substances,Opdivo,278936,,IU/kg,63.0,102.0
SYNTHETIC-6,DONOR_2582,TREATMENT_10582,,Alecensa,278936,NCI Thesaurus,g/m2,94.0,
SYNTHETIC-6,DONOR_2583,TREATMENT_10583,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,987654,NCI Thesaurus,cells/kg,60.0,173.0
SYNTHETIC-6,DONOR_2584,TREATMENT_10584,Cell-based,,8836851,RxNorm,mg/m2,105.0,104.0
SYNTHETIC-6,DONOR_2585,TREATMENT_10585,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,8836851,RxNorm,mg/kg,,191.0
SYNTHETIC-6,DONOR_2586,TREATMENT_10586,,Pembrolizumab,4459876,NCI Thesaurus,IU/kg,197.0,109.0
SYNTHETIC-6,DONOR_2587,TREATMENT_10587,Cell-based,Imfinzi,8756456,,IU/m2,189.0,121.0
SYNTHETIC-6,DONOR_2588,TREATMENT_10588,Other immunomodulatory substances,Pembrolizumab,,PubChem,IU/kg,148.0,78.0
SYNTHETIC-6,DONOR_2589,TREATMENT_10589,Other immunomodulatory substances,Ipilimumab,239766,PubChem,ug/m2,70.0,
SYNTHETIC-6,DONOR_2590,TREATMENT_10590,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,,,IU/m2,177.0,152.0
SYNTHETIC-6,DONOR_2591,TREATMENT_10591,Other immunomodulatory substances,Ibrance,8836851,RxNorm,IU/kg,,173.0
SYNTHETIC-6,DONOR_2592,TREATMENT_10592,Other immunomodulatory substances,Trastuzumab,8756456,,mg/m2,145.0,197.0
SYNTHETIC-6,DONOR_2593,TREATMENT_10593,,Cotellic,8836851,PubChem,,58.0,151.0
SYNTHETIC-6,DONOR_2594,TREATMENT_10594,Other immunomodulatory substances,Xalkori,278936,NCI Thesaurus,mg/m2,165.0,163.0
SYNTHETIC-6,DONOR_2595,TREATMENT_10595,Other immunomodulatory substances,Tecentriq,4459876,PubChem,ug/m2,52.0,
SYNTHETIC-6,DONOR_2596,TREATMENT_10596,Other immunomodulatory substances,Ibrance,278936,NCI Thesaurus,IU/m2,69.0,181.0
SYNTHETIC-6,DONOR_2597,TREATMENT_10597,Cell-based,Copanlisib,,NCI Thesaurus,IU/kg,95.0,137.0
SYNTHETIC-6,DONOR_2598,TREATMENT_10598,Other immunomodulatory substances,Inotuzumab ozogamicin,8836851,NCI Thesaurus,cells/kg,112.0,166.0
SYNTHETIC-6,DONOR_2599,TREATMENT_10599,Immune checkpoint inhibitors,Crizotinib,,RxNorm,IU/m2,80.0,
SYNTHETIC-6,DONOR_2600,TREATMENT_10600,Immune checkpoint inhibitors,Trametinib,987654,RxNorm,cells/kg,154.0,101.0
SYNTHETIC-6,DONOR_2601,TREATMENT_10601,Other immunomodulatory substances,,8836851,PubChem,IU/kg,,122.0
SYNTHETIC-6,DONOR_2602,TREATMENT_10602,Immune checkpoint inhibitors,Durvalumab,8756456,PubChem,mg/m2,83.0,56.0
SYNTHETIC-6,DONOR_2603,TREATMENT_10603,Cell-based,Tecentriq,4459876,PubChem,IU/kg,96.0,70.0
SYNTHETIC-6,DONOR_2604,TREATMENT_10604,Other immunomodulatory substances,Durvalumab,,NCI Thesaurus,mg/m2,,163.0
SYNTHETIC-6,DONOR_2605,TREATMENT_10605,Immune checkpoint inhibitors,Gefitinib,987654,RxNorm,mg/m2,,138.0
SYNTHETIC-6,DONOR_2606,TREATMENT_10606,,Yervoy,8836851,RxNorm,mg/kg,171.0,90.0
SYNTHETIC-6,DONOR_2607,TREATMENT_10607,,Trametinib,987654,PubChem,mg/kg,,66.0
SYNTHETIC-6,DONOR_2608,TREATMENT_10608,Cell-based,Ipilimumab,,RxNorm,g/m2,154.0,141.0
SYNTHETIC-6,DONOR_2609,TREATMENT_10609,Other immunomodulatory substances,Xalkori,4459876,PubChem,mg/kg,,
SYNTHETIC-6,DONOR_2610,TREATMENT_10610,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,8836851,NCI Thesaurus,cells/kg,188.0,96.0
SYNTHETIC-6,DONOR_2611,TREATMENT_10611,Cell-based,Perjeta,8756456,PubChem,,142.0,
SYNTHETIC-6,DONOR_2612,TREATMENT_10612,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,987654,RxNorm,cells/kg,61.0,105.0
SYNTHETIC-6,DONOR_2613,TREATMENT_10613,,Brentuximab vedotin,278936,RxNorm,,121.0,200.0
SYNTHETIC-6,DONOR_2614,TREATMENT_10614,Other immunomodulatory substances,Yervoy,,RxNorm,IU/kg,,103.0
SYNTHETIC-6,DONOR_2615,TREATMENT_10615,Other immunomodulatory substances,Atezolizumab,8836851,PubChem,mg/kg,80.0,127.0
SYNTHETIC-6,DONOR_2616,TREATMENT_10616,Immune checkpoint inhibitors,Kadcyla,239766,,mg/kg,199.0,
SYNTHETIC-6,DONOR_2617,TREATMENT_10617,Immune checkpoint inhibitors,Daratumumab,4459876,RxNorm,g/m2,59.0,145.0
SYNTHETIC-6,DONOR_2618,TREATMENT_10618,Other immunomodulatory substances,Yescarta,8756456,RxNorm,ug/m2,82.0,79.0
SYNTHETIC-6,DONOR_2619,TREATMENT_10619,Immune checkpoint inhibitors,,239766,PubChem,mg/kg,169.0,172.0
SYNTHETIC-6,DONOR_2620,TREATMENT_10620,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,4459876,PubChem,IU/kg,124.0,144.0
SYNTHETIC-6,DONOR_2621,TREATMENT_10621,Immune checkpoint inhibitors,Enhertu,278936,PubChem,,87.0,73.0
SYNTHETIC-6,DONOR_2622,TREATMENT_10622,Immune checkpoint inhibitors,Rubraca,8756456,NCI Thesaurus,,61.0,73.0
SYNTHETIC-6,DONOR_2623,TREATMENT_10623,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,4459876,RxNorm,mg/kg,180.0,178.0
SYNTHETIC-6,DONOR_2624,TREATMENT_10624,Immune checkpoint inhibitors,Gazyva,,RxNorm,mg/m2,149.0,159.0
SYNTHETIC-6,DONOR_2625,TREATMENT_10625,Other immunomodulatory substances,,8836851,NCI Thesaurus,cells/kg,66.0,117.0
SYNTHETIC-6,DONOR_2626,TREATMENT_10626,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,4459876,RxNorm,mg/m2,101.0,99.0
SYNTHETIC-6,DONOR_2627,TREATMENT_10627,Other immunomodulatory substances,Tarceva,8756456,RxNorm,ug/m2,104.0,
SYNTHETIC-6,DONOR_2628,TREATMENT_10628,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,cells/kg,71.0,53.0
SYNTHETIC-6,DONOR_2629,TREATMENT_10629,Other immunomodulatory substances,Yescarta,239766,RxNorm,mg/kg,,84.0
SYNTHETIC-6,DONOR_2630,TREATMENT_10630,,Brigatinib,8836851,,cells/kg,85.0,137.0
SYNTHETIC-6,DONOR_2631,TREATMENT_10631,Cell-based,Mekinist,4459876,NCI Thesaurus,,184.0,159.0
SYNTHETIC-6,DONOR_2632,TREATMENT_10632,Cell-based,Alunbrig,278936,PubChem,ug/m2,90.0,103.0
SYNTHETIC-6,DONOR_2633,TREATMENT_10633,Cell-based,Trametinib,4459876,PubChem,g/m2,,124.0
SYNTHETIC-6,DONOR_2634,TREATMENT_10634,Cell-based,Crizotinib,8756456,RxNorm,mg/m2,98.0,84.0
SYNTHETIC-6,DONOR_2635,TREATMENT_10635,Immune checkpoint inhibitors,,,PubChem,cells/kg,73.0,186.0
SYNTHETIC-6,DONOR_2636,TREATMENT_10636,Other immunomodulatory substances,Venclexta,8756456,NCI Thesaurus,,146.0,127.0
SYNTHETIC-6,DONOR_2637,TREATMENT_10637,,Darzalex,278936,PubChem,,84.0,73.0
SYNTHETIC-6,DONOR_2638,TREATMENT_10638,Cell-based,Venetoclax,987654,NCI Thesaurus,IU/m2,111.0,155.0
SYNTHETIC-6,DONOR_2639,TREATMENT_10639,,Keytruda,239766,,mg/m2,67.0,127.0
SYNTHETIC-6,DONOR_2640,TREATMENT_10640,Cell-based,Iressa,,PubChem,,193.0,177.0
SYNTHETIC-6,DONOR_2641,TREATMENT_10641,Cell-based,Opdivo,8836851,,,181.0,51.0
SYNTHETIC-6,DONOR_2642,TREATMENT_10642,Cell-based,Ipilimumab,987654,PubChem,mg/kg,62.0,103.0
SYNTHETIC-6,DONOR_2643,TREATMENT_10643,Other immunomodulatory substances,Yescarta,239766,PubChem,g/m2,176.0,171.0
SYNTHETIC-6,DONOR_2644,TREATMENT_10644,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8836851,,IU/kg,129.0,192.0
SYNTHETIC-6,DONOR_2645,TREATMENT_10645,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,g/m2,172.0,125.0
SYNTHETIC-6,DONOR_2646,TREATMENT_10646,Cell-based,,4459876,PubChem,ug/m2,160.0,74.0
SYNTHETIC-6,DONOR_2647,TREATMENT_10647,Immune checkpoint inhibitors,Enhertu,239766,PubChem,ug/m2,73.0,192.0
SYNTHETIC-6,DONOR_2648,TREATMENT_10648,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8836851,RxNorm,IU/m2,70.0,
SYNTHETIC-6,DONOR_2649,TREATMENT_10649,,Ribociclib,8836851,PubChem,IU/m2,122.0,109.0
SYNTHETIC-6,DONOR_2650,TREATMENT_10650,Cell-based,Kisqali,278936,RxNorm,IU/kg,,
SYNTHETIC-6,DONOR_2651,TREATMENT_10651,Other immunomodulatory substances,Rituxan,8836851,RxNorm,ug/m2,73.0,199.0
SYNTHETIC-6,DONOR_2652,TREATMENT_10652,Immune checkpoint inhibitors,Enhertu,8756456,RxNorm,,71.0,89.0
SYNTHETIC-6,DONOR_2653,TREATMENT_10653,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8836851,PubChem,cells/kg,87.0,
SYNTHETIC-6,DONOR_2654,TREATMENT_10654,Cell-based,Adcetris,4459876,NCI Thesaurus,cells/kg,149.0,96.0
SYNTHETIC-6,DONOR_2655,TREATMENT_10655,Other immunomodulatory substances,Brigatinib,278936,,mg/m2,88.0,56.0
SYNTHETIC-6,DONOR_2656,TREATMENT_10656,Cell-based,Lenvatinib,8836851,RxNorm,IU/m2,198.0,99.0
SYNTHETIC-6,DONOR_2657,TREATMENT_10657,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,PubChem,IU/m2,,187.0
SYNTHETIC-6,DONOR_2658,TREATMENT_10658,Cell-based,Tagrisso,,NCI Thesaurus,,154.0,87.0
SYNTHETIC-6,DONOR_2659,TREATMENT_10659,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,,PubChem,mg/m2,87.0,189.0
SYNTHETIC-6,DONOR_2660,TREATMENT_10660,Cell-based,Nivolumab,4459876,NCI Thesaurus,IU/m2,72.0,139.0
SYNTHETIC-6,DONOR_2661,TREATMENT_10661,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,239766,RxNorm,ug/m2,155.0,103.0
SYNTHETIC-6,DONOR_2662,TREATMENT_10662,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,987654,RxNorm,IU/kg,158.0,112.0
SYNTHETIC-6,DONOR_2663,TREATMENT_10663,Cell-based,Atezolizumab,987654,RxNorm,g/m2,78.0,99.0
SYNTHETIC-6,DONOR_2664,TREATMENT_10664,Cell-based,Verzenio,239766,NCI Thesaurus,IU/kg,149.0,174.0
SYNTHETIC-6,DONOR_2665,TREATMENT_10665,Cell-based,,278936,NCI Thesaurus,mg/m2,61.0,185.0
SYNTHETIC-6,DONOR_2666,TREATMENT_10666,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,cells/kg,124.0,146.0
SYNTHETIC-6,DONOR_2667,TREATMENT_10667,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,239766,NCI Thesaurus,IU/kg,80.0,154.0
SYNTHETIC-6,DONOR_2668,TREATMENT_10668,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,278936,PubChem,,53.0,
SYNTHETIC-6,DONOR_2669,TREATMENT_10669,Cell-based,,987654,RxNorm,IU/kg,150.0,116.0
SYNTHETIC-6,DONOR_2670,TREATMENT_10670,Other immunomodulatory substances,Tecentriq,8836851,RxNorm,mg/m2,66.0,150.0
SYNTHETIC-6,DONOR_2671,TREATMENT_10671,Immune checkpoint inhibitors,Erlotinib,4459876,PubChem,g/m2,119.0,111.0
SYNTHETIC-6,DONOR_2672,TREATMENT_10672,Immune checkpoint inhibitors,Nexavar,239766,RxNorm,mg/kg,53.0,
SYNTHETIC-6,DONOR_2673,TREATMENT_10673,Cell-based,Encorafenib,4459876,,,183.0,181.0
SYNTHETIC-6,DONOR_2674,TREATMENT_10674,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,278936,RxNorm,ug/m2,140.0,
SYNTHETIC-6,DONOR_2675,TREATMENT_10675,Other immunomodulatory substances,Pembrolizumab,239766,RxNorm,,68.0,69.0
SYNTHETIC-6,DONOR_2676,TREATMENT_10676,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,239766,RxNorm,IU/kg,63.0,196.0
SYNTHETIC-6,DONOR_2677,TREATMENT_10677,Cell-based,Pexidartinib,239766,NCI Thesaurus,cells/kg,83.0,158.0
SYNTHETIC-6,DONOR_2678,TREATMENT_10678,Immune checkpoint inhibitors,,278936,RxNorm,,,51.0
SYNTHETIC-6,DONOR_2679,TREATMENT_10679,Immune checkpoint inhibitors,Ibrance,,NCI Thesaurus,ug/m2,62.0,
SYNTHETIC-6,DONOR_2680,TREATMENT_10680,Cell-based,Tarceva,987654,RxNorm,g/m2,,171.0
SYNTHETIC-6,DONOR_2681,TREATMENT_10681,Immune checkpoint inhibitors,Cabozantinib,8836851,NCI Thesaurus,g/m2,116.0,131.0
SYNTHETIC-6,DONOR_2682,TREATMENT_10682,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,987654,PubChem,IU/kg,200.0,124.0
SYNTHETIC-6,DONOR_2683,TREATMENT_10683,Other immunomodulatory substances,Ribociclib,239766,RxNorm,g/m2,149.0,
SYNTHETIC-6,DONOR_2684,TREATMENT_10684,,,8756456,RxNorm,IU/kg,62.0,96.0
SYNTHETIC-6,DONOR_2685,TREATMENT_10685,Cell-based,Imfinzi,987654,RxNorm,g/m2,116.0,
SYNTHETIC-6,DONOR_2686,TREATMENT_10686,,Gazyva,278936,PubChem,mg/m2,185.0,84.0
SYNTHETIC-6,DONOR_2687,TREATMENT_10687,Cell-based,Braftovi,4459876,NCI Thesaurus,mg/m2,150.0,180.0
SYNTHETIC-6,DONOR_2688,TREATMENT_10688,Immune checkpoint inhibitors,Tagrisso,278936,RxNorm,cells/kg,,118.0
SYNTHETIC-6,DONOR_2689,TREATMENT_10689,,Necitumumab,4459876,,IU/m2,188.0,123.0
SYNTHETIC-6,DONOR_2690,TREATMENT_10690,Cell-based,Pembrolizumab,987654,,,115.0,79.0
SYNTHETIC-6,DONOR_2691,TREATMENT_10691,Immune checkpoint inhibitors,Yervoy,987654,NCI Thesaurus,IU/m2,128.0,78.0
SYNTHETIC-6,DONOR_2692,TREATMENT_10692,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,ug/m2,187.0,122.0
SYNTHETIC-6,DONOR_2693,TREATMENT_10693,Immune checkpoint inhibitors,Besponsa,4459876,PubChem,mg/m2,117.0,171.0
SYNTHETIC-6,DONOR_2694,TREATMENT_10694,Immune checkpoint inhibitors,Durvalumab,987654,NCI Thesaurus,mg/m2,158.0,
SYNTHETIC-6,DONOR_2695,TREATMENT_10695,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,8756456,,g/m2,101.0,96.0
SYNTHETIC-6,DONOR_2696,TREATMENT_10696,,Vandetanib,4459876,RxNorm,mg/kg,124.0,52.0
SYNTHETIC-6,DONOR_2697,TREATMENT_10697,,Venclexta,278936,,mg/m2,129.0,97.0
SYNTHETIC-6,DONOR_2698,TREATMENT_10698,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,278936,NCI Thesaurus,mg/kg,50.0,
SYNTHETIC-6,DONOR_2699,TREATMENT_10699,Cell-based,Keytruda,239766,RxNorm,,58.0,
SYNTHETIC-6,DONOR_2700,TREATMENT_10700,,Atezolizumab,,PubChem,g/m2,52.0,130.0
SYNTHETIC-6,DONOR_2701,TREATMENT_10701,Other immunomodulatory substances,Trastuzumab,8756456,,cells/kg,105.0,53.0
SYNTHETIC-6,DONOR_2702,TREATMENT_10702,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,,131.0,
SYNTHETIC-6,DONOR_2703,TREATMENT_10703,Cell-based,Alecensa,278936,RxNorm,g/m2,95.0,185.0
SYNTHETIC-6,DONOR_2704,TREATMENT_10704,Cell-based,Venclexta,278936,RxNorm,mg/m2,54.0,151.0
SYNTHETIC-6,DONOR_2705,TREATMENT_10705,Cell-based,Opdivo,4459876,PubChem,IU/kg,78.0,
SYNTHETIC-6,DONOR_2706,TREATMENT_10706,Immune checkpoint inhibitors,Cometriq,,RxNorm,mg/kg,128.0,67.0
SYNTHETIC-6,DONOR_2707,TREATMENT_10707,Cell-based,,278936,RxNorm,IU/m2,164.0,159.0
SYNTHETIC-6,DONOR_2708,TREATMENT_10708,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,,126.0,
SYNTHETIC-6,DONOR_2709,TREATMENT_10709,Immune checkpoint inhibitors,Ceritinib,,,mg/m2,191.0,
SYNTHETIC-6,DONOR_2710,TREATMENT_10710,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,4459876,,mg/m2,200.0,61.0
SYNTHETIC-6,DONOR_2711,TREATMENT_10711,Cell-based,Durvalumab,987654,PubChem,IU/kg,74.0,95.0
SYNTHETIC-6,DONOR_2712,TREATMENT_10712,Cell-based,,278936,NCI Thesaurus,IU/m2,84.0,73.0
SYNTHETIC-6,DONOR_2713,TREATMENT_10713,Other immunomodulatory substances,Yervoy,278936,RxNorm,IU/kg,93.0,74.0
SYNTHETIC-6,DONOR_2714,TREATMENT_10714,Other immunomodulatory substances,Ipilimumab,239766,RxNorm,mg/kg,170.0,144.0
SYNTHETIC-6,DONOR_2715,TREATMENT_10715,Other immunomodulatory substances,Yervoy,987654,PubChem,cells/kg,74.0,161.0
SYNTHETIC-6,DONOR_2716,TREATMENT_10716,Other immunomodulatory substances,Tecentriq,4459876,PubChem,IU/kg,84.0,143.0
SYNTHETIC-6,DONOR_2717,TREATMENT_10717,Cell-based,Ribociclib,8756456,PubChem,ug/m2,53.0,54.0
SYNTHETIC-6,DONOR_2718,TREATMENT_10718,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,278936,RxNorm,IU/kg,59.0,128.0
SYNTHETIC-6,DONOR_2719,TREATMENT_10719,Cell-based,Pembrolizumab,8836851,PubChem,ug/m2,,99.0
SYNTHETIC-6,DONOR_2720,TREATMENT_10720,Other immunomodulatory substances,,987654,RxNorm,IU/kg,118.0,132.0
SYNTHETIC-6,DONOR_2721,TREATMENT_10721,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,8756456,,IU/kg,74.0,180.0
SYNTHETIC-6,DONOR_2722,TREATMENT_10722,Other immunomodulatory substances,Gazyva,8836851,RxNorm,cells/kg,199.0,179.0
SYNTHETIC-6,DONOR_2723,TREATMENT_10723,Cell-based,Pembrolizumab,,RxNorm,g/m2,77.0,114.0
SYNTHETIC-6,DONOR_2724,TREATMENT_10724,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,4459876,RxNorm,ug/m2,84.0,
SYNTHETIC-6,DONOR_2725,TREATMENT_10725,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,8756456,PubChem,cells/kg,131.0,73.0
SYNTHETIC-6,DONOR_2726,TREATMENT_10726,Cell-based,Daratumumab,987654,PubChem,IU/kg,,
SYNTHETIC-6,DONOR_2727,TREATMENT_10727,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,987654,RxNorm,mg/m2,199.0,197.0
SYNTHETIC-6,DONOR_2728,TREATMENT_10728,Cell-based,Tafinlar,,NCI Thesaurus,g/m2,175.0,197.0
SYNTHETIC-6,DONOR_2729,TREATMENT_10729,Immune checkpoint inhibitors,Gazyva,,RxNorm,cells/kg,154.0,192.0
SYNTHETIC-6,DONOR_2730,TREATMENT_10730,Cell-based,Daratumumab,8756456,,,80.0,140.0
SYNTHETIC-6,DONOR_2731,TREATMENT_10731,Immune checkpoint inhibitors,Pembrolizumab,8756456,,mg/m2,188.0,157.0
SYNTHETIC-6,DONOR_2732,TREATMENT_10732,Cell-based,Trastuzumab,8836851,RxNorm,cells/kg,108.0,169.0
SYNTHETIC-6,DONOR_2733,TREATMENT_10733,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,4459876,RxNorm,mg/kg,110.0,181.0
SYNTHETIC-6,DONOR_2734,TREATMENT_10734,Immune checkpoint inhibitors,Cometriq,8836851,RxNorm,IU/kg,142.0,89.0
SYNTHETIC-6,DONOR_2735,TREATMENT_10735,Immune checkpoint inhibitors,Rituximab,8756456,,IU/kg,,
SYNTHETIC-6,DONOR_2736,TREATMENT_10736,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,RxNorm,IU/m2,136.0,175.0
SYNTHETIC-6,DONOR_2737,TREATMENT_10737,Cell-based,Keytruda,278936,RxNorm,,186.0,149.0
SYNTHETIC-6,DONOR_2738,TREATMENT_10738,Other immunomodulatory substances,Zykadia,8756456,PubChem,mg/m2,,
SYNTHETIC-6,DONOR_2739,TREATMENT_10739,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,,IU/m2,108.0,168.0
SYNTHETIC-6,DONOR_2740,TREATMENT_10740,Other immunomodulatory substances,Imfinzi,8756456,RxNorm,IU/kg,92.0,101.0
SYNTHETIC-6,DONOR_2741,TREATMENT_10741,Other immunomodulatory substances,Xalkori,278936,NCI Thesaurus,IU/kg,96.0,72.0
SYNTHETIC-6,DONOR_2742,TREATMENT_10742,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,cells/kg,96.0,56.0
SYNTHETIC-6,DONOR_2743,TREATMENT_10743,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,IU/m2,176.0,142.0
SYNTHETIC-6,DONOR_2744,TREATMENT_10744,,Palbociclib,8836851,,IU/m2,166.0,200.0
SYNTHETIC-6,DONOR_2745,TREATMENT_10745,Other immunomodulatory substances,Keytruda,8836851,NCI Thesaurus,g/m2,93.0,133.0
SYNTHETIC-6,DONOR_2746,TREATMENT_10746,Immune checkpoint inhibitors,Durvalumab,4459876,PubChem,,136.0,118.0
SYNTHETIC-6,DONOR_2747,TREATMENT_10747,,Atezolizumab,,NCI Thesaurus,mg/m2,149.0,114.0
SYNTHETIC-6,DONOR_2748,TREATMENT_10748,Cell-based,Yervoy,8836851,RxNorm,ug/m2,125.0,177.0
SYNTHETIC-6,DONOR_2749,TREATMENT_10749,Cell-based,Alectinib,8836851,PubChem,mg/kg,54.0,170.0
SYNTHETIC-6,DONOR_2750,TREATMENT_10750,Cell-based,Alunbrig,278936,PubChem,,114.0,
SYNTHETIC-6,DONOR_2751,TREATMENT_10751,Other immunomodulatory substances,,,NCI Thesaurus,ug/m2,79.0,77.0
SYNTHETIC-6,DONOR_2752,TREATMENT_10752,Cell-based,Gazyva,239766,PubChem,cells/kg,55.0,
SYNTHETIC-6,DONOR_2753,TREATMENT_10753,Immune checkpoint inhibitors,Herceptin,987654,RxNorm,mg/m2,,
SYNTHETIC-6,DONOR_2754,TREATMENT_10754,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,PubChem,IU/m2,194.0,168.0
SYNTHETIC-6,DONOR_2755,TREATMENT_10755,Cell-based,Cotellic,278936,PubChem,mg/m2,189.0,154.0
SYNTHETIC-6,DONOR_2756,TREATMENT_10756,,Binimetinib,8836851,PubChem,mg/m2,76.0,171.0
SYNTHETIC-6,DONOR_2757,TREATMENT_10757,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,278936,PubChem,ug/m2,116.0,188.0
SYNTHETIC-6,DONOR_2758,TREATMENT_10758,Immune checkpoint inhibitors,Kisqali,8756456,RxNorm,mg/kg,171.0,113.0
SYNTHETIC-6,DONOR_2759,TREATMENT_10759,Immune checkpoint inhibitors,Lynparza,278936,PubChem,mg/m2,129.0,108.0
SYNTHETIC-6,DONOR_2760,TREATMENT_10760,Cell-based,Yervoy,8836851,RxNorm,g/m2,82.0,56.0
SYNTHETIC-6,DONOR_2761,TREATMENT_10761,Cell-based,Sorafenib,239766,RxNorm,ug/m2,124.0,186.0
SYNTHETIC-6,DONOR_2762,TREATMENT_10762,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,,PubChem,mg/m2,115.0,97.0
SYNTHETIC-6,DONOR_2763,TREATMENT_10763,,Pertuzumab,,,cells/kg,151.0,147.0
SYNTHETIC-6,DONOR_2764,TREATMENT_10764,,Tecentriq,,RxNorm,IU/kg,,147.0
SYNTHETIC-6,DONOR_2765,TREATMENT_10765,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,,IU/m2,153.0,166.0
SYNTHETIC-6,DONOR_2766,TREATMENT_10766,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,987654,NCI Thesaurus,ug/m2,69.0,146.0
SYNTHETIC-6,DONOR_2767,TREATMENT_10767,Immune checkpoint inhibitors,Rituximab,8836851,NCI Thesaurus,mg/kg,,170.0
SYNTHETIC-6,DONOR_2768,TREATMENT_10768,Other immunomodulatory substances,Herceptin,987654,NCI Thesaurus,g/m2,,123.0
SYNTHETIC-6,DONOR_2769,TREATMENT_10769,Other immunomodulatory substances,Rituxan,278936,,g/m2,73.0,
SYNTHETIC-6,DONOR_2770,TREATMENT_10770,Cell-based,Trametinib,239766,RxNorm,,186.0,165.0
SYNTHETIC-6,DONOR_2771,TREATMENT_10771,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,987654,RxNorm,g/m2,,78.0
SYNTHETIC-6,DONOR_2772,TREATMENT_10772,Other immunomodulatory substances,Darzalex,8836851,PubChem,,64.0,163.0
SYNTHETIC-6,DONOR_2773,TREATMENT_10773,Immune checkpoint inhibitors,Keytruda,239766,NCI Thesaurus,mg/m2,104.0,95.0
SYNTHETIC-6,DONOR_2774,TREATMENT_10774,Cell-based,Imfinzi,987654,NCI Thesaurus,mg/m2,114.0,158.0
SYNTHETIC-6,DONOR_2775,TREATMENT_10775,Immune checkpoint inhibitors,Atezolizumab,278936,PubChem,mg/kg,,137.0
SYNTHETIC-6,DONOR_2776,TREATMENT_10776,,Nivolumab,8836851,,cells/kg,127.0,98.0
SYNTHETIC-6,DONOR_2777,TREATMENT_10777,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,,106.0,102.0
SYNTHETIC-6,DONOR_2778,TREATMENT_10778,Other immunomodulatory substances,Cabozantinib,,NCI Thesaurus,g/m2,98.0,139.0
SYNTHETIC-6,DONOR_2779,TREATMENT_10779,Cell-based,Enhertu,8836851,RxNorm,,174.0,
SYNTHETIC-6,DONOR_2780,TREATMENT_10780,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,IU/kg,163.0,68.0
SYNTHETIC-6,DONOR_2781,TREATMENT_10781,Cell-based,Gefitinib,278936,NCI Thesaurus,mg/m2,114.0,136.0
SYNTHETIC-6,DONOR_2782,TREATMENT_10782,Monoclonal antibodies other than immune checkpoint inhibitors,Blinatumomab,278936,RxNorm,g/m2,81.0,186.0
SYNTHETIC-6,DONOR_2783,TREATMENT_10783,Immune checkpoint inhibitors,Durvalumab,,RxNorm,,163.0,109.0
SYNTHETIC-6,DONOR_2784,TREATMENT_10784,Other immunomodulatory substances,Yervoy,8756456,,,112.0,176.0
SYNTHETIC-6,DONOR_2785,TREATMENT_10785,Cell-based,Rucaparib,8836851,NCI Thesaurus,cells/kg,66.0,84.0
SYNTHETIC-6,DONOR_2786,TREATMENT_10786,Cell-based,Ado-trastuzumab emtansine,,PubChem,cells/kg,73.0,175.0
SYNTHETIC-6,DONOR_2787,TREATMENT_10787,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,278936,RxNorm,mg/m2,167.0,65.0
SYNTHETIC-6,DONOR_2788,TREATMENT_10788,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,278936,PubChem,,65.0,193.0
SYNTHETIC-6,DONOR_2789,TREATMENT_10789,,Pembrolizumab,8756456,RxNorm,mg/m2,170.0,121.0
SYNTHETIC-6,DONOR_2790,TREATMENT_10790,Other immunomodulatory substances,Lynparza,239766,RxNorm,IU/kg,98.0,
SYNTHETIC-6,DONOR_2791,TREATMENT_10791,Other immunomodulatory substances,Pertuzumab,8836851,RxNorm,IU/kg,112.0,88.0
SYNTHETIC-6,DONOR_2792,TREATMENT_10792,Other immunomodulatory substances,Atezolizumab,239766,RxNorm,mg/kg,132.0,94.0
SYNTHETIC-6,DONOR_2793,TREATMENT_10793,Cell-based,Olaparib,8836851,NCI Thesaurus,cells/kg,158.0,182.0
SYNTHETIC-6,DONOR_2794,TREATMENT_10794,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8836851,PubChem,,61.0,170.0
SYNTHETIC-6,DONOR_2795,TREATMENT_10795,Other immunomodulatory substances,Blincyto,987654,NCI Thesaurus,g/m2,166.0,189.0
SYNTHETIC-6,DONOR_2796,TREATMENT_10796,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,mg/m2,173.0,120.0
SYNTHETIC-6,DONOR_2797,TREATMENT_10797,Other immunomodulatory substances,Encorafenib,8836851,NCI Thesaurus,ug/m2,115.0,83.0
SYNTHETIC-6,DONOR_2798,TREATMENT_10798,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,mg/kg,68.0,187.0
SYNTHETIC-6,DONOR_2799,TREATMENT_10799,Other immunomodulatory substances,Braftovi,8756456,NCI Thesaurus,cells/kg,92.0,112.0
SYNTHETIC-6,DONOR_2800,TREATMENT_10800,Immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,ug/m2,188.0,
SYNTHETIC-6,DONOR_2801,TREATMENT_10801,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,239766,RxNorm,mg/m2,142.0,
SYNTHETIC-6,DONOR_2802,TREATMENT_10802,Other immunomodulatory substances,Pertuzumab,278936,,ug/m2,122.0,69.0
SYNTHETIC-6,DONOR_2803,TREATMENT_10803,Immune checkpoint inhibitors,Venclexta,4459876,PubChem,ug/m2,116.0,144.0
SYNTHETIC-6,DONOR_2804,TREATMENT_10804,Cell-based,Herceptin,278936,PubChem,ug/m2,106.0,178.0
SYNTHETIC-6,DONOR_2805,TREATMENT_10805,Other immunomodulatory substances,Abemaciclib,239766,PubChem,mg/kg,195.0,122.0
SYNTHETIC-6,DONOR_2806,TREATMENT_10806,Cell-based,,8756456,RxNorm,mg/m2,,137.0
SYNTHETIC-6,DONOR_2807,TREATMENT_10807,Immune checkpoint inhibitors,Ribociclib,,NCI Thesaurus,,96.0,
SYNTHETIC-6,DONOR_2808,TREATMENT_10808,Immune checkpoint inhibitors,Brigatinib,8836851,PubChem,g/m2,,52.0
SYNTHETIC-6,DONOR_2809,TREATMENT_10809,Immune checkpoint inhibitors,Brigatinib,239766,PubChem,mg/kg,192.0,178.0
SYNTHETIC-6,DONOR_2810,TREATMENT_10810,,Cometriq,4459876,RxNorm,mg/kg,122.0,159.0
SYNTHETIC-6,DONOR_2811,TREATMENT_10811,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,278936,RxNorm,,65.0,141.0
SYNTHETIC-6,DONOR_2812,TREATMENT_10812,Cell-based,,,RxNorm,IU/kg,181.0,74.0
SYNTHETIC-6,DONOR_2813,TREATMENT_10813,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,PubChem,IU/kg,95.0,184.0
SYNTHETIC-6,DONOR_2814,TREATMENT_10814,Cell-based,Inotuzumab ozogamicin,8836851,,cells/kg,132.0,187.0
SYNTHETIC-6,DONOR_2815,TREATMENT_10815,Immune checkpoint inhibitors,Brigatinib,278936,PubChem,IU/kg,189.0,
SYNTHETIC-6,DONOR_2816,TREATMENT_10816,Other immunomodulatory substances,Mekinist,987654,NCI Thesaurus,mg/m2,128.0,90.0
SYNTHETIC-6,DONOR_2817,TREATMENT_10817,Other immunomodulatory substances,Encorafenib,4459876,RxNorm,mg/m2,152.0,74.0
SYNTHETIC-6,DONOR_2818,TREATMENT_10818,Cell-based,Nivolumab,278936,NCI Thesaurus,cells/kg,143.0,123.0
SYNTHETIC-6,DONOR_2819,TREATMENT_10819,Immune checkpoint inhibitors,Mektovi,239766,,mg/m2,54.0,87.0
SYNTHETIC-6,DONOR_2820,TREATMENT_10820,Other immunomodulatory substances,Pembrolizumab,987654,NCI Thesaurus,ug/m2,166.0,184.0
SYNTHETIC-6,DONOR_2821,TREATMENT_10821,Cell-based,Cabozantinib,8836851,PubChem,ug/m2,182.0,194.0
SYNTHETIC-6,DONOR_2822,TREATMENT_10822,Other immunomodulatory substances,Palbociclib,4459876,,g/m2,67.0,148.0
SYNTHETIC-6,DONOR_2823,TREATMENT_10823,,Binimetinib,239766,PubChem,ug/m2,138.0,118.0
SYNTHETIC-6,DONOR_2824,TREATMENT_10824,Other immunomodulatory substances,,239766,RxNorm,ug/m2,128.0,
SYNTHETIC-6,DONOR_2825,TREATMENT_10825,Immune checkpoint inhibitors,Mekinist,,NCI Thesaurus,cells/kg,90.0,168.0
SYNTHETIC-6,DONOR_2826,TREATMENT_10826,Other immunomodulatory substances,Ado-trastuzumab emtansine,,NCI Thesaurus,cells/kg,158.0,97.0
SYNTHETIC-6,DONOR_2827,TREATMENT_10827,Cell-based,Cometriq,239766,RxNorm,IU/m2,183.0,
SYNTHETIC-6,DONOR_2828,TREATMENT_10828,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,,RxNorm,IU/kg,136.0,65.0
SYNTHETIC-6,DONOR_2829,TREATMENT_10829,Other immunomodulatory substances,Lenvima,278936,PubChem,,98.0,74.0
SYNTHETIC-6,DONOR_2830,TREATMENT_10830,Immune checkpoint inhibitors,,,,IU/m2,153.0,147.0
SYNTHETIC-6,DONOR_2831,TREATMENT_10831,Cell-based,Gazyva,987654,,g/m2,,
SYNTHETIC-6,DONOR_2832,TREATMENT_10832,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,mg/m2,88.0,177.0
SYNTHETIC-6,DONOR_2833,TREATMENT_10833,Cell-based,Lenvima,4459876,,cells/kg,85.0,
SYNTHETIC-6,DONOR_2834,TREATMENT_10834,,Tagrisso,987654,PubChem,mg/kg,141.0,145.0
SYNTHETIC-6,DONOR_2835,TREATMENT_10835,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,239766,NCI Thesaurus,mg/kg,58.0,
SYNTHETIC-6,DONOR_2836,TREATMENT_10836,Immune checkpoint inhibitors,Venetoclax,278936,PubChem,ug/m2,157.0,150.0
SYNTHETIC-6,DONOR_2837,TREATMENT_10837,Cell-based,,239766,PubChem,mg/m2,,124.0
SYNTHETIC-6,DONOR_2838,TREATMENT_10838,Cell-based,Alectinib,4459876,NCI Thesaurus,g/m2,197.0,114.0
SYNTHETIC-6,DONOR_2839,TREATMENT_10839,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,987654,,,,
SYNTHETIC-6,DONOR_2840,TREATMENT_10840,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,NCI Thesaurus,g/m2,56.0,54.0
SYNTHETIC-6,DONOR_2841,TREATMENT_10841,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8756456,NCI Thesaurus,ug/m2,76.0,125.0
SYNTHETIC-6,DONOR_2842,TREATMENT_10842,Other immunomodulatory substances,Pexidartinib,278936,NCI Thesaurus,,64.0,92.0
SYNTHETIC-6,DONOR_2843,TREATMENT_10843,,Yervoy,8836851,NCI Thesaurus,g/m2,96.0,123.0
SYNTHETIC-6,DONOR_2844,TREATMENT_10844,Other immunomodulatory substances,Opdivo,4459876,PubChem,,,123.0
SYNTHETIC-6,DONOR_2845,TREATMENT_10845,Immune checkpoint inhibitors,Osimertinib,278936,NCI Thesaurus,,70.0,
SYNTHETIC-6,DONOR_2846,TREATMENT_10846,Other immunomodulatory substances,Perjeta,278936,NCI Thesaurus,g/m2,54.0,118.0
SYNTHETIC-6,DONOR_2847,TREATMENT_10847,,Durvalumab,8756456,PubChem,,130.0,95.0
SYNTHETIC-6,DONOR_2848,TREATMENT_10848,Immune checkpoint inhibitors,Atezolizumab,4459876,PubChem,IU/m2,,50.0
SYNTHETIC-6,DONOR_2849,TREATMENT_10849,Other immunomodulatory substances,,987654,,mg/kg,91.0,87.0
SYNTHETIC-6,DONOR_2850,TREATMENT_10850,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,,52.0,192.0
SYNTHETIC-6,DONOR_2851,TREATMENT_10851,Immune checkpoint inhibitors,Cobimetinib,8756456,RxNorm,g/m2,69.0,115.0
SYNTHETIC-6,DONOR_2852,TREATMENT_10852,Cell-based,Axicabtagene ciloleucel,8836851,,cells/kg,78.0,
SYNTHETIC-6,DONOR_2853,TREATMENT_10853,Immune checkpoint inhibitors,Durvalumab,278936,RxNorm,ug/m2,125.0,160.0
SYNTHETIC-6,DONOR_2854,TREATMENT_10854,Immune checkpoint inhibitors,Ceritinib,8756456,PubChem,cells/kg,,
SYNTHETIC-6,DONOR_2855,TREATMENT_10855,Cell-based,Niraparib,,NCI Thesaurus,g/m2,177.0,127.0
SYNTHETIC-6,DONOR_2856,TREATMENT_10856,Other immunomodulatory substances,,278936,NCI Thesaurus,g/m2,52.0,105.0
SYNTHETIC-6,DONOR_2857,TREATMENT_10857,Immune checkpoint inhibitors,Nexavar,278936,NCI Thesaurus,cells/kg,,188.0
SYNTHETIC-6,DONOR_2858,TREATMENT_10858,,Braftovi,4459876,NCI Thesaurus,cells/kg,183.0,140.0
SYNTHETIC-6,DONOR_2859,TREATMENT_10859,Immune checkpoint inhibitors,Atezolizumab,278936,PubChem,mg/kg,155.0,
SYNTHETIC-6,DONOR_2860,TREATMENT_10860,Cell-based,Tafinlar,987654,,mg/kg,73.0,98.0
SYNTHETIC-6,DONOR_2861,TREATMENT_10861,Cell-based,Keytruda,987654,RxNorm,mg/m2,63.0,68.0
SYNTHETIC-6,DONOR_2862,TREATMENT_10862,,Belantamab,987654,PubChem,,172.0,164.0
SYNTHETIC-6,DONOR_2863,TREATMENT_10863,Cell-based,Darzalex,8836851,,,193.0,163.0
SYNTHETIC-6,DONOR_2864,TREATMENT_10864,,Pembrolizumab,,NCI Thesaurus,,,72.0
SYNTHETIC-6,DONOR_2865,TREATMENT_10865,Other immunomodulatory substances,Nexavar,8756456,PubChem,IU/m2,144.0,173.0
SYNTHETIC-6,DONOR_2866,TREATMENT_10866,Immune checkpoint inhibitors,Keytruda,239766,PubChem,IU/m2,148.0,80.0
SYNTHETIC-6,DONOR_2867,TREATMENT_10867,Other immunomodulatory substances,,,NCI Thesaurus,IU/kg,132.0,192.0
SYNTHETIC-6,DONOR_2868,TREATMENT_10868,Cell-based,Trametinib,278936,RxNorm,IU/m2,99.0,122.0
SYNTHETIC-6,DONOR_2869,TREATMENT_10869,Other immunomodulatory substances,,8756456,NCI Thesaurus,cells/kg,,143.0
SYNTHETIC-6,DONOR_2870,TREATMENT_10870,,Cotellic,,RxNorm,,150.0,173.0
SYNTHETIC-6,DONOR_2871,TREATMENT_10871,Immune checkpoint inhibitors,Imfinzi,278936,NCI Thesaurus,IU/m2,187.0,133.0
SYNTHETIC-6,DONOR_2872,TREATMENT_10872,Immune checkpoint inhibitors,Perjeta,8836851,RxNorm,IU/kg,84.0,181.0
SYNTHETIC-6,DONOR_2873,TREATMENT_10873,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,987654,PubChem,,61.0,193.0
SYNTHETIC-6,DONOR_2874,TREATMENT_10874,Other immunomodulatory substances,Pexidartinib,239766,PubChem,IU/kg,150.0,63.0
SYNTHETIC-6,DONOR_2875,TREATMENT_10875,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,239766,NCI Thesaurus,ug/m2,157.0,141.0
SYNTHETIC-6,DONOR_2876,TREATMENT_10876,Immune checkpoint inhibitors,Selumitinib,278936,PubChem,ug/m2,,
SYNTHETIC-6,DONOR_2877,TREATMENT_10877,Other immunomodulatory substances,Lynparza,4459876,PubChem,mg/kg,172.0,137.0
SYNTHETIC-6,DONOR_2878,TREATMENT_10878,Immune checkpoint inhibitors,Ipilimumab,278936,,,73.0,111.0
SYNTHETIC-6,DONOR_2879,TREATMENT_10879,,Nivolumab,4459876,NCI Thesaurus,mg/kg,,130.0
SYNTHETIC-6,DONOR_2880,TREATMENT_10880,Cell-based,Tafinlar,8836851,RxNorm,,160.0,182.0
SYNTHETIC-6,DONOR_2881,TREATMENT_10881,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,g/m2,,131.0
SYNTHETIC-6,DONOR_2882,TREATMENT_10882,Immune checkpoint inhibitors,Alectinib,4459876,RxNorm,g/m2,60.0,154.0
SYNTHETIC-6,DONOR_2883,TREATMENT_10883,Immune checkpoint inhibitors,Dabrafenib,239766,PubChem,IU/kg,82.0,77.0
SYNTHETIC-6,DONOR_2884,TREATMENT_10884,Other immunomodulatory substances,Blincyto,8836851,PubChem,mg/m2,147.0,95.0
SYNTHETIC-6,DONOR_2885,TREATMENT_10885,Other immunomodulatory substances,Selumitinib,987654,PubChem,ug/m2,116.0,
SYNTHETIC-6,DONOR_2886,TREATMENT_10886,Cell-based,Ribociclib,4459876,NCI Thesaurus,mg/kg,111.0,109.0
SYNTHETIC-6,DONOR_2887,TREATMENT_10887,,Rubraca,4459876,PubChem,ug/m2,127.0,
SYNTHETIC-6,DONOR_2888,TREATMENT_10888,Cell-based,Atezolizumab,8836851,RxNorm,mg/kg,,50.0
SYNTHETIC-6,DONOR_2889,TREATMENT_10889,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8836851,RxNorm,IU/m2,78.0,140.0
SYNTHETIC-6,DONOR_2890,TREATMENT_10890,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,4459876,NCI Thesaurus,cells/kg,186.0,100.0
SYNTHETIC-6,DONOR_2891,TREATMENT_10891,Other immunomodulatory substances,Opdivo,8756456,NCI Thesaurus,IU/m2,86.0,155.0
SYNTHETIC-6,DONOR_2892,TREATMENT_10892,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,ug/m2,140.0,
SYNTHETIC-6,DONOR_2893,TREATMENT_10893,Immune checkpoint inhibitors,Mektovi,987654,RxNorm,mg/kg,,161.0
SYNTHETIC-6,DONOR_2894,TREATMENT_10894,Other immunomodulatory substances,Atezolizumab,8756456,RxNorm,mg/m2,101.0,145.0
SYNTHETIC-6,DONOR_2895,TREATMENT_10895,Immune checkpoint inhibitors,Daratumumab,278936,PubChem,IU/kg,80.0,140.0
SYNTHETIC-6,DONOR_2896,TREATMENT_10896,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,cells/kg,126.0,142.0
SYNTHETIC-6,DONOR_2897,TREATMENT_10897,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8836851,PubChem,g/m2,156.0,
SYNTHETIC-6,DONOR_2898,TREATMENT_10898,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,8756456,NCI Thesaurus,ug/m2,,
SYNTHETIC-6,DONOR_2899,TREATMENT_10899,Other immunomodulatory substances,Cometriq,278936,NCI Thesaurus,IU/m2,125.0,53.0
SYNTHETIC-6,DONOR_2900,TREATMENT_10900,Other immunomodulatory substances,Zykadia,239766,RxNorm,,69.0,50.0
SYNTHETIC-6,DONOR_2901,TREATMENT_10901,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8756456,NCI Thesaurus,IU/m2,65.0,53.0
SYNTHETIC-6,DONOR_2902,TREATMENT_10902,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,8756456,RxNorm,IU/kg,172.0,87.0
SYNTHETIC-6,DONOR_2903,TREATMENT_10903,Cell-based,Belantamab,8836851,RxNorm,cells/kg,,98.0
SYNTHETIC-6,DONOR_2904,TREATMENT_10904,Cell-based,Imfinzi,4459876,RxNorm,,118.0,123.0
SYNTHETIC-6,DONOR_2905,TREATMENT_10905,Cell-based,,987654,RxNorm,mg/kg,194.0,
SYNTHETIC-6,DONOR_2906,TREATMENT_10906,Immune checkpoint inhibitors,Vandetanib,278936,RxNorm,,190.0,127.0
SYNTHETIC-6,DONOR_2907,TREATMENT_10907,Immune checkpoint inhibitors,Vandetanib,239766,RxNorm,,,94.0
SYNTHETIC-6,DONOR_2908,TREATMENT_10908,Immune checkpoint inhibitors,Nexavar,987654,RxNorm,IU/m2,95.0,149.0
SYNTHETIC-6,DONOR_2909,TREATMENT_10909,Cell-based,Xalkori,,NCI Thesaurus,,151.0,136.0
SYNTHETIC-6,DONOR_2910,TREATMENT_10910,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,mg/kg,169.0,
SYNTHETIC-6,DONOR_2911,TREATMENT_10911,,Nivolumab,8836851,PubChem,,,77.0
SYNTHETIC-6,DONOR_2912,TREATMENT_10912,Immune checkpoint inhibitors,Gilteritinib,987654,PubChem,g/m2,111.0,92.0
SYNTHETIC-6,DONOR_2913,TREATMENT_10913,,,8756456,NCI Thesaurus,IU/kg,181.0,123.0
SYNTHETIC-6,DONOR_2914,TREATMENT_10914,Other immunomodulatory substances,Belantamab,8836851,PubChem,ug/m2,138.0,146.0
SYNTHETIC-6,DONOR_2915,TREATMENT_10915,Other immunomodulatory substances,Sorafenib,278936,PubChem,IU/kg,184.0,159.0
SYNTHETIC-6,DONOR_2916,TREATMENT_10916,Immune checkpoint inhibitors,Niraparib,,PubChem,,146.0,141.0
SYNTHETIC-6,DONOR_2917,TREATMENT_10917,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,PubChem,,70.0,
SYNTHETIC-6,DONOR_2918,TREATMENT_10918,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,987654,RxNorm,IU/m2,94.0,90.0
SYNTHETIC-6,DONOR_2919,TREATMENT_10919,Immune checkpoint inhibitors,,278936,NCI Thesaurus,IU/m2,188.0,
SYNTHETIC-6,DONOR_2920,TREATMENT_10920,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,PubChem,cells/kg,143.0,
SYNTHETIC-6,DONOR_2921,TREATMENT_10921,Immune checkpoint inhibitors,Osimertinib,,RxNorm,ug/m2,85.0,64.0
SYNTHETIC-6,DONOR_2922,TREATMENT_10922,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,278936,,g/m2,160.0,73.0
SYNTHETIC-6,DONOR_2923,TREATMENT_10923,Other immunomodulatory substances,Perjeta,8836851,RxNorm,IU/kg,80.0,173.0
SYNTHETIC-6,DONOR_2924,TREATMENT_10924,Cell-based,Mekinist,8836851,NCI Thesaurus,mg/m2,110.0,190.0
SYNTHETIC-6,DONOR_2925,TREATMENT_10925,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,8836851,,cells/kg,70.0,85.0
SYNTHETIC-6,DONOR_2926,TREATMENT_10926,Other immunomodulatory substances,Cometriq,239766,RxNorm,mg/m2,,86.0
SYNTHETIC-6,DONOR_2927,TREATMENT_10927,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,8836851,NCI Thesaurus,IU/m2,149.0,
SYNTHETIC-6,DONOR_2928,TREATMENT_10928,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,RxNorm,mg/m2,139.0,189.0
SYNTHETIC-6,DONOR_2929,TREATMENT_10929,Immune checkpoint inhibitors,Cotellic,,RxNorm,g/m2,176.0,110.0
SYNTHETIC-6,DONOR_2930,TREATMENT_10930,Other immunomodulatory substances,Alecensa,278936,RxNorm,IU/kg,70.0,83.0
SYNTHETIC-6,DONOR_2931,TREATMENT_10931,Other immunomodulatory substances,,239766,RxNorm,,120.0,
SYNTHETIC-6,DONOR_2932,TREATMENT_10932,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,NCI Thesaurus,ug/m2,143.0,137.0
SYNTHETIC-6,DONOR_2933,TREATMENT_10933,Immune checkpoint inhibitors,Brentuximab vedotin,278936,PubChem,,126.0,69.0
SYNTHETIC-6,DONOR_2934,TREATMENT_10934,Cell-based,,,RxNorm,mg/m2,,143.0
SYNTHETIC-6,DONOR_2935,TREATMENT_10935,,Tecentriq,8756456,PubChem,IU/kg,173.0,
SYNTHETIC-6,DONOR_2936,TREATMENT_10936,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,239766,,cells/kg,113.0,80.0
SYNTHETIC-6,DONOR_2937,TREATMENT_10937,Cell-based,Pembrolizumab,4459876,RxNorm,IU/kg,91.0,155.0
SYNTHETIC-6,DONOR_2938,TREATMENT_10938,Other immunomodulatory substances,Tecentriq,,RxNorm,IU/m2,146.0,66.0
SYNTHETIC-6,DONOR_2939,TREATMENT_10939,Immune checkpoint inhibitors,Opdivo,239766,RxNorm,IU/kg,190.0,50.0
SYNTHETIC-6,DONOR_2940,TREATMENT_10940,Other immunomodulatory substances,Imfinzi,,PubChem,IU/kg,144.0,176.0
SYNTHETIC-6,DONOR_2941,TREATMENT_10941,Immune checkpoint inhibitors,,8836851,RxNorm,mg/m2,171.0,198.0
SYNTHETIC-6,DONOR_2942,TREATMENT_10942,Other immunomodulatory substances,Opdivo,239766,NCI Thesaurus,IU/m2,152.0,71.0
SYNTHETIC-6,DONOR_2943,TREATMENT_10943,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,cells/kg,,177.0
SYNTHETIC-6,DONOR_2944,TREATMENT_10944,Immune checkpoint inhibitors,Atezolizumab,987654,RxNorm,,,113.0
SYNTHETIC-6,DONOR_2945,TREATMENT_10945,Immune checkpoint inhibitors,Adcetris,239766,RxNorm,,103.0,183.0
SYNTHETIC-6,DONOR_2946,TREATMENT_10946,Immune checkpoint inhibitors,Durvalumab,239766,NCI Thesaurus,mg/m2,83.0,134.0
SYNTHETIC-6,DONOR_2947,TREATMENT_10947,Cell-based,Keytruda,239766,PubChem,mg/kg,165.0,62.0
SYNTHETIC-6,DONOR_2948,TREATMENT_10948,Cell-based,,4459876,RxNorm,cells/kg,59.0,
SYNTHETIC-6,DONOR_2949,TREATMENT_10949,Cell-based,Rituxan,4459876,,IU/kg,145.0,156.0
SYNTHETIC-6,DONOR_2950,TREATMENT_10950,Other immunomodulatory substances,Opdivo,,NCI Thesaurus,ug/m2,,143.0
SYNTHETIC-6,DONOR_2951,TREATMENT_10951,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,NCI Thesaurus,IU/m2,191.0,200.0
SYNTHETIC-6,DONOR_2952,TREATMENT_10952,Other immunomodulatory substances,Niraparib,4459876,,IU/m2,189.0,91.0
SYNTHETIC-6,DONOR_2953,TREATMENT_10953,Cell-based,Brentuximab vedotin,4459876,RxNorm,cells/kg,175.0,184.0
SYNTHETIC-6,DONOR_2954,TREATMENT_10954,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,,189.0,50.0
SYNTHETIC-6,DONOR_2955,TREATMENT_10955,,Niraparib,239766,PubChem,cells/kg,88.0,170.0
SYNTHETIC-6,DONOR_2956,TREATMENT_10956,Other immunomodulatory substances,Brigatinib,8836851,PubChem,mg/kg,83.0,175.0
SYNTHETIC-6,DONOR_2957,TREATMENT_10957,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,IU/kg,70.0,152.0
SYNTHETIC-6,DONOR_2958,TREATMENT_10958,,Pembrolizumab,239766,NCI Thesaurus,mg/m2,99.0,169.0
SYNTHETIC-6,DONOR_2959,TREATMENT_10959,Cell-based,Cotellic,987654,NCI Thesaurus,IU/kg,95.0,65.0
SYNTHETIC-6,DONOR_2960,TREATMENT_10960,Other immunomodulatory substances,Adcetris,8836851,RxNorm,mg/m2,,71.0
SYNTHETIC-6,DONOR_2961,TREATMENT_10961,Immune checkpoint inhibitors,Atezolizumab,4459876,NCI Thesaurus,g/m2,76.0,121.0
SYNTHETIC-6,DONOR_2962,TREATMENT_10962,Other immunomodulatory substances,Venclexta,4459876,NCI Thesaurus,IU/m2,69.0,119.0
SYNTHETIC-6,DONOR_2963,TREATMENT_10963,Other immunomodulatory substances,Tecentriq,4459876,NCI Thesaurus,IU/kg,131.0,131.0
SYNTHETIC-6,DONOR_2964,TREATMENT_10964,Cell-based,,8756456,PubChem,g/m2,,177.0
SYNTHETIC-6,DONOR_2965,TREATMENT_10965,Immune checkpoint inhibitors,Yervoy,239766,RxNorm,ug/m2,96.0,74.0
SYNTHETIC-6,DONOR_2966,TREATMENT_10966,Cell-based,Durvalumab,,,mg/kg,,70.0
SYNTHETIC-6,DONOR_2967,TREATMENT_10967,Immune checkpoint inhibitors,,8756456,,mg/kg,65.0,130.0
SYNTHETIC-6,DONOR_2968,TREATMENT_10968,Other immunomodulatory substances,Encorafenib,8836851,RxNorm,ug/m2,117.0,
SYNTHETIC-6,DONOR_2969,TREATMENT_10969,Immune checkpoint inhibitors,Enhertu,4459876,RxNorm,mg/kg,87.0,175.0
SYNTHETIC-6,DONOR_2970,TREATMENT_10970,Cell-based,Pembrolizumab,8836851,RxNorm,mg/kg,150.0,
SYNTHETIC-6,DONOR_2971,TREATMENT_10971,Immune checkpoint inhibitors,Herceptin,4459876,RxNorm,g/m2,155.0,190.0
SYNTHETIC-6,DONOR_2972,TREATMENT_10972,Other immunomodulatory substances,Gilotrif,239766,PubChem,,120.0,183.0
SYNTHETIC-6,DONOR_2973,TREATMENT_10973,Immune checkpoint inhibitors,Kisqali,4459876,PubChem,g/m2,,133.0
SYNTHETIC-6,DONOR_2974,TREATMENT_10974,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,ug/m2,169.0,169.0
SYNTHETIC-6,DONOR_2975,TREATMENT_10975,Other immunomodulatory substances,Copanlisib,4459876,NCI Thesaurus,IU/kg,96.0,102.0
SYNTHETIC-6,DONOR_2976,TREATMENT_10976,Immune checkpoint inhibitors,Tarceva,4459876,RxNorm,ug/m2,,98.0
SYNTHETIC-6,DONOR_2977,TREATMENT_10977,Cell-based,Encorafenib,4459876,RxNorm,,168.0,111.0
SYNTHETIC-6,DONOR_2978,TREATMENT_10978,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,PubChem,IU/m2,144.0,117.0
SYNTHETIC-6,DONOR_2979,TREATMENT_10979,Other immunomodulatory substances,Tecentriq,987654,PubChem,cells/kg,105.0,184.0
SYNTHETIC-6,DONOR_2980,TREATMENT_10980,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,8836851,PubChem,mg/kg,144.0,115.0
SYNTHETIC-6,DONOR_2981,TREATMENT_10981,Other immunomodulatory substances,Mektovi,,RxNorm,cells/kg,113.0,110.0
SYNTHETIC-6,DONOR_2982,TREATMENT_10982,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,8756456,RxNorm,IU/kg,181.0,116.0
SYNTHETIC-6,DONOR_2983,TREATMENT_10983,Immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,PubChem,,97.0,116.0
SYNTHETIC-6,DONOR_2984,TREATMENT_10984,Immune checkpoint inhibitors,Trastuzumab,8756456,NCI Thesaurus,g/m2,77.0,
SYNTHETIC-6,DONOR_2985,TREATMENT_10985,Immune checkpoint inhibitors,Ipilimumab,278936,,ug/m2,170.0,59.0
SYNTHETIC-6,DONOR_2986,TREATMENT_10986,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8836851,PubChem,g/m2,160.0,108.0
SYNTHETIC-6,DONOR_2987,TREATMENT_10987,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,cells/kg,,147.0
SYNTHETIC-6,DONOR_2988,TREATMENT_10988,Cell-based,Ribociclib,239766,RxNorm,ug/m2,197.0,61.0
SYNTHETIC-6,DONOR_2989,TREATMENT_10989,Cell-based,Zejula,8756456,PubChem,mg/kg,191.0,162.0
SYNTHETIC-6,DONOR_2990,TREATMENT_10990,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,PubChem,mg/m2,78.0,
SYNTHETIC-6,DONOR_2991,TREATMENT_10991,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,PubChem,IU/m2,116.0,
SYNTHETIC-6,DONOR_2992,TREATMENT_10992,Other immunomodulatory substances,Yescarta,4459876,,cells/kg,,132.0
SYNTHETIC-6,DONOR_2993,TREATMENT_10993,Immune checkpoint inhibitors,Tarceva,278936,NCI Thesaurus,g/m2,188.0,192.0
SYNTHETIC-6,DONOR_2994,TREATMENT_10994,Other immunomodulatory substances,Durvalumab,8756456,RxNorm,,164.0,111.0
SYNTHETIC-6,DONOR_2995,TREATMENT_10995,Cell-based,,8836851,NCI Thesaurus,mg/kg,82.0,89.0
SYNTHETIC-6,DONOR_2996,TREATMENT_10996,Cell-based,Durvalumab,,PubChem,ug/m2,57.0,181.0
SYNTHETIC-6,DONOR_2997,TREATMENT_10997,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8756456,RxNorm,mg/m2,,111.0
SYNTHETIC-6,DONOR_2998,TREATMENT_10998,Cell-based,Tarceva,4459876,PubChem,ug/m2,109.0,
SYNTHETIC-6,DONOR_2999,TREATMENT_10999,Cell-based,Gazyva,239766,RxNorm,IU/m2,195.0,98.0
SYNTHETIC-6,DONOR_3000,TREATMENT_11000,Other immunomodulatory substances,Darzalex,8756456,NCI Thesaurus,cells/kg,161.0,80.0
SYNTHETIC-6,DONOR_2501,TREATMENT_11001,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,RxNorm,ug/m2,156.0,184.0
SYNTHETIC-6,DONOR_2502,TREATMENT_11002,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,mg/kg,193.0,63.0
SYNTHETIC-6,DONOR_2503,TREATMENT_11003,Cell-based,Darzalex,8756456,RxNorm,ug/m2,94.0,144.0
SYNTHETIC-6,DONOR_2504,TREATMENT_11004,Other immunomodulatory substances,,8836851,RxNorm,mg/m2,154.0,99.0
SYNTHETIC-6,DONOR_2505,TREATMENT_11005,Cell-based,Tisagenlecleucel,8836851,RxNorm,mg/m2,198.0,90.0
SYNTHETIC-6,DONOR_2506,TREATMENT_11006,Cell-based,Durvalumab,8836851,RxNorm,IU/kg,175.0,136.0
SYNTHETIC-6,DONOR_2507,TREATMENT_11007,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,4459876,,,154.0,62.0
SYNTHETIC-6,DONOR_2508,TREATMENT_11008,,Opdivo,8836851,PubChem,,60.0,160.0
SYNTHETIC-6,DONOR_2509,TREATMENT_11009,Cell-based,Pembrolizumab,,RxNorm,,147.0,53.0
SYNTHETIC-6,DONOR_2510,TREATMENT_11010,,,4459876,PubChem,mg/m2,,119.0
SYNTHETIC-6,DONOR_2511,TREATMENT_11011,Cell-based,Ipilimumab,239766,NCI Thesaurus,IU/kg,171.0,77.0
SYNTHETIC-6,DONOR_2512,TREATMENT_11012,Immune checkpoint inhibitors,Ipilimumab,8836851,NCI Thesaurus,cells/kg,93.0,
SYNTHETIC-6,DONOR_2513,TREATMENT_11013,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,RxNorm,,72.0,185.0
SYNTHETIC-6,DONOR_2514,TREATMENT_11014,Cell-based,Alecensa,278936,PubChem,IU/m2,59.0,165.0
SYNTHETIC-6,DONOR_2515,TREATMENT_11015,Other immunomodulatory substances,Keytruda,239766,,ug/m2,199.0,146.0
SYNTHETIC-6,DONOR_2516,TREATMENT_11016,Cell-based,Atezolizumab,8836851,NCI Thesaurus,,,139.0
SYNTHETIC-6,DONOR_2517,TREATMENT_11017,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,RxNorm,mg/kg,112.0,101.0
SYNTHETIC-6,DONOR_2518,TREATMENT_11018,Cell-based,Rituxan,239766,,ug/m2,,122.0
SYNTHETIC-6,DONOR_2519,TREATMENT_11019,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,PubChem,mg/m2,155.0,
SYNTHETIC-6,DONOR_2520,TREATMENT_11020,Other immunomodulatory substances,Gilotrif,4459876,PubChem,IU/m2,117.0,175.0
SYNTHETIC-6,DONOR_2521,TREATMENT_11021,Cell-based,Ipilimumab,987654,NCI Thesaurus,IU/m2,51.0,
SYNTHETIC-6,DONOR_2522,TREATMENT_11022,,,239766,,IU/m2,195.0,
SYNTHETIC-6,DONOR_2523,TREATMENT_11023,Other immunomodulatory substances,Keytruda,8836851,PubChem,,98.0,
SYNTHETIC-6,DONOR_2524,TREATMENT_11024,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8756456,PubChem,cells/kg,,82.0
SYNTHETIC-6,DONOR_2525,TREATMENT_11025,Immune checkpoint inhibitors,,987654,RxNorm,,164.0,52.0
SYNTHETIC-6,DONOR_2526,TREATMENT_11026,Cell-based,Zykadia,8836851,,IU/m2,180.0,149.0
SYNTHETIC-6,DONOR_2527,TREATMENT_11027,Immune checkpoint inhibitors,Keytruda,987654,NCI Thesaurus,ug/m2,166.0,66.0
SYNTHETIC-6,DONOR_2528,TREATMENT_11028,Cell-based,,4459876,NCI Thesaurus,mg/m2,59.0,154.0
SYNTHETIC-6,DONOR_2529,TREATMENT_11029,Cell-based,,278936,RxNorm,mg/m2,64.0,76.0
SYNTHETIC-6,DONOR_2530,TREATMENT_11030,Cell-based,Tisagenlecleucel,987654,RxNorm,cells/kg,,50.0
SYNTHETIC-6,DONOR_2531,TREATMENT_11031,Other immunomodulatory substances,Imfinzi,8756456,RxNorm,,100.0,166.0
SYNTHETIC-6,DONOR_2532,TREATMENT_11032,Cell-based,Imfinzi,4459876,,g/m2,197.0,109.0
SYNTHETIC-6,DONOR_2533,TREATMENT_11033,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,RxNorm,IU/kg,120.0,192.0
SYNTHETIC-6,DONOR_2534,TREATMENT_11034,,Ipilimumab,278936,NCI Thesaurus,IU/m2,128.0,130.0
SYNTHETIC-6,DONOR_2535,TREATMENT_11035,Cell-based,Alunbrig,278936,NCI Thesaurus,ug/m2,80.0,77.0
SYNTHETIC-6,DONOR_2536,TREATMENT_11036,Cell-based,Enhertu,8756456,NCI Thesaurus,IU/m2,89.0,171.0
SYNTHETIC-6,DONOR_2537,TREATMENT_11037,Other immunomodulatory substances,Alunbrig,987654,NCI Thesaurus,IU/m2,103.0,101.0
SYNTHETIC-6,DONOR_2538,TREATMENT_11038,Immune checkpoint inhibitors,,8836851,RxNorm,mg/kg,98.0,134.0
SYNTHETIC-6,DONOR_2539,TREATMENT_11039,Cell-based,Ipilimumab,278936,,mg/m2,53.0,158.0
SYNTHETIC-6,DONOR_2540,TREATMENT_11040,Immune checkpoint inhibitors,,278936,,mg/kg,80.0,73.0
SYNTHETIC-6,DONOR_2541,TREATMENT_11041,Other immunomodulatory substances,Imfinzi,4459876,NCI Thesaurus,mg/m2,103.0,197.0
SYNTHETIC-6,DONOR_2542,TREATMENT_11042,Cell-based,Kymriah,,PubChem,ug/m2,101.0,157.0
SYNTHETIC-6,DONOR_2543,TREATMENT_11043,Cell-based,Pembrolizumab,8756456,PubChem,ug/m2,,
SYNTHETIC-6,DONOR_2544,TREATMENT_11044,Cell-based,Alectinib,987654,NCI Thesaurus,,,133.0
SYNTHETIC-6,DONOR_2545,TREATMENT_11045,Other immunomodulatory substances,Atezolizumab,8756456,RxNorm,ug/m2,190.0,178.0
SYNTHETIC-6,DONOR_2546,TREATMENT_11046,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,8756456,PubChem,IU/kg,185.0,175.0
SYNTHETIC-6,DONOR_2547,TREATMENT_11047,Other immunomodulatory substances,Imfinzi,278936,RxNorm,ug/m2,79.0,89.0
SYNTHETIC-6,DONOR_2548,TREATMENT_11048,Immune checkpoint inhibitors,Rubraca,278936,NCI Thesaurus,mg/kg,161.0,199.0
SYNTHETIC-6,DONOR_2549,TREATMENT_11049,Cell-based,Nivolumab,8756456,PubChem,cells/kg,169.0,189.0
SYNTHETIC-6,DONOR_2550,TREATMENT_11050,Cell-based,Ceritinib,8836851,RxNorm,mg/m2,73.0,63.0
SYNTHETIC-6,DONOR_2551,TREATMENT_11051,Cell-based,,987654,,g/m2,66.0,114.0
SYNTHETIC-6,DONOR_2552,TREATMENT_11052,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,4459876,PubChem,mg/kg,154.0,180.0
SYNTHETIC-6,DONOR_2553,TREATMENT_11053,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,,199.0,
SYNTHETIC-6,DONOR_2554,TREATMENT_11054,Other immunomodulatory substances,Cotellic,4459876,PubChem,mg/m2,60.0,139.0
SYNTHETIC-6,DONOR_2555,TREATMENT_11055,Cell-based,Cotellic,987654,PubChem,mg/kg,,70.0
SYNTHETIC-6,DONOR_2556,TREATMENT_11056,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,8756456,NCI Thesaurus,IU/m2,71.0,161.0
SYNTHETIC-6,DONOR_2557,TREATMENT_11057,Immune checkpoint inhibitors,Imfinzi,239766,NCI Thesaurus,IU/m2,89.0,89.0
SYNTHETIC-6,DONOR_2558,TREATMENT_11058,,Ipilimumab,8836851,,,143.0,129.0
SYNTHETIC-6,DONOR_2559,TREATMENT_11059,,Daratumumab,4459876,RxNorm,,140.0,99.0
SYNTHETIC-6,DONOR_2560,TREATMENT_11060,Immune checkpoint inhibitors,Tecentriq,4459876,NCI Thesaurus,,117.0,56.0
SYNTHETIC-6,DONOR_2561,TREATMENT_11061,Cell-based,Opdivo,987654,,ug/m2,,83.0
SYNTHETIC-6,DONOR_2562,TREATMENT_11062,Cell-based,Adcetris,239766,NCI Thesaurus,ug/m2,92.0,71.0
SYNTHETIC-6,DONOR_2563,TREATMENT_11063,Other immunomodulatory substances,Trastuzumab,987654,NCI Thesaurus,ug/m2,149.0,142.0
SYNTHETIC-6,DONOR_2564,TREATMENT_11064,Immune checkpoint inhibitors,Afatinib,987654,RxNorm,g/m2,94.0,94.0
SYNTHETIC-6,DONOR_2565,TREATMENT_11065,Cell-based,Erlotinib,987654,PubChem,g/m2,178.0,
SYNTHETIC-6,DONOR_2566,TREATMENT_11066,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,239766,,ug/m2,59.0,115.0
SYNTHETIC-6,DONOR_2567,TREATMENT_11067,,Olaparib,8756456,RxNorm,,124.0,124.0
SYNTHETIC-6,DONOR_2568,TREATMENT_11068,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,4459876,PubChem,mg/m2,161.0,
SYNTHETIC-6,DONOR_2569,TREATMENT_11069,,Necitumumab,8836851,RxNorm,g/m2,123.0,102.0
SYNTHETIC-6,DONOR_2570,TREATMENT_11070,Other immunomodulatory substances,Kisqali,,RxNorm,IU/kg,150.0,118.0
SYNTHETIC-6,DONOR_2571,TREATMENT_11071,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,,mg/kg,117.0,
SYNTHETIC-6,DONOR_2572,TREATMENT_11072,,Cotellic,8756456,PubChem,,139.0,147.0
SYNTHETIC-6,DONOR_2573,TREATMENT_11073,Immune checkpoint inhibitors,Zykadia,,,mg/m2,91.0,
SYNTHETIC-6,DONOR_2574,TREATMENT_11074,Cell-based,Vandetanib,8836851,,,135.0,124.0
SYNTHETIC-6,DONOR_2575,TREATMENT_11075,Cell-based,Keytruda,987654,RxNorm,mg/kg,135.0,89.0
SYNTHETIC-6,DONOR_2576,TREATMENT_11076,,Gazyva,4459876,PubChem,mg/m2,82.0,
SYNTHETIC-6,DONOR_2577,TREATMENT_11077,Other immunomodulatory substances,Tisagenlecleucel,8836851,RxNorm,IU/kg,73.0,146.0
SYNTHETIC-6,DONOR_2578,TREATMENT_11078,Cell-based,Cometriq,278936,NCI Thesaurus,mg/kg,119.0,98.0
SYNTHETIC-6,DONOR_2579,TREATMENT_11079,Other immunomodulatory substances,Venclexta,239766,,,,
SYNTHETIC-6,DONOR_2580,TREATMENT_11080,Other immunomodulatory substances,Trastuzumab,8836851,,mg/m2,165.0,198.0
SYNTHETIC-6,DONOR_2581,TREATMENT_11081,Immune checkpoint inhibitors,Yescarta,239766,PubChem,IU/kg,,134.0
SYNTHETIC-6,DONOR_2582,TREATMENT_11082,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,IU/kg,187.0,113.0
SYNTHETIC-6,DONOR_2583,TREATMENT_11083,Immune checkpoint inhibitors,Nexavar,4459876,PubChem,ug/m2,,
SYNTHETIC-6,DONOR_2584,TREATMENT_11084,Cell-based,Keytruda,,,IU/kg,145.0,99.0
SYNTHETIC-6,DONOR_2585,TREATMENT_11085,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,8756456,PubChem,mg/m2,98.0,177.0
SYNTHETIC-6,DONOR_2586,TREATMENT_11086,Other immunomodulatory substances,Opdivo,987654,RxNorm,mg/m2,109.0,84.0
SYNTHETIC-6,DONOR_2587,TREATMENT_11087,Cell-based,,987654,NCI Thesaurus,,120.0,
SYNTHETIC-6,DONOR_2588,TREATMENT_11088,Immune checkpoint inhibitors,Opdivo,239766,NCI Thesaurus,cells/kg,191.0,177.0
SYNTHETIC-6,DONOR_2589,TREATMENT_11089,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,8836851,PubChem,cells/kg,174.0,117.0
SYNTHETIC-6,DONOR_2590,TREATMENT_11090,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,,ug/m2,77.0,133.0
SYNTHETIC-6,DONOR_2591,TREATMENT_11091,Immune checkpoint inhibitors,Ipilimumab,,PubChem,mg/kg,188.0,159.0
SYNTHETIC-6,DONOR_2592,TREATMENT_11092,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,,PubChem,IU/m2,182.0,181.0
SYNTHETIC-6,DONOR_2593,TREATMENT_11093,Other immunomodulatory substances,Opdivo,4459876,RxNorm,IU/m2,125.0,
SYNTHETIC-6,DONOR_2594,TREATMENT_11094,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,239766,RxNorm,mg/kg,191.0,
SYNTHETIC-6,DONOR_2595,TREATMENT_11095,Cell-based,Obinutuzumab,,PubChem,g/m2,68.0,125.0
SYNTHETIC-6,DONOR_2596,TREATMENT_11096,Other immunomodulatory substances,Ceritinib,239766,PubChem,mg/m2,114.0,67.0
SYNTHETIC-6,DONOR_2597,TREATMENT_11097,Immune checkpoint inhibitors,Durvalumab,239766,PubChem,mg/kg,147.0,104.0
SYNTHETIC-6,DONOR_2598,TREATMENT_11098,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,mg/kg,87.0,54.0
SYNTHETIC-6,DONOR_2599,TREATMENT_11099,Other immunomodulatory substances,Ado-trastuzumab emtansine,4459876,PubChem,ug/m2,112.0,99.0
SYNTHETIC-6,DONOR_2600,TREATMENT_11100,,Afatinib,278936,,mg/kg,84.0,62.0
SYNTHETIC-6,DONOR_2601,TREATMENT_11101,Cell-based,Atezolizumab,8756456,RxNorm,,102.0,176.0
SYNTHETIC-6,DONOR_2602,TREATMENT_11102,Immune checkpoint inhibitors,,239766,PubChem,ug/m2,86.0,67.0
SYNTHETIC-6,DONOR_2603,TREATMENT_11103,Immune checkpoint inhibitors,Kisqali,987654,RxNorm,mg/m2,76.0,140.0
SYNTHETIC-6,DONOR_2604,TREATMENT_11104,Cell-based,Yervoy,8836851,NCI Thesaurus,cells/kg,74.0,
SYNTHETIC-6,DONOR_2605,TREATMENT_11105,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,4459876,RxNorm,cells/kg,98.0,141.0
SYNTHETIC-6,DONOR_2606,TREATMENT_11106,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,987654,NCI Thesaurus,ug/m2,,
SYNTHETIC-6,DONOR_2607,TREATMENT_11107,Other immunomodulatory substances,Durvalumab,8836851,PubChem,ug/m2,173.0,192.0
SYNTHETIC-6,DONOR_2608,TREATMENT_11108,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,RxNorm,ug/m2,113.0,161.0
SYNTHETIC-6,DONOR_2609,TREATMENT_11109,Immune checkpoint inhibitors,Binimetinib,4459876,NCI Thesaurus,IU/m2,,116.0
SYNTHETIC-6,DONOR_2610,TREATMENT_11110,Other immunomodulatory substances,Caprelsa,239766,,,144.0,
SYNTHETIC-6,DONOR_2611,TREATMENT_11111,Other immunomodulatory substances,Rituximab,278936,NCI Thesaurus,IU/kg,134.0,78.0
SYNTHETIC-6,DONOR_2612,TREATMENT_11112,Other immunomodulatory substances,Durvalumab,8756456,NCI Thesaurus,mg/m2,128.0,
SYNTHETIC-6,DONOR_2613,TREATMENT_11113,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,987654,NCI Thesaurus,,101.0,91.0
SYNTHETIC-6,DONOR_2614,TREATMENT_11114,Other immunomodulatory substances,Selumitinib,278936,NCI Thesaurus,,165.0,149.0
SYNTHETIC-6,DONOR_2615,TREATMENT_11115,Immune checkpoint inhibitors,Brigatinib,278936,NCI Thesaurus,IU/m2,110.0,
SYNTHETIC-6,DONOR_2616,TREATMENT_11116,Other immunomodulatory substances,,278936,NCI Thesaurus,ug/m2,102.0,168.0
SYNTHETIC-6,DONOR_2617,TREATMENT_11117,Cell-based,Tagrisso,278936,RxNorm,g/m2,,
SYNTHETIC-6,DONOR_2618,TREATMENT_11118,Immune checkpoint inhibitors,Erlotinib,4459876,NCI Thesaurus,mg/m2,194.0,
SYNTHETIC-6,DONOR_2619,TREATMENT_11119,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,g/m2,88.0,163.0
SYNTHETIC-6,DONOR_2620,TREATMENT_11120,,Yervoy,987654,,ug/m2,184.0,70.0
SYNTHETIC-6,DONOR_2621,TREATMENT_11121,,Ado-trastuzumab emtansine,278936,PubChem,mg/kg,163.0,93.0
SYNTHETIC-6,DONOR_2622,TREATMENT_11122,Cell-based,Gazyva,4459876,RxNorm,IU/m2,177.0,83.0
SYNTHETIC-6,DONOR_2623,TREATMENT_11123,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,ug/m2,131.0,148.0
SYNTHETIC-6,DONOR_2624,TREATMENT_11124,Cell-based,Durvalumab,987654,,,136.0,97.0
SYNTHETIC-6,DONOR_2625,TREATMENT_11125,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,239766,RxNorm,cells/kg,181.0,143.0
SYNTHETIC-6,DONOR_2626,TREATMENT_11126,Immune checkpoint inhibitors,Dabrafenib,4459876,,cells/kg,96.0,
SYNTHETIC-6,DONOR_2627,TREATMENT_11127,Immune checkpoint inhibitors,Axicabtagene ciloleucel,278936,,IU/m2,124.0,
SYNTHETIC-6,DONOR_2628,TREATMENT_11128,Immune checkpoint inhibitors,Pertuzumab,,NCI Thesaurus,g/m2,197.0,167.0
SYNTHETIC-6,DONOR_2629,TREATMENT_11129,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,IU/kg,182.0,65.0
SYNTHETIC-6,DONOR_2630,TREATMENT_11130,Immune checkpoint inhibitors,Tagrisso,8756456,,,125.0,172.0
SYNTHETIC-6,DONOR_2631,TREATMENT_11131,Cell-based,Tafinlar,,,ug/m2,53.0,
SYNTHETIC-6,DONOR_2632,TREATMENT_11132,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,8836851,,IU/m2,188.0,157.0
SYNTHETIC-6,DONOR_2633,TREATMENT_11133,Other immunomodulatory substances,Xalkori,987654,RxNorm,g/m2,193.0,191.0
SYNTHETIC-6,DONOR_2634,TREATMENT_11134,Cell-based,Yervoy,239766,RxNorm,ug/m2,191.0,57.0
SYNTHETIC-6,DONOR_2635,TREATMENT_11135,,Opdivo,8756456,,mg/m2,149.0,145.0
SYNTHETIC-6,DONOR_2636,TREATMENT_11136,Other immunomodulatory substances,Durvalumab,,NCI Thesaurus,IU/m2,103.0,86.0
SYNTHETIC-6,DONOR_2637,TREATMENT_11137,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,,,,196.0
SYNTHETIC-6,DONOR_2638,TREATMENT_11138,Immune checkpoint inhibitors,Tarceva,8756456,,IU/m2,143.0,147.0
SYNTHETIC-6,DONOR_2639,TREATMENT_11139,Cell-based,Atezolizumab,987654,PubChem,mg/kg,115.0,78.0
SYNTHETIC-6,DONOR_2640,TREATMENT_11140,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,278936,RxNorm,IU/m2,143.0,133.0
SYNTHETIC-6,DONOR_2641,TREATMENT_11141,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,g/m2,91.0,80.0
SYNTHETIC-6,DONOR_2642,TREATMENT_11142,Other immunomodulatory substances,Gazyva,4459876,RxNorm,ug/m2,182.0,
SYNTHETIC-6,DONOR_2643,TREATMENT_11143,Cell-based,Gazyva,8756456,,mg/m2,199.0,83.0
SYNTHETIC-6,DONOR_2644,TREATMENT_11144,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,NCI Thesaurus,mg/kg,114.0,80.0
SYNTHETIC-6,DONOR_2645,TREATMENT_11145,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,278936,RxNorm,mg/kg,,80.0
SYNTHETIC-6,DONOR_2646,TREATMENT_11146,Cell-based,Xalkori,8836851,RxNorm,,78.0,
SYNTHETIC-6,DONOR_2647,TREATMENT_11147,,Nivolumab,4459876,RxNorm,,118.0,79.0
SYNTHETIC-6,DONOR_2648,TREATMENT_11148,Other immunomodulatory substances,Tecentriq,239766,NCI Thesaurus,ug/m2,166.0,136.0
SYNTHETIC-6,DONOR_2649,TREATMENT_11149,Other immunomodulatory substances,Tagrisso,8836851,,ug/m2,,163.0
SYNTHETIC-6,DONOR_2650,TREATMENT_11150,Other immunomodulatory substances,Ibrance,4459876,NCI Thesaurus,ug/m2,164.0,
SYNTHETIC-6,DONOR_2651,TREATMENT_11151,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,ug/m2,72.0,77.0
SYNTHETIC-6,DONOR_2652,TREATMENT_11152,Immune checkpoint inhibitors,Brigatinib,278936,RxNorm,g/m2,81.0,
SYNTHETIC-6,DONOR_2653,TREATMENT_11153,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,278936,PubChem,IU/kg,73.0,120.0
SYNTHETIC-6,DONOR_2654,TREATMENT_11154,Other immunomodulatory substances,Zejula,,PubChem,mg/m2,110.0,72.0
SYNTHETIC-6,DONOR_2655,TREATMENT_11155,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,987654,PubChem,g/m2,127.0,96.0
SYNTHETIC-6,DONOR_2656,TREATMENT_11156,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,RxNorm,cells/kg,,54.0
SYNTHETIC-6,DONOR_2657,TREATMENT_11157,Immune checkpoint inhibitors,Zelboraf,4459876,PubChem,,192.0,53.0
SYNTHETIC-6,DONOR_2658,TREATMENT_11158,Immune checkpoint inhibitors,Keytruda,,NCI Thesaurus,mg/m2,127.0,187.0
SYNTHETIC-6,DONOR_2659,TREATMENT_11159,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,239766,RxNorm,ug/m2,127.0,167.0
SYNTHETIC-6,DONOR_2660,TREATMENT_11160,Cell-based,Tisagenlecleucel,4459876,PubChem,mg/kg,152.0,116.0
SYNTHETIC-6,DONOR_2661,TREATMENT_11161,Other immunomodulatory substances,Axicabtagene ciloleucel,278936,NCI Thesaurus,ug/m2,128.0,114.0
SYNTHETIC-6,DONOR_2662,TREATMENT_11162,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,4459876,RxNorm,ug/m2,159.0,
SYNTHETIC-6,DONOR_2663,TREATMENT_11163,Other immunomodulatory substances,Nivolumab,239766,RxNorm,g/m2,51.0,184.0
SYNTHETIC-6,DONOR_2664,TREATMENT_11164,Cell-based,Ipilimumab,4459876,RxNorm,g/m2,95.0,
SYNTHETIC-6,DONOR_2665,TREATMENT_11165,Cell-based,Tecentriq,8836851,PubChem,IU/kg,103.0,105.0
SYNTHETIC-6,DONOR_2666,TREATMENT_11166,Other immunomodulatory substances,Cometriq,239766,RxNorm,mg/m2,117.0,142.0
SYNTHETIC-6,DONOR_2667,TREATMENT_11167,,Enhertu,239766,PubChem,IU/m2,102.0,65.0
SYNTHETIC-6,DONOR_2668,TREATMENT_11168,,Alunbrig,4459876,RxNorm,IU/m2,141.0,114.0
SYNTHETIC-6,DONOR_2669,TREATMENT_11169,Cell-based,Afatinib,,NCI Thesaurus,cells/kg,,
SYNTHETIC-6,DONOR_2670,TREATMENT_11170,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,PubChem,cells/kg,165.0,128.0
SYNTHETIC-6,DONOR_2671,TREATMENT_11171,Immune checkpoint inhibitors,Nexavar,278936,NCI Thesaurus,,70.0,57.0
SYNTHETIC-6,DONOR_2672,TREATMENT_11172,Other immunomodulatory substances,Cotellic,8836851,NCI Thesaurus,,112.0,56.0
SYNTHETIC-6,DONOR_2673,TREATMENT_11173,Immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,,111.0,80.0
SYNTHETIC-6,DONOR_2674,TREATMENT_11174,Other immunomodulatory substances,Necitumumab,239766,PubChem,ug/m2,164.0,
SYNTHETIC-6,DONOR_2675,TREATMENT_11175,Cell-based,Zejula,278936,NCI Thesaurus,cells/kg,52.0,134.0
SYNTHETIC-6,DONOR_2676,TREATMENT_11176,Cell-based,Erlotinib,4459876,RxNorm,mg/m2,107.0,51.0
SYNTHETIC-6,DONOR_2677,TREATMENT_11177,Immune checkpoint inhibitors,Herceptin,8836851,NCI Thesaurus,mg/m2,62.0,161.0
SYNTHETIC-6,DONOR_2678,TREATMENT_11178,Cell-based,Inotuzumab ozogamicin,239766,RxNorm,IU/kg,173.0,144.0
SYNTHETIC-6,DONOR_2679,TREATMENT_11179,Immune checkpoint inhibitors,Vandetanib,8756456,NCI Thesaurus,g/m2,67.0,147.0
SYNTHETIC-6,DONOR_2680,TREATMENT_11180,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,8756456,NCI Thesaurus,IU/m2,137.0,162.0
SYNTHETIC-6,DONOR_2681,TREATMENT_11181,Immune checkpoint inhibitors,Tafinlar,8836851,PubChem,IU/m2,67.0,156.0
SYNTHETIC-6,DONOR_2682,TREATMENT_11182,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,8756456,PubChem,IU/m2,73.0,
SYNTHETIC-6,DONOR_2683,TREATMENT_11183,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,278936,RxNorm,mg/m2,118.0,119.0
SYNTHETIC-6,DONOR_2684,TREATMENT_11184,Cell-based,Alunbrig,8756456,RxNorm,,171.0,131.0
SYNTHETIC-6,DONOR_2685,TREATMENT_11185,Cell-based,Fam-trastuzumab deruxtecan-nxki,4459876,RxNorm,g/m2,113.0,193.0
SYNTHETIC-6,DONOR_2686,TREATMENT_11186,Immune checkpoint inhibitors,Abemaciclib,8756456,PubChem,mg/kg,195.0,195.0
SYNTHETIC-6,DONOR_2687,TREATMENT_11187,Cell-based,Darzalex,8756456,NCI Thesaurus,mg/m2,159.0,55.0
SYNTHETIC-6,DONOR_2688,TREATMENT_11188,Cell-based,Copanlisib,278936,NCI Thesaurus,cells/kg,50.0,
SYNTHETIC-6,DONOR_2689,TREATMENT_11189,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,,mg/kg,71.0,200.0
SYNTHETIC-6,DONOR_2690,TREATMENT_11190,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,NCI Thesaurus,,155.0,
SYNTHETIC-6,DONOR_2691,TREATMENT_11191,Other immunomodulatory substances,Gefitinib,8836851,,mg/kg,,
SYNTHETIC-6,DONOR_2692,TREATMENT_11192,Other immunomodulatory substances,Vemurafenib,987654,NCI Thesaurus,cells/kg,,195.0
SYNTHETIC-6,DONOR_2693,TREATMENT_11193,Other immunomodulatory substances,Vandetanib,,NCI Thesaurus,mg/m2,98.0,80.0
SYNTHETIC-6,DONOR_2694,TREATMENT_11194,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,8756456,NCI Thesaurus,mg/m2,,138.0
SYNTHETIC-6,DONOR_2695,TREATMENT_11195,Cell-based,Alunbrig,987654,,cells/kg,160.0,84.0
SYNTHETIC-6,DONOR_2696,TREATMENT_11196,Immune checkpoint inhibitors,Zykadia,,PubChem,mg/kg,177.0,128.0
SYNTHETIC-6,DONOR_2697,TREATMENT_11197,Other immunomodulatory substances,,8756456,RxNorm,g/m2,147.0,109.0
SYNTHETIC-6,DONOR_2698,TREATMENT_11198,Cell-based,Keytruda,8756456,PubChem,,,132.0
SYNTHETIC-6,DONOR_2699,TREATMENT_11199,Other immunomodulatory substances,Pexidartinib,8836851,RxNorm,mg/m2,165.0,109.0
SYNTHETIC-6,DONOR_2700,TREATMENT_11200,Immune checkpoint inhibitors,,239766,,IU/kg,144.0,93.0
SYNTHETIC-6,DONOR_2701,TREATMENT_11201,Immune checkpoint inhibitors,Cotellic,4459876,RxNorm,ug/m2,179.0,117.0
SYNTHETIC-6,DONOR_2702,TREATMENT_11202,Other immunomodulatory substances,,4459876,PubChem,ug/m2,61.0,118.0
SYNTHETIC-6,DONOR_2703,TREATMENT_11203,Other immunomodulatory substances,Belantamab,,,ug/m2,67.0,
SYNTHETIC-6,DONOR_2704,TREATMENT_11204,Cell-based,,8756456,NCI Thesaurus,,181.0,114.0
SYNTHETIC-6,DONOR_2705,TREATMENT_11205,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,987654,RxNorm,IU/kg,83.0,146.0
SYNTHETIC-6,DONOR_2706,TREATMENT_11206,Cell-based,Verzenio,987654,RxNorm,mg/m2,,164.0
SYNTHETIC-6,DONOR_2707,TREATMENT_11207,Cell-based,Braftovi,987654,PubChem,IU/m2,101.0,160.0
SYNTHETIC-6,DONOR_2708,TREATMENT_11208,,Erlotinib,8836851,RxNorm,IU/kg,176.0,150.0
SYNTHETIC-6,DONOR_2709,TREATMENT_11209,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,4459876,PubChem,,108.0,188.0
SYNTHETIC-6,DONOR_2710,TREATMENT_11210,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8756456,PubChem,g/m2,,128.0
SYNTHETIC-6,DONOR_2711,TREATMENT_11211,Immune checkpoint inhibitors,Durvalumab,987654,RxNorm,cells/kg,,
SYNTHETIC-6,DONOR_2712,TREATMENT_11212,Immune checkpoint inhibitors,,987654,NCI Thesaurus,cells/kg,129.0,160.0
SYNTHETIC-6,DONOR_2713,TREATMENT_11213,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,PubChem,mg/kg,97.0,158.0
SYNTHETIC-6,DONOR_2714,TREATMENT_11214,Immune checkpoint inhibitors,Durvalumab,239766,NCI Thesaurus,mg/kg,,87.0
SYNTHETIC-6,DONOR_2715,TREATMENT_11215,Cell-based,Fam-trastuzumab deruxtecan-nxki,987654,PubChem,IU/m2,,
SYNTHETIC-6,DONOR_2716,TREATMENT_11216,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,8756456,PubChem,cells/kg,78.0,50.0
SYNTHETIC-6,DONOR_2717,TREATMENT_11217,Other immunomodulatory substances,Iressa,8836851,NCI Thesaurus,ug/m2,67.0,115.0
SYNTHETIC-6,DONOR_2718,TREATMENT_11218,Other immunomodulatory substances,Lenvatinib,,RxNorm,ug/m2,151.0,69.0
SYNTHETIC-6,DONOR_2719,TREATMENT_11219,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,278936,RxNorm,IU/m2,146.0,146.0
SYNTHETIC-6,DONOR_2720,TREATMENT_11220,Cell-based,Perjeta,8756456,NCI Thesaurus,ug/m2,80.0,60.0
SYNTHETIC-6,DONOR_2721,TREATMENT_11221,Cell-based,Venetoclax,8836851,PubChem,ug/m2,196.0,53.0
SYNTHETIC-6,DONOR_2722,TREATMENT_11222,,Opdivo,8756456,NCI Thesaurus,IU/m2,119.0,61.0
SYNTHETIC-6,DONOR_2723,TREATMENT_11223,Other immunomodulatory substances,Lynparza,,RxNorm,mg/kg,,
SYNTHETIC-6,DONOR_2724,TREATMENT_11224,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,4459876,NCI Thesaurus,cells/kg,90.0,96.0
SYNTHETIC-6,DONOR_2725,TREATMENT_11225,Other immunomodulatory substances,,,RxNorm,,85.0,56.0
SYNTHETIC-6,DONOR_2726,TREATMENT_11226,Immune checkpoint inhibitors,Ipilimumab,8836851,RxNorm,cells/kg,120.0,108.0
SYNTHETIC-6,DONOR_2727,TREATMENT_11227,Cell-based,Tarceva,4459876,,g/m2,,195.0
SYNTHETIC-6,DONOR_2728,TREATMENT_11228,Immune checkpoint inhibitors,Durvalumab,8756456,,IU/m2,100.0,104.0
SYNTHETIC-6,DONOR_2729,TREATMENT_11229,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,,PubChem,,172.0,90.0
SYNTHETIC-6,DONOR_2730,TREATMENT_11230,Immune checkpoint inhibitors,Abemaciclib,239766,NCI Thesaurus,IU/kg,180.0,119.0
SYNTHETIC-6,DONOR_2731,TREATMENT_11231,Immune checkpoint inhibitors,Tafinlar,8756456,PubChem,IU/kg,164.0,
SYNTHETIC-6,DONOR_2732,TREATMENT_11232,,Trametinib,8836851,RxNorm,g/m2,182.0,76.0
SYNTHETIC-6,DONOR_2733,TREATMENT_11233,,Pembrolizumab,239766,NCI Thesaurus,mg/kg,,
SYNTHETIC-6,DONOR_2734,TREATMENT_11234,Cell-based,Ipilimumab,239766,RxNorm,IU/kg,107.0,
SYNTHETIC-6,DONOR_2735,TREATMENT_11235,,,987654,,ug/m2,156.0,60.0
SYNTHETIC-6,DONOR_2736,TREATMENT_11236,Cell-based,Atezolizumab,8756456,RxNorm,g/m2,79.0,74.0
SYNTHETIC-6,DONOR_2737,TREATMENT_11237,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,987654,RxNorm,g/m2,174.0,185.0
SYNTHETIC-6,DONOR_2738,TREATMENT_11238,Immune checkpoint inhibitors,Verzenio,8836851,RxNorm,,119.0,163.0
SYNTHETIC-6,DONOR_2739,TREATMENT_11239,,Imfinzi,,PubChem,mg/m2,147.0,144.0
SYNTHETIC-6,DONOR_2740,TREATMENT_11240,Immune checkpoint inhibitors,Copanlisib,8756456,NCI Thesaurus,IU/m2,137.0,151.0
SYNTHETIC-6,DONOR_2741,TREATMENT_11241,Cell-based,Nivolumab,278936,RxNorm,,137.0,156.0
SYNTHETIC-6,DONOR_2742,TREATMENT_11242,,,8756456,NCI Thesaurus,IU/m2,75.0,121.0
SYNTHETIC-6,DONOR_2743,TREATMENT_11243,Immune checkpoint inhibitors,Belantamab,8836851,NCI Thesaurus,IU/m2,105.0,124.0
SYNTHETIC-6,DONOR_2744,TREATMENT_11244,Immune checkpoint inhibitors,Necitumumab,8836851,PubChem,g/m2,195.0,81.0
SYNTHETIC-6,DONOR_2745,TREATMENT_11245,Immune checkpoint inhibitors,Yescarta,278936,NCI Thesaurus,cells/kg,190.0,112.0
SYNTHETIC-6,DONOR_2746,TREATMENT_11246,Cell-based,Gilteritinib,4459876,RxNorm,g/m2,96.0,94.0
SYNTHETIC-6,DONOR_2747,TREATMENT_11247,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,RxNorm,mg/kg,,149.0
SYNTHETIC-6,DONOR_2748,TREATMENT_11248,Other immunomodulatory substances,Yervoy,8836851,RxNorm,IU/kg,109.0,114.0
SYNTHETIC-6,DONOR_2749,TREATMENT_11249,Immune checkpoint inhibitors,Xalkori,278936,PubChem,g/m2,171.0,138.0
SYNTHETIC-6,DONOR_2750,TREATMENT_11250,Cell-based,Palbociclib,8756456,PubChem,g/m2,61.0,183.0
SYNTHETIC-6,DONOR_2751,TREATMENT_11251,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,RxNorm,mg/m2,137.0,110.0
SYNTHETIC-6,DONOR_2752,TREATMENT_11252,Other immunomodulatory substances,Rubraca,4459876,PubChem,IU/kg,124.0,78.0
SYNTHETIC-6,DONOR_2753,TREATMENT_11253,Other immunomodulatory substances,,239766,RxNorm,,128.0,175.0
SYNTHETIC-6,DONOR_2754,TREATMENT_11254,Other immunomodulatory substances,Enhertu,278936,PubChem,IU/m2,114.0,192.0
SYNTHETIC-6,DONOR_2755,TREATMENT_11255,Other immunomodulatory substances,Alecensa,239766,NCI Thesaurus,ug/m2,188.0,
SYNTHETIC-6,DONOR_2756,TREATMENT_11256,Other immunomodulatory substances,Opdivo,8836851,RxNorm,mg/m2,99.0,141.0
SYNTHETIC-6,DONOR_2757,TREATMENT_11257,Other immunomodulatory substances,Crizotinib,987654,PubChem,ug/m2,52.0,135.0
SYNTHETIC-6,DONOR_2758,TREATMENT_11258,Cell-based,Braftovi,278936,,mg/kg,112.0,
SYNTHETIC-6,DONOR_2759,TREATMENT_11259,Other immunomodulatory substances,Herceptin,8836851,PubChem,mg/m2,186.0,137.0
SYNTHETIC-6,DONOR_2760,TREATMENT_11260,Immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,ug/m2,143.0,187.0
SYNTHETIC-6,DONOR_2761,TREATMENT_11261,Immune checkpoint inhibitors,Opdivo,8756456,PubChem,mg/kg,72.0,91.0
SYNTHETIC-6,DONOR_2762,TREATMENT_11262,Other immunomodulatory substances,Nivolumab,4459876,PubChem,cells/kg,94.0,193.0
SYNTHETIC-6,DONOR_2763,TREATMENT_11263,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,278936,RxNorm,mg/kg,67.0,180.0
SYNTHETIC-6,DONOR_2764,TREATMENT_11264,Immune checkpoint inhibitors,Necitumumab,8756456,,IU/kg,97.0,147.0
SYNTHETIC-6,DONOR_2765,TREATMENT_11265,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,4459876,RxNorm,IU/kg,137.0,155.0
SYNTHETIC-6,DONOR_2766,TREATMENT_11266,,Cobimetinib,278936,PubChem,,194.0,79.0
SYNTHETIC-6,DONOR_2767,TREATMENT_11267,,Xalkori,987654,RxNorm,g/m2,164.0,153.0
SYNTHETIC-6,DONOR_2768,TREATMENT_11268,Cell-based,Nexavar,987654,,ug/m2,76.0,181.0
SYNTHETIC-6,DONOR_2769,TREATMENT_11269,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,278936,NCI Thesaurus,g/m2,63.0,189.0
SYNTHETIC-6,DONOR_2770,TREATMENT_11270,Immune checkpoint inhibitors,Atezolizumab,8756456,PubChem,mg/m2,193.0,167.0
SYNTHETIC-6,DONOR_2771,TREATMENT_11271,Other immunomodulatory substances,Atezolizumab,,,g/m2,129.0,106.0
SYNTHETIC-6,DONOR_2772,TREATMENT_11272,Other immunomodulatory substances,Brentuximab vedotin,8836851,,mg/kg,,111.0
SYNTHETIC-6,DONOR_2773,TREATMENT_11273,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,RxNorm,mg/m2,97.0,194.0
SYNTHETIC-6,DONOR_2774,TREATMENT_11274,Immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,IU/m2,55.0,
SYNTHETIC-6,DONOR_2775,TREATMENT_11275,Immune checkpoint inhibitors,Keytruda,8756456,RxNorm,mg/m2,101.0,75.0
SYNTHETIC-6,DONOR_2776,TREATMENT_11276,Other immunomodulatory substances,Mekinist,987654,NCI Thesaurus,ug/m2,181.0,124.0
SYNTHETIC-6,DONOR_2777,TREATMENT_11277,Other immunomodulatory substances,Ibrance,8836851,NCI Thesaurus,mg/m2,161.0,95.0
SYNTHETIC-6,DONOR_2778,TREATMENT_11278,Cell-based,Belantamab,987654,NCI Thesaurus,cells/kg,187.0,109.0
SYNTHETIC-6,DONOR_2779,TREATMENT_11279,Other immunomodulatory substances,Rituximab,8756456,RxNorm,cells/kg,64.0,66.0
SYNTHETIC-6,DONOR_2780,TREATMENT_11280,Cell-based,Opdivo,987654,RxNorm,IU/m2,147.0,180.0
SYNTHETIC-6,DONOR_2781,TREATMENT_11281,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,4459876,NCI Thesaurus,g/m2,83.0,121.0
SYNTHETIC-6,DONOR_2782,TREATMENT_11282,Immune checkpoint inhibitors,Trastuzumab,239766,,ug/m2,144.0,74.0
SYNTHETIC-6,DONOR_2783,TREATMENT_11283,Other immunomodulatory substances,Yescarta,8836851,NCI Thesaurus,,,72.0
SYNTHETIC-6,DONOR_2784,TREATMENT_11284,Other immunomodulatory substances,Axicabtagene ciloleucel,8836851,RxNorm,IU/kg,144.0,103.0
SYNTHETIC-6,DONOR_2785,TREATMENT_11285,Other immunomodulatory substances,Zejula,,PubChem,IU/m2,104.0,100.0
SYNTHETIC-6,DONOR_2786,TREATMENT_11286,Cell-based,Inotuzumab ozogamicin,239766,PubChem,IU/m2,59.0,125.0
SYNTHETIC-6,DONOR_2787,TREATMENT_11287,Cell-based,Atezolizumab,278936,NCI Thesaurus,g/m2,,62.0
SYNTHETIC-6,DONOR_2788,TREATMENT_11288,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,4459876,PubChem,mg/kg,132.0,58.0
SYNTHETIC-6,DONOR_2789,TREATMENT_11289,Immune checkpoint inhibitors,Kymriah,4459876,NCI Thesaurus,g/m2,71.0,89.0
SYNTHETIC-6,DONOR_2790,TREATMENT_11290,Other immunomodulatory substances,Gazyva,,RxNorm,ug/m2,112.0,163.0
SYNTHETIC-6,DONOR_2791,TREATMENT_11291,Immune checkpoint inhibitors,Atezolizumab,987654,NCI Thesaurus,g/m2,67.0,83.0
SYNTHETIC-6,DONOR_2792,TREATMENT_11292,Cell-based,Durvalumab,,,IU/kg,192.0,73.0
SYNTHETIC-6,DONOR_2793,TREATMENT_11293,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,278936,NCI Thesaurus,IU/kg,,179.0
SYNTHETIC-6,DONOR_2794,TREATMENT_11294,Cell-based,Rituximab,4459876,NCI Thesaurus,ug/m2,188.0,92.0
SYNTHETIC-6,DONOR_2795,TREATMENT_11295,,Verzenio,8836851,,,,200.0
SYNTHETIC-6,DONOR_2796,TREATMENT_11296,Cell-based,Rubraca,8836851,NCI Thesaurus,mg/kg,78.0,150.0
SYNTHETIC-6,DONOR_2797,TREATMENT_11297,Cell-based,Nivolumab,4459876,NCI Thesaurus,mg/kg,192.0,57.0
SYNTHETIC-6,DONOR_2798,TREATMENT_11298,,Mektovi,278936,RxNorm,IU/m2,,
SYNTHETIC-6,DONOR_2799,TREATMENT_11299,,Vandetanib,239766,PubChem,,130.0,80.0
SYNTHETIC-6,DONOR_2800,TREATMENT_11300,Immune checkpoint inhibitors,,,RxNorm,IU/kg,128.0,
SYNTHETIC-6,DONOR_2801,TREATMENT_11301,Immune checkpoint inhibitors,Ceritinib,,,,58.0,78.0
SYNTHETIC-6,DONOR_2802,TREATMENT_11302,Other immunomodulatory substances,Atezolizumab,8836851,RxNorm,mg/kg,76.0,129.0
SYNTHETIC-6,DONOR_2803,TREATMENT_11303,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,8756456,RxNorm,g/m2,193.0,164.0
SYNTHETIC-6,DONOR_2804,TREATMENT_11304,Cell-based,Xalkori,8836851,NCI Thesaurus,,102.0,129.0
SYNTHETIC-6,DONOR_2805,TREATMENT_11305,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,cells/kg,118.0,172.0
SYNTHETIC-6,DONOR_2806,TREATMENT_11306,,Kisqali,239766,PubChem,,,60.0
SYNTHETIC-6,DONOR_2807,TREATMENT_11307,Immune checkpoint inhibitors,Nexavar,278936,RxNorm,g/m2,80.0,86.0
SYNTHETIC-6,DONOR_2808,TREATMENT_11308,Immune checkpoint inhibitors,Venetoclax,239766,NCI Thesaurus,g/m2,82.0,115.0
SYNTHETIC-6,DONOR_2809,TREATMENT_11309,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,,IU/kg,57.0,
SYNTHETIC-6,DONOR_2810,TREATMENT_11310,Cell-based,Durvalumab,239766,PubChem,IU/kg,82.0,68.0
SYNTHETIC-6,DONOR_2811,TREATMENT_11311,Other immunomodulatory substances,Opdivo,,PubChem,IU/kg,101.0,194.0
SYNTHETIC-6,DONOR_2812,TREATMENT_11312,Immune checkpoint inhibitors,Lynparza,987654,PubChem,g/m2,155.0,123.0
SYNTHETIC-6,DONOR_2813,TREATMENT_11313,Immune checkpoint inhibitors,Atezolizumab,987654,RxNorm,mg/m2,194.0,
SYNTHETIC-6,DONOR_2814,TREATMENT_11314,Cell-based,Atezolizumab,8756456,NCI Thesaurus,mg/m2,111.0,51.0
SYNTHETIC-6,DONOR_2815,TREATMENT_11315,Cell-based,Ibrance,,PubChem,IU/kg,128.0,142.0
SYNTHETIC-6,DONOR_2816,TREATMENT_11316,Immune checkpoint inhibitors,Rituximab,8756456,,ug/m2,,
SYNTHETIC-6,DONOR_2817,TREATMENT_11317,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,278936,PubChem,mg/kg,170.0,
SYNTHETIC-6,DONOR_2818,TREATMENT_11318,Immune checkpoint inhibitors,Nivolumab,278936,NCI Thesaurus,mg/m2,151.0,83.0
SYNTHETIC-6,DONOR_2819,TREATMENT_11319,Other immunomodulatory substances,Atezolizumab,4459876,RxNorm,IU/kg,139.0,133.0
SYNTHETIC-6,DONOR_2820,TREATMENT_11320,Other immunomodulatory substances,Daratumumab,278936,NCI Thesaurus,IU/m2,137.0,115.0
SYNTHETIC-6,DONOR_2821,TREATMENT_11321,Cell-based,Tecentriq,4459876,RxNorm,IU/kg,67.0,166.0
SYNTHETIC-6,DONOR_2822,TREATMENT_11322,,Nivolumab,239766,NCI Thesaurus,mg/kg,90.0,175.0
SYNTHETIC-6,DONOR_2823,TREATMENT_11323,Immune checkpoint inhibitors,Zelboraf,4459876,NCI Thesaurus,IU/m2,158.0,179.0
SYNTHETIC-6,DONOR_2824,TREATMENT_11324,Immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,cells/kg,,83.0
SYNTHETIC-6,DONOR_2825,TREATMENT_11325,Other immunomodulatory substances,Perjeta,8836851,RxNorm,mg/kg,160.0,71.0
SYNTHETIC-6,DONOR_2826,TREATMENT_11326,,Encorafenib,278936,PubChem,cells/kg,136.0,107.0
SYNTHETIC-6,DONOR_2827,TREATMENT_11327,Other immunomodulatory substances,,278936,PubChem,cells/kg,60.0,144.0
SYNTHETIC-6,DONOR_2828,TREATMENT_11328,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,PubChem,IU/m2,199.0,110.0
SYNTHETIC-6,DONOR_2829,TREATMENT_11329,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,g/m2,126.0,59.0
SYNTHETIC-6,DONOR_2830,TREATMENT_11330,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,4459876,PubChem,g/m2,177.0,117.0
SYNTHETIC-6,DONOR_2831,TREATMENT_11331,Immune checkpoint inhibitors,Mekinist,4459876,NCI Thesaurus,ug/m2,,56.0
SYNTHETIC-6,DONOR_2832,TREATMENT_11332,Cell-based,Afatinib,278936,RxNorm,IU/kg,65.0,72.0
SYNTHETIC-6,DONOR_2833,TREATMENT_11333,Cell-based,Gazyva,987654,NCI Thesaurus,IU/kg,161.0,86.0
SYNTHETIC-6,DONOR_2834,TREATMENT_11334,Cell-based,Durvalumab,278936,PubChem,cells/kg,51.0,153.0
SYNTHETIC-6,DONOR_2835,TREATMENT_11335,Immune checkpoint inhibitors,,239766,PubChem,cells/kg,59.0,118.0
SYNTHETIC-6,DONOR_2836,TREATMENT_11336,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,,IU/kg,83.0,158.0
SYNTHETIC-6,DONOR_2837,TREATMENT_11337,Immune checkpoint inhibitors,Besponsa,8756456,NCI Thesaurus,IU/m2,145.0,52.0
SYNTHETIC-6,DONOR_2838,TREATMENT_11338,,Brigatinib,4459876,NCI Thesaurus,IU/m2,107.0,
SYNTHETIC-6,DONOR_2839,TREATMENT_11339,Cell-based,,239766,RxNorm,IU/kg,,136.0
SYNTHETIC-6,DONOR_2840,TREATMENT_11340,Other immunomodulatory substances,Kisqali,239766,RxNorm,IU/kg,,165.0
SYNTHETIC-6,DONOR_2841,TREATMENT_11341,Other immunomodulatory substances,Mekinist,4459876,NCI Thesaurus,,195.0,159.0
SYNTHETIC-6,DONOR_2842,TREATMENT_11342,Cell-based,Cabozantinib,239766,RxNorm,g/m2,57.0,68.0
SYNTHETIC-6,DONOR_2843,TREATMENT_11343,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,,,IU/kg,,55.0
SYNTHETIC-6,DONOR_2844,TREATMENT_11344,,Durvalumab,239766,PubChem,mg/kg,75.0,158.0
SYNTHETIC-6,DONOR_2845,TREATMENT_11345,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,8756456,,ug/m2,75.0,144.0
SYNTHETIC-6,DONOR_2846,TREATMENT_11346,Cell-based,Erlotinib,8836851,RxNorm,,75.0,154.0
SYNTHETIC-6,DONOR_2847,TREATMENT_11347,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,987654,NCI Thesaurus,cells/kg,,52.0
SYNTHETIC-6,DONOR_2848,TREATMENT_11348,Cell-based,Imfinzi,239766,RxNorm,IU/m2,72.0,83.0
SYNTHETIC-6,DONOR_2849,TREATMENT_11349,Other immunomodulatory substances,Nivolumab,,NCI Thesaurus,g/m2,116.0,193.0
SYNTHETIC-6,DONOR_2850,TREATMENT_11350,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,239766,PubChem,mg/m2,102.0,78.0
SYNTHETIC-6,DONOR_2851,TREATMENT_11351,Cell-based,Nivolumab,239766,RxNorm,g/m2,152.0,
SYNTHETIC-6,DONOR_2852,TREATMENT_11352,Immune checkpoint inhibitors,Necitumumab,8756456,,g/m2,155.0,
SYNTHETIC-6,DONOR_2853,TREATMENT_11353,Cell-based,Lenvima,8756456,NCI Thesaurus,ug/m2,189.0,
SYNTHETIC-6,DONOR_2854,TREATMENT_11354,Cell-based,Tisagenlecleucel,987654,RxNorm,mg/m2,191.0,131.0
SYNTHETIC-6,DONOR_2855,TREATMENT_11355,Immune checkpoint inhibitors,Alunbrig,239766,NCI Thesaurus,mg/kg,73.0,156.0
SYNTHETIC-6,DONOR_2856,TREATMENT_11356,Other immunomodulatory substances,Lenvatinib,8836851,NCI Thesaurus,mg/kg,70.0,109.0
SYNTHETIC-6,DONOR_2857,TREATMENT_11357,Cell-based,,239766,RxNorm,IU/kg,167.0,51.0
SYNTHETIC-6,DONOR_2858,TREATMENT_11358,Cell-based,Tecentriq,,RxNorm,IU/m2,98.0,111.0
SYNTHETIC-6,DONOR_2859,TREATMENT_11359,Cell-based,Tisagenlecleucel,8756456,NCI Thesaurus,g/m2,132.0,68.0
SYNTHETIC-6,DONOR_2860,TREATMENT_11360,Cell-based,Belantamab,987654,RxNorm,g/m2,129.0,95.0
SYNTHETIC-6,DONOR_2861,TREATMENT_11361,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,PubChem,mg/kg,153.0,105.0
SYNTHETIC-6,DONOR_2862,TREATMENT_11362,Other immunomodulatory substances,,,,cells/kg,110.0,175.0
SYNTHETIC-6,DONOR_2863,TREATMENT_11363,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,RxNorm,ug/m2,61.0,119.0
SYNTHETIC-6,DONOR_2864,TREATMENT_11364,Immune checkpoint inhibitors,Vandetanib,8756456,RxNorm,,93.0,70.0
SYNTHETIC-6,DONOR_2865,TREATMENT_11365,Immune checkpoint inhibitors,Vemurafenib,278936,PubChem,,70.0,106.0
SYNTHETIC-6,DONOR_2866,TREATMENT_11366,Immune checkpoint inhibitors,Nivolumab,8836851,RxNorm,ug/m2,168.0,102.0
SYNTHETIC-6,DONOR_2867,TREATMENT_11367,,,278936,NCI Thesaurus,,110.0,82.0
SYNTHETIC-6,DONOR_2868,TREATMENT_11368,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,PubChem,IU/kg,94.0,81.0
SYNTHETIC-6,DONOR_2869,TREATMENT_11369,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,IU/kg,159.0,165.0
SYNTHETIC-6,DONOR_2870,TREATMENT_11370,Other immunomodulatory substances,Verzenio,239766,,cells/kg,79.0,83.0
SYNTHETIC-6,DONOR_2871,TREATMENT_11371,Other immunomodulatory substances,Ibrance,4459876,RxNorm,mg/m2,146.0,69.0
SYNTHETIC-6,DONOR_2872,TREATMENT_11372,Immune checkpoint inhibitors,Rituxan,239766,RxNorm,mg/m2,200.0,
SYNTHETIC-6,DONOR_2873,TREATMENT_11373,Immune checkpoint inhibitors,Yervoy,,PubChem,IU/kg,71.0,156.0
SYNTHETIC-6,DONOR_2874,TREATMENT_11374,Other immunomodulatory substances,,239766,NCI Thesaurus,mg/kg,188.0,163.0
SYNTHETIC-6,DONOR_2875,TREATMENT_11375,Cell-based,Kymriah,,NCI Thesaurus,mg/kg,75.0,97.0
SYNTHETIC-6,DONOR_2876,TREATMENT_11376,,Obinutuzumab,,NCI Thesaurus,g/m2,,95.0
SYNTHETIC-6,DONOR_2877,TREATMENT_11377,Cell-based,Opdivo,,NCI Thesaurus,IU/kg,,59.0
SYNTHETIC-6,DONOR_2878,TREATMENT_11378,Cell-based,Venetoclax,8756456,,cells/kg,126.0,159.0
SYNTHETIC-6,DONOR_2879,TREATMENT_11379,Other immunomodulatory substances,Ipilimumab,987654,PubChem,IU/m2,180.0,132.0
SYNTHETIC-6,DONOR_2880,TREATMENT_11380,Other immunomodulatory substances,Enhertu,4459876,PubChem,g/m2,69.0,
SYNTHETIC-6,DONOR_2881,TREATMENT_11381,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,,IU/kg,,200.0
SYNTHETIC-6,DONOR_2882,TREATMENT_11382,Other immunomodulatory substances,Opdivo,987654,RxNorm,mg/m2,,68.0
SYNTHETIC-6,DONOR_2883,TREATMENT_11383,Immune checkpoint inhibitors,,8836851,RxNorm,mg/m2,140.0,84.0
SYNTHETIC-6,DONOR_2884,TREATMENT_11384,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,987654,PubChem,g/m2,118.0,58.0
SYNTHETIC-6,DONOR_2885,TREATMENT_11385,Other immunomodulatory substances,Sorafenib,8756456,,mg/kg,,154.0
SYNTHETIC-6,DONOR_2886,TREATMENT_11386,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,8756456,RxNorm,ug/m2,173.0,
SYNTHETIC-6,DONOR_2887,TREATMENT_11387,Cell-based,Keytruda,8836851,PubChem,mg/kg,128.0,
SYNTHETIC-6,DONOR_2888,TREATMENT_11388,Cell-based,Ipilimumab,4459876,PubChem,ug/m2,185.0,119.0
SYNTHETIC-6,DONOR_2889,TREATMENT_11389,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,239766,RxNorm,mg/kg,163.0,65.0
SYNTHETIC-6,DONOR_2890,TREATMENT_11390,Other immunomodulatory substances,Dabrafenib,,NCI Thesaurus,IU/m2,50.0,136.0
SYNTHETIC-6,DONOR_2891,TREATMENT_11391,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,cells/kg,67.0,114.0
SYNTHETIC-6,DONOR_2892,TREATMENT_11392,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,IU/kg,189.0,103.0
SYNTHETIC-6,DONOR_2893,TREATMENT_11393,Cell-based,Ceritinib,8836851,RxNorm,cells/kg,198.0,54.0
SYNTHETIC-6,DONOR_2894,TREATMENT_11394,Cell-based,Kadcyla,278936,RxNorm,mg/kg,134.0,180.0
SYNTHETIC-6,DONOR_2895,TREATMENT_11395,Other immunomodulatory substances,Alectinib,4459876,NCI Thesaurus,ug/m2,110.0,145.0
SYNTHETIC-6,DONOR_2896,TREATMENT_11396,Immune checkpoint inhibitors,Kymriah,,PubChem,cells/kg,,58.0
SYNTHETIC-6,DONOR_2897,TREATMENT_11397,Immune checkpoint inhibitors,Yervoy,8756456,RxNorm,mg/m2,,
SYNTHETIC-6,DONOR_2898,TREATMENT_11398,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,987654,NCI Thesaurus,,,125.0
SYNTHETIC-6,DONOR_2899,TREATMENT_11399,Immune checkpoint inhibitors,Trametinib,,NCI Thesaurus,IU/m2,,83.0
SYNTHETIC-6,DONOR_2900,TREATMENT_11400,,Nexavar,4459876,,,167.0,74.0
SYNTHETIC-6,DONOR_2901,TREATMENT_11401,Other immunomodulatory substances,Nivolumab,8836851,PubChem,g/m2,136.0,100.0
SYNTHETIC-6,DONOR_2902,TREATMENT_11402,Immune checkpoint inhibitors,Zykadia,4459876,,g/m2,153.0,93.0
SYNTHETIC-6,DONOR_2903,TREATMENT_11403,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,4459876,NCI Thesaurus,mg/kg,87.0,136.0
SYNTHETIC-6,DONOR_2904,TREATMENT_11404,Other immunomodulatory substances,Palbociclib,239766,NCI Thesaurus,mg/kg,75.0,157.0
SYNTHETIC-6,DONOR_2905,TREATMENT_11405,Other immunomodulatory substances,Brentuximab vedotin,987654,RxNorm,IU/kg,122.0,190.0
SYNTHETIC-6,DONOR_2906,TREATMENT_11406,Cell-based,Copanlisib,239766,PubChem,mg/m2,,99.0
SYNTHETIC-6,DONOR_2907,TREATMENT_11407,Cell-based,Iressa,987654,RxNorm,ug/m2,111.0,174.0
SYNTHETIC-6,DONOR_2908,TREATMENT_11408,Cell-based,Ceritinib,239766,PubChem,mg/m2,142.0,85.0
SYNTHETIC-6,DONOR_2909,TREATMENT_11409,Other immunomodulatory substances,Ipilimumab,8836851,PubChem,g/m2,145.0,150.0
SYNTHETIC-6,DONOR_2910,TREATMENT_11410,Other immunomodulatory substances,Iressa,239766,NCI Thesaurus,mg/kg,190.0,
SYNTHETIC-6,DONOR_2911,TREATMENT_11411,Other immunomodulatory substances,Venetoclax,239766,NCI Thesaurus,ug/m2,91.0,
SYNTHETIC-6,DONOR_2912,TREATMENT_11412,Cell-based,Tafinlar,278936,NCI Thesaurus,mg/kg,193.0,77.0
SYNTHETIC-6,DONOR_2913,TREATMENT_11413,Cell-based,Binimetinib,987654,RxNorm,cells/kg,68.0,102.0
SYNTHETIC-6,DONOR_2914,TREATMENT_11414,Cell-based,Pembrolizumab,4459876,RxNorm,,64.0,136.0
SYNTHETIC-6,DONOR_2915,TREATMENT_11415,Cell-based,Tecentriq,4459876,RxNorm,mg/m2,136.0,
SYNTHETIC-6,DONOR_2916,TREATMENT_11416,Other immunomodulatory substances,Pexidartinib,4459876,PubChem,ug/m2,151.0,78.0
SYNTHETIC-6,DONOR_2917,TREATMENT_11417,Other immunomodulatory substances,Lenvatinib,987654,NCI Thesaurus,mg/m2,128.0,100.0
SYNTHETIC-6,DONOR_2918,TREATMENT_11418,Cell-based,Gazyva,239766,PubChem,IU/m2,,90.0
SYNTHETIC-6,DONOR_2919,TREATMENT_11419,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,278936,PubChem,g/m2,164.0,106.0
SYNTHETIC-6,DONOR_2920,TREATMENT_11420,Immune checkpoint inhibitors,Gilteritinib,8756456,NCI Thesaurus,cells/kg,165.0,190.0
SYNTHETIC-6,DONOR_2921,TREATMENT_11421,Other immunomodulatory substances,,4459876,PubChem,IU/m2,101.0,190.0
SYNTHETIC-6,DONOR_2922,TREATMENT_11422,Other immunomodulatory substances,Opdivo,8756456,,cells/kg,116.0,
SYNTHETIC-6,DONOR_2923,TREATMENT_11423,Immune checkpoint inhibitors,Blincyto,278936,RxNorm,,106.0,99.0
SYNTHETIC-6,DONOR_2924,TREATMENT_11424,Other immunomodulatory substances,Adcetris,4459876,RxNorm,g/m2,168.0,165.0
SYNTHETIC-6,DONOR_2925,TREATMENT_11425,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,278936,RxNorm,g/m2,102.0,94.0
SYNTHETIC-6,DONOR_2926,TREATMENT_11426,Cell-based,Pertuzumab,4459876,NCI Thesaurus,mg/m2,,155.0
SYNTHETIC-6,DONOR_2927,TREATMENT_11427,Other immunomodulatory substances,,278936,RxNorm,IU/m2,179.0,129.0
SYNTHETIC-6,DONOR_2928,TREATMENT_11428,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,239766,,,196.0,
SYNTHETIC-6,DONOR_2929,TREATMENT_11429,,Brentuximab vedotin,,PubChem,mg/kg,54.0,120.0
SYNTHETIC-6,DONOR_2930,TREATMENT_11430,Immune checkpoint inhibitors,Mektovi,987654,PubChem,g/m2,170.0,100.0
SYNTHETIC-6,DONOR_2931,TREATMENT_11431,Cell-based,Niraparib,8836851,PubChem,cells/kg,51.0,89.0
SYNTHETIC-6,DONOR_2932,TREATMENT_11432,Immune checkpoint inhibitors,Besponsa,4459876,RxNorm,IU/kg,197.0,
SYNTHETIC-6,DONOR_2933,TREATMENT_11433,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8836851,,mg/kg,,197.0
SYNTHETIC-6,DONOR_2934,TREATMENT_11434,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,278936,RxNorm,IU/m2,90.0,164.0
SYNTHETIC-6,DONOR_2935,TREATMENT_11435,Other immunomodulatory substances,Pembrolizumab,987654,RxNorm,,,195.0
SYNTHETIC-6,DONOR_2936,TREATMENT_11436,Immune checkpoint inhibitors,,278936,NCI Thesaurus,g/m2,123.0,67.0
SYNTHETIC-6,DONOR_2937,TREATMENT_11437,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,RxNorm,g/m2,,62.0
SYNTHETIC-6,DONOR_2938,TREATMENT_11438,,Alectinib,8756456,NCI Thesaurus,ug/m2,108.0,
SYNTHETIC-6,DONOR_2939,TREATMENT_11439,Other immunomodulatory substances,Nivolumab,8756456,NCI Thesaurus,cells/kg,139.0,78.0
SYNTHETIC-6,DONOR_2940,TREATMENT_11440,Other immunomodulatory substances,Erlotinib,278936,RxNorm,mg/m2,,66.0
SYNTHETIC-6,DONOR_2941,TREATMENT_11441,Immune checkpoint inhibitors,Tarceva,239766,,,169.0,159.0
SYNTHETIC-6,DONOR_2942,TREATMENT_11442,,Ipilimumab,4459876,NCI Thesaurus,g/m2,196.0,125.0
SYNTHETIC-6,DONOR_2943,TREATMENT_11443,Immune checkpoint inhibitors,Opdivo,8836851,RxNorm,cells/kg,168.0,125.0
SYNTHETIC-6,DONOR_2944,TREATMENT_11444,,Belantamab,8756456,PubChem,IU/m2,173.0,
SYNTHETIC-6,DONOR_2945,TREATMENT_11445,Immune checkpoint inhibitors,Necitumumab,8836851,NCI Thesaurus,g/m2,60.0,
SYNTHETIC-6,DONOR_2946,TREATMENT_11446,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,987654,RxNorm,g/m2,,161.0
SYNTHETIC-6,DONOR_2947,TREATMENT_11447,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8756456,PubChem,IU/m2,184.0,74.0
SYNTHETIC-6,DONOR_2948,TREATMENT_11448,Other immunomodulatory substances,Kymriah,,PubChem,cells/kg,93.0,
SYNTHETIC-6,DONOR_2949,TREATMENT_11449,Other immunomodulatory substances,Tecentriq,239766,,ug/m2,124.0,131.0
SYNTHETIC-6,DONOR_2950,TREATMENT_11450,Cell-based,Nivolumab,8756456,,ug/m2,130.0,88.0
SYNTHETIC-6,DONOR_2951,TREATMENT_11451,Immune checkpoint inhibitors,Caprelsa,8756456,RxNorm,mg/m2,98.0,158.0
SYNTHETIC-6,DONOR_2952,TREATMENT_11452,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,,g/m2,162.0,55.0
SYNTHETIC-6,DONOR_2953,TREATMENT_11453,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,278936,PubChem,mg/m2,146.0,111.0
SYNTHETIC-6,DONOR_2954,TREATMENT_11454,Other immunomodulatory substances,Atezolizumab,8836851,RxNorm,g/m2,196.0,61.0
SYNTHETIC-6,DONOR_2955,TREATMENT_11455,Other immunomodulatory substances,Palbociclib,278936,RxNorm,,172.0,143.0
SYNTHETIC-6,DONOR_2956,TREATMENT_11456,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,4459876,RxNorm,,69.0,53.0
SYNTHETIC-6,DONOR_2957,TREATMENT_11457,Cell-based,Pertuzumab,278936,PubChem,IU/m2,,65.0
SYNTHETIC-6,DONOR_2958,TREATMENT_11458,Other immunomodulatory substances,Tecentriq,,,mg/kg,,79.0
SYNTHETIC-6,DONOR_2959,TREATMENT_11459,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,RxNorm,cells/kg,,199.0
SYNTHETIC-6,DONOR_2960,TREATMENT_11460,Cell-based,Durvalumab,8756456,,cells/kg,88.0,51.0
SYNTHETIC-6,DONOR_2961,TREATMENT_11461,Immune checkpoint inhibitors,Lynparza,,RxNorm,cells/kg,167.0,114.0
SYNTHETIC-6,DONOR_2962,TREATMENT_11462,Other immunomodulatory substances,Zykadia,4459876,RxNorm,ug/m2,,71.0
SYNTHETIC-6,DONOR_2963,TREATMENT_11463,,Osimertinib,278936,NCI Thesaurus,cells/kg,162.0,112.0
SYNTHETIC-6,DONOR_2964,TREATMENT_11464,Immune checkpoint inhibitors,Adcetris,987654,RxNorm,,151.0,190.0
SYNTHETIC-6,DONOR_2965,TREATMENT_11465,Cell-based,Cobimetinib,987654,RxNorm,mg/kg,166.0,127.0
SYNTHETIC-6,DONOR_2966,TREATMENT_11466,Other immunomodulatory substances,Crizotinib,8836851,PubChem,mg/kg,122.0,98.0
SYNTHETIC-6,DONOR_2967,TREATMENT_11467,Other immunomodulatory substances,Belantamab,987654,NCI Thesaurus,IU/kg,131.0,103.0
SYNTHETIC-6,DONOR_2968,TREATMENT_11468,Immune checkpoint inhibitors,Nivolumab,987654,NCI Thesaurus,ug/m2,65.0,176.0
SYNTHETIC-6,DONOR_2969,TREATMENT_11469,Immune checkpoint inhibitors,Erlotinib,8756456,NCI Thesaurus,IU/kg,119.0,110.0
SYNTHETIC-6,DONOR_2970,TREATMENT_11470,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,g/m2,,75.0
SYNTHETIC-6,DONOR_2971,TREATMENT_11471,Cell-based,Palbociclib,4459876,RxNorm,mg/kg,148.0,
SYNTHETIC-6,DONOR_2972,TREATMENT_11472,Cell-based,Zejula,987654,PubChem,mg/m2,122.0,75.0
SYNTHETIC-6,DONOR_2973,TREATMENT_11473,Cell-based,,278936,NCI Thesaurus,mg/m2,190.0,85.0
SYNTHETIC-6,DONOR_2974,TREATMENT_11474,Cell-based,Daratumumab,8836851,NCI Thesaurus,,106.0,60.0
SYNTHETIC-6,DONOR_2975,TREATMENT_11475,Immune checkpoint inhibitors,Opdivo,239766,RxNorm,IU/kg,63.0,188.0
SYNTHETIC-6,DONOR_2976,TREATMENT_11476,Cell-based,Besponsa,987654,,IU/m2,136.0,
SYNTHETIC-6,DONOR_2977,TREATMENT_11477,Cell-based,Ipilimumab,8756456,PubChem,IU/kg,,163.0
SYNTHETIC-6,DONOR_2978,TREATMENT_11478,Cell-based,Mektovi,8756456,PubChem,cells/kg,129.0,135.0
SYNTHETIC-6,DONOR_2979,TREATMENT_11479,Cell-based,Erlotinib,987654,RxNorm,IU/kg,181.0,69.0
SYNTHETIC-6,DONOR_2980,TREATMENT_11480,Other immunomodulatory substances,Opdivo,239766,PubChem,,75.0,183.0
SYNTHETIC-6,DONOR_2981,TREATMENT_11481,Immune checkpoint inhibitors,Mektovi,4459876,RxNorm,cells/kg,70.0,154.0
SYNTHETIC-6,DONOR_2982,TREATMENT_11482,,Axicabtagene ciloleucel,987654,RxNorm,cells/kg,68.0,158.0
SYNTHETIC-6,DONOR_2983,TREATMENT_11483,Other immunomodulatory substances,Adcetris,4459876,PubChem,IU/m2,76.0,105.0
SYNTHETIC-6,DONOR_2984,TREATMENT_11484,Cell-based,Lenvima,987654,PubChem,mg/kg,169.0,175.0
SYNTHETIC-6,DONOR_2985,TREATMENT_11485,Cell-based,Yervoy,278936,NCI Thesaurus,,104.0,149.0
SYNTHETIC-6,DONOR_2986,TREATMENT_11486,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,cells/kg,193.0,108.0
SYNTHETIC-6,DONOR_2987,TREATMENT_11487,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,,cells/kg,158.0,168.0
SYNTHETIC-6,DONOR_2988,TREATMENT_11488,Other immunomodulatory substances,Trametinib,,RxNorm,g/m2,97.0,99.0
SYNTHETIC-6,DONOR_2989,TREATMENT_11489,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8756456,PubChem,g/m2,,159.0
SYNTHETIC-6,DONOR_2990,TREATMENT_11490,,Adcetris,8756456,PubChem,cells/kg,153.0,112.0
SYNTHETIC-6,DONOR_2991,TREATMENT_11491,Immune checkpoint inhibitors,Imfinzi,239766,PubChem,IU/m2,124.0,186.0
SYNTHETIC-6,DONOR_2992,TREATMENT_11492,Cell-based,Yervoy,278936,RxNorm,,70.0,183.0
SYNTHETIC-6,DONOR_2993,TREATMENT_11493,Other immunomodulatory substances,Imfinzi,987654,RxNorm,,67.0,161.0
SYNTHETIC-6,DONOR_2994,TREATMENT_11494,Cell-based,,8836851,RxNorm,IU/m2,173.0,68.0
SYNTHETIC-6,DONOR_2995,TREATMENT_11495,Cell-based,Tagrisso,987654,,g/m2,161.0,141.0
SYNTHETIC-6,DONOR_2996,TREATMENT_11496,Cell-based,Tisagenlecleucel,8756456,PubChem,g/m2,,140.0
SYNTHETIC-6,DONOR_2997,TREATMENT_11497,Cell-based,,8836851,RxNorm,ug/m2,160.0,
SYNTHETIC-6,DONOR_2998,TREATMENT_11498,Immune checkpoint inhibitors,Ipilimumab,8756456,PubChem,IU/m2,118.0,164.0
SYNTHETIC-6,DONOR_2999,TREATMENT_11499,,Ado-trastuzumab emtansine,8836851,NCI Thesaurus,mg/kg,174.0,83.0
SYNTHETIC-6,DONOR_3000,TREATMENT_11500,Cell-based,Rubraca,4459876,NCI Thesaurus,IU/kg,177.0,120.0
SYNTHETIC-6,DONOR_2501,TREATMENT_11501,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,239766,,cells/kg,57.0,183.0
SYNTHETIC-6,DONOR_2502,TREATMENT_11502,Other immunomodulatory substances,Alectinib,987654,RxNorm,IU/m2,,166.0
SYNTHETIC-6,DONOR_2503,TREATMENT_11503,,Trastuzumab,987654,PubChem,mg/m2,104.0,104.0
SYNTHETIC-6,DONOR_2504,TREATMENT_11504,Immune checkpoint inhibitors,Cotellic,239766,NCI Thesaurus,cells/kg,118.0,
SYNTHETIC-6,DONOR_2505,TREATMENT_11505,Immune checkpoint inhibitors,Pertuzumab,,RxNorm,IU/m2,,
SYNTHETIC-6,DONOR_2506,TREATMENT_11506,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,239766,PubChem,IU/kg,,127.0
SYNTHETIC-6,DONOR_2507,TREATMENT_11507,Immune checkpoint inhibitors,Tafinlar,987654,PubChem,,67.0,
SYNTHETIC-6,DONOR_2508,TREATMENT_11508,Other immunomodulatory substances,Mekinist,278936,RxNorm,mg/m2,172.0,134.0
SYNTHETIC-6,DONOR_2509,TREATMENT_11509,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,NCI Thesaurus,ug/m2,,187.0
SYNTHETIC-6,DONOR_2510,TREATMENT_11510,Other immunomodulatory substances,Mekinist,,PubChem,,186.0,137.0
SYNTHETIC-6,DONOR_2511,TREATMENT_11511,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,4459876,RxNorm,IU/m2,121.0,122.0
SYNTHETIC-6,DONOR_2512,TREATMENT_11512,Immune checkpoint inhibitors,Tagrisso,,NCI Thesaurus,IU/m2,117.0,70.0
SYNTHETIC-6,DONOR_2513,TREATMENT_11513,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,,ug/m2,120.0,107.0
SYNTHETIC-6,DONOR_2514,TREATMENT_11514,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,,,,149.0,172.0
SYNTHETIC-6,DONOR_2515,TREATMENT_11515,Cell-based,Verzenio,8836851,PubChem,,184.0,117.0
SYNTHETIC-6,DONOR_2516,TREATMENT_11516,,Keytruda,278936,NCI Thesaurus,mg/m2,129.0,158.0
SYNTHETIC-6,DONOR_2517,TREATMENT_11517,Cell-based,Keytruda,4459876,PubChem,IU/kg,57.0,168.0
SYNTHETIC-6,DONOR_2518,TREATMENT_11518,Other immunomodulatory substances,Lynparza,8756456,NCI Thesaurus,g/m2,171.0,74.0
SYNTHETIC-6,DONOR_2519,TREATMENT_11519,Immune checkpoint inhibitors,Keytruda,8836851,PubChem,,142.0,152.0
SYNTHETIC-6,DONOR_2520,TREATMENT_11520,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,8756456,RxNorm,,63.0,192.0
SYNTHETIC-6,DONOR_2521,TREATMENT_11521,Immune checkpoint inhibitors,Tagrisso,,,IU/kg,93.0,123.0
SYNTHETIC-6,DONOR_2522,TREATMENT_11522,,Kisqali,,PubChem,cells/kg,82.0,
SYNTHETIC-6,DONOR_2523,TREATMENT_11523,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,IU/m2,92.0,100.0
SYNTHETIC-6,DONOR_2524,TREATMENT_11524,Cell-based,Niraparib,8756456,PubChem,IU/m2,114.0,71.0
SYNTHETIC-6,DONOR_2525,TREATMENT_11525,,,,NCI Thesaurus,g/m2,52.0,195.0
SYNTHETIC-6,DONOR_2526,TREATMENT_11526,Immune checkpoint inhibitors,Durvalumab,239766,,IU/kg,187.0,74.0
SYNTHETIC-6,DONOR_2527,TREATMENT_11527,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,NCI Thesaurus,ug/m2,133.0,176.0
SYNTHETIC-6,DONOR_2528,TREATMENT_11528,Other immunomodulatory substances,Ipilimumab,278936,NCI Thesaurus,mg/kg,65.0,98.0
SYNTHETIC-6,DONOR_2529,TREATMENT_11529,Other immunomodulatory substances,Ipilimumab,,,mg/m2,,173.0
SYNTHETIC-6,DONOR_2530,TREATMENT_11530,Other immunomodulatory substances,Perjeta,987654,RxNorm,IU/m2,174.0,121.0
SYNTHETIC-6,DONOR_2531,TREATMENT_11531,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,278936,,g/m2,165.0,
SYNTHETIC-6,DONOR_2532,TREATMENT_11532,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,NCI Thesaurus,,94.0,124.0
SYNTHETIC-6,DONOR_2533,TREATMENT_11533,Other immunomodulatory substances,Adcetris,8836851,PubChem,IU/m2,,184.0
SYNTHETIC-6,DONOR_2534,TREATMENT_11534,Cell-based,Blinatumomab,987654,NCI Thesaurus,IU/m2,190.0,153.0
SYNTHETIC-6,DONOR_2535,TREATMENT_11535,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,RxNorm,mg/m2,160.0,81.0
SYNTHETIC-6,DONOR_2536,TREATMENT_11536,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,8756456,PubChem,mg/kg,53.0,175.0
SYNTHETIC-6,DONOR_2537,TREATMENT_11537,Immune checkpoint inhibitors,Abemaciclib,4459876,RxNorm,IU/m2,154.0,152.0
SYNTHETIC-6,DONOR_2538,TREATMENT_11538,,Atezolizumab,987654,,ug/m2,160.0,
SYNTHETIC-6,DONOR_2539,TREATMENT_11539,Other immunomodulatory substances,Trastuzumab,4459876,,ug/m2,121.0,194.0
SYNTHETIC-6,DONOR_2540,TREATMENT_11540,Other immunomodulatory substances,Alectinib,4459876,RxNorm,IU/m2,195.0,83.0
SYNTHETIC-6,DONOR_2541,TREATMENT_11541,Immune checkpoint inhibitors,Venetoclax,239766,,,,138.0
SYNTHETIC-6,DONOR_2542,TREATMENT_11542,Immune checkpoint inhibitors,Durvalumab,239766,NCI Thesaurus,g/m2,80.0,91.0
SYNTHETIC-6,DONOR_2543,TREATMENT_11543,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8836851,RxNorm,IU/m2,177.0,
SYNTHETIC-6,DONOR_2544,TREATMENT_11544,Immune checkpoint inhibitors,Pembrolizumab,239766,,IU/m2,139.0,152.0
SYNTHETIC-6,DONOR_2545,TREATMENT_11545,Immune checkpoint inhibitors,Gazyva,239766,,g/m2,182.0,147.0
SYNTHETIC-6,DONOR_2546,TREATMENT_11546,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,278936,RxNorm,IU/m2,144.0,164.0
SYNTHETIC-6,DONOR_2547,TREATMENT_11547,Cell-based,Alunbrig,278936,,mg/m2,,52.0
SYNTHETIC-6,DONOR_2548,TREATMENT_11548,Cell-based,Imfinzi,987654,PubChem,ug/m2,163.0,116.0
SYNTHETIC-6,DONOR_2549,TREATMENT_11549,Other immunomodulatory substances,Gilotrif,4459876,RxNorm,ug/m2,130.0,83.0
SYNTHETIC-6,DONOR_2550,TREATMENT_11550,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,NCI Thesaurus,ug/m2,55.0,162.0
SYNTHETIC-6,DONOR_2551,TREATMENT_11551,Immune checkpoint inhibitors,Trametinib,8756456,PubChem,,131.0,50.0
SYNTHETIC-6,DONOR_2552,TREATMENT_11552,Other immunomodulatory substances,Enhertu,987654,PubChem,mg/kg,81.0,150.0
SYNTHETIC-6,DONOR_2553,TREATMENT_11553,Other immunomodulatory substances,Opdivo,278936,PubChem,IU/kg,,63.0
SYNTHETIC-6,DONOR_2554,TREATMENT_11554,Cell-based,Cometriq,239766,RxNorm,g/m2,122.0,173.0
SYNTHETIC-6,DONOR_2555,TREATMENT_11555,Immune checkpoint inhibitors,Yervoy,8756456,RxNorm,,132.0,
SYNTHETIC-6,DONOR_2556,TREATMENT_11556,Cell-based,Belantamab,8836851,,g/m2,200.0,176.0
SYNTHETIC-6,DONOR_2557,TREATMENT_11557,Cell-based,Durvalumab,4459876,PubChem,IU/kg,184.0,53.0
SYNTHETIC-6,DONOR_2558,TREATMENT_11558,Other immunomodulatory substances,Ipilimumab,239766,RxNorm,IU/kg,,99.0
SYNTHETIC-6,DONOR_2559,TREATMENT_11559,Cell-based,Zelboraf,8756456,,IU/m2,70.0,132.0
SYNTHETIC-6,DONOR_2560,TREATMENT_11560,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8756456,RxNorm,mg/m2,78.0,79.0
SYNTHETIC-6,DONOR_2561,TREATMENT_11561,,Opdivo,8836851,RxNorm,IU/m2,56.0,
SYNTHETIC-6,DONOR_2562,TREATMENT_11562,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,RxNorm,IU/kg,155.0,
SYNTHETIC-6,DONOR_2563,TREATMENT_11563,Other immunomodulatory substances,Gilteritinib,278936,,,,64.0
SYNTHETIC-6,DONOR_2564,TREATMENT_11564,Immune checkpoint inhibitors,Yescarta,8756456,RxNorm,IU/kg,165.0,170.0
SYNTHETIC-6,DONOR_2565,TREATMENT_11565,Immune checkpoint inhibitors,Tisagenlecleucel,4459876,PubChem,mg/kg,67.0,
SYNTHETIC-6,DONOR_2566,TREATMENT_11566,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,mg/kg,53.0,145.0
SYNTHETIC-6,DONOR_2567,TREATMENT_11567,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,987654,RxNorm,ug/m2,78.0,150.0
SYNTHETIC-6,DONOR_2568,TREATMENT_11568,Immune checkpoint inhibitors,Alectinib,8756456,PubChem,ug/m2,159.0,
SYNTHETIC-6,DONOR_2569,TREATMENT_11569,Other immunomodulatory substances,Caprelsa,,PubChem,cells/kg,115.0,
SYNTHETIC-6,DONOR_2570,TREATMENT_11570,Immune checkpoint inhibitors,Xalkori,,,mg/kg,,122.0
SYNTHETIC-6,DONOR_2571,TREATMENT_11571,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,cells/kg,,157.0
SYNTHETIC-6,DONOR_2572,TREATMENT_11572,Cell-based,Keytruda,8836851,NCI Thesaurus,IU/m2,117.0,135.0
SYNTHETIC-6,DONOR_2573,TREATMENT_11573,Cell-based,Erlotinib,239766,RxNorm,mg/m2,,199.0
SYNTHETIC-6,DONOR_2574,TREATMENT_11574,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8836851,RxNorm,mg/m2,,87.0
SYNTHETIC-6,DONOR_2575,TREATMENT_11575,Other immunomodulatory substances,Yescarta,239766,RxNorm,IU/kg,120.0,191.0
SYNTHETIC-6,DONOR_2576,TREATMENT_11576,Other immunomodulatory substances,Atezolizumab,278936,NCI Thesaurus,g/m2,164.0,54.0
SYNTHETIC-6,DONOR_2577,TREATMENT_11577,Immune checkpoint inhibitors,Cobimetinib,8836851,RxNorm,IU/kg,183.0,181.0
SYNTHETIC-6,DONOR_2578,TREATMENT_11578,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,mg/m2,68.0,68.0
SYNTHETIC-6,DONOR_2579,TREATMENT_11579,Monoclonal antibodies other than immune checkpoint inhibitors,Zykadia,278936,RxNorm,IU/m2,69.0,125.0
SYNTHETIC-6,DONOR_2580,TREATMENT_11580,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,239766,,g/m2,,
SYNTHETIC-6,DONOR_2581,TREATMENT_11581,Other immunomodulatory substances,Tarceva,278936,NCI Thesaurus,,182.0,
SYNTHETIC-6,DONOR_2582,TREATMENT_11582,Other immunomodulatory substances,Nexavar,278936,RxNorm,mg/m2,179.0,117.0
SYNTHETIC-6,DONOR_2583,TREATMENT_11583,Other immunomodulatory substances,Zykadia,278936,RxNorm,ug/m2,,181.0
SYNTHETIC-6,DONOR_2584,TREATMENT_11584,,Ipilimumab,8836851,PubChem,mg/kg,117.0,132.0
SYNTHETIC-6,DONOR_2585,TREATMENT_11585,Cell-based,Nivolumab,987654,NCI Thesaurus,,168.0,118.0
SYNTHETIC-6,DONOR_2586,TREATMENT_11586,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,4459876,RxNorm,mg/m2,146.0,111.0
SYNTHETIC-6,DONOR_2587,TREATMENT_11587,,Crizotinib,987654,,mg/m2,153.0,94.0
SYNTHETIC-6,DONOR_2588,TREATMENT_11588,Cell-based,Tarceva,239766,NCI Thesaurus,ug/m2,172.0,161.0
SYNTHETIC-6,DONOR_2589,TREATMENT_11589,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,8756456,PubChem,mg/m2,,163.0
SYNTHETIC-6,DONOR_2590,TREATMENT_11590,Immune checkpoint inhibitors,Perjeta,8836851,PubChem,,,195.0
SYNTHETIC-6,DONOR_2591,TREATMENT_11591,Cell-based,Crizotinib,239766,RxNorm,ug/m2,150.0,187.0
SYNTHETIC-6,DONOR_2592,TREATMENT_11592,Other immunomodulatory substances,,278936,,cells/kg,99.0,52.0
SYNTHETIC-6,DONOR_2593,TREATMENT_11593,Immune checkpoint inhibitors,Alunbrig,987654,PubChem,IU/kg,87.0,77.0
SYNTHETIC-6,DONOR_2594,TREATMENT_11594,Immune checkpoint inhibitors,Lenvima,987654,NCI Thesaurus,g/m2,194.0,179.0
SYNTHETIC-6,DONOR_2595,TREATMENT_11595,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,,RxNorm,,143.0,81.0
SYNTHETIC-6,DONOR_2596,TREATMENT_11596,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,987654,RxNorm,mg/m2,165.0,53.0
SYNTHETIC-6,DONOR_2597,TREATMENT_11597,Immune checkpoint inhibitors,Gilteritinib,8836851,RxNorm,cells/kg,119.0,194.0
SYNTHETIC-6,DONOR_2598,TREATMENT_11598,Other immunomodulatory substances,Tisagenlecleucel,278936,PubChem,g/m2,196.0,166.0
SYNTHETIC-6,DONOR_2599,TREATMENT_11599,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,987654,PubChem,IU/m2,,200.0
SYNTHETIC-6,DONOR_2600,TREATMENT_11600,Other immunomodulatory substances,,239766,PubChem,cells/kg,169.0,111.0
SYNTHETIC-6,DONOR_2601,TREATMENT_11601,Other immunomodulatory substances,Lynparza,4459876,RxNorm,ug/m2,139.0,196.0
SYNTHETIC-6,DONOR_2602,TREATMENT_11602,Other immunomodulatory substances,,,RxNorm,,158.0,152.0
SYNTHETIC-6,DONOR_2603,TREATMENT_11603,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,,184.0,101.0
SYNTHETIC-6,DONOR_2604,TREATMENT_11604,Other immunomodulatory substances,,8756456,RxNorm,IU/kg,106.0,195.0
SYNTHETIC-6,DONOR_2605,TREATMENT_11605,Other immunomodulatory substances,Necitumumab,987654,NCI Thesaurus,,190.0,131.0
SYNTHETIC-6,DONOR_2606,TREATMENT_11606,Other immunomodulatory substances,Gilotrif,4459876,RxNorm,mg/kg,62.0,115.0
SYNTHETIC-6,DONOR_2607,TREATMENT_11607,,Ado-trastuzumab emtansine,8836851,PubChem,mg/kg,,196.0
SYNTHETIC-6,DONOR_2608,TREATMENT_11608,Cell-based,Tecentriq,278936,PubChem,,190.0,91.0
SYNTHETIC-6,DONOR_2609,TREATMENT_11609,Other immunomodulatory substances,Ado-trastuzumab emtansine,278936,RxNorm,IU/kg,139.0,147.0
SYNTHETIC-6,DONOR_2610,TREATMENT_11610,Cell-based,,8756456,PubChem,IU/kg,191.0,106.0
SYNTHETIC-6,DONOR_2611,TREATMENT_11611,Immune checkpoint inhibitors,Gefitinib,4459876,NCI Thesaurus,IU/kg,,
SYNTHETIC-6,DONOR_2612,TREATMENT_11612,Immune checkpoint inhibitors,Pembrolizumab,987654,NCI Thesaurus,IU/kg,93.0,180.0
SYNTHETIC-6,DONOR_2613,TREATMENT_11613,Other immunomodulatory substances,Mektovi,987654,NCI Thesaurus,,177.0,153.0
SYNTHETIC-6,DONOR_2614,TREATMENT_11614,Immune checkpoint inhibitors,Cotellic,278936,RxNorm,mg/kg,88.0,
SYNTHETIC-6,DONOR_2615,TREATMENT_11615,Cell-based,,8756456,RxNorm,,,118.0
SYNTHETIC-6,DONOR_2616,TREATMENT_11616,Cell-based,Venclexta,8836851,NCI Thesaurus,IU/kg,91.0,147.0
SYNTHETIC-6,DONOR_2617,TREATMENT_11617,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,239766,NCI Thesaurus,IU/kg,196.0,64.0
SYNTHETIC-6,DONOR_2618,TREATMENT_11618,Cell-based,Ipilimumab,,PubChem,mg/m2,96.0,127.0
SYNTHETIC-6,DONOR_2619,TREATMENT_11619,Other immunomodulatory substances,,278936,NCI Thesaurus,,159.0,158.0
SYNTHETIC-6,DONOR_2620,TREATMENT_11620,Immune checkpoint inhibitors,Nivolumab,4459876,PubChem,g/m2,,
SYNTHETIC-6,DONOR_2621,TREATMENT_11621,Other immunomodulatory substances,Tagrisso,239766,NCI Thesaurus,g/m2,196.0,57.0
SYNTHETIC-6,DONOR_2622,TREATMENT_11622,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8756456,RxNorm,IU/kg,145.0,57.0
SYNTHETIC-6,DONOR_2623,TREATMENT_11623,Other immunomodulatory substances,Zelboraf,987654,RxNorm,g/m2,99.0,177.0
SYNTHETIC-6,DONOR_2624,TREATMENT_11624,Other immunomodulatory substances,Vandetanib,239766,NCI Thesaurus,IU/m2,196.0,145.0
SYNTHETIC-6,DONOR_2625,TREATMENT_11625,Other immunomodulatory substances,Gilotrif,8836851,PubChem,IU/kg,125.0,131.0
SYNTHETIC-6,DONOR_2626,TREATMENT_11626,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,8836851,NCI Thesaurus,IU/kg,62.0,79.0
SYNTHETIC-6,DONOR_2627,TREATMENT_11627,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvima,4459876,NCI Thesaurus,IU/m2,68.0,
SYNTHETIC-6,DONOR_2628,TREATMENT_11628,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,169.0,146.0
SYNTHETIC-6,DONOR_2629,TREATMENT_11629,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,278936,PubChem,g/m2,,86.0
SYNTHETIC-6,DONOR_2630,TREATMENT_11630,Other immunomodulatory substances,Ipilimumab,987654,PubChem,ug/m2,138.0,167.0
SYNTHETIC-6,DONOR_2631,TREATMENT_11631,,,8756456,NCI Thesaurus,ug/m2,98.0,162.0
SYNTHETIC-6,DONOR_2632,TREATMENT_11632,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,,PubChem,mg/kg,174.0,
SYNTHETIC-6,DONOR_2633,TREATMENT_11633,Immune checkpoint inhibitors,,,RxNorm,ug/m2,,183.0
SYNTHETIC-6,DONOR_2634,TREATMENT_11634,Other immunomodulatory substances,Inotuzumab ozogamicin,239766,RxNorm,mg/m2,,
SYNTHETIC-6,DONOR_2635,TREATMENT_11635,Cell-based,Durvalumab,987654,PubChem,IU/m2,196.0,
SYNTHETIC-6,DONOR_2636,TREATMENT_11636,Cell-based,Opdivo,8756456,RxNorm,g/m2,,80.0
SYNTHETIC-6,DONOR_2637,TREATMENT_11637,Other immunomodulatory substances,,4459876,RxNorm,mg/m2,63.0,95.0
SYNTHETIC-6,DONOR_2638,TREATMENT_11638,Other immunomodulatory substances,Cometriq,,NCI Thesaurus,cells/kg,58.0,189.0
SYNTHETIC-6,DONOR_2639,TREATMENT_11639,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,8836851,PubChem,ug/m2,144.0,59.0
SYNTHETIC-6,DONOR_2640,TREATMENT_11640,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,PubChem,mg/kg,106.0,90.0
SYNTHETIC-6,DONOR_2641,TREATMENT_11641,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,NCI Thesaurus,g/m2,57.0,164.0
SYNTHETIC-6,DONOR_2642,TREATMENT_11642,Immune checkpoint inhibitors,Adcetris,8756456,PubChem,g/m2,,174.0
SYNTHETIC-6,DONOR_2643,TREATMENT_11643,Other immunomodulatory substances,Crizotinib,278936,PubChem,g/m2,,138.0
SYNTHETIC-6,DONOR_2644,TREATMENT_11644,Cell-based,Inotuzumab ozogamicin,239766,,ug/m2,174.0,
SYNTHETIC-6,DONOR_2645,TREATMENT_11645,,Ceritinib,8756456,PubChem,mg/m2,130.0,105.0
SYNTHETIC-6,DONOR_2646,TREATMENT_11646,Cell-based,Tecentriq,8756456,RxNorm,IU/kg,94.0,173.0
SYNTHETIC-6,DONOR_2647,TREATMENT_11647,Cell-based,Opdivo,239766,NCI Thesaurus,IU/m2,,114.0
SYNTHETIC-6,DONOR_2648,TREATMENT_11648,Immune checkpoint inhibitors,Rituxan,278936,RxNorm,,,120.0
SYNTHETIC-6,DONOR_2649,TREATMENT_11649,Other immunomodulatory substances,Atezolizumab,8836851,PubChem,,,188.0
SYNTHETIC-6,DONOR_2650,TREATMENT_11650,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,IU/kg,168.0,91.0
SYNTHETIC-6,DONOR_2651,TREATMENT_11651,Other immunomodulatory substances,Mekinist,278936,PubChem,mg/kg,169.0,
SYNTHETIC-6,DONOR_2652,TREATMENT_11652,Immune checkpoint inhibitors,Besponsa,8836851,RxNorm,IU/kg,,173.0
SYNTHETIC-6,DONOR_2653,TREATMENT_11653,Other immunomodulatory substances,,239766,RxNorm,g/m2,,151.0
SYNTHETIC-6,DONOR_2654,TREATMENT_11654,Other immunomodulatory substances,Alunbrig,278936,RxNorm,,105.0,73.0
SYNTHETIC-6,DONOR_2655,TREATMENT_11655,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,239766,NCI Thesaurus,mg/kg,140.0,135.0
SYNTHETIC-6,DONOR_2656,TREATMENT_11656,Other immunomodulatory substances,Lenvatinib,,PubChem,IU/m2,,92.0
SYNTHETIC-6,DONOR_2657,TREATMENT_11657,Other immunomodulatory substances,Opdivo,8756456,,ug/m2,136.0,67.0
SYNTHETIC-6,DONOR_2658,TREATMENT_11658,Other immunomodulatory substances,Tecentriq,278936,NCI Thesaurus,g/m2,164.0,
SYNTHETIC-6,DONOR_2659,TREATMENT_11659,Cell-based,Yervoy,239766,NCI Thesaurus,,94.0,140.0
SYNTHETIC-6,DONOR_2660,TREATMENT_11660,Immune checkpoint inhibitors,Tarceva,987654,PubChem,ug/m2,105.0,
SYNTHETIC-6,DONOR_2661,TREATMENT_11661,Immune checkpoint inhibitors,Brigatinib,278936,NCI Thesaurus,IU/kg,90.0,
SYNTHETIC-6,DONOR_2662,TREATMENT_11662,Immune checkpoint inhibitors,,987654,PubChem,g/m2,134.0,159.0
SYNTHETIC-6,DONOR_2663,TREATMENT_11663,Other immunomodulatory substances,Zykadia,8836851,PubChem,ug/m2,145.0,199.0
SYNTHETIC-6,DONOR_2664,TREATMENT_11664,Immune checkpoint inhibitors,Xalkori,278936,PubChem,ug/m2,100.0,184.0
SYNTHETIC-6,DONOR_2665,TREATMENT_11665,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,4459876,NCI Thesaurus,g/m2,132.0,108.0
SYNTHETIC-6,DONOR_2666,TREATMENT_11666,Immune checkpoint inhibitors,Gilotrif,4459876,RxNorm,ug/m2,62.0,71.0
SYNTHETIC-6,DONOR_2667,TREATMENT_11667,Other immunomodulatory substances,,239766,RxNorm,IU/kg,73.0,
SYNTHETIC-6,DONOR_2668,TREATMENT_11668,Cell-based,Ceritinib,239766,,mg/kg,,152.0
SYNTHETIC-6,DONOR_2669,TREATMENT_11669,Cell-based,Mektovi,4459876,,IU/kg,,183.0
SYNTHETIC-6,DONOR_2670,TREATMENT_11670,,,239766,NCI Thesaurus,mg/m2,95.0,175.0
SYNTHETIC-6,DONOR_2671,TREATMENT_11671,Cell-based,Pertuzumab,239766,PubChem,g/m2,,
SYNTHETIC-6,DONOR_2672,TREATMENT_11672,Other immunomodulatory substances,Lynparza,4459876,PubChem,IU/m2,169.0,132.0
SYNTHETIC-6,DONOR_2673,TREATMENT_11673,Cell-based,Atezolizumab,278936,RxNorm,mg/kg,143.0,124.0
SYNTHETIC-6,DONOR_2674,TREATMENT_11674,Cell-based,Rituxan,239766,PubChem,ug/m2,,
SYNTHETIC-6,DONOR_2675,TREATMENT_11675,Cell-based,Atezolizumab,278936,,IU/m2,147.0,192.0
SYNTHETIC-6,DONOR_2676,TREATMENT_11676,Cell-based,Tecentriq,239766,PubChem,mg/kg,68.0,56.0
SYNTHETIC-6,DONOR_2677,TREATMENT_11677,,Tecentriq,278936,RxNorm,,118.0,104.0
SYNTHETIC-6,DONOR_2678,TREATMENT_11678,Immune checkpoint inhibitors,Tafinlar,239766,RxNorm,g/m2,64.0,136.0
SYNTHETIC-6,DONOR_2679,TREATMENT_11679,Cell-based,Alectinib,278936,PubChem,mg/m2,77.0,55.0
SYNTHETIC-6,DONOR_2680,TREATMENT_11680,Immune checkpoint inhibitors,Tecentriq,4459876,PubChem,IU/m2,79.0,77.0
SYNTHETIC-6,DONOR_2681,TREATMENT_11681,,Zelboraf,278936,PubChem,mg/m2,154.0,
SYNTHETIC-6,DONOR_2682,TREATMENT_11682,Other immunomodulatory substances,Atezolizumab,8836851,NCI Thesaurus,IU/m2,,
SYNTHETIC-6,DONOR_2683,TREATMENT_11683,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,,NCI Thesaurus,g/m2,174.0,97.0
SYNTHETIC-6,DONOR_2684,TREATMENT_11684,Cell-based,Selumitinib,,RxNorm,ug/m2,132.0,
SYNTHETIC-6,DONOR_2685,TREATMENT_11685,Immune checkpoint inhibitors,Osimertinib,4459876,RxNorm,mg/kg,198.0,188.0
SYNTHETIC-6,DONOR_2686,TREATMENT_11686,Other immunomodulatory substances,Tagrisso,,RxNorm,ug/m2,181.0,61.0
SYNTHETIC-6,DONOR_2687,TREATMENT_11687,Other immunomodulatory substances,Ipilimumab,987654,NCI Thesaurus,cells/kg,188.0,167.0
SYNTHETIC-6,DONOR_2688,TREATMENT_11688,Immune checkpoint inhibitors,Perjeta,,RxNorm,cells/kg,111.0,147.0
SYNTHETIC-6,DONOR_2689,TREATMENT_11689,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,8836851,RxNorm,IU/m2,103.0,110.0
SYNTHETIC-6,DONOR_2690,TREATMENT_11690,Cell-based,Rituxan,8756456,,cells/kg,137.0,126.0
SYNTHETIC-6,DONOR_2691,TREATMENT_11691,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,239766,PubChem,mg/kg,71.0,
SYNTHETIC-6,DONOR_2692,TREATMENT_11692,Immune checkpoint inhibitors,Braftovi,987654,NCI Thesaurus,mg/m2,,54.0
SYNTHETIC-6,DONOR_2693,TREATMENT_11693,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,4459876,RxNorm,IU/m2,123.0,
SYNTHETIC-6,DONOR_2694,TREATMENT_11694,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,987654,NCI Thesaurus,,121.0,173.0
SYNTHETIC-6,DONOR_2695,TREATMENT_11695,Immune checkpoint inhibitors,Inotuzumab ozogamicin,8756456,PubChem,g/m2,183.0,
SYNTHETIC-6,DONOR_2696,TREATMENT_11696,Other immunomodulatory substances,Trastuzumab,8836851,,mg/kg,129.0,
SYNTHETIC-6,DONOR_2697,TREATMENT_11697,Cell-based,Brigatinib,987654,RxNorm,IU/m2,,87.0
SYNTHETIC-6,DONOR_2698,TREATMENT_11698,Immune checkpoint inhibitors,Nivolumab,278936,NCI Thesaurus,,88.0,189.0
SYNTHETIC-6,DONOR_2699,TREATMENT_11699,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,239766,PubChem,,51.0,
SYNTHETIC-6,DONOR_2700,TREATMENT_11700,Cell-based,Necitumumab,278936,NCI Thesaurus,ug/m2,51.0,66.0
SYNTHETIC-6,DONOR_2701,TREATMENT_11701,Immune checkpoint inhibitors,Mekinist,,,g/m2,119.0,93.0
SYNTHETIC-6,DONOR_2702,TREATMENT_11702,Other immunomodulatory substances,Imfinzi,987654,NCI Thesaurus,,60.0,114.0
SYNTHETIC-6,DONOR_2703,TREATMENT_11703,Other immunomodulatory substances,Vemurafenib,239766,NCI Thesaurus,cells/kg,,197.0
SYNTHETIC-6,DONOR_2704,TREATMENT_11704,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,987654,PubChem,mg/m2,,188.0
SYNTHETIC-6,DONOR_2705,TREATMENT_11705,Other immunomodulatory substances,Enhertu,239766,RxNorm,,115.0,79.0
SYNTHETIC-6,DONOR_2706,TREATMENT_11706,Other immunomodulatory substances,Atezolizumab,8756456,,IU/m2,133.0,89.0
SYNTHETIC-6,DONOR_2707,TREATMENT_11707,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,4459876,RxNorm,IU/m2,199.0,
SYNTHETIC-6,DONOR_2708,TREATMENT_11708,Other immunomodulatory substances,Lenvatinib,8756456,NCI Thesaurus,mg/m2,117.0,64.0
SYNTHETIC-6,DONOR_2709,TREATMENT_11709,Cell-based,,8756456,,,96.0,
SYNTHETIC-6,DONOR_2710,TREATMENT_11710,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,NCI Thesaurus,IU/m2,127.0,63.0
SYNTHETIC-6,DONOR_2711,TREATMENT_11711,Other immunomodulatory substances,Keytruda,278936,NCI Thesaurus,ug/m2,,114.0
SYNTHETIC-6,DONOR_2712,TREATMENT_11712,Immune checkpoint inhibitors,Pexidartinib,987654,RxNorm,,121.0,172.0
SYNTHETIC-6,DONOR_2713,TREATMENT_11713,Other immunomodulatory substances,Xalkori,,,IU/m2,56.0,58.0
SYNTHETIC-6,DONOR_2714,TREATMENT_11714,Cell-based,,278936,PubChem,cells/kg,72.0,92.0
SYNTHETIC-6,DONOR_2715,TREATMENT_11715,Other immunomodulatory substances,Kisqali,4459876,PubChem,,61.0,118.0
SYNTHETIC-6,DONOR_2716,TREATMENT_11716,Cell-based,Perjeta,8836851,NCI Thesaurus,IU/kg,81.0,77.0
SYNTHETIC-6,DONOR_2717,TREATMENT_11717,Immune checkpoint inhibitors,Nexavar,,NCI Thesaurus,g/m2,51.0,60.0
SYNTHETIC-6,DONOR_2718,TREATMENT_11718,,Selumitinib,8836851,PubChem,IU/m2,182.0,55.0
SYNTHETIC-6,DONOR_2719,TREATMENT_11719,Immune checkpoint inhibitors,Blincyto,239766,NCI Thesaurus,mg/m2,,62.0
SYNTHETIC-6,DONOR_2720,TREATMENT_11720,,Ipilimumab,,PubChem,IU/kg,105.0,52.0
SYNTHETIC-6,DONOR_2721,TREATMENT_11721,,Rituximab,8836851,PubChem,IU/kg,70.0,63.0
SYNTHETIC-6,DONOR_2722,TREATMENT_11722,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,,PubChem,g/m2,151.0,
SYNTHETIC-6,DONOR_2723,TREATMENT_11723,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,278936,NCI Thesaurus,cells/kg,53.0,
SYNTHETIC-6,DONOR_2724,TREATMENT_11724,Cell-based,,987654,PubChem,IU/kg,128.0,154.0
SYNTHETIC-6,DONOR_2725,TREATMENT_11725,Immune checkpoint inhibitors,Lynparza,278936,RxNorm,,189.0,164.0
SYNTHETIC-6,DONOR_2726,TREATMENT_11726,Cell-based,Caprelsa,4459876,,IU/m2,,141.0
SYNTHETIC-6,DONOR_2727,TREATMENT_11727,Cell-based,Osimertinib,239766,PubChem,IU/m2,195.0,122.0
SYNTHETIC-6,DONOR_2728,TREATMENT_11728,Immune checkpoint inhibitors,Opdivo,8836851,NCI Thesaurus,ug/m2,190.0,
SYNTHETIC-6,DONOR_2729,TREATMENT_11729,Cell-based,Copanlisib,278936,NCI Thesaurus,cells/kg,102.0,121.0
SYNTHETIC-6,DONOR_2730,TREATMENT_11730,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,ug/m2,166.0,
SYNTHETIC-6,DONOR_2731,TREATMENT_11731,Immune checkpoint inhibitors,Yervoy,4459876,RxNorm,,59.0,119.0
SYNTHETIC-6,DONOR_2732,TREATMENT_11732,Cell-based,Atezolizumab,239766,RxNorm,cells/kg,101.0,89.0
SYNTHETIC-6,DONOR_2733,TREATMENT_11733,,Iressa,987654,PubChem,IU/kg,102.0,69.0
SYNTHETIC-6,DONOR_2734,TREATMENT_11734,Cell-based,Cometriq,8756456,PubChem,g/m2,90.0,106.0
SYNTHETIC-6,DONOR_2735,TREATMENT_11735,Other immunomodulatory substances,Yervoy,8836851,NCI Thesaurus,g/m2,95.0,
SYNTHETIC-6,DONOR_2736,TREATMENT_11736,Immune checkpoint inhibitors,Mektovi,,PubChem,ug/m2,69.0,
SYNTHETIC-6,DONOR_2737,TREATMENT_11737,Immune checkpoint inhibitors,Belantamab,8836851,,cells/kg,110.0,156.0
SYNTHETIC-6,DONOR_2738,TREATMENT_11738,Immune checkpoint inhibitors,Herceptin,8836851,NCI Thesaurus,,159.0,165.0
SYNTHETIC-6,DONOR_2739,TREATMENT_11739,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,278936,PubChem,cells/kg,119.0,148.0
SYNTHETIC-6,DONOR_2740,TREATMENT_11740,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,PubChem,IU/m2,68.0,131.0
SYNTHETIC-6,DONOR_2741,TREATMENT_11741,Immune checkpoint inhibitors,Pembrolizumab,4459876,RxNorm,IU/m2,77.0,183.0
SYNTHETIC-6,DONOR_2742,TREATMENT_11742,Immune checkpoint inhibitors,Cometriq,987654,PubChem,,,120.0
SYNTHETIC-6,DONOR_2743,TREATMENT_11743,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8836851,RxNorm,,67.0,151.0
SYNTHETIC-6,DONOR_2744,TREATMENT_11744,Other immunomodulatory substances,Tagrisso,4459876,NCI Thesaurus,IU/m2,140.0,72.0
SYNTHETIC-6,DONOR_2745,TREATMENT_11745,,Obinutuzumab,987654,PubChem,IU/kg,191.0,141.0
SYNTHETIC-6,DONOR_2746,TREATMENT_11746,Other immunomodulatory substances,,4459876,PubChem,,126.0,
SYNTHETIC-6,DONOR_2747,TREATMENT_11747,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,987654,PubChem,mg/kg,75.0,
SYNTHETIC-6,DONOR_2748,TREATMENT_11748,Cell-based,Selumitinib,,RxNorm,cells/kg,135.0,163.0
SYNTHETIC-6,DONOR_2749,TREATMENT_11749,Immune checkpoint inhibitors,,4459876,,mg/m2,50.0,
SYNTHETIC-6,DONOR_2750,TREATMENT_11750,Cell-based,Pembrolizumab,239766,NCI Thesaurus,ug/m2,192.0,169.0
SYNTHETIC-6,DONOR_2751,TREATMENT_11751,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,987654,,cells/kg,63.0,107.0
SYNTHETIC-6,DONOR_2752,TREATMENT_11752,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,8836851,RxNorm,g/m2,176.0,147.0
SYNTHETIC-6,DONOR_2753,TREATMENT_11753,Other immunomodulatory substances,Pembrolizumab,8756456,NCI Thesaurus,IU/m2,61.0,161.0
SYNTHETIC-6,DONOR_2754,TREATMENT_11754,Cell-based,Brentuximab vedotin,239766,NCI Thesaurus,IU/m2,73.0,167.0
SYNTHETIC-6,DONOR_2755,TREATMENT_11755,Other immunomodulatory substances,Lenvatinib,987654,PubChem,g/m2,,162.0
SYNTHETIC-6,DONOR_2756,TREATMENT_11756,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,8836851,NCI Thesaurus,cells/kg,174.0,142.0
SYNTHETIC-6,DONOR_2757,TREATMENT_11757,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,278936,,IU/m2,157.0,68.0
SYNTHETIC-6,DONOR_2758,TREATMENT_11758,Immune checkpoint inhibitors,Cobimetinib,987654,RxNorm,mg/kg,181.0,
SYNTHETIC-6,DONOR_2759,TREATMENT_11759,Cell-based,Trastuzumab,4459876,PubChem,IU/m2,109.0,118.0
SYNTHETIC-6,DONOR_2760,TREATMENT_11760,Immune checkpoint inhibitors,Sorafenib,239766,RxNorm,IU/kg,143.0,163.0
SYNTHETIC-6,DONOR_2761,TREATMENT_11761,,Pertuzumab,4459876,PubChem,ug/m2,132.0,108.0
SYNTHETIC-6,DONOR_2762,TREATMENT_11762,Cell-based,Caprelsa,8836851,NCI Thesaurus,cells/kg,52.0,140.0
SYNTHETIC-6,DONOR_2763,TREATMENT_11763,Other immunomodulatory substances,Yescarta,4459876,,mg/m2,173.0,149.0
SYNTHETIC-6,DONOR_2764,TREATMENT_11764,Other immunomodulatory substances,Atezolizumab,987654,NCI Thesaurus,mg/kg,139.0,182.0
SYNTHETIC-6,DONOR_2765,TREATMENT_11765,Immune checkpoint inhibitors,Kisqali,278936,RxNorm,ug/m2,131.0,
SYNTHETIC-6,DONOR_2766,TREATMENT_11766,,Nivolumab,278936,RxNorm,IU/kg,115.0,115.0
SYNTHETIC-6,DONOR_2767,TREATMENT_11767,Cell-based,Venetoclax,4459876,NCI Thesaurus,,,180.0
SYNTHETIC-6,DONOR_2768,TREATMENT_11768,,Vandetanib,8756456,NCI Thesaurus,IU/kg,181.0,
SYNTHETIC-6,DONOR_2769,TREATMENT_11769,Other immunomodulatory substances,,,NCI Thesaurus,mg/kg,95.0,186.0
SYNTHETIC-6,DONOR_2770,TREATMENT_11770,Cell-based,Tafinlar,4459876,NCI Thesaurus,cells/kg,167.0,108.0
SYNTHETIC-6,DONOR_2771,TREATMENT_11771,,Mektovi,239766,,,119.0,66.0
SYNTHETIC-6,DONOR_2772,TREATMENT_11772,Cell-based,Besponsa,239766,PubChem,mg/kg,,61.0
SYNTHETIC-6,DONOR_2773,TREATMENT_11773,Cell-based,Caprelsa,987654,RxNorm,g/m2,58.0,
SYNTHETIC-6,DONOR_2774,TREATMENT_11774,Cell-based,Imfinzi,8836851,,mg/m2,187.0,164.0
SYNTHETIC-6,DONOR_2775,TREATMENT_11775,Other immunomodulatory substances,Atezolizumab,987654,RxNorm,g/m2,134.0,112.0
SYNTHETIC-6,DONOR_2776,TREATMENT_11776,Immune checkpoint inhibitors,Verzenio,,NCI Thesaurus,ug/m2,188.0,148.0
SYNTHETIC-6,DONOR_2777,TREATMENT_11777,Immune checkpoint inhibitors,Zelboraf,8756456,NCI Thesaurus,g/m2,,141.0
SYNTHETIC-6,DONOR_2778,TREATMENT_11778,Cell-based,Trametinib,4459876,PubChem,g/m2,67.0,168.0
SYNTHETIC-6,DONOR_2779,TREATMENT_11779,Monoclonal antibodies other than immune checkpoint inhibitors,Inotuzumab ozogamicin,8836851,RxNorm,ug/m2,78.0,105.0
SYNTHETIC-6,DONOR_2780,TREATMENT_11780,Other immunomodulatory substances,Crizotinib,8756456,NCI Thesaurus,ug/m2,55.0,172.0
SYNTHETIC-6,DONOR_2781,TREATMENT_11781,,Ado-trastuzumab emtansine,,RxNorm,mg/kg,79.0,106.0
SYNTHETIC-6,DONOR_2782,TREATMENT_11782,Cell-based,Erlotinib,,NCI Thesaurus,g/m2,146.0,130.0
SYNTHETIC-6,DONOR_2783,TREATMENT_11783,Other immunomodulatory substances,Trastuzumab,278936,NCI Thesaurus,mg/kg,102.0,
SYNTHETIC-6,DONOR_2784,TREATMENT_11784,Immune checkpoint inhibitors,Keytruda,4459876,PubChem,mg/kg,138.0,194.0
SYNTHETIC-6,DONOR_2785,TREATMENT_11785,Immune checkpoint inhibitors,Venclexta,278936,RxNorm,IU/m2,156.0,82.0
SYNTHETIC-6,DONOR_2786,TREATMENT_11786,Immune checkpoint inhibitors,Perjeta,8756456,PubChem,mg/kg,163.0,165.0
SYNTHETIC-6,DONOR_2787,TREATMENT_11787,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,,NCI Thesaurus,mg/kg,,174.0
SYNTHETIC-6,DONOR_2788,TREATMENT_11788,Immune checkpoint inhibitors,Nivolumab,,RxNorm,IU/kg,174.0,
SYNTHETIC-6,DONOR_2789,TREATMENT_11789,,Opdivo,239766,PubChem,mg/kg,163.0,138.0
SYNTHETIC-6,DONOR_2790,TREATMENT_11790,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,,PubChem,IU/m2,,141.0
SYNTHETIC-6,DONOR_2791,TREATMENT_11791,Other immunomodulatory substances,Cometriq,8756456,RxNorm,mg/kg,94.0,148.0
SYNTHETIC-6,DONOR_2792,TREATMENT_11792,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,987654,,IU/kg,100.0,
SYNTHETIC-6,DONOR_2793,TREATMENT_11793,Immune checkpoint inhibitors,Yervoy,8836851,PubChem,IU/kg,95.0,156.0
SYNTHETIC-6,DONOR_2794,TREATMENT_11794,Cell-based,Lenvima,987654,RxNorm,ug/m2,166.0,131.0
SYNTHETIC-6,DONOR_2795,TREATMENT_11795,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,,mg/m2,167.0,101.0
SYNTHETIC-6,DONOR_2796,TREATMENT_11796,Other immunomodulatory substances,Zelboraf,,,,128.0,167.0
SYNTHETIC-6,DONOR_2797,TREATMENT_11797,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,4459876,NCI Thesaurus,,178.0,121.0
SYNTHETIC-6,DONOR_2798,TREATMENT_11798,Immune checkpoint inhibitors,Cometriq,4459876,NCI Thesaurus,IU/kg,145.0,134.0
SYNTHETIC-6,DONOR_2799,TREATMENT_11799,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8756456,RxNorm,IU/kg,59.0,
SYNTHETIC-6,DONOR_2800,TREATMENT_11800,Other immunomodulatory substances,,278936,,mg/m2,156.0,
SYNTHETIC-6,DONOR_2801,TREATMENT_11801,Immune checkpoint inhibitors,Gilteritinib,,RxNorm,IU/m2,93.0,130.0
SYNTHETIC-6,DONOR_2802,TREATMENT_11802,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,IU/m2,111.0,190.0
SYNTHETIC-6,DONOR_2803,TREATMENT_11803,,,239766,RxNorm,cells/kg,63.0,
SYNTHETIC-6,DONOR_2804,TREATMENT_11804,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8756456,PubChem,mg/m2,119.0,
SYNTHETIC-6,DONOR_2805,TREATMENT_11805,Other immunomodulatory substances,Dabrafenib,987654,PubChem,,,137.0
SYNTHETIC-6,DONOR_2806,TREATMENT_11806,Other immunomodulatory substances,Tecentriq,8836851,PubChem,IU/kg,124.0,99.0
SYNTHETIC-6,DONOR_2807,TREATMENT_11807,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,987654,NCI Thesaurus,mg/m2,,89.0
SYNTHETIC-6,DONOR_2808,TREATMENT_11808,Other immunomodulatory substances,Ipilimumab,239766,NCI Thesaurus,,141.0,177.0
SYNTHETIC-6,DONOR_2809,TREATMENT_11809,Other immunomodulatory substances,Mekinist,4459876,PubChem,cells/kg,60.0,95.0
SYNTHETIC-6,DONOR_2810,TREATMENT_11810,Other immunomodulatory substances,,4459876,,,53.0,
SYNTHETIC-6,DONOR_2811,TREATMENT_11811,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,4459876,NCI Thesaurus,,197.0,142.0
SYNTHETIC-6,DONOR_2812,TREATMENT_11812,Other immunomodulatory substances,Inotuzumab ozogamicin,278936,,IU/kg,,53.0
SYNTHETIC-6,DONOR_2813,TREATMENT_11813,Cell-based,Mekinist,4459876,NCI Thesaurus,cells/kg,120.0,62.0
SYNTHETIC-6,DONOR_2814,TREATMENT_11814,Immune checkpoint inhibitors,Keytruda,,PubChem,IU/m2,165.0,
SYNTHETIC-6,DONOR_2815,TREATMENT_11815,Other immunomodulatory substances,,8836851,NCI Thesaurus,g/m2,84.0,159.0
SYNTHETIC-6,DONOR_2816,TREATMENT_11816,Immune checkpoint inhibitors,Belantamab,,RxNorm,,,
SYNTHETIC-6,DONOR_2817,TREATMENT_11817,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,,PubChem,mg/m2,187.0,108.0
SYNTHETIC-6,DONOR_2818,TREATMENT_11818,Other immunomodulatory substances,Yervoy,8836851,PubChem,IU/m2,69.0,
SYNTHETIC-6,DONOR_2819,TREATMENT_11819,,Vemurafenib,239766,PubChem,IU/kg,88.0,63.0
SYNTHETIC-6,DONOR_2820,TREATMENT_11820,Cell-based,Perjeta,8756456,PubChem,mg/m2,137.0,186.0
SYNTHETIC-6,DONOR_2821,TREATMENT_11821,,Ibrance,8836851,RxNorm,,66.0,132.0
SYNTHETIC-6,DONOR_2822,TREATMENT_11822,Immune checkpoint inhibitors,,,NCI Thesaurus,mg/kg,111.0,79.0
SYNTHETIC-6,DONOR_2823,TREATMENT_11823,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8836851,NCI Thesaurus,mg/m2,197.0,77.0
SYNTHETIC-6,DONOR_2824,TREATMENT_11824,,Tarceva,4459876,NCI Thesaurus,cells/kg,61.0,153.0
SYNTHETIC-6,DONOR_2825,TREATMENT_11825,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,239766,,ug/m2,105.0,85.0
SYNTHETIC-6,DONOR_2826,TREATMENT_11826,Cell-based,Yervoy,278936,RxNorm,,62.0,119.0
SYNTHETIC-6,DONOR_2827,TREATMENT_11827,Other immunomodulatory substances,Durvalumab,4459876,PubChem,ug/m2,82.0,183.0
SYNTHETIC-6,DONOR_2828,TREATMENT_11828,Other immunomodulatory substances,Niraparib,8756456,RxNorm,IU/kg,72.0,98.0
SYNTHETIC-6,DONOR_2829,TREATMENT_11829,Monoclonal antibodies other than immune checkpoint inhibitors,Copanlisib,987654,NCI Thesaurus,IU/kg,135.0,142.0
SYNTHETIC-6,DONOR_2830,TREATMENT_11830,Other immunomodulatory substances,Tisagenlecleucel,278936,RxNorm,ug/m2,158.0,155.0
SYNTHETIC-6,DONOR_2831,TREATMENT_11831,,Yervoy,8836851,PubChem,,,152.0
SYNTHETIC-6,DONOR_2832,TREATMENT_11832,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,,PubChem,,126.0,62.0
SYNTHETIC-6,DONOR_2833,TREATMENT_11833,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,8836851,RxNorm,,140.0,123.0
SYNTHETIC-6,DONOR_2834,TREATMENT_11834,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,239766,PubChem,IU/m2,148.0,178.0
SYNTHETIC-6,DONOR_2835,TREATMENT_11835,Immune checkpoint inhibitors,Trametinib,8756456,,mg/m2,103.0,63.0
SYNTHETIC-6,DONOR_2836,TREATMENT_11836,,Imfinzi,8756456,RxNorm,IU/m2,59.0,118.0
SYNTHETIC-6,DONOR_2837,TREATMENT_11837,Other immunomodulatory substances,Sorafenib,278936,RxNorm,ug/m2,,123.0
SYNTHETIC-6,DONOR_2838,TREATMENT_11838,Immune checkpoint inhibitors,Dabrafenib,,NCI Thesaurus,IU/kg,176.0,112.0
SYNTHETIC-6,DONOR_2839,TREATMENT_11839,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,987654,NCI Thesaurus,IU/kg,77.0,183.0
SYNTHETIC-6,DONOR_2840,TREATMENT_11840,,Zykadia,,PubChem,,,62.0
SYNTHETIC-6,DONOR_2841,TREATMENT_11841,,Vemurafenib,278936,RxNorm,ug/m2,81.0,162.0
SYNTHETIC-6,DONOR_2842,TREATMENT_11842,Cell-based,Gilotrif,8756456,NCI Thesaurus,mg/kg,87.0,136.0
SYNTHETIC-6,DONOR_2843,TREATMENT_11843,Other immunomodulatory substances,,8836851,RxNorm,cells/kg,71.0,65.0
SYNTHETIC-6,DONOR_2844,TREATMENT_11844,Other immunomodulatory substances,Pembrolizumab,4459876,RxNorm,IU/kg,68.0,175.0
SYNTHETIC-6,DONOR_2845,TREATMENT_11845,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,4459876,RxNorm,,135.0,103.0
SYNTHETIC-6,DONOR_2846,TREATMENT_11846,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,NCI Thesaurus,IU/m2,,116.0
SYNTHETIC-6,DONOR_2847,TREATMENT_11847,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,,PubChem,mg/m2,123.0,195.0
SYNTHETIC-6,DONOR_2848,TREATMENT_11848,Cell-based,Atezolizumab,,PubChem,g/m2,,
SYNTHETIC-6,DONOR_2849,TREATMENT_11849,Immune checkpoint inhibitors,Keytruda,8836851,PubChem,,101.0,
SYNTHETIC-6,DONOR_2850,TREATMENT_11850,,Adcetris,4459876,NCI Thesaurus,IU/m2,145.0,122.0
SYNTHETIC-6,DONOR_2851,TREATMENT_11851,Immune checkpoint inhibitors,Brentuximab vedotin,987654,,g/m2,,88.0
SYNTHETIC-6,DONOR_2852,TREATMENT_11852,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,RxNorm,mg/kg,184.0,100.0
SYNTHETIC-6,DONOR_2853,TREATMENT_11853,Other immunomodulatory substances,Kisqali,4459876,NCI Thesaurus,IU/m2,175.0,147.0
SYNTHETIC-6,DONOR_2854,TREATMENT_11854,Cell-based,,278936,RxNorm,mg/m2,,99.0
SYNTHETIC-6,DONOR_2855,TREATMENT_11855,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,8836851,RxNorm,IU/m2,108.0,169.0
SYNTHETIC-6,DONOR_2856,TREATMENT_11856,Other immunomodulatory substances,Cometriq,8836851,PubChem,ug/m2,,88.0
SYNTHETIC-6,DONOR_2857,TREATMENT_11857,Immune checkpoint inhibitors,Blincyto,4459876,NCI Thesaurus,ug/m2,102.0,161.0
SYNTHETIC-6,DONOR_2858,TREATMENT_11858,Cell-based,Opdivo,987654,,IU/kg,122.0,105.0
SYNTHETIC-6,DONOR_2859,TREATMENT_11859,Immune checkpoint inhibitors,Opdivo,278936,PubChem,mg/kg,75.0,114.0
SYNTHETIC-6,DONOR_2860,TREATMENT_11860,Cell-based,Ipilimumab,8756456,RxNorm,cells/kg,171.0,141.0
SYNTHETIC-6,DONOR_2861,TREATMENT_11861,Immune checkpoint inhibitors,Blincyto,987654,,,,87.0
SYNTHETIC-6,DONOR_2862,TREATMENT_11862,Immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,mg/kg,196.0,147.0
SYNTHETIC-6,DONOR_2863,TREATMENT_11863,Immune checkpoint inhibitors,Trastuzumab,,PubChem,IU/kg,197.0,
SYNTHETIC-6,DONOR_2864,TREATMENT_11864,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,NCI Thesaurus,IU/kg,132.0,167.0
SYNTHETIC-6,DONOR_2865,TREATMENT_11865,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,239766,PubChem,mg/kg,113.0,69.0
SYNTHETIC-6,DONOR_2866,TREATMENT_11866,Other immunomodulatory substances,Yervoy,4459876,PubChem,cells/kg,66.0,116.0
SYNTHETIC-6,DONOR_2867,TREATMENT_11867,Other immunomodulatory substances,Blinatumomab,278936,PubChem,g/m2,176.0,150.0
SYNTHETIC-6,DONOR_2868,TREATMENT_11868,Immune checkpoint inhibitors,Kisqali,239766,NCI Thesaurus,,57.0,
SYNTHETIC-6,DONOR_2869,TREATMENT_11869,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,,RxNorm,IU/kg,,
SYNTHETIC-6,DONOR_2870,TREATMENT_11870,Cell-based,Brigatinib,4459876,PubChem,,66.0,121.0
SYNTHETIC-6,DONOR_2871,TREATMENT_11871,Immune checkpoint inhibitors,Braftovi,278936,PubChem,,162.0,54.0
SYNTHETIC-6,DONOR_2872,TREATMENT_11872,Immune checkpoint inhibitors,Tagrisso,8836851,NCI Thesaurus,cells/kg,,126.0
SYNTHETIC-6,DONOR_2873,TREATMENT_11873,Other immunomodulatory substances,Gazyva,8836851,,mg/m2,71.0,175.0
SYNTHETIC-6,DONOR_2874,TREATMENT_11874,Cell-based,Ipilimumab,278936,RxNorm,IU/m2,,190.0
SYNTHETIC-6,DONOR_2875,TREATMENT_11875,Immune checkpoint inhibitors,Selumitinib,4459876,RxNorm,mg/kg,159.0,101.0
SYNTHETIC-6,DONOR_2876,TREATMENT_11876,Cell-based,Rucaparib,4459876,PubChem,mg/m2,104.0,119.0
SYNTHETIC-6,DONOR_2877,TREATMENT_11877,Cell-based,Venetoclax,4459876,PubChem,ug/m2,140.0,93.0
SYNTHETIC-6,DONOR_2878,TREATMENT_11878,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,239766,PubChem,mg/m2,108.0,121.0
SYNTHETIC-6,DONOR_2879,TREATMENT_11879,Other immunomodulatory substances,Perjeta,8836851,RxNorm,IU/kg,103.0,123.0
SYNTHETIC-6,DONOR_2880,TREATMENT_11880,Immune checkpoint inhibitors,Necitumumab,8836851,NCI Thesaurus,mg/m2,66.0,165.0
SYNTHETIC-6,DONOR_2881,TREATMENT_11881,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,987654,PubChem,mg/kg,80.0,67.0
SYNTHETIC-6,DONOR_2882,TREATMENT_11882,,Ribociclib,4459876,PubChem,IU/kg,81.0,50.0
SYNTHETIC-6,DONOR_2883,TREATMENT_11883,Immune checkpoint inhibitors,Axicabtagene ciloleucel,4459876,NCI Thesaurus,,130.0,140.0
SYNTHETIC-6,DONOR_2884,TREATMENT_11884,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,PubChem,mg/kg,141.0,183.0
SYNTHETIC-6,DONOR_2885,TREATMENT_11885,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,g/m2,168.0,70.0
SYNTHETIC-6,DONOR_2886,TREATMENT_11886,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,,NCI Thesaurus,cells/kg,192.0,144.0
SYNTHETIC-6,DONOR_2887,TREATMENT_11887,Other immunomodulatory substances,Gilteritinib,239766,NCI Thesaurus,cells/kg,120.0,99.0
SYNTHETIC-6,DONOR_2888,TREATMENT_11888,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,,106.0,74.0
SYNTHETIC-6,DONOR_2889,TREATMENT_11889,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,987654,PubChem,IU/kg,180.0,97.0
SYNTHETIC-6,DONOR_2890,TREATMENT_11890,Other immunomodulatory substances,Rubraca,4459876,NCI Thesaurus,,183.0,72.0
SYNTHETIC-6,DONOR_2891,TREATMENT_11891,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,4459876,NCI Thesaurus,,121.0,169.0
SYNTHETIC-6,DONOR_2892,TREATMENT_11892,Cell-based,Xalkori,8756456,PubChem,g/m2,,135.0
SYNTHETIC-6,DONOR_2893,TREATMENT_11893,Cell-based,Tarceva,987654,NCI Thesaurus,g/m2,84.0,182.0
SYNTHETIC-6,DONOR_2894,TREATMENT_11894,,Daratumumab,239766,,cells/kg,149.0,56.0
SYNTHETIC-6,DONOR_2895,TREATMENT_11895,Immune checkpoint inhibitors,Darzalex,8756456,NCI Thesaurus,cells/kg,69.0,179.0
SYNTHETIC-6,DONOR_2896,TREATMENT_11896,Other immunomodulatory substances,Atezolizumab,278936,PubChem,mg/kg,185.0,60.0
SYNTHETIC-6,DONOR_2897,TREATMENT_11897,Immune checkpoint inhibitors,Imfinzi,8836851,NCI Thesaurus,cells/kg,188.0,124.0
SYNTHETIC-6,DONOR_2898,TREATMENT_11898,Immune checkpoint inhibitors,Besponsa,8836851,PubChem,mg/kg,,78.0
SYNTHETIC-6,DONOR_2899,TREATMENT_11899,Immune checkpoint inhibitors,Binimetinib,987654,RxNorm,mg/m2,97.0,79.0
SYNTHETIC-6,DONOR_2900,TREATMENT_11900,Monoclonal antibodies other than immune checkpoint inhibitors,Gilteritinib,8756456,RxNorm,mg/kg,165.0,146.0
SYNTHETIC-6,DONOR_2901,TREATMENT_11901,Other immunomodulatory substances,Rubraca,239766,RxNorm,cells/kg,178.0,134.0
SYNTHETIC-6,DONOR_2902,TREATMENT_11902,Cell-based,Niraparib,8756456,NCI Thesaurus,mg/kg,124.0,90.0
SYNTHETIC-6,DONOR_2903,TREATMENT_11903,,Opdivo,8756456,RxNorm,g/m2,183.0,66.0
SYNTHETIC-6,DONOR_2904,TREATMENT_11904,Immune checkpoint inhibitors,Nivolumab,8756456,,mg/m2,106.0,125.0
SYNTHETIC-6,DONOR_2905,TREATMENT_11905,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8836851,PubChem,mg/m2,115.0,184.0
SYNTHETIC-6,DONOR_2906,TREATMENT_11906,Cell-based,Verzenio,987654,PubChem,mg/m2,57.0,74.0
SYNTHETIC-6,DONOR_2907,TREATMENT_11907,Cell-based,Yervoy,987654,PubChem,mg/m2,125.0,133.0
SYNTHETIC-6,DONOR_2908,TREATMENT_11908,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8756456,PubChem,g/m2,112.0,81.0
SYNTHETIC-6,DONOR_2909,TREATMENT_11909,Other immunomodulatory substances,Axicabtagene ciloleucel,4459876,NCI Thesaurus,,107.0,59.0
SYNTHETIC-6,DONOR_2910,TREATMENT_11910,Immune checkpoint inhibitors,Mektovi,8756456,,ug/m2,120.0,119.0
SYNTHETIC-6,DONOR_2911,TREATMENT_11911,Cell-based,Daratumumab,8836851,NCI Thesaurus,,151.0,146.0
SYNTHETIC-6,DONOR_2912,TREATMENT_11912,Cell-based,,987654,PubChem,ug/m2,142.0,
SYNTHETIC-6,DONOR_2913,TREATMENT_11913,,Ipilimumab,4459876,NCI Thesaurus,,74.0,55.0
SYNTHETIC-6,DONOR_2914,TREATMENT_11914,Cell-based,Alecensa,,NCI Thesaurus,cells/kg,141.0,189.0
SYNTHETIC-6,DONOR_2915,TREATMENT_11915,Immune checkpoint inhibitors,Brigatinib,987654,RxNorm,cells/kg,97.0,178.0
SYNTHETIC-6,DONOR_2916,TREATMENT_11916,Cell-based,Herceptin,8836851,PubChem,,190.0,73.0
SYNTHETIC-6,DONOR_2917,TREATMENT_11917,Other immunomodulatory substances,,239766,NCI Thesaurus,ug/m2,145.0,
SYNTHETIC-6,DONOR_2918,TREATMENT_11918,Cell-based,Cobimetinib,987654,RxNorm,IU/m2,155.0,153.0
SYNTHETIC-6,DONOR_2919,TREATMENT_11919,Immune checkpoint inhibitors,Ipilimumab,987654,RxNorm,mg/m2,126.0,54.0
SYNTHETIC-6,DONOR_2920,TREATMENT_11920,Other immunomodulatory substances,Daratumumab,8836851,NCI Thesaurus,,110.0,
SYNTHETIC-6,DONOR_2921,TREATMENT_11921,,Tecentriq,278936,NCI Thesaurus,cells/kg,191.0,159.0
SYNTHETIC-6,DONOR_2922,TREATMENT_11922,Other immunomodulatory substances,Sorafenib,8756456,RxNorm,mg/m2,,189.0
SYNTHETIC-6,DONOR_2923,TREATMENT_11923,Cell-based,Blinatumomab,4459876,NCI Thesaurus,IU/kg,194.0,147.0
SYNTHETIC-6,DONOR_2924,TREATMENT_11924,Cell-based,Nivolumab,8756456,PubChem,mg/m2,,152.0
SYNTHETIC-6,DONOR_2925,TREATMENT_11925,,Caprelsa,987654,RxNorm,mg/m2,,126.0
SYNTHETIC-6,DONOR_2926,TREATMENT_11926,Other immunomodulatory substances,Rituximab,4459876,RxNorm,IU/kg,125.0,
SYNTHETIC-6,DONOR_2927,TREATMENT_11927,Immune checkpoint inhibitors,Pertuzumab,239766,NCI Thesaurus,,126.0,142.0
SYNTHETIC-6,DONOR_2928,TREATMENT_11928,Cell-based,Imfinzi,8756456,NCI Thesaurus,,193.0,
SYNTHETIC-6,DONOR_2929,TREATMENT_11929,Other immunomodulatory substances,,278936,NCI Thesaurus,g/m2,187.0,58.0
SYNTHETIC-6,DONOR_2930,TREATMENT_11930,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,NCI Thesaurus,mg/m2,163.0,113.0
SYNTHETIC-6,DONOR_2931,TREATMENT_11931,Cell-based,Brentuximab vedotin,239766,PubChem,mg/m2,109.0,184.0
SYNTHETIC-6,DONOR_2932,TREATMENT_11932,,,4459876,PubChem,mg/m2,146.0,116.0
SYNTHETIC-6,DONOR_2933,TREATMENT_11933,Cell-based,Ipilimumab,278936,RxNorm,IU/kg,191.0,72.0
SYNTHETIC-6,DONOR_2934,TREATMENT_11934,Immune checkpoint inhibitors,Tisagenlecleucel,278936,NCI Thesaurus,ug/m2,61.0,122.0
SYNTHETIC-6,DONOR_2935,TREATMENT_11935,Cell-based,Gazyva,8756456,NCI Thesaurus,mg/m2,56.0,170.0
SYNTHETIC-6,DONOR_2936,TREATMENT_11936,,Nivolumab,4459876,RxNorm,IU/kg,192.0,157.0
SYNTHETIC-6,DONOR_2937,TREATMENT_11937,Immune checkpoint inhibitors,Kymriah,278936,NCI Thesaurus,IU/m2,,145.0
SYNTHETIC-6,DONOR_2938,TREATMENT_11938,,Opdivo,239766,PubChem,cells/kg,56.0,86.0
SYNTHETIC-6,DONOR_2939,TREATMENT_11939,Cell-based,Pembrolizumab,987654,PubChem,g/m2,85.0,171.0
SYNTHETIC-6,DONOR_2940,TREATMENT_11940,,Selumitinib,,PubChem,,83.0,95.0
SYNTHETIC-6,DONOR_2941,TREATMENT_11941,Immune checkpoint inhibitors,Selumitinib,8836851,NCI Thesaurus,g/m2,,142.0
SYNTHETIC-6,DONOR_2942,TREATMENT_11942,,Copanlisib,278936,RxNorm,,,71.0
SYNTHETIC-6,DONOR_2943,TREATMENT_11943,Other immunomodulatory substances,Alectinib,4459876,NCI Thesaurus,IU/kg,138.0,
SYNTHETIC-6,DONOR_2944,TREATMENT_11944,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,987654,RxNorm,cells/kg,70.0,70.0
SYNTHETIC-6,DONOR_2945,TREATMENT_11945,Other immunomodulatory substances,Rituximab,278936,PubChem,IU/kg,108.0,124.0
SYNTHETIC-6,DONOR_2946,TREATMENT_11946,Cell-based,Durvalumab,,RxNorm,g/m2,136.0,183.0
SYNTHETIC-6,DONOR_2947,TREATMENT_11947,,Yescarta,8756456,RxNorm,mg/kg,99.0,176.0
SYNTHETIC-6,DONOR_2948,TREATMENT_11948,Cell-based,Lenvatinib,239766,NCI Thesaurus,g/m2,88.0,63.0
SYNTHETIC-6,DONOR_2949,TREATMENT_11949,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,161.0,176.0
SYNTHETIC-6,DONOR_2950,TREATMENT_11950,Cell-based,Nivolumab,987654,PubChem,mg/m2,,66.0
SYNTHETIC-6,DONOR_2951,TREATMENT_11951,Cell-based,Yervoy,278936,NCI Thesaurus,IU/kg,,84.0
SYNTHETIC-6,DONOR_2952,TREATMENT_11952,Cell-based,,4459876,NCI Thesaurus,g/m2,,109.0
SYNTHETIC-6,DONOR_2953,TREATMENT_11953,Cell-based,Tecentriq,987654,PubChem,cells/kg,62.0,181.0
SYNTHETIC-6,DONOR_2954,TREATMENT_11954,Immune checkpoint inhibitors,Crizotinib,987654,PubChem,,152.0,131.0
SYNTHETIC-6,DONOR_2955,TREATMENT_11955,Monoclonal antibodies other than immune checkpoint inhibitors,Rituxan,8836851,,IU/m2,82.0,84.0
SYNTHETIC-6,DONOR_2956,TREATMENT_11956,Immune checkpoint inhibitors,Trametinib,8756456,PubChem,ug/m2,157.0,103.0
SYNTHETIC-6,DONOR_2957,TREATMENT_11957,Other immunomodulatory substances,Nexavar,239766,NCI Thesaurus,IU/m2,145.0,
SYNTHETIC-6,DONOR_2958,TREATMENT_11958,,Gilteritinib,8836851,NCI Thesaurus,IU/m2,157.0,64.0
SYNTHETIC-6,DONOR_2959,TREATMENT_11959,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8756456,,mg/m2,,80.0
SYNTHETIC-6,DONOR_2960,TREATMENT_11960,Immune checkpoint inhibitors,Atezolizumab,8836851,PubChem,mg/kg,,80.0
SYNTHETIC-6,DONOR_2961,TREATMENT_11961,Cell-based,Durvalumab,4459876,NCI Thesaurus,IU/m2,114.0,77.0
SYNTHETIC-6,DONOR_2962,TREATMENT_11962,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,987654,PubChem,cells/kg,111.0,59.0
SYNTHETIC-6,DONOR_2963,TREATMENT_11963,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,987654,RxNorm,,,
SYNTHETIC-6,DONOR_2964,TREATMENT_11964,Cell-based,,987654,NCI Thesaurus,mg/kg,150.0,113.0
SYNTHETIC-6,DONOR_2965,TREATMENT_11965,Immune checkpoint inhibitors,Kadcyla,4459876,NCI Thesaurus,,88.0,155.0
SYNTHETIC-6,DONOR_2966,TREATMENT_11966,Other immunomodulatory substances,Vandetanib,4459876,NCI Thesaurus,cells/kg,167.0,
SYNTHETIC-6,DONOR_2967,TREATMENT_11967,Cell-based,Alecensa,8756456,RxNorm,cells/kg,177.0,
SYNTHETIC-6,DONOR_2968,TREATMENT_11968,Cell-based,Ipilimumab,278936,NCI Thesaurus,cells/kg,168.0,124.0
SYNTHETIC-6,DONOR_2969,TREATMENT_11969,,Rubraca,239766,,IU/m2,166.0,72.0
SYNTHETIC-6,DONOR_2970,TREATMENT_11970,,,278936,NCI Thesaurus,mg/kg,,149.0
SYNTHETIC-6,DONOR_2971,TREATMENT_11971,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,278936,,,84.0,115.0
SYNTHETIC-6,DONOR_2972,TREATMENT_11972,Other immunomodulatory substances,,4459876,RxNorm,,199.0,153.0
SYNTHETIC-6,DONOR_2973,TREATMENT_11973,Other immunomodulatory substances,Ribociclib,239766,RxNorm,ug/m2,189.0,108.0
SYNTHETIC-6,DONOR_2974,TREATMENT_11974,Cell-based,Trastuzumab,4459876,PubChem,mg/m2,,167.0
SYNTHETIC-6,DONOR_2975,TREATMENT_11975,Other immunomodulatory substances,Gilteritinib,,RxNorm,IU/kg,,179.0
SYNTHETIC-6,DONOR_2976,TREATMENT_11976,Cell-based,,278936,PubChem,mg/m2,66.0,149.0
SYNTHETIC-6,DONOR_2977,TREATMENT_11977,Other immunomodulatory substances,Blincyto,278936,NCI Thesaurus,mg/m2,109.0,
SYNTHETIC-6,DONOR_2978,TREATMENT_11978,Cell-based,Dabrafenib,8836851,PubChem,mg/kg,61.0,130.0
SYNTHETIC-6,DONOR_2979,TREATMENT_11979,Other immunomodulatory substances,Axicabtagene ciloleucel,278936,PubChem,IU/kg,,184.0
SYNTHETIC-6,DONOR_2980,TREATMENT_11980,Other immunomodulatory substances,Nexavar,8756456,RxNorm,g/m2,144.0,128.0
SYNTHETIC-6,DONOR_2981,TREATMENT_11981,Cell-based,Tagrisso,278936,PubChem,,171.0,62.0
SYNTHETIC-6,DONOR_2982,TREATMENT_11982,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,278936,RxNorm,IU/kg,199.0,52.0
SYNTHETIC-6,DONOR_2983,TREATMENT_11983,Immune checkpoint inhibitors,Abemaciclib,987654,,IU/m2,142.0,110.0
SYNTHETIC-6,DONOR_2984,TREATMENT_11984,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,4459876,,,98.0,156.0
SYNTHETIC-6,DONOR_2985,TREATMENT_11985,,Gefitinib,,NCI Thesaurus,IU/m2,180.0,
SYNTHETIC-6,DONOR_2986,TREATMENT_11986,Other immunomodulatory substances,Tafinlar,987654,NCI Thesaurus,IU/m2,84.0,77.0
SYNTHETIC-6,DONOR_2987,TREATMENT_11987,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,PubChem,mg/kg,50.0,183.0
SYNTHETIC-6,DONOR_2988,TREATMENT_11988,Immune checkpoint inhibitors,,8756456,NCI Thesaurus,cells/kg,83.0,102.0
SYNTHETIC-6,DONOR_2989,TREATMENT_11989,Immune checkpoint inhibitors,Durvalumab,8836851,RxNorm,mg/m2,109.0,
SYNTHETIC-6,DONOR_2990,TREATMENT_11990,Immune checkpoint inhibitors,Obinutuzumab,,NCI Thesaurus,mg/kg,148.0,147.0
SYNTHETIC-6,DONOR_2991,TREATMENT_11991,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,4459876,NCI Thesaurus,,168.0,
SYNTHETIC-6,DONOR_2992,TREATMENT_11992,Cell-based,Ipilimumab,4459876,RxNorm,cells/kg,69.0,184.0
SYNTHETIC-6,DONOR_2993,TREATMENT_11993,Immune checkpoint inhibitors,,,RxNorm,mg/kg,115.0,135.0
SYNTHETIC-6,DONOR_2994,TREATMENT_11994,Cell-based,Blincyto,239766,NCI Thesaurus,mg/m2,168.0,131.0
SYNTHETIC-6,DONOR_2995,TREATMENT_11995,Immune checkpoint inhibitors,Cobimetinib,239766,RxNorm,ug/m2,114.0,128.0
SYNTHETIC-6,DONOR_2996,TREATMENT_11996,Monoclonal antibodies other than immune checkpoint inhibitors,Darzalex,8836851,PubChem,ug/m2,200.0,192.0
SYNTHETIC-6,DONOR_2997,TREATMENT_11997,Cell-based,Encorafenib,8836851,NCI Thesaurus,IU/m2,176.0,179.0
SYNTHETIC-6,DONOR_2998,TREATMENT_11998,Immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,IU/m2,172.0,181.0
SYNTHETIC-6,DONOR_2999,TREATMENT_11999,Cell-based,Crizotinib,8836851,RxNorm,g/m2,102.0,98.0
SYNTHETIC-6,DONOR_3000,TREATMENT_12000,Immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,IU/m2,55.0,64.0
SYNTHETIC-2,DONOR_NULL,TREATMENT_2a,Other immunomodulatory substances,,,,,,
SYNTHETIC-2,DONOR_NULL,TREATMENT_2a,,Nivolumab,987654,PubChem,,,
SYNTHETIC-2,DONOR_NULL,TREATMENT_1a,,,,,mg/kg,,
SYNTHETIC-2,DONOR_ALL_01,TREATMENT_ALL_01,Other immunomodulatory substances,Braftovi,2049112,RxNorm,ug/m2,133.0,100.0
